data_1s6i_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1s6i _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.4 tp . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.516 0.198 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.728 ' HB3' ' HZ1' ' A' ' 13' ' ' LYS . 6.3 ttpm? -55.83 -30.93 62.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.752 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 8.1 mp0 -76.97 -38.3 53.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.959 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.725 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 54.5 tp -55.01 -28.12 49.62 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.681 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -70.6 -45.07 66.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.776 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.752 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 63.5 pttt -82.47 -12.5 57.78 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.6 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.44 -25.9 68.21 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.431 178.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.59 HG23 HG21 ' A' ' 27' ' ' ILE . 3.2 mt -86.39 -59.4 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.511 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.587 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -82.62 57.35 3.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.347 0.594 . . . . 0.0 110.547 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.511 HG21 HH22 ' A' ' 38' ' ' ARG . 13.6 t -81.24 -6.72 59.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.16 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -129.2 -14.61 4.3 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.562 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -74.42 -87.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.802 0.334 . . . . 0.0 111.208 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 p -176.66 6.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.817 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.551 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.42 31.48 2.79 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.587 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 45.9 p -150.07 145.78 26.57 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.189 -0.505 . . . . 0.0 109.946 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.787 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.2 mt -102.87 103.91 15.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 68.3 p -103.42 164.84 11.39 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.557 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 20.5 t80 -34.09 -36.4 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.683 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.19 -49.84 16.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.715 0.293 . . . . 0.0 111.659 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.646 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -75.72 -19.9 58.74 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.922 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.875 HD13 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -46.03 -47.38 16.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.914 0.864 . . . . 0.0 108.693 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.718 ' HB3' HD12 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -85.43 -51.89 6.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.485 179.243 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.646 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 59.3 m-20 -36.34 -36.17 0.09 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.531 ' HA3' HG21 ' A' ' 19' ' ' ILE . . . -68.02 -57.34 8.76 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 115.114 0.805 . . . . 0.0 115.114 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.668 HD13 ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -73.85 -28.55 61.65 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.163 0.981 . . . . 0.0 111.989 -177.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.609 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 19.4 ptpt -66.14 -4.7 7.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.511 HH22 HG21 ' A' ' 21' ' ' THR . 36.9 ttm180 -87.15 -42.71 12.8 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.249 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.44 -0.22 2.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.81 -36.93 3.71 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.352 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 18.5 m -52.45 153.02 3.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.471 0.177 . . . . 0.0 110.553 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -143.3 103.79 4.17 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.298 0.57 . . . . 0.0 112.142 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.718 HD12 ' HB3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -105.35 167.98 9.38 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.124 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.474 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 5.3 mtm -104.66 165.51 11.01 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 48' ' ' ILE . 92.8 mt-10 -47.71 -59.99 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.495 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 94.4 p -39.47 -34.99 0.25 Allowed 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.474 ' OE1' ' HB2' ' A' ' 44' ' ' MET . 37.2 mp0 -66.38 -41.03 89.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.053 0.454 . . . . 0.0 110.172 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.875 HG13 HD13 ' A' ' 32' ' ' LEU . 2.0 mp -57.06 -60.49 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.984 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.557 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 42.4 tttm -64.45 -25.6 68.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.318 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 46' ' ' SER . 62.6 t0 -71.13 -37.45 72.29 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.607 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 tt -76.36 -23.07 54.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.024 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.73 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 18.2 mmt -71.88 -45.01 62.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.122 0.487 . . . . 0.0 111.518 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.52 -30.29 20.71 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.988 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.55 -19.31 22.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -127.02 -43.81 1.65 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.73 ' HB3' ' O ' ' A' ' 52' ' ' MET . 15.6 t0 -61.24 95.98 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.3 mm -48.65 -22.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.031 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.564 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 59.0 t0 -129.11 44.5 2.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.818 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.672 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.5 tmtm? -32.57 90.38 0.0 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.74 0.781 . . . . 0.0 112.662 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.1 p -127.74 18.04 6.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.151 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 70.88 17.76 75.58 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.384 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 86.1 m -150.36 127.15 11.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.542 0.337 . . . . 0.0 110.561 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.787 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 70.1 mt -108.06 129.46 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 121.055 0.455 . . . . 0.0 111.367 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -105.06 167.33 9.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.09 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.61 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 47.9 t80 -35.52 -45.78 0.37 Allowed 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.389 0.431 . . . . 0.0 111.474 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.38 -63.7 4.12 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.331 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.564 ' OE2' ' HB3' ' A' ' 58' ' ' ASP . 63.0 mt-10 -51.92 -26.11 9.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.662 0.267 . . . . 0.0 110.905 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 71.9 t80 -63.87 -65.18 0.72 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.434 0.635 . . . . 0.0 110.879 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 65' ' ' TYR . 14.5 mm -52.13 -41.17 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.653 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.23 -25.76 66.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.0 110.59 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.035 179.705 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.466 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 14.4 p . . . . . 0 C--O 1.233 0.19 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.7 m -51.05 -55.01 19.66 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.402 . . . . 0.0 110.173 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -81.18 -39.77 24.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.902 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.807 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 8.1 t80 -45.95 -23.04 0.25 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.366 0.603 . . . . 0.0 110.055 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.3 t -89.13 -44.79 10.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.769 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -89.3 -63.65 1.26 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.56 ' HB3' HD12 ' A' ' 99' ' ' ILE . 2.5 m-85 -51.98 -62.36 1.68 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.807 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.6 OUTLIER -76.13 55.29 0.93 Allowed 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 176.123 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -44.53 -52.91 7.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.451 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.35 -21.46 64.73 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.328 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.08 68.61 1.09 Allowed Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.4 p -115.54 -23.06 8.95 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.589 ' O ' ' HB2' ' A' ' 134' ' ' ASP . . . 130.58 -4.55 5.84 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 113.162 -1.836 . . . . 0.0 112.606 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.87 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.5 OUTLIER -148.62 161.82 40.94 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.781 HG12 ' HA ' ' A' ' 92' ' ' ASP . 22.1 mt -133.09 104.27 6.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.833 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 102' ' ' ASP . 69.6 p -72.3 147.1 46.69 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.719 ' HB3' HG21 ' A' ' 122' ' ' ILE . 4.1 pp -34.44 -33.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 100' ' ' THR . 54.2 m-20 -54.35 -55.89 24.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 97.4 mt-10 -71.21 -31.43 67.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.174 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.492 HG13 ' CG2' ' A' ' 99' ' ' ILE . 51.1 mt -65.74 -65.25 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.166 0.508 . . . . 0.0 110.439 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 119' ' ' ASP . 87.8 mt-30 -58.14 -39.05 77.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.636 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.435 ' C ' ' H ' ' A' ' 108' ' ' CYS . 53.4 tt0 -59.84 -44.12 94.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.082 0.468 . . . . 0.0 110.66 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.7 -3.05 1.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.145 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.775 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 73.2 m -115.09 44.07 1.88 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.922 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -59.54 -36.63 76.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.841 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -75.09 -22.12 58.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.11 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.775 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 2.7 m-85 -76.78 -5.18 47.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.953 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 113' ' ' LEU . . . 62.35 38.8 96.85 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.036 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.907 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -33.09 132.74 0.15 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.545 0.688 . . . . 0.0 111.501 -177.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.688 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 91.9 m-20 -135.99 167.69 20.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.217 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.627 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.6 m-20 -82.88 -7.98 59.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.178 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.59 -64.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.068 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -89.52 -69.24 0.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.907 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.3 mm -52.77 -19.45 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.942 0.401 . . . . 0.0 111.238 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.627 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 33.6 t70 -71.14 -46.91 60.59 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' GLU . 63.9 t0 -62.37 -26.27 68.37 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.978 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.5 ttt -60.75 -29.87 69.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.474 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.719 HG21 ' HB3' ' A' ' 101' ' ' LEU . 56.8 mt -58.32 -43.62 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.469 ' CE ' ' HB ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -86.67 -13.8 44.46 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.367 178.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.978 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 71.5 tt0 -84.61 -23.73 29.45 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.789 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.924 HG22 HG13 ' A' ' 133' ' ' ILE . 13.6 mm -107.56 -21.8 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.968 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.4 t70 -62.8 98.37 0.12 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.594 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.91 HE21 ' HG2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -87.23 -13.95 42.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.433 ' OD1' ' ND2' ' A' ' 129' ' ' ASN . 50.6 p30 -127.57 -33.19 2.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.739 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 179.96 -71.76 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 178.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.739 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 56.3 m-20 -64.92 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -173.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.968 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.53 37.93 78.04 Favored Glycine 0 CA--C 1.505 -0.566 0 C-N-CA 118.348 -1.882 . . . . 0.0 110.04 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.551 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 8.6 pt20 -133.33 170.53 15.33 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 113.895 -1.152 . . . . 0.0 110.075 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.924 HG13 HG22 ' A' ' 125' ' ' ILE . 5.0 mm -133.02 121.88 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.91 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 4.3 p-10 -113.01 162.47 15.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.161 177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.785 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 22.5 t80 -38.76 -30.48 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.768 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 134' ' ' ASP . . . -84.27 -45.16 6.31 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.728 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.91 ' HG2' HE21 ' A' ' 127' ' ' GLN . 39.3 mt-10 -63.04 -51.3 67.29 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.565 ' HB2' ' CG2' ' A' ' 133' ' ' ILE . 13.6 t80 -56.62 -18.68 12.86 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 135' ' ' TYR . . . -86.06 -40.85 15.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.151 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.497 ' CB ' ' HG3' ' A' ' 127' ' ' GLN . . . -87.25 -11.66 49.04 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.552 ' HG2' ' HA ' ' A' ' 138' ' ' PHE . 5.5 ppp? -72.41 -6.68 45.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.635 0.255 . . . . 0.0 111.557 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.994 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.607 HD12 ' HE2' ' A' ' 68' ' ' PHE . 46.5 tp . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.643 ' HG3' ' OE1' ' A' ' 14' ' ' GLU . 20.6 pttp -58.59 -24.99 62.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.643 ' OE1' ' HG3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -80.43 -52.27 7.85 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.626 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 31.0 tp -47.23 -30.2 2.85 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.847 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.497 ' CZ ' ' N ' ' A' ' 65' ' ' TYR . 20.1 t80 -66.61 -52.04 49.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.164 0.506 . . . . 0.0 110.446 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.487 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -76.0 -13.06 60.23 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.621 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 63.4 mmm -71.04 -22.61 62.12 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.499 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.679 HG23 HD12 ' A' ' 27' ' ' ILE . 10.9 mm -77.42 -61.31 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.269 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.575 ' HB3' ' O ' ' A' ' 26' ' ' THR . 1.0 OUTLIER -80.23 66.79 5.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.534 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 t -82.75 -6.34 59.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.348 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -131.75 -27.28 1.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.473 ' ND2' ' OG1' ' A' ' 26' ' ' THR . 48.2 t30 -69.82 -82.45 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.1 p -175.91 5.42 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.46 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 111.11 27.13 4.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.373 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.575 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 64.8 p -143.66 149.18 36.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.034 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.839 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.1 mt -103.43 103.02 14.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.506 HG22 HG23 ' A' ' 62' ' ' THR . 66.9 p -104.16 162.29 13.3 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.129 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.613 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 44.1 t80 -34.03 -27.87 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 28' ' ' THR . 56.1 m-20 -82.51 -45.06 15.17 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.791 0.329 . . . . 0.0 111.159 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 8.0 mp0 -83.13 -15.13 51.93 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.901 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.623 HD12 HG13 ' A' ' 48' ' ' ILE . 2.2 tm? -53.03 -50.16 64.84 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.888 ' HB2' ' HE3' ' A' ' 37' ' ' LYS . 12.5 ptpt -82.59 -46.15 13.68 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.091 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.577 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 31.0 t70 -42.86 -64.9 0.54 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA3' HG21 ' A' ' 19' ' ' ILE . . . -46.43 -28.36 3.33 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.142 -0.552 . . . . 0.0 113.633 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.434 HD11 ' CB ' ' A' ' 41' ' ' SER . 0.2 OUTLIER -90.1 -59.68 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.986 0.393 . . . . 0.0 110.772 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.888 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 18.8 ptpt -60.43 -9.55 3.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.032 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -68.3 -34.67 76.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.868 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.4 m -80.84 -8.72 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.393 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.7 -17.66 5.48 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.842 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.434 ' CB ' HD11 ' A' ' 36' ' ' LEU . 65.1 m -63.42 168.51 4.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.964 0.412 . . . . 0.0 111.445 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -147.57 111.12 4.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.608 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.7 mt -120.55 165.83 14.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.374 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -114.15 162.43 16.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 47' ' ' GLU . 44.4 mt-10 -47.63 -65.43 0.57 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 80.8 p -41.73 -18.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 55.8 mt-10 -89.72 -47.57 7.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.623 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -53.64 -59.78 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.912 0.863 . . . . 0.0 109.138 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.995 ' HD3' ' HD2' ' A' ' 93' ' ' LYS . 21.8 ttmm -55.15 -27.39 45.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.212 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.508 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 8.8 t70 -69.9 -45.05 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.153 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.512 ' O ' HD21 ' A' ' 51' ' ' LEU . 9.7 tt -68.26 -21.67 64.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.086 0.47 . . . . 0.0 109.966 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.685 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 13.4 mmt -71.93 -44.01 64.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.855 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' A' ' 90' ' ' TYR . 9.7 t70 -87.05 -18.04 31.51 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.672 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.58 -42.36 10.26 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 71' ' ' ALA . . . -110.7 -43.13 3.88 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.685 ' HB3' ' O ' ' A' ' 52' ' ' MET . 12.3 t0 -49.39 97.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.706 -0.398 . . . . 0.0 109.979 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.7 mm -54.75 -17.53 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.276 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.545 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 38.9 t70 -132.21 44.48 2.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.951 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.591 ' HD3' ' C ' ' A' ' 52' ' ' MET . 27.1 tptp -30.94 88.03 0.0 OUTLIER 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.5 p -128.7 18.94 6.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.469 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 71.32 17.12 75.81 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 51.0 m -151.69 128.03 10.61 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.949 -0.625 . . . . 0.0 110.723 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.839 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.7 mt -105.06 133.41 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 120.927 0.394 . . . . 0.0 110.67 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -105.49 167.75 9.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.325 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.545 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 14.9 t80 -35.82 -46.89 0.48 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.476 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.51 -54.07 7.98 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.65 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.802 ' HB2' HG23 ' A' ' 63' ' ' ILE . 48.5 mt-10 -53.25 -24.05 10.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.294 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.626 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 57.1 t80 -67.8 -60.41 2.54 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.505 0.669 . . . . 0.0 110.487 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 65' ' ' TYR . 8.5 mm -49.21 -49.27 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.813 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.42 -47.25 86.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.806 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.202 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 85' ' ' VAL . 9.9 p . . . . . 0 C--O 1.231 0.121 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.411 ' N ' HG11 ' A' ' 85' ' ' VAL . 90.9 p -52.8 -34.85 55.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 110.12 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -82.22 -52.69 6.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.161 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.724 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 10.9 t80 -44.25 -26.43 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.056 0.455 . . . . 0.0 110.359 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 t -89.73 -47.69 7.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.66 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.46 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 1.0 OUTLIER -82.64 -62.75 1.52 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.378 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.0 m-85 -56.36 -64.62 0.8 Allowed 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.796 ' HA ' HG12 ' A' ' 99' ' ' ILE . 11.9 t0 -76.85 69.2 3.15 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.995 ' HD2' ' HD3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -44.43 -40.85 5.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.347 -177.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.3 m-20 -78.5 -21.35 49.05 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.889 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . 64.62 -8.06 0.57 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.676 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.521 ' H ' ' C ' ' A' ' 94' ' ' ASP . 72.2 p -55.37 -9.07 0.4 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 122.628 0.371 . . . . 0.0 111.203 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 134' ' ' ASP . . . 107.28 -6.54 36.6 Favored Glycine 0 C--O 1.216 -1.029 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.683 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -127.46 145.69 50.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.991 0.424 . . . . 0.0 112.01 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.796 HG12 ' HA ' ' A' ' 92' ' ' ASP . 65.5 mt -131.99 102.93 6.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.368 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 101' ' ' LEU . 44.0 p -76.27 152.84 36.37 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.257 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.495 HD12 ' OD1' ' A' ' 102' ' ' ASP . 3.7 pp -35.47 -39.03 0.12 Allowed 'General case' 0 N--CA 1.461 0.125 0 O-C-N 123.194 0.309 . . . . 0.0 111.139 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.495 ' OD1' HD12 ' A' ' 101' ' ' LEU . 64.4 m-20 -50.89 -57.08 9.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.147 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.403 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 50.4 mt-10 -63.82 -32.17 73.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.597 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' A' ' 132' ' ' GLN . 91.3 mt -70.36 -66.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 111.19 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.578 ' NE2' ' HA ' ' A' ' 119' ' ' ASP . 85.1 mt-30 -56.39 -35.76 68.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.289 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -55.69 -40.37 72.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.774 0.321 . . . . 0.0 110.543 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.54 -65.24 0.66 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.239 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.538 ' HB3' ' CG ' ' A' ' 111' ' ' PHE . 83.3 m -64.4 76.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.509 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 1.0 OUTLIER -88.8 -43.91 10.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.597 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -72.72 -4.68 32.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.721 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.538 ' CG ' ' HB3' ' A' ' 108' ' ' CYS . 1.2 m-85 -81.86 -1.17 46.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.775 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.18 37.2 94.13 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.598 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.459 ' HA ' ' CD1' ' A' ' 118' ' ' ILE . 2.1 pp -34.06 144.5 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.674 0.75 . . . . 0.0 112.875 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 119' ' ' ASP . 11.2 p-10 -160.16 -164.06 1.22 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.986 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.653 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 2.8 p30 -87.73 -7.93 56.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.12 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.7 mm -89.45 -64.69 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 121' ' ' MET . 18.0 t-160 -92.06 -68.51 0.79 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.661 HG23 ' HE3' ' A' ' 121' ' ' MET . 2.2 mp -56.89 -20.31 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.653 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 38.8 t70 -79.71 -59.25 2.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' GLU . 1.2 m-20 -59.2 -17.24 25.99 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.724 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 22.4 ttp -59.72 -39.65 85.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.333 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.598 HG23 ' NZ ' ' A' ' 123' ' ' LYS . 59.7 mt -54.69 -45.0 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.626 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -84.15 -13.6 52.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.98 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.724 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 15.9 tp10 -78.18 -27.8 48.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.894 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.818 HG22 HG12 ' A' ' 133' ' ' ILE . 22.6 mt -109.06 -7.87 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.818 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.599 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 28.0 t70 -73.78 81.34 1.59 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.112 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.562 ' OE1' ' HB3' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -87.54 -9.36 54.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.052 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 6.3 m-20 -119.87 -34.56 3.7 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.609 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 10.4 p-10 179.63 -80.89 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 118.438 2.755 . . . . 0.0 118.438 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.824 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 5.7 t70 -64.32 -17.68 63.91 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 118.813 2.894 . . . . 0.0 118.813 -171.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.599 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 92.15 37.13 6.05 Favored Glycine 0 CA--C 1.501 -0.836 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.824 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 3.2 pt20 -139.15 166.53 24.28 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 112.729 -1.735 . . . . 0.0 108.957 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.818 HG12 HG22 ' A' ' 125' ' ' ILE . 48.0 mt -123.29 128.32 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 121.441 0.638 . . . . 0.0 110.805 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.819 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 1.5 t70 -104.16 157.9 16.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.476 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.724 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 18.9 t80 -39.33 -46.24 1.56 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.376 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.91 -44.01 80.68 Favored Glycine 0 N--CA 1.422 -2.279 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.303 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.819 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 27.8 mt-10 -55.88 -62.23 1.84 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.413 -0.394 . . . . 0.0 110.143 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.728 ' HB2' HG21 ' A' ' 133' ' ' ILE . 2.5 t80 -55.3 -30.16 59.63 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.943 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 135' ' ' TYR . . . -74.88 -26.36 59.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.339 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.71 -51.23 5.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.851 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -57.72 -12.65 3.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.925 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 C--N 1.332 -0.172 0 CA-C-O 120.683 0.278 . . . . 0.0 110.836 179.741 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 95.7 mt . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.457 0.17 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.617 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 62.2 tttp -57.51 -43.83 84.55 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' A' ' 18' ' ' MET . 44.8 tt0 -71.75 -47.97 50.03 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.714 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 28.2 tp -48.85 -29.01 4.15 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.55 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.488 ' CZ ' ' N ' ' A' ' 65' ' ' TYR . 15.3 t80 -64.87 -51.67 60.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.581 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.536 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.6 ptpt -77.79 -12.77 60.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.05 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.663 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 56.8 mmm -68.19 -24.05 64.91 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.491 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.83 HG21 HG23 ' A' ' 27' ' ' ILE . 4.0 mt -83.73 -52.0 13.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.162 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.683 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -80.73 51.84 1.58 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.436 0.636 . . . . 0.0 112.378 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -79.59 -6.31 56.79 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.558 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -111.28 -27.9 8.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.611 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.468 ' O ' ' OG ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -87.49 -91.19 0.11 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.889 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 23' ' ' ASN . 74.9 m -176.06 21.73 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.261 0.351 . . . . 0.0 110.988 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.45 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 111.18 24.8 5.29 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.529 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.683 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 78.6 p -140.39 142.13 35.51 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.166 0.508 . . . . 0.0 110.218 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.83 HG23 HG21 ' A' ' 19' ' ' ILE . 5.6 mt -102.95 102.96 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.816 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 62' ' ' THR . 79.7 p -103.6 165.04 11.28 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.197 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.548 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 52.9 t80 -34.36 -33.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.723 0.64 . . . . 0.0 111.864 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . 33.2 t70 -76.91 -47.58 20.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.955 0.407 . . . . 0.0 110.695 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 20' ' ' ASP . 25.1 mp0 -73.07 -25.09 60.78 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.235 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.659 HD12 HD22 ' A' ' 51' ' ' LEU . 1.8 tm? -48.73 -51.45 28.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.464 0.649 . . . . 0.0 109.792 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.656 ' HB2' ' HE2' ' A' ' 37' ' ' LYS . 6.9 ptpp? -82.45 -40.32 21.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.898 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -39.06 -62.11 0.68 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.088 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -50.76 -37.22 34.33 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.211 -0.518 . . . . 0.0 113.984 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.565 ' O ' HG13 ' A' ' 39' ' ' VAL . 49.5 mt -79.67 -58.42 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.34 0.57 . . . . 0.0 111.759 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.656 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -54.93 -17.65 3.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.247 0.546 . . . . 0.0 109.668 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.3 ttt85 -77.37 -42.83 35.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.545 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -70.89 -1.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.161 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.92 5.71 33.01 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.45 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 74.5 m -81.9 166.46 19.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.79 0.329 . . . . 0.0 111.151 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -138.9 104.68 5.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.816 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.4 mt -128.68 166.09 19.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.407 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.559 ' O ' HD12 ' A' ' 48' ' ' ILE . 23.1 mtp -107.34 161.68 14.59 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG2' ' HE2' ' A' ' 33' ' ' LYS . 37.1 mt-10 -55.64 -60.28 3.66 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.503 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.476 ' HB2' ' HZ ' ' A' ' 111' ' ' PHE . 41.2 t -43.24 -29.07 0.36 Allowed 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.8 mm-40 -72.98 -42.36 63.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.265 0.555 . . . . 0.0 110.037 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.622 HG12 ' HB3' ' A' ' 33' ' ' LYS . 1.7 mp -55.57 -56.82 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.756 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.576 ' HE2' ' CE1' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -47.53 -28.25 2.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.764 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.542 ' HA ' ' HZ2' ' A' ' 49' ' ' LYS . 63.8 t0 -75.29 -54.93 6.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.601 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.659 HD22 HD12 ' A' ' 32' ' ' LEU . 36.4 tp -53.89 -37.66 63.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.236 0.541 . . . . 0.0 111.058 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.635 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 33.8 ttm -74.36 -66.35 0.74 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.331 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.656 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -54.48 -26.21 29.92 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.764 -178.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.68 -41.09 15.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 51' ' ' LEU . . . -100.3 -43.39 6.29 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.446 ' OD2' ' HA ' ' A' ' 59' ' ' LYS . 60.5 t0 -46.37 98.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 110.144 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.4 mm -54.14 -19.64 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.243 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.568 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 62.0 m-20 -131.35 44.47 2.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.872 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.656 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 21.8 tptm -32.27 92.04 0.01 OUTLIER 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 58' ' ' ASP . 49.0 m -127.71 18.44 6.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.404 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.635 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 70.08 23.46 77.14 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.47 -178.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.697 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 42.5 m -159.72 129.97 5.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.797 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.768 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 75.8 mt -108.19 130.13 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.962 0.411 . . . . 0.0 111.511 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -104.87 167.61 9.6 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.085 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.617 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 28.9 t80 -35.22 -47.3 0.39 Allowed 'General case' 0 CA--C 1.52 -0.182 0 O-C-N 123.446 0.466 . . . . 0.0 111.731 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.98 -56.66 10.2 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.361 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.616 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 71.4 mt-10 -54.75 -22.66 14.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 110.692 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.714 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 64.9 t80 -68.32 -64.31 0.89 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.623 0.725 . . . . 0.0 110.905 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' A' ' 68' ' ' PHE . 7.9 mm -52.39 -41.79 36.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.613 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.75 -32.98 66.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.143 0.497 . . . . 0.0 110.803 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.23 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.234 0.255 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 79.2 p -43.32 -45.28 5.91 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.975 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.405 ' C ' ' N ' ' A' ' 89' ' ' SER . . . -90.14 -38.57 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.712 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.708 ' HZ ' ' HA2' ' A' ' 97' ' ' GLY . 8.6 t80 -44.33 -24.15 0.15 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.269 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 87' ' ' ALA . 47.7 t -89.05 -45.38 9.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.898 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -81.69 -63.68 1.34 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.365 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.576 ' CE1' ' HE2' ' A' ' 49' ' ' LYS . 4.0 m-85 -56.44 -64.41 0.88 Allowed 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.713 ' HA ' HG12 ' A' ' 99' ' ' ILE . 61.8 t0 -76.78 67.4 2.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -55.85 -25.72 43.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.397 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -84.18 -20.69 31.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 39.22 67.3 0.61 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.1 p -122.87 -19.12 6.26 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.708 ' HA2' ' HZ ' ' A' ' 88' ' ' PHE . . . 123.37 -3.14 9.59 Favored Glycine 0 N--CA 1.434 -1.443 0 CA-C-N 113.435 -1.711 . . . . 0.0 112.379 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.783 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -136.05 151.92 50.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.363 0.601 . . . . 0.0 111.702 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.713 HG12 ' HA ' ' A' ' 92' ' ' ASP . 83.0 mt -130.95 102.78 6.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.054 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 101' ' ' LEU . 51.2 p -79.81 151.46 30.28 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.642 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.4 OUTLIER -34.29 -34.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.022 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.97 -54.98 31.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.904 0.383 . . . . 0.0 110.527 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.4 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 51.3 mt-10 -65.75 -28.68 69.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.185 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.423 HG21 ' OE1' ' A' ' 105' ' ' GLN . 72.8 mt -72.42 -65.38 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 111.004 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.652 ' NE2' HG21 ' A' ' 118' ' ' ILE . 2.4 mm-40 -47.65 -45.2 27.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.139 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -64.13 -42.92 96.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.468 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.87 -4.54 32.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 26.5 p -124.04 91.4 3.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.069 0.462 . . . . 0.0 111.385 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -88.44 -50.78 6.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.326 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.91 -17.75 62.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.517 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.58 ' HB2' ' HB2' ' A' ' 108' ' ' CYS . 3.7 m-85 -63.92 -11.32 27.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.627 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.41 34.79 24.89 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.3 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.496 HD22 HG12 ' A' ' 118' ' ' ILE . 0.5 OUTLIER -35.52 109.94 0.09 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.24 0.543 . . . . 0.0 111.508 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.717 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 38.4 t70 -160.96 138.54 9.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.334 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -50.81 -9.49 0.05 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.419 ' H ' ' C ' ' A' ' 114' ' ' ASP . 73.4 mt -89.44 -59.55 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.644 0.259 . . . . 0.0 111.648 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -91.07 -59.41 2.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 111.622 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.717 ' HB ' ' H ' ' A' ' 114' ' ' ASP . 3.6 tp -48.47 -28.25 2.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.534 ' N ' HG22 ' A' ' 118' ' ' ILE . 33.5 t70 -65.64 -51.52 58.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.874 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 124' ' ' GLU . 7.7 t70 -56.45 -29.23 61.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.978 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 6.6 ttt -66.79 -39.64 87.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.661 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 101' ' ' LEU . 33.1 mm -56.97 -43.06 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.689 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -83.78 -13.3 54.18 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.632 178.304 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.978 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 31.1 tt0 -87.65 -17.03 32.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.43 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.69 HG12 ' O ' ' A' ' 121' ' ' MET . 14.9 mm -115.96 -32.13 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.558 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 131' ' ' GLY . 2.7 t70 -75.5 92.11 2.85 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.599 ' NE2' ' H ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -86.02 -8.71 57.75 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.909 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 20.1 m-20 -111.86 -33.71 6.22 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.587 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.32 -86.34 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 117.603 2.445 . . . . 0.0 117.603 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.73 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 22.0 m-20 -64.65 26.06 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -172.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.438 ' H ' ' CG ' ' A' ' 126' ' ' ASP . . . 55.51 37.51 67.26 Favored Glycine 0 CA--C 1.505 -0.574 0 C-N-CA 117.917 -2.087 . . . . 0.0 109.192 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.783 ' NE2' ' HB3' ' A' ' 98' ' ' TYR . 8.7 pt20 -136.3 168.95 18.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.074 -1.063 . . . . 0.0 110.384 -177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.634 HG12 HG22 ' A' ' 125' ' ' ILE . 60.0 mt -123.45 129.49 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.614 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.787 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 30.3 t70 -101.81 158.55 16.03 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.027 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.674 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 4.9 t80 -45.39 -32.54 2.13 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.913 0.387 . . . . 0.0 110.721 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.59 -38.15 17.99 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.071 -1.061 . . . . 0.0 110.729 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.787 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 30.8 mt-10 -59.98 -57.79 11.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.803 -0.198 . . . . 0.0 110.8 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.543 ' HB2' HG21 ' A' ' 133' ' ' ILE . 2.6 t80 -58.89 -26.77 64.6 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.527 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 135' ' ' TYR . . . -79.7 -36.68 37.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.002 0.429 . . . . 0.0 110.836 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -90.0 -14.22 34.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.033 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -57.34 -18.53 17.56 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.465 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 24.4 ptt? . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.083 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 15' ' ' LEU . 53.9 tp . . . . . 0 N--CA 1.461 0.109 0 CA-C-O 120.469 0.176 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.58 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 24.0 pttm -66.36 -32.11 73.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -78.18 -36.85 46.9 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.757 ' O ' HG12 ' A' ' 19' ' ' ILE . 52.3 tp -53.87 -42.57 68.75 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.366 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.539 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 10.9 t80 -51.69 -45.06 63.34 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.443 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -85.06 -12.45 53.03 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.9 ttp -85.55 -13.76 47.95 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.614 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.757 HG12 ' O ' ' A' ' 15' ' ' LEU . 22.4 mm -74.92 -52.44 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.685 ' HB2' ' HB3' ' A' ' 23' ' ' ASN . 4.4 p-10 -81.93 50.6 1.57 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.033 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.0 t -61.97 -6.82 3.12 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.877 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -133.94 -10.88 2.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.979 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.685 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 30.9 t30 -87.49 -95.83 0.09 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.2 p -177.72 12.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 111.59 24.37 5.32 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.948 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.498 ' OG1' ' ND2' ' A' ' 23' ' ' ASN . 40.6 p -147.62 144.23 28.26 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.972 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 6.9 mt -104.02 104.84 17.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 68.8 p -102.21 163.52 12.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.704 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.738 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 49.2 t80 -34.28 -37.32 0.05 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.86 -45.75 40.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.92 0.39 . . . . 0.0 111.167 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -78.56 -13.83 59.63 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.719 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.976 HD13 ' HB2' ' A' ' 52' ' ' MET . 6.2 tt -53.05 -49.01 67.2 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.635 ' HD3' ' NZ ' ' A' ' 37' ' ' LYS . 4.0 ptpp? -84.75 -41.17 16.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.491 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 17.9 t70 -47.57 -30.29 3.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.048 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' HA3' HG21 ' A' ' 19' ' ' ILE . . . -65.03 -40.31 96.99 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.888 -0.673 . . . . 0.0 113.351 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.544 ' O ' HG11 ' A' ' 39' ' ' VAL . 1.3 mm? -91.99 -33.15 14.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.324 0.583 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.635 ' NZ ' ' HD3' ' A' ' 33' ' ' LYS . 76.5 mttt -60.94 -45.8 93.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.698 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.44 ' HG2' HH11 ' A' ' 38' ' ' ARG . 46.9 ttt-85 -69.77 -40.74 75.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.62 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.544 HG11 ' O ' ' A' ' 36' ' ' LEU . 8.2 p -71.13 -14.25 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.48 54.86 0.3 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.121 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 70.1 m -146.0 166.98 24.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.605 0.24 . . . . 0.0 110.483 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 23.2 pt-20 -137.29 114.67 10.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 111.378 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.4 mt -125.13 165.58 17.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.272 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.431 ' O ' HD11 ' A' ' 48' ' ' ILE . 20.4 mtm -113.41 164.41 13.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -64.98 0.65 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.154 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.1 p -39.78 -26.81 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 93.9 mt-10 -79.22 -49.72 12.08 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.764 HG13 HD22 ' A' ' 32' ' ' LEU . 1.7 mp -52.99 -60.86 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.591 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.738 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 51.6 tttp -57.05 -22.79 41.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.889 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 36.8 t70 -76.62 -44.58 33.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 tt -63.44 -44.76 93.62 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 111.092 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.976 ' HB2' HD13 ' A' ' 32' ' ' LEU . 37.3 ttm -66.6 -64.09 0.93 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.249 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.679 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 9.6 t70 -55.88 -29.29 59.72 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.05 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 50' ' ' ASP . . . -88.58 -36.64 16.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -103.23 -41.65 5.99 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.52 ' OD1' HG12 ' A' ' 63' ' ' ILE . 15.8 t70 -50.94 95.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.937 0.399 . . . . 0.0 110.188 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.9 mm -51.49 -18.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.551 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.53 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.2 m-20 -131.05 43.91 3.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.174 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.679 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 28.1 tptp -32.53 89.65 0.0 OUTLIER 'General case' 0 C--O 1.231 0.117 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 58' ' ' ASP . 87.7 p -127.85 18.21 6.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.519 -1.218 . . . . 0.0 109.02 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.527 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 76.34 22.63 72.82 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.087 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 91.1 m -147.54 153.84 39.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.243 0.617 . . . . 0.0 109.597 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.972 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 71.7 mt -135.16 127.53 47.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.995 0.426 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -104.6 167.52 9.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.492 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.58 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 41.2 t80 -35.41 -44.71 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.558 0.536 . . . . 0.0 111.663 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.04 -60.63 5.48 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.197 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.53 ' OE2' ' HB2' ' A' ' 58' ' ' ASP . 40.9 mt-10 -53.88 -21.83 8.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.851 0.358 . . . . 0.0 110.945 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.665 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 26.2 t80 -67.77 -65.11 0.73 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.501 0.667 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 65' ' ' TYR . 10.5 mm -52.44 -43.09 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.583 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.63 -39.44 73.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.47 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.361 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 85' ' ' VAL . 14.5 p . . . . . 0 CA--C 1.53 0.187 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -38.43 -49.23 1.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.264 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' A' ' 91' ' ' PHE . . . -71.89 -50.17 31.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.499 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.761 ' HE1' ' HB2' ' A' ' 135' ' ' TYR . 11.5 t80 -36.23 -33.55 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.492 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 87' ' ' ALA . 29.5 t -89.67 -50.69 5.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.728 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.66 -64.21 1.24 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.165 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.586 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 5.0 m-85 -58.93 -59.9 4.71 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.73 ' HA ' HG12 ' A' ' 99' ' ' ILE . 1.2 m-20 -75.68 57.65 1.01 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -52.06 -41.15 62.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.701 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -67.87 -20.9 65.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 42.49 64.32 1.62 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.474 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 54.5 p -119.48 -35.32 3.59 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.39 4.1 0.81 Allowed Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.337 -1.756 . . . . 0.0 112.873 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.863 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.3 OUTLIER -152.67 165.64 34.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.494 0.664 . . . . 0.0 112.072 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.794 HG22 HG12 ' A' ' 104' ' ' ILE . 91.4 mt -132.35 104.08 7.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.14 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 102' ' ' ASP . 50.5 p -76.09 149.27 37.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.602 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER -34.57 -33.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 100' ' ' THR . 1.5 m-20 -57.69 -52.34 65.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.85 0.357 . . . . 0.0 110.276 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.429 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 49.3 mt-10 -67.83 -28.39 67.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.543 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.794 HG12 HG22 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -70.2 -62.12 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.575 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.618 ' OE1' HG22 ' A' ' 104' ' ' ILE . 4.7 mm100 -53.66 -38.28 63.98 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.898 0.38 . . . . 0.0 110.49 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -61.81 -59.22 5.48 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.96 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.75 -10.77 13.95 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.198 0.523 . . . . 0.0 110.558 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.59 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 31.3 t -100.59 63.44 1.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.737 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.463 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 1.2 tmtp? -85.82 -61.08 1.84 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -57.89 -5.39 0.41 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.573 ' HB2' ' SG ' ' A' ' 108' ' ' CYS . 33.3 m-85 -90.75 7.68 38.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.53 37.05 94.07 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.633 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.96 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -33.67 125.94 0.41 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.317 0.58 . . . . 0.0 112.202 -178.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.548 ' N ' HD23 ' A' ' 113' ' ' LEU . 10.1 t70 -160.65 159.44 30.37 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.681 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 1.4 m-20 -71.74 -6.92 44.85 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.0 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.733 HG13 ' H ' ' A' ' 117' ' ' HIS . 14.0 pt -77.87 -64.6 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.733 ' H ' HG13 ' A' ' 116' ' ' ILE . 13.0 m-70 -92.01 -61.97 1.51 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.09 0.472 . . . . 0.0 111.417 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.96 HG13 ' HA ' ' A' ' 113' ' ' LEU . 13.2 mm -45.16 -36.17 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.11 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.2 -48.28 62.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.946 0.403 . . . . 0.0 110.025 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 124' ' ' GLU . 61.8 t0 -67.59 -27.66 67.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.564 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 1.053 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.0 ttt -62.87 -40.28 97.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.487 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.582 HD13 ' NE2' ' A' ' 105' ' ' GLN . 48.1 mt -53.52 -44.4 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 123' ' ' LYS . 24.3 mmtp -85.18 -13.46 49.96 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.17 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 1.053 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 24.3 tt0 -87.95 -13.52 41.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.497 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.824 HG21 HD13 ' A' ' 133' ' ' ILE . 81.3 mt -117.31 -23.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.759 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.923 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 22.0 t70 -65.25 101.68 0.58 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.566 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.795 ' NE2' ' HA ' ' A' ' 137' ' ' GLU . 18.8 mt-30 -88.05 -18.44 28.92 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -119.39 -34.63 3.77 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.737 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 178.92 -73.28 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.737 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 1.2 m-20 -64.2 20.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.923 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.31 38.18 67.69 Favored Glycine 0 CA--C 1.5 -0.88 0 C-N-CA 117.48 -2.295 . . . . 0.0 108.075 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 6.8 pt20 -131.68 167.12 20.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.628 -1.286 . . . . 0.0 109.055 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.846 HD12 ' HB3' ' A' ' 137' ' ' GLU . 11.0 mm -134.18 124.99 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.326 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.863 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 2.4 p-10 -102.42 161.25 13.86 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.761 ' HB2' ' HE1' ' A' ' 88' ' ' PHE . 12.0 t80 -41.07 -32.63 0.26 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.812 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.88 -46.43 10.82 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.642 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.846 ' HB3' HD12 ' A' ' 133' ' ' ILE . 33.5 mt-10 -54.41 -59.85 4.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.367 -0.416 . . . . 0.0 111.347 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.453 ' HB2' ' CG2' ' A' ' 133' ' ' ILE . 3.6 t80 -57.56 -29.9 64.8 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.92 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 135' ' ' TYR . . . -79.51 -20.06 48.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.074 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.84 -49.01 6.87 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.085 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.413 ' SD ' ' CD1' ' A' ' 138' ' ' PHE . 28.0 ptm -55.41 -16.46 3.67 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.35 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 56.0 ttp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.631 179.889 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.569 HD12 HD22 ' A' ' 15' ' ' LEU . 50.0 tp . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 120.667 0.27 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HG2' ' OH ' ' A' ' 65' ' ' TYR . 33.9 mtmm -56.94 -46.68 81.92 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.627 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -68.48 -34.52 76.07 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.621 ' HA ' ' HB3' ' A' ' 18' ' ' MET . 45.2 tp -59.52 -28.7 67.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.169 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.442 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 13.1 t80 -67.47 -38.98 85.22 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.016 0.436 . . . . 0.0 110.971 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.627 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 61.7 pttt -86.63 -19.82 28.75 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.621 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -63.44 -27.2 69.13 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.491 176.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.616 HG23 HG22 ' A' ' 27' ' ' ILE . 18.7 mm -70.61 -59.65 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.212 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.45 ' HB2' ' OE1' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -78.59 89.79 4.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.3 178.077 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.5 t -88.27 -34.71 17.61 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.525 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -139.83 16.7 2.49 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.534 ' HB2' ' OE1' ' A' ' 31' ' ' GLU . 3.5 m120 -92.44 -88.65 0.2 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.947 0.794 . . . . 0.0 112.89 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -164.95 -1.55 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.75 20.53 7.22 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.514 ' HB ' ' HG1' ' A' ' 62' ' ' THR . 75.4 p -128.09 166.43 18.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.841 ' O ' ' HA ' ' A' ' 62' ' ' THR . 6.1 mt -123.14 101.53 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.083 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 67.5 p -103.56 164.98 11.31 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.704 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -33.72 -39.21 0.06 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.839 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.662 ' OD1' ' HG3' ' A' ' 31' ' ' GLU . 1.8 p30 -73.05 -43.69 61.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.64 0.257 . . . . 0.0 111.281 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.662 ' HG3' ' OD1' ' A' ' 30' ' ' ASP . 42.4 mt-10 -74.68 -24.07 58.73 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 110.265 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.632 HD21 HG21 ' A' ' 48' ' ' ILE . 6.3 tt -54.43 -54.24 43.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.87 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.697 ' HG3' ' H ' ' A' ' 34' ' ' ASP . 17.0 ptpt -75.97 -62.31 1.64 Allowed 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.466 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.697 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 35.9 t70 -37.59 -48.55 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . -48.85 -54.44 14.18 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.98 -0.555 . . . . 0.0 113.858 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.524 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -89.8 -45.94 8.93 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.216 0.531 . . . . 0.0 110.144 -179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -17.21 0.56 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.079 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.581 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 32.0 ttm-85 -59.66 -43.22 94.01 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.778 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 36' ' ' LEU . 34.3 m -78.53 31.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.98 -22.66 24.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.752 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.408 ' HG ' HG21 ' A' ' 39' ' ' VAL . 75.7 m -53.46 154.44 3.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.648 0.261 . . . . 0.0 110.648 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.09 118.18 9.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 111.432 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 mt -119.67 165.77 14.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.481 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.677 ' HE3' ' HB3' ' A' ' 86' ' ' SER . 0.0 OUTLIER -105.02 152.92 22.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.21 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -42.46 -56.05 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.663 ' HB2' ' SD ' ' A' ' 44' ' ' MET . 52.3 m -54.7 -21.66 11.46 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 119.236 0.925 . . . . 0.0 111.888 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 44' ' ' MET . 38.2 mt-10 -74.57 -44.54 50.42 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.632 HG21 HD21 ' A' ' 32' ' ' LEU . 2.0 mp -58.17 -53.31 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.119 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.597 ' HE2' ' HE1' ' A' ' 91' ' ' PHE . 10.5 ttpp -52.92 -30.27 33.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.459 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.609 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 8.8 t70 -62.96 -50.09 72.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.379 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.578 ' HG ' HD12 ' A' ' 63' ' ' ILE . 41.1 tp -60.63 -14.88 23.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.694 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.931 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 13.4 mmt -88.13 -65.84 0.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -78.94 -32.95 45.72 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.939 -0.475 . . . . 0.0 111.726 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . -87.46 -18.32 30.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 51' ' ' LEU . . . -127.09 -43.57 1.65 Allowed 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.626 ' OD1' HG12 ' A' ' 63' ' ' ILE . 21.2 t70 -59.91 96.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.784 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.5 mm -46.26 -25.63 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.866 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.53 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.7 m-20 -129.63 44.09 3.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.27 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.931 ' HD3' ' HB3' ' A' ' 52' ' ' MET . 51.4 tptt -33.27 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.046 0.927 . . . . 0.0 113.347 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.7 p -127.29 9.56 6.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.77 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 97.85 -5.7 61.94 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.517 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.841 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 3.0 t -141.11 165.01 28.72 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.062 0.458 . . . . 0.0 110.681 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.836 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 98.4 mt -125.81 135.38 64.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.33 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.89 166.21 10.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.649 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.638 ' O ' HG12 ' A' ' 69' ' ' ILE . 51.3 t80 -36.31 -46.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.733 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.55 -63.84 4.0 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.441 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.74 ' HB2' HG21 ' A' ' 63' ' ' ILE . 40.9 mt-10 -49.86 -29.2 7.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.739 0.304 . . . . 0.0 111.473 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 34.1 t80 -65.83 -62.63 1.4 Allowed 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.364 0.602 . . . . 0.0 111.16 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.638 HG12 ' O ' ' A' ' 65' ' ' TYR . 19.8 mm -53.32 -48.38 56.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.692 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.45 -41.16 84.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.922 0.392 . . . . 0.0 110.905 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.26 -179.915 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.598 0.237 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.677 ' HB3' ' HE3' ' A' ' 44' ' ' MET . 48.3 t -41.75 -62.66 0.85 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.271 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -73.41 -36.08 65.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.463 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.774 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 2.8 t80 -45.72 -25.74 0.53 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.413 0.625 . . . . 0.0 109.65 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.7 t -89.62 -43.56 10.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.863 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -87.07 -64.45 1.15 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.82 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.621 ' HB3' HD11 ' A' ' 99' ' ' ILE . 2.8 m-85 -56.26 -59.99 4.15 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.783 ' HA ' HG12 ' A' ' 99' ' ' ILE . 1.6 m-20 -78.73 55.66 1.73 Allowed 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -51.16 -41.66 60.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.697 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.56 -20.61 65.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 92' ' ' ASP . . . 43.74 65.06 1.67 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.276 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.9 p -119.08 -33.79 4.06 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.565 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 147.8 -37.08 1.12 Allowed Glycine 0 N--CA 1.433 -1.53 0 CA-C-N 112.786 -2.006 . . . . 0.0 112.196 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.888 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.2 OUTLIER -109.45 164.88 12.1 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.783 HG12 ' HA ' ' A' ' 92' ' ' ASP . 77.8 mt -132.6 103.54 6.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.231 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 102' ' ' ASP . 44.4 p -72.2 146.09 47.57 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.519 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.3 OUTLIER -34.64 -32.95 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 100' ' ' THR . 45.4 t0 -55.47 -56.38 20.89 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.03 -28.34 68.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.825 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.673 HD13 ' HA ' ' A' ' 132' ' ' GLN . 78.9 mt -69.57 -65.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.031 0.443 . . . . 0.0 111.247 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 101' ' ' LEU . 6.6 mm100 -50.09 -51.87 39.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.596 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.481 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 70.1 mt-30 -64.49 -24.68 67.69 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.48 -6.86 58.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 72.2 m -123.78 68.57 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.867 0.365 . . . . 0.0 111.391 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 106' ' ' GLN . 74.6 mmtt -84.03 -32.09 25.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.584 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -83.21 -4.86 58.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.596 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 0.9 OUTLIER -93.46 16.33 13.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.359 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.05 36.82 45.14 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.602 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.874 ' HA ' HG13 ' A' ' 118' ' ' ILE . 3.1 tm? -34.36 110.0 0.09 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.969 0.414 . . . . 0.0 111.323 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.435 ' OD2' ' HB ' ' A' ' 116' ' ' ILE . 12.1 p-10 -160.12 -176.07 5.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.734 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.579 ' HA ' ' CG ' ' A' ' 119' ' ' ASP . 2.8 p30 -89.48 -8.94 51.82 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.435 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 60.5 mt -81.8 -64.6 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.914 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.421 ' HD1' HG22 ' A' ' 116' ' ' ILE . 12.9 m80 -91.61 -68.9 0.77 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.874 HG13 ' HA ' ' A' ' 113' ' ' LEU . 31.4 mm -40.52 -36.56 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.579 ' CG ' ' HA ' ' A' ' 115' ' ' ASP . 42.2 m-20 -71.2 -52.4 19.3 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 122.139 -0.351 . . . . 0.0 110.86 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 124' ' ' GLU . 32.4 m-20 -57.59 -23.62 51.78 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.98 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.5 ttt -65.39 -36.27 83.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.746 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.487 HG21 ' HB3' ' A' ' 101' ' ' LEU . 52.8 mt -57.06 -45.89 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 10.6 mmpt? -83.57 -13.19 54.99 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.57 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.98 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 29.8 tt0 -87.97 -19.21 27.53 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.458 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.649 HG23 HG12 ' A' ' 133' ' ' ILE . 63.9 mt -107.59 -50.52 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.89 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.543 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 5.4 p-10 -46.76 100.1 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.858 0.837 . . . . 0.0 110.697 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.691 ' NE2' ' H ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -87.3 -9.9 53.72 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.996 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 53.7 p30 -117.05 -33.19 4.8 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.686 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.43 -81.4 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.686 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 59.0 m-20 -64.51 22.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 -172.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 126' ' ' ASP . . . 56.37 38.29 78.33 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 117.219 -2.419 . . . . 0.0 109.414 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.673 ' HA ' HD13 ' A' ' 104' ' ' ILE . 12.1 pt20 -132.0 167.29 19.92 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.362 -0.919 . . . . 0.0 111.722 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.649 HG12 HG23 ' A' ' 125' ' ' ILE . 15.3 mt -125.67 116.15 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.549 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.888 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 38.6 t70 -104.8 161.78 13.87 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.574 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.646 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 37.0 t80 -40.28 -32.81 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.22 -41.41 9.35 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.696 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 26.3 mt-10 -62.39 -53.28 57.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 87' ' ' ALA . 29.0 t80 -52.3 -31.69 34.14 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.284 0.564 . . . . 0.0 109.649 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.27 -23.91 64.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.975 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.94 -52.93 4.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.29 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 138' ' ' PHE . 5.2 ppp? -51.35 -22.57 2.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.447 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 36.9 ttm . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.761 178.579 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.538 0.209 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.729 ' HB3' ' HZ1' ' A' ' 13' ' ' LYS . 6.4 ttpm? -55.74 -30.92 62.03 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.742 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 8.1 mp0 -77.0 -38.26 53.43 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.968 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.736 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 54.5 tp -55.04 -28.12 49.78 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.664 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -70.54 -45.11 66.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.787 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.742 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 63.5 pttt -82.46 -12.46 57.82 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.593 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.45 -25.86 68.21 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.429 178.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.6 HG23 HG21 ' A' ' 27' ' ' ILE . 3.3 mt -86.4 -59.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.53 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.586 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -82.68 57.37 3.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.391 0.615 . . . . 0.0 110.523 179.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.5 HG21 HH22 ' A' ' 38' ' ' ARG . 13.6 t -81.26 -6.66 59.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.17 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -129.21 -14.65 4.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.58 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -74.38 -87.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.832 0.348 . . . . 0.0 111.197 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 p -176.67 6.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.811 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.44 31.47 2.79 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.586 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 45.8 p -150.07 145.79 26.58 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.192 -0.504 . . . . 0.0 109.938 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.788 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.2 mt -102.85 103.87 15.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 67.3 p -103.37 164.83 11.4 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.445 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.567 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 20.4 t80 -34.06 -36.44 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.72 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.15 -49.88 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.715 0.293 . . . . 0.0 111.676 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -75.7 -19.9 58.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.939 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.845 HD13 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -46.03 -47.4 16.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.893 0.854 . . . . 0.0 108.707 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.734 ' HB3' HD12 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -85.38 -51.9 6.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.488 179.215 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.634 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 59.4 m-20 -36.34 -36.17 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.54 ' HA3' HG21 ' A' ' 19' ' ' ILE . . . -68.02 -57.32 8.79 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 115.124 0.81 . . . . 0.0 115.124 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.661 HD13 ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -73.86 -28.53 61.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.195 0.997 . . . . 0.0 111.983 -177.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.632 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 19.3 ptpt -66.18 -4.67 8.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.5 HH22 HG21 ' A' ' 21' ' ' THR . 36.9 ttm180 -87.12 -42.72 12.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.278 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.45 -0.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.75 -36.86 3.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.361 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 18.5 m -52.45 153.01 3.19 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.565 -0.161 . . . . 0.0 110.565 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -143.31 103.76 4.17 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.285 0.564 . . . . 0.0 112.153 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.734 HD12 ' HB3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -105.36 167.97 9.38 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.125 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.472 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 5.3 mtm -104.62 165.54 11.0 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 48' ' ' ILE . 92.8 mt-10 -47.68 -60.04 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.51 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 94.9 p -39.42 -35.0 0.24 Allowed 'General case' 0 C--N 1.335 -0.047 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.472 ' OE1' ' HB2' ' A' ' 44' ' ' MET . 37.1 mp0 -66.42 -41.02 89.87 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.055 0.455 . . . . 0.0 110.15 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.845 HG13 HD13 ' A' ' 32' ' ' LEU . 2.0 mp -57.02 -60.58 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.958 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.567 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 42.3 tttm -64.34 -25.66 68.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.353 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' SER . 62.6 t0 -71.12 -37.46 72.32 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.654 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 tt -76.34 -23.04 54.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.049 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.73 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 18.1 mmt -71.92 -45.01 62.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.058 0.456 . . . . 0.0 111.468 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.51 -30.27 20.72 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.716 -0.394 . . . . 0.0 112.01 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.53 -19.36 22.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -127.04 -43.75 1.65 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.73 ' HB3' ' O ' ' A' ' 52' ' ' MET . 15.6 t0 -61.24 95.96 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.2 mm -48.62 -22.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.044 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.551 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 59.1 t0 -129.13 44.49 2.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.864 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.707 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.5 tmtm? -32.58 90.43 0.0 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.741 0.781 . . . . 0.0 112.659 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.3 p -127.72 17.98 6.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.184 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 70.92 17.76 75.66 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.428 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 85.9 m -150.35 127.1 10.97 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 123.779 0.341 . . . . 0.0 110.58 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.788 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 70.3 mt -108.02 129.43 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 121.058 0.456 . . . . 0.0 111.399 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -105.04 167.3 9.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.076 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.614 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 48.1 t80 -35.47 -45.81 0.36 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.486 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.4 -63.71 4.11 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.322 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.551 ' OE2' ' HB3' ' A' ' 58' ' ' ASP . 63.0 mt-10 -51.89 -26.15 9.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.684 0.278 . . . . 0.0 110.894 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.736 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 71.7 t80 -63.88 -65.12 0.72 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.431 0.634 . . . . 0.0 110.91 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.575 HG12 ' O ' ' A' ' 65' ' ' TYR . 14.5 mm -52.2 -41.13 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.659 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.2 -25.77 66.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.47 . . . . 0.0 110.572 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.028 179.768 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.454 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 14.4 p . . . . . 0 C--O 1.233 0.187 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 52.3 m -51.11 -55.01 19.88 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.921 0.391 . . . . 0.0 110.118 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -81.12 -39.81 25.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.913 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.818 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 8.1 t80 -45.98 -23.01 0.25 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.358 0.599 . . . . 0.0 110.041 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 87' ' ' ALA . 28.4 t -89.15 -44.81 10.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.737 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -89.29 -63.7 1.25 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.571 ' HB3' HD12 ' A' ' 99' ' ' ILE . 2.5 m-85 -51.97 -62.33 1.7 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.818 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.6 OUTLIER -76.13 55.31 0.93 Allowed 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -44.59 -52.88 7.69 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.42 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.4 -21.44 64.69 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.344 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.08 68.69 1.07 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.5 p -115.59 -23.04 8.93 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.588 ' O ' ' HB2' ' A' ' 134' ' ' ASP . . . 130.51 -4.51 5.86 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-N 113.136 -1.847 . . . . 0.0 112.604 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.836 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.5 OUTLIER -148.69 161.83 40.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.399 0.618 . . . . 0.0 112.649 179.437 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.77 HG12 ' HA ' ' A' ' 92' ' ' ASP . 22.1 mt -133.12 104.24 6.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.779 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 102' ' ' ASP . 69.5 p -72.29 147.11 46.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.712 ' HB3' HG21 ' A' ' 122' ' ' ILE . 4.1 pp -34.41 -33.97 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 100' ' ' THR . 54.2 m-20 -54.31 -55.92 23.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.406 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 97.4 mt-10 -71.19 -31.38 67.57 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.209 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.495 HG13 ' CG2' ' A' ' 99' ' ' ILE . 50.9 mt -65.74 -65.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.187 0.518 . . . . 0.0 110.403 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 119' ' ' ASP . 87.8 mt-30 -58.14 -39.03 77.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.608 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' A' ' 108' ' ' CYS . 53.4 tt0 -59.87 -44.07 94.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.095 0.474 . . . . 0.0 110.644 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.71 -3.06 1.33 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.17 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.753 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 73.2 m -115.09 44.12 1.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.93 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -59.54 -36.71 76.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.811 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -75.02 -22.11 58.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.155 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.753 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 2.7 m-85 -76.76 -5.24 47.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.944 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.37 38.81 96.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.572 -1.299 . . . . 0.0 111.026 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.903 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -33.01 132.72 0.14 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.525 0.679 . . . . 0.0 111.486 -177.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.677 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 91.9 m-20 -135.98 167.68 20.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.259 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.617 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.8 m-20 -82.95 -7.93 59.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.167 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.63 -64.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.039 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -89.46 -69.29 0.72 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.903 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.4 mm -52.72 -19.49 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.958 0.409 . . . . 0.0 111.268 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.617 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 33.6 t70 -71.11 -46.96 60.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 124' ' ' GLU . 63.9 t0 -62.37 -26.26 68.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 1.031 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.4 ttt -60.74 -29.82 69.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.501 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.712 HG21 ' HB3' ' A' ' 101' ' ' LEU . 56.8 mt -58.37 -43.59 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.67 -13.79 44.47 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.584 -1.644 . . . . 0.0 110.374 178.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 1.031 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 71.4 tt0 -84.61 -23.71 29.45 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.79 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.956 HG22 HG13 ' A' ' 133' ' ' ILE . 13.4 mm -107.58 -21.77 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.971 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.3 t70 -62.89 98.43 0.13 Allowed 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.593 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.909 HE21 ' HG2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -87.24 -13.95 42.39 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.439 ' OD1' ' ND2' ' A' ' 129' ' ' ASN . 50.5 p30 -127.57 -33.19 2.33 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.73 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 179.92 -71.71 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.73 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 56.3 m-20 -64.93 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.971 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.53 37.92 77.91 Favored Glycine 0 CA--C 1.505 -0.577 0 C-N-CA 118.358 -1.877 . . . . 0.0 110.044 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.547 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 8.5 pt20 -133.31 170.54 15.3 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 113.929 -1.135 . . . . 0.0 110.073 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.956 HG13 HG22 ' A' ' 125' ' ' ILE . 5.0 mm -133.05 121.89 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.856 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.91 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 4.3 p-10 -113.08 162.48 15.88 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.172 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.788 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 22.4 t80 -38.79 -30.45 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.0 0.428 . . . . 0.0 110.738 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 134' ' ' ASP . . . -84.25 -45.15 6.32 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.726 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.91 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 39.3 mt-10 -63.07 -51.3 67.2 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.569 ' HB2' ' CG2' ' A' ' 133' ' ' ILE . 13.5 t80 -56.61 -18.66 12.77 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 135' ' ' TYR . . . -86.1 -40.82 15.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.5 ' CB ' ' HG3' ' A' ' 127' ' ' GLN . . . -87.29 -11.59 49.1 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' A' ' 138' ' ' PHE . 5.5 ppp? -72.46 -6.67 45.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.635 0.255 . . . . 0.0 111.543 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.009 179.886 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.401 0.143 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.652 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 39.9 ttmt -55.89 -33.1 64.3 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -81.65 -37.93 26.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.755 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 51.8 tp -59.53 -25.96 64.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.143 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -70.89 -40.06 72.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.425 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -86.36 -11.97 50.59 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.656 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -59.46 -34.48 72.59 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.635 HG21 HG21 ' A' ' 27' ' ' ILE . 3.0 mt -81.18 -62.09 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.884 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.647 ' HB2' ' O ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -83.85 66.93 9.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.313 1.054 . . . . 0.0 109.529 178.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -89.34 -20.99 23.34 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.094 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -138.73 8.92 2.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.613 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 31.6 t30 -82.94 -82.61 0.14 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.593 1.088 . . . . 0.0 110.981 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.0 p -176.13 15.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.05 18.51 9.23 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.628 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 39.9 p -148.84 161.2 42.3 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.403 0.62 . . . . 0.0 111.749 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.713 ' O ' ' HA ' ' A' ' 62' ' ' THR . 4.7 mt -111.01 103.82 16.09 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.502 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.616 ' O ' ' N ' ' A' ' 30' ' ' ASP . 65.4 p -112.7 158.22 20.32 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.644 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.809 ' HE2' ' HB2' ' A' ' 49' ' ' LYS . 14.7 t80 -34.45 -20.01 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.616 ' N ' ' O ' ' A' ' 28' ' ' THR . 32.7 t70 -86.18 -39.06 17.04 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.08 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.613 ' OE2' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -90.87 -32.08 16.18 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.727 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -40.45 -51.45 2.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.401 0.62 . . . . 0.0 110.318 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.711 ' HB3' HG12 ' A' ' 48' ' ' ILE . 12.4 ptpt -71.47 -39.4 70.94 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.267 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 38' ' ' ARG . 8.2 t70 -43.98 -47.81 8.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.217 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.476 ' HA3' HG12 ' A' ' 19' ' ' ILE . . . -45.21 -47.22 10.68 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 114.695 0.638 . . . . 0.0 114.695 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.694 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.7 mm? -95.2 -44.13 7.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.592 0.696 . . . . 0.0 112.214 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.688 ' NZ ' ' HD3' ' A' ' 33' ' ' LYS . 15.3 ptpt -56.32 -18.67 11.46 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 38' ' ' ARG . 22.2 ttm-85 -90.83 -25.02 20.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.22 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.694 HG12 ' O ' ' A' ' 36' ' ' LEU . 6.3 p -80.56 -37.48 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.63 -42.65 0.59 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.447 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.6 m -62.75 177.21 0.57 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.795 0.331 . . . . 0.0 110.963 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.34 112.03 7.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.405 ' HB2' HD11 ' A' ' 48' ' ' ILE . 50.5 mt -108.02 165.48 11.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.503 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.431 ' HE3' ' HG3' ' A' ' 47' ' ' GLU . 26.8 ptt? -112.22 162.08 15.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.69 -14.29 19.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.7 t -87.64 -17.11 32.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.199 0.523 . . . . 0.0 109.938 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 97.0 mt-10 -90.73 -46.24 8.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.783 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.727 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -50.77 -50.65 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 122.275 1.036 . . . . 0.0 109.086 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.809 ' HB2' ' HE2' ' A' ' 29' ' ' PHE . 52.3 tttp -64.11 -30.3 71.38 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.383 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 64.1 t0 -64.26 -48.71 74.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.721 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.9 mt -60.43 -15.75 29.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.525 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.728 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 30.5 mtt -88.02 -65.24 1.04 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.439 ' CA ' ' HG3' ' A' ' 59' ' ' LYS . 2.5 p30 -66.73 -25.6 66.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.654 0.264 . . . . 0.0 111.595 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 50' ' ' ASP . . . -91.33 -28.39 17.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.41 -43.93 1.88 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 64.2 t0 -51.18 101.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.032 0.444 . . . . 0.0 110.243 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.9 mm -44.87 -26.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.674 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.597 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 38.7 t70 -133.26 44.72 2.79 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.364 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.728 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 10.2 tmtt? -32.07 92.03 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.941 0.877 . . . . 0.0 112.642 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.1 p -126.71 19.06 7.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.833 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 71.85 16.23 76.29 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.21 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.713 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 58.5 m -147.64 128.14 14.08 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.405 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.697 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 71.5 mt -113.23 130.33 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.157 0.503 . . . . 0.0 110.871 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.43 167.73 9.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.058 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.652 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 66.3 t80 -42.67 -25.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.019 0.437 . . . . 0.0 110.799 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.71 -59.48 2.34 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.753 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HB2' HG22 ' A' ' 63' ' ' ILE . 37.8 mt-10 -56.04 -23.26 32.19 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.646 0.26 . . . . 0.0 110.828 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.755 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 60.4 t80 -68.54 -65.54 0.69 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.566 0.698 . . . . 0.0 110.416 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.548 HG12 ' O ' ' A' ' 65' ' ' TYR . 44.2 mm -47.1 -58.47 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.106 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -44.65 -53.18 7.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.077 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.481 0.181 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 89' ' ' SER . 81.0 p -46.09 -56.72 5.23 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.923 0.392 . . . . 0.0 110.187 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.432 ' C ' ' N ' ' A' ' 89' ' ' SER . . . -68.58 -45.39 72.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.798 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 18.9 t80 -47.51 -19.26 0.17 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.584 0.707 . . . . 0.0 109.979 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 86' ' ' SER . 30.7 m -89.81 -59.61 2.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.695 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.421 ' CG ' ' HB2' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -74.25 -62.97 1.33 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -51.73 -60.55 3.04 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.798 ' HB3' ' O ' ' A' ' 88' ' ' PHE . 62.6 t0 -82.91 69.54 9.74 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.486 ' HZ1' ' HZ3' ' A' ' 49' ' ' LYS . 31.3 ttmt -53.25 -16.05 1.14 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.668 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.8 m-20 -97.49 -24.4 15.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.579 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.93 -12.47 0.81 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.804 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 94' ' ' ASP . 78.9 p -51.83 -22.84 4.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.204 0.502 . . . . 0.0 110.606 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.582 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 126.01 -3.84 7.9 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.038 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -125.8 144.68 50.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.038 0.447 . . . . 0.0 111.849 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.717 HG12 ' HA ' ' A' ' 92' ' ' ASP . 31.2 mt -131.58 102.59 6.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.61 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 103' ' ' GLU . 70.6 p -81.52 156.94 25.01 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.215 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.446 ' HB3' ' CG2' ' A' ' 122' ' ' ILE . 4.0 pp -35.01 -39.86 0.11 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.69 0.281 . . . . 0.0 111.259 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.42 ' N ' HD12 ' A' ' 101' ' ' LEU . 8.3 t70 -57.86 -57.78 11.29 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.469 ' HB2' HG21 ' A' ' 99' ' ' ILE . 51.0 mt-10 -58.89 -48.22 82.19 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.57 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.499 HG21 ' HE2' ' A' ' 121' ' ' MET . 91.1 mt -55.73 -65.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.151 0.5 . . . . 0.0 110.653 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.484 ' HB3' HD12 ' A' ' 113' ' ' LEU . 91.6 mt-30 -56.83 -65.14 0.67 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.11 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -42.38 -32.96 0.58 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.51 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -53.28 -65.57 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.623 ' SG ' ' HB3' ' A' ' 111' ' ' PHE . 51.6 t -62.01 135.0 57.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.881 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -89.12 -47.87 7.79 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -78.9 -3.32 44.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.628 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.7 ' CE2' ' HB2' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -47.19 -27.21 1.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.538 ' O ' HD13 ' A' ' 118' ' ' ILE . . . 60.44 37.61 93.49 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.371 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.7 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 6.4 tt -31.8 126.92 0.23 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.327 0.584 . . . . 0.0 112.306 -176.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.633 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 29.6 t70 -160.2 177.09 11.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.955 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.685 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 2.9 p30 -89.2 -8.19 54.07 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.692 HG23 ' H ' ' A' ' 117' ' ' HIS . 7.1 tp -88.51 -64.69 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.692 ' H ' HG23 ' A' ' 116' ' ' ILE . 16.6 t-160 -92.7 -67.11 0.88 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.031 0.443 . . . . 0.0 111.975 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.633 ' HB ' ' H ' ' A' ' 114' ' ' ASP . 4.4 mp -50.23 -20.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.694 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.685 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 7.7 t70 -76.12 -52.34 10.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' GLU . 37.1 t70 -58.92 -19.64 44.5 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.824 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.5 ttt -68.79 -45.39 71.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.259 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.556 HG23 ' HA3' ' A' ' 131' ' ' GLY . 54.1 mt -51.44 -40.85 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.64 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.6 -13.84 44.53 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.512 -1.677 . . . . 0.0 110.267 178.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.824 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 41.8 tp10 -83.98 -21.42 31.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.493 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.894 HG21 HG13 ' A' ' 133' ' ' ILE . 1.1 mt -105.71 -33.75 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 1.027 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.8 t70 -54.75 95.64 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.793 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 125' ' ' ILE . 15.4 mt-30 -87.67 -9.8 53.13 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.188 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 7.1 t70 -126.79 -32.73 2.56 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -177.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.736 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 178.33 -68.79 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 179.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.736 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 7.3 t70 -63.82 -24.18 67.65 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -172.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 1.027 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 94.95 36.83 5.38 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 107.169 -2.372 . . . . 0.0 107.169 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.657 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 5.3 pt20 -138.21 168.01 20.64 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 112.846 -1.677 . . . . 0.0 108.922 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.894 HG13 HG21 ' A' ' 125' ' ' ILE . 21.5 mm -130.86 131.12 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-O 121.797 0.808 . . . . 0.0 110.978 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.848 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 10.7 t70 -103.03 163.06 12.44 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.69 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.783 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 21.8 t80 -43.76 -37.18 2.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.287 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.2 -36.06 18.94 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.834 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.848 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 46.4 mt-10 -61.13 -57.62 11.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.586 ' HD1' HG23 ' A' ' 133' ' ' ILE . 3.4 t80 -55.49 -39.15 70.07 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.916 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 135' ' ' TYR . . . -65.68 -25.11 67.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.785 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.35 -44.68 10.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -31.17 69.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.565 0.221 . . . . 0.0 111.419 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.1 ttp . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.04 0.448 . . . . 0.0 110.177 179.381 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.441 HD13 ' HE2' ' A' ' 68' ' ' PHE . 43.1 tp . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.602 0.239 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -75.69 -46.61 30.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HG3' ' HE3' ' A' ' 17' ' ' LYS . 85.1 tt0 -69.37 -17.91 63.73 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.681 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.823 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 2.3 tm? -83.6 -39.07 20.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.406 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.551 ' HE1' HG13 ' A' ' 27' ' ' ILE . 2.3 t80 -57.79 -42.67 84.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.1 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HE3' ' HG3' ' A' ' 14' ' ' GLU . 19.5 pttp -80.48 -17.72 50.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.61 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.823 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.39 -32.87 74.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.623 HG22 ' HA3' ' A' ' 35' ' ' GLY . 1.1 mm -71.5 -62.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.289 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB3' HG12 ' A' ' 27' ' ' ILE . 2.5 p30 -89.08 47.23 1.47 Allowed 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.84 0.829 . . . . 0.0 111.255 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 t -71.35 -18.4 62.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.924 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -108.33 -11.48 15.19 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.437 ' HB2' ' CD ' ' A' ' 31' ' ' GLU . 27.1 t-20 -83.06 -88.73 0.09 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 111.426 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.4 p -176.45 12.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.119 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.39 17.88 9.01 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.101 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -135.58 143.59 45.73 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.002 0.43 . . . . 0.0 109.86 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.778 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 8.4 mt -103.73 104.03 16.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 76.6 p -102.55 159.79 15.13 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.536 ' CE1' HG21 ' A' ' 48' ' ' ILE . 25.7 t80 -34.37 -34.13 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 O-C-N 123.79 0.681 . . . . 0.0 111.906 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 28' ' ' THR . 35.8 m-20 -73.45 -50.29 22.42 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.338 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.582 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 28.2 mp0 -78.06 -14.73 59.39 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.714 0.293 . . . . 0.0 111.033 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.841 HD12 HG13 ' A' ' 48' ' ' ILE . 1.6 tm? -55.43 -48.78 73.9 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.849 0.833 . . . . 0.0 108.928 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.886 ' HB2' ' HE3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -82.89 -49.19 9.92 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.313 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.582 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 36.3 m-20 -39.51 -45.33 1.55 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.623 ' HA3' HG22 ' A' ' 19' ' ' ILE . . . -52.37 -50.56 46.79 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.059 -0.591 . . . . 0.0 114.234 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.833 ' HB2' HD23 ' A' ' 43' ' ' LEU . 85.3 mt -75.53 -52.05 11.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.246 0.523 . . . . 0.0 111.685 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.886 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 18.2 ptpt -55.97 -16.03 4.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.985 0.421 . . . . 0.0 110.211 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.436 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -87.1 -39.58 15.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.995 178.421 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.6 p -70.91 -10.73 14.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.285 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.09 -5.22 22.05 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.502 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 61.5 m -78.93 157.86 28.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.664 0.268 . . . . 0.0 111.401 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 14.2 pt-20 -123.54 104.22 8.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.516 0.674 . . . . 0.0 110.936 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.833 HD23 ' HB2' ' A' ' 36' ' ' LEU . 1.7 pp -117.96 166.09 12.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.736 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.446 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 25.9 ptm -118.06 156.04 29.31 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 32.6 tt0 -44.65 -58.22 3.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.6 m -49.39 -25.79 2.76 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 97.8 mt-10 -73.52 -31.84 63.9 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.125 0.488 . . . . 0.0 109.838 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.841 HG13 HD12 ' A' ' 32' ' ' LEU . 1.9 mp -59.78 -64.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.752 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.473 ' HD2' ' CD ' ' A' ' 93' ' ' LYS . 4.5 ttmp? -55.35 -34.07 63.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.267 0.555 . . . . 0.0 109.747 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 36.4 t70 -52.86 -61.0 2.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.474 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.49 HD12 HD23 ' A' ' 32' ' ' LEU . 4.1 pp -65.71 -14.88 62.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.752 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 27.3 mtt -80.76 -65.83 0.96 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.171 0.51 . . . . 0.0 110.987 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 90' ' ' TYR . 41.2 t0 -61.71 -21.94 64.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.867 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -91.53 -40.46 11.35 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 51' ' ' LEU . . . -112.33 -44.27 3.41 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 52' ' ' MET . 66.6 t0 -51.67 98.26 0.02 OUTLIER 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.402 ' O ' HG22 ' A' ' 57' ' ' ILE . 68.2 mt -38.34 -35.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.802 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 60' ' ' SER . 2.8 p30 -133.65 45.37 2.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.013 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.752 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.6 tmtm? -31.74 90.83 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.914 0.864 . . . . 0.0 112.174 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 58' ' ' ASP . 73.4 p -123.98 16.74 9.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.874 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 83.71 14.22 73.6 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.394 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.663 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 57.9 m -153.03 127.2 9.11 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.778 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 68.9 mt -112.28 133.46 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.205 0.526 . . . . 0.0 111.798 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' N ' HG21 ' A' ' 63' ' ' ILE . 1.5 m-20 -104.72 167.32 9.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.679 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.518 ' O ' HG13 ' A' ' 69' ' ' ILE . 25.2 t80 -36.54 -48.33 0.68 Allowed 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.49 -59.86 7.76 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.358 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.651 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 34.7 mt-10 -51.43 -30.07 18.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.854 0.359 . . . . 0.0 110.567 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.534 ' CD2' ' HB2' ' A' ' 16' ' ' PHE . 30.6 t80 -61.87 -46.9 87.41 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.271 0.558 . . . . 0.0 110.945 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 65' ' ' TYR . 10.7 mt -59.96 -19.45 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.616 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.65 -20.51 65.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.251 0.548 . . . . 0.0 109.617 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 68' ' ' PHE . . . . . . . . 0 N--CA 1.454 -0.226 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.057 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.235 0.3 0 CA-C-O 120.476 0.179 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 72.5 m -54.41 -23.87 17.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.238 0.542 . . . . 0.0 109.666 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -84.7 -51.08 7.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.488 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.818 ' HE1' ' HB2' ' A' ' 135' ' ' TYR . 7.9 t80 -39.14 -36.42 0.31 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.116 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.4 t -89.24 -55.49 3.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.228 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.496 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 7.8 t80 -75.77 -63.89 1.2 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.561 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.543 ' O ' ' HB3' ' A' ' 103' ' ' GLU . 3.1 m-85 -58.14 -65.21 0.68 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.769 ' HA ' HG12 ' A' ' 99' ' ' ILE . 12.4 t0 -74.54 60.04 0.86 Allowed 'General case' 0 C--N 1.335 -0.056 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.473 ' CD ' ' HD2' ' A' ' 49' ' ' LYS . 3.0 tppp? -49.2 -40.72 34.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.507 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.52 -21.35 60.42 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.383 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 49.02 72.33 0.48 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.1 p -132.57 -5.0 3.29 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 105.87 5.78 38.16 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 113.799 -1.546 . . . . 0.0 113.322 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.753 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -144.27 157.46 44.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.456 0.646 . . . . 0.0 111.495 179.108 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.769 HG12 ' HA ' ' A' ' 92' ' ' ASP . 77.8 mt -133.18 104.14 6.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.956 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 103' ' ' GLU . 43.6 p -70.8 147.99 48.35 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.766 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.549 ' HB3' HG21 ' A' ' 122' ' ' ILE . 3.6 pp -34.84 -39.22 0.09 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.443 ' N ' HD11 ' A' ' 101' ' ' LEU . 1.6 m-20 -55.55 -54.71 40.6 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.585 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 49.3 mt-10 -60.48 -44.46 95.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.235 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.502 HG13 HG22 ' A' ' 99' ' ' ILE . 96.6 mt -56.72 -65.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.381 0.61 . . . . 0.0 110.676 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.407 ' HG2' ' CE ' ' A' ' 121' ' ' MET . 87.5 mt-30 -58.35 -65.47 0.65 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.488 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -42.79 -34.23 0.89 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -56.17 -66.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.314 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 98.5 m -49.78 134.17 20.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.811 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -89.29 -60.91 1.82 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -75.49 -3.07 31.92 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.82 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.693 ' CE2' ' HB2' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -46.81 -29.39 1.93 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -178.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 62.87 39.21 97.74 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 118.85 -1.643 . . . . 0.0 110.777 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.693 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 9.1 tt -31.63 130.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.463 ' OD2' HG13 ' A' ' 116' ' ' ILE . 35.9 t70 -157.21 175.67 13.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.905 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.702 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.0 m-20 -88.89 -7.45 56.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.495 HG22 ' CE1' ' A' ' 117' ' ' HIS . 60.5 mt -84.86 -65.53 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.495 ' CE1' HG22 ' A' ' 116' ' ' ILE . 4.8 m-70 -92.45 -69.04 0.76 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.711 HG23 ' HE1' ' A' ' 121' ' ' MET . 60.5 mt -52.1 -19.68 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.935 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.702 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 37.4 t70 -75.89 -51.67 12.0 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' GLU . 32.2 m-20 -65.07 -17.9 64.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 1.045 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 13.6 tmm? -65.31 -41.25 94.25 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.823 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.549 HG21 ' HB3' ' A' ' 101' ' ' LEU . 61.1 mt -54.12 -39.68 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.777 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 10.9 mmpt? -86.7 -13.89 44.1 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 112.403 -2.18 . . . . 0.0 110.574 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 1.045 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 29.7 tt0 -94.27 -14.78 25.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.689 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.921 HG23 HG13 ' A' ' 133' ' ' ILE . 29.9 mt -111.97 -35.55 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.379 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.775 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 1.8 t70 -47.02 129.83 12.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.705 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.472 ' HB2' ' CD ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -88.41 -23.15 23.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.529 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 45.3 p-10 -135.24 -32.73 0.93 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.719 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 179.36 -52.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.719 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 31.1 m-20 -64.6 8.76 0.1 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -173.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.775 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.5 37.06 65.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 118.45 -1.833 . . . . 0.0 108.772 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.699 ' NE2' ' HB3' ' A' ' 98' ' ' TYR . 5.7 pt20 -127.59 169.37 13.81 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.805 -1.197 . . . . 0.0 108.982 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.921 HG13 HG23 ' A' ' 125' ' ' ILE . 25.6 mm -135.94 129.97 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.4 0 CA-C-O 121.622 0.725 . . . . 0.0 110.803 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.753 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -102.24 165.19 11.27 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.173 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.818 ' HB2' ' HE1' ' A' ' 88' ' ' PHE . 41.0 t80 -48.06 -31.0 4.93 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.1 -26.52 36.72 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.462 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.649 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 78.7 mt-10 -76.12 -53.86 7.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.824 -0.188 . . . . 0.0 110.521 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.561 ' HB2' HG22 ' A' ' 133' ' ' ILE . 4.1 t80 -60.85 -23.96 65.53 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.838 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 135' ' ' TYR . . . -86.0 -32.55 21.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.747 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.8 -27.8 19.75 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.552 ' HE3' ' CE1' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -62.56 -11.4 16.38 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.749 0.309 . . . . 0.0 111.141 -179.945 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.536 HD22 HD13 ' A' ' 69' ' ' ILE . 52.2 tp . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.609 0.242 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 61.6 tttm -60.78 -43.03 98.61 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.97 -26.94 67.79 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.736 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.702 ' HA ' ' HB3' ' A' ' 18' ' ' MET . 33.4 tp -72.48 -31.12 65.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.946 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.453 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 10.4 t80 -65.94 -48.18 72.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.283 0.564 . . . . 0.0 109.788 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.472 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -76.22 -16.23 59.87 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.702 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 3.1 tpp -66.79 -36.21 81.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.887 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.723 HG23 HG23 ' A' ' 27' ' ' ILE . 10.4 mm -62.85 -57.54 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.614 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.584 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 1.3 t70 -82.48 87.55 6.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.285 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 t -88.19 -24.9 23.17 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.62 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -139.71 -6.14 1.32 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.541 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 53.7 t30 -75.43 -80.42 0.09 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.897 1.226 . . . . 0.0 112.837 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 p -172.34 -0.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.443 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 110.26 23.57 6.01 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.459 ' HB ' ' OG1' ' A' ' 62' ' ' THR . 65.2 p -138.86 147.37 42.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.013 -1.093 . . . . 0.0 109.464 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.843 ' O ' ' HA ' ' A' ' 62' ' ' THR . 2.3 mt -104.21 103.71 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.724 HG23 ' HG1' ' A' ' 62' ' ' THR . 59.9 p -101.97 161.97 13.27 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.48 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 2.0 t80 -34.21 -36.67 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.797 0.686 . . . . 0.0 111.076 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -74.95 -52.16 11.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.432 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.584 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 3.1 tt0 -70.85 -16.41 62.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.183 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.69 HD21 HD11 ' A' ' 51' ' ' LEU . 2.4 tm? -58.98 -55.25 37.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.353 0.597 . . . . 0.0 109.992 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 10.9 ptpt -76.22 -33.42 59.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.668 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -48.47 -58.38 4.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.636 ' HA3' ' HA ' ' A' ' 19' ' ' ILE . . . -61.4 -22.45 61.24 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 114.849 0.7 . . . . 0.0 114.849 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.664 HD11 ' HG ' ' A' ' 43' ' ' LEU . 4.6 pp -95.1 -39.09 10.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.785 0.792 . . . . 0.0 111.252 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HG2' ' O ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -71.28 -15.23 62.41 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.498 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -87.68 -36.85 17.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.255 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 36' ' ' LEU . 9.0 p -75.08 -17.84 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.533 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.49 42.45 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.641 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 35.5 t -130.68 164.1 25.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.676 0.274 . . . . 0.0 110.456 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 10.7 pt-20 -141.89 104.78 4.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.198 0.523 . . . . 0.0 111.695 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.664 ' HG ' HD11 ' A' ' 36' ' ' LEU . 20.5 mt -124.58 165.99 16.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.188 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.551 ' HG3' ' HG ' ' A' ' 46' ' ' SER . 24.4 ptm -113.08 164.03 13.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -45.52 -64.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.8 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.551 ' HG ' ' HG3' ' A' ' 44' ' ' MET . 78.6 p -41.83 -22.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.3 mm-40 -82.31 -47.52 12.27 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.679 HG13 HD11 ' A' ' 32' ' ' LEU . 1.8 mp -51.59 -62.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.553 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . 3.1 tmtm? -46.67 -33.57 4.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.81 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 9.6 t70 -65.55 -43.87 88.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.69 HD11 HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -64.35 -26.54 68.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.425 178.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.892 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 17.7 mmt -80.08 -66.43 0.88 Allowed 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.562 0.696 . . . . 0.0 112.183 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.711 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 1.5 m-20 -59.84 -21.86 61.49 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.873 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.695 ' HB1' ' HB3' ' A' ' 89' ' ' SER . . . -92.55 -42.8 9.49 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ILE . . . -111.73 -39.45 4.58 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.773 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 38.1 t0 -50.07 87.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' ALA . 37.6 mm -47.51 -22.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.559 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 60.0 m-20 -133.06 43.52 2.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.612 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.892 ' HD3' ' HB3' ' A' ' 52' ' ' MET . 56.5 tptt -33.12 90.32 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.695 0.76 . . . . 0.0 112.609 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.8 p -127.68 18.82 6.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.458 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 84.71 5.37 86.61 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.902 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 1.3 t -153.41 150.94 29.35 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.983 0.421 . . . . 0.0 111.312 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.732 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 68.7 mt -117.08 136.48 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.344 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.473 ' N ' HG22 ' A' ' 63' ' ' ILE . 3.1 p30 -105.94 167.57 9.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.139 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.488 ' O ' HG12 ' A' ' 69' ' ' ILE . 18.9 t80 -36.19 -49.57 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.406 0.441 . . . . 0.0 111.615 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.11 -60.37 7.7 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.723 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.535 ' OE1' ' HB2' ' A' ' 58' ' ' ASP . 23.8 mt-10 -53.68 -25.13 16.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.716 0.293 . . . . 0.0 110.602 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.568 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 47.1 t80 -64.79 -50.68 65.82 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.264 0.554 . . . . 0.0 110.474 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.536 HD13 HD22 ' A' ' 12' ' ' LEU . 5.0 mm -60.27 -50.16 81.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.125 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.96 -30.15 68.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.029 0.442 . . . . 0.0 110.215 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 67' ' ' GLU . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.19 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.695 0.284 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.6 m -56.24 -44.46 79.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.198 0.523 . . . . 0.0 109.666 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HA ' ' CD1' ' A' ' 91' ' ' PHE . . . -75.77 -55.04 6.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.831 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.788 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 4.9 t80 -40.59 -25.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.73 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.695 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 22.6 m -90.92 -64.48 1.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -79.16 -42.38 26.27 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.763 0.316 . . . . 0.0 111.683 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 87' ' ' ALA . 5.7 m-85 -63.65 -64.5 0.88 Allowed 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 176.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.882 ' HA ' HG12 ' A' ' 99' ' ' ILE . 56.9 t0 -77.78 70.56 4.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.711 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 22.4 ttmt -43.54 -49.22 7.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.362 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -67.75 -22.71 65.21 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.138 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 49.98 54.27 19.26 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.653 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.8 p -125.49 12.31 8.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.693 ' HA2' ' HE1' ' A' ' 88' ' ' PHE . . . 84.66 21.18 56.78 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.447 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.421 ' HA ' ' OD1' ' A' ' 134' ' ' ASP . 14.3 m-85 -143.52 131.9 22.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.882 HG12 ' HA ' ' A' ' 92' ' ' ASP . 48.6 mt -130.19 101.96 6.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.88 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.48 ' HA ' ' HB3' ' A' ' 132' ' ' GLN . 58.8 p -74.12 164.69 26.3 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.07 -0.394 . . . . 0.0 111.086 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.713 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER -41.28 -36.55 0.81 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.425 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -67.46 -52.38 40.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.279 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 56.3 mt-10 -64.95 -15.88 62.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.636 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.779 HD12 HG13 ' A' ' 133' ' ' ILE . 96.6 mt -87.33 -62.82 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.124 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.713 ' HG2' ' O ' ' A' ' 101' ' ' LEU . 7.1 mm100 -50.27 -51.69 42.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.96 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -60.73 -31.19 70.5 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.22 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 103' ' ' GLU . . . -59.81 -21.54 61.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.87 0.367 . . . . 0.0 110.927 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.546 ' HB3' ' CG ' ' A' ' 111' ' ' PHE . 72.4 m -117.13 66.72 0.73 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.682 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.613 ' HD3' ' H ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -78.4 -39.37 39.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -68.81 -12.6 61.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.183 0.516 . . . . 0.0 110.347 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.546 ' CG ' ' HB3' ' A' ' 108' ' ' CYS . 3.2 m-85 -74.77 -46.81 34.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.827 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.72 37.98 2.66 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.74 ' HA ' HG13 ' A' ' 118' ' ' ILE . 1.0 OUTLIER -33.33 139.07 0.06 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.481 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 52.8 t0 -152.67 150.7 29.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.272 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.654 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 10.2 t70 -57.74 -8.74 0.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.493 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.3 mm -86.67 -64.8 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.439 ' HD1' ' N ' ' A' ' 118' ' ' ILE . 11.3 t-80 -91.68 -68.98 0.76 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.74 HG13 ' HA ' ' A' ' 113' ' ' LEU . 17.5 mm -51.05 -24.36 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.2 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.654 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 36.1 t70 -75.08 -46.26 35.82 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 124' ' ' GLU . 33.3 t70 -62.31 -21.48 65.29 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.874 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 3.8 ttp -65.36 -33.32 75.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.637 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 126' ' ' ASP . 46.3 mt -59.12 -42.48 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.655 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 2.4 mptt -86.72 -12.97 46.73 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.51 -1.677 . . . . 0.0 109.882 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.874 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 17.2 tp10 -86.11 -22.82 26.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.451 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.864 HG22 HG12 ' A' ' 133' ' ' ILE . 14.7 mm -116.56 -13.36 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.566 ' OD1' ' HA ' ' A' ' 123' ' ' LYS . 4.2 p-10 -79.8 54.09 1.77 Allowed 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.564 0.697 . . . . 0.0 110.084 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.523 HE22 ' CG ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -62.56 -9.32 8.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.553 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 6.4 t70 -107.95 -32.91 7.38 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.584 ' N ' HD21 ' A' ' 129' ' ' ASN . 0.0 OUTLIER 178.54 -95.65 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 178.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.697 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 1.5 m-20 -64.75 29.29 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 119.44 3.126 . . . . 0.0 119.44 -173.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.517 ' HA2' ' HB3' ' A' ' 126' ' ' ASP . . . 58.76 37.67 90.52 Favored Glycine 0 CA--C 1.504 -0.631 0 C-N-CA 117.236 -2.411 . . . . 0.0 109.133 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.697 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 6.6 pt20 -136.57 169.28 17.97 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 113.738 -1.231 . . . . 0.0 109.831 -177.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.864 HG12 HG22 ' A' ' 125' ' ' ILE . 49.2 mt -133.16 124.2 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.556 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 54.0 m-20 -101.73 165.53 11.16 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.417 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.635 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 25.8 t80 -44.19 -29.78 0.68 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.068 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.54 -39.64 8.17 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.683 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.768 ' HB2' HG21 ' A' ' 133' ' ' ILE . 32.9 mt-10 -60.54 -50.59 72.93 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.559 ' O ' ' HG2' ' A' ' 142' ' ' MET . 1.3 t80 -64.37 -61.11 2.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.49 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.452 ' HA ' ' HE1' ' A' ' 142' ' ' MET . . . -47.81 -32.95 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.64 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.69 -58.18 2.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.19 -33.02 3.32 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.559 ' HG2' ' O ' ' A' ' 138' ' ' PHE . 27.6 ptt? . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.749 0.309 . . . . 0.0 111.097 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.52 -0.192 0 CA-C-O 120.562 0.22 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 62.8 tttm -64.68 -51.46 62.38 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -65.54 -18.28 65.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.176 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 18' ' ' MET . 0.3 OUTLIER -80.15 -40.31 27.6 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.738 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.46 ' HA ' ' CE1' ' A' ' 68' ' ' PHE . 11.1 t80 -57.4 -44.01 84.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.192 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.565 ' NZ ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -81.75 -12.59 58.52 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.825 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.743 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -67.97 -43.07 79.83 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.834 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 7.7 mt -61.45 -58.07 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.652 ' OD1' ' HB3' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -74.96 84.65 2.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.35 1.071 . . . . 0.0 109.817 178.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -89.18 -22.29 22.87 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.595 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -138.66 -5.67 1.54 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.652 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -71.16 -87.53 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.141 0.882 . . . . 0.0 111.292 -178.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.1 p -177.77 11.65 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.483 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.84 31.23 3.21 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 55.1 p -144.13 152.06 40.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.612 -0.794 . . . . 0.0 110.627 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.849 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 4.5 mt -114.42 104.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.758 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 82.7 p -102.5 160.11 14.85 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.617 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.559 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 17.1 t80 -34.24 -34.61 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.723 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -77.85 -45.48 24.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.843 0.354 . . . . 0.0 110.456 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.526 ' OE2' ' HB2' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -73.04 -24.56 60.72 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.204 178.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.597 ' HB3' HG21 ' A' ' 48' ' ' ILE . 1.4 tm? -50.61 -54.66 20.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.418 0.628 . . . . 0.0 110.059 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 3.8 ptpt -79.03 -39.03 35.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.334 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 37.8 t70 -47.66 -36.6 11.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.468 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.834 ' HA3' ' HA ' ' A' ' 19' ' ' ILE . . . -95.09 -49.62 2.21 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.259 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 41' ' ' SER . 0.2 OUTLIER -57.98 -51.71 68.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.467 0.651 . . . . 0.0 109.898 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.667 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.85 -9.19 42.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.728 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.619 ' HA ' ' HZ2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -80.86 -32.21 35.1 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.802 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.1 m -76.94 2.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.733 0.301 . . . . 0.0 111.404 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.18 10.85 11.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.271 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 40.9 m -92.22 156.98 16.94 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.725 0.298 . . . . 0.0 110.649 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -142.5 104.43 4.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.046 0.45 . . . . 0.0 110.741 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.645 ' HB2' HD13 ' A' ' 48' ' ' ILE . 21.4 mt -131.16 165.52 23.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.465 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.44 ' HG3' ' OE2' ' A' ' 47' ' ' GLU . 37.9 mtm -105.0 165.5 11.03 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.8 mp0 -47.96 -60.72 2.39 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.677 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 t -48.94 -17.19 0.17 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 52.0 mt-10 -90.86 -48.75 6.83 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.645 HD13 ' HB2' ' A' ' 43' ' ' LEU . 1.7 mp -49.83 -58.13 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.559 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . 44.5 tttp -39.9 -34.65 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.106 -1.861 . . . . 0.0 111.115 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.499 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 8.7 t70 -64.26 -50.81 66.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.399 . . . . 0.0 110.216 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 53.2 tp -56.13 -33.28 65.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.995 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.602 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 41.6 ttm -87.54 -66.5 0.91 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.529 0.68 . . . . 0.0 112.705 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.498 ' HA ' ' CG ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -58.42 -34.52 70.88 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.235 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 50' ' ' ASP . . . -91.15 -18.48 24.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 71' ' ' ALA . . . -123.91 -43.56 2.11 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 52' ' ' MET . 65.6 t0 -50.48 101.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.033 0.444 . . . . 0.0 110.093 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.632 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 6.3 mt -50.73 -17.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.481 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 60' ' ' SER . 55.7 m-20 -129.76 43.36 3.14 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.052 -178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.566 ' HD3' ' C ' ' A' ' 59' ' ' LYS . 1.6 tmtp? -33.42 87.16 0.0 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.68 0.753 . . . . 0.0 111.854 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 58' ' ' ASP . 45.6 m -128.04 19.18 6.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.459 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.602 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 68.84 20.87 74.77 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 86.0 m -155.24 133.02 11.34 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.886 -0.657 . . . . 0.0 110.299 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.849 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.1 mt -113.48 134.76 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.152 0.501 . . . . 0.0 111.14 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.523 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 40.1 m-20 -106.68 167.87 9.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.747 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.541 ' O ' HG13 ' A' ' 69' ' ' ILE . 25.2 t80 -35.79 -46.96 0.48 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.695 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.7 -53.82 7.98 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.976 -1.106 . . . . 0.0 112.313 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.641 ' HB2' HG21 ' A' ' 63' ' ' ILE . 24.2 mt-10 -52.08 -25.15 8.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.297 0.57 . . . . 0.0 109.847 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.672 ' HE1' HD12 ' A' ' 19' ' ' ILE . 88.9 t80 -67.77 -65.51 0.68 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.139 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 65' ' ' TYR . 2.8 mt -47.35 -46.72 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.629 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -50.16 75.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 110.421 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.589 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.027 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.559 0.218 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -44.45 -50.96 9.13 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.013 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -75.23 -51.51 13.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.511 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.684 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 3.5 t80 -43.34 -26.97 0.22 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.017 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.446 ' OG ' ' HB2' ' A' ' 54' ' ' ALA . 25.3 t -89.38 -57.99 2.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.536 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -84.61 -54.37 4.77 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.734 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 87' ' ' ALA . 3.1 m-85 -56.97 -65.08 0.68 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.815 ' HA ' HG12 ' A' ' 99' ' ' ILE . 66.2 t0 -72.61 63.23 0.58 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 29.6 ttmt -51.26 -39.49 56.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.225 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.632 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 63.7 m-20 -72.0 -25.02 61.67 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.189 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 44.39 64.56 2.0 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.364 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 77.8 p -118.38 11.22 12.98 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 97.57 4.92 57.99 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 112.195 -2.275 . . . . 0.0 112.697 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 1.1 p90 -165.25 144.94 6.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.815 HG12 ' HA ' ' A' ' 92' ' ' ASP . 51.1 mt -103.24 141.76 18.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.794 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.493 ' HA ' ' CB ' ' A' ' 132' ' ' GLN . 77.0 p -110.73 159.73 17.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.86 0.3 . . . . 0.0 110.255 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.651 ' HA ' HD12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -38.09 -37.56 0.27 Allowed 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.159 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.406 ' N ' ' HG ' ' A' ' 101' ' ' LEU . 65.1 t0 -60.96 -59.77 4.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.628 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -60.05 -22.66 62.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.77 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 101' ' ' LEU . 82.9 mt -75.79 -61.38 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 101' ' ' LEU . 4.0 mm100 -55.29 -33.57 63.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.638 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -80.47 -28.58 37.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.003 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.71 -4.57 9.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.816 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 76.2 m -115.55 77.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.516 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -79.54 -53.87 6.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.55 -16.75 59.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.005 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.816 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 11.1 m-85 -63.46 -56.67 14.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.916 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.45 38.75 1.07 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.998 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.813 HD23 HG22 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -32.63 124.09 0.34 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.541 0.686 . . . . 0.0 112.258 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.55 ' N ' HD21 ' A' ' 113' ' ' LEU . 34.1 t0 -150.71 173.77 13.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.275 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.801 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 1.4 m-20 -77.85 -7.44 56.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.012 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.8 mt -81.71 -65.52 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -92.55 -69.27 0.75 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.813 HG22 HD23 ' A' ' 113' ' ' LEU . 15.1 mt -54.29 -18.89 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.801 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 38.8 t70 -70.6 -64.96 0.8 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.429 0.157 . . . . 0.0 110.924 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 124' ' ' GLU . 54.8 p30 -61.13 -16.99 50.33 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.852 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 22.2 ttp -61.15 -33.74 73.9 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.38 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 131' ' ' GLY . 61.2 mt -58.32 -44.02 87.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.659 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 4.5 mptt -86.33 -13.06 47.66 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.562 -1.654 . . . . 0.0 110.187 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.852 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 41.4 tp10 -81.65 -24.4 36.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.84 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.712 HG23 HG12 ' A' ' 133' ' ' ILE . 19.3 mt -112.17 -19.4 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.206 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.859 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 14.1 t70 -66.13 83.86 0.09 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.844 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.561 ' NE2' ' HA ' ' A' ' 137' ' ' GLU . 8.2 mt-30 -85.19 -8.69 58.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.307 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 12.4 p-10 -126.61 -30.25 2.83 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.716 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.74 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.716 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 1.3 m-20 -65.21 25.95 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 -173.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.859 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.65 37.56 68.56 Favored Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 117.505 -2.283 . . . . 0.0 108.193 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.807 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 10.0 pt20 -129.27 167.07 18.23 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.678 -1.261 . . . . 0.0 109.87 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.745 HG21 ' HB2' ' A' ' 137' ' ' GLU . 18.6 mt -129.75 116.39 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.753 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.735 ' OD1' ' HG3' ' A' ' 137' ' ' GLU . 0.7 OUTLIER -100.33 165.53 11.42 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.684 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 32.5 t80 -45.81 -23.43 0.27 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.178 0.513 . . . . 0.0 110.149 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.43 ' H ' ' CG ' ' A' ' 134' ' ' ASP . . . -82.45 -39.95 10.45 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.049 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.745 ' HB2' HG21 ' A' ' 133' ' ' ILE . 38.8 mt-10 -70.01 -57.46 4.97 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 116.075 -0.063 . . . . 0.0 111.065 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 133' ' ' ILE . 1.3 t80 -57.87 -50.95 71.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.519 -178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 135' ' ' TYR . . . -60.4 -19.52 56.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.648 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' A' ' 142' ' ' MET . . . -90.73 -51.72 5.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.956 0.408 . . . . 0.0 111.86 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -65.19 8.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.325 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.482 ' H ' ' C ' ' A' ' 140' ' ' ALA . 4.1 ppp? . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 110.998 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.516 HD22 HG23 ' A' ' 69' ' ' ILE . 44.2 tp . . . . . 0 CA--C 1.522 -0.106 0 CA-C-O 120.509 0.195 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -60.42 -41.42 93.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 18' ' ' MET . 87.6 tt0 -68.01 -27.68 66.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.72 177.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.706 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 32.6 tp -72.08 -32.88 67.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.082 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.433 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 6.0 t80 -64.58 -50.25 67.97 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.337 0.589 . . . . 0.0 109.537 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -73.64 -15.03 61.26 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.706 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -70.07 -20.46 63.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.805 178.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.718 HG22 HG22 ' A' ' 27' ' ' ILE . 9.2 mm -81.24 -62.16 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.828 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.624 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -85.76 70.42 10.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.895 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.696 HG22 HH22 ' A' ' 38' ' ' ARG . 15.1 t -87.25 -6.46 58.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.244 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -131.98 -24.13 2.16 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.58 -76.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.7 p -175.0 -4.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.461 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 110.4 30.12 3.44 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -177.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.568 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 49.6 p -143.71 146.34 33.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 113.837 -1.182 . . . . 0.0 109.413 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.891 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.1 mt -103.24 104.22 16.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 68.6 p -103.39 165.99 10.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.609 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.643 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 9.5 t80 -34.24 -33.33 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.146 -0.933 . . . . 0.0 112.327 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -79.49 -52.66 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.889 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.624 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 31.9 mt-10 -73.65 -14.16 61.12 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.494 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.523 HD11 HG13 ' A' ' 48' ' ' ILE . 2.3 tm? -54.89 -56.21 22.01 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 12.8 ptpt -75.62 -44.01 45.05 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.281 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 62.3 t0 -43.15 -65.33 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 0.0 110.494 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.513 ' HA3' HD13 ' A' ' 19' ' ' ILE . . . -62.21 -50.68 62.79 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.542 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.508 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -60.72 -65.11 0.74 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 117.263 0.532 . . . . 0.0 110.738 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.607 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -51.97 -23.95 5.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.204 179.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.696 HH22 HG22 ' A' ' 21' ' ' THR . 38.4 ttm180 -57.73 -43.67 85.47 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.143 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 36' ' ' LEU . 22.3 m -73.5 20.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 38' ' ' ARG . . . 100.0 -15.45 59.32 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.414 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 37' ' ' LYS . 74.4 m -60.45 155.4 18.36 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.795 0.331 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 15.5 pt-20 -138.56 107.25 5.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.163 0.506 . . . . 0.0 110.854 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 mt -125.34 166.1 17.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.153 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.454 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 30.2 mtm -111.69 163.99 13.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HG2' ' HZ3' ' A' ' 33' ' ' LYS . 34.0 mt-10 -49.15 -65.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.043 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.2 m -48.9 -20.67 0.53 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.465 0.575 . . . . 0.0 111.932 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 95.1 mt-10 -80.29 -43.84 20.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.523 HG13 HD11 ' A' ' 32' ' ' LEU . 1.7 mp -55.44 -54.86 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 122.266 1.031 . . . . 0.0 108.5 177.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.643 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . 50.8 tttp -58.81 -29.0 66.54 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.322 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 38.0 t70 -67.99 -53.77 23.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.687 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 tt -54.91 -32.13 60.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.47 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.514 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 25.2 mtt -72.1 -65.72 0.74 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.585 ' N ' ' HD3' ' A' ' 59' ' ' LYS . 41.9 t0 -65.36 -18.82 65.62 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.119 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . -91.77 -34.1 14.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.859 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -118.67 -43.67 2.67 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 52' ' ' MET . 63.7 t0 -46.89 99.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.5 mm -50.38 -23.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.041 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.634 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 7.9 t70 -130.59 45.66 2.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.416 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.585 ' HD3' ' N ' ' A' ' 53' ' ' ASP . 23.3 tptm -31.99 91.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.83 0.824 . . . . 0.0 112.992 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 58' ' ' ASP . 39.7 m -127.42 18.62 6.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.546 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 68.33 19.09 72.11 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 97.0 m -146.55 143.35 28.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.6 -0.8 . . . . 0.0 109.759 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.891 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.9 mt -128.3 126.6 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.191 0.52 . . . . 0.0 111.587 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 65' ' ' TYR . 31.4 m-20 -104.29 167.73 9.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.596 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.607 ' O ' HG13 ' A' ' 69' ' ' ILE . 33.9 t80 -34.85 -47.92 0.37 Allowed 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.229 0.331 . . . . 0.0 111.412 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.31 -61.71 6.81 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.115 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.634 ' OE2' ' HB3' ' A' ' 58' ' ' ASP . 28.0 mt-10 -56.28 -24.82 45.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.687 0.28 . . . . 0.0 111.16 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.648 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 39.4 t80 -65.21 -53.8 39.08 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.298 0.571 . . . . 0.0 110.817 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.607 HG13 ' O ' ' A' ' 65' ' ' TYR . 3.7 mt -61.25 -46.3 96.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.063 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.18 -10.78 53.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.308 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.558 -179.837 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.434 ' HA ' ' CB ' ' A' ' 88' ' ' PHE . 32.6 m . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.626 0.25 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -53.3 -66.04 0.46 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.847 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.463 ' HB2' ' CE2' ' A' ' 138' ' ' PHE . . . -69.78 -33.27 72.16 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.81 ' HZ ' ' HA2' ' A' ' 97' ' ' GLY . 11.3 t80 -46.42 -22.12 0.23 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.528 177.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.422 ' N ' ' C ' ' A' ' 87' ' ' ALA . 46.6 t -89.17 -43.3 11.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.6 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -81.09 -64.48 1.18 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.496 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -56.12 -61.89 2.08 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.778 ' HA ' HG12 ' A' ' 99' ' ' ILE . 63.1 t0 -80.6 61.69 4.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.418 ' HE3' ' NE2' ' A' ' 106' ' ' GLN . 19.6 ttmm -42.28 -36.08 1.15 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.144 -177.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -89.84 -22.84 21.87 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.601 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.403 ' HA2' ' OD2' ' A' ' 92' ' ' ASP . . . 52.97 73.88 0.36 Allowed Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 60.1 p -122.37 -5.3 8.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.81 ' HA2' ' HZ ' ' A' ' 88' ' ' PHE . . . 109.78 -9.8 32.24 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.967 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.518 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -142.24 158.54 43.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.558 0.694 . . . . 0.0 112.383 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.778 HG12 ' HA ' ' A' ' 92' ' ' ASP . 82.3 mt -131.61 104.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.711 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.7 p -69.14 147.34 51.53 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.751 HD12 HD13 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -35.27 -35.63 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -57.02 -52.82 63.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.672 0.273 . . . . 0.0 111.023 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.445 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 97.4 mt-10 -59.93 -30.4 69.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.723 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.761 HD12 HG12 ' A' ' 133' ' ' ILE . 88.4 mt -75.67 -61.58 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.104 0.478 . . . . 0.0 110.283 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.736 ' NE2' ' HA ' ' A' ' 118' ' ' ILE . 0.7 OUTLIER -51.91 -29.26 19.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.734 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.418 ' NE2' ' HE3' ' A' ' 93' ' ' LYS . 41.5 tt0 -63.82 -42.86 97.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.904 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 108' ' ' CYS . . . -50.02 -65.9 0.48 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.974 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.797 ' HB2' ' CD1' ' A' ' 111' ' ' PHE . 10.6 p -34.31 115.89 0.28 Allowed 'General case' 0 C--O 1.22 -0.475 0 O-C-N 123.739 0.649 . . . . 0.0 109.622 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.546 ' HE2' ' NZ ' ' A' ' 49' ' ' LYS . 25.1 ttmm -88.46 -58.66 2.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.25 -15.55 4.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.444 0.64 . . . . 0.0 110.065 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.797 ' CD1' ' HB2' ' A' ' 108' ' ' CYS . 0.2 OUTLIER -112.27 -49.76 2.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.189 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 108' ' ' CYS . . . 79.62 -21.94 4.28 Favored Glycine 0 CA--C 1.509 -0.33 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.248 -177.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.675 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER 176.44 53.84 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.512 ' O ' HG13 ' A' ' 118' ' ' ILE . 51.1 t0 -34.04 100.2 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 112.248 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.62 -18.0 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.502 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.4 mm -92.35 -49.39 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.795 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.568 ' CD2' ' HG3' ' A' ' 121' ' ' MET . 15.2 t-160 -78.65 -38.85 38.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.448 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.736 ' HA ' ' NE2' ' A' ' 105' ' ' GLN . 3.2 mt -36.11 -61.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -48.26 -60.44 2.65 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.9 0.381 . . . . 0.0 111.412 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.703 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 57.9 m-20 -67.64 -17.08 64.48 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.613 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.727 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.8 mtp -77.26 -52.69 8.78 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 123.631 0.772 . . . . 0.0 112.338 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.751 HD13 HD12 ' A' ' 101' ' ' LEU . 55.4 mt -50.05 -39.47 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.676 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.51 -19.13 29.97 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.249 -1.796 . . . . 0.0 110.959 178.401 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.727 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 17.0 tp10 -79.32 -18.26 52.92 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.933 HG22 HG13 ' A' ' 133' ' ' ILE . 16.2 mt -115.43 -32.89 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.213 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.707 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 13.1 t0 -62.98 112.7 2.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.236 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.678 ' NE2' ' HB3' ' A' ' 137' ' ' GLU . 0.3 OUTLIER -89.22 -9.71 49.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -133.54 -32.35 1.15 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -178.42 -72.49 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 117.314 2.339 . . . . 0.0 117.314 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.454 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 40.1 t0 -63.78 13.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -172.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.707 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.97 37.68 71.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 117.804 -2.141 . . . . 0.0 108.967 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.772 ' O ' HD13 ' A' ' 133' ' ' ILE . 7.7 pt20 -128.98 167.18 17.83 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 113.435 -1.382 . . . . 0.0 109.675 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.933 HG13 HG22 ' A' ' 125' ' ' ILE . 40.1 mm -125.8 124.56 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 CA-C-O 122.107 0.956 . . . . 0.0 111.404 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.894 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 35.4 t70 -103.03 158.79 16.05 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.18 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.644 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 16.0 t80 -48.41 -27.83 2.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.136 0.493 . . . . 0.0 109.872 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.51 -38.04 9.2 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.894 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 51.0 mt-10 -63.45 -57.99 8.49 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 133' ' ' ILE . 26.4 t80 -52.41 -18.53 1.68 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.151 0.5 . . . . 0.0 109.978 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.69 -36.14 29.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.251 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.64 -38.45 25.92 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.647 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.569 ' HB3' ' OE1' ' A' ' 127' ' ' GLN . 5.3 ppp? -56.49 -20.19 19.06 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.851 0.357 . . . . 0.0 110.997 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 36.8 ttm . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.68 -179.933 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 86.6 mt . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.483 0.183 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -68.24 -53.7 22.86 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.815 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 39.2 tt0 -64.92 -22.99 67.09 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.624 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 47.9 tp -74.88 -37.77 62.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.873 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.532 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 14.1 t80 -61.36 -46.85 88.51 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.815 ' HE2' ' HA ' ' A' ' 14' ' ' GLU . 59.5 pttt -75.96 -12.92 60.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.624 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.73 -18.01 60.56 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.891 178.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.551 ' HA ' ' CA ' ' A' ' 35' ' ' GLY . 7.1 mm -82.61 -61.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.932 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.716 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -77.65 59.81 2.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.823 -178.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 t -87.18 -6.15 58.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.495 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.608 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 5.4 m-20 -113.82 -28.1 7.54 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -83.03 -89.81 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.864 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.0 p -176.15 19.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.395 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.616 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.54 22.97 5.86 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.716 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 76.2 p -137.62 143.64 41.54 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.911 -0.644 . . . . 0.0 110.154 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.853 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.3 mt -102.34 103.7 15.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.745 -177.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 82.2 p -104.02 165.47 11.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.097 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.475 ' CD1' HG22 ' A' ' 48' ' ' ILE . 43.2 t80 -34.13 -34.47 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.778 0.674 . . . . 0.0 112.438 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -79.31 -48.02 14.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.929 0.395 . . . . 0.0 110.494 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.608 ' OE2' ' HB2' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -74.57 -14.32 60.77 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.363 178.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.667 HD11 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -58.63 -56.03 27.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.611 ' NZ ' HG12 ' A' ' 48' ' ' ILE . 6.4 ptpp? -73.92 -48.1 33.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.523 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.665 ' O ' ' HB3' ' A' ' 38' ' ' ARG . 32.1 t70 -37.84 -64.18 0.42 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.41 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.551 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . -47.39 -41.02 16.34 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 115.459 0.944 . . . . 0.0 115.459 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.489 HD11 ' C ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -94.99 -56.08 2.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.91 0.855 . . . . 0.0 110.955 -178.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.647 ' HZ3' ' HA ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -50.18 -18.08 0.53 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.401 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.665 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 6.3 ptm180 -67.14 -38.43 85.51 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.9 23.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.76 -23.25 33.12 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.735 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m -59.52 156.13 13.88 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.741 0.305 . . . . 0.0 110.632 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -136.78 109.28 7.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.233 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 mt -113.04 165.27 12.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.974 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.417 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 28.0 mtm -113.86 157.55 22.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 48' ' ' ILE . 37.5 mt-10 -44.87 -64.99 0.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.1 t -42.95 -29.44 0.33 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 56.7 mm-40 -70.39 -40.36 73.96 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.264 0.555 . . . . 0.0 109.569 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.667 HG13 HD11 ' A' ' 32' ' ' LEU . 1.7 mp -59.67 -60.94 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.321 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -56.58 -26.63 55.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.645 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.547 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 60.6 t0 -66.29 -46.17 77.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.829 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.65 -21.69 65.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.142 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.772 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 21.7 mmt -73.24 -43.54 61.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.477 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -86.96 -23.66 25.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.867 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . -91.56 -25.55 19.17 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -127.49 -43.77 1.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.74 ' HB3' ' O ' ' A' ' 52' ' ' MET . 67.3 t0 -59.2 94.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.345 0.593 . . . . 0.0 110.241 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 57' ' ' ILE . 37.0 mm -51.91 -19.43 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.337 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 60' ' ' SER . 8.4 t70 -130.3 43.9 3.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.638 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.772 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 12.7 tmtt? -32.7 88.2 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.744 0.783 . . . . 0.0 112.436 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' ASP . 76.3 p -128.55 18.32 6.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.062 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 75.89 15.24 81.47 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.375 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 97.2 m -146.55 142.71 28.28 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.118 0.567 . . . . 0.0 109.62 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.853 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 57.7 mt -128.98 133.69 65.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.271 0.558 . . . . 0.0 112.204 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 58.0 m-20 -106.53 167.97 9.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.616 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.413 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 29.4 t80 -35.27 -44.04 0.25 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.509 0.505 . . . . 0.0 111.717 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -56.0 7.99 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.765 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.737 ' HB2' HG23 ' A' ' 63' ' ' ILE . 24.1 mt-10 -56.25 -19.7 15.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 110.441 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.59 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 42.0 t80 -68.57 -60.04 2.7 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.555 0.693 . . . . 0.0 110.495 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.411 ' C ' ' H ' ' A' ' 71' ' ' ALA . 16.9 mm -59.97 -26.13 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.291 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 55' ' ' ALA . . . -61.78 -8.86 5.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.961 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 68' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.639 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.536 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . 33.8 m . . . . . 0 C--O 1.234 0.246 0 CA-C-O 120.719 0.295 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.486 ' N ' HG22 ' A' ' 85' ' ' VAL . 51.2 m -53.73 -21.98 8.29 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -76.92 -55.02 5.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.409 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.689 ' CE1' ' HA ' ' A' ' 135' ' ' TYR . 40.6 m-85 -49.77 -20.07 0.77 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.217 0.532 . . . . 0.0 109.719 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 87' ' ' ALA . 48.1 t -88.93 -48.06 7.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.05 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -83.11 -63.82 1.29 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.492 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.8 m-85 -58.99 -62.56 1.79 Allowed 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.747 ' HA ' HG12 ' A' ' 99' ' ' ILE . 62.7 t0 -74.81 63.89 1.21 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -48.19 -43.33 31.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.231 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.8 m-20 -74.08 -22.63 59.43 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.474 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . 64.56 -10.02 0.34 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.339 -0.458 . . . . 0.0 112.963 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 94' ' ' ASP . 79.1 p -49.58 -16.3 0.21 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 95' ' ' GLY . . . 130.56 -29.78 3.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.623 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.747 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -115.03 163.31 15.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.678 0.751 . . . . 0.0 112.709 -178.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.747 HG12 ' HA ' ' A' ' 92' ' ' ASP . 54.5 mt -133.13 102.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.221 177.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 101' ' ' LEU . 44.9 p -73.63 149.28 42.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.75 HD23 HG21 ' A' ' 122' ' ' ILE . 4.0 pp -34.95 -39.41 0.1 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.75 0.31 . . . . 0.0 111.115 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.443 ' N ' HD11 ' A' ' 101' ' ' LEU . 1.6 m-20 -54.89 -60.97 2.63 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.623 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 50.4 mt-10 -51.87 -47.88 64.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.977 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.8 HD12 HG12 ' A' ' 133' ' ' ILE . 90.5 mt -54.73 -65.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.701 0.762 . . . . 0.0 111.362 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.696 ' HB3' ' CD2' ' A' ' 113' ' ' LEU . 2.4 mm-40 -62.18 -65.23 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.925 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -42.26 -37.4 1.49 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.699 0.285 . . . . 0.0 111.667 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 103' ' ' GLU . . . -48.65 -57.99 5.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 3.4 t -57.0 131.87 51.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.557 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.9 -48.0 7.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.126 0.489 . . . . 0.0 112.294 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.13 -0.63 55.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.334 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.612 ' HB3' ' HB3' ' A' ' 108' ' ' CYS . 0.0 OUTLIER -44.94 -83.76 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.327 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.461 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 107.05 40.09 1.88 Allowed Glycine 0 C--N 1.333 0.399 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.207 -176.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.798 ' HA ' HG12 ' A' ' 118' ' ' ILE . 15.2 mt -31.25 133.02 0.09 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -176.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.707 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 12.4 p-10 -152.79 172.78 16.19 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.651 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 8.7 t70 -73.85 -22.22 59.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.548 HG23 ' HD1' ' A' ' 117' ' ' HIS . 62.3 mt -72.39 -64.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.548 ' HD1' HG23 ' A' ' 116' ' ' ILE . 16.9 m80 -92.17 -70.1 0.71 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.798 HG12 ' HA ' ' A' ' 113' ' ' LEU . 1.7 mp -47.31 -55.36 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -177.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.497 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 37.9 m-20 -60.63 -49.3 78.06 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.744 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 8.6 t70 -67.66 -19.48 65.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.953 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.2 mtp -69.89 -40.04 75.9 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.844 0.858 . . . . 0.0 110.274 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.75 HG21 HD23 ' A' ' 101' ' ' LEU . 56.8 mt -50.8 -46.63 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 43.7 mmtt -87.37 -13.58 43.06 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.006 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.953 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 15.9 tp10 -86.27 -17.1 35.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.71 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.847 HG21 HG13 ' A' ' 133' ' ' ILE . 22.6 mt -113.52 -32.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.331 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.614 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 17.3 t70 -63.33 112.29 2.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.954 0.407 . . . . 0.0 111.618 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.664 ' NE2' ' HB3' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -88.31 -9.37 53.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 36.7 m-20 -131.32 -32.13 1.58 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -176.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -178.79 -74.26 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.67 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 21.4 m-20 -63.97 17.77 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.614 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.07 37.29 62.91 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.376 -1.869 . . . . 0.0 108.99 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.758 ' O ' HD12 ' A' ' 133' ' ' ILE . 8.7 pt20 -131.55 166.92 20.33 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 113.934 -1.133 . . . . 0.0 109.148 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.847 HG13 HG21 ' A' ' 125' ' ' ILE . 36.0 mm -123.5 131.99 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-O 121.736 0.779 . . . . 0.0 111.172 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.784 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 39.0 t70 -101.09 160.32 14.48 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.876 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.689 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 15.0 t80 -48.05 -31.44 5.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.132 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.61 -33.55 15.99 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 119.888 -1.148 . . . . 0.0 110.429 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.784 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 52.6 mt-10 -64.28 -58.0 7.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.37 -0.415 . . . . 0.0 111.197 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.455 ' CD1' HG22 ' A' ' 133' ' ' ILE . 2.8 t80 -54.53 -37.94 65.98 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.753 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.09 -20.92 64.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.181 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.3 -50.33 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -19.91 9.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.688 0.28 . . . . 0.0 111.292 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.408 ' HB2' ' HE1' ' A' ' 142' ' ' MET . 67.6 mtm . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.811 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.6 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 7.5 mp . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 111.341 0.126 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.578 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 7.9 tmtm? -56.39 -53.64 54.96 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.627 ' HA ' ' NZ ' ' A' ' 17' ' ' LYS . 88.7 tt0 -66.4 -43.82 84.75 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.982 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.747 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 29.0 tp -58.79 -23.04 59.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.729 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' LEU . 37.9 t80 -76.02 -56.58 4.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.995 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.627 ' NZ ' ' HA ' ' A' ' 14' ' ' GLU . 25.2 pttm -71.52 -12.52 61.42 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.426 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 10.1 mtp -70.26 -37.98 75.02 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.199 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.833 HG21 HG22 ' A' ' 27' ' ' ILE . 3.3 mt -64.56 -57.6 10.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.997 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 26' ' ' THR . 1.6 p30 -81.33 61.09 4.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.876 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -72.85 -14.51 61.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.333 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -138.21 -15.26 1.29 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.622 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 27.6 t-20 -64.18 -81.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.0 p -176.91 2.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.504 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.41 12.43 17.26 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.549 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 53.5 p -126.24 152.97 45.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.574 -0.813 . . . . 0.0 108.944 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.833 HG22 HG21 ' A' ' 19' ' ' ILE . 3.6 mt -110.0 103.22 15.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 81.3 p -103.9 153.55 20.66 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.898 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.667 ' HZ ' ' HB3' ' A' ' 45' ' ' GLU . 59.8 t80 -34.12 -26.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 28' ' ' THR . 54.9 m-20 -80.5 -39.78 27.31 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.622 ' HG2' ' HB2' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -86.83 -29.6 22.12 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.531 178.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.702 HD13 HG13 ' A' ' 48' ' ' ILE . 2.1 tm? -39.91 -49.52 2.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.789 0.804 . . . . 0.0 109.644 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.733 ' HZ1' ' HG3' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -77.24 -37.41 53.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.143 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.595 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 9.5 t70 -46.53 -27.73 1.2 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.08 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.673 ' HA2' ' HA ' ' A' ' 19' ' ' ILE . . . -55.92 -50.5 60.97 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.802 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.688 ' O ' HG12 ' A' ' 39' ' ' VAL . 2.2 mm? -92.59 -28.62 16.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.825 0.345 . . . . 0.0 110.766 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.602 ' HZ3' ' HD3' ' A' ' 33' ' ' LYS . 51.7 mtmt -56.94 -48.51 78.12 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -59.74 -37.63 79.48 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.842 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -70.19 -21.99 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.811 -178.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.33 -27.11 4.28 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.052 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 74.1 m -65.03 154.54 37.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.689 0.28 . . . . 0.0 111.095 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -126.82 103.08 7.32 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.564 0.697 . . . . 0.0 111.241 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.704 HD11 ' HB3' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -111.61 166.87 10.79 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.397 -179.366 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.507 ' HG3' ' HG3' ' A' ' 47' ' ' GLU . 17.3 ptt? -107.84 165.45 11.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.646 0.26 . . . . 0.0 110.829 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.733 ' HG3' ' HZ1' ' A' ' 33' ' ' LYS . 58.5 mp0 -51.82 -64.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.7 m -43.18 -17.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.507 ' HG3' ' HG3' ' A' ' 44' ' ' MET . 96.0 mt-10 -84.69 -41.59 16.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.702 HG13 HD13 ' A' ' 32' ' ' LEU . 1.5 mp -56.17 -49.77 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.44 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.526 ' CE ' ' HD3' ' A' ' 93' ' ' LYS . 4.3 ttmp? -57.95 -22.45 49.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.566 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 9.0 t70 -75.18 -25.7 58.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.622 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.447 ' HB3' HD11 ' A' ' 32' ' ' LEU . 62.4 tp -90.37 -30.89 17.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.05 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.736 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 39.1 ttm -88.02 -66.16 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.802 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.83 ' HA ' ' HG3' ' A' ' 59' ' ' LYS . 60.9 t0 -68.16 -38.77 82.45 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.75 -12.06 49.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -127.34 -44.12 1.58 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.63 ' HB3' ' O ' ' A' ' 52' ' ' MET . 63.2 t0 -53.97 132.67 42.69 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.2 mm -81.61 -14.75 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.805 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 60' ' ' SER . 74.0 m-20 -128.21 28.62 5.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.762 -178.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.83 ' HG3' ' HA ' ' A' ' 53' ' ' ASP . 12.1 tmtt? -31.61 90.68 0.0 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.937 0.875 . . . . 0.0 112.137 -177.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.7 p -128.26 18.39 6.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.519 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.542 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 81.72 15.42 75.61 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.65 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.703 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 40.4 m -155.82 128.47 7.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.494 0.318 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.819 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 52.9 mt -110.86 136.47 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 121.178 0.513 . . . . 0.0 110.941 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' N ' HG23 ' A' ' 63' ' ' ILE . 49.9 m-20 -104.6 168.96 8.74 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.161 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.578 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 26.6 t80 -40.6 -39.26 1.01 Allowed 'General case' 0 CA--C 1.519 -0.213 0 O-C-N 123.42 0.45 . . . . 0.0 111.093 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.9 -57.78 4.31 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.922 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.551 ' HB3' ' OD1' ' A' ' 56' ' ' ASP . 34.4 mt-10 -49.79 -20.77 0.92 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.242 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.747 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 68.6 t80 -69.89 -57.26 5.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.389 0.614 . . . . 0.0 110.653 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mt -63.54 -40.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.16 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.92 -6.58 28.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.043 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 67' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.495 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.685 0.278 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 m -48.9 -30.37 5.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.396 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.41 ' C ' ' N ' ' A' ' 89' ' ' SER . . . -81.53 -52.2 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.241 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.814 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 11.9 t80 -42.81 -26.5 0.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.278 0.561 . . . . 0.0 109.854 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.41 ' N ' ' C ' ' A' ' 87' ' ' ALA . 31.7 t -89.22 -58.33 2.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.952 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -77.03 -63.84 1.27 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.398 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.575 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.6 m-85 -55.47 -61.84 2.07 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.814 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 1.0 OUTLIER -74.55 60.41 0.88 Allowed 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.526 ' HD3' ' CE ' ' A' ' 49' ' ' LYS . 26.3 ttmt -47.61 -41.63 22.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.037 -177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 96' ' ' SER . 1.4 m-20 -79.73 -21.15 44.9 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.919 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . 65.06 -6.16 1.09 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.971 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 94' ' ' ASP . 86.1 p -55.7 -8.28 0.38 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.886 0.374 . . . . 0.0 110.894 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 95' ' ' GLY . . . 108.17 -0.49 33.31 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.729 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.77 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.6 OUTLIER -139.24 154.1 47.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.675 0.75 . . . . 0.0 112.818 -178.649 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.861 HG21 HG12 ' A' ' 104' ' ' ILE . 85.9 mt -132.15 102.95 6.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.345 177.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.519 ' HA ' ' CB ' ' A' ' 132' ' ' GLN . 67.8 p -87.02 163.74 16.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.947 0.794 . . . . 0.0 111.226 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.852 ' HB3' HG23 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -35.95 -36.99 0.09 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.105 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.3 -54.15 44.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.905 0.383 . . . . 0.0 110.111 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.595 ' O ' ' HB1' ' A' ' 107' ' ' ALA . 52.1 mt-10 -62.66 -31.42 72.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.143 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.861 HG12 HG21 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -75.39 -64.97 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.638 ' NE2' HD11 ' A' ' 122' ' ' ILE . 14.6 mt-30 -54.4 -31.88 56.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.688 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -73.19 -47.33 44.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.044 0.45 . . . . 0.0 110.078 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' A' ' 103' ' ' GLU . . . -64.82 -2.99 2.89 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.161 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.625 ' SG ' HG22 ' A' ' 118' ' ' ILE . 24.2 p -135.58 39.66 2.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.094 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -67.54 -23.05 65.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.956 0.408 . . . . 0.0 110.477 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.36 -6.59 59.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.599 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -91.48 14.27 15.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.851 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.92 37.57 56.63 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.078 -1.058 . . . . 0.0 111.875 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.8 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -34.55 117.25 0.35 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.371 0.605 . . . . 0.0 112.042 -178.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.643 ' N ' HD23 ' A' ' 113' ' ' LEU . 54.5 m-20 -154.58 -177.09 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.027 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.719 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 12.3 p-10 -84.07 -7.65 59.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.436 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.6 mm -83.38 -64.77 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.422 ' O ' ' HB2' ' A' ' 121' ' ' MET . 4.6 m-70 -91.91 -68.5 0.79 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.8 HG13 ' HA ' ' A' ' 113' ' ' LEU . 40.5 mm -52.09 -20.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.214 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.719 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 8.1 t70 -76.5 -60.94 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 124' ' ' GLU . 33.9 m-20 -58.42 -17.09 17.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.719 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 14.2 ttp -67.51 -46.84 71.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.584 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.852 HG23 ' HB3' ' A' ' 101' ' ' LEU . 59.9 mt -48.74 -41.48 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 176.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 123' ' ' LYS . 24.4 mmtp -87.36 -19.84 27.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.308 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.719 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 4.8 tp10 -76.12 -16.31 59.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.568 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.737 HD12 HD12 ' A' ' 133' ' ' ILE . 1.2 mt -117.15 -34.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.033 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.76 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 22.8 t70 -55.27 93.32 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.113 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.557 ' NE2' ' HA ' ' A' ' 137' ' ' GLU . 17.8 mt-30 -83.81 -9.27 58.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.009 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 6.6 p-10 -131.65 -30.6 1.63 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.723 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -176.79 -80.42 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 118.277 2.695 . . . . 0.0 118.277 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.723 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 15.7 m-20 -64.08 27.41 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -172.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.76 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 54.95 37.69 63.24 Favored Glycine 0 CA--C 1.498 -1.004 0 C-N-CA 118.184 -1.96 . . . . 0.0 108.893 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.77 ' NE2' ' HB3' ' A' ' 98' ' ' TYR . 12.7 pt20 -135.17 166.26 23.5 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.375 -0.912 . . . . 0.0 110.841 -176.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.737 HD12 HD12 ' A' ' 125' ' ' ILE . 4.4 mt -121.54 125.28 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.353 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.615 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -103.97 165.54 10.98 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.658 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 30.5 t80 -49.84 -24.42 2.43 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.763 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.88 -44.87 11.28 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.557 ' HA ' ' NE2' ' A' ' 127' ' ' GLN . 42.1 mt-10 -62.08 -62.75 1.56 Allowed 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.644 ' HD1' HG23 ' A' ' 133' ' ' ILE . 1.9 t80 -56.38 -32.63 64.97 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.2 -0.6 . . . . 0.0 112.111 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.74 -23.07 49.42 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.143 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.71 -51.2 5.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.037 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 138' ' ' PHE . 27.3 ptm -49.11 -22.91 1.04 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.58 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.415 ' HB2' ' HE3' ' A' ' 142' ' ' MET . 63.3 mtm . . . . . 0 C--N 1.332 -0.185 0 CA-C-O 120.868 0.366 . . . . 0.0 110.695 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.495 HD22 ' HE2' ' A' ' 68' ' ' PHE . 3.2 tm? . . . . . 0 C--O 1.231 0.082 0 N-CA-C 110.771 -0.085 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -51.99 -38.96 58.56 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.101 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.693 ' O ' ' HG2' ' A' ' 18' ' ' MET . 38.6 tt0 -70.94 -49.72 42.53 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.641 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 55.5 tp -47.99 -33.12 7.39 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.037 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.497 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 32.1 t80 -60.05 -50.33 74.15 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.151 0.5 . . . . 0.0 110.927 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -79.95 -15.6 56.95 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.094 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.693 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 81.4 mmm -69.51 -28.73 66.29 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.363 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.698 HG22 HD13 ' A' ' 27' ' ' ILE . 0.9 OUTLIER -69.36 -59.11 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.636 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.741 ' HB3' ' O ' ' A' ' 26' ' ' THR . 2.1 p30 -80.84 45.66 0.83 Allowed 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.932 0.873 . . . . 0.0 111.771 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.589 HG21 ' HD2' ' A' ' 38' ' ' ARG . 15.1 t -66.0 -6.53 13.05 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.986 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.57 -7.17 2.87 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.445 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 24.2 t-20 -91.83 -93.86 0.14 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.698 -0.401 . . . . 0.0 112.063 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.6 p -177.36 14.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.498 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.47 17.17 9.49 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.185 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 74.0 p -125.17 158.98 32.62 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.866 ' O ' ' HA ' ' A' ' 62' ' ' THR . 1.6 mt -123.09 101.66 9.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 76.7 p -103.28 156.87 17.41 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.385 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.551 ' CD1' HG23 ' A' ' 48' ' ' ILE . 60.3 t80 -33.65 -38.49 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.98 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 9.6 t70 -71.18 -43.9 66.52 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 111.243 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.56 ' O ' HG23 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -79.43 -27.72 41.7 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.65 178.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.767 ' HB2' ' HE3' ' A' ' 52' ' ' MET . 1.6 tm? -50.75 -55.08 18.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.129 0.49 . . . . 0.0 109.965 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' CG1' ' A' ' 48' ' ' ILE . 1.1 ptmm? -77.02 -39.04 51.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.119 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.524 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 38.8 t70 -41.73 -41.18 2.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.562 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.99 91.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.443 -0.408 . . . . 0.0 114.097 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.593 ' O ' HG12 ' A' ' 39' ' ' VAL . 2.2 mp -89.26 -45.07 9.81 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 41' ' ' SER . 17.4 ptpt -59.12 -21.92 60.04 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.589 ' HD2' HG21 ' A' ' 21' ' ' THR . 36.8 ttt-85 -79.57 -40.56 29.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.39 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 36' ' ' LEU . 2.9 p -78.98 -12.96 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.72 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.54 -44.62 1.19 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.375 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 69.4 m -52.96 161.9 0.71 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.681 0.277 . . . . 0.0 111.525 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -134.24 105.1 6.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.606 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD13 ' CD2' ' A' ' 36' ' ' LEU . 68.7 mt -108.42 166.15 10.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.007 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.434 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 32.1 mtm -109.21 165.7 11.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.773 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.442 ' HB3' ' HZ ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -55.47 -59.79 4.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.128 -179.309 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.7 m -55.09 -17.6 4.28 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.924 0.329 . . . . 0.0 111.737 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.4 mm-40 -79.69 -48.42 13.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.756 HD12 HD13 ' A' ' 32' ' ' LEU . 6.1 mm -56.86 -51.96 61.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.915 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -46.97 -33.16 4.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.006 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 63.9 t0 -60.3 -45.31 93.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.484 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 67.3 mt -67.07 -14.77 63.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.767 ' HE3' ' HB2' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -87.6 -65.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.04 0.448 . . . . 0.0 111.804 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.66 -37.13 70.84 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . -91.28 -13.63 32.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . . . -127.16 -43.56 1.64 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.602 ' OD1' HG12 ' A' ' 63' ' ' ILE . 34.0 t70 -62.25 103.6 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.857 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.0 mm -43.35 -27.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.286 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.582 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.6 m-20 -133.63 44.66 2.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.035 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.59 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 1.2 tmtp? -31.99 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.819 0.818 . . . . 0.0 112.339 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.0 p -126.81 10.54 7.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.165 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 103.63 -15.31 53.11 Favored Glycine 0 C--O 1.238 0.35 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.597 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.866 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 5.4 t -140.49 148.81 41.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.67 0.272 . . . . 0.0 110.88 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.836 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 78.6 mt -108.88 142.42 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.03 0.443 . . . . 0.0 111.244 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -105.69 166.78 10.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.971 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.637 ' O ' HG13 ' A' ' 69' ' ' ILE . 31.2 t80 -40.58 -48.91 2.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.794 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.34 -59.17 7.03 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.783 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.795 ' HB2' HG23 ' A' ' 63' ' ' ILE . 48.9 mt-10 -45.47 -31.9 1.95 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.804 0.335 . . . . 0.0 110.726 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.497 ' CD2' ' HB2' ' A' ' 16' ' ' PHE . 9.9 t80 -66.06 -55.0 18.82 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.378 0.609 . . . . 0.0 110.152 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.637 HG13 ' O ' ' A' ' 65' ' ' TYR . 10.8 mt -57.06 -65.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.061 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -44.85 -48.33 11.08 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.557 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 68' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.455 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.4 p . . . . . 0 C--O 1.232 0.168 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.4 m -56.46 -37.43 70.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.127 0.489 . . . . 0.0 109.797 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -82.66 -47.92 11.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.064 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.748 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 21.7 t80 -41.85 -30.0 0.23 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.551 0.691 . . . . 0.0 109.65 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -89.9 -47.58 7.78 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.194 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -84.99 -63.88 1.25 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.271 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.569 ' HB3' HD12 ' A' ' 99' ' ' ILE . 4.1 m-85 -56.53 -56.5 20.45 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.81 ' HA ' HG12 ' A' ' 99' ' ' ILE . 0.4 OUTLIER -77.81 54.69 1.29 Allowed 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.649 ' HB2' ' HZ2' ' A' ' 93' ' ' LYS . 3.7 ttmp? -49.07 -38.28 23.77 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.778 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -75.43 -23.06 56.92 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.777 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.74 73.07 0.31 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.4 p -132.1 -28.59 1.72 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 134.56 7.13 2.2 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 113.925 -1.488 . . . . 0.0 113.037 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.801 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -150.87 160.73 43.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.451 0.643 . . . . 0.0 111.362 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.81 HG12 ' HA ' ' A' ' 92' ' ' ASP . 70.1 mt -133.96 102.78 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.884 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 103' ' ' GLU . 72.9 p -73.14 150.93 41.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.347 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.752 ' HB3' HG23 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -35.03 -34.25 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -62.13 -51.69 66.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 100' ' ' THR . 53.9 mt-10 -71.13 -29.44 65.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.954 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 132' ' ' GLN . 27.1 mt -68.39 -64.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.981 0.42 . . . . 0.0 110.395 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.492 ' NE2' ' HA ' ' A' ' 119' ' ' ASP . 81.8 mt-30 -55.49 -39.57 70.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.456 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -65.31 -31.93 73.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.048 0.451 . . . . 0.0 110.447 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.73 -4.09 3.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.145 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.622 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 9.8 p -105.04 118.27 36.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.133 0.492 . . . . 0.0 110.587 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -88.82 -61.32 1.73 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.257 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.88 -4.45 58.47 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 108' ' ' CYS . 2.8 m-85 -65.71 -18.15 65.12 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.501 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.59 38.95 97.25 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.611 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.969 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -33.27 149.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.242 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.567 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 26.7 t70 -160.48 178.89 9.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.185 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.405 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 53.6 p-10 -89.38 -8.45 53.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.921 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.787 HG22 ' H ' ' A' ' 117' ' ' HIS . 6.6 tp -92.53 -57.6 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.787 ' H ' HG22 ' A' ' 116' ' ' ILE . 10.0 t-80 -91.47 -68.65 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.969 HG13 ' HA ' ' A' ' 113' ' ' LEU . 46.9 mm -54.02 -19.61 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.968 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.492 ' HA ' ' NE2' ' A' ' 105' ' ' GLN . 38.5 t70 -66.91 -41.9 86.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 124' ' ' GLU . 7.4 t70 -71.2 -26.04 62.78 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.893 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 3.7 ttt -57.77 -30.26 65.5 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.161 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.752 HG23 ' HB3' ' A' ' 101' ' ' LEU . 58.9 mt -58.84 -43.95 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.682 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 3.7 mptt -86.64 -13.32 45.93 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 113.271 -1.786 . . . . 0.0 110.351 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.893 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 36.5 tp10 -82.14 -27.77 32.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.753 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.928 HG22 HG13 ' A' ' 133' ' ' ILE . 45.0 mt -100.41 -33.88 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.278 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.669 ' CG ' ' H ' ' A' ' 131' ' ' GLY . 7.3 t70 -83.47 84.92 7.34 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.41 0.624 . . . . 0.0 110.318 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.447 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 2.9 pm0 -88.09 -9.29 53.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.806 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.642 ' HB3' ' OE1' ' A' ' 137' ' ' GLU . 5.6 t70 -130.17 -19.52 3.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 -177.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.519 HD21 ' HG2' ' A' ' 132' ' ' GLN . 15.3 t30 -115.37 -127.19 0.29 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -177.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.472 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 9.5 t0 -116.61 27.04 9.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -173.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.669 ' H ' ' CG ' ' A' ' 126' ' ' ASP . . . 94.65 37.11 5.37 Favored Glycine 0 CA--C 1.501 -0.836 0 N-CA-C 108.258 -1.937 . . . . 0.0 108.258 -177.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.685 ' NE2' ' HB3' ' A' ' 98' ' ' TYR . 8.4 pt20 -153.72 169.21 23.88 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.172 -1.514 . . . . 0.0 108.966 -177.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.928 HG13 HG22 ' A' ' 125' ' ' ILE . 25.9 mm -131.33 127.01 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-O 121.68 0.752 . . . . 0.0 111.067 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.801 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -102.09 160.51 14.45 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.208 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.731 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 24.4 t80 -41.64 -33.95 0.54 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.576 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.75 -35.54 18.89 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.855 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.673 ' HB3' HD11 ' A' ' 133' ' ' ILE . 61.2 mm-40 -62.11 -57.03 13.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.289 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.557 ' HB2' HG21 ' A' ' 133' ' ' ILE . 2.7 t80 -61.09 -38.37 86.02 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.14 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 135' ' ' TYR . . . -58.71 -33.82 70.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.163 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.411 ' C ' ' N ' ' A' ' 142' ' ' MET . . . -90.72 -26.87 19.32 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.43 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.517 ' HG2' ' CD1' ' A' ' 138' ' ' PHE . 2.8 ppp? -51.6 -28.0 12.87 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 138' ' ' PHE . 17.1 ptp . . . . . 0 N--CA 1.444 -0.737 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.498 HD23 HD23 ' A' ' 15' ' ' LEU . 96.3 mt . . . . . 0 N--CA 1.461 0.08 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.712 ' HZ1' ' HB2' ' A' ' 13' ' ' LYS . 4.5 ttmp? -59.58 -51.35 70.21 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.624 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 84.8 tt0 -62.05 -30.73 71.18 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.134 178.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.717 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 40.4 tp -68.86 -30.33 68.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.662 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.414 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 22.0 t80 -68.16 -49.48 60.68 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.223 0.535 . . . . 0.0 110.333 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 14' ' ' GLU . 60.2 pttt -75.66 -12.91 60.29 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.561 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 2.3 tpp -66.03 -28.91 69.22 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.862 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.625 HD13 ' HE1' ' A' ' 68' ' ' PHE . 3.3 mt -81.26 -55.01 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.052 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -82.71 62.8 6.51 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.775 0.798 . . . . 0.0 111.292 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 t -81.81 -11.75 58.83 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.173 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.3 p30 -138.36 -11.43 1.42 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -72.25 -81.92 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.143 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 p -175.8 5.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.684 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.58 20.94 7.07 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.525 ' HB ' ' CG2' ' A' ' 62' ' ' THR . 68.5 p -139.22 150.63 45.76 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.042 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 62' ' ' THR . 3.8 mt -104.16 103.35 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 31' ' ' GLU . 71.2 p -104.31 162.55 13.11 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.492 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -34.11 -35.95 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.942 0.497 . . . . 0.0 111.821 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -77.36 -41.15 41.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 110.759 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.611 ' HG3' HG21 ' A' ' 19' ' ' ILE . 11.4 tp10 -77.09 -30.55 55.43 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.429 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.696 ' HG ' HG23 ' A' ' 48' ' ' ILE . 0.9 OUTLIER -41.18 -48.73 3.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.981 0.895 . . . . 0.0 109.732 -179.294 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.798 ' HB3' HD12 ' A' ' 43' ' ' LEU . 6.0 ptpt -85.15 -30.87 23.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.886 -1.507 . . . . 0.0 111.624 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 9.1 t70 -46.62 -46.1 19.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.345 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.15 -37.55 95.09 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.008 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.891 ' HG ' HD21 ' A' ' 43' ' ' LEU . 3.8 mm? -71.62 -58.18 3.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.598 ' NZ ' ' HE2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -58.58 -26.88 64.08 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.108 0.48 . . . . 0.0 110.41 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 56.4 ttt-85 -59.16 -49.45 77.81 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.397 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.474 HG22 ' H ' ' A' ' 41' ' ' SER . 3.3 m -77.46 -14.25 14.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.33 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.89 -19.99 8.23 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.971 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.474 ' H ' HG22 ' A' ' 39' ' ' VAL . 49.2 m -55.69 153.77 7.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.749 0.275 . . . . 0.0 110.963 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -131.64 104.17 6.79 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.446 0.641 . . . . 0.0 112.04 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.891 HD21 ' HG ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -116.58 167.6 10.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.865 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.562 ' HE2' ' HB2' ' A' ' 86' ' ' SER . 27.0 ptt? -109.67 165.22 11.85 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.516 0.198 . . . . 0.0 110.562 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -50.19 -55.63 14.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.5 t -48.53 -24.27 1.25 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HG2' ' OG ' ' A' ' 86' ' ' SER . 49.2 mt-10 -71.15 -36.2 71.97 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.696 HG23 ' HG ' ' A' ' 32' ' ' LEU . 1.9 mp -66.42 -60.61 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.747 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.448 ' HE3' ' CE1' ' A' ' 111' ' ' PHE . 22.1 ttmm -54.5 -31.26 55.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.489 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.475 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 35.8 t70 -70.9 -45.18 64.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.244 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.601 HD23 HD23 ' A' ' 32' ' ' LEU . 36.0 tp -66.35 -16.56 64.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.529 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.644 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 23.5 mmt -85.45 -60.85 1.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.291 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -76.12 -39.32 55.4 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.859 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 50' ' ' ASP . . . -82.72 -19.08 38.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . . . -127.51 -43.98 1.56 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.636 ' HB3' ' O ' ' A' ' 52' ' ' MET . 33.3 t70 -60.26 107.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.214 0.531 . . . . 0.0 110.199 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.1 mt -49.45 -25.08 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.676 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.521 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 74.8 m-20 -130.4 44.03 3.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.023 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.644 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 1.3 tmtp? -31.98 92.3 0.01 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.798 0.808 . . . . 0.0 112.468 -177.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' ASP . 82.8 p -128.0 10.46 6.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.796 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 81.45 17.33 71.46 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.601 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 53.2 m -153.94 127.19 8.48 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.42 0.288 . . . . 0.0 110.371 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.631 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 64.2 mt -107.5 132.44 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.034 0.445 . . . . 0.0 111.479 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -105.19 168.15 9.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.3 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.516 ' O ' HG12 ' A' ' 69' ' ' ILE . 28.4 t80 -35.82 -48.23 0.54 Allowed 'General case' 0 N--CA 1.464 0.23 0 O-C-N 123.296 0.372 . . . . 0.0 111.913 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.92 -64.0 3.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.709 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 63.7 mt-10 -50.57 -26.18 4.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.764 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.717 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 68.2 t80 -62.0 -61.85 2.19 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.48 0.657 . . . . 0.0 110.894 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 65' ' ' TYR . 10.4 mm -55.07 -50.62 61.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.777 -178.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.31 -12.5 21.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.936 0.398 . . . . 0.0 111.261 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 67' ' ' GLU . . . . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.447 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.416 ' HA ' ' CB ' ' A' ' 88' ' ' PHE . 22.0 m . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.562 ' HB2' ' HE2' ' A' ' 44' ' ' MET . 53.1 m -34.98 -65.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.15 0.281 . . . . 0.0 111.701 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -73.29 -38.55 65.84 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.709 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 25.4 t80 -43.16 -23.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.913 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.1 t -88.88 -42.53 11.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.737 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -82.76 -62.92 1.47 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.578 ' HB3' HD12 ' A' ' 99' ' ' ILE . 2.9 m-85 -53.61 -62.82 1.41 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.465 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.598 ' OD1' HG13 ' A' ' 99' ' ' ILE . 1.2 m-20 -79.0 50.16 1.0 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 89' ' ' SER . 37.3 ttmt -36.66 -59.81 0.64 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.629 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -83.48 -20.93 33.11 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.705 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.25 85.69 0.01 OUTLIER Glycine 0 N--CA 1.424 -2.156 0 CA-C-O 121.713 0.618 . . . . 0.0 112.887 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.4 p -100.58 -14.62 18.11 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 124.44 -4.02 8.8 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 111.526 -2.579 . . . . 0.0 110.942 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.1 OUTLIER -147.9 165.67 29.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.764 -0.718 . . . . 0.0 110.746 178.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.767 HG22 HG12 ' A' ' 104' ' ' ILE . 72.4 mt -131.75 104.15 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.512 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 102' ' ' ASP . 71.5 p -72.12 147.08 47.03 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.863 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -34.27 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 106' ' ' GLN . 34.6 t70 -57.16 -56.59 19.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.47 -32.29 71.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.163 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.767 HG12 HG22 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -61.39 -50.07 81.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.179 0.514 . . . . 0.0 110.723 179.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.613 ' NE2' HD12 ' A' ' 122' ' ' ILE . 41.3 mt-30 -71.94 -49.45 37.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.031 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 102' ' ' ASP . 87.0 mt-30 -55.83 -41.84 74.85 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.837 0.351 . . . . 0.0 110.979 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.13 -4.01 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.246 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.755 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 74.3 m -119.93 67.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.812 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.647 ' HD3' ' H ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -80.2 -36.34 35.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 -179.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -89.04 -5.0 58.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.755 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 4.2 m-85 -83.81 5.08 26.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.744 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.75 37.55 13.35 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.783 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.868 ' HA ' HG13 ' A' ' 118' ' ' ILE . 2.3 tm? -33.88 105.21 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.319 0.58 . . . . 0.0 111.327 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.484 ' OD1' HG12 ' A' ' 116' ' ' ILE . 10.3 t70 -160.5 156.05 25.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.754 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.641 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 10.7 p-10 -64.19 -7.73 10.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.067 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.484 HG12 ' OD1' ' A' ' 114' ' ' ASP . 49.0 mm -80.66 -64.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.586 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.442 ' HD1' HG21 ' A' ' 116' ' ' ILE . 16.0 m80 -91.69 -68.26 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.868 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.5 mm -48.17 -19.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.257 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.641 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 8.8 t70 -78.12 -59.1 2.92 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 124' ' ' GLU . 34.8 t70 -59.52 -17.15 29.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.743 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 25.2 ttp -64.27 -42.66 96.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.577 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.863 HG22 ' HB3' ' A' ' 101' ' ' LEU . 53.8 mt -54.89 -49.33 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.84 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -76.92 -13.27 60.0 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.513 178.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.743 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 40.3 tp10 -84.06 -25.44 29.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.262 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.809 HG21 HG13 ' A' ' 133' ' ' ILE . 31.2 mt -107.41 -15.74 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.993 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 1.9 t70 -77.76 82.74 4.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.025 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.5 HE21 ' HB2' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -88.63 -9.36 52.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.663 179.38 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 45.0 t0 -116.15 -35.49 4.36 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.655 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.97 -84.82 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.655 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 34.8 t70 -65.36 15.78 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -172.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.993 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.56 38.85 83.27 Favored Glycine 0 CA--C 1.509 -0.313 0 C-N-CA 117.223 -2.417 . . . . 0.0 109.193 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.631 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 7.4 pt20 -134.61 167.4 20.88 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 113.461 -1.369 . . . . 0.0 108.692 -177.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.809 HG13 HG21 ' A' ' 125' ' ' ILE . 5.8 mm -129.14 125.26 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 122.26 1.028 . . . . 0.0 111.532 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.929 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 6.4 t70 -103.14 152.09 21.83 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.969 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.709 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 17.1 t80 -40.96 -42.68 1.93 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.749 0.309 . . . . 0.0 110.931 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.77 -28.53 38.1 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.883 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.929 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 31.9 mt-10 -68.92 -59.07 3.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.625 ' HB2' ' CG2' ' A' ' 133' ' ' ILE . 13.4 t80 -50.41 -18.53 0.66 Allowed 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.392 0.615 . . . . 0.0 109.776 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 137' ' ' GLU . . . -78.48 -40.21 36.08 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.519 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -90.13 -12.8 37.22 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.703 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.479 ' HG2' ' CD1' ' A' ' 138' ' ' PHE . 4.9 ppp? -55.8 -27.68 52.36 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.735 0.302 . . . . 0.0 111.238 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 110.227 179.095 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.814 0.34 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -126.74 -10.93 6.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.008 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.452 ' HD2' ' C ' ' A' ' 3' ' ' ARG . 4.6 tmm_? -162.18 115.91 1.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.344 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.7 tp -159.63 -43.43 0.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.801 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.8 t -95.39 179.67 5.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.81 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -109.33 41.96 1.55 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.975 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -64.27 -16.67 62.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.73 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.13 -43.3 99.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.996 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mp -67.48 -69.02 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.907 0.384 . . . . 0.0 111.264 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 12' ' ' LEU . . . -166.13 165.88 38.42 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.61 77.87 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.494 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 10' ' ' GLY . 31.4 tp -88.25 -46.72 8.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.516 0.198 . . . . 0.0 110.605 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.728 ' HB3' ' HZ1' ' A' ' 13' ' ' LYS . 6.3 ttpm? -55.83 -30.93 62.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.752 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 8.1 mp0 -76.97 -38.3 53.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.959 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.725 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 54.5 tp -55.01 -28.12 49.62 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.681 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -70.6 -45.07 66.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.776 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.752 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 63.5 pttt -82.47 -12.5 57.78 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.6 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.44 -25.9 68.21 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.431 178.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.59 HG23 HG21 ' A' ' 27' ' ' ILE . 3.2 mt -86.39 -59.4 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.511 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.551 ' OD2' ' HA2' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -82.62 57.35 3.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.347 0.594 . . . . 0.0 110.547 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.511 HG21 HH22 ' A' ' 38' ' ' ARG . 13.6 t -81.24 -6.72 59.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.16 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -129.2 -14.61 4.3 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.562 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -74.42 -87.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.802 0.334 . . . . 0.0 111.208 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 p -176.66 6.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.817 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.551 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.42 31.48 2.79 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.507 ' HB ' ' CG2' ' A' ' 62' ' ' THR . 45.9 p -150.07 145.78 26.57 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.189 -0.505 . . . . 0.0 109.946 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.787 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.2 mt -102.87 103.91 15.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 68.3 p -103.42 164.84 11.39 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.557 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 20.5 t80 -34.09 -36.4 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.683 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.19 -49.84 16.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.715 0.293 . . . . 0.0 111.659 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.646 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -75.72 -19.9 58.74 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.922 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.875 HD13 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -46.03 -47.38 16.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.914 0.864 . . . . 0.0 108.693 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.718 ' HB3' HD12 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -85.43 -51.89 6.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.485 179.243 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.646 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 59.3 m-20 -36.34 -36.17 0.09 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.531 ' HA3' HG21 ' A' ' 19' ' ' ILE . . . -68.02 -57.34 8.76 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 115.114 0.805 . . . . 0.0 115.114 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.668 HD13 ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -73.85 -28.55 61.65 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.163 0.981 . . . . 0.0 111.989 -177.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.609 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 19.4 ptpt -66.14 -4.7 7.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.511 HH22 HG21 ' A' ' 21' ' ' THR . 36.9 ttm180 -87.15 -42.71 12.8 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.249 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.44 -0.22 2.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.81 -36.93 3.71 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.352 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 18.5 m -52.45 153.02 3.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.471 0.177 . . . . 0.0 110.553 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -143.3 103.79 4.17 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.298 0.57 . . . . 0.0 112.142 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.718 HD12 ' HB3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -105.35 167.98 9.38 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.124 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.474 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 5.3 mtm -104.66 165.51 11.01 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 48' ' ' ILE . 92.8 mt-10 -47.71 -59.99 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.495 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 94.4 p -39.47 -34.99 0.25 Allowed 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.474 ' OE1' ' HB2' ' A' ' 44' ' ' MET . 37.2 mp0 -66.38 -41.03 89.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.053 0.454 . . . . 0.0 110.172 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.875 HG13 HD13 ' A' ' 32' ' ' LEU . 2.0 mp -57.06 -60.49 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.984 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.557 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 42.4 tttm -64.45 -25.6 68.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.318 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 46' ' ' SER . 62.6 t0 -71.13 -37.45 72.29 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.607 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 tt -76.36 -23.07 54.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.024 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.73 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 18.2 mmt -71.88 -45.01 62.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.122 0.487 . . . . 0.0 111.518 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.52 -30.29 20.71 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.988 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.55 -19.31 22.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -127.02 -43.81 1.65 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.73 ' HB3' ' O ' ' A' ' 52' ' ' MET . 15.6 t0 -61.24 95.98 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.3 mm -48.65 -22.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.031 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.564 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 59.0 t0 -129.11 44.5 2.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.818 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.672 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.5 tmtm? -32.57 90.38 0.0 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.74 0.781 . . . . 0.0 112.662 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.1 p -127.74 18.04 6.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.151 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 70.88 17.76 75.58 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.384 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 86.1 m -150.36 127.15 11.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.542 0.337 . . . . 0.0 110.561 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.787 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 70.1 mt -108.06 129.46 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 121.055 0.455 . . . . 0.0 111.367 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -105.06 167.33 9.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.09 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.61 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 47.9 t80 -35.52 -45.78 0.37 Allowed 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.389 0.431 . . . . 0.0 111.474 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.38 -63.7 4.12 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.331 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.564 ' OE2' ' HB3' ' A' ' 58' ' ' ASP . 63.0 mt-10 -51.92 -26.11 9.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.662 0.267 . . . . 0.0 110.905 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 71.9 t80 -63.87 -65.18 0.72 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.434 0.635 . . . . 0.0 110.879 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 65' ' ' TYR . 14.5 mm -52.13 -41.17 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.653 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.23 -25.76 66.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.0 110.59 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.07 -12.55 26.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.035 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.5 m -87.74 -43.69 11.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.738 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.611 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 58.0 t -67.03 -18.11 23.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.117 0.484 . . . . 0.0 110.581 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -71.02 -47.56 58.01 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.7 mt -81.79 0.94 36.98 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.238 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.611 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 0.7 OUTLIER -102.78 75.28 1.4 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.007 -179.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -175.4 -156.27 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.294 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.656 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.6 mm? -99.19 60.03 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 110.46 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -104.55 150.41 24.65 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.005 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -139.39 100.31 3.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.737 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.573 ' HB2' HG11 ' A' ' 85' ' ' VAL . 11.7 pt-20 -165.81 38.89 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.075 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -90.61 22.1 3.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.969 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -109.05 -155.98 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.483 HD21 ' HA ' ' A' ' 139' ' ' ALA . 7.3 mp -57.14 -29.58 63.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.561 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.573 HG11 ' HB2' ' A' ' 81' ' ' GLU . 14.4 p -45.67 -27.67 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.721 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.7 m -51.05 -55.01 19.66 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.402 . . . . 0.0 110.173 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -81.18 -39.77 24.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.902 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.807 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 8.1 t80 -45.95 -23.04 0.25 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.366 0.603 . . . . 0.0 110.055 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.3 t -89.13 -44.79 10.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.769 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -89.3 -63.65 1.26 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.56 ' HB3' HD12 ' A' ' 99' ' ' ILE . 2.5 m-85 -51.98 -62.36 1.68 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.807 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.6 OUTLIER -76.13 55.29 0.93 Allowed 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 176.123 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -44.53 -52.91 7.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.451 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.35 -21.46 64.73 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.328 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.08 68.61 1.09 Allowed Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.4 p -115.54 -23.06 8.95 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.589 ' O ' ' HB2' ' A' ' 134' ' ' ASP . . . 130.58 -4.55 5.84 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 113.162 -1.836 . . . . 0.0 112.606 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.87 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.5 OUTLIER -148.62 161.82 40.94 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.781 HG12 ' HA ' ' A' ' 92' ' ' ASP . 22.1 mt -133.09 104.27 6.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.833 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 102' ' ' ASP . 69.6 p -72.3 147.1 46.69 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.719 ' HB3' HG21 ' A' ' 122' ' ' ILE . 4.1 pp -34.44 -33.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 100' ' ' THR . 54.2 m-20 -54.35 -55.89 24.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 97.4 mt-10 -71.21 -31.43 67.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.174 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.492 HG13 ' CG2' ' A' ' 99' ' ' ILE . 51.1 mt -65.74 -65.25 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.166 0.508 . . . . 0.0 110.439 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 119' ' ' ASP . 87.8 mt-30 -58.14 -39.05 77.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.636 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.435 ' C ' ' H ' ' A' ' 108' ' ' CYS . 53.4 tt0 -59.84 -44.12 94.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.082 0.468 . . . . 0.0 110.66 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.7 -3.05 1.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.145 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.775 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 73.2 m -115.09 44.07 1.88 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.922 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -59.54 -36.63 76.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.841 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -75.09 -22.12 58.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.11 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.775 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 2.7 m-85 -76.78 -5.18 47.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.953 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 113' ' ' LEU . . . 62.35 38.8 96.85 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.036 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.907 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -33.09 132.74 0.15 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.545 0.688 . . . . 0.0 111.501 -177.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.688 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 91.9 m-20 -135.99 167.69 20.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.217 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.627 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.6 m-20 -82.88 -7.98 59.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.178 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.59 -64.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.068 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -89.52 -69.24 0.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.907 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.3 mm -52.77 -19.45 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.942 0.401 . . . . 0.0 111.238 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.627 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 33.6 t70 -71.14 -46.91 60.59 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' GLU . 63.9 t0 -62.37 -26.27 68.37 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.978 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.5 ttt -60.75 -29.87 69.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.474 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.719 HG21 ' HB3' ' A' ' 101' ' ' LEU . 56.8 mt -58.32 -43.62 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.469 ' CE ' ' HB ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -86.67 -13.8 44.46 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.367 178.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.978 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 71.5 tt0 -84.61 -23.73 29.45 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.789 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.924 HG22 HG13 ' A' ' 133' ' ' ILE . 13.6 mm -107.56 -21.8 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.968 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.4 t70 -62.8 98.37 0.12 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.594 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.91 HE21 ' HG2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -87.23 -13.95 42.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.433 ' OD1' ' ND2' ' A' ' 129' ' ' ASN . 50.6 p30 -127.57 -33.19 2.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.739 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 179.96 -71.76 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 178.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.739 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 56.3 m-20 -64.92 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -173.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.968 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.53 37.93 78.04 Favored Glycine 0 CA--C 1.505 -0.566 0 C-N-CA 118.348 -1.882 . . . . 0.0 110.04 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.551 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 8.6 pt20 -133.33 170.53 15.33 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 113.895 -1.152 . . . . 0.0 110.075 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.924 HG13 HG22 ' A' ' 125' ' ' ILE . 5.0 mm -133.02 121.88 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.91 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 4.3 p-10 -113.01 162.47 15.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.161 177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.785 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 22.5 t80 -38.76 -30.48 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.768 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.716 ' HA3' ' N ' ' A' ' 153' ' ' ARG . . . -84.27 -45.16 6.31 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.728 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.91 ' HG2' HE21 ' A' ' 127' ' ' GLN . 39.3 mt-10 -63.04 -51.3 67.29 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.565 ' HB2' ' CG2' ' A' ' 133' ' ' ILE . 13.6 t80 -56.62 -18.68 12.86 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 135' ' ' TYR . . . -86.06 -40.85 15.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.151 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.497 ' CB ' ' HG3' ' A' ' 127' ' ' GLN . . . -87.25 -11.66 49.04 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.552 ' HG2' ' HA ' ' A' ' 138' ' ' PHE . 5.5 ppp? -72.41 -6.68 45.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.635 0.255 . . . . 0.0 111.557 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -134.97 -31.13 1.02 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.994 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.595 ' HG2' ' H ' ' A' ' 144' ' ' LYS . 62.1 ttt180 -112.11 -137.62 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.438 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.595 ' H ' ' HG2' ' A' ' 143' ' ' ARG . 95.5 mttt -131.23 -175.53 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.623 0.249 . . . . 0.0 110.57 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.638 ' H ' ' HE ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -101.29 78.32 1.88 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.272 0.558 . . . . 0.0 111.855 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.633 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -53.76 155.57 3.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.916 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -85.87 -4.78 84.48 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.862 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -79.78 161.67 25.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.816 0.341 . . . . 0.0 111.107 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -47.75 -23.75 2.54 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.998 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -42.54 -26.0 0.36 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.356 -0.45 . . . . 0.0 113.032 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.684 ' HA ' ' NH1' ' A' ' 153' ' ' ARG . 44.1 mt -48.78 149.11 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 CA-C-O 120.751 0.31 . . . . 0.0 111.113 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.669 ' N ' HG22 ' A' ' 151' ' ' ILE . . . -159.02 -4.59 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.413 -0.898 . . . . 0.0 111.889 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.817 ' HD2' ' H ' ' A' ' 153' ' ' ARG . 4.2 mpt_? -53.78 170.55 0.12 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.786 0.326 . . . . 0.0 110.13 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 156' ' ' MET . 23.3 tpt85 -71.19 149.02 46.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.179 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.502 ' H ' HH11 ' A' ' 154' ' ' ARG . 56.5 m -50.23 80.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.341 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 154' ' ' ARG . 27.8 ttt -175.9 -18.64 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.213 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.516 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 6.7 ppt_? -63.22 -15.53 57.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.139 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.778 ' HG3' HG22 ' A' ' 159' ' ' THR . 4.9 tppp? -161.49 -87.23 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.778 HG22 ' HG3' ' A' ' 158' ' ' LYS . 6.9 t -162.96 -36.42 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.766 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 97.2 mt -78.47 179.48 7.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.774 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -103.96 -101.17 0.31 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.786 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.1 tp -174.83 154.35 1.89 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.623 0.249 . . . . 0.0 110.821 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -89.75 138.85 31.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.689 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -78.05 146.14 35.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.866 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.69 165.03 13.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.063 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.84 -10.03 32.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.191 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 146.74 150.03 5.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.597 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 97.4 mt -100.15 139.16 36.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.88 149.76 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.932 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -156.72 156.18 32.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 111.155 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.23 -49.57 4.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.652 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.14 -174.48 31.3 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.476 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 81.1 p -159.65 174.52 14.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -119.56 -174.76 2.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.952 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -101.85 107.92 19.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.799 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.08 141.46 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.344 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 tp -123.85 130.11 74.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -132.53 141.36 48.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -171.7 -65.82 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.376 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.75 -13.11 22.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.86 0.362 . . . . 0.0 110.804 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -110.72 136.86 49.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.827 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.55 ' HD3' ' N ' ' A' ' 182' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.813 0.339 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -125.03 -32.08 3.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.045 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.53 ' NE ' ' H ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -157.37 169.23 25.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.817 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp -115.84 112.55 22.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -77.82 -15.14 59.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.998 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.405 ' HB3' HD12 ' A' ' 9' ' ' ILE . 93.1 mt-10 -83.98 17.95 2.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -67.55 -23.68 65.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.73 -29.17 69.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.781 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.429 ' O ' HG21 ' A' ' 9' ' ' ILE . 59.7 mt -69.6 -20.15 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.86 135.45 12.54 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.477 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 119.76 -39.98 2.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.166 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.607 HD12 ' HE2' ' A' ' 68' ' ' PHE . 46.5 tp -71.66 -29.24 64.39 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.643 ' HG3' ' OE1' ' A' ' 14' ' ' GLU . 20.6 pttp -58.59 -24.99 62.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.643 ' OE1' ' HG3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -80.43 -52.27 7.85 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.626 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 31.0 tp -47.23 -30.2 2.85 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.847 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.497 ' CZ ' ' N ' ' A' ' 65' ' ' TYR . 20.1 t80 -66.61 -52.04 49.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.164 0.506 . . . . 0.0 110.446 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.487 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -76.0 -13.06 60.23 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.621 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 63.4 mmm -71.04 -22.61 62.12 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.499 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.679 HG23 HD12 ' A' ' 27' ' ' ILE . 10.9 mm -77.42 -61.31 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.269 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.487 ' OD1' ' HA ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -80.23 66.79 5.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.534 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 t -82.75 -6.34 59.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.348 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -131.75 -27.28 1.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.473 ' ND2' ' OG1' ' A' ' 26' ' ' THR . 48.2 t30 -69.82 -82.45 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.1 p -175.91 5.42 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.46 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 111.11 27.13 4.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.373 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.473 ' OG1' ' ND2' ' A' ' 23' ' ' ASN . 64.8 p -143.66 149.18 36.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.034 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.839 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.1 mt -103.43 103.02 14.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.506 HG22 HG23 ' A' ' 62' ' ' THR . 66.9 p -104.16 162.29 13.3 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.129 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.613 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 44.1 t80 -34.03 -27.87 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 28' ' ' THR . 56.1 m-20 -82.51 -45.06 15.17 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.791 0.329 . . . . 0.0 111.159 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 8.0 mp0 -83.13 -15.13 51.93 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.901 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.623 HD12 HG13 ' A' ' 48' ' ' ILE . 2.2 tm? -53.03 -50.16 64.84 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.888 ' HB2' ' HE3' ' A' ' 37' ' ' LYS . 12.5 ptpt -82.59 -46.15 13.68 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.091 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.577 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 31.0 t70 -42.86 -64.9 0.54 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA3' HG21 ' A' ' 19' ' ' ILE . . . -46.43 -28.36 3.33 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.142 -0.552 . . . . 0.0 113.633 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.434 HD11 ' CB ' ' A' ' 41' ' ' SER . 0.2 OUTLIER -90.1 -59.68 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.986 0.393 . . . . 0.0 110.772 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.888 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 18.8 ptpt -60.43 -9.55 3.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.032 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -68.3 -34.67 76.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.868 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.4 m -80.84 -8.72 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.393 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.7 -17.66 5.48 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.842 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.434 ' CB ' HD11 ' A' ' 36' ' ' LEU . 65.1 m -63.42 168.51 4.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.964 0.412 . . . . 0.0 111.445 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -147.57 111.12 4.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.608 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.7 mt -120.55 165.83 14.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.374 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -114.15 162.43 16.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 47' ' ' GLU . 44.4 mt-10 -47.63 -65.43 0.57 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 80.8 p -41.73 -18.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 55.8 mt-10 -89.72 -47.57 7.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.623 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -53.64 -59.78 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.912 0.863 . . . . 0.0 109.138 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.995 ' HD3' ' HD2' ' A' ' 93' ' ' LYS . 21.8 ttmm -55.15 -27.39 45.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.212 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.508 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 8.8 t70 -69.9 -45.05 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.153 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.512 ' O ' HD21 ' A' ' 51' ' ' LEU . 9.7 tt -68.26 -21.67 64.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.086 0.47 . . . . 0.0 109.966 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.685 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 13.4 mmt -71.93 -44.01 64.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.855 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' A' ' 90' ' ' TYR . 9.7 t70 -87.05 -18.04 31.51 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.672 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.458 ' HA ' ' OE2' ' A' ' 81' ' ' GLU . . . -91.58 -42.36 10.26 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 71' ' ' ALA . . . -110.7 -43.13 3.88 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.685 ' HB3' ' O ' ' A' ' 52' ' ' MET . 12.3 t0 -49.39 97.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.706 -0.398 . . . . 0.0 109.979 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.7 mm -54.75 -17.53 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.276 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.545 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 38.9 t70 -132.21 44.48 2.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.951 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.591 ' HD3' ' C ' ' A' ' 52' ' ' MET . 27.1 tptp -30.94 88.03 0.0 OUTLIER 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.5 p -128.7 18.94 6.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.469 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 71.32 17.12 75.81 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 51.0 m -151.69 128.03 10.61 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.949 -0.625 . . . . 0.0 110.723 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.839 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.7 mt -105.06 133.41 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 120.927 0.394 . . . . 0.0 110.67 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -105.49 167.75 9.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.325 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.545 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 14.9 t80 -35.82 -46.89 0.48 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.476 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.51 -54.07 7.98 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.65 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.802 ' HB2' HG23 ' A' ' 63' ' ' ILE . 48.5 mt-10 -53.25 -24.05 10.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.294 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.626 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 57.1 t80 -67.8 -60.41 2.54 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.505 0.669 . . . . 0.0 110.487 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 65' ' ' TYR . 8.5 mm -49.21 -49.27 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.813 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.485 ' O ' HG13 ' A' ' 73' ' ' VAL . . . -59.42 -47.25 86.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.806 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . . . -44.73 -27.62 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.202 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.9 p -90.94 -51.09 5.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.85 0.357 . . . . 0.0 110.446 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 70' ' ' ALA . 3.6 p -62.04 -15.16 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.696 0.76 . . . . 0.0 110.031 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -76.36 -50.97 12.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.132 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 71' ' ' ALA . 61.1 mt -60.0 -16.12 28.15 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 24.1 t-20 -122.3 74.75 1.19 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.595 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 76' ' ' ASN . 14.6 mmtp -174.42 -153.91 0.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.39 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.473 ' H ' ' HB3' ' A' ' 77' ' ' LYS . 90.4 mt -100.78 62.27 1.01 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.482 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -44.36 110.8 0.24 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.518 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.453 ' HD3' ' C ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -139.3 119.86 14.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.202 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.458 ' OE2' ' HA ' ' A' ' 54' ' ' ALA . 55.5 mt-10 -120.47 133.14 55.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.252 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.99 90.47 0.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.888 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 20.9 t-20 -152.82 164.33 38.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.882 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 85' ' ' VAL . 3.4 tm? -70.71 -64.22 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.766 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.565 ' N ' HD12 ' A' ' 84' ' ' LEU . 9.9 p -63.19 -28.34 44.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.842 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.538 ' HB3' ' HB3' ' A' ' 83' ' ' ASN . 90.9 p -52.8 -34.85 55.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 110.12 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -82.22 -52.69 6.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.161 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.724 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 10.9 t80 -44.25 -26.43 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.056 0.455 . . . . 0.0 110.359 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 t -89.73 -47.69 7.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.66 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.46 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 1.0 OUTLIER -82.64 -62.75 1.52 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.378 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.0 m-85 -56.36 -64.62 0.8 Allowed 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.796 ' HA ' HG12 ' A' ' 99' ' ' ILE . 11.9 t0 -76.85 69.2 3.15 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.995 ' HD2' ' HD3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -44.43 -40.85 5.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.347 -177.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.3 m-20 -78.5 -21.35 49.05 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.889 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . 64.62 -8.06 0.57 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.676 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.521 ' H ' ' C ' ' A' ' 94' ' ' ASP . 72.2 p -55.37 -9.07 0.4 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 122.628 0.371 . . . . 0.0 111.203 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 134' ' ' ASP . . . 107.28 -6.54 36.6 Favored Glycine 0 C--O 1.216 -1.029 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.683 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -127.46 145.69 50.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.991 0.424 . . . . 0.0 112.01 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.796 HG12 ' HA ' ' A' ' 92' ' ' ASP . 65.5 mt -131.99 102.93 6.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.368 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 101' ' ' LEU . 44.0 p -76.27 152.84 36.37 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.257 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.495 HD12 ' OD1' ' A' ' 102' ' ' ASP . 3.7 pp -35.47 -39.03 0.12 Allowed 'General case' 0 N--CA 1.461 0.125 0 O-C-N 123.194 0.309 . . . . 0.0 111.139 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.495 ' OD1' HD12 ' A' ' 101' ' ' LEU . 64.4 m-20 -50.89 -57.08 9.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.147 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.403 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 50.4 mt-10 -63.82 -32.17 73.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.597 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' A' ' 132' ' ' GLN . 91.3 mt -70.36 -66.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 111.19 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.578 ' NE2' ' HA ' ' A' ' 119' ' ' ASP . 85.1 mt-30 -56.39 -35.76 68.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.289 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -55.69 -40.37 72.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.774 0.321 . . . . 0.0 110.543 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.54 -65.24 0.66 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.239 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.538 ' HB3' ' CG ' ' A' ' 111' ' ' PHE . 83.3 m -64.4 76.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.509 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 1.0 OUTLIER -88.8 -43.91 10.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.597 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -72.72 -4.68 32.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.721 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.538 ' CG ' ' HB3' ' A' ' 108' ' ' CYS . 1.2 m-85 -81.86 -1.17 46.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.775 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.18 37.2 94.13 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.598 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.459 ' HA ' ' CD1' ' A' ' 118' ' ' ILE . 2.1 pp -34.06 144.5 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.674 0.75 . . . . 0.0 112.875 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 119' ' ' ASP . 11.2 p-10 -160.16 -164.06 1.22 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.986 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.653 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 2.8 p30 -87.73 -7.93 56.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.12 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.7 mm -89.45 -64.69 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 121' ' ' MET . 18.0 t-160 -92.06 -68.51 0.79 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.661 HG23 ' HE3' ' A' ' 121' ' ' MET . 2.2 mp -56.89 -20.31 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.653 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 38.8 t70 -79.71 -59.25 2.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' GLU . 1.2 m-20 -59.2 -17.24 25.99 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.724 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 22.4 ttp -59.72 -39.65 85.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.333 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.598 HG23 ' NZ ' ' A' ' 123' ' ' LYS . 59.7 mt -54.69 -45.0 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.626 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -84.15 -13.6 52.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.98 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.724 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 15.9 tp10 -78.18 -27.8 48.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.894 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.818 HG22 HG12 ' A' ' 133' ' ' ILE . 22.6 mt -109.06 -7.87 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.818 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.599 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 28.0 t70 -73.78 81.34 1.59 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.112 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.562 ' OE1' ' HB3' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -87.54 -9.36 54.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.052 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 6.3 m-20 -119.87 -34.56 3.7 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.609 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 10.4 p-10 179.63 -80.89 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 118.438 2.755 . . . . 0.0 118.438 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.824 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 5.7 t70 -64.32 -17.68 63.91 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 118.813 2.894 . . . . 0.0 118.813 -171.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.599 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 92.15 37.13 6.05 Favored Glycine 0 CA--C 1.501 -0.836 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.824 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 3.2 pt20 -139.15 166.53 24.28 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 112.729 -1.735 . . . . 0.0 108.957 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.818 HG12 HG22 ' A' ' 125' ' ' ILE . 48.0 mt -123.29 128.32 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 121.441 0.638 . . . . 0.0 110.805 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.819 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 1.5 t70 -104.16 157.9 16.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.476 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.724 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 18.9 t80 -39.33 -46.24 1.56 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.376 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 153' ' ' ARG . . . -67.91 -44.01 80.68 Favored Glycine 0 N--CA 1.422 -2.279 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.303 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.819 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 27.8 mt-10 -55.88 -62.23 1.84 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.413 -0.394 . . . . 0.0 110.143 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.728 ' HB2' HG21 ' A' ' 133' ' ' ILE . 2.5 t80 -55.3 -30.16 59.63 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.943 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 135' ' ' TYR . . . -74.88 -26.36 59.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.339 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.71 -51.23 5.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.851 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -57.72 -12.65 3.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.925 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.7 ttp -111.54 -30.17 7.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.683 0.278 . . . . 0.0 110.836 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 139' ' ' ALA . 14.9 tpp85 -65.9 -59.04 4.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.162 0.506 . . . . 0.0 110.078 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.562 ' HB2' ' NZ ' ' A' ' 144' ' ' LYS . 9.9 mtmp? -128.91 -153.53 0.58 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.987 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.485 ' NE ' ' N ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -74.06 -38.85 63.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.714 0.292 . . . . 0.0 110.644 179.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.425 ' NZ ' ' HA2' ' A' ' 149' ' ' GLY . 26.3 ttpp -175.62 159.27 2.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.505 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -65.56 -65.68 2.78 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.18 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -151.37 150.27 30.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.425 ' HA2' ' NZ ' ' A' ' 146' ' ' LYS . . . -40.24 -64.66 1.09 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.102 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.455 ' C ' HD11 ' A' ' 151' ' ' ILE . . . -54.8 -65.31 3.62 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.94 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.58 HD11 ' N ' ' A' ' 151' ' ' ILE . 2.7 mp -129.79 149.85 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.122 0.487 . . . . 0.0 112.064 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.538 ' HA3' ' HB2' ' A' ' 127' ' ' GLN . . . -69.89 -116.19 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.512 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.539 ' HA ' ' HE ' ' A' ' 153' ' ' ARG . 5.4 tpm_? -130.51 83.29 2.11 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 121.261 0.553 . . . . 0.0 111.266 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.763 ' HB3' ' HB3' ' A' ' 157' ' ' ARG . 35.7 ttm180 -89.75 148.21 23.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.159 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.41 ' O ' HG21 ' A' ' 155' ' ' THR . 89.6 m -68.28 -19.95 64.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.03 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.698 ' H ' ' HG2' ' A' ' 154' ' ' ARG . 25.1 ptt? -132.42 54.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 111.494 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.763 ' HB3' ' HB3' ' A' ' 154' ' ' ARG . 21.6 tpp180 -157.39 118.44 3.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.009 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.585 ' HB3' ' NZ ' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -164.97 -45.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.203 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.1 t -152.05 2.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.002 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.7 mt -76.11 166.9 22.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.864 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -60.6 136.65 58.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.039 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.27 -5.04 42.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -96.75 165.57 12.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.721 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -102.43 137.42 40.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.962 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -101.64 156.43 17.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.113 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.443 HD11 ' H ' ' A' ' 166' ' ' LEU . 6.2 mp -82.33 -24.98 34.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.753 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 138.57 -126.47 3.46 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.447 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 55.8 tp -97.82 109.67 22.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.787 0.327 . . . . 0.0 110.818 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.45 141.66 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.24 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -136.07 161.67 35.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.818 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -104.78 -42.04 5.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 109.31 -167.43 12.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.551 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.5 m -151.16 -35.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.756 0.313 . . . . 0.0 110.826 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -97.94 -16.77 19.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.769 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.53 ' NE2' ' H ' ' A' ' 175' ' ' GLN . 0.0 OUTLIER -98.96 97.88 8.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.468 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 177' ' ' ILE . 9.5 p -66.84 138.44 22.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.295 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.405 ' N ' HG22 ' A' ' 176' ' ' VAL . 10.7 tt -114.27 127.15 71.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.88 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -76.9 110.29 11.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.003 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -76.17 164.34 53.55 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.416 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.08 15.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.112 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -143.48 -13.6 0.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.949 -179.867 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.834 0.349 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -165.16 104.78 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.346 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.403 ' HG2' HH11 ' A' ' 3' ' ' ARG . 50.5 ttt-85 -105.9 133.71 50.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.943 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.5 tp -106.37 -91.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.8 p -175.12 157.1 2.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.867 0.365 . . . . 0.0 111.129 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -99.34 41.25 1.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.492 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -67.14 -12.4 59.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.424 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.85 -69.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.113 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.18 -14.12 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.54 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.0 165.29 12.86 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.777 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.34 37.04 93.95 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.055 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 95.7 mt -80.63 -32.92 36.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.457 0.17 . . . . 0.0 111.24 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.617 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 62.2 tttp -57.51 -43.83 84.55 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' A' ' 18' ' ' MET . 44.8 tt0 -71.75 -47.97 50.03 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.714 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 28.2 tp -48.85 -29.01 4.15 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.55 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.488 ' CZ ' ' N ' ' A' ' 65' ' ' TYR . 15.3 t80 -64.87 -51.67 60.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.581 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.536 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.6 ptpt -77.79 -12.77 60.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.05 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.663 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 56.8 mmm -68.19 -24.05 64.91 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.491 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.83 HG21 HG23 ' A' ' 27' ' ' ILE . 4.0 mt -83.73 -52.0 13.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.162 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.683 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -80.73 51.84 1.58 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.436 0.636 . . . . 0.0 112.378 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -79.59 -6.31 56.79 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.558 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -111.28 -27.9 8.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.611 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.468 ' O ' ' OG ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -87.49 -91.19 0.11 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.889 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 23' ' ' ASN . 74.9 m -176.06 21.73 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.261 0.351 . . . . 0.0 110.988 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.45 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 111.18 24.8 5.29 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.529 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.683 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 78.6 p -140.39 142.13 35.51 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.166 0.508 . . . . 0.0 110.218 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.83 HG23 HG21 ' A' ' 19' ' ' ILE . 5.6 mt -102.95 102.96 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.816 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 62' ' ' THR . 79.7 p -103.6 165.04 11.28 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.197 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.548 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 52.9 t80 -34.36 -33.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.723 0.64 . . . . 0.0 111.864 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . 33.2 t70 -76.91 -47.58 20.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.955 0.407 . . . . 0.0 110.695 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 28' ' ' THR . 25.1 mp0 -73.07 -25.09 60.78 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.235 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.659 HD12 HD22 ' A' ' 51' ' ' LEU . 1.8 tm? -48.73 -51.45 28.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.464 0.649 . . . . 0.0 109.792 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.656 ' HB2' ' HE2' ' A' ' 37' ' ' LYS . 6.9 ptpp? -82.45 -40.32 21.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.898 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -39.06 -62.11 0.68 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.088 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -50.76 -37.22 34.33 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.211 -0.518 . . . . 0.0 113.984 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.565 ' O ' HG13 ' A' ' 39' ' ' VAL . 49.5 mt -79.67 -58.42 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.34 0.57 . . . . 0.0 111.759 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.656 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -54.93 -17.65 3.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.247 0.546 . . . . 0.0 109.668 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.3 ttt85 -77.37 -42.83 35.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.545 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -70.89 -1.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.161 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.92 5.71 33.01 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.45 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 74.5 m -81.9 166.46 19.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.79 0.329 . . . . 0.0 111.151 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -138.9 104.68 5.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.816 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.4 mt -128.68 166.09 19.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.407 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.559 ' O ' HD12 ' A' ' 48' ' ' ILE . 23.1 mtp -107.34 161.68 14.59 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG2' ' HE2' ' A' ' 33' ' ' LYS . 37.1 mt-10 -55.64 -60.28 3.66 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.503 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.476 ' HB2' ' HZ ' ' A' ' 111' ' ' PHE . 41.2 t -43.24 -29.07 0.36 Allowed 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.8 mm-40 -72.98 -42.36 63.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.265 0.555 . . . . 0.0 110.037 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.622 HG12 ' HB3' ' A' ' 33' ' ' LYS . 1.7 mp -55.57 -56.82 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.756 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.576 ' HE2' ' CE1' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -47.53 -28.25 2.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.764 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.542 ' HA ' ' HZ2' ' A' ' 49' ' ' LYS . 63.8 t0 -75.29 -54.93 6.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.601 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.659 HD22 HD12 ' A' ' 32' ' ' LEU . 36.4 tp -53.89 -37.66 63.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.236 0.541 . . . . 0.0 111.058 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.635 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 33.8 ttm -74.36 -66.35 0.74 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.331 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.656 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -54.48 -26.21 29.92 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.764 -178.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.68 -41.09 15.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 51' ' ' LEU . . . -100.3 -43.39 6.29 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.446 ' OD2' ' HA ' ' A' ' 59' ' ' LYS . 60.5 t0 -46.37 98.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 110.144 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.4 mm -54.14 -19.64 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.243 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.568 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 62.0 m-20 -131.35 44.47 2.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.872 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.656 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 21.8 tptm -32.27 92.04 0.01 OUTLIER 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 58' ' ' ASP . 49.0 m -127.71 18.44 6.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.404 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.635 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 70.08 23.46 77.14 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.47 -178.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.697 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 42.5 m -159.72 129.97 5.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.797 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.768 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 75.8 mt -108.19 130.13 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.962 0.411 . . . . 0.0 111.511 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -104.87 167.61 9.6 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.085 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.617 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 28.9 t80 -35.22 -47.3 0.39 Allowed 'General case' 0 CA--C 1.52 -0.182 0 O-C-N 123.446 0.466 . . . . 0.0 111.731 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.98 -56.66 10.2 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.361 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.616 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 71.4 mt-10 -54.75 -22.66 14.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 110.692 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.714 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 64.9 t80 -68.32 -64.31 0.89 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.623 0.725 . . . . 0.0 110.905 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' A' ' 68' ' ' PHE . 7.9 mm -52.39 -41.79 36.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.613 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.75 -32.98 66.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.143 0.497 . . . . 0.0 110.803 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.38 -28.34 52.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.23 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.5 p -95.35 -8.53 35.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.977 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.7 p -95.47 -15.41 7.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.961 0.41 . . . . 0.0 110.668 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -75.98 -47.07 26.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.362 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -15.26 61.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -78.04 79.58 4.5 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.238 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -136.54 -43.05 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.631 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.584 ' HG ' ' HG3' ' A' ' 79' ' ' GLU . 67.9 tp -166.14 -61.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.515 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.584 ' HG3' ' HG ' ' A' ' 78' ' ' LEU . 51.1 mt-10 -145.93 160.46 41.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.717 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -64.33 127.2 30.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.093 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -125.82 10.29 7.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.057 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -85.4 111.91 20.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.764 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -132.6 -155.19 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.344 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.647 HD21 ' HE1' ' A' ' 142' ' ' MET . 3.4 tm? -58.93 -37.63 77.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.183 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.5 p -49.63 -25.14 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.61 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 79.2 p -43.32 -45.28 5.91 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.975 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.405 ' C ' ' N ' ' A' ' 89' ' ' SER . . . -90.14 -38.57 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.712 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.708 ' HZ ' ' HA2' ' A' ' 97' ' ' GLY . 8.6 t80 -44.33 -24.15 0.15 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.269 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 87' ' ' ALA . 47.7 t -89.05 -45.38 9.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.898 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -81.69 -63.68 1.34 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.365 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.576 ' CE1' ' HE2' ' A' ' 49' ' ' LYS . 4.0 m-85 -56.44 -64.41 0.88 Allowed 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.713 ' HA ' HG12 ' A' ' 99' ' ' ILE . 61.8 t0 -76.78 67.4 2.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -55.85 -25.72 43.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.397 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -84.18 -20.69 31.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 39.22 67.3 0.61 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.1 p -122.87 -19.12 6.26 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.708 ' HA2' ' HZ ' ' A' ' 88' ' ' PHE . . . 123.37 -3.14 9.59 Favored Glycine 0 N--CA 1.434 -1.443 0 CA-C-N 113.435 -1.711 . . . . 0.0 112.379 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.783 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -136.05 151.92 50.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.363 0.601 . . . . 0.0 111.702 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.713 HG12 ' HA ' ' A' ' 92' ' ' ASP . 83.0 mt -130.95 102.78 6.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.054 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 101' ' ' LEU . 51.2 p -79.81 151.46 30.28 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.642 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.4 OUTLIER -34.29 -34.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.022 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.97 -54.98 31.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.904 0.383 . . . . 0.0 110.527 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.4 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 51.3 mt-10 -65.75 -28.68 69.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.185 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.423 HG21 ' OE1' ' A' ' 105' ' ' GLN . 72.8 mt -72.42 -65.38 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 111.004 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.652 ' NE2' HG21 ' A' ' 118' ' ' ILE . 2.4 mm-40 -47.65 -45.2 27.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.139 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -64.13 -42.92 96.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.468 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.87 -4.54 32.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 26.5 p -124.04 91.4 3.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.069 0.462 . . . . 0.0 111.385 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -88.44 -50.78 6.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.326 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.91 -17.75 62.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.517 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.58 ' HB2' ' HB2' ' A' ' 108' ' ' CYS . 3.7 m-85 -63.92 -11.32 27.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.627 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.41 34.79 24.89 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.3 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.496 HD22 HG12 ' A' ' 118' ' ' ILE . 0.5 OUTLIER -35.52 109.94 0.09 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.24 0.543 . . . . 0.0 111.508 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.717 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 38.4 t70 -160.96 138.54 9.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.334 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -50.81 -9.49 0.05 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.419 ' H ' ' C ' ' A' ' 114' ' ' ASP . 73.4 mt -89.44 -59.55 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.644 0.259 . . . . 0.0 111.648 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -91.07 -59.41 2.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 111.622 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.717 ' HB ' ' H ' ' A' ' 114' ' ' ASP . 3.6 tp -48.47 -28.25 2.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.534 ' N ' HG22 ' A' ' 118' ' ' ILE . 33.5 t70 -65.64 -51.52 58.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.874 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 124' ' ' GLU . 7.7 t70 -56.45 -29.23 61.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.978 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 6.6 ttt -66.79 -39.64 87.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.661 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 101' ' ' LEU . 33.1 mm -56.97 -43.06 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.689 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -83.78 -13.3 54.18 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.632 178.304 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.978 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 31.1 tt0 -87.65 -17.03 32.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.43 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.69 HG12 ' O ' ' A' ' 121' ' ' MET . 14.9 mm -115.96 -32.13 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.558 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 131' ' ' GLY . 2.7 t70 -75.5 92.11 2.85 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.599 ' NE2' ' H ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -86.02 -8.71 57.75 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.909 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 20.1 m-20 -111.86 -33.71 6.22 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.587 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.32 -86.34 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 117.603 2.445 . . . . 0.0 117.603 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.73 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 22.0 m-20 -64.65 26.06 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -172.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.438 ' H ' ' CG ' ' A' ' 126' ' ' ASP . . . 55.51 37.51 67.26 Favored Glycine 0 CA--C 1.505 -0.574 0 C-N-CA 117.917 -2.087 . . . . 0.0 109.192 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.783 ' NE2' ' HB3' ' A' ' 98' ' ' TYR . 8.7 pt20 -136.3 168.95 18.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.074 -1.063 . . . . 0.0 110.384 -177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.634 HG12 HG22 ' A' ' 125' ' ' ILE . 60.0 mt -123.45 129.49 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.614 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.787 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 30.3 t70 -101.81 158.55 16.03 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.027 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.674 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 4.9 t80 -45.39 -32.54 2.13 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.913 0.387 . . . . 0.0 110.721 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.592 ' HA3' ' HA3' ' A' ' 152' ' ' GLY . . . -80.59 -38.15 17.99 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.071 -1.061 . . . . 0.0 110.729 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.933 ' HA ' ' HB3' ' A' ' 153' ' ' ARG . 30.8 mt-10 -59.98 -57.79 11.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.803 -0.198 . . . . 0.0 110.8 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.543 ' HB2' HG21 ' A' ' 133' ' ' ILE . 2.6 t80 -58.89 -26.77 64.6 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.527 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 135' ' ' TYR . . . -79.7 -36.68 37.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.002 0.429 . . . . 0.0 110.836 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.458 ' HB3' ' NE ' ' A' ' 153' ' ' ARG . . . -90.0 -14.22 34.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.033 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -57.34 -18.53 17.56 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.647 ' HE1' HD21 ' A' ' 84' ' ' LEU . 24.4 ptt? -127.88 50.12 2.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.083 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -34.26 136.1 0.14 Allowed 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.347 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.88 -56.16 1.77 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.556 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -150.3 38.71 0.72 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.72 ' HZ3' ' HB2' ' A' ' 146' ' ' LYS . 10.0 mtmp? -42.86 105.61 0.05 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -95.9 -37.9 4.8 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.883 -0.675 . . . . 0.0 114.667 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.652 ' O ' HG13 ' A' ' 151' ' ' ILE . 23.4 p30 -149.67 162.29 40.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.33 0.565 . . . . 0.0 111.445 -178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 151' ' ' ILE . . . -36.42 -22.63 0.01 OUTLIER Glycine 0 C--N 1.339 0.744 0 O-C-N 123.814 0.696 . . . . 0.0 114.155 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 148' ' ' ASN . . . -59.89 -4.49 3.3 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.979 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 148' ' ' ASN . 8.4 mt -38.07 -84.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 123.061 0.544 . . . . 0.0 111.407 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.592 ' HA3' ' HA3' ' A' ' 136' ' ' GLY . . . 161.4 -62.96 0.28 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.633 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.933 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . 34.5 ptt85 -76.63 82.37 3.28 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.681 0.753 . . . . 0.0 110.595 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.745 ' HG3' ' H ' ' A' ' 156' ' ' MET . 5.0 tpm_? -130.66 148.29 52.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.33 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.474 ' H ' ' HE ' ' A' ' 154' ' ' ARG . 86.1 m -69.63 -16.03 63.3 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.745 ' H ' ' HG3' ' A' ' 154' ' ' ARG . 25.3 ptm -138.98 34.72 2.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.41 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.682 ' HB3' ' HB3' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -58.19 -12.32 3.46 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.508 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.556 ' N ' ' HD3' ' A' ' 157' ' ' ARG . 17.9 tppt? -55.28 -86.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.171 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 50.3 p -143.43 -72.57 0.29 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.055 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.435 HD21 ' N ' ' A' ' 161' ' ' ASN . 6.1 tt -160.47 123.42 3.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.298 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.6 ' H ' ' HE2' ' A' ' 156' ' ' MET . 47.6 t30 -112.46 158.14 20.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.578 ' N ' HD13 ' A' ' 162' ' ' LEU . 5.8 mp -84.86 -81.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.775 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 51.0 mmt-85 -103.2 109.54 21.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.926 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.84 149.38 26.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.953 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -116.66 146.2 42.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.962 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.2 mp -109.09 -16.54 14.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.994 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.88 -116.83 4.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.515 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.75 114.34 3.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.812 0.339 . . . . 0.0 110.26 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.2 m -67.32 127.53 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.477 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -151.71 -50.88 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.77 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.87 -32.66 73.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.703 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -144.69 142.1 10.63 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.43 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.3 m -137.44 91.75 2.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 110.891 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.439 ' OD1' ' HG2' ' A' ' 175' ' ' GLN . 25.1 t-20 -141.02 -90.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.55 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.439 ' HG2' ' OD1' ' A' ' 174' ' ' ASN . 98.1 mm-40 -138.03 110.86 7.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.595 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.59 103.41 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.289 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.5 mm -90.28 131.15 38.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.889 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -107.8 119.69 40.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -105.76 101.54 1.85 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.368 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -68.45 157.16 36.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 111.178 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -172.06 -75.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.799 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.867 -179.944 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.578 ' HB1' HH12 ' A' ' 3' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.828 0.347 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -98.39 123.58 42.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.811 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.578 HH12 ' HB1' ' A' ' 1' ' ' ALA . 21.6 ptt-85 -165.13 164.14 20.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.6 tp -165.79 90.97 0.47 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.719 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.2 p -130.51 171.78 12.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 5.1 mm-40 -65.53 148.32 51.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.093 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -89.0 -42.94 11.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.1 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -76.53 -43.08 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.786 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 6' ' ' GLU . 2.1 mp -74.05 -43.73 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.791 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.36 115.38 4.41 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.38 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.86 26.57 0.4 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.49 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 72' ' ' THR . 53.9 tp -87.85 -37.98 16.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.469 0.176 . . . . 0.0 110.61 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.58 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 24.0 pttm -66.36 -32.11 73.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -78.18 -36.85 46.9 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.757 ' O ' HG12 ' A' ' 19' ' ' ILE . 52.3 tp -53.87 -42.57 68.75 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.366 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.539 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 10.9 t80 -51.69 -45.06 63.34 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.443 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -85.06 -12.45 53.03 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.9 ttp -85.55 -13.76 47.95 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.614 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.757 HG12 ' O ' ' A' ' 15' ' ' LEU . 22.4 mm -74.92 -52.44 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.685 ' HB2' ' HB3' ' A' ' 23' ' ' ASN . 4.4 p-10 -81.93 50.6 1.57 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.033 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.0 t -61.97 -6.82 3.12 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.877 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -133.94 -10.88 2.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.979 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.685 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 30.9 t30 -87.49 -95.83 0.09 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.2 p -177.72 12.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 111.59 24.37 5.32 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.948 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.498 ' OG1' ' ND2' ' A' ' 23' ' ' ASN . 40.6 p -147.62 144.23 28.26 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.972 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 6.9 mt -104.02 104.84 17.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 68.8 p -102.21 163.52 12.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.704 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.738 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 49.2 t80 -34.28 -37.32 0.05 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.86 -45.75 40.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.92 0.39 . . . . 0.0 111.167 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -78.56 -13.83 59.63 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.719 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.976 HD13 ' HB2' ' A' ' 52' ' ' MET . 6.2 tt -53.05 -49.01 67.2 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.635 ' HD3' ' NZ ' ' A' ' 37' ' ' LYS . 4.0 ptpp? -84.75 -41.17 16.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.491 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 17.9 t70 -47.57 -30.29 3.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.048 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' HA3' HG21 ' A' ' 19' ' ' ILE . . . -65.03 -40.31 96.99 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.888 -0.673 . . . . 0.0 113.351 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.544 ' O ' HG11 ' A' ' 39' ' ' VAL . 1.3 mm? -91.99 -33.15 14.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.324 0.583 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.635 ' NZ ' ' HD3' ' A' ' 33' ' ' LYS . 76.5 mttt -60.94 -45.8 93.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.698 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.44 ' HG2' HH11 ' A' ' 38' ' ' ARG . 46.9 ttt-85 -69.77 -40.74 75.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.62 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.544 HG11 ' O ' ' A' ' 36' ' ' LEU . 8.2 p -71.13 -14.25 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.48 54.86 0.3 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.121 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 70.1 m -146.0 166.98 24.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.605 0.24 . . . . 0.0 110.483 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 23.2 pt-20 -137.29 114.67 10.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 111.378 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.4 mt -125.13 165.58 17.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.272 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.431 ' O ' HD11 ' A' ' 48' ' ' ILE . 20.4 mtm -113.41 164.41 13.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -64.98 0.65 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.154 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.1 p -39.78 -26.81 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 93.9 mt-10 -79.22 -49.72 12.08 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.764 HG13 HD22 ' A' ' 32' ' ' LEU . 1.7 mp -52.99 -60.86 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.591 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.738 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 51.6 tttp -57.05 -22.79 41.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.889 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 36.8 t70 -76.62 -44.58 33.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 tt -63.44 -44.76 93.62 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 111.092 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.976 ' HB2' HD13 ' A' ' 32' ' ' LEU . 37.3 ttm -66.6 -64.09 0.93 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.249 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.679 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 9.6 t70 -55.88 -29.29 59.72 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.05 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 50' ' ' ASP . . . -88.58 -36.64 16.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -103.23 -41.65 5.99 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.52 ' OD1' HG12 ' A' ' 63' ' ' ILE . 15.8 t70 -50.94 95.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.937 0.399 . . . . 0.0 110.188 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.9 mm -51.49 -18.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.551 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.53 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.2 m-20 -131.05 43.91 3.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.174 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.679 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 28.1 tptp -32.53 89.65 0.0 OUTLIER 'General case' 0 C--O 1.231 0.117 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 58' ' ' ASP . 87.7 p -127.85 18.21 6.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.519 -1.218 . . . . 0.0 109.02 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.527 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 76.34 22.63 72.82 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.087 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 91.1 m -147.54 153.84 39.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.243 0.617 . . . . 0.0 109.597 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.972 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 71.7 mt -135.16 127.53 47.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.995 0.426 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -104.6 167.52 9.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.492 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.58 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 41.2 t80 -35.41 -44.71 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.558 0.536 . . . . 0.0 111.663 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.04 -60.63 5.48 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.197 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.53 ' OE2' ' HB2' ' A' ' 58' ' ' ASP . 40.9 mt-10 -53.88 -21.83 8.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.851 0.358 . . . . 0.0 110.945 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.665 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 26.2 t80 -67.77 -65.11 0.73 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.501 0.667 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 65' ' ' TYR . 10.5 mm -52.44 -43.09 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.583 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.63 -39.44 73.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.47 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.42 ' O ' HD23 ' A' ' 75' ' ' LEU . . . -64.43 -49.25 72.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.361 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.491 HG23 HD11 ' A' ' 12' ' ' LEU . 65.8 p -55.8 -38.55 70.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.267 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.445 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 45.9 t -81.52 -16.75 12.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.063 0.458 . . . . 0.0 110.941 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -81.21 -25.69 36.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 71' ' ' ALA . 4.5 mm? -97.75 -4.07 37.79 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.784 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.445 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 26.5 t-20 -101.12 75.84 1.69 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.738 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.662 ' HG3' ' H ' ' A' ' 79' ' ' GLU . 18.5 ptpt -174.91 -161.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.033 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.07 8.09 7.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.965 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.662 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 17.6 tp10 -58.41 157.59 8.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.644 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 45.0 mmt-85 -51.11 143.38 10.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.068 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -60.09 -77.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.171 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.04 31.77 0.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.239 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.515 HD21 ' H ' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -55.97 133.7 51.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.907 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.515 ' H ' HD21 ' A' ' 83' ' ' ASN . 2.0 pp -58.6 -17.01 18.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.433 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 85' ' ' VAL . 14.5 p -48.3 -19.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.832 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -38.43 -49.23 1.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.264 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' A' ' 91' ' ' PHE . . . -71.89 -50.17 31.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.499 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.761 ' HE1' ' HB2' ' A' ' 135' ' ' TYR . 11.5 t80 -36.23 -33.55 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.492 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 87' ' ' ALA . 29.5 t -89.67 -50.69 5.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.728 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.66 -64.21 1.24 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.165 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.586 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 5.0 m-85 -58.93 -59.9 4.71 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.73 ' HA ' HG12 ' A' ' 99' ' ' ILE . 1.2 m-20 -75.68 57.65 1.01 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -52.06 -41.15 62.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.701 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.461 ' HB3' 'CA ' ' A' ' 191' ' ' ' CA' . 37.2 t70 -67.87 -20.9 65.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 42.49 64.32 1.62 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.474 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 54.5 p -119.48 -35.32 3.59 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.39 4.1 0.81 Allowed Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.337 -1.756 . . . . 0.0 112.873 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.863 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.3 OUTLIER -152.67 165.64 34.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.494 0.664 . . . . 0.0 112.072 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.794 HG22 HG12 ' A' ' 104' ' ' ILE . 91.4 mt -132.35 104.08 7.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.14 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 102' ' ' ASP . 50.5 p -76.09 149.27 37.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.602 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER -34.57 -33.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 100' ' ' THR . 1.5 m-20 -57.69 -52.34 65.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.85 0.357 . . . . 0.0 110.276 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.429 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 49.3 mt-10 -67.83 -28.39 67.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.543 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.794 HG12 HG22 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -70.2 -62.12 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.575 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.618 ' OE1' HG22 ' A' ' 104' ' ' ILE . 4.7 mm100 -53.66 -38.28 63.98 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.898 0.38 . . . . 0.0 110.49 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -61.81 -59.22 5.48 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.96 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.75 -10.77 13.95 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.198 0.523 . . . . 0.0 110.558 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.59 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 31.3 t -100.59 63.44 1.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.737 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.463 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 1.2 tmtp? -85.82 -61.08 1.84 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -57.89 -5.39 0.41 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.573 ' HB2' ' SG ' ' A' ' 108' ' ' CYS . 33.3 m-85 -90.75 7.68 38.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.53 37.05 94.07 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.633 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.96 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -33.67 125.94 0.41 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.317 0.58 . . . . 0.0 112.202 -178.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.548 ' N ' HD23 ' A' ' 113' ' ' LEU . 10.1 t70 -160.65 159.44 30.37 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.681 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 1.4 m-20 -71.74 -6.92 44.85 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.0 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.733 HG13 ' H ' ' A' ' 117' ' ' HIS . 14.0 pt -77.87 -64.6 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.733 ' H ' HG13 ' A' ' 116' ' ' ILE . 13.0 m-70 -92.01 -61.97 1.51 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.09 0.472 . . . . 0.0 111.417 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.96 HG13 ' HA ' ' A' ' 113' ' ' LEU . 13.2 mm -45.16 -36.17 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.11 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.2 -48.28 62.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.946 0.403 . . . . 0.0 110.025 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 124' ' ' GLU . 61.8 t0 -67.59 -27.66 67.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.564 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 1.053 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.0 ttt -62.87 -40.28 97.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.487 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.582 HD13 ' NE2' ' A' ' 105' ' ' GLN . 48.1 mt -53.52 -44.4 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 123' ' ' LYS . 24.3 mmtp -85.18 -13.46 49.96 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.17 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 1.053 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 24.3 tt0 -87.95 -13.52 41.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.497 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.824 HG21 HD13 ' A' ' 133' ' ' ILE . 81.3 mt -117.31 -23.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.759 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.923 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 22.0 t70 -65.25 101.68 0.58 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.566 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.795 ' NE2' ' HA ' ' A' ' 137' ' ' GLU . 18.8 mt-30 -88.05 -18.44 28.92 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.749 ' HB2' ' HD2' ' A' ' 153' ' ' ARG . 45.7 t0 -119.39 -34.63 3.77 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.737 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 178.92 -73.28 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.737 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 1.2 m-20 -64.2 20.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.923 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.31 38.18 67.69 Favored Glycine 0 CA--C 1.5 -0.88 0 C-N-CA 117.48 -2.295 . . . . 0.0 108.075 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 6.8 pt20 -131.68 167.12 20.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.628 -1.286 . . . . 0.0 109.055 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.846 HD12 ' HB3' ' A' ' 137' ' ' GLU . 11.0 mm -134.18 124.99 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.326 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.863 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 2.4 p-10 -102.42 161.25 13.86 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.761 ' HB2' ' HE1' ' A' ' 88' ' ' PHE . 12.0 t80 -41.07 -32.63 0.26 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.812 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.712 ' HA3' ' N ' ' A' ' 153' ' ' ARG . . . -76.88 -46.43 10.82 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.642 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.916 ' HG3' ' HE ' ' A' ' 153' ' ' ARG . 33.5 mt-10 -54.41 -59.85 4.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.367 -0.416 . . . . 0.0 111.347 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.453 ' HB2' ' CG2' ' A' ' 133' ' ' ILE . 3.6 t80 -57.56 -29.9 64.8 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.92 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 135' ' ' TYR . . . -79.51 -20.06 48.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.074 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.84 -49.01 6.87 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.085 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.413 ' SD ' ' CD1' ' A' ' 138' ' ' PHE . 28.0 ptm -55.41 -16.46 3.67 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.35 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 56.0 ttp -99.86 -25.23 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.631 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 143' ' ' ARG . 68.0 mtt-85 -111.37 -99.08 0.41 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.792 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -141.01 -163.03 1.46 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.726 0.298 . . . . 0.0 110.346 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.738 ' HG3' ' HG2' ' A' ' 146' ' ' LYS . 23.3 ptt-85 -89.84 -23.04 21.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.87 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.738 ' HG2' ' HG3' ' A' ' 145' ' ' ARG . 17.9 ptpt -175.73 85.22 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.154 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -90.32 -37.68 6.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.695 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -149.13 162.17 40.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.607 0.241 . . . . 0.0 110.839 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -51.66 -14.04 1.55 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.85 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -66.47 -4.2 23.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.173 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.523 HG12 ' N ' ' A' ' 152' ' ' GLY . 6.9 tt -44.02 155.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 121.117 0.484 . . . . 0.0 111.788 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.528 ' C ' ' HA3' ' A' ' 136' ' ' GLY . . . -133.52 -46.61 0.11 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.916 ' HE ' ' HG3' ' A' ' 137' ' ' GLU . 8.7 tpp180 -75.51 120.71 21.3 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.675 0.75 . . . . 0.0 110.161 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.733 ' N ' ' HD3' ' A' ' 153' ' ' ARG . 70.4 mtp180 -131.22 148.23 52.68 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.693 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.0 t -58.8 -16.0 14.98 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.8 ttt -162.18 59.45 0.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.691 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.583 ' HB3' ' HB2' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -63.0 -172.21 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.433 -179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -165.34 121.2 1.36 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.795 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.8 t -164.85 161.17 20.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.1 mt -77.54 154.86 32.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.776 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -106.27 171.02 7.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.199 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.598 HD21 ' N ' ' A' ' 163' ' ' ARG . 7.9 tt -104.37 140.36 38.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.489 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.598 ' N ' HD21 ' A' ' 162' ' ' LEU . 57.6 ttp180 -132.91 -69.48 0.56 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.53 142.48 58.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.796 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.4 130.6 41.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.363 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.65 -14.55 59.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.986 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -106.5 -154.41 20.48 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.553 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.502 ' H ' HD22 ' A' ' 168' ' ' LEU . 2.4 pt? -111.29 -178.75 3.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.736 0.303 . . . . 0.0 110.828 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 50.0 t -71.1 112.31 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.872 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -68.28 90.27 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.125 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -90.52 11.62 21.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.39 124.39 24.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.425 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.3 t -95.74 49.79 1.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.896 0.379 . . . . 0.0 110.869 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -134.11 49.12 2.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.935 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 175' ' ' GLN . 20.7 pt20 -78.46 106.18 10.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.09 0.471 . . . . 0.0 110.975 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.55 136.93 24.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.128 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.459 ' C ' HD12 ' A' ' 177' ' ' ILE . 2.8 pp -121.77 148.65 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.402 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -126.1 134.98 51.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 176.63 45.53 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.705 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -77.81 166.95 22.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 0.0 110.949 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -84.38 132.46 34.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.017 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.933 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ' CA' . . . . . 0.461 'CA ' ' HB3' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -117.58 -7.69 11.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.082 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -118.14 80.05 1.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.913 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.3 mt -114.15 -177.3 3.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.8 m -137.9 168.31 19.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.01 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -108.25 -11.74 15.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.904 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -89.26 -19.87 24.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -73.59 -36.29 65.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.192 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 10' ' ' GLY . 8.0 tp -66.31 -31.23 52.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.415 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -106.45 150.92 16.92 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.684 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.42 -11.29 72.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.621 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.569 HD12 HD22 ' A' ' 15' ' ' LEU . 50.0 tp -86.95 -39.11 16.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.667 0.27 . . . . 0.0 110.823 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HG2' ' OH ' ' A' ' 65' ' ' TYR . 33.9 mtmm -56.94 -46.68 81.92 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.627 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -68.48 -34.52 76.07 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.621 ' HA ' ' HB3' ' A' ' 18' ' ' MET . 45.2 tp -59.52 -28.7 67.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.169 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.442 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 13.1 t80 -67.47 -38.98 85.22 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.016 0.436 . . . . 0.0 110.971 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.627 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 61.7 pttt -86.63 -19.82 28.75 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.621 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -63.44 -27.2 69.13 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.491 176.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.616 HG23 HG22 ' A' ' 27' ' ' ILE . 18.7 mm -70.61 -59.65 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.212 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' HB2' ' OE1' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -78.59 89.79 4.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.3 178.077 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.5 t -88.27 -34.71 17.61 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.525 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -139.83 16.7 2.49 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.534 ' HB2' ' OE1' ' A' ' 31' ' ' GLU . 3.5 m120 -92.44 -88.65 0.2 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.947 0.794 . . . . 0.0 112.89 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -164.95 -1.55 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.75 20.53 7.22 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.514 ' HB ' ' HG1' ' A' ' 62' ' ' THR . 75.4 p -128.09 166.43 18.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.841 ' O ' ' HA ' ' A' ' 62' ' ' THR . 6.1 mt -123.14 101.53 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.083 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 67.5 p -103.56 164.98 11.31 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.704 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -33.72 -39.21 0.06 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.839 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.662 ' OD1' ' HG3' ' A' ' 31' ' ' GLU . 1.8 p30 -73.05 -43.69 61.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.64 0.257 . . . . 0.0 111.281 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.662 ' HG3' ' OD1' ' A' ' 30' ' ' ASP . 42.4 mt-10 -74.68 -24.07 58.73 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 110.265 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.632 HD21 HG21 ' A' ' 48' ' ' ILE . 6.3 tt -54.43 -54.24 43.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.87 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.697 ' HG3' ' H ' ' A' ' 34' ' ' ASP . 17.0 ptpt -75.97 -62.31 1.64 Allowed 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.466 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.697 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 35.9 t70 -37.59 -48.55 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . -48.85 -54.44 14.18 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.98 -0.555 . . . . 0.0 113.858 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.524 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -89.8 -45.94 8.93 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.216 0.531 . . . . 0.0 110.144 -179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -17.21 0.56 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.079 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.581 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 32.0 ttm-85 -59.66 -43.22 94.01 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.778 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 36' ' ' LEU . 34.3 m -78.53 31.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.98 -22.66 24.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.752 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.408 ' HG ' HG21 ' A' ' 39' ' ' VAL . 75.7 m -53.46 154.44 3.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.648 0.261 . . . . 0.0 110.648 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.09 118.18 9.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 111.432 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 mt -119.67 165.77 14.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.481 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.677 ' HE3' ' HB3' ' A' ' 86' ' ' SER . 0.0 OUTLIER -105.02 152.92 22.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.21 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -42.46 -56.05 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.663 ' HB2' ' SD ' ' A' ' 44' ' ' MET . 52.3 m -54.7 -21.66 11.46 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 119.236 0.925 . . . . 0.0 111.888 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.596 ' OE2' ' HA ' ' A' ' 83' ' ' ASN . 38.2 mt-10 -74.57 -44.54 50.42 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.632 HG21 HD21 ' A' ' 32' ' ' LEU . 2.0 mp -58.17 -53.31 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.119 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.597 ' HE2' ' HE1' ' A' ' 91' ' ' PHE . 10.5 ttpp -52.92 -30.27 33.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.459 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.609 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 8.8 t70 -62.96 -50.09 72.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.379 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.578 ' HG ' HD12 ' A' ' 63' ' ' ILE . 41.1 tp -60.63 -14.88 23.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.694 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.931 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 13.4 mmt -88.13 -65.84 0.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -78.94 -32.95 45.72 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.939 -0.475 . . . . 0.0 111.726 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . -87.46 -18.32 30.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 51' ' ' LEU . . . -127.09 -43.57 1.65 Allowed 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.626 ' OD1' HG12 ' A' ' 63' ' ' ILE . 21.2 t70 -59.91 96.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.784 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.5 mm -46.26 -25.63 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.866 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.53 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.7 m-20 -129.63 44.09 3.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.27 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.931 ' HD3' ' HB3' ' A' ' 52' ' ' MET . 51.4 tptt -33.27 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.046 0.927 . . . . 0.0 113.347 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.7 p -127.29 9.56 6.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.77 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 97.85 -5.7 61.94 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.517 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.841 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 3.0 t -141.11 165.01 28.72 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.062 0.458 . . . . 0.0 110.681 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.836 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 98.4 mt -125.81 135.38 64.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.33 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.89 166.21 10.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.649 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.638 ' O ' HG12 ' A' ' 69' ' ' ILE . 51.3 t80 -36.31 -46.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.733 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.55 -63.84 4.0 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.441 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.74 ' HB2' HG21 ' A' ' 63' ' ' ILE . 40.9 mt-10 -49.86 -29.2 7.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.739 0.304 . . . . 0.0 111.473 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 34.1 t80 -65.83 -62.63 1.4 Allowed 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.364 0.602 . . . . 0.0 111.16 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.638 HG12 ' O ' ' A' ' 65' ' ' TYR . 19.8 mm -53.32 -48.38 56.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.692 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.45 -41.16 84.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.922 0.392 . . . . 0.0 110.905 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 74' ' ' HIS . . . -58.11 -55.85 29.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.26 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.8 p -59.12 -56.07 26.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.492 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.651 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 49.5 t -56.92 -22.23 15.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.374 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.469 ' O ' ' HE3' ' A' ' 77' ' ' LYS . 77.3 t60 -67.9 -52.69 33.51 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.68 -9.45 58.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.227 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.651 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 49.3 t30 -91.51 78.8 5.58 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.087 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.469 ' HE3' ' O ' ' A' ' 74' ' ' HIS . 20.8 pttp -166.45 -24.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.833 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.5 mt -138.91 -85.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.539 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -175.04 137.68 0.42 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.713 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.647 ' HD2' ' O ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -114.16 130.89 56.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.444 . . . . 0.0 110.978 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -150.74 9.5 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.515 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.51 93.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.992 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.596 ' HA ' ' OE2' ' A' ' 47' ' ' GLU . 3.3 m120 -97.39 -87.19 0.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.737 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -74.47 -36.73 63.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.018 0.437 . . . . 0.0 110.311 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.17 -19.47 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.456 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.677 ' HB3' ' HE3' ' A' ' 44' ' ' MET . 48.3 t -41.75 -62.66 0.85 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.271 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -73.41 -36.08 65.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.463 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.774 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 2.8 t80 -45.72 -25.74 0.53 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.413 0.625 . . . . 0.0 109.65 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.7 t -89.62 -43.56 10.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.863 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -87.07 -64.45 1.15 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.82 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.621 ' HB3' HD11 ' A' ' 99' ' ' ILE . 2.8 m-85 -56.26 -59.99 4.15 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.783 ' HA ' HG12 ' A' ' 99' ' ' ILE . 1.6 m-20 -78.73 55.66 1.73 Allowed 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -51.16 -41.66 60.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.697 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.424 ' HB3' 'CA ' ' A' ' 191' ' ' ' CA' . 8.6 t70 -67.56 -20.61 65.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 92' ' ' ASP . . . 43.74 65.06 1.67 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.276 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.9 p -119.08 -33.79 4.06 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.565 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 147.8 -37.08 1.12 Allowed Glycine 0 N--CA 1.433 -1.53 0 CA-C-N 112.786 -2.006 . . . . 0.0 112.196 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.888 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.2 OUTLIER -109.45 164.88 12.1 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.783 HG12 ' HA ' ' A' ' 92' ' ' ASP . 77.8 mt -132.6 103.54 6.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.231 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 102' ' ' ASP . 44.4 p -72.2 146.09 47.57 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.519 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.3 OUTLIER -34.64 -32.95 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 100' ' ' THR . 45.4 t0 -55.47 -56.38 20.89 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.03 -28.34 68.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.825 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.673 HD13 ' HA ' ' A' ' 132' ' ' GLN . 78.9 mt -69.57 -65.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.031 0.443 . . . . 0.0 111.247 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 101' ' ' LEU . 6.6 mm100 -50.09 -51.87 39.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.596 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.481 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 70.1 mt-30 -64.49 -24.68 67.69 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.48 -6.86 58.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 72.2 m -123.78 68.57 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.867 0.365 . . . . 0.0 111.391 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 106' ' ' GLN . 74.6 mmtt -84.03 -32.09 25.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.584 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -83.21 -4.86 58.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.596 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 0.9 OUTLIER -93.46 16.33 13.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.359 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.05 36.82 45.14 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.602 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.874 ' HA ' HG13 ' A' ' 118' ' ' ILE . 3.1 tm? -34.36 110.0 0.09 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.969 0.414 . . . . 0.0 111.323 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.435 ' OD2' ' HB ' ' A' ' 116' ' ' ILE . 12.1 p-10 -160.12 -176.07 5.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.734 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.579 ' HA ' ' CG ' ' A' ' 119' ' ' ASP . 2.8 p30 -89.48 -8.94 51.82 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.435 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 60.5 mt -81.8 -64.6 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.914 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.421 ' HD1' HG22 ' A' ' 116' ' ' ILE . 12.9 m80 -91.61 -68.9 0.77 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.874 HG13 ' HA ' ' A' ' 113' ' ' LEU . 31.4 mm -40.52 -36.56 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.579 ' CG ' ' HA ' ' A' ' 115' ' ' ASP . 42.2 m-20 -71.2 -52.4 19.3 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 122.139 -0.351 . . . . 0.0 110.86 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 124' ' ' GLU . 32.4 m-20 -57.59 -23.62 51.78 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.98 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.5 ttt -65.39 -36.27 83.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.746 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.487 HG21 ' HB3' ' A' ' 101' ' ' LEU . 52.8 mt -57.06 -45.89 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 10.6 mmpt? -83.57 -13.19 54.99 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.57 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.98 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 29.8 tt0 -87.97 -19.21 27.53 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.458 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.649 HG23 HG12 ' A' ' 133' ' ' ILE . 63.9 mt -107.59 -50.52 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.89 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.543 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 5.4 p-10 -46.76 100.1 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.858 0.837 . . . . 0.0 110.697 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.691 ' NE2' ' H ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -87.3 -9.9 53.72 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.996 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 53.7 p30 -117.05 -33.19 4.8 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.686 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.43 -81.4 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.686 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 59.0 m-20 -64.51 22.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 -172.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 126' ' ' ASP . . . 56.37 38.29 78.33 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 117.219 -2.419 . . . . 0.0 109.414 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.673 ' HA ' HD13 ' A' ' 104' ' ' ILE . 12.1 pt20 -132.0 167.29 19.92 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.362 -0.919 . . . . 0.0 111.722 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.649 HG12 HG23 ' A' ' 125' ' ' ILE . 15.3 mt -125.67 116.15 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.549 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.888 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 38.6 t70 -104.8 161.78 13.87 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.574 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.646 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 37.0 t80 -40.28 -32.81 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.22 -41.41 9.35 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.696 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 26.3 mt-10 -62.39 -53.28 57.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 87' ' ' ALA . 29.0 t80 -52.3 -31.69 34.14 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.284 0.564 . . . . 0.0 109.649 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.533 ' HB2' ' NH2' ' A' ' 153' ' ' ARG . . . -68.27 -23.91 64.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.975 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.658 ' HB2' ' HD3' ' A' ' 153' ' ' ARG . . . -88.94 -52.93 4.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.29 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 138' ' ' PHE . 5.2 ppp? -51.35 -22.57 2.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.447 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 36.9 ttm -93.09 -68.02 0.82 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.761 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HD3' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -83.16 -144.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.326 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.627 ' NZ ' ' HB3' ' A' ' 144' ' ' LYS . 8.2 mtpm? -148.58 47.81 1.03 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.796 0.331 . . . . 0.0 110.845 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.792 ' HA ' HD21 ' A' ' 148' ' ' ASN . 66.4 mtt-85 -83.6 53.57 2.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.411 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.511 ' HE3' ' HZ1' ' A' ' 144' ' ' LYS . 96.1 mttt -53.15 -93.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.487 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -84.98 -4.92 86.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.947 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.792 HD21 ' HA ' ' A' ' 145' ' ' ARG . 75.0 m-80 -52.87 158.22 1.45 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 111.012 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -64.74 -8.98 36.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.376 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -95.63 -3.05 61.22 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.61 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.527 HG12 ' N ' ' A' ' 152' ' ' GLY . 2.7 tt -33.3 -84.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.527 ' N ' HG12 ' A' ' 151' ' ' ILE . . . 85.23 -48.15 3.98 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.468 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.702 HH12 ' HB2' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -57.44 83.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.616 0.722 . . . . 0.0 110.574 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 152' ' ' GLY . 45.4 mtp85 -130.76 149.11 52.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.105 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.475 HG23 ' OD1' ' A' ' 129' ' ' ASN . 77.4 m -55.84 -44.01 77.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.151 0.5 . . . . 0.0 109.809 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -132.83 73.6 1.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.143 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 152' ' ' GLY . 75.1 mtp180 -48.28 155.78 0.46 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.869 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -161.9 152.3 17.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.572 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 82.4 p -112.12 -179.86 3.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.378 . . . . 0.0 110.998 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.16 -165.89 1.03 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.815 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -131.48 122.61 26.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.5 pp -132.44 20.57 4.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.276 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -65.91 -65.02 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.13 145.08 56.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.983 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.79 134.38 49.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.025 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 98.3 mt -81.99 -21.18 37.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.93 107.99 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.443 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 168' ' ' LEU . 6.3 mp -83.77 146.93 27.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 111.056 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.94 123.16 56.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.985 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.04 -80.98 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -113.8 46.37 1.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.147 0.499 . . . . 0.0 110.277 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.48 130.6 4.04 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.5 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.3 t -145.04 -6.73 0.65 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.756 0.312 . . . . 0.0 110.809 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -116.13 -30.02 6.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -108.55 114.54 28.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.799 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.4 p -77.48 140.93 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 69.7 mt -90.14 107.54 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.054 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -136.27 127.57 28.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.98 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 69.54 -129.78 22.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.526 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -167.97 -5.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.797 0.332 . . . . 0.0 111.192 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.406 ' HD2' ' HZ3' ' A' ' 182' ' ' LYS . 13.2 t80 -97.6 165.75 11.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.589 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.406 ' HZ3' ' HD2' ' A' ' 181' ' ' PHE . 61.5 mttp . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.794 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ' CA' . . . . . 0.424 'CA ' ' HB3' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.837 0.351 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -126.73 -10.94 6.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.036 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.451 ' HD2' ' C ' ' A' ' 3' ' ' ARG . 4.6 tmm_? -162.11 115.91 1.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.361 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.7 tp -159.62 -43.45 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.804 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.8 t -95.42 179.65 5.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.806 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -109.29 41.96 1.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.937 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -64.27 -16.68 62.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.755 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.12 -43.33 99.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.973 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mp -67.51 -68.97 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.875 0.369 . . . . 0.0 111.25 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 12' ' ' LEU . . . -166.13 165.86 38.41 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.62 77.88 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.537 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 10' ' ' GLY . 31.5 tp -88.25 -46.78 8.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.538 0.209 . . . . 0.0 110.605 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.729 ' HB3' ' HZ1' ' A' ' 13' ' ' LYS . 6.4 ttpm? -55.74 -30.92 62.03 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.742 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 8.1 mp0 -77.0 -38.26 53.43 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.968 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.736 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 54.5 tp -55.04 -28.12 49.78 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.664 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -70.54 -45.11 66.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.787 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.742 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 63.5 pttt -82.46 -12.46 57.82 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.593 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.45 -25.86 68.21 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.429 178.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.6 HG23 HG21 ' A' ' 27' ' ' ILE . 3.3 mt -86.4 -59.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.53 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.544 ' OD2' ' HA2' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -82.68 57.37 3.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.391 0.615 . . . . 0.0 110.523 179.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.5 HG21 HH22 ' A' ' 38' ' ' ARG . 13.6 t -81.26 -6.66 59.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.17 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -129.21 -14.65 4.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.58 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -74.38 -87.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.832 0.348 . . . . 0.0 111.197 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 p -176.67 6.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.811 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.44 31.47 2.79 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.507 ' HB ' ' CG2' ' A' ' 62' ' ' THR . 45.8 p -150.07 145.79 26.58 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.192 -0.504 . . . . 0.0 109.938 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.788 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.2 mt -102.85 103.87 15.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 67.3 p -103.37 164.83 11.4 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.445 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.567 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 20.4 t80 -34.06 -36.44 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.72 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.15 -49.88 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.715 0.293 . . . . 0.0 111.676 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -75.7 -19.9 58.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.939 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.845 HD13 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -46.03 -47.4 16.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.893 0.854 . . . . 0.0 108.707 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.734 ' HB3' HD12 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -85.38 -51.9 6.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.488 179.215 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.634 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 59.4 m-20 -36.34 -36.17 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.54 ' HA3' HG21 ' A' ' 19' ' ' ILE . . . -68.02 -57.32 8.79 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 115.124 0.81 . . . . 0.0 115.124 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.661 HD13 ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -73.86 -28.53 61.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.195 0.997 . . . . 0.0 111.983 -177.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.632 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 19.3 ptpt -66.18 -4.67 8.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.5 HH22 HG21 ' A' ' 21' ' ' THR . 36.9 ttm180 -87.12 -42.72 12.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.278 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.45 -0.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.75 -36.86 3.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.361 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 18.5 m -52.45 153.01 3.19 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.565 -0.161 . . . . 0.0 110.565 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -143.31 103.76 4.17 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.285 0.564 . . . . 0.0 112.153 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.734 HD12 ' HB3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -105.36 167.97 9.38 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.125 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.472 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 5.3 mtm -104.62 165.54 11.0 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 48' ' ' ILE . 92.8 mt-10 -47.68 -60.04 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.51 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 94.9 p -39.42 -35.0 0.24 Allowed 'General case' 0 C--N 1.335 -0.047 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.472 ' OE1' ' HB2' ' A' ' 44' ' ' MET . 37.1 mp0 -66.42 -41.02 89.87 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.055 0.455 . . . . 0.0 110.15 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.845 HG13 HD13 ' A' ' 32' ' ' LEU . 2.0 mp -57.02 -60.58 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.958 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.567 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 42.3 tttm -64.34 -25.66 68.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.353 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' SER . 62.6 t0 -71.12 -37.46 72.32 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.654 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 tt -76.34 -23.04 54.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.049 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.73 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 18.1 mmt -71.92 -45.01 62.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.058 0.456 . . . . 0.0 111.468 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.51 -30.27 20.72 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.716 -0.394 . . . . 0.0 112.01 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.53 -19.36 22.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -127.04 -43.75 1.65 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.73 ' HB3' ' O ' ' A' ' 52' ' ' MET . 15.6 t0 -61.24 95.96 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.2 mm -48.62 -22.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.044 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.551 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 59.1 t0 -129.13 44.49 2.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.864 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.707 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.5 tmtm? -32.58 90.43 0.0 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.741 0.781 . . . . 0.0 112.659 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.3 p -127.72 17.98 6.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.184 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 70.92 17.76 75.66 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.428 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 85.9 m -150.35 127.1 10.97 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 123.779 0.341 . . . . 0.0 110.58 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.788 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 70.3 mt -108.02 129.43 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 121.058 0.456 . . . . 0.0 111.399 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -105.04 167.3 9.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.076 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.614 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 48.1 t80 -35.47 -45.81 0.36 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.486 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.4 -63.71 4.11 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.322 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.551 ' OE2' ' HB3' ' A' ' 58' ' ' ASP . 63.0 mt-10 -51.89 -26.15 9.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.684 0.278 . . . . 0.0 110.894 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.736 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 71.7 t80 -63.88 -65.12 0.72 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.431 0.634 . . . . 0.0 110.91 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.575 HG12 ' O ' ' A' ' 65' ' ' TYR . 14.5 mm -52.2 -41.13 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.659 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.2 -25.77 66.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.47 . . . . 0.0 110.572 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.11 -12.57 26.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.028 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.4 m -87.72 -43.73 11.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.783 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.619 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 57.4 t -67.0 -18.12 23.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.081 0.467 . . . . 0.0 110.594 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -71.01 -47.54 58.19 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.6 mt -81.83 0.98 36.97 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.202 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.619 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 0.7 OUTLIER -102.82 75.29 1.39 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.984 -179.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -175.43 -156.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.274 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.642 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.6 mm? -99.18 59.99 1.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.432 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -104.54 150.33 24.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.036 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -139.34 100.28 3.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.767 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.571 ' HB2' HG11 ' A' ' 85' ' ' VAL . 11.7 pt-20 -165.78 38.96 0.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.095 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -90.66 22.11 3.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.998 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -109.05 -155.96 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.975 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.487 HD21 ' HA ' ' A' ' 139' ' ' ALA . 7.3 mp -57.16 -29.55 63.72 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.59 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.571 HG11 ' HB2' ' A' ' 81' ' ' GLU . 14.4 p -45.71 -27.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.732 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 52.3 m -51.11 -55.01 19.88 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.921 0.391 . . . . 0.0 110.118 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -81.12 -39.81 25.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.913 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.818 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 8.1 t80 -45.98 -23.01 0.25 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.358 0.599 . . . . 0.0 110.041 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 87' ' ' ALA . 28.4 t -89.15 -44.81 10.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.737 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -89.29 -63.7 1.25 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.571 ' HB3' HD12 ' A' ' 99' ' ' ILE . 2.5 m-85 -51.97 -62.33 1.7 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.818 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.6 OUTLIER -76.13 55.31 0.93 Allowed 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -44.59 -52.88 7.69 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.42 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.4 -21.44 64.69 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.344 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.08 68.69 1.07 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.5 p -115.59 -23.04 8.93 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.588 ' O ' ' HB2' ' A' ' 134' ' ' ASP . . . 130.51 -4.51 5.86 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-N 113.136 -1.847 . . . . 0.0 112.604 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.836 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.5 OUTLIER -148.69 161.83 40.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.399 0.618 . . . . 0.0 112.649 179.437 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.77 HG12 ' HA ' ' A' ' 92' ' ' ASP . 22.1 mt -133.12 104.24 6.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.779 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 102' ' ' ASP . 69.5 p -72.29 147.11 46.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.712 ' HB3' HG21 ' A' ' 122' ' ' ILE . 4.1 pp -34.41 -33.97 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 100' ' ' THR . 54.2 m-20 -54.31 -55.92 23.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.406 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 97.4 mt-10 -71.19 -31.38 67.57 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.209 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.495 HG13 ' CG2' ' A' ' 99' ' ' ILE . 50.9 mt -65.74 -65.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.187 0.518 . . . . 0.0 110.403 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' A' ' 119' ' ' ASP . 87.8 mt-30 -58.14 -39.03 77.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.608 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' A' ' 108' ' ' CYS . 53.4 tt0 -59.87 -44.07 94.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.095 0.474 . . . . 0.0 110.644 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.71 -3.06 1.33 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.17 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.753 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 73.2 m -115.09 44.12 1.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.93 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -59.54 -36.71 76.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.811 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -75.02 -22.11 58.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.155 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.753 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 2.7 m-85 -76.76 -5.24 47.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.944 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.37 38.81 96.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.572 -1.299 . . . . 0.0 111.026 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.903 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -33.01 132.72 0.14 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.525 0.679 . . . . 0.0 111.486 -177.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.677 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 91.9 m-20 -135.98 167.68 20.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.259 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.617 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.8 m-20 -82.95 -7.93 59.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.167 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.63 -64.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.039 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -89.46 -69.29 0.72 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.903 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.4 mm -52.72 -19.49 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.958 0.409 . . . . 0.0 111.268 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.617 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 33.6 t70 -71.11 -46.96 60.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 124' ' ' GLU . 63.9 t0 -62.37 -26.26 68.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 1.031 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.4 ttt -60.74 -29.82 69.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.501 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.712 HG21 ' HB3' ' A' ' 101' ' ' LEU . 56.8 mt -58.37 -43.59 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.67 -13.79 44.47 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.584 -1.644 . . . . 0.0 110.374 178.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 1.031 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 71.4 tt0 -84.61 -23.71 29.45 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.79 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.956 HG22 HG13 ' A' ' 133' ' ' ILE . 13.4 mm -107.58 -21.77 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.971 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.3 t70 -62.89 98.43 0.13 Allowed 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.593 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.909 HE21 ' HG2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -87.24 -13.95 42.39 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.439 ' OD1' ' ND2' ' A' ' 129' ' ' ASN . 50.5 p30 -127.57 -33.19 2.33 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.73 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 179.92 -71.71 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.73 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 56.3 m-20 -64.93 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.971 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.53 37.92 77.91 Favored Glycine 0 CA--C 1.505 -0.577 0 C-N-CA 118.358 -1.877 . . . . 0.0 110.044 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.547 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 8.5 pt20 -133.31 170.54 15.3 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 113.929 -1.135 . . . . 0.0 110.073 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.956 HG13 HG22 ' A' ' 125' ' ' ILE . 5.0 mm -133.05 121.89 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.856 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.91 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 4.3 p-10 -113.08 162.48 15.88 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.172 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.788 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 22.4 t80 -38.79 -30.45 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.0 0.428 . . . . 0.0 110.738 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.716 ' HA3' ' N ' ' A' ' 153' ' ' ARG . . . -84.25 -45.15 6.32 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.726 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.91 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 39.3 mt-10 -63.07 -51.3 67.2 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.569 ' HB2' ' CG2' ' A' ' 133' ' ' ILE . 13.5 t80 -56.61 -18.66 12.77 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 135' ' ' TYR . . . -86.1 -40.82 15.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.5 ' CB ' ' HG3' ' A' ' 127' ' ' GLN . . . -87.29 -11.59 49.1 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' A' ' 138' ' ' PHE . 5.5 ppp? -72.46 -6.67 45.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.635 0.255 . . . . 0.0 111.543 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -134.94 -31.13 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.009 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.606 ' HG2' ' H ' ' A' ' 144' ' ' LYS . 62.2 ttt180 -112.08 -137.65 0.37 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.397 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.606 ' H ' ' HG2' ' A' ' 143' ' ' ARG . 95.5 mttt -131.18 -175.47 3.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.607 0.241 . . . . 0.0 110.59 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.638 ' H ' ' HE ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -101.32 78.29 1.87 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.249 0.547 . . . . 0.0 111.853 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.629 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -53.78 155.6 3.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.881 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -85.94 -4.71 84.38 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.83 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -79.75 161.67 25.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 0.0 111.129 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -47.72 -23.84 2.56 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.961 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -42.56 -25.96 0.36 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.349 -0.453 . . . . 0.0 113.008 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.691 HG22 ' N ' ' A' ' 152' ' ' GLY . 44.2 mt -48.78 149.05 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 120.78 0.324 . . . . 0.0 111.104 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.691 ' N ' HG22 ' A' ' 151' ' ' ILE . . . -158.98 -4.57 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.885 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.813 ' HD2' ' H ' ' A' ' 153' ' ' ARG . 4.2 mpt_? -53.75 170.57 0.11 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.8 0.333 . . . . 0.0 110.113 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 156' ' ' MET . 23.2 tpt85 -71.19 148.94 46.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.203 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.505 ' H ' HH11 ' A' ' 154' ' ' ARG . 56.2 m -50.16 80.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.394 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.538 ' N ' ' O ' ' A' ' 154' ' ' ARG . 27.8 ttt -175.92 -18.7 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.207 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.521 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 6.7 ppt_? -63.19 -15.5 57.14 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.169 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.77 ' HG3' HG22 ' A' ' 159' ' ' THR . 4.9 tppp? -161.53 -87.23 0.03 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.77 HG22 ' HG3' ' A' ' 158' ' ' LYS . 6.9 t -162.96 -36.38 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.814 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.51 179.46 7.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.741 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -103.94 -101.15 0.3 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.0 tp -174.82 154.32 1.89 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.639 0.257 . . . . 0.0 110.81 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -89.76 138.84 31.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.687 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -78.04 146.13 35.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.65 165.0 13.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.84 -10.03 32.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 146.76 150.02 5.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.572 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 97.3 mt -100.11 139.14 36.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.939 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.89 149.76 14.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.935 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -156.68 156.18 32.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 0.0 111.161 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.24 -49.57 4.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.652 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.1 -174.47 31.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.511 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 81.4 p -159.6 174.56 14.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.36 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -119.61 -174.78 2.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.966 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -101.82 107.95 19.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.784 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.14 141.53 46.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.287 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 tp -123.85 130.08 74.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.848 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -132.53 141.37 48.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -171.65 -65.89 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.393 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.74 -13.06 22.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.352 . . . . 0.0 110.835 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -110.73 136.9 49.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.555 ' HD3' ' N ' ' A' ' 182' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.851 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.26 123.35 29.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.908 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.484 ' HD2' ' C ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -118.47 174.06 6.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.127 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.2 tp -135.8 -82.99 0.4 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.813 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.8 p -172.84 15.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.994 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -96.96 50.48 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.167 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -89.06 -28.28 20.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.815 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.98 -70.56 0.64 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.498 0.666 . . . . 0.0 110.99 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.433 HD13 HG22 ' A' ' 9' ' ' ILE . 15.0 pt -55.92 -24.2 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.642 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.06 164.12 12.86 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.369 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.8 -12.86 53.43 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.098 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.34 -41.03 49.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.401 0.143 . . . . 0.0 110.878 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.652 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 39.9 ttmt -55.89 -33.1 64.3 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -81.65 -37.93 26.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.755 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 51.8 tp -59.53 -25.96 64.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.143 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -70.89 -40.06 72.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.425 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -86.36 -11.97 50.59 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.656 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -59.46 -34.48 72.59 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.635 HG21 HG21 ' A' ' 27' ' ' ILE . 3.0 mt -81.18 -62.09 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.884 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.647 ' HB2' ' O ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -83.85 66.93 9.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.313 1.054 . . . . 0.0 109.529 178.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -89.34 -20.99 23.34 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.094 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -138.73 8.92 2.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.613 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 31.6 t30 -82.94 -82.61 0.14 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.593 1.088 . . . . 0.0 110.981 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.0 p -176.13 15.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.05 18.51 9.23 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.628 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 39.9 p -148.84 161.2 42.3 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.403 0.62 . . . . 0.0 111.749 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.713 ' O ' ' HA ' ' A' ' 62' ' ' THR . 4.7 mt -111.01 103.82 16.09 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.502 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.616 ' O ' ' N ' ' A' ' 30' ' ' ASP . 65.4 p -112.7 158.22 20.32 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.644 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.809 ' HE2' ' HB2' ' A' ' 49' ' ' LYS . 14.7 t80 -34.45 -20.01 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.616 ' N ' ' O ' ' A' ' 28' ' ' THR . 32.7 t70 -86.18 -39.06 17.04 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.08 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.613 ' OE2' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -90.87 -32.08 16.18 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.727 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -40.45 -51.45 2.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.401 0.62 . . . . 0.0 110.318 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.711 ' HB3' HG12 ' A' ' 48' ' ' ILE . 12.4 ptpt -71.47 -39.4 70.94 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.267 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 38' ' ' ARG . 8.2 t70 -43.98 -47.81 8.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.217 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.476 ' HA3' HG12 ' A' ' 19' ' ' ILE . . . -45.21 -47.22 10.68 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 114.695 0.638 . . . . 0.0 114.695 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.694 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.7 mm? -95.2 -44.13 7.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.592 0.696 . . . . 0.0 112.214 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.688 ' NZ ' ' HD3' ' A' ' 33' ' ' LYS . 15.3 ptpt -56.32 -18.67 11.46 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 38' ' ' ARG . 22.2 ttm-85 -90.83 -25.02 20.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.22 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.694 HG12 ' O ' ' A' ' 36' ' ' LEU . 6.3 p -80.56 -37.48 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.63 -42.65 0.59 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.447 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.6 m -62.75 177.21 0.57 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.795 0.331 . . . . 0.0 110.963 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.34 112.03 7.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.405 ' HB2' HD11 ' A' ' 48' ' ' ILE . 50.5 mt -108.02 165.48 11.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.503 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.431 ' HE3' ' HG3' ' A' ' 47' ' ' GLU . 26.8 ptt? -112.22 162.08 15.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.69 -14.29 19.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.7 t -87.64 -17.11 32.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.199 0.523 . . . . 0.0 109.938 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 97.0 mt-10 -90.73 -46.24 8.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.783 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.727 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -50.77 -50.65 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 122.275 1.036 . . . . 0.0 109.086 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.809 ' HB2' ' HE2' ' A' ' 29' ' ' PHE . 52.3 tttp -64.11 -30.3 71.38 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.383 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 64.1 t0 -64.26 -48.71 74.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.721 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.9 mt -60.43 -15.75 29.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.525 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.728 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 30.5 mtt -88.02 -65.24 1.04 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.439 ' CA ' ' HG3' ' A' ' 59' ' ' LYS . 2.5 p30 -66.73 -25.6 66.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.654 0.264 . . . . 0.0 111.595 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 50' ' ' ASP . . . -91.33 -28.39 17.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.41 -43.93 1.88 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 64.2 t0 -51.18 101.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.032 0.444 . . . . 0.0 110.243 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.9 mm -44.87 -26.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.674 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.597 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 38.7 t70 -133.26 44.72 2.79 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.364 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.728 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 10.2 tmtt? -32.07 92.03 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.941 0.877 . . . . 0.0 112.642 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.1 p -126.71 19.06 7.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.833 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 71.85 16.23 76.29 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.21 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.713 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 58.5 m -147.64 128.14 14.08 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.405 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.697 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 71.5 mt -113.23 130.33 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.157 0.503 . . . . 0.0 110.871 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.43 167.73 9.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.058 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.652 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 66.3 t80 -42.67 -25.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.019 0.437 . . . . 0.0 110.799 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.71 -59.48 2.34 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.753 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HB2' HG22 ' A' ' 63' ' ' ILE . 37.8 mt-10 -56.04 -23.26 32.19 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.646 0.26 . . . . 0.0 110.828 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.755 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 60.4 t80 -68.54 -65.54 0.69 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.566 0.698 . . . . 0.0 110.416 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.685 HG23 HG11 ' A' ' 73' ' ' VAL . 44.2 mm -47.1 -58.47 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.106 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.626 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . . . -44.65 -53.18 7.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -48.06 -37.84 16.01 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 t -95.43 -26.89 15.67 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.685 HG11 HG23 ' A' ' 69' ' ' ILE . 16.7 m -85.93 -13.87 10.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.178 0.513 . . . . 0.0 110.696 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.649 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 18.5 t-160 -67.82 -45.65 74.09 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.1 -11.56 57.53 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.405 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 49.6 t30 -123.47 74.13 1.23 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.401 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.683 ' HG3' ' O ' ' A' ' 73' ' ' VAL . 53.0 mtmt -164.79 -82.16 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.107 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.08 91.4 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.419 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -39.84 -39.94 0.89 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.969 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 22.2 ptt-85 -63.95 122.16 15.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.012 0.435 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -113.64 166.17 11.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.76 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -161.32 74.27 0.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.767 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -161.35 147.32 14.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.952 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -87.71 -17.96 30.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.726 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 m -54.12 -19.47 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.436 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 89' ' ' SER . 81.0 p -46.09 -56.72 5.23 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.923 0.392 . . . . 0.0 110.187 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.432 ' C ' ' N ' ' A' ' 89' ' ' SER . . . -68.58 -45.39 72.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.798 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 18.9 t80 -47.51 -19.26 0.17 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.584 0.707 . . . . 0.0 109.979 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 86' ' ' SER . 30.7 m -89.81 -59.61 2.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.695 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.421 ' CG ' ' HB2' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -74.25 -62.97 1.33 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -51.73 -60.55 3.04 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.798 ' HB3' ' O ' ' A' ' 88' ' ' PHE . 62.6 t0 -82.91 69.54 9.74 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.486 ' HZ1' ' HZ3' ' A' ' 49' ' ' LYS . 31.3 ttmt -53.25 -16.05 1.14 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.668 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.8 m-20 -97.49 -24.4 15.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.579 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.93 -12.47 0.81 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.804 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 94' ' ' ASP . 78.9 p -51.83 -22.84 4.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.204 0.502 . . . . 0.0 110.606 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.582 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 126.01 -3.84 7.9 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.038 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.405 ' OH ' ' HB ' ' A' ' 155' ' ' THR . 0.8 OUTLIER -125.8 144.68 50.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.038 0.447 . . . . 0.0 111.849 -179.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.717 HG12 ' HA ' ' A' ' 92' ' ' ASP . 31.2 mt -131.58 102.59 6.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.61 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 103' ' ' GLU . 70.6 p -81.52 156.94 25.01 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.215 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.446 ' HB3' ' CG2' ' A' ' 122' ' ' ILE . 4.0 pp -35.01 -39.86 0.11 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.69 0.281 . . . . 0.0 111.259 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.42 ' N ' HD12 ' A' ' 101' ' ' LEU . 8.3 t70 -57.86 -57.78 11.29 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.469 ' HB2' HG21 ' A' ' 99' ' ' ILE . 51.0 mt-10 -58.89 -48.22 82.19 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.57 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.499 HG21 ' HE2' ' A' ' 121' ' ' MET . 91.1 mt -55.73 -65.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.151 0.5 . . . . 0.0 110.653 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.484 ' HB3' HD12 ' A' ' 113' ' ' LEU . 91.6 mt-30 -56.83 -65.14 0.67 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.11 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -42.38 -32.96 0.58 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.51 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -53.28 -65.57 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.623 ' SG ' ' HB3' ' A' ' 111' ' ' PHE . 51.6 t -62.01 135.0 57.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.881 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -89.12 -47.87 7.79 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -78.9 -3.32 44.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.628 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.7 ' CE2' ' HB2' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -47.19 -27.21 1.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.538 ' O ' HD13 ' A' ' 118' ' ' ILE . . . 60.44 37.61 93.49 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.371 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.7 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 6.4 tt -31.8 126.92 0.23 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.327 0.584 . . . . 0.0 112.306 -176.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.633 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 29.6 t70 -160.2 177.09 11.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.955 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.685 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 2.9 p30 -89.2 -8.19 54.07 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.692 HG23 ' H ' ' A' ' 117' ' ' HIS . 7.1 tp -88.51 -64.69 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.692 ' H ' HG23 ' A' ' 116' ' ' ILE . 16.6 t-160 -92.7 -67.11 0.88 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.031 0.443 . . . . 0.0 111.975 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.633 ' HB ' ' H ' ' A' ' 114' ' ' ASP . 4.4 mp -50.23 -20.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.694 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.685 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 7.7 t70 -76.12 -52.34 10.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' GLU . 37.1 t70 -58.92 -19.64 44.5 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.824 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.5 ttt -68.79 -45.39 71.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.259 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.556 HG23 ' HA3' ' A' ' 131' ' ' GLY . 54.1 mt -51.44 -40.85 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.64 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.6 -13.84 44.53 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.512 -1.677 . . . . 0.0 110.267 178.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.824 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 41.8 tp10 -83.98 -21.42 31.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.493 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.894 HG21 HG13 ' A' ' 133' ' ' ILE . 1.1 mt -105.71 -33.75 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 1.027 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.8 t70 -54.75 95.64 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.793 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.583 ' O ' ' HA ' ' A' ' 151' ' ' ILE . 15.4 mt-30 -87.67 -9.8 53.13 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.188 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 7.1 t70 -126.79 -32.73 2.56 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -177.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.736 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 178.33 -68.79 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 179.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.736 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 7.3 t70 -63.82 -24.18 67.65 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -172.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 1.027 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 94.95 36.83 5.38 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 107.169 -2.372 . . . . 0.0 107.169 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.657 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 5.3 pt20 -138.21 168.01 20.64 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 112.846 -1.677 . . . . 0.0 108.922 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.894 HG13 HG21 ' A' ' 125' ' ' ILE . 21.5 mm -130.86 131.12 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-O 121.797 0.808 . . . . 0.0 110.978 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.848 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 10.7 t70 -103.03 163.06 12.44 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.69 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.783 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 21.8 t80 -43.76 -37.18 2.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.287 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.612 ' C ' ' HB2' ' A' ' 153' ' ' ARG . . . -82.2 -36.06 18.94 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.834 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.848 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 46.4 mt-10 -61.13 -57.62 11.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.586 ' HD1' HG23 ' A' ' 133' ' ' ILE . 3.4 t80 -55.49 -39.15 70.07 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.916 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 135' ' ' TYR . . . -65.68 -25.11 67.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.785 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.465 ' HB2' ' HB3' ' A' ' 146' ' ' LYS . . . -89.35 -44.68 10.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -31.17 69.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.565 0.221 . . . . 0.0 111.419 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.1 ttp -86.67 -27.95 23.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.04 0.448 . . . . 0.0 110.177 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.55 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 98.7 mtt180 -118.83 -129.8 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.192 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -153.71 38.48 0.47 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.932 0.396 . . . . 0.0 110.44 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.421 ' HG2' HH11 ' A' ' 145' ' ' ARG . 14.3 tpp85 -79.05 -2.35 40.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.993 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 153' ' ' ARG . 8.8 ptpp? -80.19 136.6 36.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.925 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.98 40.41 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.927 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -131.15 144.84 51.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.626 0.25 . . . . 0.0 110.327 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.74 -20.19 38.81 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.537 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -71.36 -42.2 57.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.733 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.617 HG22 ' HG3' ' A' ' 157' ' ' ARG . 37.6 mt -125.09 134.91 65.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.31 0.576 . . . . 0.0 112.303 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.467 ' O ' ' HD2' ' A' ' 153' ' ' ARG . . . -82.16 -133.17 1.7 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.542 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.612 ' HB2' ' C ' ' A' ' 136' ' ' GLY . 26.0 mmm180 -130.75 82.55 2.06 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.855 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.619 HH11 HD22 ' A' ' 129' ' ' ASN . 79.3 ttt180 -107.05 148.13 29.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.843 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.405 ' HB ' ' OH ' ' A' ' 98' ' ' TYR . 77.0 m -57.02 -19.01 16.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.187 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.495 ' H ' ' HG2' ' A' ' 154' ' ' ARG . 50.2 ttm -67.84 -40.16 83.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.115 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.617 ' HG3' HG22 ' A' ' 151' ' ' ILE . 4.1 mmp_? -83.96 -65.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.951 0.405 . . . . 0.0 110.829 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -156.07 135.41 12.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.825 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.9 t -129.57 32.89 4.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.84 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.7 tp -93.69 91.09 6.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -166.05 101.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 0.0 111.048 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 162' ' ' LEU . 1.5 tm? -138.95 80.89 1.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.994 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.411 HH11 ' HG3' ' A' ' 163' ' ' ARG . 20.8 mmt85 -145.79 131.01 18.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.842 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -62.72 111.7 2.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.731 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -125.64 159.9 31.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.192 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -127.16 11.88 7.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.039 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.14 -142.3 15.92 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.436 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 168' ' ' LEU . 2.8 mm? -90.5 176.51 6.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.35 134.19 27.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -113.85 177.74 4.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.772 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -97.3 30.69 2.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.821 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -161.22 123.56 1.22 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.305 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 79.5 p -112.52 -21.26 11.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.722 0.296 . . . . 0.0 111.161 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -141.39 149.61 41.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.994 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -88.23 117.86 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.813 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 48.0 t -124.24 125.28 70.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.099 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 66.3 mt -79.7 143.11 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -76.44 103.18 6.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.8 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -148.8 -26.99 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.517 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.72 5.72 39.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.784 0.326 . . . . 0.0 110.65 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -101.88 33.7 2.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.794 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.943 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.441 ' H3 ' ' H ' ' A' ' 2' ' ' GLU . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.787 0.327 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.441 ' H ' ' H3 ' ' A' ' 1' ' ' ALA . 12.4 pt-20 -109.43 170.92 7.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -127.91 -56.07 1.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.813 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 tt -156.71 -57.58 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.288 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.0 p -82.92 140.43 32.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.582 ' HB3' HD12 ' A' ' 9' ' ' ILE . 17.8 tp10 -63.71 158.08 22.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.811 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -77.16 -53.9 7.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.45 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -56.34 -27.52 56.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.336 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 6' ' ' GLU . 68.0 mt -74.26 -58.98 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.816 0.341 . . . . 0.0 110.833 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.3 116.32 4.72 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.411 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.84 52.94 0.82 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.428 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.441 HD13 ' HE2' ' A' ' 68' ' ' PHE . 43.1 tp -81.42 -19.05 43.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.602 0.239 . . . . 0.0 111.005 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -75.69 -46.61 30.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HG3' ' HE3' ' A' ' 17' ' ' LYS . 85.1 tt0 -69.37 -17.91 63.73 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.681 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.823 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 2.3 tm? -83.6 -39.07 20.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.406 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.551 ' HE1' HG13 ' A' ' 27' ' ' ILE . 2.3 t80 -57.79 -42.67 84.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.1 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HE3' ' HG3' ' A' ' 14' ' ' GLU . 19.5 pttp -80.48 -17.72 50.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.61 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.823 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.39 -32.87 74.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.623 HG22 ' HA3' ' A' ' 35' ' ' GLY . 1.1 mm -71.5 -62.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.289 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB3' HG12 ' A' ' 27' ' ' ILE . 2.5 p30 -89.08 47.23 1.47 Allowed 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.84 0.829 . . . . 0.0 111.255 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 t -71.35 -18.4 62.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.924 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -108.33 -11.48 15.19 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -83.06 -88.73 0.09 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 111.426 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.4 p -176.45 12.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.119 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.39 17.88 9.01 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.101 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -135.58 143.59 45.73 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.002 0.43 . . . . 0.0 109.86 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.778 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 8.4 mt -103.73 104.03 16.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 76.6 p -102.55 159.79 15.13 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.536 ' CE1' HG21 ' A' ' 48' ' ' ILE . 25.7 t80 -34.37 -34.13 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 O-C-N 123.79 0.681 . . . . 0.0 111.906 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 28' ' ' THR . 35.8 m-20 -73.45 -50.29 22.42 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.338 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.582 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 28.2 mp0 -78.06 -14.73 59.39 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.714 0.293 . . . . 0.0 111.033 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.841 HD12 HG13 ' A' ' 48' ' ' ILE . 1.6 tm? -55.43 -48.78 73.9 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.849 0.833 . . . . 0.0 108.928 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.886 ' HB2' ' HE3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -82.89 -49.19 9.92 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.313 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.582 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 36.3 m-20 -39.51 -45.33 1.55 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.623 ' HA3' HG22 ' A' ' 19' ' ' ILE . . . -52.37 -50.56 46.79 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.059 -0.591 . . . . 0.0 114.234 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.833 ' HB2' HD23 ' A' ' 43' ' ' LEU . 85.3 mt -75.53 -52.05 11.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.246 0.523 . . . . 0.0 111.685 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.886 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 18.2 ptpt -55.97 -16.03 4.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.985 0.421 . . . . 0.0 110.211 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.436 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -87.1 -39.58 15.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.995 178.421 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.6 p -70.91 -10.73 14.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.285 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.09 -5.22 22.05 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.502 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 61.5 m -78.93 157.86 28.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.664 0.268 . . . . 0.0 111.401 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 14.2 pt-20 -123.54 104.22 8.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.516 0.674 . . . . 0.0 110.936 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.833 HD23 ' HB2' ' A' ' 36' ' ' LEU . 1.7 pp -117.96 166.09 12.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.736 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.446 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 25.9 ptm -118.06 156.04 29.31 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' O ' ' HB ' ' A' ' 48' ' ' ILE . 32.6 tt0 -44.65 -58.22 3.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.6 m -49.39 -25.79 2.76 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 97.8 mt-10 -73.52 -31.84 63.9 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.125 0.488 . . . . 0.0 109.838 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.841 HG13 HD12 ' A' ' 32' ' ' LEU . 1.9 mp -59.78 -64.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.752 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.473 ' HD2' ' CD ' ' A' ' 93' ' ' LYS . 4.5 ttmp? -55.35 -34.07 63.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.267 0.555 . . . . 0.0 109.747 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 36.4 t70 -52.86 -61.0 2.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.474 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.49 HD12 HD23 ' A' ' 32' ' ' LEU . 4.1 pp -65.71 -14.88 62.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.752 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 27.3 mtt -80.76 -65.83 0.96 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.171 0.51 . . . . 0.0 110.987 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 90' ' ' TYR . 41.2 t0 -61.71 -21.94 64.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.867 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -91.53 -40.46 11.35 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 51' ' ' LEU . . . -112.33 -44.27 3.41 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 52' ' ' MET . 66.6 t0 -51.67 98.26 0.02 OUTLIER 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.402 ' O ' HG22 ' A' ' 57' ' ' ILE . 68.2 mt -38.34 -35.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.802 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 60' ' ' SER . 2.8 p30 -133.65 45.37 2.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.013 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.752 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.6 tmtm? -31.74 90.83 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.914 0.864 . . . . 0.0 112.174 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 58' ' ' ASP . 73.4 p -123.98 16.74 9.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.874 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 83.71 14.22 73.6 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.394 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.663 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 57.9 m -153.03 127.2 9.11 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.778 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 68.9 mt -112.28 133.46 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.205 0.526 . . . . 0.0 111.798 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' N ' HG21 ' A' ' 63' ' ' ILE . 1.5 m-20 -104.72 167.32 9.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.679 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.518 ' O ' HG13 ' A' ' 69' ' ' ILE . 25.2 t80 -36.54 -48.33 0.68 Allowed 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.49 -59.86 7.76 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.358 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.651 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 34.7 mt-10 -51.43 -30.07 18.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.854 0.359 . . . . 0.0 110.567 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.534 ' CD2' ' HB2' ' A' ' 16' ' ' PHE . 30.6 t80 -61.87 -46.9 87.41 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.271 0.558 . . . . 0.0 110.945 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 65' ' ' TYR . 10.7 mt -59.96 -19.45 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.616 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.65 -20.51 65.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.251 0.548 . . . . 0.0 109.617 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 74' ' ' HIS . . . -68.61 -32.86 73.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.057 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.3 p -77.69 -16.93 58.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.1 t -90.44 -14.13 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.977 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.537 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 14.3 t-80 -61.59 -42.92 99.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.955 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.4 mp -74.82 -6.23 47.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.533 ' ND2' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -118.71 75.18 1.01 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.939 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 74' ' ' HIS . 98.7 mttt -112.04 50.68 0.84 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.936 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.533 ' HG ' ' ND2' ' A' ' 76' ' ' ASN . 85.7 mt -63.65 -10.5 19.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.953 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -106.67 171.49 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.884 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 73.0 mtt-85 -115.31 148.17 39.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -134.97 147.37 49.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.554 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -162.45 131.98 4.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.834 0.349 . . . . 0.0 111.475 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 75.7 m-80 -150.93 -179.65 7.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.556 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -90.3 -65.47 1.01 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.166 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 m -68.11 -25.75 32.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.326 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 72.5 m -54.41 -23.87 17.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.238 0.542 . . . . 0.0 109.666 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -84.7 -51.08 7.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.488 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.818 ' HE1' ' HB2' ' A' ' 135' ' ' TYR . 7.9 t80 -39.14 -36.42 0.31 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.116 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.4 t -89.24 -55.49 3.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.228 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.496 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 7.8 t80 -75.77 -63.89 1.2 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.561 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.543 ' O ' ' HB3' ' A' ' 103' ' ' GLU . 3.1 m-85 -58.14 -65.21 0.68 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.769 ' HA ' HG12 ' A' ' 99' ' ' ILE . 12.4 t0 -74.54 60.04 0.86 Allowed 'General case' 0 C--N 1.335 -0.056 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.473 ' CD ' ' HD2' ' A' ' 49' ' ' LYS . 3.0 tppp? -49.2 -40.72 34.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.507 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.52 -21.35 60.42 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.383 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 49.02 72.33 0.48 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.1 p -132.57 -5.0 3.29 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 105.87 5.78 38.16 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 113.799 -1.546 . . . . 0.0 113.322 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.753 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -144.27 157.46 44.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.456 0.646 . . . . 0.0 111.495 179.108 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.769 HG12 ' HA ' ' A' ' 92' ' ' ASP . 77.8 mt -133.18 104.14 6.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.956 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 103' ' ' GLU . 43.6 p -70.8 147.99 48.35 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.766 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.549 ' HB3' HG21 ' A' ' 122' ' ' ILE . 3.6 pp -34.84 -39.22 0.09 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.443 ' N ' HD11 ' A' ' 101' ' ' LEU . 1.6 m-20 -55.55 -54.71 40.6 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.585 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 49.3 mt-10 -60.48 -44.46 95.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.235 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.502 HG13 HG22 ' A' ' 99' ' ' ILE . 96.6 mt -56.72 -65.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.381 0.61 . . . . 0.0 110.676 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.407 ' HG2' ' CE ' ' A' ' 121' ' ' MET . 87.5 mt-30 -58.35 -65.47 0.65 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.488 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -42.79 -34.23 0.89 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 103' ' ' GLU . . . -56.17 -66.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.314 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 98.5 m -49.78 134.17 20.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.811 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -89.29 -60.91 1.82 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -75.49 -3.07 31.92 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.82 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.693 ' CE2' ' HB2' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -46.81 -29.39 1.93 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -178.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 62.87 39.21 97.74 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 118.85 -1.643 . . . . 0.0 110.777 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.693 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 9.1 tt -31.63 130.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.463 ' OD2' HG13 ' A' ' 116' ' ' ILE . 35.9 t70 -157.21 175.67 13.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.905 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.702 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.0 m-20 -88.89 -7.45 56.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.495 HG22 ' CE1' ' A' ' 117' ' ' HIS . 60.5 mt -84.86 -65.53 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.495 ' CE1' HG22 ' A' ' 116' ' ' ILE . 4.8 m-70 -92.45 -69.04 0.76 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.711 HG23 ' HE1' ' A' ' 121' ' ' MET . 60.5 mt -52.1 -19.68 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.935 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.702 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 37.4 t70 -75.89 -51.67 12.0 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' GLU . 32.2 m-20 -65.07 -17.9 64.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 1.045 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 13.6 tmm? -65.31 -41.25 94.25 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.823 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.549 HG21 ' HB3' ' A' ' 101' ' ' LEU . 61.1 mt -54.12 -39.68 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.777 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 10.9 mmpt? -86.7 -13.89 44.1 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 112.403 -2.18 . . . . 0.0 110.574 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 1.045 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 29.7 tt0 -94.27 -14.78 25.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.689 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.921 HG23 HG13 ' A' ' 133' ' ' ILE . 29.9 mt -111.97 -35.55 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.379 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.775 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 1.8 t70 -47.02 129.83 12.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.705 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.529 ' HG2' ' HB2' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -88.41 -23.15 23.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.529 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.687 ' HB3' ' HB3' ' A' ' 154' ' ' ARG . 45.3 p-10 -135.24 -32.73 0.93 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.719 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 179.36 -52.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.719 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 31.1 m-20 -64.6 8.76 0.1 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -173.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.775 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.5 37.06 65.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 118.45 -1.833 . . . . 0.0 108.772 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.699 ' NE2' ' HB3' ' A' ' 98' ' ' TYR . 5.7 pt20 -127.59 169.37 13.81 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.805 -1.197 . . . . 0.0 108.982 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.921 HG13 HG23 ' A' ' 125' ' ' ILE . 25.6 mm -135.94 129.97 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.4 0 CA-C-O 121.622 0.725 . . . . 0.0 110.803 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.753 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -102.24 165.19 11.27 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.173 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.818 ' HB2' ' HE1' ' A' ' 88' ' ' PHE . 41.0 t80 -48.06 -31.0 4.93 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.465 ' HA3' ' N ' ' A' ' 153' ' ' ARG . . . -85.1 -26.52 36.72 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.462 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.649 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 78.7 mt-10 -76.12 -53.86 7.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.824 -0.188 . . . . 0.0 110.521 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.561 ' HB2' HG22 ' A' ' 133' ' ' ILE . 4.1 t80 -60.85 -23.96 65.53 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.838 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 135' ' ' TYR . . . -86.0 -32.55 21.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.747 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.683 ' HB3' HD11 ' A' ' 151' ' ' ILE . . . -89.8 -27.8 19.75 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.552 ' HE3' ' CE1' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -62.56 -11.4 16.38 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -122.62 -23.31 5.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.749 0.309 . . . . 0.0 111.141 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -100.22 -165.88 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.73 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.545 ' HB2' ' NZ ' ' A' ' 146' ' ' LYS . 67.4 mttm -70.14 -169.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.561 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.637 ' HD3' HH12 ' A' ' 153' ' ' ARG . 24.4 tpp180 -101.39 82.5 2.33 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.43 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.545 ' NZ ' ' HB2' ' A' ' 144' ' ' LYS . 48.7 mmtm -83.85 117.49 23.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.235 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -93.75 -4.97 63.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.342 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -60.89 161.08 8.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.803 0.335 . . . . 0.0 111.12 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -64.72 -36.87 93.64 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.984 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -42.78 -33.55 1.64 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.451 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.775 HG12 ' H ' ' A' ' 152' ' ' GLY . 11.5 tt -70.82 -169.74 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.775 ' H ' HG12 ' A' ' 151' ' ' ILE . . . -153.5 -4.65 0.12 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.536 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.637 HH12 ' HD3' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -56.71 143.22 37.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.912 0.387 . . . . 0.0 110.24 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.687 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 2.5 tmt_? -76.8 103.66 6.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.423 0.63 . . . . 0.0 111.798 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.429 ' HB ' ' NE ' ' A' ' 153' ' ' ARG . 95.6 m -168.76 -26.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 45.7 ttp -175.25 37.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.705 -1.589 . . . . 0.0 107.694 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.596 ' HD3' ' HG2' ' A' ' 154' ' ' ARG . 10.6 mtm105 -39.19 149.83 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.923 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -153.7 101.18 2.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.635 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.3 m -137.49 88.48 2.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.907 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 160' ' ' LEU . 33.7 tp -168.03 33.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.247 0.546 . . . . 0.0 110.419 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -108.89 -177.86 3.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.893 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.4 tt -85.79 118.33 25.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.368 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.439 ' HG2' HH11 ' A' ' 163' ' ' ARG . 11.6 tpt180 -88.36 105.78 17.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.807 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -134.45 127.87 32.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -56.35 158.38 4.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.391 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.85 9.1 17.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.78 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.79 104.58 0.47 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.595 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.566 HD11 ' N ' ' A' ' 168' ' ' LEU . 6.6 mp -109.91 133.02 53.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.832 0.348 . . . . 0.0 110.789 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 41.1 t -69.55 113.29 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -106.1 29.26 6.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -110.99 -23.11 11.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.915 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 104.05 155.43 23.76 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.39 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 42.8 t -153.66 -7.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.723 0.297 . . . . 0.0 111.082 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.35 112.47 24.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.425 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.56 103.55 16.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.145 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.28 132.95 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.986 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 69.9 mt -115.31 132.91 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.08 130.89 43.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.892 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.04 173.42 14.28 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.529 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -91.59 -91.83 0.15 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.641 0.257 . . . . 0.0 110.68 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -173.58 1.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.916 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.901 -179.902 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.812 0.339 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -78.15 -62.21 1.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.797 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -100.93 29.88 4.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 63.5 tp -92.63 93.54 8.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.4 p -121.92 179.75 4.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -60.14 137.16 58.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.01 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -80.14 -30.57 38.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.002 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -61.31 -25.14 66.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.034 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.5 mm -79.06 -34.36 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.055 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.58 105.1 0.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.02 28.69 0.54 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.636 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.536 HD22 HD13 ' A' ' 69' ' ' ILE . 52.2 tp -60.08 -32.16 70.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.609 0.242 . . . . 0.0 110.624 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 61.6 tttm -60.78 -43.03 98.61 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.97 -26.94 67.79 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.736 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.702 ' HA ' ' HB3' ' A' ' 18' ' ' MET . 33.4 tp -72.48 -31.12 65.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.946 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.453 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 10.4 t80 -65.94 -48.18 72.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.283 0.564 . . . . 0.0 109.788 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.472 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -76.22 -16.23 59.87 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.702 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 3.1 tpp -66.79 -36.21 81.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.887 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.723 HG23 HG23 ' A' ' 27' ' ' ILE . 10.4 mm -62.85 -57.54 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.614 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.584 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 1.3 t70 -82.48 87.55 6.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.285 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 t -88.19 -24.9 23.17 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.62 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -139.71 -6.14 1.32 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.541 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 53.7 t30 -75.43 -80.42 0.09 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.897 1.226 . . . . 0.0 112.837 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 p -172.34 -0.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 110.26 23.57 6.01 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.459 ' HB ' ' OG1' ' A' ' 62' ' ' THR . 65.2 p -138.86 147.37 42.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.013 -1.093 . . . . 0.0 109.464 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.843 ' O ' ' HA ' ' A' ' 62' ' ' THR . 2.3 mt -104.21 103.71 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.724 HG23 ' HG1' ' A' ' 62' ' ' THR . 59.9 p -101.97 161.97 13.27 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.48 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 2.0 t80 -34.21 -36.67 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.797 0.686 . . . . 0.0 111.076 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -74.95 -52.16 11.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.432 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.584 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 3.1 tt0 -70.85 -16.41 62.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.183 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.69 HD21 HD11 ' A' ' 51' ' ' LEU . 2.4 tm? -58.98 -55.25 37.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.353 0.597 . . . . 0.0 109.992 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 10.9 ptpt -76.22 -33.42 59.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.668 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -48.47 -58.38 4.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.636 ' HA3' ' HA ' ' A' ' 19' ' ' ILE . . . -61.4 -22.45 61.24 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 114.849 0.7 . . . . 0.0 114.849 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.664 HD11 ' HG ' ' A' ' 43' ' ' LEU . 4.6 pp -95.1 -39.09 10.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.785 0.792 . . . . 0.0 111.252 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HG2' ' O ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -71.28 -15.23 62.41 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.498 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -87.68 -36.85 17.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.255 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 36' ' ' LEU . 9.0 p -75.08 -17.84 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.533 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.49 42.45 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.641 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 35.5 t -130.68 164.1 25.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.676 0.274 . . . . 0.0 110.456 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 10.7 pt-20 -141.89 104.78 4.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.198 0.523 . . . . 0.0 111.695 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.664 ' HG ' HD11 ' A' ' 36' ' ' LEU . 20.5 mt -124.58 165.99 16.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.188 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.551 ' HG3' ' HG ' ' A' ' 46' ' ' SER . 24.4 ptm -113.08 164.03 13.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -45.52 -64.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.8 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.551 ' HG ' ' HG3' ' A' ' 44' ' ' MET . 78.6 p -41.83 -22.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.3 mm-40 -82.31 -47.52 12.27 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.679 HG13 HD11 ' A' ' 32' ' ' LEU . 1.8 mp -51.59 -62.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.553 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . 3.1 tmtm? -46.67 -33.57 4.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.81 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 9.6 t70 -65.55 -43.87 88.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.69 HD11 HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -64.35 -26.54 68.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.425 178.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.892 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 17.7 mmt -80.08 -66.43 0.88 Allowed 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.562 0.696 . . . . 0.0 112.183 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.711 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 1.5 m-20 -59.84 -21.86 61.49 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.873 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.695 ' HB1' ' HB3' ' A' ' 89' ' ' SER . . . -92.55 -42.8 9.49 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ILE . . . -111.73 -39.45 4.58 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.773 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 38.1 t0 -50.07 87.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' ALA . 37.6 mm -47.51 -22.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.559 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 60.0 m-20 -133.06 43.52 2.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.612 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.892 ' HD3' ' HB3' ' A' ' 52' ' ' MET . 56.5 tptt -33.12 90.32 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.695 0.76 . . . . 0.0 112.609 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.8 p -127.68 18.82 6.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.458 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 84.71 5.37 86.61 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.902 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 1.3 t -153.41 150.94 29.35 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.983 0.421 . . . . 0.0 111.312 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.732 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 68.7 mt -117.08 136.48 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.344 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.473 ' N ' HG22 ' A' ' 63' ' ' ILE . 3.1 p30 -105.94 167.57 9.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.139 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.488 ' O ' HG12 ' A' ' 69' ' ' ILE . 18.9 t80 -36.19 -49.57 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.406 0.441 . . . . 0.0 111.615 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.11 -60.37 7.7 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.723 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.535 ' OE1' ' HB2' ' A' ' 58' ' ' ASP . 23.8 mt-10 -53.68 -25.13 16.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.716 0.293 . . . . 0.0 110.602 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.568 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 47.1 t80 -64.79 -50.68 65.82 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.264 0.554 . . . . 0.0 110.474 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.536 HD13 HD22 ' A' ' 12' ' ' LEU . 5.0 mm -60.27 -50.16 81.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.125 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.96 -30.15 68.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.029 0.442 . . . . 0.0 110.215 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.608 ' O ' HD21 ' A' ' 75' ' ' LEU . . . -72.46 -45.28 60.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.19 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.3 p -65.41 -30.9 71.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.978 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.423 ' O ' HG11 ' A' ' 73' ' ' VAL . 61.1 t -89.07 -15.84 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.723 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.472 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 27.0 t-80 -76.28 -43.7 40.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.608 HD21 ' O ' ' A' ' 71' ' ' ALA . 4.4 mm? -71.79 -15.13 62.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.626 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -89.15 75.48 7.85 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.202 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 74' ' ' HIS . 97.7 mttt -146.73 42.08 1.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.534 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.25 -4.71 3.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.632 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.54 -80.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.3 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.689 ' HA ' ' HE ' ' A' ' 80' ' ' ARG . 2.7 mmp_? -134.83 115.37 13.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.469 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.728 ' HB2' HG11 ' A' ' 85' ' ' VAL . 10.6 pt-20 -175.0 129.85 0.3 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.801 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -174.29 8.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.492 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -164.68 -79.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -56.32 -30.25 62.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.89 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.728 HG11 ' HB2' ' A' ' 81' ' ' GLU . 7.2 p -54.78 -23.29 11.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.695 0.284 . . . . 0.0 111.286 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.6 m -56.24 -44.46 79.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.198 0.523 . . . . 0.0 109.666 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HA ' ' CD1' ' A' ' 91' ' ' PHE . . . -75.77 -55.04 6.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.831 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.788 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 4.9 t80 -40.59 -25.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.73 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.695 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 22.6 m -90.92 -64.48 1.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -79.16 -42.38 26.27 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.763 0.316 . . . . 0.0 111.683 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 87' ' ' ALA . 5.7 m-85 -63.65 -64.5 0.88 Allowed 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 176.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.882 ' HA ' HG12 ' A' ' 99' ' ' ILE . 56.9 t0 -77.78 70.56 4.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.711 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 22.4 ttmt -43.54 -49.22 7.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.362 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -67.75 -22.71 65.21 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.138 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 49.98 54.27 19.26 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.653 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.8 p -125.49 12.31 8.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.693 ' HA2' ' HE1' ' A' ' 88' ' ' PHE . . . 84.66 21.18 56.78 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.447 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.421 ' HA ' ' OD1' ' A' ' 134' ' ' ASP . 14.3 m-85 -143.52 131.9 22.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.882 HG12 ' HA ' ' A' ' 92' ' ' ASP . 48.6 mt -130.19 101.96 6.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.88 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.48 ' HA ' ' HB3' ' A' ' 132' ' ' GLN . 58.8 p -74.12 164.69 26.3 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.07 -0.394 . . . . 0.0 111.086 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.713 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER -41.28 -36.55 0.81 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.425 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -67.46 -52.38 40.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.279 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 56.3 mt-10 -64.95 -15.88 62.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.636 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.779 HD12 HG13 ' A' ' 133' ' ' ILE . 96.6 mt -87.33 -62.82 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.124 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.713 ' HG2' ' O ' ' A' ' 101' ' ' LEU . 7.1 mm100 -50.27 -51.69 42.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.96 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -60.73 -31.19 70.5 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.22 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 103' ' ' GLU . . . -59.81 -21.54 61.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.87 0.367 . . . . 0.0 110.927 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.546 ' HB3' ' CG ' ' A' ' 111' ' ' PHE . 72.4 m -117.13 66.72 0.73 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.682 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.613 ' HD3' ' H ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -78.4 -39.37 39.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -68.81 -12.6 61.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.183 0.516 . . . . 0.0 110.347 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.546 ' CG ' ' HB3' ' A' ' 108' ' ' CYS . 3.2 m-85 -74.77 -46.81 34.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.827 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.72 37.98 2.66 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.74 ' HA ' HG13 ' A' ' 118' ' ' ILE . 1.0 OUTLIER -33.33 139.07 0.06 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.481 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 52.8 t0 -152.67 150.7 29.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.272 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.654 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 10.2 t70 -57.74 -8.74 0.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.493 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.3 mm -86.67 -64.8 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.439 ' HD1' ' N ' ' A' ' 118' ' ' ILE . 11.3 t-80 -91.68 -68.98 0.76 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.74 HG13 ' HA ' ' A' ' 113' ' ' LEU . 17.5 mm -51.05 -24.36 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.2 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.654 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 36.1 t70 -75.08 -46.26 35.82 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 124' ' ' GLU . 33.3 t70 -62.31 -21.48 65.29 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.874 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 3.8 ttp -65.36 -33.32 75.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.637 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 126' ' ' ASP . 46.3 mt -59.12 -42.48 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.655 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 2.4 mptt -86.72 -12.97 46.73 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.51 -1.677 . . . . 0.0 109.882 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.874 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 17.2 tp10 -86.11 -22.82 26.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.451 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.864 HG22 HG12 ' A' ' 133' ' ' ILE . 14.7 mm -116.56 -13.36 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.566 ' OD1' ' HA ' ' A' ' 123' ' ' LYS . 4.2 p-10 -79.8 54.09 1.77 Allowed 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.564 0.697 . . . . 0.0 110.084 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.523 HE22 ' CG ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -62.56 -9.32 8.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.553 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.61 ' HA ' ' CZ ' ' A' ' 157' ' ' ARG . 6.4 t70 -107.95 -32.91 7.38 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.584 ' N ' HD21 ' A' ' 129' ' ' ASN . 0.0 OUTLIER 178.54 -95.65 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 178.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.697 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 1.5 m-20 -64.75 29.29 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 119.44 3.126 . . . . 0.0 119.44 -173.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.517 ' HA2' ' HB3' ' A' ' 126' ' ' ASP . . . 58.76 37.67 90.52 Favored Glycine 0 CA--C 1.504 -0.631 0 C-N-CA 117.236 -2.411 . . . . 0.0 109.133 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.697 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 6.6 pt20 -136.57 169.28 17.97 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 113.738 -1.231 . . . . 0.0 109.831 -177.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.864 HG12 HG22 ' A' ' 125' ' ' ILE . 49.2 mt -133.16 124.2 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.556 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 54.0 m-20 -101.73 165.53 11.16 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.417 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.635 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 25.8 t80 -44.19 -29.78 0.68 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.068 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 153' ' ' ARG . . . -85.54 -39.64 8.17 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.683 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.768 ' HB2' HG21 ' A' ' 133' ' ' ILE . 32.9 mt-10 -60.54 -50.59 72.93 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.559 ' O ' ' HG2' ' A' ' 142' ' ' MET . 1.3 t80 -64.37 -61.11 2.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.49 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.452 ' HA ' ' HE1' ' A' ' 142' ' ' MET . . . -47.81 -32.95 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.64 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.69 -58.18 2.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.19 -33.02 3.32 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.559 ' HG2' ' O ' ' A' ' 138' ' ' PHE . 27.6 ptt? -87.54 -32.66 19.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.749 0.309 . . . . 0.0 111.097 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.416 ' HG2' ' HG3' ' A' ' 142' ' ' MET . 27.8 mmm180 -95.09 -167.18 1.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.845 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -63.13 177.63 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.377 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.625 ' HB2' ' HD3' ' A' ' 158' ' ' LYS . 16.3 ptp180 -108.08 28.53 8.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.416 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.442 ' O ' ' HB ' ' A' ' 151' ' ' ILE . 40.3 ttmt -62.29 111.0 1.81 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.32 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.72 ' HA3' ' HA ' ' A' ' 159' ' ' THR . . . -67.45 -17.64 68.83 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.774 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -54.77 161.66 1.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.734 0.302 . . . . 0.0 110.926 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -52.0 -13.78 1.71 Allowed Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.432 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -69.37 -5.13 47.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.511 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.871 HG12 ' H ' ' A' ' 152' ' ' GLY . 10.9 tt -80.88 -156.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.871 ' H ' HG12 ' A' ' 151' ' ' ILE . . . -151.45 -37.37 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.829 ' HG2' ' HG2' ' A' ' 157' ' ' ARG . 3.2 tpm_? -58.75 171.24 0.67 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.014 -0.593 . . . . 0.0 109.942 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.64 ' H ' ' NH1' ' A' ' 153' ' ' ARG . 45.4 ttt85 -69.28 136.15 51.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 110.906 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 76.4 p -43.53 -35.51 1.71 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.576 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.434 ' HB3' ' HE3' ' A' ' 156' ' ' MET . 51.2 ttp -83.21 52.72 2.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.418 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.829 ' HG2' ' HG2' ' A' ' 153' ' ' ARG . 14.9 tpp180 -130.53 -69.93 0.64 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.625 ' HD3' ' HB2' ' A' ' 145' ' ' ARG . 7.6 ptpp? -152.8 112.56 3.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.055 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.72 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 68.3 p -96.93 174.62 6.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.715 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.486 ' HB2' ' H ' ' A' ' 147' ' ' GLY . 7.1 tt -120.85 124.57 45.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.829 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -156.58 75.54 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.336 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 81.6 mt -122.89 179.55 4.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.795 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.56 ' HD2' ' N ' ' A' ' 163' ' ' ARG . 1.0 OUTLIER -86.51 78.86 9.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.653 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -93.69 159.6 15.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.929 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.96 114.04 2.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.244 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -117.06 -27.23 6.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.335 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -113.85 60.0 0.38 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.478 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 58.6 tp -90.61 152.06 21.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.2 m -73.77 147.18 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.127 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -104.0 120.42 41.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -79.05 -15.86 57.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 124.77 -17.13 7.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.565 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.0 t -163.44 137.18 5.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 0.0 110.807 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.17 56.65 2.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.507 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -69.38 99.81 1.27 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.678 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.65 141.13 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.153 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.99 117.75 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -110.02 147.99 32.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.988 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 176.49 -168.64 40.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.298 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -125.79 94.1 4.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.87 0.367 . . . . 0.0 111.001 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.52 177.56 7.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.067 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.571 ' HB3' ' NZ ' ' A' ' 182' ' ' LYS . 3.0 mmmp? . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.95 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.95 0.405 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -134.79 162.81 31.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.955 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.746 ' HD3' ' H ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -119.67 -172.81 2.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.724 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 pp -159.2 -2.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.359 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.8 p -160.41 -62.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.33 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -137.12 109.63 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.34 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.479 ' OE1' ' HD2' ' A' ' 3' ' ' ARG . 38.9 tt0 -89.15 -47.92 7.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.609 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -87.45 -56.54 3.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.672 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.8 mm -64.78 -25.48 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.579 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.78 165.34 13.93 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.656 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.528 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . 109.67 -24.37 19.85 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.6 mt -72.39 -33.7 67.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.745 -0.228 . . . . 0.0 110.793 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 62.8 tttm -64.68 -51.46 62.38 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -65.54 -18.28 65.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.176 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 18' ' ' MET . 0.3 OUTLIER -80.15 -40.31 27.6 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.738 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.46 ' HA ' ' CE1' ' A' ' 68' ' ' PHE . 11.1 t80 -57.4 -44.01 84.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.192 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.565 ' NZ ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -81.75 -12.59 58.52 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.825 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.743 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -67.97 -43.07 79.83 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.834 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 7.7 mt -61.45 -58.07 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.609 ' HB2' ' O ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -74.96 84.65 2.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.35 1.071 . . . . 0.0 109.817 178.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -89.18 -22.29 22.87 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.595 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -138.66 -5.67 1.54 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.526 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -71.16 -87.53 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.141 0.882 . . . . 0.0 111.292 -178.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.1 p -177.77 11.65 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.483 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.84 31.23 3.21 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 55.1 p -144.13 152.06 40.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.612 -0.794 . . . . 0.0 110.627 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.849 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 4.5 mt -114.42 104.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.758 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 82.7 p -102.5 160.11 14.85 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.617 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.559 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 17.1 t80 -34.24 -34.61 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.723 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -77.85 -45.48 24.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.843 0.354 . . . . 0.0 110.456 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.526 ' OE2' ' HB2' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -73.04 -24.56 60.72 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.204 178.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.597 ' HB3' HG21 ' A' ' 48' ' ' ILE . 1.4 tm? -50.61 -54.66 20.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.418 0.628 . . . . 0.0 110.059 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 3.8 ptpt -79.03 -39.03 35.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.334 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 37.8 t70 -47.66 -36.6 11.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.468 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.834 ' HA3' ' HA ' ' A' ' 19' ' ' ILE . . . -95.09 -49.62 2.21 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.259 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 41' ' ' SER . 0.2 OUTLIER -57.98 -51.71 68.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.467 0.651 . . . . 0.0 109.898 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.667 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.85 -9.19 42.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.728 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.619 ' HA ' ' HZ2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -80.86 -32.21 35.1 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.802 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.1 m -76.94 2.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.733 0.301 . . . . 0.0 111.404 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.18 10.85 11.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.271 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 40.9 m -92.22 156.98 16.94 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.725 0.298 . . . . 0.0 110.649 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -142.5 104.43 4.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.046 0.45 . . . . 0.0 110.741 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.645 ' HB2' HD13 ' A' ' 48' ' ' ILE . 21.4 mt -131.16 165.52 23.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.465 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.44 ' HG3' ' OE2' ' A' ' 47' ' ' GLU . 37.9 mtm -105.0 165.5 11.03 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.8 mp0 -47.96 -60.72 2.39 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.677 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 t -48.94 -17.19 0.17 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 52.0 mt-10 -90.86 -48.75 6.83 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.645 HD13 ' HB2' ' A' ' 43' ' ' LEU . 1.7 mp -49.83 -58.13 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.559 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . 44.5 tttp -39.9 -34.65 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.106 -1.861 . . . . 0.0 111.115 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.499 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 8.7 t70 -64.26 -50.81 66.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.399 . . . . 0.0 110.216 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 53.2 tp -56.13 -33.28 65.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.995 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.602 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 41.6 ttm -87.54 -66.5 0.91 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.529 0.68 . . . . 0.0 112.705 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.498 ' HA ' ' CG ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -58.42 -34.52 70.88 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.235 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 50' ' ' ASP . . . -91.15 -18.48 24.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 71' ' ' ALA . . . -123.91 -43.56 2.11 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 52' ' ' MET . 65.6 t0 -50.48 101.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.033 0.444 . . . . 0.0 110.093 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.632 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 6.3 mt -50.73 -17.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.481 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 60' ' ' SER . 55.7 m-20 -129.76 43.36 3.14 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.052 -178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.566 ' HD3' ' C ' ' A' ' 59' ' ' LYS . 1.6 tmtp? -33.42 87.16 0.0 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.68 0.753 . . . . 0.0 111.854 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 58' ' ' ASP . 45.6 m -128.04 19.18 6.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.459 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.602 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 68.84 20.87 74.77 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 86.0 m -155.24 133.02 11.34 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.886 -0.657 . . . . 0.0 110.299 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.849 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.1 mt -113.48 134.76 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.152 0.501 . . . . 0.0 111.14 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.523 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 40.1 m-20 -106.68 167.87 9.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.747 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.541 ' O ' HG13 ' A' ' 69' ' ' ILE . 25.2 t80 -35.79 -46.96 0.48 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.695 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.7 -53.82 7.98 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.976 -1.106 . . . . 0.0 112.313 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.641 ' HB2' HG21 ' A' ' 63' ' ' ILE . 24.2 mt-10 -52.08 -25.15 8.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.297 0.57 . . . . 0.0 109.847 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.672 ' HE1' HD12 ' A' ' 19' ' ' ILE . 88.9 t80 -67.77 -65.51 0.68 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.139 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 65' ' ' TYR . 2.8 mt -47.35 -46.72 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.629 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -50.16 75.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 110.421 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.589 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . . . -54.78 -33.55 61.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.027 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.5 p -84.6 -59.52 2.34 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 69' ' ' ILE . 49.4 t -51.41 -15.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.993 0.425 . . . . 0.0 111.366 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -76.22 -49.75 16.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.43 HD13 HD13 ' A' ' 51' ' ' LEU . 5.4 mt -77.86 -15.3 59.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -123.42 91.91 3.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.504 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.438 ' HE2' ' CG ' ' A' ' 79' ' ' GLU . 21.0 ptmt -165.68 168.23 16.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.728 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.459 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 2.3 pt? -79.83 36.89 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.397 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.438 ' CG ' ' HE2' ' A' ' 77' ' ' LYS . 67.4 mm-40 -132.1 164.9 25.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 111.155 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.64 ' HD3' ' H ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -127.09 156.43 41.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.861 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 pm0 -72.5 147.26 46.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -113.54 -148.69 0.43 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.653 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -112.27 -31.73 6.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.977 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.573 HD21 ' HE3' ' A' ' 142' ' ' MET . 3.4 tm? -78.84 -28.66 44.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.391 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.6 p -54.19 -19.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.544 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -44.45 -50.96 9.13 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.013 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -75.23 -51.51 13.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.511 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.684 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 3.5 t80 -43.34 -26.97 0.22 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.017 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.446 ' OG ' ' HB2' ' A' ' 54' ' ' ALA . 25.3 t -89.38 -57.99 2.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.536 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -84.61 -54.37 4.77 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.734 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 87' ' ' ALA . 3.1 m-85 -56.97 -65.08 0.68 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.815 ' HA ' HG12 ' A' ' 99' ' ' ILE . 66.2 t0 -72.61 63.23 0.58 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 29.6 ttmt -51.26 -39.49 56.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.225 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.632 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 63.7 m-20 -72.0 -25.02 61.67 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.189 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 44.39 64.56 2.0 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.364 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 77.8 p -118.38 11.22 12.98 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 97.57 4.92 57.99 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 112.195 -2.275 . . . . 0.0 112.697 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 1.1 p90 -165.25 144.94 6.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.815 HG12 ' HA ' ' A' ' 92' ' ' ASP . 51.1 mt -103.24 141.76 18.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.794 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.493 ' HA ' ' CB ' ' A' ' 132' ' ' GLN . 77.0 p -110.73 159.73 17.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.86 0.3 . . . . 0.0 110.255 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.651 ' HA ' HD12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -38.09 -37.56 0.27 Allowed 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.159 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.406 ' N ' ' HG ' ' A' ' 101' ' ' LEU . 65.1 t0 -60.96 -59.77 4.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.628 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -60.05 -22.66 62.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.77 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 101' ' ' LEU . 82.9 mt -75.79 -61.38 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 101' ' ' LEU . 4.0 mm100 -55.29 -33.57 63.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.638 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -80.47 -28.58 37.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.003 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.71 -4.57 9.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.816 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 76.2 m -115.55 77.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.516 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -79.54 -53.87 6.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.55 -16.75 59.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.005 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.816 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 11.1 m-85 -63.46 -56.67 14.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.916 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.45 38.75 1.07 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.998 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.813 HD23 HG22 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -32.63 124.09 0.34 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.541 0.686 . . . . 0.0 112.258 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.55 ' N ' HD21 ' A' ' 113' ' ' LEU . 34.1 t0 -150.71 173.77 13.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.275 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.801 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 1.4 m-20 -77.85 -7.44 56.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.012 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.8 mt -81.71 -65.52 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -92.55 -69.27 0.75 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.813 HG22 HD23 ' A' ' 113' ' ' LEU . 15.1 mt -54.29 -18.89 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.801 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 38.8 t70 -70.6 -64.96 0.8 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.429 0.157 . . . . 0.0 110.924 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 124' ' ' GLU . 54.8 p30 -61.13 -16.99 50.33 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.852 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 22.2 ttp -61.15 -33.74 73.9 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.38 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 131' ' ' GLY . 61.2 mt -58.32 -44.02 87.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.659 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 4.5 mptt -86.33 -13.06 47.66 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.562 -1.654 . . . . 0.0 110.187 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.852 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 41.4 tp10 -81.65 -24.4 36.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.84 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.712 HG23 HG12 ' A' ' 133' ' ' ILE . 19.3 mt -112.17 -19.4 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.206 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.859 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 14.1 t70 -66.13 83.86 0.09 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.844 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.561 ' NE2' ' HA ' ' A' ' 137' ' ' GLU . 8.2 mt-30 -85.19 -8.69 58.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.307 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.584 ' CB ' ' HA ' ' A' ' 154' ' ' ARG . 12.4 p-10 -126.61 -30.25 2.83 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.716 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.74 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.716 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 1.3 m-20 -65.21 25.95 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 -173.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.859 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.65 37.56 68.56 Favored Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 117.505 -2.283 . . . . 0.0 108.193 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.807 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 10.0 pt20 -129.27 167.07 18.23 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.678 -1.261 . . . . 0.0 109.87 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.745 HG21 ' HB2' ' A' ' 137' ' ' GLU . 18.6 mt -129.75 116.39 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.753 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.735 ' OD1' ' HG3' ' A' ' 137' ' ' GLU . 0.7 OUTLIER -100.33 165.53 11.42 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.684 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 32.5 t80 -45.81 -23.43 0.27 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.178 0.513 . . . . 0.0 110.149 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.613 ' C ' ' HB3' ' A' ' 153' ' ' ARG . . . -82.45 -39.95 10.45 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.049 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.745 ' HB2' HG21 ' A' ' 133' ' ' ILE . 38.8 mt-10 -70.01 -57.46 4.97 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 116.075 -0.063 . . . . 0.0 111.065 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 133' ' ' ILE . 1.3 t80 -57.87 -50.95 71.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.519 -178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 135' ' ' TYR . . . -60.4 -19.52 56.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.648 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 145' ' ' ARG . . . -90.73 -51.72 5.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.956 0.408 . . . . 0.0 111.86 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -65.19 8.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.325 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.573 ' HE3' HD21 ' A' ' 84' ' ' LEU . 4.1 ppp? -115.3 3.64 14.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 110.998 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.669 ' HG2' ' HG3' ' A' ' 144' ' ' LYS . 43.5 ttt85 -128.97 -84.52 0.57 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.052 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.669 ' HG3' ' HG2' ' A' ' 143' ' ' ARG . 98.5 mttt -128.14 -68.88 0.75 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.011 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.484 ' O ' ' HB3' ' A' ' 140' ' ' ALA . 39.4 ptt180 -159.12 -49.18 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.402 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.476 ' HE2' ' HA2' ' A' ' 149' ' ' GLY . 24.7 pttm -172.3 142.48 1.34 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.759 0.314 . . . . 0.0 111.171 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -64.52 -57.84 11.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.156 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -85.72 115.36 23.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.688 0.28 . . . . 0.0 110.462 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.476 ' HA2' ' HE2' ' A' ' 146' ' ' LYS . . . -60.0 -14.48 31.64 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.535 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -96.3 -47.21 2.43 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.482 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.744 HG22 ' HG3' ' A' ' 157' ' ' ARG . 17.0 mm -73.71 -98.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.826 0.346 . . . . 0.0 111.203 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.451 ' HA2' ' HD2' ' A' ' 146' ' ' LYS . . . 130.67 -128.87 5.64 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.24 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.613 ' HB3' ' C ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -141.23 83.78 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.146 0.498 . . . . 0.0 111.064 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.755 ' HD2' ' HG2' ' A' ' 157' ' ' ARG . 66.6 mtt-85 -128.78 148.43 50.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.994 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.9 t -64.75 -33.95 77.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.443 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.5 mtt -143.7 55.65 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.775 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.755 ' HG2' ' HD2' ' A' ' 154' ' ' ARG . 2.8 tmt_? -57.34 127.53 32.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.488 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.622 ' NZ ' ' HB2' ' A' ' 158' ' ' LYS . 4.9 ttmp? -154.01 147.01 24.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.684 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 87.7 m -62.65 -82.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.067 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 64.2 tp -167.51 108.14 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.843 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -151.88 -97.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.928 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.426 ' HA ' HD21 ' A' ' 162' ' ' LEU . 94.4 mt -129.2 -169.85 2.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.775 0.322 . . . . 0.0 110.906 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -80.55 -47.33 14.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -104.37 137.07 42.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.951 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.517 ' HB3' ' HE2' ' A' ' 158' ' ' LYS . . . -110.31 132.57 54.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.095 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 84.3 mt -121.27 -0.3 9.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.537 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.7 -168.1 37.44 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.187 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 2.0 pt? -88.55 90.89 8.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.373 0.606 . . . . 0.0 110.77 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 48.4 t -120.8 132.54 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.039 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -131.52 -46.57 0.98 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.806 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -88.65 45.81 1.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -114.56 -148.39 9.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.551 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 79.4 p -77.53 -170.74 1.9 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.481 ' N ' HD21 ' A' ' 174' ' ' ASN . 0.0 OUTLIER -156.04 25.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.944 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -88.83 110.27 20.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.078 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.21 137.07 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.86 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 177' ' ' ILE . 2.6 pp -104.82 148.41 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.047 0.451 . . . . 0.0 111.723 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -148.39 129.51 14.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.537 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 90.93 98.36 1.21 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.03 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -103.43 -3.66 25.14 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -162.88 0.16 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.814 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 27.7 tptp . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.978 179.856 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.791 0.329 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -120.44 42.71 2.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.777 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -160.95 -15.76 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.792 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.9 mt -104.36 99.67 9.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.971 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.5 m -73.11 166.91 22.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -124.23 -166.15 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -12.41 61.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.177 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -56.95 -29.17 62.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.224 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 10' ' ' GLY . 14.4 tt -77.59 -30.88 17.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.821 0.343 . . . . 0.0 111.006 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -142.5 108.25 0.52 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.597 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.03 13.13 3.36 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.626 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.516 HD22 HG23 ' A' ' 69' ' ' ILE . 44.2 tp -76.17 -32.72 59.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.509 0.195 . . . . 0.0 110.734 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -60.42 -41.42 93.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 18' ' ' MET . 87.6 tt0 -68.01 -27.68 66.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.72 177.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.706 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 32.6 tp -72.08 -32.88 67.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.082 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.433 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 6.0 t80 -64.58 -50.25 67.97 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.337 0.589 . . . . 0.0 109.537 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -73.64 -15.03 61.26 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.706 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -70.07 -20.46 63.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.805 178.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.718 HG22 HG22 ' A' ' 27' ' ' ILE . 9.2 mm -81.24 -62.16 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.828 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.624 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -85.76 70.42 10.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.895 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.696 HG22 HH22 ' A' ' 38' ' ' ARG . 15.1 t -87.25 -6.46 58.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.244 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -131.98 -24.13 2.16 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.58 -76.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.7 p -175.0 -4.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.461 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 110.4 30.12 3.44 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -177.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.568 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 49.6 p -143.71 146.34 33.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 113.837 -1.182 . . . . 0.0 109.413 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.891 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.1 mt -103.24 104.22 16.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 68.6 p -103.39 165.99 10.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.609 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.643 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 9.5 t80 -34.24 -33.33 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.146 -0.933 . . . . 0.0 112.327 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -79.49 -52.66 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.889 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.624 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 31.9 mt-10 -73.65 -14.16 61.12 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.494 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.523 HD11 HG13 ' A' ' 48' ' ' ILE . 2.3 tm? -54.89 -56.21 22.01 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 12.8 ptpt -75.62 -44.01 45.05 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.281 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 62.3 t0 -43.15 -65.33 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 0.0 110.494 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' HA3' HD13 ' A' ' 19' ' ' ILE . . . -62.21 -50.68 62.79 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.542 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.508 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -60.72 -65.11 0.74 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 117.263 0.532 . . . . 0.0 110.738 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.607 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -51.97 -23.95 5.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.204 179.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.696 HH22 HG22 ' A' ' 21' ' ' THR . 38.4 ttm180 -57.73 -43.67 85.47 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.143 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 36' ' ' LEU . 22.3 m -73.5 20.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 38' ' ' ARG . . . 100.0 -15.45 59.32 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.414 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 37' ' ' LYS . 74.4 m -60.45 155.4 18.36 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.795 0.331 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 15.5 pt-20 -138.56 107.25 5.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.163 0.506 . . . . 0.0 110.854 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 mt -125.34 166.1 17.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.153 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.454 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 30.2 mtm -111.69 163.99 13.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HG2' ' HZ3' ' A' ' 33' ' ' LYS . 34.0 mt-10 -49.15 -65.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.043 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.2 m -48.9 -20.67 0.53 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.465 0.575 . . . . 0.0 111.932 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 95.1 mt-10 -80.29 -43.84 20.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.523 HG13 HD11 ' A' ' 32' ' ' LEU . 1.7 mp -55.44 -54.86 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 122.266 1.031 . . . . 0.0 108.5 177.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.643 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . 50.8 tttp -58.81 -29.0 66.54 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.322 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 38.0 t70 -67.99 -53.77 23.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.687 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 tt -54.91 -32.13 60.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.47 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.514 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 25.2 mtt -72.1 -65.72 0.74 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.585 ' N ' ' HD3' ' A' ' 59' ' ' LYS . 41.9 t0 -65.36 -18.82 65.62 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.119 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . -91.77 -34.1 14.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.859 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -118.67 -43.67 2.67 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 52' ' ' MET . 63.7 t0 -46.89 99.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.5 mm -50.38 -23.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.041 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.634 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 7.9 t70 -130.59 45.66 2.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.416 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.585 ' HD3' ' N ' ' A' ' 53' ' ' ASP . 23.3 tptm -31.99 91.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.83 0.824 . . . . 0.0 112.992 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 58' ' ' ASP . 39.7 m -127.42 18.62 6.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.546 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 68.33 19.09 72.11 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 97.0 m -146.55 143.35 28.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.6 -0.8 . . . . 0.0 109.759 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.891 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.9 mt -128.3 126.6 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.191 0.52 . . . . 0.0 111.587 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 65' ' ' TYR . 31.4 m-20 -104.29 167.73 9.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.596 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.607 ' O ' HG13 ' A' ' 69' ' ' ILE . 33.9 t80 -34.85 -47.92 0.37 Allowed 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.229 0.331 . . . . 0.0 111.412 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.31 -61.71 6.81 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.115 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.634 ' OE2' ' HB3' ' A' ' 58' ' ' ASP . 28.0 mt-10 -56.28 -24.82 45.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.687 0.28 . . . . 0.0 111.16 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.648 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 39.4 t80 -65.21 -53.8 39.08 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.298 0.571 . . . . 0.0 110.817 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.607 HG13 ' O ' ' A' ' 65' ' ' TYR . 3.7 mt -61.25 -46.3 96.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.063 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.18 -10.78 53.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.308 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.25 -55.43 3.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.558 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 t -65.83 -48.54 71.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.442 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.652 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 58.7 t -61.22 -15.88 13.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.02 0.438 . . . . 0.0 111.199 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -66.21 -44.56 83.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.8 mt -96.17 -8.29 33.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.187 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.652 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 0.7 OUTLIER -108.99 86.55 2.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.647 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -127.02 -84.33 0.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.41 ' N ' HD21 ' A' ' 78' ' ' LEU . 2.9 mm? -109.6 -53.4 2.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.784 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -160.98 152.1 18.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.572 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -56.72 119.41 6.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.378 . . . . 0.0 111.063 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -172.97 -36.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.057 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -85.94 30.46 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.086 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -88.99 -35.29 16.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.909 HD22 ' HA ' ' A' ' 139' ' ' ALA . 28.6 mt -74.62 -45.58 44.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.357 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.434 ' HA ' ' CB ' ' A' ' 88' ' ' PHE . 32.6 m -57.91 -19.47 12.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.435 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -53.3 -66.04 0.46 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.847 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.463 ' HB2' ' CE2' ' A' ' 138' ' ' PHE . . . -69.78 -33.27 72.16 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.81 ' HZ ' ' HA2' ' A' ' 97' ' ' GLY . 11.3 t80 -46.42 -22.12 0.23 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.528 177.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.422 ' N ' ' C ' ' A' ' 87' ' ' ALA . 46.6 t -89.17 -43.3 11.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.6 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -81.09 -64.48 1.18 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.496 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -56.12 -61.89 2.08 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.778 ' HA ' HG12 ' A' ' 99' ' ' ILE . 63.1 t0 -80.6 61.69 4.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.418 ' HE3' ' NE2' ' A' ' 106' ' ' GLN . 19.6 ttmm -42.28 -36.08 1.15 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.144 -177.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -89.84 -22.84 21.87 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.601 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.403 ' HA2' ' OD2' ' A' ' 92' ' ' ASP . . . 52.97 73.88 0.36 Allowed Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 60.1 p -122.37 -5.3 8.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.81 ' HA2' ' HZ ' ' A' ' 88' ' ' PHE . . . 109.78 -9.8 32.24 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.967 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.518 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -142.24 158.54 43.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.558 0.694 . . . . 0.0 112.383 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.778 HG12 ' HA ' ' A' ' 92' ' ' ASP . 82.3 mt -131.61 104.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.711 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.7 p -69.14 147.34 51.53 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.751 HD12 HD13 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -35.27 -35.63 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -57.02 -52.82 63.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.672 0.273 . . . . 0.0 111.023 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.445 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 97.4 mt-10 -59.93 -30.4 69.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.723 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.761 HD12 HG12 ' A' ' 133' ' ' ILE . 88.4 mt -75.67 -61.58 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.104 0.478 . . . . 0.0 110.283 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.736 ' NE2' ' HA ' ' A' ' 118' ' ' ILE . 0.7 OUTLIER -51.91 -29.26 19.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.734 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.418 ' NE2' ' HE3' ' A' ' 93' ' ' LYS . 41.5 tt0 -63.82 -42.86 97.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.904 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 108' ' ' CYS . . . -50.02 -65.9 0.48 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.974 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.797 ' HB2' ' CD1' ' A' ' 111' ' ' PHE . 10.6 p -34.31 115.89 0.28 Allowed 'General case' 0 C--O 1.22 -0.475 0 O-C-N 123.739 0.649 . . . . 0.0 109.622 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.546 ' HE2' ' NZ ' ' A' ' 49' ' ' LYS . 25.1 ttmm -88.46 -58.66 2.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.25 -15.55 4.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.444 0.64 . . . . 0.0 110.065 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.797 ' CD1' ' HB2' ' A' ' 108' ' ' CYS . 0.2 OUTLIER -112.27 -49.76 2.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.189 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 108' ' ' CYS . . . 79.62 -21.94 4.28 Favored Glycine 0 CA--C 1.509 -0.33 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.248 -177.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.675 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER 176.44 53.84 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.512 ' O ' HG13 ' A' ' 118' ' ' ILE . 51.1 t0 -34.04 100.2 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 112.248 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.62 -18.0 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.502 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.4 mm -92.35 -49.39 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.795 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.568 ' CD2' ' HG3' ' A' ' 121' ' ' MET . 15.2 t-160 -78.65 -38.85 38.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.448 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.736 ' HA ' ' NE2' ' A' ' 105' ' ' GLN . 3.2 mt -36.11 -61.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -48.26 -60.44 2.65 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.9 0.381 . . . . 0.0 111.412 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.703 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 57.9 m-20 -67.64 -17.08 64.48 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.613 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.727 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.8 mtp -77.26 -52.69 8.78 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 123.631 0.772 . . . . 0.0 112.338 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.751 HD13 HD12 ' A' ' 101' ' ' LEU . 55.4 mt -50.05 -39.47 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.676 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.51 -19.13 29.97 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.249 -1.796 . . . . 0.0 110.959 178.401 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.727 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 17.0 tp10 -79.32 -18.26 52.92 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.933 HG22 HG13 ' A' ' 133' ' ' ILE . 16.2 mt -115.43 -32.89 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.213 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.707 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 13.1 t0 -62.98 112.7 2.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.236 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.678 ' NE2' ' HB3' ' A' ' 137' ' ' GLU . 0.3 OUTLIER -89.22 -9.71 49.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.434 ' OD2' ' HB3' ' A' ' 154' ' ' ARG . 53.1 p30 -133.54 -32.35 1.15 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -176.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.685 ' HB3' ' NH2' ' A' ' 154' ' ' ARG . 5.0 t30 -178.42 -72.49 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 117.314 2.339 . . . . 0.0 117.314 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.454 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 40.1 t0 -63.78 13.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -172.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.707 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.97 37.68 71.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 117.804 -2.141 . . . . 0.0 108.967 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.772 ' O ' HD13 ' A' ' 133' ' ' ILE . 7.7 pt20 -128.98 167.18 17.83 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 113.435 -1.382 . . . . 0.0 109.675 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.933 HG13 HG22 ' A' ' 125' ' ' ILE . 40.1 mm -125.8 124.56 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 CA-C-O 122.107 0.956 . . . . 0.0 111.404 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.894 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 35.4 t70 -103.03 158.79 16.05 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.18 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.644 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 16.0 t80 -48.41 -27.83 2.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.136 0.493 . . . . 0.0 109.872 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.508 ' HA3' ' C ' ' A' ' 152' ' ' GLY . . . -85.51 -38.04 9.2 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 177.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.894 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 51.0 mt-10 -63.45 -57.99 8.49 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 133' ' ' ILE . 26.4 t80 -52.41 -18.53 1.68 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.151 0.5 . . . . 0.0 109.978 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.909 ' HA ' HD22 ' A' ' 84' ' ' LEU . . . -81.69 -36.14 29.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.251 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.487 ' CB ' ' HD2' ' A' ' 153' ' ' ARG . . . -81.64 -38.45 25.92 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.647 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.569 ' HB3' ' OE1' ' A' ' 127' ' ' GLN . 5.3 ppp? -56.49 -20.19 19.06 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.851 0.357 . . . . 0.0 110.997 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 36.8 ttm -93.0 -64.5 1.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.68 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 143' ' ' ARG . 0.2 OUTLIER -74.05 -106.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.106 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -143.6 -168.37 2.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.822 0.344 . . . . 0.0 110.704 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -94.94 -2.84 49.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.701 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -164.33 49.49 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.832 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -86.51 -43.43 6.17 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.779 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -149.08 157.47 43.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.849 0.357 . . . . 0.0 111.162 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -69.22 -5.17 47.23 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.585 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.13 -4.81 12.77 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.58 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.463 HG22 HD11 ' A' ' 151' ' ' ILE . 52.4 mt -43.32 151.5 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-O 121.095 0.474 . . . . 0.0 111.915 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.508 ' C ' ' HA3' ' A' ' 136' ' ' GLY . . . -146.99 4.36 0.99 Allowed Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.678 ' NH2' ' HB3' ' A' ' 127' ' ' GLN . 38.4 mtp180 -54.11 168.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.013 -0.593 . . . . 0.0 110.198 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.685 ' NH2' ' HB3' ' A' ' 129' ' ' ASN . 40.7 ttp180 -71.84 149.19 45.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 86.6 m -34.86 -31.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.599 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.428 ' HE3' ' NE ' ' A' ' 154' ' ' ARG . 65.1 mtm -78.31 48.81 0.79 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.878 0.37 . . . . 0.0 111.17 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.468 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -118.55 -7.76 10.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.803 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.819 ' HA ' ' HE3' ' A' ' 158' ' ' LYS . 0.5 OUTLIER -65.22 -20.51 66.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.833 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.2 m -79.32 124.34 28.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.546 HD23 ' N ' ' A' ' 160' ' ' LEU . 2.3 pt? -144.16 165.82 26.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -115.38 150.84 35.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.622 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.4 pp -121.8 7.12 9.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.543 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -84.41 -12.96 53.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 110.544 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -92.79 136.7 33.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.728 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.59 143.97 26.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.225 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 57.1 tp -62.77 -21.99 66.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.633 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 178.15 175.07 45.0 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.32 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.551 HD13 ' N ' ' A' ' 168' ' ' LEU . 6.0 mp -71.8 134.91 46.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.791 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.71 133.22 31.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -88.32 94.86 9.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.732 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.481 ' H ' HD21 ' A' ' 171' ' ' ASN . 0.0 OUTLIER -113.06 25.73 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.144 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -149.04 44.15 0.75 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.312 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 83.4 p -159.2 122.95 3.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.812 0.339 . . . . 0.0 111.086 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -117.75 30.49 7.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.775 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.447 ' N ' ' OE1' ' A' ' 175' ' ' GLN . 0.5 OUTLIER -66.29 104.9 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.844 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 82.8 t -85.05 115.31 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.099 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.7 pp -105.44 148.42 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.192 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -87.26 123.21 32.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.033 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -139.42 -169.66 11.66 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.426 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -71.49 -29.83 65.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.755 0.312 . . . . 0.0 111.028 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -60.89 -67.26 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.059 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.913 179.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.762 0.315 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -112.57 27.78 9.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.693 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.45 ' HE ' ' N ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -69.34 -166.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.542 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.447 ' HA ' HD11 ' A' ' 4' ' ' LEU . 3.1 mm? -113.14 -71.47 0.75 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.768 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.7 m -67.0 161.49 24.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.739 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.447 ' HB3' HG13 ' A' ' 9' ' ' ILE . 38.6 tt0 -132.95 136.84 46.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.118 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -86.85 -28.27 22.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.302 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.428 ' HB3' ' OE2' ' A' ' 6' ' ' GLU . 5.5 tp10 -60.95 -27.8 68.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.435 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.447 HG13 ' HB3' ' A' ' 6' ' ' GLU . 64.1 mt -58.05 -19.26 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.44 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.55 160.86 15.45 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.33 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.36 30.15 76.96 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.57 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 86.6 mt -59.58 -23.53 63.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.705 -0.248 . . . . 0.0 111.094 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -68.24 -53.7 22.86 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.815 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 39.2 tt0 -64.92 -22.99 67.09 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.624 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 47.9 tp -74.88 -37.77 62.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.873 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.532 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 14.1 t80 -61.36 -46.85 88.51 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.815 ' HE2' ' HA ' ' A' ' 14' ' ' GLU . 59.5 pttt -75.96 -12.92 60.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.624 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.73 -18.01 60.56 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.891 178.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.551 ' HA ' ' CA ' ' A' ' 35' ' ' GLY . 7.1 mm -82.61 -61.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.932 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.716 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -77.65 59.81 2.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.823 -178.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 t -87.18 -6.15 58.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.495 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.608 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 5.4 m-20 -113.82 -28.1 7.54 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -83.03 -89.81 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.864 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.0 p -176.15 19.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.395 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.616 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.54 22.97 5.86 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.716 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 76.2 p -137.62 143.64 41.54 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.911 -0.644 . . . . 0.0 110.154 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.853 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.3 mt -102.34 103.7 15.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.745 -177.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 82.2 p -104.02 165.47 11.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.097 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.475 ' CD1' HG22 ' A' ' 48' ' ' ILE . 43.2 t80 -34.13 -34.47 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.778 0.674 . . . . 0.0 112.438 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -79.31 -48.02 14.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.929 0.395 . . . . 0.0 110.494 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.608 ' OE2' ' HB2' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -74.57 -14.32 60.77 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.363 178.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.667 HD11 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -58.63 -56.03 27.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.611 ' NZ ' HG12 ' A' ' 48' ' ' ILE . 6.4 ptpp? -73.92 -48.1 33.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.523 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.665 ' O ' ' HB3' ' A' ' 38' ' ' ARG . 32.1 t70 -37.84 -64.18 0.42 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.41 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.551 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . -47.39 -41.02 16.34 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 115.459 0.944 . . . . 0.0 115.459 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.489 HD11 ' C ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -94.99 -56.08 2.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.91 0.855 . . . . 0.0 110.955 -178.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.647 ' HZ3' ' HA ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -50.18 -18.08 0.53 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.401 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.665 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 6.3 ptm180 -67.14 -38.43 85.51 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.9 23.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.76 -23.25 33.12 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.735 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m -59.52 156.13 13.88 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.741 0.305 . . . . 0.0 110.632 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -136.78 109.28 7.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.233 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 mt -113.04 165.27 12.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.974 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.417 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 28.0 mtm -113.86 157.55 22.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 48' ' ' ILE . 37.5 mt-10 -44.87 -64.99 0.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.1 t -42.95 -29.44 0.33 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 56.7 mm-40 -70.39 -40.36 73.96 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.264 0.555 . . . . 0.0 109.569 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.667 HG13 HD11 ' A' ' 32' ' ' LEU . 1.7 mp -59.67 -60.94 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.321 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -56.58 -26.63 55.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.645 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.547 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 60.6 t0 -66.29 -46.17 77.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.829 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.65 -21.69 65.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.142 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.772 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 21.7 mmt -73.24 -43.54 61.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.477 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -86.96 -23.66 25.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.867 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.56 ' HA ' HH12 ' A' ' 80' ' ' ARG . . . -91.56 -25.55 19.17 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 70' ' ' ALA . . . -127.49 -43.77 1.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.74 ' HB3' ' O ' ' A' ' 52' ' ' MET . 67.3 t0 -59.2 94.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.345 0.593 . . . . 0.0 110.241 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 57' ' ' ILE . 37.0 mm -51.91 -19.43 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.337 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 60' ' ' SER . 8.4 t70 -130.3 43.9 3.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.638 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.772 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 12.7 tmtt? -32.7 88.2 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.744 0.783 . . . . 0.0 112.436 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' ASP . 76.3 p -128.55 18.32 6.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.062 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 75.89 15.24 81.47 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.375 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 97.2 m -146.55 142.71 28.28 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.118 0.567 . . . . 0.0 109.62 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.853 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 57.7 mt -128.98 133.69 65.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.271 0.558 . . . . 0.0 112.204 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 58.0 m-20 -106.53 167.97 9.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.616 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.413 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 29.4 t80 -35.27 -44.04 0.25 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.509 0.505 . . . . 0.0 111.717 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -56.0 7.99 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.765 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.737 ' HB2' HG23 ' A' ' 63' ' ' ILE . 24.1 mt-10 -56.25 -19.7 15.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 110.441 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.59 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 42.0 t80 -68.57 -60.04 2.7 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.555 0.693 . . . . 0.0 110.495 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.438 HG23 ' HG1' ' A' ' 72' ' ' THR . 16.9 mm -59.97 -26.13 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.291 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 55' ' ' ALA . . . -61.78 -8.86 5.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.961 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 68' ' ' PHE . . . -95.1 -30.18 14.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.639 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.438 ' HG1' HG23 ' A' ' 69' ' ' ILE . 42.9 p -80.66 -10.41 59.73 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.598 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.605 HG22 ' HG2' ' A' ' 79' ' ' GLU . 8.3 p -95.2 -14.42 7.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.589 178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -71.93 -52.99 14.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.251 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -16.38 47.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.633 ' ND2' ' HG2' ' A' ' 77' ' ' LYS . 55.3 t30 -81.49 174.96 10.94 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.451 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.633 ' HG2' ' ND2' ' A' ' 76' ' ' ASN . 8.1 ptpp? -32.52 136.12 0.08 Allowed 'General case' 0 N--CA 1.462 0.127 0 O-C-N 123.304 0.378 . . . . 0.0 110.675 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.411 ' HA ' HD21 ' A' ' 78' ' ' LEU . 87.3 mt -34.55 79.36 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.959 0.787 . . . . 0.0 112.676 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.605 ' HG2' HG22 ' A' ' 73' ' ' VAL . 42.7 tp10 -101.23 79.1 1.96 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.76 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.56 HH12 ' HA ' ' A' ' 54' ' ' ALA . 44.7 ttt85 -130.73 157.83 41.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.649 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -128.9 -174.94 3.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.937 0.399 . . . . 0.0 111.604 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 83' ' ' ASN . 88.6 tt0 -71.66 162.78 28.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.975 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.955 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 12.8 p-10 -170.37 114.5 0.47 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.011 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tt -90.48 -65.74 0.99 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.999 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.536 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . 33.8 m -78.09 -32.31 17.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.955 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 51.2 m -53.73 -21.98 8.29 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -76.92 -55.02 5.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.409 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.689 ' CE1' ' HA ' ' A' ' 135' ' ' TYR . 40.6 m-85 -49.77 -20.07 0.77 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.217 0.532 . . . . 0.0 109.719 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 87' ' ' ALA . 48.1 t -88.93 -48.06 7.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.05 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -83.11 -63.82 1.29 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.492 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.8 m-85 -58.99 -62.56 1.79 Allowed 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.747 ' HA ' HG12 ' A' ' 99' ' ' ILE . 62.7 t0 -74.81 63.89 1.21 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -48.19 -43.33 31.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.231 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.8 m-20 -74.08 -22.63 59.43 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.474 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . 64.56 -10.02 0.34 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.339 -0.458 . . . . 0.0 112.963 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 94' ' ' ASP . 79.1 p -49.58 -16.3 0.21 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 95' ' ' GLY . . . 130.56 -29.78 3.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.623 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.747 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -115.03 163.31 15.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.678 0.751 . . . . 0.0 112.709 -178.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.747 HG12 ' HA ' ' A' ' 92' ' ' ASP . 54.5 mt -133.13 102.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.221 177.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 101' ' ' LEU . 44.9 p -73.63 149.28 42.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.75 HD23 HG21 ' A' ' 122' ' ' ILE . 4.0 pp -34.95 -39.41 0.1 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.75 0.31 . . . . 0.0 111.115 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.443 ' N ' HD11 ' A' ' 101' ' ' LEU . 1.6 m-20 -54.89 -60.97 2.63 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.623 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 50.4 mt-10 -51.87 -47.88 64.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.977 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.8 HD12 HG12 ' A' ' 133' ' ' ILE . 90.5 mt -54.73 -65.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.701 0.762 . . . . 0.0 111.362 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.696 ' HB3' ' CD2' ' A' ' 113' ' ' LEU . 2.4 mm-40 -62.18 -65.23 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.925 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -42.26 -37.4 1.49 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.699 0.285 . . . . 0.0 111.667 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 103' ' ' GLU . . . -48.65 -57.99 5.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 3.4 t -57.0 131.87 51.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.557 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.9 -48.0 7.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.126 0.489 . . . . 0.0 112.294 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.13 -0.63 55.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.334 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.612 ' HB3' ' HB3' ' A' ' 108' ' ' CYS . 0.0 OUTLIER -44.94 -83.76 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.327 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.461 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 107.05 40.09 1.88 Allowed Glycine 0 C--N 1.333 0.399 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.207 -176.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.798 ' HA ' HG12 ' A' ' 118' ' ' ILE . 15.2 mt -31.25 133.02 0.09 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -176.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.707 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 12.4 p-10 -152.79 172.78 16.19 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.651 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 8.7 t70 -73.85 -22.22 59.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.548 HG23 ' HD1' ' A' ' 117' ' ' HIS . 62.3 mt -72.39 -64.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.548 ' HD1' HG23 ' A' ' 116' ' ' ILE . 16.9 m80 -92.17 -70.1 0.71 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.798 HG12 ' HA ' ' A' ' 113' ' ' LEU . 1.7 mp -47.31 -55.36 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -177.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.497 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 37.9 m-20 -60.63 -49.3 78.06 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.744 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 8.6 t70 -67.66 -19.48 65.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.953 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.2 mtp -69.89 -40.04 75.9 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.844 0.858 . . . . 0.0 110.274 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.75 HG21 HD23 ' A' ' 101' ' ' LEU . 56.8 mt -50.8 -46.63 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 43.7 mmtt -87.37 -13.58 43.06 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.006 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.953 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 15.9 tp10 -86.27 -17.1 35.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.71 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.847 HG21 HG13 ' A' ' 133' ' ' ILE . 22.6 mt -113.52 -32.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.331 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.614 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 17.3 t70 -63.33 112.29 2.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.954 0.407 . . . . 0.0 111.618 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.664 ' NE2' ' HB3' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -88.31 -9.37 53.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.812 ' HB3' ' HA ' ' A' ' 155' ' ' THR . 36.7 m-20 -131.32 -32.13 1.58 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -176.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -178.79 -74.26 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.67 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 21.4 m-20 -63.97 17.77 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.614 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.07 37.29 62.91 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.376 -1.869 . . . . 0.0 108.99 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.758 ' O ' HD12 ' A' ' 133' ' ' ILE . 8.7 pt20 -131.55 166.92 20.33 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 113.934 -1.133 . . . . 0.0 109.148 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.847 HG13 HG21 ' A' ' 125' ' ' ILE . 36.0 mm -123.5 131.99 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-O 121.736 0.779 . . . . 0.0 111.172 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.784 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 39.0 t70 -101.09 160.32 14.48 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.876 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.689 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 15.0 t80 -48.05 -31.44 5.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.132 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.691 ' HA3' ' HA3' ' A' ' 152' ' ' GLY . . . -85.61 -33.55 15.99 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 119.888 -1.148 . . . . 0.0 110.429 177.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.784 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 52.6 mt-10 -64.28 -58.0 7.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.37 -0.415 . . . . 0.0 111.197 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.455 ' CD1' HG22 ' A' ' 133' ' ' ILE . 2.8 t80 -54.53 -37.94 65.98 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.753 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.09 -20.92 64.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.181 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.3 -50.33 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -19.91 9.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.688 0.28 . . . . 0.0 111.292 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.408 ' HB2' ' HE1' ' A' ' 142' ' ' MET . 67.6 mtm -99.44 -34.56 10.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.811 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.584 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -109.45 -140.41 0.38 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.059 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.584 ' H ' ' HD2' ' A' ' 143' ' ' ARG . 60.6 mttp -114.7 -77.55 0.57 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.744 0.307 . . . . 0.0 111.072 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -133.51 47.6 2.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.074 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -105.51 41.89 1.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.828 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.32 -66.96 2.44 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.158 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.418 ' ND2' ' H ' ' A' ' 150' ' ' GLY . 46.4 t30 -156.22 157.1 35.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.647 0.223 . . . . 0.0 110.952 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -50.75 -31.33 23.2 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.418 ' H ' ' ND2' ' A' ' 148' ' ' ASN . . . -96.03 -65.02 0.95 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.405 ' H ' HD21 ' A' ' 148' ' ' ASN . 18.0 tt -175.92 150.71 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.134 -0.533 . . . . 0.0 110.666 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.691 ' HA3' ' HA3' ' A' ' 136' ' ' GLY . . . -117.72 -104.57 2.27 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.62 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.63 ' HD3' ' H ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -47.26 100.49 0.02 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.325 0.583 . . . . 0.0 110.91 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.779 ' HB3' ' HB3' ' A' ' 157' ' ' ARG . 11.7 tpt180 -128.76 137.91 51.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.252 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.812 ' HA ' ' HB3' ' A' ' 128' ' ' ASP . 66.5 p -61.1 -33.57 73.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.558 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.57 ' H ' ' HG3' ' A' ' 154' ' ' ARG . 51.9 ttm -149.59 75.72 1.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.3 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.779 ' HB3' ' HB3' ' A' ' 154' ' ' ARG . 3.2 ptm85 -84.55 36.55 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.216 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -164.38 154.7 14.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.843 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.2 t -156.26 -12.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.153 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 56.7 tp -126.93 151.44 48.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.088 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -61.36 132.39 53.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.69 -154.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.596 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.433 ' HG2' HH11 ' A' ' 163' ' ' ARG . 51.9 ttt-85 -54.1 132.14 42.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.795 0.331 . . . . 0.0 110.686 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -58.47 131.24 50.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -130.43 142.28 50.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.967 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -125.32 12.34 8.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.873 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.48 110.95 2.46 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.537 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.14 176.16 6.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.735 0.302 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.45 138.19 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.068 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -95.24 108.5 20.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.715 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -89.15 31.03 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.027 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -110.7 -104.45 2.82 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.473 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 53.7 m -126.19 -163.77 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.647 0.26 . . . . 0.0 110.838 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -78.45 146.27 34.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.834 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.449 ' N ' ' OE1' ' A' ' 175' ' ' GLN . 1.1 mp0 -83.14 106.83 15.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 176' ' ' VAL . 34.7 m -85.29 139.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 13.3 tt -108.2 133.65 52.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.977 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -146.98 127.13 13.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -158.32 158.28 29.09 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.433 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -101.27 -13.12 18.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 110.618 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -60.5 -25.05 65.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.975 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.861 179.846 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.807 0.337 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -91.91 26.03 2.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.013 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -106.23 12.88 29.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.5 mt -93.14 -88.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.335 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.0 t -132.16 1.37 3.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.319 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.506 ' HB3' ' H ' ' A' ' 11' ' ' GLY . 19.7 pt-20 -97.47 88.26 4.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.941 0.401 . . . . 0.0 110.74 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -89.34 -64.39 1.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -90.39 -73.35 0.53 Allowed 'General case' 0 C--O 1.232 0.136 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.0 mm -91.63 -71.52 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-O 120.929 0.395 . . . . 0.0 111.896 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 12' ' ' LEU . . . -167.97 119.91 0.87 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.932 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.506 ' H ' ' HB3' ' A' ' 6' ' ' GLU . . . -70.4 -1.23 34.82 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.6 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 7.5 mp -84.92 -27.68 26.43 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.751 -0.724 . . . . 0.0 111.341 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.578 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 7.9 tmtm? -56.39 -53.64 54.96 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.627 ' HA ' ' NZ ' ' A' ' 17' ' ' LYS . 88.7 tt0 -66.4 -43.82 84.75 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.982 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.747 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 29.0 tp -58.79 -23.04 59.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.729 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' LEU . 37.9 t80 -76.02 -56.58 4.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.995 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.627 ' NZ ' ' HA ' ' A' ' 14' ' ' GLU . 25.2 pttm -71.52 -12.52 61.42 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.426 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 10.1 mtp -70.26 -37.98 75.02 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.199 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.833 HG21 HG22 ' A' ' 27' ' ' ILE . 3.3 mt -64.56 -57.6 10.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.997 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 26' ' ' THR . 1.6 p30 -81.33 61.09 4.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.876 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -72.85 -14.51 61.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.333 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -138.21 -15.26 1.29 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.622 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 27.6 t-20 -64.18 -81.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.0 p -176.91 2.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.504 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.41 12.43 17.26 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.549 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 53.5 p -126.24 152.97 45.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.574 -0.813 . . . . 0.0 108.944 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.833 HG22 HG21 ' A' ' 19' ' ' ILE . 3.6 mt -110.0 103.22 15.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 81.3 p -103.9 153.55 20.66 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.898 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.667 ' HZ ' ' HB3' ' A' ' 45' ' ' GLU . 59.8 t80 -34.12 -26.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 28' ' ' THR . 54.9 m-20 -80.5 -39.78 27.31 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.622 ' HG2' ' HB2' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -86.83 -29.6 22.12 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.531 178.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.702 HD13 HG13 ' A' ' 48' ' ' ILE . 2.1 tm? -39.91 -49.52 2.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.789 0.804 . . . . 0.0 109.644 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.733 ' HZ1' ' HG3' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -77.24 -37.41 53.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.143 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.595 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 9.5 t70 -46.53 -27.73 1.2 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.08 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.673 ' HA2' ' HA ' ' A' ' 19' ' ' ILE . . . -55.92 -50.5 60.97 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.802 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.688 ' O ' HG12 ' A' ' 39' ' ' VAL . 2.2 mm? -92.59 -28.62 16.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.825 0.345 . . . . 0.0 110.766 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.602 ' HZ3' ' HD3' ' A' ' 33' ' ' LYS . 51.7 mtmt -56.94 -48.51 78.12 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.8 ttt85 -59.74 -37.63 79.48 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.842 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -70.19 -21.99 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.811 -178.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.33 -27.11 4.28 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.052 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 74.1 m -65.03 154.54 37.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.689 0.28 . . . . 0.0 111.095 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -126.82 103.08 7.32 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.564 0.697 . . . . 0.0 111.241 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.704 HD11 ' HB3' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -111.61 166.87 10.79 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.397 -179.366 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.507 ' HG3' ' HG3' ' A' ' 47' ' ' GLU . 17.3 ptt? -107.84 165.45 11.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.646 0.26 . . . . 0.0 110.829 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.733 ' HG3' ' HZ1' ' A' ' 33' ' ' LYS . 58.5 mp0 -51.82 -64.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.7 m -43.18 -17.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.507 ' HG3' ' HG3' ' A' ' 44' ' ' MET . 96.0 mt-10 -84.69 -41.59 16.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.702 HG13 HD13 ' A' ' 32' ' ' LEU . 1.5 mp -56.17 -49.77 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.44 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.526 ' CE ' ' HD3' ' A' ' 93' ' ' LYS . 4.3 ttmp? -57.95 -22.45 49.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.566 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 9.0 t70 -75.18 -25.7 58.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.622 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.447 ' HB3' HD11 ' A' ' 32' ' ' LEU . 62.4 tp -90.37 -30.89 17.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.05 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.736 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 39.1 ttm -88.02 -66.16 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.802 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.83 ' HA ' ' HG3' ' A' ' 59' ' ' LYS . 60.9 t0 -68.16 -38.77 82.45 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.75 -12.06 49.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -127.34 -44.12 1.58 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.63 ' HB3' ' O ' ' A' ' 52' ' ' MET . 63.2 t0 -53.97 132.67 42.69 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.2 mm -81.61 -14.75 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.805 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 60' ' ' SER . 74.0 m-20 -128.21 28.62 5.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.762 -178.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.83 ' HG3' ' HA ' ' A' ' 53' ' ' ASP . 12.1 tmtt? -31.61 90.68 0.0 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.937 0.875 . . . . 0.0 112.137 -177.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.7 p -128.26 18.39 6.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.519 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.542 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 81.72 15.42 75.61 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.65 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.703 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 40.4 m -155.82 128.47 7.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.494 0.318 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.819 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 52.9 mt -110.86 136.47 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 121.178 0.513 . . . . 0.0 110.941 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' N ' HG23 ' A' ' 63' ' ' ILE . 49.9 m-20 -104.6 168.96 8.74 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.161 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.578 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 26.6 t80 -40.6 -39.26 1.01 Allowed 'General case' 0 CA--C 1.519 -0.213 0 O-C-N 123.42 0.45 . . . . 0.0 111.093 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.9 -57.78 4.31 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.922 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.551 ' HB3' ' OD1' ' A' ' 56' ' ' ASP . 34.4 mt-10 -49.79 -20.77 0.92 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.242 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.747 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 68.6 t80 -69.89 -57.26 5.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.389 0.614 . . . . 0.0 110.653 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 73' ' ' VAL . 1.2 mt -63.54 -40.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.16 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 74' ' ' HIS . . . -68.92 -6.58 28.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.043 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 67' ' ' GLU . . . -90.74 -28.27 18.4 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.495 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.1 p -95.66 -54.22 3.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.822 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.698 HG21 ' HE2' ' A' ' 77' ' ' LYS . 9.8 p -56.86 -15.61 3.04 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.133 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.76 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.515 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 30.6 t-80 -69.37 -48.29 61.71 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.1 mt -64.68 -13.21 53.25 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.182 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.16 75.34 1.0 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.08 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.698 ' HE2' HG21 ' A' ' 73' ' ' VAL . 71.0 mmtt -154.12 -152.32 0.4 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.797 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.437 ' N ' HD21 ' A' ' 78' ' ' LEU . 2.9 mm? -76.13 90.19 3.08 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -41.76 -22.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.299 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -48.16 154.72 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.666 0.27 . . . . 0.0 110.932 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -53.08 153.69 3.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.408 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -95.39 -155.75 0.48 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.04 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.1 m-80 -80.19 -164.74 0.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.421 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.627 ' H ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -90.09 -27.94 19.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.547 -179.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -73.93 -19.86 17.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.685 0.278 . . . . 0.0 110.999 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 m -48.9 -30.37 5.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.396 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.41 ' C ' ' N ' ' A' ' 89' ' ' SER . . . -81.53 -52.2 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.241 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.814 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 11.9 t80 -42.81 -26.5 0.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.278 0.561 . . . . 0.0 109.854 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.41 ' N ' ' C ' ' A' ' 87' ' ' ALA . 31.7 t -89.22 -58.33 2.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.952 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -77.03 -63.84 1.27 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.398 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.575 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.6 m-85 -55.47 -61.84 2.07 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.814 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 1.0 OUTLIER -74.55 60.41 0.88 Allowed 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.526 ' HD3' ' CE ' ' A' ' 49' ' ' LYS . 26.3 ttmt -47.61 -41.63 22.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.037 -177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 96' ' ' SER . 1.4 m-20 -79.73 -21.15 44.9 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.919 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . 65.06 -6.16 1.09 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.971 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 94' ' ' ASP . 86.1 p -55.7 -8.28 0.38 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.886 0.374 . . . . 0.0 110.894 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 95' ' ' GLY . . . 108.17 -0.49 33.31 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.729 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.77 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.6 OUTLIER -139.24 154.1 47.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.675 0.75 . . . . 0.0 112.818 -178.649 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.861 HG21 HG12 ' A' ' 104' ' ' ILE . 85.9 mt -132.15 102.95 6.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.345 177.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.519 ' HA ' ' CB ' ' A' ' 132' ' ' GLN . 67.8 p -87.02 163.74 16.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.947 0.794 . . . . 0.0 111.226 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.852 ' HB3' HG23 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -35.95 -36.99 0.09 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.105 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.3 -54.15 44.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.905 0.383 . . . . 0.0 110.111 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.595 ' O ' ' HB1' ' A' ' 107' ' ' ALA . 52.1 mt-10 -62.66 -31.42 72.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.143 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.861 HG12 HG21 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -75.39 -64.97 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.638 ' NE2' HD11 ' A' ' 122' ' ' ILE . 14.6 mt-30 -54.4 -31.88 56.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.688 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -73.19 -47.33 44.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.044 0.45 . . . . 0.0 110.078 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' A' ' 103' ' ' GLU . . . -64.82 -2.99 2.89 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.161 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.625 ' SG ' HG22 ' A' ' 118' ' ' ILE . 24.2 p -135.58 39.66 2.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.094 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -67.54 -23.05 65.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.956 0.408 . . . . 0.0 110.477 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.36 -6.59 59.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.599 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -91.48 14.27 15.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.851 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.92 37.57 56.63 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.078 -1.058 . . . . 0.0 111.875 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.8 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -34.55 117.25 0.35 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.371 0.605 . . . . 0.0 112.042 -178.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.643 ' N ' HD23 ' A' ' 113' ' ' LEU . 54.5 m-20 -154.58 -177.09 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.027 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.719 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 12.3 p-10 -84.07 -7.65 59.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.436 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.6 mm -83.38 -64.77 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.422 ' O ' ' HB2' ' A' ' 121' ' ' MET . 4.6 m-70 -91.91 -68.5 0.79 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.8 HG13 ' HA ' ' A' ' 113' ' ' LEU . 40.5 mm -52.09 -20.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.214 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.719 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 8.1 t70 -76.5 -60.94 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 124' ' ' GLU . 33.9 m-20 -58.42 -17.09 17.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.719 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 14.2 ttp -67.51 -46.84 71.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.584 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.852 HG23 ' HB3' ' A' ' 101' ' ' LEU . 59.9 mt -48.74 -41.48 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 176.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 24.4 mmtp -87.36 -19.84 27.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.308 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.719 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 4.8 tp10 -76.12 -16.31 59.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.568 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.737 HD12 HD12 ' A' ' 133' ' ' ILE . 1.2 mt -117.15 -34.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.033 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.76 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 22.8 t70 -55.27 93.32 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.113 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.557 ' NE2' ' HA ' ' A' ' 137' ' ' GLU . 17.8 mt-30 -83.81 -9.27 58.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.009 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 6.6 p-10 -131.65 -30.6 1.63 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.723 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -176.79 -80.42 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 118.277 2.695 . . . . 0.0 118.277 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.723 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 15.7 m-20 -64.08 27.41 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -172.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.76 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 54.95 37.69 63.24 Favored Glycine 0 CA--C 1.498 -1.004 0 C-N-CA 118.184 -1.96 . . . . 0.0 108.893 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.77 ' NE2' ' HB3' ' A' ' 98' ' ' TYR . 12.7 pt20 -135.17 166.26 23.5 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.375 -0.912 . . . . 0.0 110.841 -176.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.737 HD12 HD12 ' A' ' 125' ' ' ILE . 4.4 mt -121.54 125.28 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.353 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.615 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -103.97 165.54 10.98 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.658 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 30.5 t80 -49.84 -24.42 2.43 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.763 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.629 ' C ' ' HB2' ' A' ' 153' ' ' ARG . . . -77.88 -44.87 11.28 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 177.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.557 ' HA ' ' NE2' ' A' ' 127' ' ' GLN . 42.1 mt-10 -62.08 -62.75 1.56 Allowed 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.644 ' HD1' HG23 ' A' ' 133' ' ' ILE . 1.9 t80 -56.38 -32.63 64.97 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.2 -0.6 . . . . 0.0 112.111 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.74 -23.07 49.42 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.143 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.71 -51.2 5.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.037 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 138' ' ' PHE . 27.3 ptm -49.11 -22.91 1.04 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.58 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.415 ' HB2' ' HE3' ' A' ' 142' ' ' MET . 63.3 mtm -103.25 -20.58 14.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.868 0.366 . . . . 0.0 110.695 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.519 HH21 ' HE3' ' A' ' 146' ' ' LYS . 71.1 mtp180 -126.94 43.14 3.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.818 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -62.78 -57.69 10.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.347 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.593 ' O ' ' HD3' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -47.0 -26.48 1.03 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.774 -179.469 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.681 ' HZ1' ' HB2' ' A' ' 148' ' ' ASN . 66.3 tttm -80.51 76.1 7.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.595 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -62.73 -4.42 7.08 Favored Glycine 0 C--N 1.33 0.214 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.962 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.681 ' HB2' ' HZ1' ' A' ' 146' ' ' LYS . 2.9 m120 -47.07 156.1 0.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.017 0.436 . . . . 0.0 111.465 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -65.3 -4.85 18.64 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.128 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -65.72 -5.18 23.0 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.86 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.638 HG12 ' H ' ' A' ' 152' ' ' GLY . 12.5 tt -63.59 177.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.638 ' H ' HG12 ' A' ' 151' ' ' ILE . . . -152.34 -21.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.338 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.797 ' HE ' ' H ' ' A' ' 154' ' ' ARG . 4.2 tpm_? -72.55 168.84 17.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.066 0.46 . . . . 0.0 110.585 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.881 ' HD3' ' HE1' ' A' ' 156' ' ' MET . 38.8 ttt-85 -73.51 148.35 43.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.849 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.421 ' C ' ' H ' ' A' ' 157' ' ' ARG . 69.0 p -46.51 -17.57 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.881 ' HE1' ' HD3' ' A' ' 154' ' ' ARG . 63.8 mtm -74.39 13.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.548 0.213 . . . . 0.0 111.446 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.663 ' HG3' ' O ' ' A' ' 154' ' ' ARG . 3.9 ppt_? -84.52 33.6 0.51 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 0.0 111.224 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -58.53 176.43 0.19 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.26 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 86.6 m -56.69 151.0 14.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.81 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 59.6 tp -56.21 99.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.857 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -148.26 81.12 1.47 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.06 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.461 ' HA ' HD11 ' A' ' 162' ' ' LEU . 3.1 mm? -115.8 -69.56 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.797 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -139.87 104.37 4.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.867 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -122.43 130.25 52.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.703 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.9 124.92 28.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.079 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -127.12 -10.54 5.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.609 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -178.41 -117.89 0.54 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.321 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 92.3 mt -109.27 105.39 14.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 0.0 110.75 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -109.67 142.22 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.012 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -68.62 134.65 50.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -102.07 -44.11 5.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.76 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.72 138.73 44.78 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.571 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 78.1 p -132.61 -170.84 2.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.849 0.357 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -138.25 -37.69 0.56 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.689 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -136.4 -176.16 4.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.776 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 176' ' ' VAL . 30.4 m -90.13 134.53 28.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.974 0.416 . . . . 0.0 111.169 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.475 HD11 HG22 ' A' ' 177' ' ' ILE . 68.3 mt -113.72 113.0 42.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.951 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -121.07 153.57 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.68 165.61 52.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.372 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -119.23 129.77 55.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.871 0.367 . . . . 0.0 110.753 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.62 -168.36 2.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.267 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.971 -179.897 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ' CA' . . . . . 0.472 'CA ' ' HB2' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.404 ' H3 ' ' H ' ' A' ' 2' ' ' GLU . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.808 0.337 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' H ' ' H3 ' ' A' ' 1' ' ' ALA . 94.9 mt-10 -134.36 46.29 2.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 53.1 mtm-85 -90.63 -0.06 57.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.75 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.4 tp -71.73 -37.61 70.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.293 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.0 p -132.53 169.43 16.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.054 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -135.75 -164.19 1.51 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.774 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -77.4 -12.84 60.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.97 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -56.78 -34.42 67.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.148 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.6 mm -65.55 -23.78 33.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.317 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.77 160.74 15.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.659 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.56 25.89 65.86 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.282 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.495 HD22 ' HE2' ' A' ' 68' ' ' PHE . 3.2 tm? -87.73 -50.48 6.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.088 . . . . 0.0 110.771 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -51.99 -38.96 58.56 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.101 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.693 ' O ' ' HG2' ' A' ' 18' ' ' MET . 38.6 tt0 -70.94 -49.72 42.53 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.641 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 55.5 tp -47.99 -33.12 7.39 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.037 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.497 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 32.1 t80 -60.05 -50.33 74.15 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.151 0.5 . . . . 0.0 110.927 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -79.95 -15.6 56.95 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.094 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.693 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 81.4 mmm -69.51 -28.73 66.29 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.363 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.698 HG22 HD13 ' A' ' 27' ' ' ILE . 0.9 OUTLIER -69.36 -59.11 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.636 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.741 ' HB3' ' O ' ' A' ' 26' ' ' THR . 2.1 p30 -80.84 45.66 0.83 Allowed 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.932 0.873 . . . . 0.0 111.771 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.589 HG21 ' HD2' ' A' ' 38' ' ' ARG . 15.1 t -66.0 -6.53 13.05 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.986 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.57 -7.17 2.87 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.445 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 24.2 t-20 -91.83 -93.86 0.14 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.698 -0.401 . . . . 0.0 112.063 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.6 p -177.36 14.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.498 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.47 17.17 9.49 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.185 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 74.0 p -125.17 158.98 32.62 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.866 ' O ' ' HA ' ' A' ' 62' ' ' THR . 1.6 mt -123.09 101.66 9.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 76.7 p -103.28 156.87 17.41 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.385 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.551 ' CD1' HG23 ' A' ' 48' ' ' ILE . 60.3 t80 -33.65 -38.49 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.98 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 9.6 t70 -71.18 -43.9 66.52 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 111.243 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.56 ' O ' HG23 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -79.43 -27.72 41.7 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.65 178.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.767 ' HB2' ' HE3' ' A' ' 52' ' ' MET . 1.6 tm? -50.75 -55.08 18.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.129 0.49 . . . . 0.0 109.965 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' CG1' ' A' ' 48' ' ' ILE . 1.1 ptmm? -77.02 -39.04 51.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.119 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.524 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 38.8 t70 -41.73 -41.18 2.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.562 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.99 91.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.443 -0.408 . . . . 0.0 114.097 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.593 ' O ' HG12 ' A' ' 39' ' ' VAL . 2.2 mp -89.26 -45.07 9.81 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 41' ' ' SER . 17.4 ptpt -59.12 -21.92 60.04 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.589 ' HD2' HG21 ' A' ' 21' ' ' THR . 36.8 ttt-85 -79.57 -40.56 29.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.39 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 36' ' ' LEU . 2.9 p -78.98 -12.96 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.72 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.54 -44.62 1.19 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.375 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 69.4 m -52.96 161.9 0.71 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.681 0.277 . . . . 0.0 111.525 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -134.24 105.1 6.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.606 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD13 ' CD2' ' A' ' 36' ' ' LEU . 68.7 mt -108.42 166.15 10.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.007 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.434 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 32.1 mtm -109.21 165.7 11.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.773 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.442 ' HB3' ' HZ ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -55.47 -59.79 4.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.128 -179.309 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.7 m -55.09 -17.6 4.28 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.924 0.329 . . . . 0.0 111.737 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.4 mm-40 -79.69 -48.42 13.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.756 HD12 HD13 ' A' ' 32' ' ' LEU . 6.1 mm -56.86 -51.96 61.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.915 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -46.97 -33.16 4.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.006 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 63.9 t0 -60.3 -45.31 93.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.484 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 67.3 mt -67.07 -14.77 63.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.767 ' HE3' ' HB2' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -87.6 -65.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.04 0.448 . . . . 0.0 111.804 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.66 -37.13 70.84 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 50' ' ' ASP . . . -91.28 -13.63 32.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . . . -127.16 -43.56 1.64 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.602 ' OD1' HG12 ' A' ' 63' ' ' ILE . 34.0 t70 -62.25 103.6 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.857 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.0 mm -43.35 -27.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.286 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.582 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.6 m-20 -133.63 44.66 2.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.035 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.59 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 1.2 tmtp? -31.99 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.819 0.818 . . . . 0.0 112.339 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.0 p -126.81 10.54 7.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.165 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 103.63 -15.31 53.11 Favored Glycine 0 C--O 1.238 0.35 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.597 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.866 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 5.4 t -140.49 148.81 41.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.67 0.272 . . . . 0.0 110.88 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.836 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 78.6 mt -108.88 142.42 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.03 0.443 . . . . 0.0 111.244 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -105.69 166.78 10.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.971 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.637 ' O ' HG13 ' A' ' 69' ' ' ILE . 31.2 t80 -40.58 -48.91 2.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.794 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.34 -59.17 7.03 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.783 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.795 ' HB2' HG23 ' A' ' 63' ' ' ILE . 48.9 mt-10 -45.47 -31.9 1.95 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.804 0.335 . . . . 0.0 110.726 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.497 ' CD2' ' HB2' ' A' ' 16' ' ' PHE . 9.9 t80 -66.06 -55.0 18.82 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.378 0.609 . . . . 0.0 110.152 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.637 HG13 ' O ' ' A' ' 65' ' ' TYR . 10.8 mt -57.06 -65.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.061 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 74' ' ' HIS . . . -44.85 -48.33 11.08 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.557 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 68' ' ' PHE . . . -41.03 -42.59 1.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.455 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.418 ' HG1' HG22 ' A' ' 73' ' ' VAL . 30.9 p -69.71 -33.04 71.96 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.659 HG13 ' HZ1' ' A' ' 77' ' ' LYS . 46.7 t -95.89 -14.29 7.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.564 0.697 . . . . 0.0 110.328 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 70' ' ' ALA . 18.1 t-160 -83.44 -49.48 9.26 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.889 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.776 ' HB2' ' HD2' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -57.99 -14.54 6.66 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.324 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.425 ' N ' ' C ' ' A' ' 74' ' ' HIS . 26.3 t-20 -110.94 74.97 0.9 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.689 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.659 ' HZ1' HG13 ' A' ' 73' ' ' VAL . 60.7 mttp -158.41 -94.93 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.549 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -168.04 67.64 0.08 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.652 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -63.64 98.08 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.867 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 80' ' ' ARG . 38.2 ttt85 -101.38 144.89 29.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.897 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.54 161.49 16.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.825 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -94.94 -84.03 0.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -84.92 -166.41 1.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 85' ' ' VAL . 2.6 pt? -90.32 -42.8 10.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.436 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 6.4 p -54.73 -30.88 23.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.4 m -56.46 -37.43 70.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.127 0.489 . . . . 0.0 109.797 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -82.66 -47.92 11.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.064 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.748 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 21.7 t80 -41.85 -30.0 0.23 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.551 0.691 . . . . 0.0 109.65 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -89.9 -47.58 7.78 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.194 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -84.99 -63.88 1.25 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.271 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.569 ' HB3' HD12 ' A' ' 99' ' ' ILE . 4.1 m-85 -56.53 -56.5 20.45 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.81 ' HA ' HG12 ' A' ' 99' ' ' ILE . 0.4 OUTLIER -77.81 54.69 1.29 Allowed 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.649 ' HB2' ' HZ2' ' A' ' 93' ' ' LYS . 3.7 ttmp? -49.07 -38.28 23.77 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.778 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -75.43 -23.06 56.92 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.777 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.74 73.07 0.31 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.4 p -132.1 -28.59 1.72 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 134.56 7.13 2.2 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 113.925 -1.488 . . . . 0.0 113.037 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.801 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -150.87 160.73 43.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.451 0.643 . . . . 0.0 111.362 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.81 HG12 ' HA ' ' A' ' 92' ' ' ASP . 70.1 mt -133.96 102.78 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.884 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 103' ' ' GLU . 72.9 p -73.14 150.93 41.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.347 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.752 ' HB3' HG23 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -35.03 -34.25 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -62.13 -51.69 66.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 100' ' ' THR . 53.9 mt-10 -71.13 -29.44 65.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.954 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 132' ' ' GLN . 27.1 mt -68.39 -64.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.981 0.42 . . . . 0.0 110.395 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.492 ' NE2' ' HA ' ' A' ' 119' ' ' ASP . 81.8 mt-30 -55.49 -39.57 70.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.456 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -65.31 -31.93 73.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.048 0.451 . . . . 0.0 110.447 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.73 -4.09 3.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.145 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.622 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 9.8 p -105.04 118.27 36.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.133 0.492 . . . . 0.0 110.587 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.776 ' HD2' ' HB2' ' A' ' 75' ' ' LEU . 38.2 ttpt -88.82 -61.32 1.73 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.257 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.88 -4.45 58.47 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 108' ' ' CYS . 2.8 m-85 -65.71 -18.15 65.12 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.501 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.59 38.95 97.25 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.611 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.969 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -33.27 149.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.242 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.567 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 26.7 t70 -160.48 178.89 9.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.185 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.405 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 53.6 p-10 -89.38 -8.45 53.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.921 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.787 HG22 ' H ' ' A' ' 117' ' ' HIS . 6.6 tp -92.53 -57.6 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.787 ' H ' HG22 ' A' ' 116' ' ' ILE . 10.0 t-80 -91.47 -68.65 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.969 HG13 ' HA ' ' A' ' 113' ' ' LEU . 46.9 mm -54.02 -19.61 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.968 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.492 ' HA ' ' NE2' ' A' ' 105' ' ' GLN . 38.5 t70 -66.91 -41.9 86.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 124' ' ' GLU . 7.4 t70 -71.2 -26.04 62.78 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.893 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 3.7 ttt -57.77 -30.26 65.5 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.161 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.752 HG23 ' HB3' ' A' ' 101' ' ' LEU . 58.9 mt -58.84 -43.95 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.682 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 3.7 mptt -86.64 -13.32 45.93 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 113.271 -1.786 . . . . 0.0 110.351 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.893 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 36.5 tp10 -82.14 -27.77 32.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.753 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.928 HG22 HG13 ' A' ' 133' ' ' ILE . 45.0 mt -100.41 -33.88 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.278 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.669 ' CG ' ' H ' ' A' ' 131' ' ' GLY . 7.3 t70 -83.47 84.92 7.34 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.41 0.624 . . . . 0.0 110.318 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.447 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 2.9 pm0 -88.09 -9.29 53.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.806 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.642 ' HB3' ' OE1' ' A' ' 137' ' ' GLU . 5.6 t70 -130.17 -19.52 3.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 -177.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.519 HD21 ' HG2' ' A' ' 132' ' ' GLN . 15.3 t30 -115.37 -127.19 0.29 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -177.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.472 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 9.5 t0 -116.61 27.04 9.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -173.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.669 ' H ' ' CG ' ' A' ' 126' ' ' ASP . . . 94.65 37.11 5.37 Favored Glycine 0 CA--C 1.501 -0.836 0 N-CA-C 108.258 -1.937 . . . . 0.0 108.258 -177.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.685 ' NE2' ' HB3' ' A' ' 98' ' ' TYR . 8.4 pt20 -153.72 169.21 23.88 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.172 -1.514 . . . . 0.0 108.966 -177.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.928 HG13 HG22 ' A' ' 125' ' ' ILE . 25.9 mm -131.33 127.01 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-O 121.68 0.752 . . . . 0.0 111.067 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.801 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -102.09 160.51 14.45 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.208 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.731 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 24.4 t80 -41.64 -33.95 0.54 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.576 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.647 ' HA3' ' O ' ' A' ' 153' ' ' ARG . . . -82.75 -35.54 18.89 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.855 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.673 ' HB3' HD11 ' A' ' 133' ' ' ILE . 61.2 mm-40 -62.11 -57.03 13.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.289 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.557 ' HB2' HG21 ' A' ' 133' ' ' ILE . 2.7 t80 -61.09 -38.37 86.02 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.14 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 135' ' ' TYR . . . -58.71 -33.82 70.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.163 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.411 ' C ' ' N ' ' A' ' 142' ' ' MET . . . -90.72 -26.87 19.32 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.43 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.517 ' HG2' ' CD1' ' A' ' 138' ' ' PHE . 2.8 ppp? -51.6 -28.0 12.87 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.7 ' HG3' ' H ' ' A' ' 143' ' ' ARG . 17.1 ptp -105.13 -111.13 0.27 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.7 ' H ' ' HG3' ' A' ' 142' ' ' MET . 0.0 OUTLIER -176.4 146.16 0.61 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.701 0.763 . . . . 0.0 112.273 175.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.567 ' HA ' ' NZ ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -155.37 -73.29 0.11 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.081 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.458 ' HA ' ' NE ' ' A' ' 145' ' ' ARG . 9.9 mmp_? -104.66 -45.8 4.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.307 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -113.29 119.89 39.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.225 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -90.82 -4.44 69.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.446 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.496 ' ND2' ' H ' ' A' ' 150' ' ' GLY . 0.7 OUTLIER -46.65 112.22 0.48 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.971 0.386 . . . . 0.0 110.425 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -78.37 -17.61 77.57 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.845 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.496 ' H ' ' ND2' ' A' ' 148' ' ' ASN . . . -78.68 -20.27 71.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.596 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 5.0 mt -139.4 153.49 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 CA-C-O 121.105 0.479 . . . . 0.0 111.164 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -99.93 -132.07 7.59 Favored Glycine 0 N--CA 1.427 -1.938 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.647 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 78.3 mtp180 -142.01 80.67 1.72 Allowed 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.417 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.598 ' HB3' ' OD1' ' A' ' 128' ' ' ASP . 11.3 tpt180 -111.33 145.12 39.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.298 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.593 HG21 ' HE ' ' A' ' 154' ' ' ARG . 6.6 t -46.67 -40.2 12.75 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.253 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.511 ' HG3' HG23 ' A' ' 155' ' ' THR . 68.7 mtm -111.5 83.84 1.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.348 . . . . 0.0 110.687 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.412 ' HA ' ' OD2' ' A' ' 128' ' ' ASP . 84.3 mtm180 -72.26 141.0 48.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -166.33 134.44 2.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.726 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.0 m -97.71 98.47 9.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.78 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.511 ' C ' HD22 ' A' ' 160' ' ' LEU . 6.4 tt -145.94 101.75 3.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.371 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -171.49 138.37 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 87.2 mt -84.67 147.11 27.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.781 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -89.64 141.25 28.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.754 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -61.84 124.08 19.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.767 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.25 121.32 10.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.122 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 62.3 tp -80.79 -24.76 38.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -124.76 -116.68 2.18 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.575 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.6 mt -68.91 156.15 39.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.909 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 169' ' ' VAL . 7.7 p -105.55 134.96 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.053 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.53 -166.95 1.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -96.92 -45.88 6.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.983 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 67.75 -174.33 28.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.438 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.6 t -150.82 -80.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.667 0.27 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -166.09 67.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.407 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -114.71 98.16 6.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.88 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 35.7 m -66.32 139.53 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.213 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 177' ' ' ILE . 49.0 mm -120.2 102.93 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.827 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -103.19 104.66 14.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.491 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 175.13 74.36 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.529 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -91.53 32.69 1.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.349 . . . . 0.0 110.647 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -76.86 -51.34 11.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.969 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.793 ' HE2' ' HA ' ' A' ' 182' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.814 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.826 0.346 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -102.75 90.32 3.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.825 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -126.16 21.91 7.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.732 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.546 HD21 ' H ' ' A' ' 4' ' ' LEU . 2.1 pt? -130.24 18.7 5.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.0 p -92.28 -36.36 13.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -121.02 74.65 1.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.029 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.434 ' OE2' ' HA ' ' A' ' 4' ' ' LEU . 56.2 mm-40 -89.04 -12.68 40.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.927 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.751 ' HG3' ' H ' ' A' ' 9' ' ' ILE . 16.8 pt-20 -76.08 -71.44 0.38 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.833 HG13 ' H ' ' A' ' 10' ' ' GLY . 9.2 pt -90.96 -71.83 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.833 ' H ' HG13 ' A' ' 9' ' ' ILE . . . -168.89 166.11 39.42 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.41 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.28 24.81 2.44 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.527 ' H ' ' C ' ' A' ' 10' ' ' GLY . 96.3 mt -51.93 -21.06 2.69 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.712 ' HZ1' ' HB2' ' A' ' 13' ' ' LYS . 4.5 ttmp? -59.58 -51.35 70.21 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.624 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 84.8 tt0 -62.05 -30.73 71.18 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.134 178.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.717 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 40.4 tp -68.86 -30.33 68.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.662 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.414 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 22.0 t80 -68.16 -49.48 60.68 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.223 0.535 . . . . 0.0 110.333 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 14' ' ' GLU . 60.2 pttt -75.66 -12.91 60.29 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.561 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 2.3 tpp -66.03 -28.91 69.22 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.862 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.625 HD13 ' HE1' ' A' ' 68' ' ' PHE . 3.3 mt -81.26 -55.01 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.052 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -82.71 62.8 6.51 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.775 0.798 . . . . 0.0 111.292 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 t -81.81 -11.75 58.83 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.173 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.3 p30 -138.36 -11.43 1.42 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -72.25 -81.92 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.143 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 p -175.8 5.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.684 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.58 20.94 7.07 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.525 ' HB ' ' CG2' ' A' ' 62' ' ' THR . 68.5 p -139.22 150.63 45.76 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.042 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 62' ' ' THR . 3.8 mt -104.16 103.35 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 31' ' ' GLU . 71.2 p -104.31 162.55 13.11 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.492 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -34.11 -35.95 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.942 0.497 . . . . 0.0 111.821 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -77.36 -41.15 41.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 110.759 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.611 ' HG3' HG21 ' A' ' 19' ' ' ILE . 11.4 tp10 -77.09 -30.55 55.43 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.429 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.696 ' HG ' HG23 ' A' ' 48' ' ' ILE . 0.9 OUTLIER -41.18 -48.73 3.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.981 0.895 . . . . 0.0 109.732 -179.294 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.798 ' HB3' HD12 ' A' ' 43' ' ' LEU . 6.0 ptpt -85.15 -30.87 23.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.886 -1.507 . . . . 0.0 111.624 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 9.1 t70 -46.62 -46.1 19.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.345 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.15 -37.55 95.09 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.008 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.891 ' HG ' HD21 ' A' ' 43' ' ' LEU . 3.8 mm? -71.62 -58.18 3.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.598 ' NZ ' ' HE2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -58.58 -26.88 64.08 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.108 0.48 . . . . 0.0 110.41 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 56.4 ttt-85 -59.16 -49.45 77.81 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.397 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.474 HG22 ' H ' ' A' ' 41' ' ' SER . 3.3 m -77.46 -14.25 14.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.33 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.89 -19.99 8.23 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.971 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.474 ' H ' HG22 ' A' ' 39' ' ' VAL . 49.2 m -55.69 153.77 7.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.749 0.275 . . . . 0.0 110.963 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -131.64 104.17 6.79 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.446 0.641 . . . . 0.0 112.04 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.891 HD21 ' HG ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -116.58 167.6 10.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.865 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.562 ' HE2' ' HB2' ' A' ' 86' ' ' SER . 27.0 ptt? -109.67 165.22 11.85 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.516 0.198 . . . . 0.0 110.562 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -50.19 -55.63 14.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.5 t -48.53 -24.27 1.25 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HG2' ' OG ' ' A' ' 86' ' ' SER . 49.2 mt-10 -71.15 -36.2 71.97 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.696 HG23 ' HG ' ' A' ' 32' ' ' LEU . 1.9 mp -66.42 -60.61 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.747 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.448 ' HE3' ' CE1' ' A' ' 111' ' ' PHE . 22.1 ttmm -54.5 -31.26 55.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.489 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.475 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 35.8 t70 -70.9 -45.18 64.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.244 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.601 HD23 HD23 ' A' ' 32' ' ' LEU . 36.0 tp -66.35 -16.56 64.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.529 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.644 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 23.5 mmt -85.45 -60.85 1.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.291 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -76.12 -39.32 55.4 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.859 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 50' ' ' ASP . . . -82.72 -19.08 38.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . . . -127.51 -43.98 1.56 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.636 ' HB3' ' O ' ' A' ' 52' ' ' MET . 33.3 t70 -60.26 107.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.214 0.531 . . . . 0.0 110.199 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.1 mt -49.45 -25.08 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.676 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.521 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 74.8 m-20 -130.4 44.03 3.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.023 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.644 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 1.3 tmtp? -31.98 92.3 0.01 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.798 0.808 . . . . 0.0 112.468 -177.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' ASP . 82.8 p -128.0 10.46 6.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.796 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 81.45 17.33 71.46 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.601 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 53.2 m -153.94 127.19 8.48 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.42 0.288 . . . . 0.0 110.371 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.631 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 64.2 mt -107.5 132.44 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.034 0.445 . . . . 0.0 111.479 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -105.19 168.15 9.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.3 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.516 ' O ' HG12 ' A' ' 69' ' ' ILE . 28.4 t80 -35.82 -48.23 0.54 Allowed 'General case' 0 N--CA 1.464 0.23 0 O-C-N 123.296 0.372 . . . . 0.0 111.913 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.92 -64.0 3.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.709 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 63.7 mt-10 -50.57 -26.18 4.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.764 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.717 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 68.2 t80 -62.0 -61.85 2.19 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.48 0.657 . . . . 0.0 110.894 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 65' ' ' TYR . 10.4 mm -55.07 -50.62 61.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.777 -178.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.31 -12.5 21.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.936 0.398 . . . . 0.0 111.261 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 67' ' ' GLU . . . -95.11 -53.68 3.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.447 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 76' ' ' ASN . 77.9 p -61.54 -47.87 83.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.205 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.566 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 59.5 t -52.09 -29.86 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -72.21 -40.47 67.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 71' ' ' ALA . 6.9 mp -90.47 4.49 50.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.005 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.566 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 44.8 t30 -95.26 75.21 3.39 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.8 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -143.97 -40.69 0.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.43 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 78' ' ' LEU . 3.3 mm? -125.4 107.05 10.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.035 179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -44.2 -34.74 1.97 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.475 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -96.28 102.39 14.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.685 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -102.61 32.01 3.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.133 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -74.13 95.24 2.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.783 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.606 ' HB2' HG22 ' A' ' 85' ' ' VAL . 17.9 p30 -158.73 125.67 4.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.143 0.497 . . . . 0.0 111.447 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.491 ' N ' HD11 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -74.98 -17.37 60.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.659 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.606 HG22 ' HB2' ' A' ' 83' ' ' ASN . 22.0 m -47.31 -19.07 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.641 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.562 ' HB2' ' HE2' ' A' ' 44' ' ' MET . 53.1 m -34.98 -65.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.15 0.281 . . . . 0.0 111.701 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -73.29 -38.55 65.84 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.709 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 25.4 t80 -43.16 -23.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.913 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.1 t -88.88 -42.53 11.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.737 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -82.76 -62.92 1.47 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.578 ' HB3' HD12 ' A' ' 99' ' ' ILE . 2.9 m-85 -53.61 -62.82 1.41 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.465 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.598 ' OD1' HG13 ' A' ' 99' ' ' ILE . 1.2 m-20 -79.0 50.16 1.0 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 89' ' ' SER . 37.3 ttmt -36.66 -59.81 0.64 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.629 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -83.48 -20.93 33.11 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.705 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.25 85.69 0.01 OUTLIER Glycine 0 N--CA 1.424 -2.156 0 CA-C-O 121.713 0.618 . . . . 0.0 112.887 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.4 p -100.58 -14.62 18.11 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 124.44 -4.02 8.8 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 111.526 -2.579 . . . . 0.0 110.942 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.1 OUTLIER -147.9 165.67 29.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.764 -0.718 . . . . 0.0 110.746 178.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.767 HG22 HG12 ' A' ' 104' ' ' ILE . 72.4 mt -131.75 104.15 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.512 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 102' ' ' ASP . 71.5 p -72.12 147.08 47.03 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.863 ' HB3' HG22 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -34.27 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 106' ' ' GLN . 34.6 t70 -57.16 -56.59 19.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.47 -32.29 71.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.163 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.767 HG12 HG22 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -61.39 -50.07 81.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.179 0.514 . . . . 0.0 110.723 179.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.613 ' NE2' HD12 ' A' ' 122' ' ' ILE . 41.3 mt-30 -71.94 -49.45 37.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.031 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 102' ' ' ASP . 87.0 mt-30 -55.83 -41.84 74.85 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.837 0.351 . . . . 0.0 110.979 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.13 -4.01 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.246 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.755 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 74.3 m -119.93 67.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.812 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.647 ' HD3' ' H ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -80.2 -36.34 35.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 -179.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -89.04 -5.0 58.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.755 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 4.2 m-85 -83.81 5.08 26.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.744 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.75 37.55 13.35 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.783 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.868 ' HA ' HG13 ' A' ' 118' ' ' ILE . 2.3 tm? -33.88 105.21 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.319 0.58 . . . . 0.0 111.327 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.484 ' OD1' HG12 ' A' ' 116' ' ' ILE . 10.3 t70 -160.5 156.05 25.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.754 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.641 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 10.7 p-10 -64.19 -7.73 10.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.067 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.484 HG12 ' OD1' ' A' ' 114' ' ' ASP . 49.0 mm -80.66 -64.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.586 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.442 ' HD1' HG21 ' A' ' 116' ' ' ILE . 16.0 m80 -91.69 -68.26 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.868 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.5 mm -48.17 -19.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.257 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.641 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 8.8 t70 -78.12 -59.1 2.92 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 124' ' ' GLU . 34.8 t70 -59.52 -17.15 29.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.743 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 25.2 ttp -64.27 -42.66 96.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.577 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.863 HG22 ' HB3' ' A' ' 101' ' ' LEU . 53.8 mt -54.89 -49.33 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.84 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.652 ' HA ' ' HE3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -76.92 -13.27 60.0 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.513 178.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.743 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 40.3 tp10 -84.06 -25.44 29.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.262 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.809 HG21 HG13 ' A' ' 133' ' ' ILE . 31.2 mt -107.41 -15.74 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.993 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 1.9 t70 -77.76 82.74 4.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.025 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.752 HE21 ' HD3' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -88.63 -9.36 52.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.663 179.38 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.702 ' H ' ' NE ' ' A' ' 153' ' ' ARG . 45.0 t0 -116.15 -35.49 4.36 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.655 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.97 -84.82 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.655 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 34.8 t70 -65.36 15.78 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -172.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.993 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.56 38.85 83.27 Favored Glycine 0 CA--C 1.509 -0.313 0 C-N-CA 117.223 -2.417 . . . . 0.0 109.193 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.631 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 7.4 pt20 -134.61 167.4 20.88 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 113.461 -1.369 . . . . 0.0 108.692 -177.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.809 HG13 HG21 ' A' ' 125' ' ' ILE . 5.8 mm -129.14 125.26 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 122.26 1.028 . . . . 0.0 111.532 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.929 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 6.4 t70 -103.14 152.09 21.83 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.969 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.709 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 17.1 t80 -40.96 -42.68 1.93 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.749 0.309 . . . . 0.0 110.931 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.77 -28.53 38.1 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.883 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.929 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 31.9 mt-10 -68.92 -59.07 3.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.625 ' HB2' ' CG2' ' A' ' 133' ' ' ILE . 13.4 t80 -50.41 -18.53 0.66 Allowed 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.392 0.615 . . . . 0.0 109.776 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 137' ' ' GLU . . . -78.48 -40.21 36.08 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.519 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 144' ' ' LYS . . . -90.13 -12.8 37.22 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.703 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.479 ' HG2' ' CD1' ' A' ' 138' ' ' PHE . 4.9 ppp? -55.8 -27.68 52.36 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.735 0.302 . . . . 0.0 111.238 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -102.3 -21.03 14.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 110.227 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 63.1 mtt85 -144.15 73.37 1.38 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.162 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.77 ' H ' ' HD3' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -89.31 -85.43 0.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.496 -179.393 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.761 ' H ' ' HG2' ' A' ' 144' ' ' LYS . 73.3 mtp180 -77.36 23.35 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.769 0.319 . . . . 0.0 110.756 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.472 ' H ' ' C ' ' A' ' 144' ' ' LYS . 61.9 tttp -58.93 -87.17 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.671 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -57.9 -60.9 8.13 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -132.55 110.65 10.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 0.0 110.279 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 145' ' ' ARG . . . -60.18 -23.48 59.8 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.085 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -46.17 -26.06 2.08 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.454 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.422 HD11 HH12 ' A' ' 157' ' ' ARG . 12.9 mt -119.47 -109.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 117.032 0.416 . . . . 0.0 111.344 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.401 ' H ' ' HB ' ' A' ' 151' ' ' ILE . . . 111.96 -128.07 8.4 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.784 HH11 HD13 ' A' ' 133' ' ' ILE . 6.0 ptt180 -91.93 131.56 37.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.346 0.594 . . . . 0.0 109.536 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.642 ' HB3' ' HG2' ' A' ' 157' ' ' ARG . 79.9 ttt180 -130.82 150.15 52.12 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.432 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.9 t -47.95 -17.4 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.713 0.292 . . . . 0.0 110.91 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.4 ' N ' ' C ' ' A' ' 154' ' ' ARG . 16.6 tpt -160.59 93.91 1.03 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.252 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.642 ' HG2' ' HB3' ' A' ' 154' ' ' ARG . 23.7 mmm180 -105.68 139.44 40.27 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.825 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -84.79 -179.65 7.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.898 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 56.6 m -92.96 153.7 18.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.548 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.415 ' H ' HD22 ' A' ' 160' ' ' LEU . 2.0 pt? -131.98 -170.79 2.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.97 0.414 . . . . 0.0 111.308 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -75.01 166.27 23.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.737 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 80.2 mt -90.3 172.15 8.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.915 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.477 ' HG2' ' N ' ' A' ' 164' ' ' ASP . 71.5 ttt180 -123.62 157.14 34.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.477 ' N ' ' HG2' ' A' ' 163' ' ' ARG . 57.2 m-20 -107.58 107.3 18.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.634 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.55 158.06 3.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.372 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.786 ' H ' HD22 ' A' ' 166' ' ' LEU . 2.4 pt? -114.21 6.38 16.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.772 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -105.69 108.93 3.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.353 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.36 132.35 49.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.357 . . . . 0.0 110.897 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.9 m -67.1 153.98 8.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -161.4 134.84 6.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.784 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.526 HD21 ' N ' ' A' ' 172' ' ' GLY . 0.0 OUTLIER -110.52 -11.14 14.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.308 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.526 ' N ' HD21 ' A' ' 171' ' ' ASN . . . 69.37 -129.02 22.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.564 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.4 t -128.41 153.29 47.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.349 . . . . 0.0 111.084 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -155.25 138.26 15.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.823 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -75.83 121.87 23.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.963 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 62.4 t -107.62 119.46 57.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.094 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 12.0 tt -91.19 125.32 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.975 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -87.26 127.56 35.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -160.34 158.83 30.26 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.533 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.453 ' HD1' ' N ' ' A' ' 181' ' ' PHE . 0.2 OUTLIER -60.15 -23.86 64.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.734 0.302 . . . . 0.0 111.413 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.453 ' N ' ' HD1' ' A' ' 180' ' ' TYR . 4.1 m-85 -123.06 101.41 7.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.871 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.845 179.873 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.4 tp . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.516 0.198 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.635 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 6.3 ttpm? -55.83 -30.93 62.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.76 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 8.1 mp0 -76.97 -38.3 53.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.959 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.735 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 54.5 tp -55.01 -28.12 49.62 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.681 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -70.6 -45.07 66.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.776 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.76 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 63.5 pttt -82.47 -12.5 57.78 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.589 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.44 -25.9 68.21 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.431 178.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.532 HG23 ' HA3' ' A' ' 35' ' ' GLY . 3.2 mt -86.39 -59.4 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.511 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -82.62 57.35 3.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.347 0.594 . . . . 0.0 110.547 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.662 HG21 ' NH2' ' A' ' 38' ' ' ARG . 13.6 t -81.24 -6.72 59.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.16 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -129.2 -14.61 4.3 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.564 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -74.42 -87.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.802 0.334 . . . . 0.0 111.208 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 p -176.66 6.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.817 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.549 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.42 31.48 2.79 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 45.9 p -150.07 145.78 26.57 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.189 -0.505 . . . . 0.0 109.946 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.823 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.2 mt -102.87 103.91 15.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.629 HG22 ' OG1' ' A' ' 62' ' ' THR . 68.3 p -103.42 164.84 11.39 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.551 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 20.5 t80 -34.09 -36.4 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.683 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.19 -49.84 16.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.715 0.293 . . . . 0.0 111.659 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.652 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -75.72 -19.9 58.74 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.922 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.892 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -46.03 -47.38 16.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.914 0.864 . . . . 0.0 108.693 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.709 ' HG2' HG12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -85.43 -51.89 6.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.485 179.243 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.652 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 59.3 m-20 -36.34 -36.17 0.09 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.532 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -68.02 -57.34 8.76 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 115.114 0.805 . . . . 0.0 115.114 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.697 HD21 ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -73.85 -28.55 61.65 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.163 0.981 . . . . 0.0 111.989 -177.596 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.635 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 19.4 ptpt -66.14 -4.7 7.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.662 ' NH2' HG21 ' A' ' 21' ' ' THR . 36.9 ttm180 -87.15 -42.71 12.8 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.249 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 36' ' ' LEU . 30.8 m -73.44 -0.22 2.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.81 -36.93 3.71 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.352 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.604 ' CB ' HD23 ' A' ' 36' ' ' LEU . 18.5 m -52.45 153.02 3.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.471 0.177 . . . . 0.0 110.553 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -143.3 103.79 4.17 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.298 0.57 . . . . 0.0 112.142 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.7 HD11 ' HB3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -105.35 167.98 9.38 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.124 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 5.3 mtm -104.66 165.51 11.01 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.535 ' HA ' HD13 ' A' ' 48' ' ' ILE . 92.8 mt-10 -47.71 -59.99 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.495 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 94.4 p -39.47 -34.99 0.25 Allowed 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 44' ' ' MET . 37.2 mp0 -66.38 -41.03 89.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.053 0.454 . . . . 0.0 110.172 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.892 HG13 HD12 ' A' ' 32' ' ' LEU . 2.0 mp -57.06 -60.49 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.984 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.551 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 42.4 tttm -64.45 -25.6 68.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.318 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 46' ' ' SER . 62.6 t0 -71.13 -37.45 72.29 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.607 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.52 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 10.2 tt -76.36 -23.07 54.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.024 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.752 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 18.2 mmt -71.88 -45.01 62.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.122 0.487 . . . . 0.0 111.518 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.52 -30.29 20.71 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.988 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.55 -19.31 22.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.02 -43.81 1.65 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.752 ' HB3' ' O ' ' A' ' 52' ' ' MET . 15.6 t0 -61.24 95.98 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.3 mm -48.65 -22.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.031 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.58 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 59.0 t0 -129.11 44.5 2.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.818 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.702 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.5 tmtm? -32.57 90.38 0.0 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.74 0.781 . . . . 0.0 112.662 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.1 p -127.74 18.04 6.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.151 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 70.88 17.76 75.58 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.384 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 86.1 m -150.36 127.15 11.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.542 0.337 . . . . 0.0 110.561 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.823 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 70.1 mt -108.06 129.46 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 121.055 0.455 . . . . 0.0 111.367 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' OD1' HG22 ' A' ' 26' ' ' THR . 56.3 m-20 -105.06 167.33 9.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.09 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.635 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 47.9 t80 -35.52 -45.78 0.37 Allowed 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.389 0.431 . . . . 0.0 111.474 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.38 -63.7 4.12 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.331 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.784 ' HB2' HG23 ' A' ' 63' ' ' ILE . 63.0 mt-10 -51.92 -26.11 9.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.662 0.267 . . . . 0.0 110.905 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.735 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 71.9 t80 -63.87 -65.18 0.72 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.434 0.635 . . . . 0.0 110.879 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.614 HD13 ' HD2' ' A' ' 68' ' ' PHE . 14.5 mm -52.13 -41.17 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.653 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.23 -25.76 66.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.0 110.59 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.035 179.705 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.496 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 14.4 p . . . . . 0 C--O 1.233 0.19 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.7 m -51.05 -55.01 19.66 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.402 . . . . 0.0 110.173 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.584 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -81.18 -39.77 24.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.902 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.808 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 8.1 t80 -45.95 -23.04 0.25 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.366 0.603 . . . . 0.0 110.055 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.3 t -89.13 -44.79 10.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.769 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -89.3 -63.65 1.26 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.609 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.5 m-85 -51.98 -62.36 1.68 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.808 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.6 OUTLIER -76.13 55.29 0.93 Allowed 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 176.123 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -44.53 -52.91 7.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.451 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.35 -21.46 64.73 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.328 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.08 68.61 1.09 Allowed Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.4 p -115.54 -23.06 8.95 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 134' ' ' ASP . . . 130.58 -4.55 5.84 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 113.162 -1.836 . . . . 0.0 112.606 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.896 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.5 OUTLIER -148.62 161.82 40.94 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.792 HG12 ' HA ' ' A' ' 92' ' ' ASP . 22.1 mt -133.09 104.27 6.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.833 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 102' ' ' ASP . 69.6 p -72.3 147.1 46.69 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.709 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.1 pp -34.44 -33.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.526 ' N ' HD12 ' A' ' 101' ' ' LEU . 54.2 m-20 -54.35 -55.89 24.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.56 ' HB2' HG23 ' A' ' 99' ' ' ILE . 97.4 mt-10 -71.21 -31.43 67.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.174 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.668 HG13 HG22 ' A' ' 99' ' ' ILE . 51.1 mt -65.74 -65.25 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.166 0.508 . . . . 0.0 110.439 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.858 ' HB3' HD12 ' A' ' 113' ' ' LEU . 30.8 mt-30 -58.14 -39.05 77.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.636 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.84 -44.12 94.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.082 0.468 . . . . 0.0 110.66 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.7 -3.05 1.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.145 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.788 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 73.2 m -115.09 44.07 1.88 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.922 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -59.54 -36.63 76.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.841 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -75.09 -22.12 58.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.11 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.788 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 2.7 m-85 -76.78 -5.18 47.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.953 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 113' ' ' LEU . . . 62.35 38.8 96.85 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.036 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.928 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -33.09 132.74 0.15 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.545 0.688 . . . . 0.0 111.501 -177.125 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.717 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 91.9 m-20 -135.99 167.69 20.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.217 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.635 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.6 m-20 -82.88 -7.98 59.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.178 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.59 -64.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.068 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -89.52 -69.24 0.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.928 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.3 mm -52.77 -19.45 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.942 0.401 . . . . 0.0 111.238 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.635 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 33.6 t70 -71.14 -46.91 60.59 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' GLU . 63.9 t0 -62.37 -26.27 68.37 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' MET . . . . . 1.026 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.5 ttt -60.75 -29.87 69.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.474 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.777 HG22 ' HA3' ' A' ' 131' ' ' GLY . 56.8 mt -58.32 -43.62 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.477 ' CE ' ' HB ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -86.67 -13.8 44.46 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.367 178.534 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 1.026 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 71.5 tt0 -84.61 -23.73 29.45 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.789 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.856 HG22 HD11 ' A' ' 133' ' ' ILE . 13.6 mm -107.56 -21.8 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.977 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.4 t70 -62.8 98.37 0.12 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.594 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.605 ' HG3' ' HB3' ' A' ' 140' ' ' ALA . 5.4 tm0? -87.23 -13.95 42.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.417 ' OD1' ' OE2' ' A' ' 137' ' ' GLU . 50.6 p30 -127.57 -33.19 2.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 20.7 p-10 179.96 -71.76 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.413 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 56.3 m-20 -64.92 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -173.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.977 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.53 37.93 78.04 Favored Glycine 0 CA--C 1.505 -0.566 0 C-N-CA 118.348 -1.882 . . . . 0.0 110.04 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.562 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 2.7 pt20 -133.33 170.53 15.33 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 113.895 -1.152 . . . . 0.0 110.075 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.042 HD13 ' HB3' ' A' ' 137' ' ' GLU . 5.0 mm -133.02 121.88 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.909 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 4.3 p-10 -113.01 162.47 15.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.161 177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.796 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 22.5 t80 -38.76 -30.48 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.768 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.537 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -84.27 -45.16 6.31 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.728 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 1.042 ' HB3' HD13 ' A' ' 133' ' ' ILE . 39.3 mt-10 -63.04 -51.3 67.29 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 13.6 t80 -56.62 -18.68 12.86 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -86.06 -40.85 15.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.151 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.605 ' HB3' ' HG3' ' A' ' 127' ' ' GLN . . . -87.25 -11.66 49.04 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' A' ' 138' ' ' PHE . 5.5 ppp? -72.41 -6.68 45.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.635 0.255 . . . . 0.0 111.557 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.994 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 15' ' ' LEU . 46.5 tp . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.651 ' HG3' ' OE1' ' A' ' 14' ' ' GLU . 20.6 pttp -58.59 -24.99 62.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.651 ' OE1' ' HG3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -80.43 -52.27 7.85 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.593 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.637 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 31.0 tp -47.23 -30.2 2.85 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.847 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.497 ' CZ ' ' N ' ' A' ' 65' ' ' TYR . 20.1 t80 -66.61 -52.04 49.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.164 0.506 . . . . 0.0 110.446 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -76.0 -13.06 60.23 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.625 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 63.4 mmm -71.04 -22.61 62.12 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.499 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.664 HG23 ' HA3' ' A' ' 35' ' ' GLY . 10.9 mm -77.42 -61.31 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.269 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.591 ' HB3' ' O ' ' A' ' 26' ' ' THR . 1.0 OUTLIER -80.23 66.79 5.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.534 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 t -82.75 -6.34 59.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.348 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -131.75 -27.28 1.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -69.82 -82.45 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.1 p -175.91 5.42 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.46 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 111.11 27.13 4.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.373 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.591 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 64.8 p -143.66 149.18 36.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.034 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.86 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.1 mt -103.43 103.02 14.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.654 HG22 ' OG1' ' A' ' 62' ' ' THR . 66.9 p -104.16 162.29 13.3 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.129 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.625 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 44.1 t80 -34.03 -27.87 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 28' ' ' THR . 56.1 m-20 -82.51 -45.06 15.17 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.791 0.329 . . . . 0.0 111.159 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 8.0 mp0 -83.13 -15.13 51.93 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.901 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.71 HD12 HG13 ' A' ' 48' ' ' ILE . 2.2 tm? -53.03 -50.16 64.84 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.909 ' HB2' ' HE3' ' A' ' 37' ' ' LYS . 12.5 ptpt -82.59 -46.15 13.68 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.091 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.609 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 31.0 t70 -42.86 -64.9 0.54 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.664 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -46.43 -28.36 3.33 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.142 -0.552 . . . . 0.0 113.633 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.682 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -90.1 -59.68 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.986 0.393 . . . . 0.0 110.772 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.909 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 18.8 ptpt -60.43 -9.55 3.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.032 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.429 ' C ' ' HD3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -68.3 -34.67 76.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.868 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 36' ' ' LEU . 31.4 m -80.84 -8.72 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.393 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.7 -17.66 5.48 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.842 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 65.1 m -63.42 168.51 4.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.964 0.412 . . . . 0.0 111.445 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -147.57 111.12 4.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.608 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.7 mt -120.55 165.83 14.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.374 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.509 ' O ' HD13 ' A' ' 48' ' ' ILE . 24.0 ptt? -114.15 162.43 16.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 47' ' ' GLU . 44.4 mt-10 -47.63 -65.43 0.57 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 80.8 p -41.73 -18.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 55.8 mt-10 -89.72 -47.57 7.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.71 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -53.64 -59.78 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.912 0.863 . . . . 0.0 109.138 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 1.018 ' HD3' ' HD2' ' A' ' 93' ' ' LYS . 21.8 ttmm -55.15 -27.39 45.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.212 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 8.8 t70 -69.9 -45.05 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.153 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 51' ' ' LEU . 9.7 tt -68.26 -21.67 64.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.086 0.47 . . . . 0.0 109.966 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.713 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 13.4 mmt -71.93 -44.01 64.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.855 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 90' ' ' TYR . 9.7 t70 -87.05 -18.04 31.51 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.672 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.58 -42.36 10.26 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.876 ' HB1' ' HA ' ' A' ' 71' ' ' ALA . . . -110.7 -43.13 3.88 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.713 ' HB3' ' O ' ' A' ' 52' ' ' MET . 12.3 t0 -49.39 97.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.706 -0.398 . . . . 0.0 109.979 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.7 mm -54.75 -17.53 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.276 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.561 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 38.9 t70 -132.21 44.48 2.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.951 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.613 ' HD3' ' C ' ' A' ' 52' ' ' MET . 27.1 tptp -30.94 88.03 0.0 OUTLIER 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.5 p -128.7 18.94 6.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.469 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 71.32 17.12 75.81 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.725 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 51.0 m -151.69 128.03 10.61 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.949 -0.625 . . . . 0.0 110.723 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.86 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.7 mt -105.06 133.41 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 120.927 0.394 . . . . 0.0 110.67 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -105.49 167.75 9.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.325 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.568 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 14.9 t80 -35.82 -46.89 0.48 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.476 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.51 -54.07 7.98 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.65 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.744 ' HB2' HG23 ' A' ' 63' ' ' ILE . 48.5 mt-10 -53.25 -24.05 10.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.294 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.637 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 57.1 t80 -67.8 -60.41 2.54 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.505 0.669 . . . . 0.0 110.487 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 65' ' ' TYR . 8.5 mm -49.21 -49.27 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.813 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.42 -47.25 86.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.806 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.876 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.202 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.231 0.121 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 90.9 p -52.8 -34.85 55.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 110.12 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -82.22 -52.69 6.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.161 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.722 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 10.9 t80 -44.25 -26.43 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.056 0.455 . . . . 0.0 110.359 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 t -89.73 -47.69 7.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.66 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.466 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 1.0 OUTLIER -82.64 -62.75 1.52 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.378 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.0 m-85 -56.36 -64.62 0.8 Allowed 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.818 ' HA ' HG12 ' A' ' 99' ' ' ILE . 11.9 t0 -76.85 69.2 3.15 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 1.018 ' HD2' ' HD3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -44.43 -40.85 5.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.347 -177.022 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.3 m-20 -78.5 -21.35 49.05 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.889 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.62 -8.06 0.57 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.676 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 94' ' ' ASP . 72.2 p -55.37 -9.07 0.4 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 122.628 0.371 . . . . 0.0 111.203 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 134' ' ' ASP . . . 107.28 -6.54 36.6 Favored Glycine 0 C--O 1.216 -1.029 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.683 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -127.46 145.69 50.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.991 0.424 . . . . 0.0 112.01 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.818 HG12 ' HA ' ' A' ' 92' ' ' ASP . 65.5 mt -131.99 102.93 6.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.368 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 132' ' ' GLN . 44.0 p -76.27 152.84 36.37 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.257 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HB3' HG23 ' A' ' 122' ' ' ILE . 3.7 pp -35.47 -39.03 0.12 Allowed 'General case' 0 N--CA 1.461 0.125 0 O-C-N 123.194 0.309 . . . . 0.0 111.139 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -50.89 -57.08 9.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.147 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.607 ' HB2' HG23 ' A' ' 99' ' ' ILE . 50.4 mt-10 -63.82 -32.17 73.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.597 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.745 HG13 HG22 ' A' ' 99' ' ' ILE . 91.3 mt -70.36 -66.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 111.19 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.435 ' OE1' ' HA ' ' A' ' 119' ' ' ASP . 30.2 mt-30 -56.39 -35.76 68.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.289 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -55.69 -40.37 72.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.774 0.321 . . . . 0.0 110.543 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.54 -65.24 0.66 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.239 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.537 ' HB3' ' CG ' ' A' ' 111' ' ' PHE . 83.3 m -64.4 76.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.509 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.529 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 1.0 OUTLIER -88.8 -43.91 10.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.597 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -72.72 -4.68 32.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.721 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.537 ' CG ' ' HB3' ' A' ' 108' ' ' CYS . 1.2 m-85 -81.86 -1.17 46.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.775 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.18 37.2 94.13 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.598 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.72 ' O ' HD12 ' A' ' 113' ' ' LEU . 2.1 pp -34.06 144.5 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.674 0.75 . . . . 0.0 112.875 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 119' ' ' ASP . 11.2 p-10 -160.16 -164.06 1.22 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.986 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.686 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 2.8 p30 -87.73 -7.93 56.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.12 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.406 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 50.7 mm -89.45 -64.69 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.47 ' O ' ' HB2' ' A' ' 121' ' ' MET . 18.0 t-160 -92.06 -68.51 0.79 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 113' ' ' LEU . 2.2 mp -56.89 -20.31 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.686 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 38.8 t70 -79.71 -59.25 2.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' GLU . 1.2 m-20 -59.2 -17.24 25.99 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.758 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 22.4 ttp -59.72 -39.65 85.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.333 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.532 HG22 ' HA3' ' A' ' 131' ' ' GLY . 59.7 mt -54.69 -45.0 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -84.15 -13.6 52.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.98 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.758 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 15.9 tp10 -78.18 -27.8 48.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.894 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.767 HG21 ' CD1' ' A' ' 133' ' ' ILE . 22.6 mt -109.06 -7.87 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.818 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.619 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 28.0 t70 -73.78 81.34 1.59 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.112 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.927 HE22 ' HB3' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -87.54 -9.36 54.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.052 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 6.3 m-20 -119.87 -34.56 3.7 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.551 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 10.4 p-10 179.63 -80.89 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 118.438 2.755 . . . . 0.0 118.438 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.832 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 5.7 t70 -64.32 -17.68 63.91 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 118.813 2.894 . . . . 0.0 118.813 -171.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.619 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 92.15 37.13 6.05 Favored Glycine 0 CA--C 1.501 -0.836 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.832 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 3.2 pt20 -139.15 166.53 24.28 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 112.729 -1.735 . . . . 0.0 108.957 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.767 ' CD1' HG21 ' A' ' 125' ' ' ILE . 48.0 mt -123.29 128.32 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 121.441 0.638 . . . . 0.0 110.805 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.843 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 1.5 t70 -104.16 157.9 16.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.476 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.722 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 18.9 t80 -39.33 -46.24 1.56 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.376 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.91 -44.01 80.68 Favored Glycine 0 N--CA 1.422 -2.279 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.303 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.927 ' HB3' HE22 ' A' ' 127' ' ' GLN . 27.8 mt-10 -55.88 -62.23 1.84 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.413 -0.394 . . . . 0.0 110.143 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.514 ' HD1' HG21 ' A' ' 133' ' ' ILE . 2.5 t80 -55.3 -30.16 59.63 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.943 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.88 -26.36 59.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.339 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.71 -51.23 5.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.851 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -57.72 -12.65 3.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.925 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 C--N 1.332 -0.172 0 CA-C-O 120.683 0.278 . . . . 0.0 110.836 179.741 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 95.7 mt . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.457 0.17 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.642 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 62.2 tttp -57.51 -43.83 84.55 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.665 ' O ' ' HG2' ' A' ' 18' ' ' MET . 44.8 tt0 -71.75 -47.97 50.03 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.725 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 28.2 tp -48.85 -29.01 4.15 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.55 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.488 ' CZ ' ' N ' ' A' ' 65' ' ' TYR . 15.3 t80 -64.87 -51.67 60.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.581 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.553 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.6 ptpt -77.79 -12.77 60.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.05 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 56.8 mmm -68.19 -24.05 64.91 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.491 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.705 HD12 HD13 ' A' ' 27' ' ' ILE . 4.0 mt -83.73 -52.0 13.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.162 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.701 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -80.73 51.84 1.58 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.436 0.636 . . . . 0.0 112.378 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -79.59 -6.31 56.79 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.558 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -111.28 -27.9 8.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.611 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.403 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -87.49 -91.19 0.11 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.889 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.403 ' H ' ' HB3' ' A' ' 23' ' ' ASN . 74.9 m -176.06 21.73 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.261 0.351 . . . . 0.0 110.988 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.451 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 111.18 24.8 5.29 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.529 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.701 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 78.6 p -140.39 142.13 35.51 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.166 0.508 . . . . 0.0 110.218 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.794 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.6 mt -102.95 102.96 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.816 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.746 HG22 ' OG1' ' A' ' 62' ' ' THR . 79.7 p -103.6 165.04 11.28 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.197 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.563 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 52.9 t80 -34.36 -33.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.723 0.64 . . . . 0.0 111.864 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . 33.2 t70 -76.91 -47.58 20.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.955 0.407 . . . . 0.0 110.695 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 20' ' ' ASP . 25.1 mp0 -73.07 -25.09 60.78 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.235 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.827 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -48.73 -51.45 28.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.464 0.649 . . . . 0.0 109.792 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.662 ' HB2' ' HE2' ' A' ' 37' ' ' LYS . 6.9 ptpp? -82.45 -40.32 21.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.898 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.408 ' CB ' ' HA ' ' A' ' 31' ' ' GLU . 9.8 t70 -39.06 -62.11 0.68 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.088 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -50.76 -37.22 34.33 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.211 -0.518 . . . . 0.0 113.984 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.624 ' O ' HG12 ' A' ' 39' ' ' VAL . 49.5 mt -79.67 -58.42 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.34 0.57 . . . . 0.0 111.759 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.662 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -54.93 -17.65 3.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.247 0.546 . . . . 0.0 109.668 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.3 ttt85 -77.37 -42.83 35.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.545 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.624 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -70.89 -1.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.161 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.92 5.71 33.01 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.45 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 74.5 m -81.9 166.46 19.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.79 0.329 . . . . 0.0 111.151 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -138.9 104.68 5.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.816 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.4 mt -128.68 166.09 19.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.407 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.577 ' O ' HD13 ' A' ' 48' ' ' ILE . 23.1 mtp -107.34 161.68 14.59 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HG2' ' HE2' ' A' ' 33' ' ' LYS . 37.1 mt-10 -55.64 -60.28 3.66 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.503 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.464 ' HB2' ' HZ ' ' A' ' 111' ' ' PHE . 41.2 t -43.24 -29.07 0.36 Allowed 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.8 mm-40 -72.98 -42.36 63.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.265 0.555 . . . . 0.0 110.037 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.827 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -55.57 -56.82 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.756 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.597 ' HE2' ' CE1' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -47.53 -28.25 2.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.764 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HA ' ' NZ ' ' A' ' 49' ' ' LYS . 63.8 t0 -75.29 -54.93 6.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.601 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.504 HD23 HD11 ' A' ' 32' ' ' LEU . 36.4 tp -53.89 -37.66 63.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.236 0.541 . . . . 0.0 111.058 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.632 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 33.8 ttm -74.36 -66.35 0.74 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.331 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.671 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -54.48 -26.21 29.92 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.764 -178.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.68 -41.09 15.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -100.3 -43.39 6.29 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 59' ' ' LYS . 60.5 t0 -46.37 98.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 110.144 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.433 HD11 ' HB1' ' A' ' 70' ' ' ALA . 17.4 mm -54.14 -19.64 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.243 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.583 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 62.0 m-20 -131.35 44.47 2.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.872 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.671 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 21.8 tptm -32.27 92.04 0.01 OUTLIER 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 58' ' ' ASP . 49.0 m -127.71 18.44 6.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.404 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.632 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 70.08 23.46 77.14 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.47 -178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 28' ' ' THR . 42.5 m -159.72 129.97 5.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.797 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.794 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 75.8 mt -108.19 130.13 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.962 0.411 . . . . 0.0 111.511 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -104.87 167.61 9.6 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.085 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.642 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 28.9 t80 -35.22 -47.3 0.39 Allowed 'General case' 0 CA--C 1.52 -0.182 0 O-C-N 123.446 0.466 . . . . 0.0 111.731 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.98 -56.66 10.2 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.361 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.659 ' HB2' HG23 ' A' ' 63' ' ' ILE . 71.4 mt-10 -54.75 -22.66 14.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 110.692 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 64.9 t80 -68.32 -64.31 0.89 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.623 0.725 . . . . 0.0 110.905 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.578 HD13 ' HD2' ' A' ' 68' ' ' PHE . 7.9 mm -52.39 -41.79 36.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.613 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -56.75 -32.98 66.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.143 0.497 . . . . 0.0 110.803 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.23 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.234 0.255 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 79.2 p -43.32 -45.28 5.91 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.975 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.405 ' C ' ' N ' ' A' ' 89' ' ' SER . . . -90.14 -38.57 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.712 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.719 ' HZ ' ' HA2' ' A' ' 97' ' ' GLY . 8.6 t80 -44.33 -24.15 0.15 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.269 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 87' ' ' ALA . 47.7 t -89.05 -45.38 9.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.898 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -81.69 -63.68 1.34 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.365 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.597 ' CE1' ' HE2' ' A' ' 49' ' ' LYS . 4.0 m-85 -56.44 -64.41 0.88 Allowed 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.733 ' HA ' HG12 ' A' ' 99' ' ' ILE . 61.8 t0 -76.78 67.4 2.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -55.85 -25.72 43.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.397 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -84.18 -20.69 31.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 39.22 67.3 0.61 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.1 p -122.87 -19.12 6.26 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.719 ' HA2' ' HZ ' ' A' ' 88' ' ' PHE . . . 123.37 -3.14 9.59 Favored Glycine 0 N--CA 1.434 -1.443 0 CA-C-N 113.435 -1.711 . . . . 0.0 112.379 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.641 ' HB3' ' OE1' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -136.05 151.92 50.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.363 0.601 . . . . 0.0 111.702 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.751 HG23 ' HB2' ' A' ' 103' ' ' GLU . 83.0 mt -130.95 102.78 6.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.054 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 101' ' ' LEU . 51.2 p -79.81 151.46 30.28 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.694 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -34.29 -34.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.022 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.97 -54.98 31.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.904 0.383 . . . . 0.0 110.527 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.751 ' HB2' HG23 ' A' ' 99' ' ' ILE . 51.3 mt-10 -65.75 -28.68 69.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.185 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.747 HG13 HG22 ' A' ' 99' ' ' ILE . 72.8 mt -72.42 -65.38 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 111.004 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.818 ' NE2' HD11 ' A' ' 122' ' ' ILE . 2.4 mm-40 -47.65 -45.2 27.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.139 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -64.13 -42.92 96.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.468 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.87 -4.54 32.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 105' ' ' GLN . 26.5 p -124.04 91.4 3.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.069 0.462 . . . . 0.0 111.385 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -88.44 -50.78 6.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.326 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.91 -17.75 62.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.517 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.577 ' HB2' ' HB2' ' A' ' 108' ' ' CYS . 3.7 m-85 -63.92 -11.32 27.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.627 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.41 34.79 24.89 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.3 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.731 ' CD2' HG21 ' A' ' 118' ' ' ILE . 0.5 OUTLIER -35.52 109.94 0.09 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.24 0.543 . . . . 0.0 111.508 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.733 ' O ' HG22 ' A' ' 118' ' ' ILE . 38.4 t70 -160.96 138.54 9.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.334 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -50.81 -9.49 0.05 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 73.4 mt -89.44 -59.55 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.644 0.259 . . . . 0.0 111.648 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -91.07 -59.41 2.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 111.622 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.8 HG23 ' NE2' ' A' ' 105' ' ' GLN . 3.6 tp -48.47 -28.25 2.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.64 -51.52 58.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.874 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 124' ' ' GLU . 7.7 t70 -56.45 -29.23 61.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' MET . . . . . 1.03 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 6.6 ttt -66.79 -39.64 87.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.661 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.818 HD11 ' NE2' ' A' ' 105' ' ' GLN . 33.1 mm -56.97 -43.06 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.681 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -83.78 -13.3 54.18 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.632 178.304 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 1.03 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 31.1 tt0 -87.65 -17.03 32.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.43 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.839 HG21 HD11 ' A' ' 133' ' ' ILE . 14.9 mm -115.96 -32.13 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.558 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 131' ' ' GLY . 2.7 t70 -75.5 92.11 2.85 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.665 HE22 ' HB3' ' A' ' 137' ' ' GLU . 0.3 OUTLIER -86.02 -8.71 57.75 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.909 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.413 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 20.1 m-20 -111.86 -33.71 6.22 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.444 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 13.2 p30 -179.32 -86.34 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 117.603 2.445 . . . . 0.0 117.603 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.749 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 22.0 m-20 -64.65 26.06 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -172.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.559 ' CA ' HG22 ' A' ' 122' ' ' ILE . . . 55.51 37.51 67.26 Favored Glycine 0 CA--C 1.505 -0.574 0 C-N-CA 117.917 -2.087 . . . . 0.0 109.192 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.749 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 3.7 pt20 -136.3 168.95 18.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.074 -1.063 . . . . 0.0 110.384 -177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.839 HD11 HG21 ' A' ' 125' ' ' ILE . 60.0 mt -123.45 129.49 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.614 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.824 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 30.3 t70 -101.81 158.55 16.03 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.027 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.67 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 4.9 t80 -45.39 -32.54 2.13 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.913 0.387 . . . . 0.0 110.721 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.59 -38.15 17.99 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.071 -1.061 . . . . 0.0 110.729 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.824 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 30.8 mt-10 -59.98 -57.79 11.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.803 -0.198 . . . . 0.0 110.8 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.575 ' HD1' HD13 ' A' ' 133' ' ' ILE . 2.6 t80 -58.89 -26.77 64.6 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.527 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.7 -36.68 37.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.002 0.429 . . . . 0.0 110.836 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -90.0 -14.22 34.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.033 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -57.34 -18.53 17.56 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.486 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 24.4 ptt? . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.083 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.798 HD12 HD23 ' A' ' 15' ' ' LEU . 53.9 tp . . . . . 0 N--CA 1.461 0.109 0 CA-C-O 120.469 0.176 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.625 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 24.0 pttm -66.36 -32.11 73.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 82.2 tt0 -78.18 -36.85 46.9 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.798 HD23 HD12 ' A' ' 12' ' ' LEU . 52.3 tp -53.87 -42.57 68.75 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.366 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.54 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 10.9 t80 -51.69 -45.06 63.34 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.443 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 65.3 pttt -85.06 -12.45 53.03 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.9 ttp -85.55 -13.76 47.95 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.614 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.791 HG23 ' HA3' ' A' ' 35' ' ' GLY . 22.4 mm -74.92 -52.44 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.726 ' HB2' ' HB3' ' A' ' 23' ' ' ASN . 4.4 p-10 -81.93 50.6 1.57 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.033 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.828 HG21 ' HD2' ' A' ' 38' ' ' ARG . 13.0 t -61.97 -6.82 3.12 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.877 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -133.94 -10.88 2.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.979 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.726 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 10.1 t-20 -87.49 -95.83 0.09 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.2 p -177.72 12.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 111.59 24.37 5.32 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.948 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.427 ' HB ' ' CG2' ' A' ' 62' ' ' THR . 40.6 p -147.62 144.23 28.26 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.992 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 6.9 mt -104.02 104.84 17.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 68.8 p -102.21 163.52 12.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.704 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.743 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 49.2 t80 -34.28 -37.32 0.05 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.86 -45.75 40.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.92 0.39 . . . . 0.0 111.167 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -78.56 -13.83 59.63 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.719 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.01 HD13 HG23 ' A' ' 48' ' ' ILE . 6.2 tt -53.05 -49.01 67.2 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.65 ' HD3' ' NZ ' ' A' ' 37' ' ' LYS . 4.0 ptpp? -84.75 -41.17 16.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.491 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.552 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 17.9 t70 -47.57 -30.29 3.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.048 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.791 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -65.03 -40.31 96.99 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.888 -0.673 . . . . 0.0 113.351 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 36' ' ' LEU . 1.3 mm? -91.99 -33.15 14.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.324 0.583 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.65 ' NZ ' ' HD3' ' A' ' 33' ' ' LYS . 76.5 mttt -60.94 -45.8 93.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.698 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.828 ' HD2' HG21 ' A' ' 21' ' ' THR . 46.9 ttt-85 -69.77 -40.74 75.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.62 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 36' ' ' LEU . 8.2 p -71.13 -14.25 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.48 54.86 0.3 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.121 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 70.1 m -146.0 166.98 24.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.605 0.24 . . . . 0.0 110.483 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 23.2 pt-20 -137.29 114.67 10.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 111.378 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.41 ' HB2' HD11 ' A' ' 48' ' ' ILE . 36.4 mt -125.13 165.58 17.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.272 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.614 ' O ' HD13 ' A' ' 48' ' ' ILE . 20.4 mtm -113.41 164.41 13.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -64.98 0.65 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.154 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 89.1 p -39.78 -26.81 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 93.9 mt-10 -79.22 -49.72 12.08 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.01 HG23 HD13 ' A' ' 32' ' ' LEU . 1.7 mp -52.99 -60.86 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.591 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.743 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 51.6 tttp -57.05 -22.79 41.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.889 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 36.8 t70 -76.62 -44.58 33.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 tt -63.44 -44.76 93.62 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 111.092 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.733 ' HB2' HD11 ' A' ' 32' ' ' LEU . 37.3 ttm -66.6 -64.09 0.93 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.249 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.665 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 9.6 t70 -55.88 -29.29 59.72 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.05 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -88.58 -36.64 16.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -103.23 -41.65 5.99 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.545 ' OD1' HG12 ' A' ' 63' ' ' ILE . 15.8 t70 -50.94 95.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.937 0.399 . . . . 0.0 110.188 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.415 ' H ' HG12 ' A' ' 57' ' ' ILE . 27.9 mm -51.49 -18.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.551 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.524 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.2 m-20 -131.05 43.91 3.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.174 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.665 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 28.1 tptp -32.53 89.65 0.0 OUTLIER 'General case' 0 C--O 1.231 0.117 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 58' ' ' ASP . 87.7 p -127.85 18.21 6.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.519 -1.218 . . . . 0.0 109.02 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.522 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 76.34 22.63 72.82 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.087 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 91.1 m -147.54 153.84 39.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.243 0.617 . . . . 0.0 109.597 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.992 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 71.7 mt -135.16 127.53 47.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.995 0.426 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -104.6 167.52 9.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.492 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.625 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 41.2 t80 -35.41 -44.71 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.558 0.536 . . . . 0.0 111.663 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.04 -60.63 5.48 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.197 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.567 ' HB2' HG23 ' A' ' 63' ' ' ILE . 40.9 mt-10 -53.88 -21.83 8.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.851 0.358 . . . . 0.0 110.945 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 26.2 t80 -67.77 -65.11 0.73 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.501 0.667 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 65' ' ' TYR . 10.5 mm -52.44 -43.09 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.583 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.63 -39.44 73.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.47 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.361 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 CA--C 1.53 0.187 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -38.43 -49.23 1.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.264 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -71.89 -50.17 31.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.499 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.779 ' HE1' ' HB2' ' A' ' 135' ' ' TYR . 11.5 t80 -36.23 -33.55 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.492 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 87' ' ' ALA . 29.5 t -89.67 -50.69 5.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.728 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.66 -64.21 1.24 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.165 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.602 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 5.0 m-85 -58.93 -59.9 4.71 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.756 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 1.2 m-20 -75.68 57.65 1.01 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -52.06 -41.15 62.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.701 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -67.87 -20.9 65.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 42.49 64.32 1.62 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.474 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 54.5 p -119.48 -35.32 3.59 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.39 4.1 0.81 Allowed Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.337 -1.756 . . . . 0.0 112.873 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.878 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.3 OUTLIER -152.67 165.64 34.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.494 0.664 . . . . 0.0 112.072 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.817 HG23 ' HB2' ' A' ' 103' ' ' GLU . 91.4 mt -132.35 104.08 7.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.14 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 102' ' ' ASP . 50.5 p -76.09 149.27 37.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.7 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -34.57 -33.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 100' ' ' THR . 1.5 m-20 -57.69 -52.34 65.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.85 0.357 . . . . 0.0 110.276 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.817 ' HB2' HG23 ' A' ' 99' ' ' ILE . 49.3 mt-10 -67.83 -28.39 67.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.543 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.67 HG22 ' OE1' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -70.2 -62.12 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.575 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.709 HE22 HG22 ' A' ' 118' ' ' ILE . 4.7 mm100 -53.66 -38.28 63.98 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.898 0.38 . . . . 0.0 110.49 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -61.81 -59.22 5.48 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.96 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.75 -10.77 13.95 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.198 0.523 . . . . 0.0 110.558 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 31.3 t -100.59 63.44 1.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.737 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.472 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 1.2 tmtp? -85.82 -61.08 1.84 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -57.89 -5.39 0.41 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.578 ' HB2' ' SG ' ' A' ' 108' ' ' CYS . 33.3 m-85 -90.75 7.68 38.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.53 37.05 94.07 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.633 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.989 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -33.67 125.94 0.41 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.317 0.58 . . . . 0.0 112.202 -178.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.681 ' N ' HD22 ' A' ' 113' ' ' LEU . 10.1 t70 -160.65 159.44 30.37 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.681 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 1.4 m-20 -71.74 -6.92 44.85 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.0 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.724 HG13 ' H ' ' A' ' 117' ' ' HIS . 14.0 pt -77.87 -64.6 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.724 ' H ' HG13 ' A' ' 116' ' ' ILE . 13.0 m-70 -92.01 -61.97 1.51 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.09 0.472 . . . . 0.0 111.417 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.989 HG13 ' HA ' ' A' ' 113' ' ' LEU . 13.2 mm -45.16 -36.17 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.11 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.2 -48.28 62.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.946 0.403 . . . . 0.0 110.025 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 124' ' ' GLU . 61.8 t0 -67.59 -27.66 67.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.564 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' MET . . . . . 1.091 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.0 ttt -62.87 -40.28 97.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.487 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.703 HG22 ' HA3' ' A' ' 131' ' ' GLY . 48.1 mt -53.52 -44.4 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 123' ' ' LYS . 24.3 mmtp -85.18 -13.46 49.96 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.17 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 1.091 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 24.3 tt0 -87.95 -13.52 41.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.497 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.843 ' O ' HD11 ' A' ' 133' ' ' ILE . 81.3 mt -117.31 -23.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.759 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.925 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 22.0 t70 -65.25 101.68 0.58 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.566 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.643 ' OE1' ' HA ' ' A' ' 137' ' ' GLU . 90.0 mt-30 -88.05 -18.44 28.92 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -119.39 -34.63 3.77 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.8 p30 178.92 -73.28 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.52 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 1.2 m-20 -64.2 20.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.925 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.31 38.18 67.69 Favored Glycine 0 CA--C 1.5 -0.88 0 C-N-CA 117.48 -2.295 . . . . 0.0 108.075 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.52 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 2.7 pt20 -131.68 167.12 20.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.628 -1.286 . . . . 0.0 109.055 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.843 HD11 ' O ' ' A' ' 125' ' ' ILE . 11.0 mm -134.18 124.99 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.326 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.878 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 2.4 p-10 -102.42 161.25 13.86 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.779 ' HB2' ' HE1' ' A' ' 88' ' ' PHE . 12.0 t80 -41.07 -32.63 0.26 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.812 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.88 -46.43 10.82 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.642 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.726 ' HB3' ' CD1' ' A' ' 133' ' ' ILE . 33.5 mt-10 -54.41 -59.85 4.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.367 -0.416 . . . . 0.0 111.347 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.505 ' N ' HG23 ' A' ' 133' ' ' ILE . 3.6 t80 -57.56 -29.9 64.8 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.92 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.51 -20.06 48.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.074 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.84 -49.01 6.87 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.085 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.633 ' SD ' HG23 ' A' ' 125' ' ' ILE . 28.0 ptm -55.41 -16.46 3.67 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.35 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 56.0 ttp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.631 179.889 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.679 HD12 HD23 ' A' ' 15' ' ' LEU . 50.0 tp . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 120.667 0.27 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 33.9 mtmm -56.94 -46.68 81.92 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.637 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -68.48 -34.52 76.07 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.628 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.679 HD23 HD12 ' A' ' 12' ' ' LEU . 45.2 tp -59.52 -28.7 67.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.169 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.437 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 13.1 t80 -67.47 -38.98 85.22 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.016 0.436 . . . . 0.0 110.971 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.637 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 61.7 pttt -86.63 -19.82 28.75 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.629 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -63.44 -27.2 69.13 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.491 176.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.717 HG21 HD13 ' A' ' 27' ' ' ILE . 18.7 mm -70.61 -59.65 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.212 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -78.59 89.79 4.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.3 178.077 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.5 t -88.27 -34.71 17.61 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.525 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -139.83 16.7 2.49 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.534 ' HB2' ' OE1' ' A' ' 31' ' ' GLU . 3.5 m120 -92.44 -88.65 0.2 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.947 0.794 . . . . 0.0 112.89 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -164.95 -1.55 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.468 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 110.75 20.53 7.22 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.412 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 75.4 p -128.09 166.43 18.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.881 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 6.1 mt -123.14 101.53 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.083 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.553 HG22 ' HB ' ' A' ' 62' ' ' THR . 67.5 p -103.56 164.98 11.31 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.704 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -33.72 -39.21 0.06 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.839 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.676 ' OD1' ' HG3' ' A' ' 31' ' ' GLU . 1.8 p30 -73.05 -43.69 61.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.64 0.257 . . . . 0.0 111.281 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.676 ' HG3' ' OD1' ' A' ' 30' ' ' ASP . 42.4 mt-10 -74.68 -24.07 58.73 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 110.265 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.751 ' HG ' HD23 ' A' ' 51' ' ' LEU . 6.3 tt -54.43 -54.24 43.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.87 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.718 ' HG3' ' H ' ' A' ' 34' ' ' ASP . 17.0 ptpt -75.97 -62.31 1.64 Allowed 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.466 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.718 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 35.9 t70 -37.59 -48.55 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.498 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . -48.85 -54.44 14.18 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.98 -0.555 . . . . 0.0 113.858 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.634 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -89.8 -45.94 8.93 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.216 0.531 . . . . 0.0 110.144 -179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -17.21 0.56 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.079 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 32.0 ttm-85 -59.66 -43.22 94.01 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.778 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 36' ' ' LEU . 34.3 m -78.53 31.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.98 -22.66 24.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.752 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.7 m -53.46 154.44 3.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.648 0.261 . . . . 0.0 110.648 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.09 118.18 9.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 111.432 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 mt -119.67 165.77 14.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.481 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.665 ' SD ' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -105.02 152.92 22.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.21 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -42.46 -56.05 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.665 ' HB2' ' SD ' ' A' ' 44' ' ' MET . 52.3 m -54.7 -21.66 11.46 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 119.236 0.925 . . . . 0.0 111.888 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.524 ' HG3' ' HE2' ' A' ' 44' ' ' MET . 38.2 mt-10 -74.57 -44.54 50.42 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.704 HG23 HD13 ' A' ' 32' ' ' LEU . 2.0 mp -58.17 -53.31 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.119 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.61 ' HE2' ' HE1' ' A' ' 91' ' ' PHE . 10.5 ttpp -52.92 -30.27 33.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.459 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.556 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 8.8 t70 -62.96 -50.09 72.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.379 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.751 HD23 ' HG ' ' A' ' 32' ' ' LEU . 41.1 tp -60.63 -14.88 23.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.694 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.939 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 13.4 mmt -88.13 -65.84 0.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -78.94 -32.95 45.72 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.939 -0.475 . . . . 0.0 111.726 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -87.46 -18.32 30.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.662 ' HB3' HD12 ' A' ' 51' ' ' LEU . . . -127.09 -43.57 1.65 Allowed 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.647 ' OD1' HG12 ' A' ' 63' ' ' ILE . 21.2 t70 -59.91 96.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.784 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 57' ' ' ILE . 26.5 mm -46.26 -25.63 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.866 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.527 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.7 m-20 -129.63 44.09 3.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.27 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.939 ' HD3' ' HB3' ' A' ' 52' ' ' MET . 51.4 tptt -33.27 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.046 0.927 . . . . 0.0 113.347 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.7 p -127.29 9.56 6.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.77 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 97.85 -5.7 61.94 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.517 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.844 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 3.0 t -141.11 165.01 28.72 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.062 0.458 . . . . 0.0 110.681 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.881 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 98.4 mt -125.81 135.38 64.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.33 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.89 166.21 10.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.649 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.653 ' O ' HG12 ' A' ' 69' ' ' ILE . 51.3 t80 -36.31 -46.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.733 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.55 -63.84 4.0 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.441 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.731 ' HB2' HG23 ' A' ' 63' ' ' ILE . 40.9 mt-10 -49.86 -29.2 7.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.739 0.304 . . . . 0.0 111.473 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.522 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 34.1 t80 -65.83 -62.63 1.4 Allowed 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.364 0.602 . . . . 0.0 111.16 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.653 HG12 ' O ' ' A' ' 65' ' ' TYR . 19.8 mm -53.32 -48.38 56.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.692 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.45 -41.16 84.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.922 0.392 . . . . 0.0 110.905 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.26 -179.915 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 88' ' ' PHE . 7.3 p . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.598 0.237 . . . . 0.0 111.456 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.645 ' HB3' ' HE3' ' A' ' 44' ' ' MET . 48.3 t -41.75 -62.66 0.85 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.271 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 138' ' ' PHE . . . -73.41 -36.08 65.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.463 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.799 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 2.8 t80 -45.72 -25.74 0.53 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.413 0.625 . . . . 0.0 109.65 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.7 t -89.62 -43.56 10.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.863 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -87.07 -64.45 1.15 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.82 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.61 ' HE1' ' HE2' ' A' ' 49' ' ' LYS . 2.8 m-85 -56.26 -59.99 4.15 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.799 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 1.6 m-20 -78.73 55.66 1.73 Allowed 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -51.16 -41.66 60.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.697 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.56 -20.61 65.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 43.74 65.06 1.67 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.276 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.9 p -119.08 -33.79 4.06 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 147.8 -37.08 1.12 Allowed Glycine 0 N--CA 1.433 -1.53 0 CA-C-N 112.786 -2.006 . . . . 0.0 112.196 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.893 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.2 OUTLIER -109.45 164.88 12.1 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.843 HG22 HG13 ' A' ' 104' ' ' ILE . 77.8 mt -132.6 103.54 6.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.231 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 102' ' ' ASP . 44.4 p -72.2 146.09 47.57 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -34.64 -32.95 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 100' ' ' THR . 45.4 t0 -55.47 -56.38 20.89 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.697 ' HB2' HG23 ' A' ' 99' ' ' ILE . 51.8 mt-10 -66.03 -28.34 68.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.825 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.843 HG13 HG22 ' A' ' 99' ' ' ILE . 78.9 mt -69.57 -65.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.031 0.443 . . . . 0.0 111.247 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.732 ' OE1' HG22 ' A' ' 118' ' ' ILE . 3.1 mm-40 -50.09 -51.87 39.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.596 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.482 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 70.1 mt-30 -64.49 -24.68 67.69 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.48 -6.86 58.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 72.2 m -123.78 68.57 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.867 0.365 . . . . 0.0 111.391 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 106' ' ' GLN . 74.6 mmtt -84.03 -32.09 25.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.584 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -83.21 -4.86 58.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.596 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 0.9 OUTLIER -93.46 16.33 13.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.359 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.05 36.82 45.14 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.602 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.883 ' HA ' HG13 ' A' ' 118' ' ' ILE . 3.1 tm? -34.36 110.0 0.09 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.969 0.414 . . . . 0.0 111.323 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.446 ' OD2' ' HB ' ' A' ' 116' ' ' ILE . 12.1 p-10 -160.12 -176.07 5.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.734 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.589 ' HA ' ' CG ' ' A' ' 119' ' ' ASP . 2.8 p30 -89.48 -8.94 51.82 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.446 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 60.5 mt -81.8 -64.6 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.914 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -91.61 -68.9 0.77 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.883 HG13 ' HA ' ' A' ' 113' ' ' LEU . 31.4 mm -40.52 -36.56 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.589 ' CG ' ' HA ' ' A' ' 115' ' ' ASP . 42.2 m-20 -71.2 -52.4 19.3 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 122.139 -0.351 . . . . 0.0 110.86 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 124' ' ' GLU . 32.4 m-20 -57.59 -23.62 51.78 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.992 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.5 ttt -65.39 -36.27 83.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.746 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.528 HG22 ' HA3' ' A' ' 131' ' ' GLY . 52.8 mt -57.06 -45.89 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.824 ' HA ' ' HE2' ' A' ' 123' ' ' LYS . 10.6 mmpt? -83.57 -13.19 54.99 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.57 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.992 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 29.8 tt0 -87.97 -19.21 27.53 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.458 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.907 HG21 HD11 ' A' ' 133' ' ' ILE . 63.9 mt -107.59 -50.52 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.89 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.562 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 5.4 p-10 -46.76 100.1 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.858 0.837 . . . . 0.0 110.697 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.688 HE22 ' HB3' ' A' ' 137' ' ' GLU . 0.8 OUTLIER -87.3 -9.9 53.72 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.996 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 53.7 p30 -117.05 -33.19 4.8 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 21.4 p-10 -179.43 -81.4 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 59.0 m-20 -64.51 22.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 -172.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' A' ' 126' ' ' ASP . . . 56.37 38.29 78.33 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 117.219 -2.419 . . . . 0.0 109.414 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.563 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 4.5 pt20 -132.0 167.29 19.92 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.362 -0.919 . . . . 0.0 111.722 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.907 HD11 HG21 ' A' ' 125' ' ' ILE . 15.3 mt -125.67 116.15 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.549 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.893 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 38.6 t70 -104.8 161.78 13.87 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.574 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.631 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 37.0 t80 -40.28 -32.81 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -82.22 -41.41 9.35 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.688 ' HB3' HE22 ' A' ' 127' ' ' GLN . 26.3 mt-10 -62.39 -53.28 57.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 29.0 t80 -52.3 -31.69 34.14 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.284 0.564 . . . . 0.0 109.649 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -68.27 -23.91 64.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.975 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.94 -52.93 4.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.29 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 138' ' ' PHE . 5.2 ppp? -51.35 -22.57 2.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.447 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 36.9 ttm . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.761 178.579 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.538 0.209 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.637 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 6.4 ttpm? -55.74 -30.92 62.03 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.752 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 8.1 mp0 -77.0 -38.26 53.43 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.968 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.748 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 54.5 tp -55.04 -28.12 49.78 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.664 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -70.54 -45.11 66.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.787 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.752 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 63.5 pttt -82.46 -12.46 57.82 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.58 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.45 -25.86 68.21 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.429 178.711 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.555 HG23 ' HA3' ' A' ' 35' ' ' GLY . 3.3 mt -86.4 -59.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.53 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.607 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -82.68 57.37 3.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.391 0.615 . . . . 0.0 110.523 179.349 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.67 HG21 ' NH2' ' A' ' 38' ' ' ARG . 13.6 t -81.26 -6.66 59.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.17 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -129.21 -14.65 4.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.58 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -74.38 -87.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.832 0.348 . . . . 0.0 111.197 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 p -176.67 6.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.811 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.542 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.44 31.47 2.79 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.607 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 45.8 p -150.07 145.79 26.58 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.192 -0.504 . . . . 0.0 109.938 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.811 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.2 mt -102.85 103.87 15.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.632 HG22 ' OG1' ' A' ' 62' ' ' THR . 67.3 p -103.37 164.83 11.4 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.445 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.561 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 20.4 t80 -34.06 -36.44 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.72 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.15 -49.88 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.715 0.293 . . . . 0.0 111.676 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.637 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -75.7 -19.9 58.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.939 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.871 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -46.03 -47.4 16.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.893 0.854 . . . . 0.0 108.707 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.719 ' HG2' HG12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -85.38 -51.9 6.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.488 179.215 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.637 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 59.4 m-20 -36.34 -36.17 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.555 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -68.02 -57.32 8.79 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 115.124 0.81 . . . . 0.0 115.124 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -73.86 -28.53 61.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.195 0.997 . . . . 0.0 111.983 -177.604 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.657 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 19.3 ptpt -66.18 -4.67 8.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.67 ' NH2' HG21 ' A' ' 21' ' ' THR . 36.9 ttm180 -87.12 -42.72 12.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.278 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 36' ' ' LEU . 30.8 m -73.45 -0.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.75 -36.86 3.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.361 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.606 ' CB ' HD23 ' A' ' 36' ' ' LEU . 18.5 m -52.45 153.01 3.19 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.565 -0.161 . . . . 0.0 110.565 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -143.31 103.76 4.17 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.285 0.564 . . . . 0.0 112.153 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -105.36 167.97 9.38 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.125 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 5.3 mtm -104.62 165.54 11.0 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.53 ' HA ' HD13 ' A' ' 48' ' ' ILE . 92.8 mt-10 -47.68 -60.04 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.51 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 94.9 p -39.42 -35.0 0.24 Allowed 'General case' 0 C--N 1.335 -0.047 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 44' ' ' MET . 37.1 mp0 -66.42 -41.02 89.87 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.055 0.455 . . . . 0.0 110.15 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.871 HG13 HD12 ' A' ' 32' ' ' LEU . 2.0 mp -57.02 -60.58 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.958 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.561 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 42.3 tttm -64.34 -25.66 68.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.353 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 46' ' ' SER . 62.6 t0 -71.12 -37.46 72.32 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.654 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.53 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 10.2 tt -76.34 -23.04 54.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.049 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.751 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 18.1 mmt -71.92 -45.01 62.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.058 0.456 . . . . 0.0 111.468 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.51 -30.27 20.72 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.716 -0.394 . . . . 0.0 112.01 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.53 -19.36 22.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.04 -43.75 1.65 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.751 ' HB3' ' O ' ' A' ' 52' ' ' MET . 15.6 t0 -61.24 95.96 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.2 mm -48.62 -22.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.044 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 59.1 t0 -129.13 44.49 2.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.864 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.734 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.5 tmtm? -32.58 90.43 0.0 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.741 0.781 . . . . 0.0 112.659 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.3 p -127.72 17.98 6.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.184 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 70.92 17.76 75.66 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.428 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 85.9 m -150.35 127.1 10.97 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 123.779 0.341 . . . . 0.0 110.58 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.811 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 70.3 mt -108.02 129.43 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 121.058 0.456 . . . . 0.0 111.399 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -105.04 167.3 9.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.076 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.637 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 48.1 t80 -35.47 -45.81 0.36 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.486 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.4 -63.71 4.11 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.322 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.797 ' HB2' HG23 ' A' ' 63' ' ' ILE . 63.0 mt-10 -51.89 -26.15 9.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.684 0.278 . . . . 0.0 110.894 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.748 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 71.7 t80 -63.88 -65.12 0.72 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.431 0.634 . . . . 0.0 110.91 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.602 HD13 ' HD2' ' A' ' 68' ' ' PHE . 14.5 mm -52.2 -41.13 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.659 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.2 -25.77 66.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.47 . . . . 0.0 110.572 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.028 179.768 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 14.4 p . . . . . 0 C--O 1.233 0.187 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 52.3 m -51.11 -55.01 19.88 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.921 0.391 . . . . 0.0 110.118 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.583 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -81.12 -39.81 25.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.913 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.823 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 8.1 t80 -45.98 -23.01 0.25 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.358 0.599 . . . . 0.0 110.041 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 87' ' ' ALA . 28.4 t -89.15 -44.81 10.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.737 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -89.29 -63.7 1.25 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.601 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.5 m-85 -51.97 -62.33 1.7 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.823 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.6 OUTLIER -76.13 55.31 0.93 Allowed 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.093 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -44.59 -52.88 7.69 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.42 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.4 -21.44 64.69 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.344 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.08 68.69 1.07 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.5 p -115.59 -23.04 8.93 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.599 ' O ' ' HB2' ' A' ' 134' ' ' ASP . . . 130.51 -4.51 5.86 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-N 113.136 -1.847 . . . . 0.0 112.604 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.859 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.5 OUTLIER -148.69 161.83 40.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.399 0.618 . . . . 0.0 112.649 179.437 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.791 HG12 ' HA ' ' A' ' 92' ' ' ASP . 22.1 mt -133.12 104.24 6.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.779 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 102' ' ' ASP . 69.5 p -72.29 147.11 46.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.671 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.1 pp -34.41 -33.97 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.528 ' N ' HD12 ' A' ' 101' ' ' LEU . 54.2 m-20 -54.31 -55.92 23.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.548 ' HB2' HG23 ' A' ' 99' ' ' ILE . 97.4 mt-10 -71.19 -31.38 67.57 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.209 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.698 HG13 HG22 ' A' ' 99' ' ' ILE . 50.9 mt -65.74 -65.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.187 0.518 . . . . 0.0 110.403 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.892 ' HB3' HD12 ' A' ' 113' ' ' LEU . 30.8 mt-30 -58.14 -39.03 77.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.608 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.87 -44.07 94.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.095 0.474 . . . . 0.0 110.644 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.71 -3.06 1.33 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.17 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.762 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 73.2 m -115.09 44.12 1.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.93 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -59.54 -36.71 76.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.811 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -75.02 -22.11 58.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.155 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.762 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 2.7 m-85 -76.76 -5.24 47.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.944 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.37 38.81 96.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.572 -1.299 . . . . 0.0 111.026 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.928 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -33.01 132.72 0.14 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.525 0.679 . . . . 0.0 111.486 -177.154 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.716 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 91.9 m-20 -135.98 167.68 20.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.259 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.638 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.8 m-20 -82.95 -7.93 59.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.167 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.63 -64.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.039 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -89.46 -69.29 0.72 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.928 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.4 mm -52.72 -19.49 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.958 0.409 . . . . 0.0 111.268 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.638 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 33.6 t70 -71.11 -46.96 60.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 124' ' ' GLU . 63.9 t0 -62.37 -26.26 68.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' MET . . . . . 1.086 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.4 ttt -60.74 -29.82 69.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.501 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.769 HG22 ' HA3' ' A' ' 131' ' ' GLY . 56.8 mt -58.37 -43.59 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.475 ' CE ' ' HB ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -86.67 -13.79 44.47 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.584 -1.644 . . . . 0.0 110.374 178.517 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 1.086 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 71.4 tt0 -84.61 -23.71 29.45 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.79 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.854 HG22 HD11 ' A' ' 133' ' ' ILE . 13.4 mm -107.58 -21.77 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.978 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.3 t70 -62.89 98.43 0.13 Allowed 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.593 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.61 ' OE1' ' HG2' ' A' ' 137' ' ' GLU . 5.5 tm0? -87.24 -13.95 42.39 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 50.5 p30 -127.57 -33.19 2.33 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 20.8 p-10 179.92 -71.71 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.413 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 56.3 m-20 -64.93 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.978 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.53 37.92 77.91 Favored Glycine 0 CA--C 1.505 -0.577 0 C-N-CA 118.358 -1.877 . . . . 0.0 110.044 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.556 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 2.7 pt20 -133.31 170.54 15.3 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 113.929 -1.135 . . . . 0.0 110.073 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.006 HD13 ' HB3' ' A' ' 137' ' ' GLU . 5.0 mm -133.05 121.89 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.856 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.924 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 4.3 p-10 -113.08 162.48 15.88 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.172 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.798 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 22.4 t80 -38.79 -30.45 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.0 0.428 . . . . 0.0 110.738 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.548 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -84.25 -45.15 6.32 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.726 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 1.006 ' HB3' HD13 ' A' ' 133' ' ' ILE . 39.3 mt-10 -63.07 -51.3 67.2 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.588 ' HB2' ' CG2' ' A' ' 133' ' ' ILE . 13.5 t80 -56.61 -18.66 12.77 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -86.1 -40.82 15.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.593 ' HB3' ' HG3' ' A' ' 127' ' ' GLN . . . -87.29 -11.59 49.1 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.549 ' HG2' ' HA ' ' A' ' 138' ' ' PHE . 5.5 ppp? -72.46 -6.67 45.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.635 0.255 . . . . 0.0 111.543 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.009 179.886 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.401 0.143 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.669 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 39.9 ttmt -55.89 -33.1 64.3 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -81.65 -37.93 26.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.761 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 51.8 tp -59.53 -25.96 64.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.143 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -70.89 -40.06 72.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.425 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -86.36 -11.97 50.59 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.662 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -59.46 -34.48 72.59 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.509 HD12 HD13 ' A' ' 27' ' ' ILE . 3.0 mt -81.18 -62.09 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.884 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -83.85 66.93 9.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.313 1.054 . . . . 0.0 109.529 178.356 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -89.34 -20.99 23.34 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.094 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -138.73 8.92 2.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.622 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 14.1 t-20 -82.94 -82.61 0.14 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.593 1.088 . . . . 0.0 110.981 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.0 p -176.13 15.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.05 18.51 9.23 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.628 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.64 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 39.9 p -148.84 161.2 42.3 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.403 0.62 . . . . 0.0 111.749 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.729 ' O ' ' HA ' ' A' ' 62' ' ' THR . 4.7 mt -111.01 103.82 16.09 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.502 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.63 HG22 ' OG1' ' A' ' 62' ' ' THR . 65.4 p -112.7 158.22 20.32 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.644 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.816 ' HE2' ' HB2' ' A' ' 49' ' ' LYS . 14.7 t80 -34.45 -20.01 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.616 ' N ' ' O ' ' A' ' 28' ' ' THR . 32.7 t70 -86.18 -39.06 17.04 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.08 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.622 ' OE2' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -90.87 -32.08 16.18 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.729 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -40.45 -51.45 2.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.401 0.62 . . . . 0.0 110.318 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.721 ' HB3' HG12 ' A' ' 48' ' ' ILE . 12.4 ptpt -71.47 -39.4 70.94 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.267 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 38' ' ' ARG . 8.2 t70 -43.98 -47.81 8.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.217 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.493 ' HA3' HG12 ' A' ' 19' ' ' ILE . . . -45.21 -47.22 10.68 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 114.695 0.638 . . . . 0.0 114.695 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.752 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.7 mm? -95.2 -44.13 7.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.592 0.696 . . . . 0.0 112.214 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.699 ' NZ ' ' HD3' ' A' ' 33' ' ' LYS . 15.3 ptpt -56.32 -18.67 11.46 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HG3' HH11 ' A' ' 38' ' ' ARG . 22.2 ttm-85 -90.83 -25.02 20.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.22 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 36' ' ' LEU . 6.3 p -80.56 -37.48 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.63 -42.65 0.59 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.447 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.6 m -62.75 177.21 0.57 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.795 0.331 . . . . 0.0 110.963 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.34 112.03 7.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 mt -108.02 165.48 11.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.503 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.464 ' O ' HD13 ' A' ' 48' ' ' ILE . 26.8 ptt? -112.22 162.08 15.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.69 -14.29 19.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.7 t -87.64 -17.11 32.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.199 0.523 . . . . 0.0 109.938 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 97.0 mt-10 -90.73 -46.24 8.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.783 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.729 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -50.77 -50.65 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 122.275 1.036 . . . . 0.0 109.086 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.816 ' HB2' ' HE2' ' A' ' 29' ' ' PHE . 52.3 tttp -64.11 -30.3 71.38 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.383 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 64.1 t0 -64.26 -48.71 74.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.721 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 26.9 mt -60.43 -15.75 29.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.525 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.759 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 30.5 mtt -88.02 -65.24 1.04 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.453 ' CA ' ' HG3' ' A' ' 59' ' ' LYS . 2.5 p30 -66.73 -25.6 66.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.654 0.264 . . . . 0.0 111.595 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -91.33 -28.39 17.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -125.41 -43.93 1.88 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.636 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 64.2 t0 -51.18 101.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.032 0.444 . . . . 0.0 110.243 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.9 mm -44.87 -26.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.674 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.61 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 38.7 t70 -133.26 44.72 2.79 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.364 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.759 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 10.2 tmtt? -32.07 92.03 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.941 0.877 . . . . 0.0 112.642 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.1 p -126.71 19.06 7.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.833 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 71.85 16.23 76.29 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.21 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.729 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 58.5 m -147.64 128.14 14.08 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.405 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.725 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 71.5 mt -113.23 130.33 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.157 0.503 . . . . 0.0 110.871 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.43 167.73 9.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.058 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.669 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 66.3 t80 -42.67 -25.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.019 0.437 . . . . 0.0 110.799 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.71 -59.48 2.34 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.753 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.691 ' HB2' HG23 ' A' ' 63' ' ' ILE . 37.8 mt-10 -56.04 -23.26 32.19 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.646 0.26 . . . . 0.0 110.828 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.761 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 60.4 t80 -68.54 -65.54 0.69 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.566 0.698 . . . . 0.0 110.416 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 65' ' ' TYR . 44.2 mm -47.1 -58.47 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.106 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -44.65 -53.18 7.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.493 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.481 0.181 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 89' ' ' SER . 81.0 p -46.09 -56.72 5.23 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.923 0.392 . . . . 0.0 110.187 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.432 ' C ' ' N ' ' A' ' 89' ' ' SER . . . -68.58 -45.39 72.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.812 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 18.9 t80 -47.51 -19.26 0.17 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.584 0.707 . . . . 0.0 109.979 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 30.7 m -89.81 -59.61 2.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.695 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.439 ' CG ' ' HB2' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -74.25 -62.97 1.33 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -51.73 -60.55 3.04 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.812 ' HB3' ' O ' ' A' ' 88' ' ' PHE . 62.6 t0 -82.91 69.54 9.74 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 89' ' ' SER . 31.3 ttmt -53.25 -16.05 1.14 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.668 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -97.49 -24.4 15.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.579 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.93 -12.47 0.81 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.804 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.9 p -51.83 -22.84 4.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.204 0.502 . . . . 0.0 110.606 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.589 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 126.01 -3.84 7.9 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.038 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -125.8 144.68 50.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.038 0.447 . . . . 0.0 111.849 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.778 HG12 ' HA ' ' A' ' 92' ' ' ASP . 31.2 mt -131.58 102.59 6.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.61 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 103' ' ' GLU . 70.6 p -81.52 156.94 25.01 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.215 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.524 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.0 pp -35.01 -39.86 0.11 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.69 0.281 . . . . 0.0 111.259 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.497 ' N ' HD12 ' A' ' 101' ' ' LEU . 8.3 t70 -57.86 -57.78 11.29 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.469 ' CB ' HG23 ' A' ' 99' ' ' ILE . 51.0 mt-10 -58.89 -48.22 82.19 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.57 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.832 HG21 HD12 ' A' ' 125' ' ' ILE . 91.1 mt -55.73 -65.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.151 0.5 . . . . 0.0 110.653 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.589 ' OE1' HG22 ' A' ' 118' ' ' ILE . 24.8 mt-30 -56.83 -65.14 0.67 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.11 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -42.38 -32.96 0.58 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.51 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 104' ' ' ILE . . . -53.28 -65.57 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 111' ' ' PHE . 51.6 t -62.01 135.0 57.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.881 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -89.12 -47.87 7.79 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -78.9 -3.32 44.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.628 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.711 ' CE2' ' HB2' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -47.19 -27.21 1.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.738 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.412 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 60.44 37.61 93.49 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.371 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.711 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 6.4 tt -31.8 126.92 0.23 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.327 0.584 . . . . 0.0 112.306 -176.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.668 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 29.6 t70 -160.2 177.09 11.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.955 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.723 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 2.9 p30 -89.2 -8.19 54.07 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.704 HG23 ' H ' ' A' ' 117' ' ' HIS . 7.1 tp -88.51 -64.69 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.704 ' H ' HG23 ' A' ' 116' ' ' ILE . 16.6 t-160 -92.7 -67.11 0.88 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.031 0.443 . . . . 0.0 111.975 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.845 HD12 ' H ' ' A' ' 118' ' ' ILE . 4.4 mp -50.23 -20.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.694 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.723 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 7.7 t70 -76.12 -52.34 10.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' GLU . 37.1 t70 -58.92 -19.64 44.5 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.87 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.5 ttt -68.79 -45.39 71.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.259 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.628 HG22 ' HA3' ' A' ' 131' ' ' GLY . 54.1 mt -51.44 -40.85 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.635 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.6 -13.84 44.53 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.512 -1.677 . . . . 0.0 110.267 178.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.87 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 41.8 tp10 -83.98 -21.42 31.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.493 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.832 HD12 HG21 ' A' ' 104' ' ' ILE . 1.1 mt -105.71 -33.75 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 1.031 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.8 t70 -54.75 95.64 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.793 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 125' ' ' ILE . 15.4 mt-30 -87.67 -9.8 53.13 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.188 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 7.1 t70 -126.79 -32.73 2.56 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -177.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 18.5 p-10 178.33 -68.79 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.67 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 7.3 t70 -63.82 -24.18 67.65 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -172.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 1.031 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 94.95 36.83 5.38 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 107.169 -2.372 . . . . 0.0 107.169 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.67 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 5.3 pt20 -138.21 168.01 20.64 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 112.846 -1.677 . . . . 0.0 108.922 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.769 HD11 ' O ' ' A' ' 125' ' ' ILE . 21.5 mm -130.86 131.12 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-O 121.797 0.808 . . . . 0.0 110.978 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.878 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 10.7 t70 -103.03 163.06 12.44 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.69 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.779 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 21.8 t80 -43.76 -37.18 2.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.287 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.2 -36.06 18.94 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.834 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.878 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 46.4 mt-10 -61.13 -57.62 11.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.657 ' HD1' HG21 ' A' ' 133' ' ' ILE . 3.4 t80 -55.49 -39.15 70.07 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.916 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.68 -25.11 67.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.785 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.35 -44.68 10.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -31.17 69.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.565 0.221 . . . . 0.0 111.419 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.1 ttp . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.04 0.448 . . . . 0.0 110.177 179.381 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.1 tp . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.602 0.239 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.482 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -75.69 -46.61 30.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.438 ' HG3' ' HE3' ' A' ' 17' ' ' LYS . 85.1 tt0 -69.37 -17.91 63.73 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.681 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.818 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 2.3 tm? -83.6 -39.07 20.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.406 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.55 ' HE1' HG13 ' A' ' 27' ' ' ILE . 2.3 t80 -57.79 -42.67 84.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.1 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.438 ' HE3' ' HG3' ' A' ' 14' ' ' GLU . 19.5 pttp -80.48 -17.72 50.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.61 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.818 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.39 -32.87 74.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.653 HG23 ' HA3' ' A' ' 35' ' ' GLY . 1.1 mm -71.5 -62.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.289 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.446 ' HB3' HG12 ' A' ' 27' ' ' ILE . 2.5 p30 -89.08 47.23 1.47 Allowed 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.84 0.829 . . . . 0.0 111.255 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 t -71.35 -18.4 62.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.924 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -108.33 -11.48 15.19 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.443 ' HB2' ' CD ' ' A' ' 31' ' ' GLU . 27.1 t-20 -83.06 -88.73 0.09 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 111.426 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.4 p -176.45 12.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.119 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.39 17.88 9.01 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.101 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -135.58 143.59 45.73 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.002 0.43 . . . . 0.0 109.86 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.8 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 8.4 mt -103.73 104.03 16.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.599 HG22 ' OG1' ' A' ' 62' ' ' THR . 76.6 p -102.55 159.79 15.13 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.457 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 25.7 t80 -34.37 -34.13 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 O-C-N 123.79 0.681 . . . . 0.0 111.906 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 28' ' ' THR . 35.8 m-20 -73.45 -50.29 22.42 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.338 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 28.2 mp0 -78.06 -14.73 59.39 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.714 0.293 . . . . 0.0 111.033 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.86 HD12 HG13 ' A' ' 48' ' ' ILE . 1.6 tm? -55.43 -48.78 73.9 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.849 0.833 . . . . 0.0 108.928 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.903 ' HB2' ' HE3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -82.89 -49.19 9.92 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.313 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.591 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 36.3 m-20 -39.51 -45.33 1.55 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.653 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -52.37 -50.56 46.79 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.059 -0.591 . . . . 0.0 114.234 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.724 HD12 HD23 ' A' ' 43' ' ' LEU . 85.3 mt -75.53 -52.05 11.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.246 0.523 . . . . 0.0 111.685 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.903 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 18.2 ptpt -55.97 -16.03 4.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.985 0.421 . . . . 0.0 110.211 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.438 ' C ' ' HD3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -87.1 -39.58 15.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.995 178.421 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.6 p -70.91 -10.73 14.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.285 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.09 -5.22 22.05 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.502 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 61.5 m -78.93 157.86 28.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.664 0.268 . . . . 0.0 111.401 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 14.2 pt-20 -123.54 104.22 8.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.516 0.674 . . . . 0.0 110.936 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.854 HD13 HD11 ' A' ' 48' ' ' ILE . 1.7 pp -117.96 166.09 12.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.736 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.443 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 25.9 ptm -118.06 156.04 29.31 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.54 ' HA ' HD13 ' A' ' 48' ' ' ILE . 32.6 tt0 -44.65 -58.22 3.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.6 m -49.39 -25.79 2.76 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 97.8 mt-10 -73.52 -31.84 63.9 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.125 0.488 . . . . 0.0 109.838 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.86 HG13 HD12 ' A' ' 32' ' ' LEU . 1.9 mp -59.78 -64.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.752 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.495 ' HD2' ' CD ' ' A' ' 93' ' ' LYS . 4.5 ttmp? -55.35 -34.07 63.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.267 0.555 . . . . 0.0 109.747 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 36.4 t70 -52.86 -61.0 2.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.474 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.814 HD11 HD11 ' A' ' 32' ' ' LEU . 4.1 pp -65.71 -14.88 62.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.794 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 27.3 mtt -80.76 -65.83 0.96 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.171 0.51 . . . . 0.0 110.987 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.516 ' OD2' ' HB2' ' A' ' 90' ' ' TYR . 41.2 t0 -61.71 -21.94 64.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.867 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.53 -40.46 11.35 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -112.33 -44.27 3.41 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 52' ' ' MET . 66.6 t0 -51.67 98.26 0.02 OUTLIER 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.2 mt -38.34 -35.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.802 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 60' ' ' SER . 2.8 p30 -133.65 45.37 2.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.013 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.794 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.6 tmtm? -31.74 90.83 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.914 0.864 . . . . 0.0 112.174 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 58' ' ' ASP . 73.4 p -123.98 16.74 9.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.874 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 83.71 14.22 73.6 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.394 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 57.9 m -153.03 127.2 9.11 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.881 HG23 ' HB2' ' A' ' 67' ' ' GLU . 68.9 mt -112.28 133.46 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.205 0.526 . . . . 0.0 111.798 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.72 167.32 9.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.679 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.529 ' O ' HG13 ' A' ' 69' ' ' ILE . 25.2 t80 -36.54 -48.33 0.68 Allowed 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.49 -59.86 7.76 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.358 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.881 ' HB2' HG23 ' A' ' 63' ' ' ILE . 34.7 mt-10 -51.43 -30.07 18.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.854 0.359 . . . . 0.0 110.567 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.534 ' CD2' ' HB2' ' A' ' 16' ' ' PHE . 30.6 t80 -61.87 -46.9 87.41 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.271 0.558 . . . . 0.0 110.945 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 65' ' ' TYR . 10.7 mt -59.96 -19.45 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.616 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 67' ' ' GLU . . . -67.65 -20.51 65.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.251 0.548 . . . . 0.0 109.617 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.226 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.057 178.369 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.235 0.3 0 CA-C-O 120.476 0.179 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 72.5 m -54.41 -23.87 17.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.238 0.542 . . . . 0.0 109.666 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -84.7 -51.08 7.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.488 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.835 ' HE1' ' HB2' ' A' ' 135' ' ' TYR . 7.9 t80 -39.14 -36.42 0.31 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.116 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.4 t -89.24 -55.49 3.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.228 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.516 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 7.8 t80 -75.77 -63.89 1.2 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.561 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.751 ' HB3' HD13 ' A' ' 99' ' ' ILE . 3.1 m-85 -58.14 -65.21 0.68 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.782 ' HA ' HG12 ' A' ' 99' ' ' ILE . 12.4 t0 -74.54 60.04 0.86 Allowed 'General case' 0 C--N 1.335 -0.056 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.495 ' CD ' ' HD2' ' A' ' 49' ' ' LYS . 3.0 tppp? -49.2 -40.72 34.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.507 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.52 -21.35 60.42 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.383 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 49.02 72.33 0.48 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.1 p -132.57 -5.0 3.29 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 105.87 5.78 38.16 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 113.799 -1.546 . . . . 0.0 113.322 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.778 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -144.27 157.46 44.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.456 0.646 . . . . 0.0 111.495 179.108 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.782 HG12 ' HA ' ' A' ' 92' ' ' ASP . 77.8 mt -133.18 104.14 6.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.956 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 103' ' ' GLU . 43.6 p -70.8 147.99 48.35 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.766 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.685 ' HB3' HG23 ' A' ' 122' ' ' ILE . 3.6 pp -34.84 -39.22 0.09 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.421 ' N ' HD12 ' A' ' 101' ' ' LEU . 1.6 m-20 -55.55 -54.71 40.6 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.59 ' HB2' HG23 ' A' ' 99' ' ' ILE . 49.3 mt-10 -60.48 -44.46 95.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.235 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.77 HG13 HG22 ' A' ' 99' ' ' ILE . 96.6 mt -56.72 -65.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.381 0.61 . . . . 0.0 110.676 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.551 ' HB3' HD12 ' A' ' 113' ' ' LEU . 29.2 mt-30 -58.35 -65.47 0.65 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.488 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -42.79 -34.23 0.89 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.17 -66.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.314 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 98.5 m -49.78 134.17 20.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.811 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.589 ' HA ' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -89.29 -60.91 1.82 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -75.49 -3.07 31.92 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.82 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.749 ' O ' HD11 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -46.81 -29.39 1.93 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -178.323 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 62.87 39.21 97.74 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 118.85 -1.643 . . . . 0.0 110.777 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.793 ' HA ' HD12 ' A' ' 118' ' ' ILE . 9.1 tt -31.63 130.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.454 ' OD2' HG13 ' A' ' 116' ' ' ILE . 35.9 t70 -157.21 175.67 13.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.905 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.741 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.0 m-20 -88.89 -7.45 56.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.454 HG13 ' OD2' ' A' ' 114' ' ' ASP . 60.5 mt -84.86 -65.53 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -92.45 -69.04 0.76 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 113' ' ' LEU . 60.5 mt -52.1 -19.68 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.935 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.741 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 37.4 t70 -75.89 -51.67 12.0 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' GLU . 32.2 m-20 -65.07 -17.9 64.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' MET . . . . . 1.064 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 13.6 tmm? -65.31 -41.25 94.25 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.823 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.748 HG22 ' HA3' ' A' ' 131' ' ' GLY . 61.1 mt -54.12 -39.68 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.77 ' HA ' ' HE2' ' A' ' 123' ' ' LYS . 10.9 mmpt? -86.7 -13.89 44.1 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 112.403 -2.18 . . . . 0.0 110.574 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 1.064 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 29.7 tt0 -94.27 -14.78 25.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.689 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.845 HG22 ' CD1' ' A' ' 133' ' ' ILE . 29.9 mt -111.97 -35.55 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.379 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.782 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 1.8 t70 -47.02 129.83 12.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.705 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.493 ' HB2' ' CD ' ' A' ' 137' ' ' GLU . 1.0 OUTLIER -88.41 -23.15 23.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.529 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 45.3 p-10 -135.24 -32.73 0.93 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 29.8 p-10 179.36 -52.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.694 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 31.1 m-20 -64.6 8.76 0.1 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -173.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.782 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.5 37.06 65.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 118.45 -1.833 . . . . 0.0 108.772 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.694 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 1.7 pt20 -127.59 169.37 13.81 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.805 -1.197 . . . . 0.0 108.982 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.845 ' CD1' HG22 ' A' ' 125' ' ' ILE . 25.6 mm -135.94 129.97 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.4 0 CA-C-O 121.622 0.725 . . . . 0.0 110.803 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.778 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -102.24 165.19 11.27 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.173 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.835 ' HB2' ' HE1' ' A' ' 88' ' ' PHE . 41.0 t80 -48.06 -31.0 4.93 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.1 -26.52 36.72 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.462 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.625 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 78.7 mt-10 -76.12 -53.86 7.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.824 -0.188 . . . . 0.0 110.521 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.578 ' HD1' HG21 ' A' ' 133' ' ' ILE . 4.1 t80 -60.85 -23.96 65.53 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.838 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.0 -32.55 21.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.747 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.8 -27.8 19.75 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -11.4 16.38 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.749 0.309 . . . . 0.0 111.141 -179.945 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.632 HD12 HD23 ' A' ' 15' ' ' LEU . 52.2 tp . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.609 0.242 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 61.6 tttm -60.78 -43.03 98.61 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.97 -26.94 67.79 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.736 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.709 ' HA ' ' HB3' ' A' ' 18' ' ' MET . 33.4 tp -72.48 -31.12 65.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.946 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.461 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 10.4 t80 -65.94 -48.18 72.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.283 0.564 . . . . 0.0 109.788 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.461 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -76.22 -16.23 59.87 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.709 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 3.1 tpp -66.79 -36.21 81.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.887 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.733 HG21 HD13 ' A' ' 27' ' ' ILE . 10.4 mm -62.85 -57.54 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.614 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.596 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 1.3 t70 -82.48 87.55 6.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.285 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 t -88.19 -24.9 23.17 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.62 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -139.71 -6.14 1.32 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.548 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 53.7 t30 -75.43 -80.42 0.09 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.897 1.226 . . . . 0.0 112.837 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 p -172.34 -0.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 110.26 23.57 6.01 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.456 ' HB ' ' OG1' ' A' ' 62' ' ' THR . 65.2 p -138.86 147.37 42.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.013 -1.093 . . . . 0.0 109.464 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.849 ' O ' ' HA ' ' A' ' 62' ' ' THR . 2.3 mt -104.21 103.71 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 59.9 p -101.97 161.97 13.27 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.48 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 2.0 t80 -34.21 -36.67 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.797 0.686 . . . . 0.0 111.076 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -74.95 -52.16 11.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.432 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.596 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 3.1 tt0 -70.85 -16.41 62.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.183 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.863 HD12 HG13 ' A' ' 48' ' ' ILE . 2.4 tm? -58.98 -55.25 37.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.353 0.597 . . . . 0.0 109.992 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.601 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 10.9 ptpt -76.22 -33.42 59.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.668 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -48.47 -58.38 4.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 19' ' ' ILE . . . -61.4 -22.45 61.24 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 114.849 0.7 . . . . 0.0 114.849 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 ' N ' ' A' ' 37' ' ' LYS . 4.6 pp -95.1 -39.09 10.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.785 0.792 . . . . 0.0 111.252 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.679 ' N ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -71.28 -15.23 62.41 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.502 ' C ' ' HD3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -87.68 -36.85 17.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.255 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.624 HG12 ' O ' ' A' ' 36' ' ' LEU . 9.0 p -75.08 -17.84 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.533 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.49 42.45 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.641 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 35.5 t -130.68 164.1 25.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.676 0.274 . . . . 0.0 110.456 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 10.7 pt-20 -141.89 104.78 4.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.198 0.523 . . . . 0.0 111.695 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.457 HD12 ' CD2' ' A' ' 36' ' ' LEU . 20.5 mt -124.58 165.99 16.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.188 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.4 ptm -113.08 164.03 13.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -45.52 -64.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.8 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.6 p -41.83 -22.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.3 mm-40 -82.31 -47.52 12.27 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.863 HG13 HD12 ' A' ' 32' ' ' LEU . 1.8 mp -51.59 -62.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.553 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.536 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . 3.1 tmtm? -46.67 -33.57 4.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.81 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.506 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 9.6 t70 -65.55 -43.87 88.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.806 HD13 ' N ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -64.35 -26.54 68.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.425 178.718 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.927 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 17.7 mmt -80.08 -66.43 0.88 Allowed 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.562 0.696 . . . . 0.0 112.183 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.726 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 1.5 m-20 -59.84 -21.86 61.49 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.873 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.721 ' HB1' ' HB3' ' A' ' 89' ' ' SER . . . -92.55 -42.8 9.49 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.721 ' HB1' ' HA ' ' A' ' 71' ' ' ALA . . . -111.73 -39.45 4.58 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.787 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 38.1 t0 -50.07 87.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' ALA . 37.6 mm -47.51 -22.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.559 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.531 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 60.0 m-20 -133.06 43.52 2.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.612 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.927 ' HD3' ' HB3' ' A' ' 52' ' ' MET . 56.5 tptt -33.12 90.32 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.695 0.76 . . . . 0.0 112.609 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.8 p -127.68 18.82 6.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.458 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 84.71 5.37 86.61 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.902 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.849 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 1.3 t -153.41 150.94 29.35 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.983 0.421 . . . . 0.0 111.312 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.904 HG23 ' HB2' ' A' ' 67' ' ' GLU . 68.7 mt -117.08 136.48 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.344 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -105.94 167.57 9.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.139 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.532 ' CE1' HD11 ' A' ' 69' ' ' ILE . 18.9 t80 -36.19 -49.57 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.406 0.441 . . . . 0.0 111.615 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.11 -60.37 7.7 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.723 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.904 ' HB2' HG23 ' A' ' 63' ' ' ILE . 23.8 mt-10 -53.68 -25.13 16.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.716 0.293 . . . . 0.0 110.602 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.578 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 47.1 t80 -64.79 -50.68 65.82 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.264 0.554 . . . . 0.0 110.474 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.532 HD11 ' CE1' ' A' ' 65' ' ' TYR . 5.0 mm -60.27 -50.16 81.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.125 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.96 -30.15 68.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.029 0.442 . . . . 0.0 110.215 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.721 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.19 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.695 0.284 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.6 m -56.24 -44.46 79.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.198 0.523 . . . . 0.0 109.666 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HA ' ' CD1' ' A' ' 91' ' ' PHE . . . -75.77 -55.04 6.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.831 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.796 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 4.9 t80 -40.59 -25.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.73 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.721 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 22.6 m -90.92 -64.48 1.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -79.16 -42.38 26.27 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.763 0.316 . . . . 0.0 111.683 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 87' ' ' ALA . 5.7 m-85 -63.65 -64.5 0.88 Allowed 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 176.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.931 ' HA ' HG12 ' A' ' 99' ' ' ILE . 56.9 t0 -77.78 70.56 4.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.726 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 22.4 ttmt -43.54 -49.22 7.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.362 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.501 ' OD2' HG23 ' A' ' 57' ' ' ILE . 7.1 t70 -67.75 -22.71 65.21 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.138 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 49.98 54.27 19.26 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.653 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.8 p -125.49 12.31 8.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.688 ' HA2' ' HE1' ' A' ' 88' ' ' PHE . . . 84.66 21.18 56.78 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.447 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' HA ' ' OD1' ' A' ' 134' ' ' ASP . 14.3 m-85 -143.52 131.9 22.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.931 HG12 ' HA ' ' A' ' 92' ' ' ASP . 48.6 mt -130.19 101.96 6.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.88 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.506 ' HA ' ' HB3' ' A' ' 132' ' ' GLN . 58.8 p -74.12 164.69 26.3 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.07 -0.394 . . . . 0.0 111.086 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.726 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER -41.28 -36.55 0.81 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.425 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -67.46 -52.38 40.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.279 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.487 ' CB ' HG23 ' A' ' 99' ' ' ILE . 56.3 mt-10 -64.95 -15.88 62.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.636 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.723 HG22 ' HE3' ' A' ' 121' ' ' MET . 96.6 mt -87.33 -62.82 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.124 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.726 ' HG2' ' O ' ' A' ' 101' ' ' LEU . 7.1 mm100 -50.27 -51.69 42.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.96 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -60.73 -31.19 70.5 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.22 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 104' ' ' ILE . . . -59.81 -21.54 61.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.87 0.367 . . . . 0.0 110.927 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.55 ' HB3' ' CG ' ' A' ' 111' ' ' PHE . 72.4 m -117.13 66.72 0.73 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.682 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.698 ' HD3' ' H ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -78.4 -39.37 39.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -68.81 -12.6 61.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.183 0.516 . . . . 0.0 110.347 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.55 ' CG ' ' HB3' ' A' ' 108' ' ' CYS . 3.2 m-85 -74.77 -46.81 34.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.827 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.72 37.98 2.66 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.749 ' HA ' HG13 ' A' ' 118' ' ' ILE . 1.0 OUTLIER -33.33 139.07 0.06 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.387 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.504 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 52.8 t0 -152.67 150.7 29.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.272 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.692 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 10.2 t70 -57.74 -8.74 0.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.493 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.3 mm -86.67 -64.8 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -91.68 -68.98 0.76 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 1.022 HG23 ' HE2' ' A' ' 121' ' ' MET . 17.5 mm -51.05 -24.36 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.2 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.692 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 36.1 t70 -75.08 -46.26 35.82 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 124' ' ' GLU . 33.3 t70 -62.31 -21.48 65.29 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' MET . . . . . 1.022 ' HE2' HG23 ' A' ' 118' ' ' ILE . 3.8 ttp -65.36 -33.32 75.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.637 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 126' ' ' ASP . 46.3 mt -59.12 -42.48 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.66 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 2.4 mptt -86.72 -12.97 46.73 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.51 -1.677 . . . . 0.0 109.882 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.917 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 17.2 tp10 -86.11 -22.82 26.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.451 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.575 HG21 HD13 ' A' ' 133' ' ' ILE . 14.7 mm -116.56 -13.36 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.585 ' OD1' ' HA ' ' A' ' 123' ' ' LYS . 4.2 p-10 -79.8 54.09 1.77 Allowed 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.564 0.697 . . . . 0.0 110.084 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.689 HE21 ' HB3' ' A' ' 141' ' ' MET . 0.0 OUTLIER -62.56 -9.32 8.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.553 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 6.4 t70 -107.95 -32.91 7.38 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.545 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 21.0 p30 178.54 -95.65 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.724 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 1.5 m-20 -64.75 29.29 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 119.44 3.126 . . . . 0.0 119.44 -173.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 126' ' ' ASP . . . 58.76 37.67 90.52 Favored Glycine 0 CA--C 1.504 -0.631 0 C-N-CA 117.236 -2.411 . . . . 0.0 109.133 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.724 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 6.6 pt20 -136.57 169.28 17.97 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 113.738 -1.231 . . . . 0.0 109.831 -177.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.613 HG21 ' HD1' ' A' ' 138' ' ' PHE . 49.2 mt -133.16 124.2 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.558 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 54.0 m-20 -101.73 165.53 11.16 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.417 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.643 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 25.8 t80 -44.19 -29.78 0.68 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.068 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.54 -39.64 8.17 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.683 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.678 ' HB3' HE22 ' A' ' 127' ' ' GLN . 32.9 mt-10 -60.54 -50.59 72.93 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.613 ' HD1' HG21 ' A' ' 133' ' ' ILE . 1.3 t80 -64.37 -61.11 2.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.49 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.81 -32.95 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.64 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.69 -58.18 2.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.689 ' HB3' HE21 ' A' ' 127' ' ' GLN . 0.0 OUTLIER -46.19 -33.02 3.32 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.238 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 138' ' ' PHE . 27.6 ptt? . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.749 0.309 . . . . 0.0 111.097 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.52 -0.192 0 CA-C-O 120.562 0.22 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.451 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 62.8 tttm -64.68 -51.46 62.38 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -65.54 -18.28 65.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.176 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.822 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -80.15 -40.31 27.6 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.738 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HA ' ' CE1' ' A' ' 68' ' ' PHE . 11.1 t80 -57.4 -44.01 84.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.192 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.57 ' HB2' ' NZ ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -81.75 -12.59 58.52 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.825 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.753 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -67.97 -43.07 79.83 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.862 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 7.7 mt -61.45 -58.07 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.674 ' OD1' ' HB3' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -74.96 84.65 2.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.35 1.071 . . . . 0.0 109.817 178.468 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -89.18 -22.29 22.87 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.595 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -138.66 -5.67 1.54 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.674 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -71.16 -87.53 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.141 0.882 . . . . 0.0 111.292 -178.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.1 p -177.77 11.65 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.483 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.479 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 109.84 31.23 3.21 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 55.1 p -144.13 152.06 40.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.612 -0.794 . . . . 0.0 110.627 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.876 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 4.5 mt -114.42 104.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.758 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.677 HG22 ' OG1' ' A' ' 62' ' ' THR . 82.7 p -102.5 160.11 14.85 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.617 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 17.1 t80 -34.24 -34.61 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.723 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -77.85 -45.48 24.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.843 0.354 . . . . 0.0 110.456 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.565 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -73.04 -24.56 60.72 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.204 178.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.755 HD11 HD23 ' A' ' 51' ' ' LEU . 1.4 tm? -50.61 -54.66 20.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.418 0.628 . . . . 0.0 110.059 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.68 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 3.8 ptpt -79.03 -39.03 35.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.334 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 37.8 t70 -47.66 -36.6 11.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.468 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.862 ' HA3' ' HA ' ' A' ' 19' ' ' ILE . . . -95.09 -49.62 2.21 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.259 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.659 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -57.98 -51.71 68.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.467 0.651 . . . . 0.0 109.898 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.68 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.85 -9.19 42.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.728 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.581 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -80.86 -32.21 35.1 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.802 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 36' ' ' LEU . 25.1 m -76.94 2.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.733 0.301 . . . . 0.0 111.404 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.18 10.85 11.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.271 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 40.9 m -92.22 156.98 16.94 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.725 0.298 . . . . 0.0 110.649 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -142.5 104.43 4.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.046 0.45 . . . . 0.0 110.741 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 48' ' ' ILE . 21.4 mt -131.16 165.52 23.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.465 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.444 ' O ' HD13 ' A' ' 48' ' ' ILE . 37.9 mtm -105.0 165.5 11.03 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.8 mp0 -47.96 -60.72 2.39 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.677 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 t -48.94 -17.19 0.17 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 52.0 mt-10 -90.86 -48.75 6.83 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.743 HG23 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -49.83 -58.13 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.566 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . 44.5 tttp -39.9 -34.65 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.106 -1.861 . . . . 0.0 111.115 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.638 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 8.7 t70 -64.26 -50.81 66.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.399 . . . . 0.0 110.216 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.755 HD23 HD11 ' A' ' 32' ' ' LEU . 53.2 tp -56.13 -33.28 65.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.995 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.596 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 41.6 ttm -87.54 -66.5 0.91 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.529 0.68 . . . . 0.0 112.705 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.502 ' HA ' ' CG ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -58.42 -34.52 70.88 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.235 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB1' ' OG ' ' A' ' 89' ' ' SER . . . -91.15 -18.48 24.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -123.91 -43.56 2.11 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' MET . 65.6 t0 -50.48 101.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.033 0.444 . . . . 0.0 110.093 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 6.3 mt -50.73 -17.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.481 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 60' ' ' SER . 55.7 m-20 -129.76 43.36 3.14 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.052 -178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.577 ' C ' ' HD3' ' A' ' 59' ' ' LYS . 1.6 tmtp? -33.42 87.16 0.0 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.68 0.753 . . . . 0.0 111.854 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 58' ' ' ASP . 45.6 m -128.04 19.18 6.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.459 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.596 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 68.84 20.87 74.77 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 86.0 m -155.24 133.02 11.34 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.886 -0.657 . . . . 0.0 110.299 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.876 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.1 mt -113.48 134.76 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.152 0.501 . . . . 0.0 111.14 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.534 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 40.1 m-20 -106.68 167.87 9.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.747 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.557 ' O ' HG13 ' A' ' 69' ' ' ILE . 25.2 t80 -35.79 -46.96 0.48 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.695 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.7 -53.82 7.98 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.976 -1.106 . . . . 0.0 112.313 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.609 ' HB2' HG23 ' A' ' 63' ' ' ILE . 24.2 mt-10 -52.08 -25.15 8.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.297 0.57 . . . . 0.0 109.847 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.822 ' HZ ' HD12 ' A' ' 15' ' ' LEU . 88.9 t80 -67.77 -65.51 0.68 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.139 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 65' ' ' TYR . 2.8 mt -47.35 -46.72 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.629 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -50.16 75.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 110.421 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.681 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.027 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.559 0.218 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -44.45 -50.96 9.13 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.013 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -75.23 -51.51 13.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.511 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.702 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 3.5 t80 -43.34 -26.97 0.22 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.017 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.688 ' OG ' ' HB1' ' A' ' 54' ' ' ALA . 25.3 t -89.38 -57.99 2.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.536 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -84.61 -54.37 4.77 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.734 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 87' ' ' ALA . 3.1 m-85 -56.97 -65.08 0.68 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.85 ' HA ' HG12 ' A' ' 99' ' ' ILE . 66.2 t0 -72.61 63.23 0.58 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 29.6 ttmt -51.26 -39.49 56.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.225 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 63.7 m-20 -72.0 -25.02 61.67 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.189 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 44.39 64.56 2.0 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.364 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 77.8 p -118.38 11.22 12.98 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 97.57 4.92 57.99 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 112.195 -2.275 . . . . 0.0 112.697 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 1.1 p90 -165.25 144.94 6.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.85 HG12 ' HA ' ' A' ' 92' ' ' ASP . 51.1 mt -103.24 141.76 18.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.794 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.504 ' HA ' ' CB ' ' A' ' 132' ' ' GLN . 77.0 p -110.73 159.73 17.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.86 0.3 . . . . 0.0 110.255 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.69 ' HA ' HD12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -38.09 -37.56 0.27 Allowed 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.159 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.42 ' N ' ' HG ' ' A' ' 101' ' ' LEU . 65.1 t0 -60.96 -59.77 4.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.628 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.545 ' HB2' HG23 ' A' ' 99' ' ' ILE . 52.7 mt-10 -60.05 -22.66 62.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.77 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 133' ' ' ILE . 82.9 mt -75.79 -61.38 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.643 ' HG2' ' O ' ' A' ' 101' ' ' LEU . 4.0 mm100 -55.29 -33.57 63.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.638 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -80.47 -28.58 37.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.003 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 103' ' ' GLU . . . -66.71 -4.57 9.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.835 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 76.2 m -115.55 77.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.516 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -79.54 -53.87 6.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.55 -16.75 59.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.005 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.835 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 11.1 m-85 -63.46 -56.67 14.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.916 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.45 38.75 1.07 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.998 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.925 ' HA ' HD12 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -32.63 124.09 0.34 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.541 0.686 . . . . 0.0 112.258 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.609 ' N ' HD22 ' A' ' 113' ' ' LEU . 34.1 t0 -150.71 173.77 13.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.275 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.826 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 1.4 m-20 -77.85 -7.44 56.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.012 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.8 mt -81.71 -65.52 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -92.55 -69.27 0.75 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.925 HD12 ' HA ' ' A' ' 113' ' ' LEU . 15.1 mt -54.29 -18.89 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.826 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 38.8 t70 -70.6 -64.96 0.8 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.429 0.157 . . . . 0.0 110.924 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 124' ' ' GLU . 54.8 p30 -61.13 -16.99 50.33 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.892 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 22.2 ttp -61.15 -33.74 73.9 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.38 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.525 HG22 ' HA3' ' A' ' 131' ' ' GLY . 61.2 mt -58.32 -44.02 87.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.657 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 4.5 mptt -86.33 -13.06 47.66 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.562 -1.654 . . . . 0.0 110.187 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.892 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 41.4 tp10 -81.65 -24.4 36.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.84 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.789 HG21 HD13 ' A' ' 133' ' ' ILE . 19.3 mt -112.17 -19.4 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.206 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.864 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 14.1 t70 -66.13 83.86 0.09 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.844 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.445 ' NE2' ' HB3' ' A' ' 141' ' ' MET . 58.7 mt-30 -85.19 -8.69 58.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.307 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 12.4 p-10 -126.61 -30.25 2.83 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 18.4 p30 -179.74 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.548 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 1.3 m-20 -65.21 25.95 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 -173.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.864 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.65 37.56 68.56 Favored Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 117.505 -2.283 . . . . 0.0 108.193 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.809 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 10.0 pt20 -129.27 167.07 18.23 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.678 -1.261 . . . . 0.0 109.87 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.789 HD13 HG21 ' A' ' 125' ' ' ILE . 18.6 mt -129.75 116.39 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.753 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.764 ' OD1' ' HG3' ' A' ' 137' ' ' GLU . 0.7 OUTLIER -100.33 165.53 11.42 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.702 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 32.5 t80 -45.81 -23.43 0.27 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.178 0.513 . . . . 0.0 110.149 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.493 ' H ' ' CG ' ' A' ' 134' ' ' ASP . . . -82.45 -39.95 10.45 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.049 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.764 ' HG3' ' OD1' ' A' ' 134' ' ' ASP . 38.8 mt-10 -70.01 -57.46 4.97 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 116.075 -0.063 . . . . 0.0 111.065 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.639 ' HD1' HG21 ' A' ' 133' ' ' ILE . 1.3 t80 -57.87 -50.95 71.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.519 -178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.4 -19.52 56.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.648 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 142' ' ' MET . . . -90.73 -51.72 5.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.956 0.408 . . . . 0.0 111.86 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.445 ' HB3' ' NE2' ' A' ' 127' ' ' GLN . 5.4 ppp? -65.19 8.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.325 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.445 ' H ' ' C ' ' A' ' 140' ' ' ALA . 4.1 ppp? . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 110.998 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.612 HD12 HD23 ' A' ' 15' ' ' LEU . 44.2 tp . . . . . 0 CA--C 1.522 -0.106 0 CA-C-O 120.509 0.195 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . 22.0 pttp -60.42 -41.42 93.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 18' ' ' MET . 87.6 tt0 -68.01 -27.68 66.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.72 177.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.695 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 32.6 tp -72.08 -32.88 67.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.082 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.438 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 6.0 t80 -64.58 -50.25 67.97 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.337 0.589 . . . . 0.0 109.537 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -73.64 -15.03 61.26 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.695 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -70.07 -20.46 63.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.805 178.465 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.837 HG23 ' HA3' ' A' ' 35' ' ' GLY . 9.2 mm -81.24 -62.16 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.828 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.627 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -85.76 70.42 10.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.895 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.621 HG22 HH22 ' A' ' 38' ' ' ARG . 15.1 t -87.25 -6.46 58.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.244 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -131.98 -24.13 2.16 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -71.58 -76.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.7 p -175.0 -4.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.462 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 110.4 30.12 3.44 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -177.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.585 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 49.6 p -143.71 146.34 33.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 113.837 -1.182 . . . . 0.0 109.413 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.914 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.1 mt -103.24 104.22 16.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 68.6 p -103.39 165.99 10.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.609 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.655 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 9.5 t80 -34.24 -33.33 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.146 -0.933 . . . . 0.0 112.327 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -79.49 -52.66 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.889 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.627 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 31.9 mt-10 -73.65 -14.16 61.12 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.494 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.776 HD12 HG13 ' A' ' 48' ' ' ILE . 2.3 tm? -54.89 -56.21 22.01 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 12.8 ptpt -75.62 -44.01 45.05 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.281 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.631 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 62.3 t0 -43.15 -65.33 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 0.0 110.494 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.837 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -62.21 -50.68 62.79 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.542 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.64 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -60.72 -65.11 0.74 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 117.263 0.532 . . . . 0.0 110.738 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -51.97 -23.95 5.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.204 179.603 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.631 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 38.4 ttm180 -57.73 -43.67 85.47 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.143 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' LEU . 22.3 m -73.5 20.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 38' ' ' ARG . . . 100.0 -15.45 59.32 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.414 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 37' ' ' LYS . 74.4 m -60.45 155.4 18.36 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.795 0.331 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 15.5 pt-20 -138.56 107.25 5.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.163 0.506 . . . . 0.0 110.854 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 mt -125.34 166.1 17.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.153 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.567 ' O ' HD13 ' A' ' 48' ' ' ILE . 30.2 mtm -111.69 163.99 13.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -49.15 -65.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.043 -178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.2 m -48.9 -20.67 0.53 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.465 0.575 . . . . 0.0 111.932 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 95.1 mt-10 -80.29 -43.84 20.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.776 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -55.44 -54.86 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 122.266 1.031 . . . . 0.0 108.5 177.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.657 ' HZ1' ' HE2' ' A' ' 109' ' ' LYS . 50.8 tttp -58.81 -29.0 66.54 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.322 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 38.0 t70 -67.99 -53.77 23.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.687 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.512 HD22 HD21 ' A' ' 32' ' ' LEU . 2.5 tt -54.91 -32.13 60.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.47 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.534 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 25.2 mtt -72.1 -65.72 0.74 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.588 ' N ' ' HD3' ' A' ' 59' ' ' LYS . 41.9 t0 -65.36 -18.82 65.62 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.119 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.77 -34.1 14.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.859 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -118.67 -43.67 2.67 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' MET . 63.7 t0 -46.89 99.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.5 mm -50.38 -23.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.041 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.654 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 7.9 t70 -130.59 45.66 2.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.416 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.588 ' HD3' ' N ' ' A' ' 53' ' ' ASP . 23.3 tptm -31.99 91.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.83 0.824 . . . . 0.0 112.992 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 58' ' ' ASP . 39.7 m -127.42 18.62 6.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.546 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 68.33 19.09 72.11 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 97.0 m -146.55 143.35 28.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.6 -0.8 . . . . 0.0 109.759 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.914 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.9 mt -128.3 126.6 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.191 0.52 . . . . 0.0 111.587 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 65' ' ' TYR . 31.4 m-20 -104.29 167.73 9.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.596 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.623 ' O ' HG13 ' A' ' 69' ' ' ILE . 33.9 t80 -34.85 -47.92 0.37 Allowed 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.229 0.331 . . . . 0.0 111.412 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.31 -61.71 6.81 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.115 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.777 ' HB2' HG23 ' A' ' 63' ' ' ILE . 28.0 mt-10 -56.28 -24.82 45.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.687 0.28 . . . . 0.0 111.16 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.651 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 39.4 t80 -65.21 -53.8 39.08 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.298 0.571 . . . . 0.0 110.817 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 65' ' ' TYR . 3.7 mt -61.25 -46.3 96.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.063 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.18 -10.78 53.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.308 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.558 -179.837 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.441 ' HA ' ' CB ' ' A' ' 88' ' ' PHE . 32.6 m . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.626 0.25 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -53.3 -66.04 0.46 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.847 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.702 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -69.78 -33.27 72.16 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.813 ' HZ ' ' HA2' ' A' ' 97' ' ' GLY . 11.3 t80 -46.42 -22.12 0.23 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.528 177.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.422 ' N ' ' C ' ' A' ' 87' ' ' ALA . 46.6 t -89.17 -43.3 11.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.6 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -81.09 -64.48 1.18 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.496 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.539 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.5 m-85 -56.12 -61.89 2.08 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.806 ' HA ' HG12 ' A' ' 99' ' ' ILE . 63.1 t0 -80.6 61.69 4.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -42.28 -36.08 1.15 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.144 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -89.84 -22.84 21.87 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.601 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 52.97 73.88 0.36 Allowed Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 60.1 p -122.37 -5.3 8.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.813 ' HA2' ' HZ ' ' A' ' 88' ' ' PHE . . . 109.78 -9.8 32.24 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.967 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -142.24 158.54 43.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.558 0.694 . . . . 0.0 112.383 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.806 HG12 ' HA ' ' A' ' 92' ' ' ASP . 82.3 mt -131.61 104.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.711 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.7 p -69.14 147.34 51.53 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.8 ' HB3' HG23 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -35.27 -35.63 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -57.02 -52.82 63.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.672 0.273 . . . . 0.0 111.023 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.728 ' HB2' HG23 ' A' ' 99' ' ' ILE . 97.4 mt-10 -59.93 -30.4 69.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.723 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.802 HD11 HG12 ' A' ' 133' ' ' ILE . 88.4 mt -75.67 -61.58 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.104 0.478 . . . . 0.0 110.283 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.704 HE21 HG23 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -51.91 -29.26 19.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.734 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -63.82 -42.86 97.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.904 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 108' ' ' CYS . . . -50.02 -65.9 0.48 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.974 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.804 ' HB2' ' CD1' ' A' ' 111' ' ' PHE . 10.6 p -34.31 115.89 0.28 Allowed 'General case' 0 C--O 1.22 -0.475 0 O-C-N 123.739 0.649 . . . . 0.0 109.622 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.657 ' HE2' ' HZ1' ' A' ' 49' ' ' LYS . 25.1 ttmm -88.46 -58.66 2.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.25 -15.55 4.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.444 0.64 . . . . 0.0 110.065 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.804 ' CD1' ' HB2' ' A' ' 108' ' ' CYS . 0.2 OUTLIER -112.27 -49.76 2.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.189 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 108' ' ' CYS . . . 79.62 -21.94 4.28 Favored Glycine 0 CA--C 1.509 -0.33 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.248 -177.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.816 HD22 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER 176.44 53.84 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.508 ' O ' HG13 ' A' ' 118' ' ' ILE . 51.1 t0 -34.04 100.2 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 112.248 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.62 -18.0 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.502 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.4 mm -92.35 -49.39 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.795 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.576 ' CD2' ' HG3' ' A' ' 121' ' ' MET . 15.2 t-160 -78.65 -38.85 38.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.448 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.704 HG23 HE21 ' A' ' 105' ' ' GLN . 3.2 mt -36.11 -61.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 118' ' ' ILE . 65.6 t0 -48.26 -60.44 2.65 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.9 0.381 . . . . 0.0 111.412 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.724 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 57.9 m-20 -67.64 -17.08 64.48 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.613 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.785 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.8 mtp -77.26 -52.69 8.78 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 123.631 0.772 . . . . 0.0 112.338 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.8 HG23 ' HB3' ' A' ' 101' ' ' LEU . 55.4 mt -50.05 -39.47 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.662 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.51 -19.13 29.97 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.249 -1.796 . . . . 0.0 110.959 178.401 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.785 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 17.0 tp10 -79.32 -18.26 52.92 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.758 HG22 ' CD1' ' A' ' 133' ' ' ILE . 16.2 mt -115.43 -32.89 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.213 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.714 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 13.1 t0 -62.98 112.7 2.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.236 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.944 HE22 ' HB3' ' A' ' 141' ' ' MET . 20.6 mp0 -89.22 -9.71 49.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -133.54 -32.35 1.15 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -178.42 -72.49 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 117.314 2.339 . . . . 0.0 117.314 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.454 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 40.1 t0 -63.78 13.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -172.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.767 ' HA3' HG22 ' A' ' 122' ' ' ILE . . . 55.97 37.68 71.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 117.804 -2.141 . . . . 0.0 108.967 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.798 ' O ' HD13 ' A' ' 133' ' ' ILE . 2.3 pt20 -128.98 167.18 17.83 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 113.435 -1.382 . . . . 0.0 109.675 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.802 HG12 HD11 ' A' ' 104' ' ' ILE . 40.1 mm -125.8 124.56 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 CA-C-O 122.107 0.956 . . . . 0.0 111.404 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.909 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 35.4 t70 -103.03 158.79 16.05 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.18 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.626 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 16.0 t80 -48.41 -27.83 2.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.136 0.493 . . . . 0.0 109.872 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -85.51 -38.04 9.2 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 177.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.909 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 51.0 mt-10 -63.45 -57.99 8.49 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.702 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 26.4 t80 -52.41 -18.53 1.68 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.151 0.5 . . . . 0.0 109.978 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -81.69 -36.14 29.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.251 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.64 -38.45 25.92 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.647 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.944 ' HB3' HE22 ' A' ' 127' ' ' GLN . 5.3 ppp? -56.49 -20.19 19.06 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.851 0.357 . . . . 0.0 110.997 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 36.8 ttm . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.68 -179.933 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 86.6 mt . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.483 0.183 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -68.24 -53.7 22.86 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.857 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 39.2 tt0 -64.92 -22.99 67.09 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 47.9 tp -74.88 -37.77 62.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.873 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.534 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 14.1 t80 -61.36 -46.85 88.51 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.857 ' HE2' ' HA ' ' A' ' 14' ' ' GLU . 59.5 pttt -75.96 -12.92 60.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.634 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.73 -18.01 60.56 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.891 178.056 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.869 HG23 ' HA3' ' A' ' 35' ' ' GLY . 7.1 mm -82.61 -61.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.932 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.735 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -77.65 59.81 2.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.823 -178.512 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 t -87.18 -6.15 58.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.495 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.619 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 5.4 m-20 -113.82 -28.1 7.54 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -83.03 -89.81 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.864 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.0 p -176.15 19.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.395 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.616 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.54 22.97 5.86 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 76.2 p -137.62 143.64 41.54 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.911 -0.644 . . . . 0.0 110.154 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.873 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.3 mt -102.34 103.7 15.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.745 -177.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 82.2 p -104.02 165.47 11.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.097 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -34.13 -34.47 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.778 0.674 . . . . 0.0 112.438 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -79.31 -48.02 14.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.929 0.395 . . . . 0.0 110.494 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.619 ' OE2' ' HB2' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -74.57 -14.32 60.77 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.363 178.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.785 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -58.63 -56.03 27.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.614 ' NZ ' HG12 ' A' ' 48' ' ' ILE . 6.4 ptpp? -73.92 -48.1 33.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.523 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.663 ' O ' ' HB3' ' A' ' 38' ' ' ARG . 32.1 t70 -37.84 -64.18 0.42 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.41 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.869 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -47.39 -41.02 16.34 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 115.459 0.944 . . . . 0.0 115.459 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.638 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -94.99 -56.08 2.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.91 0.855 . . . . 0.0 110.955 -178.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -50.18 -18.08 0.53 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.401 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.663 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 6.3 ptm180 -67.14 -38.43 85.51 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 36' ' ' LEU . 27.0 m -77.9 23.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.76 -23.25 33.12 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.735 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m -59.52 156.13 13.88 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.741 0.305 . . . . 0.0 110.632 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -136.78 109.28 7.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.233 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 mt -113.04 165.27 12.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.974 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.436 ' O ' HD13 ' A' ' 48' ' ' ILE . 28.0 mtm -113.86 157.55 22.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 48' ' ' ILE . 37.5 mt-10 -44.87 -64.99 0.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.1 t -42.95 -29.44 0.33 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 56.7 mm-40 -70.39 -40.36 73.96 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.264 0.555 . . . . 0.0 109.569 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.785 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -59.67 -60.94 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.321 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -56.58 -26.63 55.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.645 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.559 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 60.6 t0 -66.29 -46.17 77.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.829 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.753 HD22 HD21 ' A' ' 32' ' ' LEU . 10.5 tt -67.65 -21.69 65.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.142 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.808 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 21.7 mmt -73.24 -43.54 61.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.477 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -86.96 -23.66 25.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.867 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.56 -25.55 19.17 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.49 -43.77 1.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.758 ' HB3' ' O ' ' A' ' 52' ' ' MET . 67.3 t0 -59.2 94.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.345 0.593 . . . . 0.0 110.241 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.0 mm -51.91 -19.43 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.337 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 60' ' ' SER . 8.4 t70 -130.3 43.9 3.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.638 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.808 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 12.7 tmtt? -32.7 88.2 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.744 0.783 . . . . 0.0 112.436 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' ASP . 76.3 p -128.55 18.32 6.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.062 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 75.89 15.24 81.47 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.375 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 97.2 m -146.55 142.71 28.28 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.118 0.567 . . . . 0.0 109.62 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.873 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 57.7 mt -128.98 133.69 65.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.271 0.558 . . . . 0.0 112.204 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 58.0 m-20 -106.53 167.97 9.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.616 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.413 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 29.4 t80 -35.27 -44.04 0.25 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.509 0.505 . . . . 0.0 111.717 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -56.0 7.99 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.765 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.732 ' HB2' HG23 ' A' ' 63' ' ' ILE . 24.1 mt-10 -56.25 -19.7 15.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 110.441 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.598 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 42.0 t80 -68.57 -60.04 2.7 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.555 0.693 . . . . 0.0 110.495 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.9 mm -59.97 -26.13 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.291 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.78 -8.86 5.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.961 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.639 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.549 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . 33.8 m . . . . . 0 C--O 1.234 0.246 0 CA-C-O 120.719 0.295 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.2 m -53.73 -21.98 8.29 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -76.92 -55.02 5.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.409 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.718 ' CE1' ' HA ' ' A' ' 135' ' ' TYR . 40.6 m-85 -49.77 -20.07 0.77 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.217 0.532 . . . . 0.0 109.719 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 87' ' ' ALA . 48.1 t -88.93 -48.06 7.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.05 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -83.11 -63.82 1.29 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.492 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.55 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.8 m-85 -58.99 -62.56 1.79 Allowed 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.774 ' HA ' HG12 ' A' ' 99' ' ' ILE . 62.7 t0 -74.81 63.89 1.21 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 93' ' ' LYS . 25.0 ttmt -48.19 -43.33 31.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.231 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.8 m-20 -74.08 -22.63 59.43 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.474 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.56 -10.02 0.34 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.339 -0.458 . . . . 0.0 112.963 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 94' ' ' ASP . 79.1 p -49.58 -16.3 0.21 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.56 -29.78 3.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.623 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.597 ' HB3' ' OE1' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -115.03 163.31 15.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.678 0.751 . . . . 0.0 112.709 -178.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.788 HG22 HG13 ' A' ' 104' ' ' ILE . 54.5 mt -133.13 102.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.221 177.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 101' ' ' LEU . 44.9 p -73.63 149.28 42.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.0 pp -34.95 -39.41 0.1 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.75 0.31 . . . . 0.0 111.115 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.512 ' N ' HD12 ' A' ' 101' ' ' LEU . 1.6 m-20 -54.89 -60.97 2.63 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.516 ' HB2' HG23 ' A' ' 99' ' ' ILE . 50.4 mt-10 -51.87 -47.88 64.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.977 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.788 HG13 HG22 ' A' ' 99' ' ' ILE . 90.5 mt -54.73 -65.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.701 0.762 . . . . 0.0 111.362 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.769 ' HB3' HD22 ' A' ' 113' ' ' LEU . 2.4 mm-40 -62.18 -65.23 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.925 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -42.26 -37.4 1.49 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.699 0.285 . . . . 0.0 111.667 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 103' ' ' GLU . . . -48.65 -57.99 5.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 3.4 t -57.0 131.87 51.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.557 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.9 -48.0 7.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.126 0.489 . . . . 0.0 112.294 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.13 -0.63 55.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.334 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.662 ' CD2' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -44.94 -83.76 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.327 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.461 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 107.05 40.09 1.88 Allowed Glycine 0 C--N 1.333 0.399 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.207 -176.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.853 HD23 HG12 ' A' ' 118' ' ' ILE . 15.2 mt -31.25 133.02 0.09 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -176.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.718 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 12.4 p-10 -152.79 172.78 16.19 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.651 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 8.7 t70 -73.85 -22.22 59.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.505 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 62.3 mt -72.39 -64.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 121' ' ' MET . 16.9 m80 -92.17 -70.1 0.71 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.853 HG12 HD23 ' A' ' 113' ' ' LEU . 1.7 mp -47.31 -55.36 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -177.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.517 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 37.9 m-20 -60.63 -49.3 78.06 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.744 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 8.6 t70 -67.66 -19.48 65.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' MET . . . . . 1.002 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.2 mtp -69.89 -40.04 75.9 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.844 0.858 . . . . 0.0 110.274 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.813 HG23 ' HB3' ' A' ' 101' ' ' LEU . 56.8 mt -50.8 -46.63 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 43.7 mmtt -87.37 -13.58 43.06 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.006 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 1.002 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 15.9 tp10 -86.27 -17.1 35.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.71 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.738 HG22 ' CD1' ' A' ' 133' ' ' ILE . 22.6 mt -113.52 -32.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.331 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.62 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 17.3 t70 -63.33 112.29 2.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.954 0.407 . . . . 0.0 111.618 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.507 ' OE1' ' HB3' ' A' ' 137' ' ' GLU . 27.6 mp0 -88.31 -9.37 53.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.413 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 36.7 m-20 -131.32 -32.13 1.58 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -176.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 15.6 p-10 -178.79 -74.26 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.623 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 21.4 m-20 -63.97 17.77 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.76 ' HA3' HG22 ' A' ' 122' ' ' ILE . . . 55.07 37.29 62.91 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.376 -1.869 . . . . 0.0 108.99 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.77 ' O ' HD13 ' A' ' 133' ' ' ILE . 2.7 pt20 -131.55 166.92 20.33 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 113.934 -1.133 . . . . 0.0 109.148 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.771 HG12 HD11 ' A' ' 104' ' ' ILE . 36.0 mm -123.5 131.99 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-O 121.736 0.779 . . . . 0.0 111.172 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.816 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 39.0 t70 -101.09 160.32 14.48 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.876 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.718 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 15.0 t80 -48.05 -31.44 5.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.132 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.61 -33.55 15.99 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 119.888 -1.148 . . . . 0.0 110.429 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.816 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 52.6 mt-10 -64.28 -58.0 7.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.37 -0.415 . . . . 0.0 111.197 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.598 ' HD1' HG21 ' A' ' 133' ' ' ILE . 2.8 t80 -54.53 -37.94 65.98 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.753 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.09 -20.92 64.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.181 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.3 -50.33 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.437 ' HB3' HE22 ' A' ' 127' ' ' GLN . 0.0 OUTLIER -55.23 -19.91 9.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.688 0.28 . . . . 0.0 111.292 -178.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 67.6 mtm . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.811 179.507 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.636 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 7.5 mp . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 111.341 0.126 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.604 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 7.9 tmtm? -56.39 -53.64 54.96 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.648 ' HA ' ' NZ ' ' A' ' 17' ' ' LYS . 88.7 tt0 -66.4 -43.82 84.75 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.982 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.759 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 29.0 tp -58.79 -23.04 59.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.729 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.45 ' HA ' ' CE1' ' A' ' 68' ' ' PHE . 37.9 t80 -76.02 -56.58 4.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.995 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.648 ' NZ ' ' HA ' ' A' ' 14' ' ' GLU . 25.2 pttm -71.52 -12.52 61.42 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.441 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 10.1 mtp -70.26 -37.98 75.02 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.199 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.704 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 3.3 mt -64.56 -57.6 10.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.997 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' A' ' 26' ' ' THR . 1.6 p30 -81.33 61.09 4.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.876 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.527 HG21 ' HD2' ' A' ' 38' ' ' ARG . 9.8 t -72.85 -14.51 61.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.333 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -138.21 -15.26 1.29 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.645 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 27.6 t-20 -64.18 -81.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.0 p -176.91 2.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.504 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.41 12.43 17.26 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 53.5 p -126.24 152.97 45.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.574 -0.813 . . . . 0.0 108.944 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.844 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 3.6 mt -110.0 103.22 15.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.665 HG22 ' OG1' ' A' ' 62' ' ' THR . 81.3 p -103.9 153.55 20.66 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.898 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.662 ' HZ ' ' HB3' ' A' ' 45' ' ' GLU . 59.8 t80 -34.12 -26.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 28' ' ' THR . 54.9 m-20 -80.5 -39.78 27.31 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.645 ' HG2' ' HB2' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -86.83 -29.6 22.12 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.531 178.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.701 ' CG ' HG23 ' A' ' 48' ' ' ILE . 2.1 tm? -39.91 -49.52 2.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.789 0.804 . . . . 0.0 109.644 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.813 ' HB3' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.24 -37.41 53.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.143 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.596 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 9.5 t70 -46.53 -27.73 1.2 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.08 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.704 ' HA2' ' HA ' ' A' ' 19' ' ' ILE . . . -55.92 -50.5 60.97 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.802 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.783 ' O ' HG12 ' A' ' 39' ' ' VAL . 2.2 mm? -92.59 -28.62 16.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.825 0.345 . . . . 0.0 110.766 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 34' ' ' ASP . 51.7 mtmt -56.94 -48.51 78.12 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.527 ' HD2' HG21 ' A' ' 21' ' ' THR . 25.8 ttt85 -59.74 -37.63 79.48 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.842 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -70.19 -21.99 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.811 -178.087 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.33 -27.11 4.28 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.052 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 74.1 m -65.03 154.54 37.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.689 0.28 . . . . 0.0 111.095 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -126.82 103.08 7.32 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.564 0.697 . . . . 0.0 111.241 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.827 HD13 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -111.61 166.87 10.79 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.397 -179.366 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.554 ' O ' HD13 ' A' ' 48' ' ' ILE . 17.3 ptt? -107.84 165.45 11.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.646 0.26 . . . . 0.0 110.829 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.694 ' HG3' ' HZ3' ' A' ' 33' ' ' LYS . 58.5 mp0 -51.82 -64.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.7 m -43.18 -17.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.517 ' HG3' ' HG3' ' A' ' 44' ' ' MET . 96.0 mt-10 -84.69 -41.59 16.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.827 HD11 HD13 ' A' ' 43' ' ' LEU . 1.5 mp -56.17 -49.77 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.44 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.54 ' CE ' ' HD3' ' A' ' 93' ' ' LYS . 4.3 ttmp? -57.95 -22.45 49.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.566 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.812 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 9.0 t70 -75.18 -25.7 58.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.622 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.779 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 62.4 tp -90.37 -30.89 17.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.05 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.775 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 39.1 ttm -88.02 -66.16 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.802 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.824 ' HA ' ' HG3' ' A' ' 59' ' ' LYS . 60.9 t0 -68.16 -38.77 82.45 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -86.75 -12.06 49.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.81 ' HB1' ' HA ' ' A' ' 71' ' ' ALA . . . -127.34 -44.12 1.58 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.65 ' HB3' ' O ' ' A' ' 52' ' ' MET . 63.2 t0 -53.97 132.67 42.69 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.2 mm -81.61 -14.75 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.805 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 60' ' ' SER . 74.0 m-20 -128.21 28.62 5.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.762 -178.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.824 ' HG3' ' HA ' ' A' ' 53' ' ' ASP . 12.1 tmtt? -31.61 90.68 0.0 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.937 0.875 . . . . 0.0 112.137 -177.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.7 p -128.26 18.39 6.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.519 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 81.72 15.42 75.61 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.65 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.715 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 40.4 m -155.82 128.47 7.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.494 0.318 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.844 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 52.9 mt -110.86 136.47 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 121.178 0.513 . . . . 0.0 110.941 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -104.6 168.96 8.74 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.161 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.604 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 26.6 t80 -40.6 -39.26 1.01 Allowed 'General case' 0 CA--C 1.519 -0.213 0 O-C-N 123.42 0.45 . . . . 0.0 111.093 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.9 -57.78 4.31 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.922 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.84 ' HB2' HG23 ' A' ' 63' ' ' ILE . 34.4 mt-10 -49.79 -20.77 0.92 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.242 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.759 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 68.6 t80 -69.89 -57.26 5.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.389 0.614 . . . . 0.0 110.653 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.464 HG23 HD22 ' A' ' 12' ' ' LEU . 1.2 mt -63.54 -40.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.16 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.92 -6.58 28.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.043 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.81 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.495 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.685 0.278 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 m -48.9 -30.37 5.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.396 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -81.53 -52.2 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.241 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.829 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 11.9 t80 -42.81 -26.5 0.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.278 0.561 . . . . 0.0 109.854 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.41 ' N ' ' C ' ' A' ' 87' ' ' ALA . 31.7 t -89.22 -58.33 2.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.952 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -77.03 -63.84 1.27 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.398 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.692 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.6 m-85 -55.47 -61.84 2.07 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.829 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 1.0 OUTLIER -74.55 60.41 0.88 Allowed 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.402 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.54 ' HD3' ' CE ' ' A' ' 49' ' ' LYS . 26.3 ttmt -47.61 -41.63 22.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.037 -177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 96' ' ' SER . 1.4 m-20 -79.73 -21.15 44.9 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.919 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . 65.06 -6.16 1.09 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.971 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 94' ' ' ASP . 86.1 p -55.7 -8.28 0.38 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.886 0.374 . . . . 0.0 110.894 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 108.17 -0.49 33.31 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.729 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.6 OUTLIER -139.24 154.1 47.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.675 0.75 . . . . 0.0 112.818 -178.649 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.692 HD13 ' HB3' ' A' ' 91' ' ' PHE . 85.9 mt -132.15 102.95 6.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.345 177.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.522 ' HA ' ' CB ' ' A' ' 132' ' ' GLN . 67.8 p -87.02 163.74 16.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.947 0.794 . . . . 0.0 111.226 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.664 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -35.95 -36.99 0.09 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.105 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.3 -54.15 44.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.905 0.383 . . . . 0.0 110.111 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.412 ' CB ' HG23 ' A' ' 99' ' ' ILE . 52.1 mt-10 -62.66 -31.42 72.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.143 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.666 HG22 ' N ' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -75.39 -64.97 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.666 ' N ' HG22 ' A' ' 104' ' ' ILE . 6.2 mt-30 -54.4 -31.88 56.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.688 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -73.19 -47.33 44.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.044 0.45 . . . . 0.0 110.078 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.82 -2.99 2.89 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.161 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 105' ' ' GLN . 24.2 p -135.58 39.66 2.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.094 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -67.54 -23.05 65.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.956 0.408 . . . . 0.0 110.477 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.36 -6.59 59.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.599 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -91.48 14.27 15.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.851 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.92 37.57 56.63 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.078 -1.058 . . . . 0.0 111.875 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.828 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -34.55 117.25 0.35 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.371 0.605 . . . . 0.0 112.042 -178.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.668 ' N ' HD22 ' A' ' 113' ' ' LEU . 54.5 m-20 -154.58 -177.09 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.027 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.744 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 12.3 p-10 -84.07 -7.65 59.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.436 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.6 mm -83.38 -64.77 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.433 ' O ' ' HB2' ' A' ' 121' ' ' MET . 4.6 m-70 -91.91 -68.5 0.79 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.828 HG13 ' HA ' ' A' ' 113' ' ' LEU . 40.5 mm -52.09 -20.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.214 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.744 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 8.1 t70 -76.5 -60.94 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 124' ' ' GLU . 33.9 m-20 -58.42 -17.09 17.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.762 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 14.2 ttp -67.51 -46.84 71.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.584 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.626 HG22 ' HA3' ' A' ' 131' ' ' GLY . 59.9 mt -48.74 -41.48 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 176.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 24.4 mmtp -87.36 -19.84 27.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.308 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.762 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 4.8 tp10 -76.12 -16.31 59.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.568 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.794 HG21 HD13 ' A' ' 133' ' ' ILE . 1.2 mt -117.15 -34.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.033 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.758 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 22.8 t70 -55.27 93.32 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.113 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.488 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 90.4 mt-30 -83.81 -9.27 58.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.009 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 6.6 p-10 -131.65 -30.6 1.63 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.412 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 25.1 p30 -176.79 -80.42 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 118.277 2.695 . . . . 0.0 118.277 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.627 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 15.7 m-20 -64.08 27.41 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -172.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.758 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 54.95 37.69 63.24 Favored Glycine 0 CA--C 1.498 -1.004 0 C-N-CA 118.184 -1.96 . . . . 0.0 108.893 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.644 ' OE1' ' HB3' ' A' ' 98' ' ' TYR . 5.4 pt20 -135.17 166.26 23.5 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.375 -0.912 . . . . 0.0 110.841 -176.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.794 HD13 HG21 ' A' ' 125' ' ' ILE . 4.4 mt -121.54 125.28 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.353 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -103.97 165.54 10.98 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.636 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.676 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 30.5 t80 -49.84 -24.42 2.43 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.763 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.88 -44.87 11.28 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.536 ' HG3' ' OD1' ' A' ' 134' ' ' ASP . 42.1 mt-10 -62.08 -62.75 1.56 Allowed 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.731 ' HD1' HG21 ' A' ' 133' ' ' ILE . 1.9 t80 -56.38 -32.63 64.97 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.2 -0.6 . . . . 0.0 112.111 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.74 -23.07 49.42 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.143 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.71 -51.2 5.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.037 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.543 ' SD ' ' HA ' ' A' ' 138' ' ' PHE . 27.3 ptm -49.11 -22.91 1.04 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.58 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 63.3 mtm . . . . . 0 C--N 1.332 -0.185 0 CA-C-O 120.868 0.366 . . . . 0.0 110.695 179.491 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.498 ' C ' HD13 ' A' ' 12' ' ' LEU . 3.2 tm? . . . . . 0 C--O 1.231 0.082 0 N-CA-C 110.771 -0.085 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -51.99 -38.96 58.56 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.101 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.696 ' O ' ' HG2' ' A' ' 18' ' ' MET . 38.6 tt0 -70.94 -49.72 42.53 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.635 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 55.5 tp -47.99 -33.12 7.39 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.037 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.489 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 32.1 t80 -60.05 -50.33 74.15 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.151 0.5 . . . . 0.0 110.927 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -79.95 -15.6 56.95 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.094 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.696 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 81.4 mmm -69.51 -28.73 66.29 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.363 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.72 HG21 HG23 ' A' ' 27' ' ' ILE . 0.9 OUTLIER -69.36 -59.11 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.636 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.765 ' HB3' ' O ' ' A' ' 26' ' ' THR . 2.1 p30 -80.84 45.66 0.83 Allowed 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.932 0.873 . . . . 0.0 111.771 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.643 HG21 ' HD2' ' A' ' 38' ' ' ARG . 15.1 t -66.0 -6.53 13.05 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.986 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.57 -7.17 2.87 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.443 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 24.2 t-20 -91.83 -93.86 0.14 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.698 -0.401 . . . . 0.0 112.063 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.6 p -177.36 14.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.498 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.47 17.17 9.49 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.185 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 74.0 p -125.17 158.98 32.62 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.879 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 1.6 mt -123.09 101.66 9.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.679 HG22 ' HB ' ' A' ' 62' ' ' THR . 76.7 p -103.28 156.87 17.41 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.385 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.43 ' HZ ' ' HB3' ' A' ' 45' ' ' GLU . 60.3 t80 -33.65 -38.49 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.98 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 9.6 t70 -71.18 -43.9 66.52 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 111.243 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -79.43 -27.72 41.7 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.65 178.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.045 HD12 HD12 ' A' ' 48' ' ' ILE . 1.6 tm? -50.75 -55.08 18.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.129 0.49 . . . . 0.0 109.965 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.587 ' HB3' HD11 ' A' ' 48' ' ' ILE . 1.1 ptmm? -77.02 -39.04 51.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.119 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 38.8 t70 -41.73 -41.18 2.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.562 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.99 91.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.443 -0.408 . . . . 0.0 114.097 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.826 HD22 HD11 ' A' ' 43' ' ' LEU . 2.2 mp -89.26 -45.07 9.81 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 41' ' ' SER . 17.4 ptpt -59.12 -21.92 60.04 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.643 ' HD2' HG21 ' A' ' 21' ' ' THR . 36.8 ttt-85 -79.57 -40.56 29.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.39 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 36' ' ' LEU . 2.9 p -78.98 -12.96 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.72 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.54 -44.62 1.19 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.375 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 69.4 m -52.96 161.9 0.71 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.681 0.277 . . . . 0.0 111.525 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -134.24 105.1 6.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.606 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.826 HD11 HD22 ' A' ' 36' ' ' LEU . 68.7 mt -108.42 166.15 10.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.007 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.431 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 32.1 mtm -109.21 165.7 11.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.773 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HB3' ' HZ ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -55.47 -59.79 4.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.128 -179.309 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.7 m -55.09 -17.6 4.28 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.924 0.329 . . . . 0.0 111.737 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.4 mm-40 -79.69 -48.42 13.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.045 HD12 HD12 ' A' ' 32' ' ' LEU . 6.1 mm -56.86 -51.96 61.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.915 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -46.97 -33.16 4.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.006 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 63.9 t0 -60.3 -45.31 93.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.484 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.838 HD12 HD11 ' A' ' 32' ' ' LEU . 67.3 mt -67.07 -14.77 63.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.604 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -87.6 -65.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.04 0.448 . . . . 0.0 111.804 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.66 -37.13 70.84 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -91.28 -13.63 32.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.16 -43.56 1.64 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.614 ' OD1' HG12 ' A' ' 63' ' ' ILE . 34.0 t70 -62.25 103.6 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.857 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.0 mm -43.35 -27.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.286 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.584 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.6 m-20 -133.63 44.66 2.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.035 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.604 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 1.2 tmtp? -31.99 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.819 0.818 . . . . 0.0 112.339 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.0 p -126.81 10.54 7.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.165 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 103.63 -15.31 53.11 Favored Glycine 0 C--O 1.238 0.35 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.597 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.876 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 5.4 t -140.49 148.81 41.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.67 0.272 . . . . 0.0 110.88 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.879 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 78.6 mt -108.88 142.42 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.03 0.443 . . . . 0.0 111.244 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -105.69 166.78 10.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.971 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.653 ' O ' HG13 ' A' ' 69' ' ' ILE . 31.2 t80 -40.58 -48.91 2.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.794 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.34 -59.17 7.03 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.783 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.673 ' HB2' HG23 ' A' ' 63' ' ' ILE . 48.9 mt-10 -45.47 -31.9 1.95 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.804 0.335 . . . . 0.0 110.726 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 16' ' ' PHE . 9.9 t80 -66.06 -55.0 18.82 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.378 0.609 . . . . 0.0 110.152 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.653 HG13 ' O ' ' A' ' 65' ' ' TYR . 10.8 mt -57.06 -65.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.061 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -44.85 -48.33 11.08 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.557 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.649 ' HB1' ' HB1' ' A' ' 55' ' ' ALA . . . . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.455 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.4 p . . . . . 0 C--O 1.232 0.168 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.4 m -56.46 -37.43 70.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.127 0.489 . . . . 0.0 109.797 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.531 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -82.66 -47.92 11.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.064 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.769 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 21.7 t80 -41.85 -30.0 0.23 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.551 0.691 . . . . 0.0 109.65 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -89.9 -47.58 7.78 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.194 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -84.99 -63.88 1.25 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.271 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.606 ' HB3' HD13 ' A' ' 99' ' ' ILE . 4.1 m-85 -56.53 -56.5 20.45 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.813 ' HA ' HG12 ' A' ' 99' ' ' ILE . 0.4 OUTLIER -77.81 54.69 1.29 Allowed 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.532 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.624 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 3.7 ttmp? -49.07 -38.28 23.77 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.778 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.405 ' HB2' ' OE2' ' A' ' 103' ' ' GLU . 8.6 t70 -75.43 -23.06 56.92 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.777 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.74 73.07 0.31 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.415 ' HG ' ' HD1' ' A' ' 98' ' ' TYR . 25.4 p -132.1 -28.59 1.72 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 134.56 7.13 2.2 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 113.925 -1.488 . . . . 0.0 113.037 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.831 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -150.87 160.73 43.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.451 0.643 . . . . 0.0 111.362 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.813 HG12 ' HA ' ' A' ' 92' ' ' ASP . 70.1 mt -133.96 102.78 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.884 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 103' ' ' GLU . 72.9 p -73.14 150.93 41.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.347 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.599 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -35.03 -34.25 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.642 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -62.13 -51.69 66.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.539 ' HB2' HG23 ' A' ' 99' ' ' ILE . 53.9 mt-10 -71.13 -29.44 65.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.954 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.778 HG13 HG22 ' A' ' 99' ' ' ILE . 27.1 mt -68.39 -64.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.981 0.42 . . . . 0.0 110.395 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.716 ' O ' HD23 ' A' ' 113' ' ' LEU . 29.2 mt-30 -55.49 -39.57 70.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.456 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -65.31 -31.93 73.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.048 0.451 . . . . 0.0 110.447 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.73 -4.09 3.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.145 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 9.8 p -105.04 118.27 36.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.133 0.492 . . . . 0.0 110.587 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -88.82 -61.32 1.73 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.257 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.88 -4.45 58.47 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 108' ' ' CYS . 2.8 m-85 -65.71 -18.15 65.12 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.501 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.59 38.95 97.25 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.611 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.999 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -33.27 149.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.242 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.646 ' OD2' HG22 ' A' ' 116' ' ' ILE . 26.7 t70 -160.48 178.89 9.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.185 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.433 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 53.6 p-10 -89.38 -8.45 53.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.921 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.646 HG22 ' OD2' ' A' ' 114' ' ' ASP . 6.6 tp -92.53 -57.6 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.545 ' N ' HG23 ' A' ' 116' ' ' ILE . 10.0 t-80 -91.47 -68.65 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.999 HG13 ' HA ' ' A' ' 113' ' ' LEU . 46.9 mm -54.02 -19.61 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.968 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.433 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 38.5 t70 -66.91 -41.9 86.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 124' ' ' GLU . 7.4 t70 -71.2 -26.04 62.78 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.943 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 3.7 ttt -57.77 -30.26 65.5 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.161 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.552 ' HB ' ' HD2' ' A' ' 123' ' ' LYS . 58.9 mt -58.84 -43.95 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.681 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 3.7 mptt -86.64 -13.32 45.93 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 113.271 -1.786 . . . . 0.0 110.351 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.943 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 36.5 tp10 -82.14 -27.77 32.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.753 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.719 HG22 ' CD1' ' A' ' 133' ' ' ILE . 45.0 mt -100.41 -33.88 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.278 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.721 ' CG ' ' H ' ' A' ' 131' ' ' GLY . 7.3 t70 -83.47 84.92 7.34 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.41 0.624 . . . . 0.0 110.318 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.533 ' CD ' ' H ' ' A' ' 127' ' ' GLN . 2.9 pm0 -88.09 -9.29 53.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.806 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.659 ' HB3' ' OE1' ' A' ' 137' ' ' GLU . 5.6 t70 -130.17 -19.52 3.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 -177.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.493 ' HB3' ' OD2' ' A' ' 126' ' ' ASP . 5.4 t-20 -115.37 -127.19 0.29 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -177.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -116.61 27.04 9.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -173.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.721 ' H ' ' CG ' ' A' ' 126' ' ' ASP . . . 94.65 37.11 5.37 Favored Glycine 0 CA--C 1.501 -0.836 0 N-CA-C 108.258 -1.937 . . . . 0.0 108.258 -177.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.549 ' OE1' ' HB3' ' A' ' 98' ' ' TYR . 2.9 pt20 -153.72 169.21 23.88 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.172 -1.514 . . . . 0.0 108.966 -177.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.719 ' CD1' HG22 ' A' ' 125' ' ' ILE . 25.9 mm -131.33 127.01 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-O 121.68 0.752 . . . . 0.0 111.067 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.831 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -102.09 160.51 14.45 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.208 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.736 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 24.4 t80 -41.64 -33.95 0.54 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.576 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.75 -35.54 18.89 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.855 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.659 ' OE1' ' HB3' ' A' ' 128' ' ' ASP . 61.2 mm-40 -62.11 -57.03 13.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.289 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.696 ' HD1' HG21 ' A' ' 133' ' ' ILE . 2.7 t80 -61.09 -38.37 86.02 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.14 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 142' ' ' MET . . . -58.71 -33.82 70.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.163 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.411 ' C ' ' N ' ' A' ' 142' ' ' MET . . . -90.72 -26.87 19.32 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.43 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.529 ' HG2' ' CD1' ' A' ' 138' ' ' PHE . 2.8 ppp? -51.6 -28.0 12.87 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 138' ' ' PHE . 17.1 ptp . . . . . 0 N--CA 1.444 -0.737 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.461 0.08 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.528 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 4.5 ttmp? -59.58 -51.35 70.21 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.659 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 84.8 tt0 -62.05 -30.73 71.18 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.134 178.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.72 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 40.4 tp -68.86 -30.33 68.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.662 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.415 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 22.0 t80 -68.16 -49.48 60.68 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.223 0.535 . . . . 0.0 110.333 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' A' ' 14' ' ' GLU . 60.2 pttt -75.66 -12.91 60.29 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.57 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 2.3 tpp -66.03 -28.91 69.22 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.862 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.585 HD12 HD13 ' A' ' 27' ' ' ILE . 3.3 mt -81.26 -55.01 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.052 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.583 ' OD1' ' HA ' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -82.71 62.8 6.51 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.775 0.798 . . . . 0.0 111.292 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 t -81.81 -11.75 58.83 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.173 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.3 p30 -138.36 -11.43 1.42 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -72.25 -81.92 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.143 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 p -175.8 5.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.684 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.58 20.94 7.07 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.51 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 68.5 p -139.22 150.63 45.76 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.042 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.714 ' O ' ' HA ' ' A' ' 62' ' ' THR . 3.8 mt -104.16 103.35 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.697 HG22 ' OG1' ' A' ' 62' ' ' THR . 71.2 p -104.31 162.55 13.11 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.492 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -34.11 -35.95 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.942 0.497 . . . . 0.0 111.821 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -77.36 -41.15 41.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 110.759 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.575 ' HG3' HG22 ' A' ' 19' ' ' ILE . 11.4 tp10 -77.09 -30.55 55.43 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.429 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.893 HD12 HG13 ' A' ' 48' ' ' ILE . 0.9 OUTLIER -41.18 -48.73 3.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.981 0.895 . . . . 0.0 109.732 -179.294 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.835 ' HB3' HD11 ' A' ' 43' ' ' LEU . 6.0 ptpt -85.15 -30.87 23.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.886 -1.507 . . . . 0.0 111.624 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 9.1 t70 -46.62 -46.1 19.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.345 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.15 -37.55 95.09 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.008 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.836 ' HG ' HD23 ' A' ' 43' ' ' LEU . 3.8 mm? -71.62 -58.18 3.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.574 ' NZ ' ' HE2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -58.58 -26.88 64.08 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.108 0.48 . . . . 0.0 110.41 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 56.4 ttt-85 -59.16 -49.45 77.81 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.397 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 36' ' ' LEU . 3.3 m -77.46 -14.25 14.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.33 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.89 -19.99 8.23 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.971 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 49.2 m -55.69 153.77 7.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.749 0.275 . . . . 0.0 110.963 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -131.64 104.17 6.79 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.446 0.641 . . . . 0.0 112.04 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.836 HD23 ' HG ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -116.58 167.6 10.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.865 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.493 ' CE ' ' HB2' ' A' ' 86' ' ' SER . 27.0 ptt? -109.67 165.22 11.85 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.516 0.198 . . . . 0.0 110.562 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -50.19 -55.63 14.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.353 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.554 ' OG ' ' HB2' ' A' ' 87' ' ' ALA . 44.5 t -48.53 -24.27 1.25 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.477 ' HG2' ' OG ' ' A' ' 86' ' ' SER . 49.2 mt-10 -71.15 -36.2 71.97 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.893 HG13 HD12 ' A' ' 32' ' ' LEU . 1.9 mp -66.42 -60.61 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.747 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.448 ' HE3' ' CE1' ' A' ' 111' ' ' PHE . 22.1 ttmm -54.5 -31.26 55.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.489 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 35.8 t70 -70.9 -45.18 64.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.244 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.867 HD23 HD21 ' A' ' 32' ' ' LEU . 36.0 tp -66.35 -16.56 64.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.529 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.677 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 23.5 mmt -85.45 -60.85 1.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.291 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -76.12 -39.32 55.4 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.859 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -82.72 -19.08 38.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.51 -43.98 1.56 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.656 ' HB3' ' O ' ' A' ' 52' ' ' MET . 33.3 t70 -60.26 107.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.214 0.531 . . . . 0.0 110.199 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.452 HD11 ' CB ' ' A' ' 70' ' ' ALA . 7.1 mt -49.45 -25.08 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.676 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.528 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 74.8 m-20 -130.4 44.03 3.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.023 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.677 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 1.3 tmtp? -31.98 92.3 0.01 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.798 0.808 . . . . 0.0 112.468 -177.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' ASP . 82.8 p -128.0 10.46 6.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.796 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 81.45 17.33 71.46 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.601 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 53.2 m -153.94 127.19 8.48 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.42 0.288 . . . . 0.0 110.371 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.661 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 64.2 mt -107.5 132.44 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.034 0.445 . . . . 0.0 111.479 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -105.19 168.15 9.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.3 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.528 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 28.4 t80 -35.82 -48.23 0.54 Allowed 'General case' 0 N--CA 1.464 0.23 0 O-C-N 123.296 0.372 . . . . 0.0 111.913 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.92 -64.0 3.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.709 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.636 ' HB2' HG23 ' A' ' 63' ' ' ILE . 63.7 mt-10 -50.57 -26.18 4.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.764 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 68.2 t80 -62.0 -61.85 2.19 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.48 0.657 . . . . 0.0 110.894 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.569 HD13 ' HD2' ' A' ' 68' ' ' PHE . 10.4 mm -55.07 -50.62 61.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.777 -178.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.452 ' CB ' HD11 ' A' ' 57' ' ' ILE . . . -62.31 -12.5 21.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.936 0.398 . . . . 0.0 111.261 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.597 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.447 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.421 ' HA ' ' CB ' ' A' ' 88' ' ' PHE . 22.0 m . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.493 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 53.1 m -34.98 -65.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.15 0.281 . . . . 0.0 111.701 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.672 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -73.29 -38.55 65.84 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.69 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 25.4 t80 -43.16 -23.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.913 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.1 t -88.88 -42.53 11.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.737 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -82.76 -62.92 1.47 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.592 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.9 m-85 -53.61 -62.82 1.41 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.465 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.605 ' HA ' HG12 ' A' ' 99' ' ' ILE . 1.2 m-20 -79.0 50.16 1.0 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 89' ' ' SER . 37.3 ttmt -36.66 -59.81 0.64 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.629 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -83.48 -20.93 33.11 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.705 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.25 85.69 0.01 OUTLIER Glycine 0 N--CA 1.424 -2.156 0 CA-C-O 121.713 0.618 . . . . 0.0 112.887 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.4 p -100.58 -14.62 18.11 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 124.44 -4.02 8.8 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 111.526 -2.579 . . . . 0.0 110.942 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.689 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.1 OUTLIER -147.9 165.67 29.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.764 -0.718 . . . . 0.0 110.746 178.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.696 HG23 ' HB2' ' A' ' 103' ' ' GLU . 72.4 mt -131.75 104.15 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.512 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 102' ' ' ASP . 71.5 p -72.12 147.08 47.03 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.702 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -34.27 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 106' ' ' GLN . 34.6 t70 -57.16 -56.59 19.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.696 ' HB2' HG23 ' A' ' 99' ' ' ILE . 48.7 mt-10 -69.47 -32.29 71.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.163 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -61.39 -50.07 81.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.179 0.514 . . . . 0.0 110.723 179.228 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.588 ' CD ' HD11 ' A' ' 122' ' ' ILE . 19.3 mt-30 -71.94 -49.45 37.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.031 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 102' ' ' ASP . 87.0 mt-30 -55.83 -41.84 74.85 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.837 0.351 . . . . 0.0 110.979 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.13 -4.01 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.246 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.762 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 74.3 m -119.93 67.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.812 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.748 ' HD3' ' H ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -80.2 -36.34 35.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 -179.781 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -89.04 -5.0 58.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.762 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 4.2 m-85 -83.81 5.08 26.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.744 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.75 37.55 13.35 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.783 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.898 ' HA ' HG13 ' A' ' 118' ' ' ILE . 2.3 tm? -33.88 105.21 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.319 0.58 . . . . 0.0 111.327 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.496 ' OD1' HG12 ' A' ' 116' ' ' ILE . 10.3 t70 -160.5 156.05 25.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.754 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.668 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 10.7 p-10 -64.19 -7.73 10.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.067 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.496 HG12 ' OD1' ' A' ' 114' ' ' ASP . 49.0 mm -80.66 -64.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.586 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -91.69 -68.26 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.898 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.5 mm -48.17 -19.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.257 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.668 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 8.8 t70 -78.12 -59.1 2.92 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 124' ' ' GLU . 34.8 t70 -59.52 -17.15 29.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.775 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 25.2 ttp -64.27 -42.66 96.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.577 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.613 HG22 ' HA3' ' A' ' 131' ' ' GLY . 53.8 mt -54.89 -49.33 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.84 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.654 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -76.92 -13.27 60.0 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.513 178.231 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.775 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 40.3 tp10 -84.06 -25.44 29.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.262 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.05 HG22 HD11 ' A' ' 133' ' ' ILE . 31.2 mt -107.41 -15.74 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 1.01 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 1.9 t70 -77.76 82.74 4.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.025 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -88.63 -9.36 52.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.663 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 45.0 t0 -116.15 -35.49 4.36 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.465 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 17.0 p30 -179.97 -84.82 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.638 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 34.8 t70 -65.36 15.78 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -172.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 1.01 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.56 38.85 83.27 Favored Glycine 0 CA--C 1.509 -0.313 0 C-N-CA 117.223 -2.417 . . . . 0.0 109.193 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.638 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 2.5 pt20 -134.61 167.4 20.88 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 113.461 -1.369 . . . . 0.0 108.692 -177.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.05 HD11 HG22 ' A' ' 125' ' ' ILE . 5.8 mm -129.14 125.26 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 122.26 1.028 . . . . 0.0 111.532 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 1.001 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 6.4 t70 -103.14 152.09 21.83 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.969 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.69 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 17.1 t80 -40.96 -42.68 1.93 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.749 0.309 . . . . 0.0 110.931 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -82.77 -28.53 38.1 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.883 178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 1.001 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 31.9 mt-10 -68.92 -59.07 3.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.672 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 13.4 t80 -50.41 -18.53 0.66 Allowed 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.392 0.615 . . . . 0.0 109.776 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -78.48 -40.21 36.08 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.519 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -90.13 -12.8 37.22 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.703 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.49 ' HG2' ' CD1' ' A' ' 138' ' ' PHE . 4.9 ppp? -55.8 -27.68 52.36 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.735 0.302 . . . . 0.0 111.238 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 110.227 179.095 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.814 0.34 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -126.74 -10.93 6.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.008 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.442 ' C ' ' HD2' ' A' ' 3' ' ' ARG . 4.6 tmm_? -162.18 115.91 1.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.344 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.7 tp -159.63 -43.43 0.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.801 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.8 t -95.39 179.67 5.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.81 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -109.33 41.96 1.55 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.975 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -64.27 -16.67 62.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.73 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.13 -43.3 99.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.996 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 9' ' ' ILE . 2.0 mp -67.48 -69.02 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.907 0.384 . . . . 0.0 111.264 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 12' ' ' LEU . . . -166.13 165.88 38.42 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.61 77.87 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.494 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 10' ' ' GLY . 31.4 tp -88.25 -46.72 8.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.516 0.198 . . . . 0.0 110.605 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.635 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 6.3 ttpm? -55.83 -30.93 62.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.76 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 8.1 mp0 -76.97 -38.3 53.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.959 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.735 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 54.5 tp -55.01 -28.12 49.62 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.681 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -70.6 -45.07 66.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.776 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.76 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 63.5 pttt -82.47 -12.5 57.78 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.589 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.44 -25.9 68.21 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.431 178.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.532 HG23 ' HA3' ' A' ' 35' ' ' GLY . 3.2 mt -86.39 -59.4 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.511 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.549 ' OD2' ' HA2' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -82.62 57.35 3.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.347 0.594 . . . . 0.0 110.547 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.662 HG21 ' NH2' ' A' ' 38' ' ' ARG . 13.6 t -81.24 -6.72 59.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.16 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -129.2 -14.61 4.3 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.564 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -74.42 -87.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.802 0.334 . . . . 0.0 111.208 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 p -176.66 6.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.817 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.42 31.48 2.79 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.492 ' HB ' ' CG2' ' A' ' 62' ' ' THR . 45.9 p -150.07 145.78 26.57 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.189 -0.505 . . . . 0.0 109.946 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.823 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.2 mt -102.87 103.91 15.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.629 HG22 ' OG1' ' A' ' 62' ' ' THR . 68.3 p -103.42 164.84 11.39 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.551 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 20.5 t80 -34.09 -36.4 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.683 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.19 -49.84 16.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.715 0.293 . . . . 0.0 111.659 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.652 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -75.72 -19.9 58.74 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.922 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.892 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -46.03 -47.38 16.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.914 0.864 . . . . 0.0 108.693 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.709 ' HG2' HG12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -85.43 -51.89 6.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.485 179.243 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.652 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 59.3 m-20 -36.34 -36.17 0.09 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.532 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -68.02 -57.34 8.76 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 115.114 0.805 . . . . 0.0 115.114 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.697 HD21 ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -73.85 -28.55 61.65 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.163 0.981 . . . . 0.0 111.989 -177.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.635 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 19.4 ptpt -66.14 -4.7 7.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.662 ' NH2' HG21 ' A' ' 21' ' ' THR . 36.9 ttm180 -87.15 -42.71 12.8 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.249 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 36' ' ' LEU . 30.8 m -73.44 -0.22 2.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.81 -36.93 3.71 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.352 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.604 ' CB ' HD23 ' A' ' 36' ' ' LEU . 18.5 m -52.45 153.02 3.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.471 0.177 . . . . 0.0 110.553 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -143.3 103.79 4.17 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.298 0.57 . . . . 0.0 112.142 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.7 HD11 ' HB3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -105.35 167.98 9.38 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.124 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 5.3 mtm -104.66 165.51 11.01 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.535 ' HA ' HD13 ' A' ' 48' ' ' ILE . 92.8 mt-10 -47.71 -59.99 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.495 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 94.4 p -39.47 -34.99 0.25 Allowed 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 44' ' ' MET . 37.2 mp0 -66.38 -41.03 89.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.053 0.454 . . . . 0.0 110.172 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.892 HG13 HD12 ' A' ' 32' ' ' LEU . 2.0 mp -57.06 -60.49 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.984 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.551 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 42.4 tttm -64.45 -25.6 68.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.318 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 46' ' ' SER . 62.6 t0 -71.13 -37.45 72.29 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.607 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.52 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 10.2 tt -76.36 -23.07 54.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.024 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.752 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 18.2 mmt -71.88 -45.01 62.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.122 0.487 . . . . 0.0 111.518 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.52 -30.29 20.71 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.988 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.55 -19.31 22.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.02 -43.81 1.65 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.752 ' HB3' ' O ' ' A' ' 52' ' ' MET . 15.6 t0 -61.24 95.98 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.3 mm -48.65 -22.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.031 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.58 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 59.0 t0 -129.11 44.5 2.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.818 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.702 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.5 tmtm? -32.57 90.38 0.0 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.74 0.781 . . . . 0.0 112.662 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.1 p -127.74 18.04 6.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.151 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 70.88 17.76 75.58 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.384 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 86.1 m -150.36 127.15 11.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.542 0.337 . . . . 0.0 110.561 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.823 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 70.1 mt -108.06 129.46 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 121.055 0.455 . . . . 0.0 111.367 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' OD1' HG22 ' A' ' 26' ' ' THR . 56.3 m-20 -105.06 167.33 9.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.09 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.635 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 47.9 t80 -35.52 -45.78 0.37 Allowed 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.389 0.431 . . . . 0.0 111.474 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.38 -63.7 4.12 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.331 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.784 ' HB2' HG23 ' A' ' 63' ' ' ILE . 63.0 mt-10 -51.92 -26.11 9.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.662 0.267 . . . . 0.0 110.905 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.735 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 71.9 t80 -63.87 -65.18 0.72 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.434 0.635 . . . . 0.0 110.879 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.614 HD13 ' HD2' ' A' ' 68' ' ' PHE . 14.5 mm -52.13 -41.17 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.653 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.23 -25.76 66.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.0 110.59 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.07 -12.55 26.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.035 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.404 HG21 HD11 ' A' ' 12' ' ' LEU . 37.5 m -87.74 -43.69 11.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.738 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.632 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 58.0 t -67.03 -18.11 23.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.117 0.484 . . . . 0.0 110.581 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -71.02 -47.56 58.01 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.7 mt -81.79 0.94 36.98 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.238 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.632 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 52.8 t-20 -102.78 75.28 1.4 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.007 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -175.4 -156.27 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.294 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.6 mm? -99.19 60.03 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 110.46 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -104.55 150.41 24.65 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.005 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -139.39 100.31 3.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.737 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -165.81 38.89 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.075 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -90.61 22.1 3.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.969 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -109.05 -155.98 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.598 HD21 ' HA ' ' A' ' 139' ' ' ALA . 7.3 mp -57.14 -29.58 63.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.561 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.496 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 14.4 p -45.67 -27.67 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.721 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.7 m -51.05 -55.01 19.66 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.402 . . . . 0.0 110.173 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.584 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -81.18 -39.77 24.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.902 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.808 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 8.1 t80 -45.95 -23.04 0.25 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.366 0.603 . . . . 0.0 110.055 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.3 t -89.13 -44.79 10.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.769 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -89.3 -63.65 1.26 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.609 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.5 m-85 -51.98 -62.36 1.68 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.808 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.6 OUTLIER -76.13 55.29 0.93 Allowed 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 176.123 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -44.53 -52.91 7.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.451 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.35 -21.46 64.73 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.328 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.08 68.61 1.09 Allowed Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.4 p -115.54 -23.06 8.95 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 134' ' ' ASP . . . 130.58 -4.55 5.84 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 113.162 -1.836 . . . . 0.0 112.606 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.896 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.5 OUTLIER -148.62 161.82 40.94 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.792 HG12 ' HA ' ' A' ' 92' ' ' ASP . 22.1 mt -133.09 104.27 6.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.833 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 102' ' ' ASP . 69.6 p -72.3 147.1 46.69 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.709 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.1 pp -34.44 -33.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.526 ' N ' HD12 ' A' ' 101' ' ' LEU . 54.2 m-20 -54.35 -55.89 24.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.56 ' HB2' HG23 ' A' ' 99' ' ' ILE . 97.4 mt-10 -71.21 -31.43 67.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.174 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.668 HG13 HG22 ' A' ' 99' ' ' ILE . 51.1 mt -65.74 -65.25 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.166 0.508 . . . . 0.0 110.439 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.858 ' HB3' HD12 ' A' ' 113' ' ' LEU . 30.8 mt-30 -58.14 -39.05 77.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.636 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.84 -44.12 94.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.082 0.468 . . . . 0.0 110.66 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.7 -3.05 1.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.145 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.788 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 73.2 m -115.09 44.07 1.88 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.922 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -59.54 -36.63 76.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.841 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -75.09 -22.12 58.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.11 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.788 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 2.7 m-85 -76.78 -5.18 47.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.953 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 113' ' ' LEU . . . 62.35 38.8 96.85 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.036 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.928 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -33.09 132.74 0.15 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.545 0.688 . . . . 0.0 111.501 -177.125 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.717 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 91.9 m-20 -135.99 167.69 20.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.217 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.635 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.6 m-20 -82.88 -7.98 59.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.178 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.59 -64.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.068 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -89.52 -69.24 0.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.928 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.3 mm -52.77 -19.45 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.942 0.401 . . . . 0.0 111.238 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.635 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 33.6 t70 -71.14 -46.91 60.59 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' GLU . 63.9 t0 -62.37 -26.27 68.37 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' MET . . . . . 1.026 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.5 ttt -60.75 -29.87 69.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.474 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.777 HG22 ' HA3' ' A' ' 131' ' ' GLY . 56.8 mt -58.32 -43.62 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.477 ' CE ' ' HB ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -86.67 -13.8 44.46 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.367 178.534 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 1.026 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 71.5 tt0 -84.61 -23.73 29.45 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.789 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.856 HG22 HD11 ' A' ' 133' ' ' ILE . 13.6 mm -107.56 -21.8 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.977 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.4 t70 -62.8 98.37 0.12 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.594 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.605 ' HG3' ' HB3' ' A' ' 140' ' ' ALA . 5.4 tm0? -87.23 -13.95 42.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.417 ' OD1' ' OE2' ' A' ' 137' ' ' GLU . 50.6 p30 -127.57 -33.19 2.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 20.7 p-10 179.96 -71.76 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.413 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 56.3 m-20 -64.92 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -173.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.977 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.53 37.93 78.04 Favored Glycine 0 CA--C 1.505 -0.566 0 C-N-CA 118.348 -1.882 . . . . 0.0 110.04 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.562 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 2.7 pt20 -133.33 170.53 15.33 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 113.895 -1.152 . . . . 0.0 110.075 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.042 HD13 ' HB3' ' A' ' 137' ' ' GLU . 5.0 mm -133.02 121.88 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.909 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 4.3 p-10 -113.01 162.47 15.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.161 177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.796 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 22.5 t80 -38.76 -30.48 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.768 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.733 ' HA3' ' N ' ' A' ' 153' ' ' ARG . . . -84.27 -45.16 6.31 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.728 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 1.042 ' HB3' HD13 ' A' ' 133' ' ' ILE . 39.3 mt-10 -63.04 -51.3 67.29 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 13.6 t80 -56.62 -18.68 12.86 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.598 ' HA ' HD21 ' A' ' 84' ' ' LEU . . . -86.06 -40.85 15.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.151 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.605 ' HB3' ' HG3' ' A' ' 127' ' ' GLN . . . -87.25 -11.66 49.04 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' A' ' 138' ' ' PHE . 5.5 ppp? -72.41 -6.68 45.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.635 0.255 . . . . 0.0 111.557 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -134.97 -31.13 1.02 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.994 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.564 ' HG2' ' H ' ' A' ' 144' ' ' LYS . 62.1 ttt180 -112.11 -137.62 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.438 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.564 ' H ' ' HG2' ' A' ' 143' ' ' ARG . 95.5 mttt -131.23 -175.53 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.623 0.249 . . . . 0.0 110.57 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.727 ' H ' ' HE ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -101.29 78.32 1.88 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.272 0.558 . . . . 0.0 111.855 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.745 ' HB2' ' HZ3' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -53.76 155.57 3.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.916 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -85.87 -4.78 84.48 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.862 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -79.78 161.67 25.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.816 0.341 . . . . 0.0 111.107 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -47.75 -23.75 2.54 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.998 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -42.54 -26.0 0.36 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.356 -0.45 . . . . 0.0 113.032 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.69 ' HA ' ' NH1' ' A' ' 153' ' ' ARG . 44.1 mt -48.78 149.11 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 CA-C-O 120.751 0.31 . . . . 0.0 111.113 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.416 ' H ' ' HD2' ' A' ' 153' ' ' ARG . . . -159.02 -4.59 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.413 -0.898 . . . . 0.0 111.889 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.89 ' H ' ' HD2' ' A' ' 153' ' ' ARG . 4.2 mpt_? -53.78 170.55 0.12 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.786 0.326 . . . . 0.0 110.13 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.572 HH11 ' H ' ' A' ' 155' ' ' THR . 23.3 tpt85 -71.19 149.02 46.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.179 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.572 ' H ' HH11 ' A' ' 154' ' ' ARG . 56.5 m -50.23 80.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.341 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 154' ' ' ARG . 27.8 ttt -175.9 -18.64 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.213 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.523 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 6.7 ppt_? -63.22 -15.53 57.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.139 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.801 ' HG3' HG22 ' A' ' 159' ' ' THR . 4.9 tppp? -161.49 -87.23 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.801 HG22 ' HG3' ' A' ' 158' ' ' LYS . 6.9 t -162.96 -36.42 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.766 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 97.2 mt -78.47 179.48 7.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.774 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -103.96 -101.17 0.31 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.786 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.1 tp -174.83 154.35 1.89 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.623 0.249 . . . . 0.0 110.821 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -89.75 138.85 31.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.689 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -78.05 146.14 35.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.866 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.69 165.03 13.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.063 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 167' ' ' GLY . 2.7 pp -94.84 -10.03 32.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.191 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.493 ' N ' HD12 ' A' ' 166' ' ' LEU . . . 146.74 150.03 5.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.597 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 97.4 mt -100.15 139.16 36.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.88 149.76 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.932 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -156.72 156.18 32.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 111.155 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -100.23 -49.57 4.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.652 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.14 -174.48 31.3 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.476 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 81.1 p -159.65 174.52 14.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -119.56 -174.76 2.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.952 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -101.85 107.92 19.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.799 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.08 141.46 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.344 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 tp -123.85 130.11 74.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -132.53 141.36 48.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -171.7 -65.82 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.376 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.75 -13.11 22.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.86 0.362 . . . . 0.0 110.804 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -110.72 136.86 49.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.827 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.559 ' N ' ' HD3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.592 ' HB3' ' NH2' ' A' ' 3' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.813 0.339 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -125.03 -32.08 3.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.045 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.592 ' NH2' ' HB3' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -157.37 169.23 25.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.817 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.499 HD12 ' C ' ' A' ' 3' ' ' ARG . 6.4 mp -115.84 112.55 22.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -77.82 -15.14 59.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.998 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -83.98 17.95 2.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -67.55 -23.68 65.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.73 -29.17 69.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.781 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.7 mt -69.6 -20.15 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.86 135.45 12.54 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.477 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 14' ' ' GLU . . . 119.76 -39.98 2.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.166 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 15' ' ' LEU . 46.5 tp -71.66 -29.24 64.39 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.651 ' HG3' ' OE1' ' A' ' 14' ' ' GLU . 20.6 pttp -58.59 -24.99 62.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.651 ' OE1' ' HG3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -80.43 -52.27 7.85 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.593 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.637 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 31.0 tp -47.23 -30.2 2.85 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.847 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.497 ' CZ ' ' N ' ' A' ' 65' ' ' TYR . 20.1 t80 -66.61 -52.04 49.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.164 0.506 . . . . 0.0 110.446 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -76.0 -13.06 60.23 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.625 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 63.4 mmm -71.04 -22.61 62.12 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.499 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.664 HG23 ' HA3' ' A' ' 35' ' ' GLY . 10.9 mm -77.42 -61.31 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.269 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.509 ' OD1' ' HA ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -80.23 66.79 5.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.534 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 t -82.75 -6.34 59.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.348 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -131.75 -27.28 1.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -69.82 -82.45 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.1 p -175.91 5.42 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.46 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 111.11 27.13 4.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.373 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.414 ' HB ' ' CG2' ' A' ' 62' ' ' THR . 64.8 p -143.66 149.18 36.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.034 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.86 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.1 mt -103.43 103.02 14.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.654 HG22 ' OG1' ' A' ' 62' ' ' THR . 66.9 p -104.16 162.29 13.3 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.129 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.625 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 44.1 t80 -34.03 -27.87 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 28' ' ' THR . 56.1 m-20 -82.51 -45.06 15.17 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.791 0.329 . . . . 0.0 111.159 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 8.0 mp0 -83.13 -15.13 51.93 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.901 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.71 HD12 HG13 ' A' ' 48' ' ' ILE . 2.2 tm? -53.03 -50.16 64.84 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.909 ' HB2' ' HE3' ' A' ' 37' ' ' LYS . 12.5 ptpt -82.59 -46.15 13.68 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.091 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.609 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 31.0 t70 -42.86 -64.9 0.54 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.664 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -46.43 -28.36 3.33 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.142 -0.552 . . . . 0.0 113.633 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.682 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -90.1 -59.68 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.986 0.393 . . . . 0.0 110.772 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.909 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 18.8 ptpt -60.43 -9.55 3.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.032 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.429 ' C ' ' HD3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -68.3 -34.67 76.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.868 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 36' ' ' LEU . 31.4 m -80.84 -8.72 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.393 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.7 -17.66 5.48 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.842 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 65.1 m -63.42 168.51 4.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.964 0.412 . . . . 0.0 111.445 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -147.57 111.12 4.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.608 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.7 mt -120.55 165.83 14.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.374 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.509 ' O ' HD13 ' A' ' 48' ' ' ILE . 24.0 ptt? -114.15 162.43 16.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 47' ' ' GLU . 44.4 mt-10 -47.63 -65.43 0.57 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 80.8 p -41.73 -18.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 55.8 mt-10 -89.72 -47.57 7.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.71 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -53.64 -59.78 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.912 0.863 . . . . 0.0 109.138 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 1.018 ' HD3' ' HD2' ' A' ' 93' ' ' LYS . 21.8 ttmm -55.15 -27.39 45.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.212 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 8.8 t70 -69.9 -45.05 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.153 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 51' ' ' LEU . 9.7 tt -68.26 -21.67 64.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.086 0.47 . . . . 0.0 109.966 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.713 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 13.4 mmt -71.93 -44.01 64.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.855 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 90' ' ' TYR . 9.7 t70 -87.05 -18.04 31.51 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.672 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.454 ' HA ' ' OE2' ' A' ' 81' ' ' GLU . . . -91.58 -42.36 10.26 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.876 ' HB1' ' HA ' ' A' ' 71' ' ' ALA . . . -110.7 -43.13 3.88 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.713 ' HB3' ' O ' ' A' ' 52' ' ' MET . 12.3 t0 -49.39 97.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.706 -0.398 . . . . 0.0 109.979 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.7 mm -54.75 -17.53 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.276 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.561 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 38.9 t70 -132.21 44.48 2.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.951 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.613 ' HD3' ' C ' ' A' ' 52' ' ' MET . 27.1 tptp -30.94 88.03 0.0 OUTLIER 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.5 p -128.7 18.94 6.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.469 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 71.32 17.12 75.81 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.725 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 51.0 m -151.69 128.03 10.61 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.949 -0.625 . . . . 0.0 110.723 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.86 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.7 mt -105.06 133.41 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 120.927 0.394 . . . . 0.0 110.67 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -105.49 167.75 9.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.325 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.568 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 14.9 t80 -35.82 -46.89 0.48 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.476 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.51 -54.07 7.98 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.65 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.744 ' HB2' HG23 ' A' ' 63' ' ' ILE . 48.5 mt-10 -53.25 -24.05 10.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.294 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.637 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 57.1 t80 -67.8 -60.41 2.54 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.505 0.669 . . . . 0.0 110.487 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 65' ' ' TYR . 8.5 mm -49.21 -49.27 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.813 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.682 ' HA ' HG12 ' A' ' 73' ' ' VAL . . . -59.42 -47.25 86.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.806 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.876 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . -44.73 -27.62 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.202 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.9 p -90.94 -51.09 5.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.85 0.357 . . . . 0.0 110.446 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.682 HG12 ' HA ' ' A' ' 70' ' ' ALA . 3.6 p -62.04 -15.16 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.696 0.76 . . . . 0.0 110.031 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -76.36 -50.97 12.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.132 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 71' ' ' ALA . 61.1 mt -60.0 -16.12 28.15 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.577 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 24.1 t-20 -122.3 74.75 1.19 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.595 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 76' ' ' ASN . 14.6 mmtp -174.42 -153.91 0.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.39 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' H ' ' HB3' ' A' ' 77' ' ' LYS . 90.4 mt -100.78 62.27 1.01 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.482 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -44.36 110.8 0.24 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.518 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.461 ' C ' ' HD3' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -139.3 119.86 14.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.202 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.454 ' OE2' ' HA ' ' A' ' 54' ' ' ALA . 55.5 mt-10 -120.47 133.14 55.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.252 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.99 90.47 0.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.888 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.536 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 20.9 t-20 -152.82 164.33 38.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.882 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.528 HD13 ' C ' ' A' ' 84' ' ' LEU . 3.4 tm? -70.71 -64.22 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.766 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.433 HG12 ' OD1' ' A' ' 83' ' ' ASN . 9.9 p -63.19 -28.34 44.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.842 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.536 ' HB3' ' HB3' ' A' ' 83' ' ' ASN . 90.9 p -52.8 -34.85 55.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 110.12 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -82.22 -52.69 6.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.161 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.722 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 10.9 t80 -44.25 -26.43 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.056 0.455 . . . . 0.0 110.359 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 t -89.73 -47.69 7.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.66 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.466 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 1.0 OUTLIER -82.64 -62.75 1.52 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.378 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.0 m-85 -56.36 -64.62 0.8 Allowed 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.818 ' HA ' HG12 ' A' ' 99' ' ' ILE . 11.9 t0 -76.85 69.2 3.15 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 1.018 ' HD2' ' HD3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -44.43 -40.85 5.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.347 -177.022 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.3 m-20 -78.5 -21.35 49.05 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.889 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.62 -8.06 0.57 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.676 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 94' ' ' ASP . 72.2 p -55.37 -9.07 0.4 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 122.628 0.371 . . . . 0.0 111.203 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 134' ' ' ASP . . . 107.28 -6.54 36.6 Favored Glycine 0 C--O 1.216 -1.029 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.683 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -127.46 145.69 50.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.991 0.424 . . . . 0.0 112.01 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.818 HG12 ' HA ' ' A' ' 92' ' ' ASP . 65.5 mt -131.99 102.93 6.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.368 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 132' ' ' GLN . 44.0 p -76.27 152.84 36.37 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.257 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HB3' HG23 ' A' ' 122' ' ' ILE . 3.7 pp -35.47 -39.03 0.12 Allowed 'General case' 0 N--CA 1.461 0.125 0 O-C-N 123.194 0.309 . . . . 0.0 111.139 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -50.89 -57.08 9.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.147 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.607 ' HB2' HG23 ' A' ' 99' ' ' ILE . 50.4 mt-10 -63.82 -32.17 73.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.597 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.745 HG13 HG22 ' A' ' 99' ' ' ILE . 91.3 mt -70.36 -66.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 111.19 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.435 ' OE1' ' HA ' ' A' ' 119' ' ' ASP . 30.2 mt-30 -56.39 -35.76 68.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.289 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -55.69 -40.37 72.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.774 0.321 . . . . 0.0 110.543 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.54 -65.24 0.66 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.239 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.537 ' HB3' ' CG ' ' A' ' 111' ' ' PHE . 83.3 m -64.4 76.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.509 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.529 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 1.0 OUTLIER -88.8 -43.91 10.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.597 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -72.72 -4.68 32.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.721 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.537 ' CG ' ' HB3' ' A' ' 108' ' ' CYS . 1.2 m-85 -81.86 -1.17 46.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.775 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.18 37.2 94.13 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.598 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.72 ' O ' HD12 ' A' ' 113' ' ' LEU . 2.1 pp -34.06 144.5 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.674 0.75 . . . . 0.0 112.875 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 119' ' ' ASP . 11.2 p-10 -160.16 -164.06 1.22 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.986 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.686 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 2.8 p30 -87.73 -7.93 56.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.12 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.406 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 50.7 mm -89.45 -64.69 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.47 ' O ' ' HB2' ' A' ' 121' ' ' MET . 18.0 t-160 -92.06 -68.51 0.79 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 113' ' ' LEU . 2.2 mp -56.89 -20.31 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.686 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 38.8 t70 -79.71 -59.25 2.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' GLU . 1.2 m-20 -59.2 -17.24 25.99 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.758 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 22.4 ttp -59.72 -39.65 85.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.333 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.532 HG22 ' HA3' ' A' ' 131' ' ' GLY . 59.7 mt -54.69 -45.0 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -84.15 -13.6 52.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.98 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.758 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 15.9 tp10 -78.18 -27.8 48.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.894 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.767 HG21 ' CD1' ' A' ' 133' ' ' ILE . 22.6 mt -109.06 -7.87 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.818 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.619 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 28.0 t70 -73.78 81.34 1.59 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.112 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.927 HE22 ' HB3' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -87.54 -9.36 54.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.052 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 154' ' ' ARG . 6.3 m-20 -119.87 -34.56 3.7 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.551 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 10.4 p-10 179.63 -80.89 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 118.438 2.755 . . . . 0.0 118.438 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.832 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 5.7 t70 -64.32 -17.68 63.91 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 118.813 2.894 . . . . 0.0 118.813 -171.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.619 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 92.15 37.13 6.05 Favored Glycine 0 CA--C 1.501 -0.836 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.832 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 3.2 pt20 -139.15 166.53 24.28 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 112.729 -1.735 . . . . 0.0 108.957 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.767 ' CD1' HG21 ' A' ' 125' ' ' ILE . 48.0 mt -123.29 128.32 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 121.441 0.638 . . . . 0.0 110.805 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.843 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 1.5 t70 -104.16 157.9 16.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.476 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.722 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 18.9 t80 -39.33 -46.24 1.56 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.376 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 153' ' ' ARG . . . -67.91 -44.01 80.68 Favored Glycine 0 N--CA 1.422 -2.279 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.303 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.927 ' HB3' HE22 ' A' ' 127' ' ' GLN . 27.8 mt-10 -55.88 -62.23 1.84 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.413 -0.394 . . . . 0.0 110.143 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.514 ' HD1' HG21 ' A' ' 133' ' ' ILE . 2.5 t80 -55.3 -30.16 59.63 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.943 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 143' ' ' ARG . . . -74.88 -26.36 59.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.339 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.71 -51.23 5.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.851 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -57.72 -12.65 3.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.925 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.7 ttp -111.54 -30.17 7.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.683 0.278 . . . . 0.0 110.836 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 139' ' ' ALA . 14.9 tpp85 -65.9 -59.04 4.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.162 0.506 . . . . 0.0 110.078 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.571 ' HB2' ' NZ ' ' A' ' 144' ' ' LYS . 9.9 mtmp? -128.91 -153.53 0.58 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.987 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.485 ' N ' ' NE ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -74.06 -38.85 63.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.714 0.292 . . . . 0.0 110.644 179.425 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.417 ' NZ ' ' HA2' ' A' ' 149' ' ' GLY . 26.3 ttpp -175.62 159.27 2.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.505 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -65.56 -65.68 2.78 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.18 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -151.37 150.27 30.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.417 ' HA2' ' NZ ' ' A' ' 146' ' ' LYS . . . -40.24 -64.66 1.09 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.102 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.725 ' C ' HD12 ' A' ' 151' ' ' ILE . . . -54.8 -65.31 3.62 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.94 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.725 HD12 ' C ' ' A' ' 150' ' ' GLY . 2.7 mp -129.79 149.85 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.122 0.487 . . . . 0.0 112.064 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.561 ' HA3' ' HB2' ' A' ' 127' ' ' GLN . . . -69.89 -116.19 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.512 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.57 ' HE ' ' HA ' ' A' ' 153' ' ' ARG . 5.4 tpm_? -130.51 83.29 2.11 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 121.261 0.553 . . . . 0.0 111.266 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.798 ' HB3' ' HB3' ' A' ' 157' ' ' ARG . 35.7 ttm180 -89.75 148.21 23.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.159 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 89.6 m -68.28 -19.95 64.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.03 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.746 ' H ' ' HG2' ' A' ' 154' ' ' ARG . 25.1 ptt? -132.42 54.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 111.494 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.798 ' HB3' ' HB3' ' A' ' 154' ' ' ARG . 21.6 tpp180 -157.39 118.44 3.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.009 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.592 ' NZ ' ' HB3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -164.97 -45.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.203 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.577 HG22 ' HG3' ' A' ' 158' ' ' LYS . 10.1 t -152.05 2.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.002 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.7 mt -76.11 166.9 22.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.864 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -60.6 136.65 58.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.039 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.473 HD12 ' N ' ' A' ' 162' ' ' LEU . 7.0 mp -75.27 -5.04 42.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -96.75 165.57 12.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.721 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -102.43 137.42 40.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.962 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -101.64 156.43 17.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.113 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 166' ' ' LEU . 6.2 mp -82.33 -24.98 34.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.753 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 138.57 -126.47 3.46 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.447 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 55.8 tp -97.82 109.67 22.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.787 0.327 . . . . 0.0 110.818 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.45 141.66 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.24 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -136.07 161.67 35.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.818 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -104.78 -42.04 5.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 109.31 -167.43 12.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.551 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.5 m -151.16 -35.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.756 0.313 . . . . 0.0 110.826 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -97.94 -16.77 19.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.769 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -98.96 97.88 8.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.468 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.84 138.44 22.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.295 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 10.7 tt -114.27 127.15 71.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.88 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -76.9 110.29 11.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.003 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -76.17 164.34 53.55 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.416 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.08 15.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.112 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -143.48 -13.6 0.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.949 -179.867 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.834 0.349 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -165.16 104.78 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.346 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.403 ' HG2' HH11 ' A' ' 3' ' ' ARG . 50.5 ttt-85 -105.9 133.71 50.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.943 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.5 tp -106.37 -91.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.8 p -175.12 157.1 2.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.867 0.365 . . . . 0.0 111.129 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -99.34 41.25 1.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.492 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -67.14 -12.4 59.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.424 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.85 -69.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.113 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.569 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -84.18 -14.12 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.54 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.0 165.29 12.86 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.777 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.34 37.04 93.95 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.055 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 95.7 mt -80.63 -32.92 36.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.457 0.17 . . . . 0.0 111.24 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.642 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 62.2 tttp -57.51 -43.83 84.55 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.665 ' O ' ' HG2' ' A' ' 18' ' ' MET . 44.8 tt0 -71.75 -47.97 50.03 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.725 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 28.2 tp -48.85 -29.01 4.15 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.55 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.488 ' CZ ' ' N ' ' A' ' 65' ' ' TYR . 15.3 t80 -64.87 -51.67 60.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.581 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.553 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.6 ptpt -77.79 -12.77 60.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.05 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 56.8 mmm -68.19 -24.05 64.91 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.491 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.705 HD12 HD13 ' A' ' 27' ' ' ILE . 4.0 mt -83.73 -52.0 13.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.162 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.701 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -80.73 51.84 1.58 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.436 0.636 . . . . 0.0 112.378 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -79.59 -6.31 56.79 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.558 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -111.28 -27.9 8.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.611 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -87.49 -91.19 0.11 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.889 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.403 ' H ' ' HB3' ' A' ' 23' ' ' ASN . 74.9 m -176.06 21.73 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.261 0.351 . . . . 0.0 110.988 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.451 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 111.18 24.8 5.29 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.529 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.701 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 78.6 p -140.39 142.13 35.51 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.166 0.508 . . . . 0.0 110.218 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.794 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.6 mt -102.95 102.96 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.816 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.746 HG22 ' OG1' ' A' ' 62' ' ' THR . 79.7 p -103.6 165.04 11.28 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.197 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.563 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 52.9 t80 -34.36 -33.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.723 0.64 . . . . 0.0 111.864 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . 33.2 t70 -76.91 -47.58 20.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.955 0.407 . . . . 0.0 110.695 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 28' ' ' THR . 25.1 mp0 -73.07 -25.09 60.78 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.235 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.827 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -48.73 -51.45 28.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.464 0.649 . . . . 0.0 109.792 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.662 ' HB2' ' HE2' ' A' ' 37' ' ' LYS . 6.9 ptpp? -82.45 -40.32 21.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.898 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.408 ' CB ' ' HA ' ' A' ' 31' ' ' GLU . 9.8 t70 -39.06 -62.11 0.68 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.088 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -50.76 -37.22 34.33 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.211 -0.518 . . . . 0.0 113.984 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.624 ' O ' HG12 ' A' ' 39' ' ' VAL . 49.5 mt -79.67 -58.42 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.34 0.57 . . . . 0.0 111.759 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.662 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -54.93 -17.65 3.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.247 0.546 . . . . 0.0 109.668 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.3 ttt85 -77.37 -42.83 35.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.545 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.624 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -70.89 -1.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.161 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.92 5.71 33.01 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.45 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 74.5 m -81.9 166.46 19.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.79 0.329 . . . . 0.0 111.151 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -138.9 104.68 5.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.816 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.4 mt -128.68 166.09 19.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.407 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.577 ' O ' HD13 ' A' ' 48' ' ' ILE . 23.1 mtp -107.34 161.68 14.59 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HG2' ' HE2' ' A' ' 33' ' ' LYS . 37.1 mt-10 -55.64 -60.28 3.66 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.503 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.464 ' HB2' ' HZ ' ' A' ' 111' ' ' PHE . 41.2 t -43.24 -29.07 0.36 Allowed 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.8 mm-40 -72.98 -42.36 63.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.265 0.555 . . . . 0.0 110.037 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.827 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -55.57 -56.82 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.756 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.597 ' HE2' ' CE1' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -47.53 -28.25 2.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.764 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HA ' ' NZ ' ' A' ' 49' ' ' LYS . 63.8 t0 -75.29 -54.93 6.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.601 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.504 HD23 HD11 ' A' ' 32' ' ' LEU . 36.4 tp -53.89 -37.66 63.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.236 0.541 . . . . 0.0 111.058 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.632 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 33.8 ttm -74.36 -66.35 0.74 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.331 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.671 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -54.48 -26.21 29.92 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.764 -178.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.68 -41.09 15.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -100.3 -43.39 6.29 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 59' ' ' LYS . 60.5 t0 -46.37 98.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 110.144 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.433 HD11 ' HB1' ' A' ' 70' ' ' ALA . 17.4 mm -54.14 -19.64 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.243 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.583 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 62.0 m-20 -131.35 44.47 2.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.872 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.671 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 21.8 tptm -32.27 92.04 0.01 OUTLIER 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 58' ' ' ASP . 49.0 m -127.71 18.44 6.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.404 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.632 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 70.08 23.46 77.14 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.47 -178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 28' ' ' THR . 42.5 m -159.72 129.97 5.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.797 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.794 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 75.8 mt -108.19 130.13 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.962 0.411 . . . . 0.0 111.511 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -104.87 167.61 9.6 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.085 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.642 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 28.9 t80 -35.22 -47.3 0.39 Allowed 'General case' 0 CA--C 1.52 -0.182 0 O-C-N 123.446 0.466 . . . . 0.0 111.731 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.98 -56.66 10.2 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.361 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.659 ' HB2' HG23 ' A' ' 63' ' ' ILE . 71.4 mt-10 -54.75 -22.66 14.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 110.692 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 64.9 t80 -68.32 -64.31 0.89 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.623 0.725 . . . . 0.0 110.905 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.578 HD13 ' HD2' ' A' ' 68' ' ' PHE . 7.9 mm -52.39 -41.79 36.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.613 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 73' ' ' VAL . . . -56.75 -32.98 66.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.143 0.497 . . . . 0.0 110.803 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.38 -28.34 52.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.23 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.5 p -95.35 -8.53 35.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.977 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 70' ' ' ALA . 9.7 p -95.47 -15.41 7.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.961 0.41 . . . . 0.0 110.668 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -75.98 -47.07 26.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.362 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.787 HD13 ' N ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -73.15 -15.26 61.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.647 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.787 ' N ' HD13 ' A' ' 75' ' ' LEU . 43.5 t30 -78.04 79.58 4.5 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.238 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -136.54 -43.05 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.631 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.595 ' HG ' ' HG3' ' A' ' 79' ' ' GLU . 67.9 tp -166.14 -61.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.515 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.595 ' HG3' ' HG ' ' A' ' 78' ' ' LEU . 51.1 mt-10 -145.93 160.46 41.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.717 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -64.33 127.2 30.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.093 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -125.82 10.29 7.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.057 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -85.4 111.91 20.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.764 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.407 ' OD1' HG12 ' A' ' 85' ' ' VAL . 13.0 p-10 -132.6 -155.19 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.344 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.595 ' O ' HD13 ' A' ' 84' ' ' LEU . 3.4 tm? -58.93 -37.63 77.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.183 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.407 HG12 ' OD1' ' A' ' 83' ' ' ASN . 13.5 p -49.63 -25.14 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.61 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 79.2 p -43.32 -45.28 5.91 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.975 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.405 ' C ' ' N ' ' A' ' 89' ' ' SER . . . -90.14 -38.57 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.712 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.719 ' HZ ' ' HA2' ' A' ' 97' ' ' GLY . 8.6 t80 -44.33 -24.15 0.15 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.269 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 87' ' ' ALA . 47.7 t -89.05 -45.38 9.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.898 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -81.69 -63.68 1.34 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.365 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.597 ' CE1' ' HE2' ' A' ' 49' ' ' LYS . 4.0 m-85 -56.44 -64.41 0.88 Allowed 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.733 ' HA ' HG12 ' A' ' 99' ' ' ILE . 61.8 t0 -76.78 67.4 2.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -55.85 -25.72 43.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.397 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -84.18 -20.69 31.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 39.22 67.3 0.61 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.1 p -122.87 -19.12 6.26 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.719 ' HA2' ' HZ ' ' A' ' 88' ' ' PHE . . . 123.37 -3.14 9.59 Favored Glycine 0 N--CA 1.434 -1.443 0 CA-C-N 113.435 -1.711 . . . . 0.0 112.379 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.641 ' HB3' ' OE1' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -136.05 151.92 50.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.363 0.601 . . . . 0.0 111.702 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.751 HG23 ' HB2' ' A' ' 103' ' ' GLU . 83.0 mt -130.95 102.78 6.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.054 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 101' ' ' LEU . 51.2 p -79.81 151.46 30.28 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.694 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -34.29 -34.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.022 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.97 -54.98 31.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.904 0.383 . . . . 0.0 110.527 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.751 ' HB2' HG23 ' A' ' 99' ' ' ILE . 51.3 mt-10 -65.75 -28.68 69.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.185 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.747 HG13 HG22 ' A' ' 99' ' ' ILE . 72.8 mt -72.42 -65.38 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 111.004 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.818 ' NE2' HD11 ' A' ' 122' ' ' ILE . 2.4 mm-40 -47.65 -45.2 27.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.139 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -64.13 -42.92 96.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.468 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.87 -4.54 32.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 105' ' ' GLN . 26.5 p -124.04 91.4 3.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.069 0.462 . . . . 0.0 111.385 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -88.44 -50.78 6.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.326 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.91 -17.75 62.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.517 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.577 ' HB2' ' HB2' ' A' ' 108' ' ' CYS . 3.7 m-85 -63.92 -11.32 27.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.627 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.41 34.79 24.89 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.3 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.731 ' CD2' HG21 ' A' ' 118' ' ' ILE . 0.5 OUTLIER -35.52 109.94 0.09 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.24 0.543 . . . . 0.0 111.508 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.733 ' O ' HG22 ' A' ' 118' ' ' ILE . 38.4 t70 -160.96 138.54 9.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.334 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -50.81 -9.49 0.05 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 73.4 mt -89.44 -59.55 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.644 0.259 . . . . 0.0 111.648 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -91.07 -59.41 2.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 111.622 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.8 HG23 ' NE2' ' A' ' 105' ' ' GLN . 3.6 tp -48.47 -28.25 2.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.64 -51.52 58.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.874 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 124' ' ' GLU . 7.7 t70 -56.45 -29.23 61.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' MET . . . . . 1.03 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 6.6 ttt -66.79 -39.64 87.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.661 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.818 HD11 ' NE2' ' A' ' 105' ' ' GLN . 33.1 mm -56.97 -43.06 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.681 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -83.78 -13.3 54.18 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.632 178.304 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 1.03 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 31.1 tt0 -87.65 -17.03 32.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.43 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.839 HG21 HD11 ' A' ' 133' ' ' ILE . 14.9 mm -115.96 -32.13 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.558 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 131' ' ' GLY . 2.7 t70 -75.5 92.11 2.85 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.665 HE22 ' HB3' ' A' ' 137' ' ' GLU . 0.3 OUTLIER -86.02 -8.71 57.75 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.909 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.413 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 20.1 m-20 -111.86 -33.71 6.22 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.444 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 13.2 p30 -179.32 -86.34 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 117.603 2.445 . . . . 0.0 117.603 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.749 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 22.0 m-20 -64.65 26.06 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -172.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.559 ' CA ' HG22 ' A' ' 122' ' ' ILE . . . 55.51 37.51 67.26 Favored Glycine 0 CA--C 1.505 -0.574 0 C-N-CA 117.917 -2.087 . . . . 0.0 109.192 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.749 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 3.7 pt20 -136.3 168.95 18.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.074 -1.063 . . . . 0.0 110.384 -177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.839 HD11 HG21 ' A' ' 125' ' ' ILE . 60.0 mt -123.45 129.49 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.614 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.824 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 30.3 t70 -101.81 158.55 16.03 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.027 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.67 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 4.9 t80 -45.39 -32.54 2.13 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.913 0.387 . . . . 0.0 110.721 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.613 ' HA3' ' HA3' ' A' ' 152' ' ' GLY . . . -80.59 -38.15 17.99 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.071 -1.061 . . . . 0.0 110.729 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.97 ' HA ' ' HB3' ' A' ' 153' ' ' ARG . 30.8 mt-10 -59.98 -57.79 11.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.803 -0.198 . . . . 0.0 110.8 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.575 ' HD1' HD13 ' A' ' 133' ' ' ILE . 2.6 t80 -58.89 -26.77 64.6 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.527 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.469 ' HB2' ' HG ' ' A' ' 84' ' ' LEU . . . -79.7 -36.68 37.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.002 0.429 . . . . 0.0 110.836 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -90.0 -14.22 34.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.033 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -57.34 -18.53 17.56 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.486 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 24.4 ptt? -127.88 50.12 2.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.083 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.414 ' HB2' ' HE3' ' A' ' 146' ' ' LYS . 38.4 ptt180 -34.26 136.1 0.14 Allowed 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.347 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.88 -56.16 1.77 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.556 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -150.3 38.71 0.72 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.523 ' HB2' ' NZ ' ' A' ' 146' ' ' LYS . 10.0 mtmp? -42.86 105.61 0.05 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -95.9 -37.9 4.8 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.883 -0.675 . . . . 0.0 114.667 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.679 ' O ' HG13 ' A' ' 151' ' ' ILE . 23.4 p30 -149.67 162.29 40.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.33 0.565 . . . . 0.0 111.445 -178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 151' ' ' ILE . . . -36.42 -22.63 0.01 OUTLIER Glycine 0 C--N 1.339 0.744 0 O-C-N 123.814 0.696 . . . . 0.0 114.155 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 148' ' ' ASN . . . -59.89 -4.49 3.3 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.979 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.679 HG13 ' O ' ' A' ' 148' ' ' ASN . 8.4 mt -38.07 -84.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 123.061 0.544 . . . . 0.0 111.407 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.613 ' HA3' ' HA3' ' A' ' 136' ' ' GLY . . . 161.4 -62.96 0.28 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.633 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.97 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . 34.5 ptt85 -76.63 82.37 3.28 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.681 0.753 . . . . 0.0 110.595 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.812 ' HG3' ' H ' ' A' ' 156' ' ' MET . 5.0 tpm_? -130.66 148.29 52.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.33 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.481 ' H ' ' HE ' ' A' ' 154' ' ' ARG . 86.1 m -69.63 -16.03 63.3 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.812 ' H ' ' HG3' ' A' ' 154' ' ' ARG . 25.3 ptm -138.98 34.72 2.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.41 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.696 ' HB3' ' HB3' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -58.19 -12.32 3.46 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.508 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.552 ' N ' ' HD3' ' A' ' 157' ' ' ARG . 17.9 tppt? -55.28 -86.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.171 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 50.3 p -143.43 -72.57 0.29 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.055 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 161' ' ' ASN . 6.1 tt -160.47 123.42 3.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.298 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.473 ' N ' HD23 ' A' ' 160' ' ' LEU . 17.1 t-20 -112.46 158.14 20.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 162' ' ' LEU . 5.8 mp -84.86 -81.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.775 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 51.0 mmt-85 -103.2 109.54 21.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.926 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.84 149.38 26.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.953 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -116.66 146.2 42.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.962 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 166' ' ' LEU . 6.2 mp -109.09 -16.54 14.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.994 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.88 -116.83 4.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.515 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.448 ' C ' HD23 ' A' ' 168' ' ' LEU . 5.9 tt -62.75 114.34 3.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.812 0.339 . . . . 0.0 110.26 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.2 m -67.32 127.53 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.477 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -151.71 -50.88 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.77 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.87 -32.66 73.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.703 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -144.69 142.1 10.63 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.43 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.3 m -137.44 91.75 2.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 110.891 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.453 ' OD1' ' HG2' ' A' ' 175' ' ' GLN . 25.1 t-20 -141.02 -90.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.55 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.453 ' HG2' ' OD1' ' A' ' 174' ' ' ASN . 30.8 mm100 -138.03 110.86 7.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.595 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.59 103.41 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.289 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.5 mm -90.28 131.15 38.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.889 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -107.8 119.69 40.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -105.76 101.54 1.85 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.368 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -68.45 157.16 36.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 111.178 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -172.06 -75.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.799 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.867 -179.944 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.564 ' HB1' HH12 ' A' ' 3' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.828 0.347 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -98.39 123.58 42.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.811 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.564 HH12 ' HB1' ' A' ' 1' ' ' ALA . 21.6 ptt-85 -165.13 164.14 20.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.6 tp -165.79 90.97 0.47 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.719 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.2 p -130.51 171.78 12.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 5.1 mm-40 -65.53 148.32 51.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.093 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -89.0 -42.94 11.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.1 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -76.53 -43.08 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.786 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.558 HD12 ' N ' ' A' ' 9' ' ' ILE . 2.1 mp -74.05 -43.73 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.791 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.36 115.38 4.41 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.38 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.86 26.57 0.4 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.49 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.798 HD12 HD23 ' A' ' 15' ' ' LEU . 53.9 tp -87.85 -37.98 16.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.469 0.176 . . . . 0.0 110.61 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.625 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 24.0 pttm -66.36 -32.11 73.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 82.2 tt0 -78.18 -36.85 46.9 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.798 HD23 HD12 ' A' ' 12' ' ' LEU . 52.3 tp -53.87 -42.57 68.75 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.366 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.54 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 10.9 t80 -51.69 -45.06 63.34 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.443 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 65.3 pttt -85.06 -12.45 53.03 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.9 ttp -85.55 -13.76 47.95 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.614 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.791 HG23 ' HA3' ' A' ' 35' ' ' GLY . 22.4 mm -74.92 -52.44 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.726 ' HB2' ' HB3' ' A' ' 23' ' ' ASN . 4.4 p-10 -81.93 50.6 1.57 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.033 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.828 HG21 ' HD2' ' A' ' 38' ' ' ARG . 13.0 t -61.97 -6.82 3.12 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.877 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -133.94 -10.88 2.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.979 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.726 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 10.1 t-20 -87.49 -95.83 0.09 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.2 p -177.72 12.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 111.59 24.37 5.32 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.948 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.427 ' HB ' ' CG2' ' A' ' 62' ' ' THR . 40.6 p -147.62 144.23 28.26 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.992 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 6.9 mt -104.02 104.84 17.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 68.8 p -102.21 163.52 12.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.704 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.743 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 49.2 t80 -34.28 -37.32 0.05 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.86 -45.75 40.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.92 0.39 . . . . 0.0 111.167 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -78.56 -13.83 59.63 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.719 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.01 HD13 HG23 ' A' ' 48' ' ' ILE . 6.2 tt -53.05 -49.01 67.2 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.65 ' HD3' ' NZ ' ' A' ' 37' ' ' LYS . 4.0 ptpp? -84.75 -41.17 16.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.491 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.552 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 17.9 t70 -47.57 -30.29 3.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.048 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.791 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -65.03 -40.31 96.99 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.888 -0.673 . . . . 0.0 113.351 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 36' ' ' LEU . 1.3 mm? -91.99 -33.15 14.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.324 0.583 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.65 ' NZ ' ' HD3' ' A' ' 33' ' ' LYS . 76.5 mttt -60.94 -45.8 93.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.698 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.828 ' HD2' HG21 ' A' ' 21' ' ' THR . 46.9 ttt-85 -69.77 -40.74 75.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.62 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 36' ' ' LEU . 8.2 p -71.13 -14.25 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.48 54.86 0.3 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.121 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 70.1 m -146.0 166.98 24.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.605 0.24 . . . . 0.0 110.483 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 23.2 pt-20 -137.29 114.67 10.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 111.378 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.41 ' HB2' HD11 ' A' ' 48' ' ' ILE . 36.4 mt -125.13 165.58 17.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.272 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.614 ' O ' HD13 ' A' ' 48' ' ' ILE . 20.4 mtm -113.41 164.41 13.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -64.98 0.65 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.154 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 89.1 p -39.78 -26.81 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 93.9 mt-10 -79.22 -49.72 12.08 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.01 HG23 HD13 ' A' ' 32' ' ' LEU . 1.7 mp -52.99 -60.86 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.591 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.743 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 51.6 tttp -57.05 -22.79 41.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.889 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 36.8 t70 -76.62 -44.58 33.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 tt -63.44 -44.76 93.62 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 111.092 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.733 ' HB2' HD11 ' A' ' 32' ' ' LEU . 37.3 ttm -66.6 -64.09 0.93 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.249 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.665 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 9.6 t70 -55.88 -29.29 59.72 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.05 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -88.58 -36.64 16.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -103.23 -41.65 5.99 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.545 ' OD1' HG12 ' A' ' 63' ' ' ILE . 15.8 t70 -50.94 95.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.937 0.399 . . . . 0.0 110.188 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.415 ' H ' HG12 ' A' ' 57' ' ' ILE . 27.9 mm -51.49 -18.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.551 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.524 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.2 m-20 -131.05 43.91 3.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.174 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.665 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 28.1 tptp -32.53 89.65 0.0 OUTLIER 'General case' 0 C--O 1.231 0.117 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 58' ' ' ASP . 87.7 p -127.85 18.21 6.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.519 -1.218 . . . . 0.0 109.02 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 76.34 22.63 72.82 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.087 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 91.1 m -147.54 153.84 39.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.243 0.617 . . . . 0.0 109.597 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.992 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 71.7 mt -135.16 127.53 47.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.995 0.426 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -104.6 167.52 9.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.492 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.625 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 41.2 t80 -35.41 -44.71 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.558 0.536 . . . . 0.0 111.663 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.04 -60.63 5.48 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.197 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.567 ' HB2' HG23 ' A' ' 63' ' ' ILE . 40.9 mt-10 -53.88 -21.83 8.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.851 0.358 . . . . 0.0 110.945 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 26.2 t80 -67.77 -65.11 0.73 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.501 0.667 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 65' ' ' TYR . 10.5 mm -52.44 -43.09 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.583 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.63 -39.44 73.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.47 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.433 ' O ' HD23 ' A' ' 75' ' ' LEU . . . -64.43 -49.25 72.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.361 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.583 HG21 HD11 ' A' ' 12' ' ' LEU . 65.8 p -55.8 -38.55 70.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.267 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 45.9 t -81.52 -16.75 12.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.063 0.458 . . . . 0.0 110.941 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -81.21 -25.69 36.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 71' ' ' ALA . 4.5 mm? -97.75 -4.07 37.79 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.784 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 26.5 t-20 -101.12 75.84 1.69 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.738 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.725 ' HG3' ' H ' ' A' ' 79' ' ' GLU . 18.5 ptpt -174.91 -161.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.033 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 78' ' ' LEU . 3.0 mm? -80.07 8.09 7.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.965 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.725 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 17.6 tp10 -58.41 157.59 8.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.644 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 45.0 mmt-85 -51.11 143.38 10.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.068 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -60.09 -77.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.171 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.04 31.77 0.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.239 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.495 ' HB3' HG12 ' A' ' 85' ' ' VAL . 50.4 t-20 -55.97 133.7 51.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.639 HD12 ' N ' ' A' ' 85' ' ' VAL . 2.0 pp -58.6 -17.01 18.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.433 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.639 ' N ' HD12 ' A' ' 84' ' ' LEU . 14.5 p -48.3 -19.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.832 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -38.43 -49.23 1.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.264 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -71.89 -50.17 31.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.499 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.779 ' HE1' ' HB2' ' A' ' 135' ' ' TYR . 11.5 t80 -36.23 -33.55 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.492 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 87' ' ' ALA . 29.5 t -89.67 -50.69 5.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.728 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.66 -64.21 1.24 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.165 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.602 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 5.0 m-85 -58.93 -59.9 4.71 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.756 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 1.2 m-20 -75.68 57.65 1.01 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -52.06 -41.15 62.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.701 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.469 ' HB3' 'CA ' ' A' ' 191' ' ' ' CA' . 37.2 t70 -67.87 -20.9 65.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 42.49 64.32 1.62 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.474 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 54.5 p -119.48 -35.32 3.59 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.39 4.1 0.81 Allowed Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.337 -1.756 . . . . 0.0 112.873 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.878 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.3 OUTLIER -152.67 165.64 34.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.494 0.664 . . . . 0.0 112.072 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.817 HG23 ' HB2' ' A' ' 103' ' ' GLU . 91.4 mt -132.35 104.08 7.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.14 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 102' ' ' ASP . 50.5 p -76.09 149.27 37.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.7 HD23 ' H ' ' A' ' 101' ' ' LEU . 0.5 OUTLIER -34.57 -33.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 100' ' ' THR . 1.5 m-20 -57.69 -52.34 65.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.85 0.357 . . . . 0.0 110.276 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.817 ' HB2' HG23 ' A' ' 99' ' ' ILE . 49.3 mt-10 -67.83 -28.39 67.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.543 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.67 HG22 ' OE1' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -70.2 -62.12 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.575 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.709 HE22 HG22 ' A' ' 118' ' ' ILE . 4.7 mm100 -53.66 -38.28 63.98 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.898 0.38 . . . . 0.0 110.49 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -61.81 -59.22 5.48 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.96 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.75 -10.77 13.95 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.198 0.523 . . . . 0.0 110.558 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 31.3 t -100.59 63.44 1.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.737 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.472 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 1.2 tmtp? -85.82 -61.08 1.84 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -57.89 -5.39 0.41 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.578 ' HB2' ' SG ' ' A' ' 108' ' ' CYS . 33.3 m-85 -90.75 7.68 38.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.53 37.05 94.07 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.633 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.989 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -33.67 125.94 0.41 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.317 0.58 . . . . 0.0 112.202 -178.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.681 ' N ' HD22 ' A' ' 113' ' ' LEU . 10.1 t70 -160.65 159.44 30.37 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.681 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 1.4 m-20 -71.74 -6.92 44.85 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.0 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.724 HG13 ' H ' ' A' ' 117' ' ' HIS . 14.0 pt -77.87 -64.6 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.724 ' H ' HG13 ' A' ' 116' ' ' ILE . 13.0 m-70 -92.01 -61.97 1.51 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.09 0.472 . . . . 0.0 111.417 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.989 HG13 ' HA ' ' A' ' 113' ' ' LEU . 13.2 mm -45.16 -36.17 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.11 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.2 -48.28 62.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.946 0.403 . . . . 0.0 110.025 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 124' ' ' GLU . 61.8 t0 -67.59 -27.66 67.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.564 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' MET . . . . . 1.091 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.0 ttt -62.87 -40.28 97.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.487 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.703 HG22 ' HA3' ' A' ' 131' ' ' GLY . 48.1 mt -53.52 -44.4 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 24.3 mmtp -85.18 -13.46 49.96 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.17 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 1.091 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 24.3 tt0 -87.95 -13.52 41.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.497 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.843 ' O ' HD11 ' A' ' 133' ' ' ILE . 81.3 mt -117.31 -23.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.759 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.925 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 22.0 t70 -65.25 101.68 0.58 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.566 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.643 ' OE1' ' HA ' ' A' ' 137' ' ' GLU . 90.0 mt-30 -88.05 -18.44 28.92 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.766 ' HB2' ' HD2' ' A' ' 153' ' ' ARG . 45.7 t0 -119.39 -34.63 3.77 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.8 p30 178.92 -73.28 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.52 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 1.2 m-20 -64.2 20.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.925 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.31 38.18 67.69 Favored Glycine 0 CA--C 1.5 -0.88 0 C-N-CA 117.48 -2.295 . . . . 0.0 108.075 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.52 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 2.7 pt20 -131.68 167.12 20.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.628 -1.286 . . . . 0.0 109.055 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.843 HD11 ' O ' ' A' ' 125' ' ' ILE . 11.0 mm -134.18 124.99 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.326 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.878 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 2.4 p-10 -102.42 161.25 13.86 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.779 ' HB2' ' HE1' ' A' ' 88' ' ' PHE . 12.0 t80 -41.07 -32.63 0.26 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.812 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.719 ' HA3' ' N ' ' A' ' 153' ' ' ARG . . . -76.88 -46.43 10.82 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.642 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.956 ' HG3' ' HE ' ' A' ' 153' ' ' ARG . 33.5 mt-10 -54.41 -59.85 4.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.367 -0.416 . . . . 0.0 111.347 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.505 ' N ' HG23 ' A' ' 133' ' ' ILE . 3.6 t80 -57.56 -29.9 64.8 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.92 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.51 -20.06 48.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.074 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.84 -49.01 6.87 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.085 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.633 ' SD ' HG23 ' A' ' 125' ' ' ILE . 28.0 ptm -55.41 -16.46 3.67 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.35 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 56.0 ttp -99.86 -25.23 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.631 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.513 HH21 HD23 ' A' ' 84' ' ' LEU . 68.0 mtt-85 -111.37 -99.08 0.41 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.792 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -141.01 -163.03 1.46 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.726 0.298 . . . . 0.0 110.346 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.762 ' HG3' ' HG2' ' A' ' 146' ' ' LYS . 23.3 ptt-85 -89.84 -23.04 21.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.87 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.762 ' HG2' ' HG3' ' A' ' 145' ' ' ARG . 17.9 ptpt -175.73 85.22 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.154 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -90.32 -37.68 6.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.695 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -149.13 162.17 40.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.607 0.241 . . . . 0.0 110.839 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -51.66 -14.04 1.55 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.85 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -66.47 -4.2 23.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.173 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.545 HG12 ' N ' ' A' ' 152' ' ' GLY . 6.9 tt -44.02 155.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 121.117 0.484 . . . . 0.0 111.788 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.545 ' N ' HG12 ' A' ' 151' ' ' ILE . . . -133.52 -46.61 0.11 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.956 ' HE ' ' HG3' ' A' ' 137' ' ' GLU . 8.7 tpp180 -75.51 120.71 21.3 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.675 0.75 . . . . 0.0 110.161 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.73 ' N ' ' HD3' ' A' ' 153' ' ' ARG . 70.4 mtp180 -131.22 148.23 52.68 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.693 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.0 t -58.8 -16.0 14.98 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.8 ttt -162.18 59.45 0.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.691 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.571 ' HB3' ' HB2' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -63.0 -172.21 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.433 -179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -165.34 121.2 1.36 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.795 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.8 t -164.85 161.17 20.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.1 mt -77.54 154.86 32.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.776 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -106.27 171.02 7.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.199 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.615 HD23 ' N ' ' A' ' 163' ' ' ARG . 7.9 tt -104.37 140.36 38.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.489 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.615 ' N ' HD23 ' A' ' 162' ' ' LEU . 57.6 ttp180 -132.91 -69.48 0.56 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.53 142.48 58.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.796 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.4 130.6 41.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.363 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 166' ' ' LEU . 6.8 mp -78.65 -14.55 59.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.986 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -106.5 -154.41 20.48 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.553 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.821 ' H ' HD23 ' A' ' 168' ' ' LEU . 2.4 pt? -111.29 -178.75 3.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.736 0.303 . . . . 0.0 110.828 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 50.0 t -71.1 112.31 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.872 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -68.28 90.27 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.125 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -90.52 11.62 21.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.39 124.39 24.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.425 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.3 t -95.74 49.79 1.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.896 0.379 . . . . 0.0 110.869 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -134.11 49.12 2.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.935 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 175' ' ' GLN . 20.7 pt20 -78.46 106.18 10.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.09 0.471 . . . . 0.0 110.975 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.55 136.93 24.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.128 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.641 ' O ' HD12 ' A' ' 177' ' ' ILE . 2.8 pp -121.77 148.65 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.402 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -126.1 134.98 51.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 176.63 45.53 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.705 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -77.81 166.95 22.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 0.0 110.949 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -84.38 132.46 34.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.017 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.933 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ' CA' . . . . . 0.469 'CA ' ' HB3' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -117.58 -7.69 11.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.082 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -118.14 80.05 1.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.913 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.3 mt -114.15 -177.3 3.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.8 m -137.9 168.31 19.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.01 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -108.25 -11.74 15.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.904 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -89.26 -19.87 24.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -73.59 -36.29 65.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.192 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.0 tp -66.31 -31.23 52.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.415 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.45 150.92 16.92 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.684 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.42 -11.29 72.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.621 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.751 HD11 HG21 ' A' ' 72' ' ' THR . 50.0 tp -86.95 -39.11 16.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.667 0.27 . . . . 0.0 110.823 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 33.9 mtmm -56.94 -46.68 81.92 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.637 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -68.48 -34.52 76.07 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.628 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.679 HD23 HD12 ' A' ' 12' ' ' LEU . 45.2 tp -59.52 -28.7 67.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.169 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.437 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 13.1 t80 -67.47 -38.98 85.22 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.016 0.436 . . . . 0.0 110.971 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.637 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 61.7 pttt -86.63 -19.82 28.75 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.629 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -63.44 -27.2 69.13 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.491 176.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.717 HG21 HD13 ' A' ' 27' ' ' ILE . 18.7 mm -70.61 -59.65 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.212 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -78.59 89.79 4.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.3 178.077 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.5 t -88.27 -34.71 17.61 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.525 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -139.83 16.7 2.49 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.534 ' HB2' ' OE1' ' A' ' 31' ' ' GLU . 3.5 m120 -92.44 -88.65 0.2 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.947 0.794 . . . . 0.0 112.89 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -164.95 -1.55 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.468 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 110.75 20.53 7.22 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.412 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 75.4 p -128.09 166.43 18.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.881 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 6.1 mt -123.14 101.53 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.083 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.553 HG22 ' HB ' ' A' ' 62' ' ' THR . 67.5 p -103.56 164.98 11.31 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.704 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -33.72 -39.21 0.06 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.839 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.676 ' OD1' ' HG3' ' A' ' 31' ' ' GLU . 1.8 p30 -73.05 -43.69 61.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.64 0.257 . . . . 0.0 111.281 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.676 ' HG3' ' OD1' ' A' ' 30' ' ' ASP . 42.4 mt-10 -74.68 -24.07 58.73 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 110.265 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.751 ' HG ' HD23 ' A' ' 51' ' ' LEU . 6.3 tt -54.43 -54.24 43.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.87 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.718 ' HG3' ' H ' ' A' ' 34' ' ' ASP . 17.0 ptpt -75.97 -62.31 1.64 Allowed 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.466 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.718 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 35.9 t70 -37.59 -48.55 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.498 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . -48.85 -54.44 14.18 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.98 -0.555 . . . . 0.0 113.858 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.634 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -89.8 -45.94 8.93 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.216 0.531 . . . . 0.0 110.144 -179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -17.21 0.56 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.079 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 32.0 ttm-85 -59.66 -43.22 94.01 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.778 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 36' ' ' LEU . 34.3 m -78.53 31.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.98 -22.66 24.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.752 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.7 m -53.46 154.44 3.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.648 0.261 . . . . 0.0 110.648 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.09 118.18 9.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 111.432 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 mt -119.67 165.77 14.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.481 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.665 ' SD ' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -105.02 152.92 22.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.21 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -42.46 -56.05 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.665 ' HB2' ' SD ' ' A' ' 44' ' ' MET . 52.3 m -54.7 -21.66 11.46 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 119.236 0.925 . . . . 0.0 111.888 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.608 ' OE2' ' HA ' ' A' ' 83' ' ' ASN . 38.2 mt-10 -74.57 -44.54 50.42 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.704 HG23 HD13 ' A' ' 32' ' ' LEU . 2.0 mp -58.17 -53.31 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.119 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.61 ' HE2' ' HE1' ' A' ' 91' ' ' PHE . 10.5 ttpp -52.92 -30.27 33.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.459 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.556 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 8.8 t70 -62.96 -50.09 72.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.379 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.751 HD23 ' HG ' ' A' ' 32' ' ' LEU . 41.1 tp -60.63 -14.88 23.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.694 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.939 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 13.4 mmt -88.13 -65.84 0.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -78.94 -32.95 45.72 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.939 -0.475 . . . . 0.0 111.726 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -87.46 -18.32 30.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.662 ' HB3' HD12 ' A' ' 51' ' ' LEU . . . -127.09 -43.57 1.65 Allowed 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.647 ' OD1' HG12 ' A' ' 63' ' ' ILE . 21.2 t70 -59.91 96.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.784 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 57' ' ' ILE . 26.5 mm -46.26 -25.63 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.866 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.527 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.7 m-20 -129.63 44.09 3.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.27 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.939 ' HD3' ' HB3' ' A' ' 52' ' ' MET . 51.4 tptt -33.27 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.046 0.927 . . . . 0.0 113.347 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.7 p -127.29 9.56 6.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.77 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 97.85 -5.7 61.94 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.517 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.844 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 3.0 t -141.11 165.01 28.72 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.062 0.458 . . . . 0.0 110.681 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.881 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 98.4 mt -125.81 135.38 64.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.33 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.89 166.21 10.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.649 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.653 ' O ' HG12 ' A' ' 69' ' ' ILE . 51.3 t80 -36.31 -46.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.733 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.55 -63.84 4.0 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.441 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.731 ' HB2' HG23 ' A' ' 63' ' ' ILE . 40.9 mt-10 -49.86 -29.2 7.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.739 0.304 . . . . 0.0 111.473 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.522 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 34.1 t80 -65.83 -62.63 1.4 Allowed 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.364 0.602 . . . . 0.0 111.16 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.653 HG12 ' O ' ' A' ' 65' ' ' TYR . 19.8 mm -53.32 -48.38 56.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.692 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.45 -41.16 84.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.922 0.392 . . . . 0.0 110.905 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 74' ' ' HIS . . . -58.11 -55.85 29.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.26 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.751 HG21 HD11 ' A' ' 12' ' ' LEU . 81.8 p -59.12 -56.07 26.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.492 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.677 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 49.5 t -56.92 -22.23 15.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.374 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.47 ' O ' ' HE3' ' A' ' 77' ' ' LYS . 77.3 t60 -67.9 -52.69 33.51 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.68 -9.45 58.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.227 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.677 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 49.3 t30 -91.51 78.8 5.58 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.087 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.47 ' HE3' ' O ' ' A' ' 74' ' ' HIS . 20.8 pttp -166.45 -24.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.833 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.5 mt -138.91 -85.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.539 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -175.04 137.68 0.42 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.713 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.656 ' HD2' ' O ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -114.16 130.89 56.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.444 . . . . 0.0 110.978 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -150.74 9.5 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.515 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.51 93.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.992 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.608 ' HA ' ' OE2' ' A' ' 47' ' ' GLU . 45.1 m-20 -97.39 -87.19 0.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.737 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.515 ' O ' HD23 ' A' ' 84' ' ' LEU . 8.1 tt -74.47 -36.73 63.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.018 0.437 . . . . 0.0 110.311 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 88' ' ' PHE . 7.3 p -57.17 -19.47 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.456 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.59 ' HB3' ' HE3' ' A' ' 44' ' ' MET . 48.3 t -41.75 -62.66 0.85 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.271 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 138' ' ' PHE . . . -73.41 -36.08 65.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.463 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.799 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 2.8 t80 -45.72 -25.74 0.53 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.413 0.625 . . . . 0.0 109.65 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.7 t -89.62 -43.56 10.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.863 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -87.07 -64.45 1.15 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.82 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.61 ' HE1' ' HE2' ' A' ' 49' ' ' LYS . 2.8 m-85 -56.26 -59.99 4.15 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.799 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 1.6 m-20 -78.73 55.66 1.73 Allowed 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -51.16 -41.66 60.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.697 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.433 ' HB3' 'CA ' ' A' ' 191' ' ' ' CA' . 8.6 t70 -67.56 -20.61 65.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 43.74 65.06 1.67 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.276 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.9 p -119.08 -33.79 4.06 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 147.8 -37.08 1.12 Allowed Glycine 0 N--CA 1.433 -1.53 0 CA-C-N 112.786 -2.006 . . . . 0.0 112.196 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.893 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.2 OUTLIER -109.45 164.88 12.1 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.843 HG22 HG13 ' A' ' 104' ' ' ILE . 77.8 mt -132.6 103.54 6.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.231 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 102' ' ' ASP . 44.4 p -72.2 146.09 47.57 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 101' ' ' LEU . 0.3 OUTLIER -34.64 -32.95 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 100' ' ' THR . 45.4 t0 -55.47 -56.38 20.89 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.697 ' HB2' HG23 ' A' ' 99' ' ' ILE . 51.8 mt-10 -66.03 -28.34 68.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.825 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.843 HG13 HG22 ' A' ' 99' ' ' ILE . 78.9 mt -69.57 -65.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.031 0.443 . . . . 0.0 111.247 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.732 ' OE1' HG22 ' A' ' 118' ' ' ILE . 3.1 mm-40 -50.09 -51.87 39.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.596 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.482 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 70.1 mt-30 -64.49 -24.68 67.69 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.48 -6.86 58.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 72.2 m -123.78 68.57 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.867 0.365 . . . . 0.0 111.391 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 106' ' ' GLN . 74.6 mmtt -84.03 -32.09 25.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.584 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -83.21 -4.86 58.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.596 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 0.9 OUTLIER -93.46 16.33 13.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.359 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.05 36.82 45.14 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.602 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.883 ' HA ' HG13 ' A' ' 118' ' ' ILE . 3.1 tm? -34.36 110.0 0.09 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.969 0.414 . . . . 0.0 111.323 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.446 ' OD2' ' HB ' ' A' ' 116' ' ' ILE . 12.1 p-10 -160.12 -176.07 5.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.734 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.589 ' HA ' ' CG ' ' A' ' 119' ' ' ASP . 2.8 p30 -89.48 -8.94 51.82 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.446 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 60.5 mt -81.8 -64.6 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.914 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -91.61 -68.9 0.77 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.883 HG13 ' HA ' ' A' ' 113' ' ' LEU . 31.4 mm -40.52 -36.56 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.589 ' CG ' ' HA ' ' A' ' 115' ' ' ASP . 42.2 m-20 -71.2 -52.4 19.3 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 122.139 -0.351 . . . . 0.0 110.86 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 124' ' ' GLU . 32.4 m-20 -57.59 -23.62 51.78 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.992 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.5 ttt -65.39 -36.27 83.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.746 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.528 HG22 ' HA3' ' A' ' 131' ' ' GLY . 52.8 mt -57.06 -45.89 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.824 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 10.6 mmpt? -83.57 -13.19 54.99 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.57 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.992 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 29.8 tt0 -87.97 -19.21 27.53 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.458 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.907 HG21 HD11 ' A' ' 133' ' ' ILE . 63.9 mt -107.59 -50.52 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.89 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.562 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 5.4 p-10 -46.76 100.1 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.858 0.837 . . . . 0.0 110.697 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.688 HE22 ' HB3' ' A' ' 137' ' ' GLU . 0.8 OUTLIER -87.3 -9.9 53.72 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.996 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 53.7 p30 -117.05 -33.19 4.8 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.786 HD21 HG23 ' A' ' 155' ' ' THR . 21.4 p-10 -179.43 -81.4 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.471 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 59.0 m-20 -64.51 22.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 -172.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' A' ' 126' ' ' ASP . . . 56.37 38.29 78.33 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 117.219 -2.419 . . . . 0.0 109.414 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.563 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 4.5 pt20 -132.0 167.29 19.92 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.362 -0.919 . . . . 0.0 111.722 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.907 HD11 HG21 ' A' ' 125' ' ' ILE . 15.3 mt -125.67 116.15 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.549 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.893 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 38.6 t70 -104.8 161.78 13.87 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.574 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.631 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 37.0 t80 -40.28 -32.81 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -82.22 -41.41 9.35 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.688 ' HB3' HE22 ' A' ' 127' ' ' GLN . 26.3 mt-10 -62.39 -53.28 57.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 29.0 t80 -52.3 -31.69 34.14 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.284 0.564 . . . . 0.0 109.649 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -68.27 -23.91 64.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.975 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.709 ' HB2' ' NH1' ' A' ' 153' ' ' ARG . . . -88.94 -52.93 4.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.29 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 138' ' ' PHE . 5.2 ppp? -51.35 -22.57 2.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.447 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 36.9 ttm -93.09 -68.02 0.82 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.761 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.626 ' HD3' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -83.16 -144.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.326 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.64 ' HB3' ' HZ3' ' A' ' 144' ' ' LYS . 8.2 mtpm? -148.58 47.81 1.03 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.796 0.331 . . . . 0.0 110.845 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.718 ' HB2' HH12 ' A' ' 153' ' ' ARG . 66.4 mtt-85 -83.6 53.57 2.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.411 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.437 ' HE3' ' HZ3' ' A' ' 144' ' ' LYS . 96.1 mttt -53.15 -93.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.487 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -84.98 -4.92 86.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.947 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -52.87 158.22 1.45 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 111.012 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -64.74 -8.98 36.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.376 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -95.63 -3.05 61.22 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.61 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.821 HG23 ' H ' ' A' ' 152' ' ' GLY . 2.7 tt -33.3 -84.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.821 ' H ' HG23 ' A' ' 151' ' ' ILE . . . 85.23 -48.15 3.98 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.468 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.718 HH12 ' HB2' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -57.44 83.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.616 0.722 . . . . 0.0 110.574 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 152' ' ' GLY . 45.4 mtp85 -130.76 149.11 52.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.105 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.786 HG23 HD21 ' A' ' 129' ' ' ASN . 77.4 m -55.84 -44.01 77.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.151 0.5 . . . . 0.0 109.809 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -132.83 73.6 1.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.143 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 152' ' ' GLY . 75.1 mtp180 -48.28 155.78 0.46 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.869 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -161.9 152.3 17.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.572 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 82.4 p -112.12 -179.86 3.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.378 . . . . 0.0 110.998 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 160' ' ' LEU . 5.3 mp -111.16 -165.89 1.03 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.815 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -131.48 122.61 26.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 162' ' ' LEU . 2.5 pp -132.44 20.57 4.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.276 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -65.91 -65.02 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.13 145.08 56.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.983 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.79 134.38 49.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.025 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 98.3 mt -81.99 -21.18 37.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.93 107.99 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.443 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 168' ' ' LEU . 6.3 mp -83.77 146.93 27.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 111.056 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.94 123.16 56.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.985 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.04 -80.98 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.4 ' O ' ' ND2' ' A' ' 171' ' ' ASN . 0.3 OUTLIER -113.8 46.37 1.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.147 0.499 . . . . 0.0 110.277 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.48 130.6 4.04 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.5 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.3 t -145.04 -6.73 0.65 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.756 0.312 . . . . 0.0 110.809 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -116.13 -30.02 6.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -108.55 114.54 28.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.799 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.4 p -77.48 140.93 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 69.7 mt -90.14 107.54 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.054 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -136.27 127.57 28.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.98 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 69.54 -129.78 22.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.526 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.401 ' H ' ' H ' ' A' ' 181' ' ' PHE . 0.7 OUTLIER -167.97 -5.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.797 0.332 . . . . 0.0 111.192 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.401 ' H ' ' H ' ' A' ' 180' ' ' TYR . 13.2 t80 -97.6 165.75 11.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.589 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 61.5 mttp . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.794 -179.741 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ' CA' . . . . . 0.433 'CA ' ' HB3' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.837 0.351 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -126.73 -10.94 6.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.036 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.439 ' C ' ' HD2' ' A' ' 3' ' ' ARG . 4.6 tmm_? -162.11 115.91 1.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.361 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.7 tp -159.62 -43.45 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.804 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.8 t -95.42 179.65 5.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.806 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -109.29 41.96 1.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.937 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -64.27 -16.68 62.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.755 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.12 -43.33 99.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.973 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 9' ' ' ILE . 2.0 mp -67.51 -68.97 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.875 0.369 . . . . 0.0 111.25 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 12' ' ' LEU . . . -166.13 165.86 38.41 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.62 77.88 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.537 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 10' ' ' GLY . 31.5 tp -88.25 -46.78 8.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.538 0.209 . . . . 0.0 110.605 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.637 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 6.4 ttpm? -55.74 -30.92 62.03 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.752 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 8.1 mp0 -77.0 -38.26 53.43 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.968 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.748 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 54.5 tp -55.04 -28.12 49.78 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.664 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -70.54 -45.11 66.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.787 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.752 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 63.5 pttt -82.46 -12.46 57.82 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.58 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.45 -25.86 68.21 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.429 178.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.555 HG23 ' HA3' ' A' ' 35' ' ' GLY . 3.3 mt -86.4 -59.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.53 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.542 ' OD2' ' HA2' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -82.68 57.37 3.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.391 0.615 . . . . 0.0 110.523 179.349 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.67 HG21 ' NH2' ' A' ' 38' ' ' ARG . 13.6 t -81.26 -6.66 59.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.17 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -129.21 -14.65 4.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.58 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -74.38 -87.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.832 0.348 . . . . 0.0 111.197 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 p -176.67 6.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.811 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.542 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.44 31.47 2.79 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.498 ' HB ' ' CG2' ' A' ' 62' ' ' THR . 45.8 p -150.07 145.79 26.58 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.192 -0.504 . . . . 0.0 109.938 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.811 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.2 mt -102.85 103.87 15.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.632 HG22 ' OG1' ' A' ' 62' ' ' THR . 67.3 p -103.37 164.83 11.4 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.445 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.561 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 20.4 t80 -34.06 -36.44 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.72 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.15 -49.88 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.715 0.293 . . . . 0.0 111.676 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.637 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -75.7 -19.9 58.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.939 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.871 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -46.03 -47.4 16.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.893 0.854 . . . . 0.0 108.707 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.719 ' HG2' HG12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -85.38 -51.9 6.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.488 179.215 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.637 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 59.4 m-20 -36.34 -36.17 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.555 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -68.02 -57.32 8.79 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 115.124 0.81 . . . . 0.0 115.124 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -73.86 -28.53 61.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.195 0.997 . . . . 0.0 111.983 -177.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.657 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 19.3 ptpt -66.18 -4.67 8.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.67 ' NH2' HG21 ' A' ' 21' ' ' THR . 36.9 ttm180 -87.12 -42.72 12.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.278 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 36' ' ' LEU . 30.8 m -73.45 -0.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.75 -36.86 3.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.361 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.606 ' CB ' HD23 ' A' ' 36' ' ' LEU . 18.5 m -52.45 153.01 3.19 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.565 -0.161 . . . . 0.0 110.565 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -143.31 103.76 4.17 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.285 0.564 . . . . 0.0 112.153 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -105.36 167.97 9.38 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.125 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 5.3 mtm -104.62 165.54 11.0 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.53 ' HA ' HD13 ' A' ' 48' ' ' ILE . 92.8 mt-10 -47.68 -60.04 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.51 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 94.9 p -39.42 -35.0 0.24 Allowed 'General case' 0 C--N 1.335 -0.047 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 44' ' ' MET . 37.1 mp0 -66.42 -41.02 89.87 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.055 0.455 . . . . 0.0 110.15 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.871 HG13 HD12 ' A' ' 32' ' ' LEU . 2.0 mp -57.02 -60.58 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.958 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.561 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 42.3 tttm -64.34 -25.66 68.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.353 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 46' ' ' SER . 62.6 t0 -71.12 -37.46 72.32 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.654 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.53 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 10.2 tt -76.34 -23.04 54.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.049 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.751 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 18.1 mmt -71.92 -45.01 62.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.058 0.456 . . . . 0.0 111.468 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.51 -30.27 20.72 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.716 -0.394 . . . . 0.0 112.01 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.53 -19.36 22.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.04 -43.75 1.65 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.751 ' HB3' ' O ' ' A' ' 52' ' ' MET . 15.6 t0 -61.24 95.96 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.2 mm -48.62 -22.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.044 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 59.1 t0 -129.13 44.49 2.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.864 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.734 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.5 tmtm? -32.58 90.43 0.0 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.741 0.781 . . . . 0.0 112.659 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.3 p -127.72 17.98 6.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.184 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 70.92 17.76 75.66 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.428 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 85.9 m -150.35 127.1 10.97 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 123.779 0.341 . . . . 0.0 110.58 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.811 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 70.3 mt -108.02 129.43 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 121.058 0.456 . . . . 0.0 111.399 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -105.04 167.3 9.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.076 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.637 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 48.1 t80 -35.47 -45.81 0.36 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.486 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.4 -63.71 4.11 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.322 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.797 ' HB2' HG23 ' A' ' 63' ' ' ILE . 63.0 mt-10 -51.89 -26.15 9.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.684 0.278 . . . . 0.0 110.894 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.748 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 71.7 t80 -63.88 -65.12 0.72 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.431 0.634 . . . . 0.0 110.91 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.602 HD13 ' HD2' ' A' ' 68' ' ' PHE . 14.5 mm -52.2 -41.13 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.659 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.2 -25.77 66.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.47 . . . . 0.0 110.572 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.11 -12.57 26.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.028 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.418 HG21 HD11 ' A' ' 12' ' ' LEU . 37.4 m -87.72 -43.73 11.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.783 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.637 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 57.4 t -67.0 -18.12 23.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.081 0.467 . . . . 0.0 110.594 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -71.01 -47.54 58.19 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.6 mt -81.83 0.98 36.97 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.202 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.637 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 52.7 t-20 -102.82 75.29 1.39 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.984 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -175.43 -156.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.274 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.6 mm? -99.18 59.99 1.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.432 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -104.54 150.33 24.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.036 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -139.34 100.28 3.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.767 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -165.78 38.96 0.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.095 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -90.66 22.11 3.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.998 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -109.05 -155.96 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.975 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 139' ' ' ALA . 7.3 mp -57.16 -29.55 63.72 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.59 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 14.4 p -45.71 -27.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.732 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 52.3 m -51.11 -55.01 19.88 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.921 0.391 . . . . 0.0 110.118 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.583 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -81.12 -39.81 25.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.913 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.823 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 8.1 t80 -45.98 -23.01 0.25 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.358 0.599 . . . . 0.0 110.041 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 87' ' ' ALA . 28.4 t -89.15 -44.81 10.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.737 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -89.29 -63.7 1.25 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.601 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.5 m-85 -51.97 -62.33 1.7 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.823 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.6 OUTLIER -76.13 55.31 0.93 Allowed 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.093 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -44.59 -52.88 7.69 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.42 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.4 -21.44 64.69 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.344 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.08 68.69 1.07 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.5 p -115.59 -23.04 8.93 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.599 ' O ' ' HB2' ' A' ' 134' ' ' ASP . . . 130.51 -4.51 5.86 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-N 113.136 -1.847 . . . . 0.0 112.604 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.859 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.5 OUTLIER -148.69 161.83 40.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.399 0.618 . . . . 0.0 112.649 179.437 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.791 HG12 ' HA ' ' A' ' 92' ' ' ASP . 22.1 mt -133.12 104.24 6.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.779 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 102' ' ' ASP . 69.5 p -72.29 147.11 46.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.671 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.1 pp -34.41 -33.97 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.528 ' N ' HD12 ' A' ' 101' ' ' LEU . 54.2 m-20 -54.31 -55.92 23.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.548 ' HB2' HG23 ' A' ' 99' ' ' ILE . 97.4 mt-10 -71.19 -31.38 67.57 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.209 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.698 HG13 HG22 ' A' ' 99' ' ' ILE . 50.9 mt -65.74 -65.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.187 0.518 . . . . 0.0 110.403 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.892 ' HB3' HD12 ' A' ' 113' ' ' LEU . 30.8 mt-30 -58.14 -39.03 77.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.608 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.87 -44.07 94.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.095 0.474 . . . . 0.0 110.644 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.71 -3.06 1.33 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.17 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.762 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 73.2 m -115.09 44.12 1.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.93 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -59.54 -36.71 76.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.811 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -75.02 -22.11 58.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.155 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.762 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 2.7 m-85 -76.76 -5.24 47.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.944 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.37 38.81 96.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.572 -1.299 . . . . 0.0 111.026 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.928 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -33.01 132.72 0.14 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.525 0.679 . . . . 0.0 111.486 -177.154 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.716 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 91.9 m-20 -135.98 167.68 20.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.259 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.638 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.8 m-20 -82.95 -7.93 59.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.167 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.63 -64.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.039 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -89.46 -69.29 0.72 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.928 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.4 mm -52.72 -19.49 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.958 0.409 . . . . 0.0 111.268 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.638 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 33.6 t70 -71.11 -46.96 60.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 124' ' ' GLU . 63.9 t0 -62.37 -26.26 68.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' MET . . . . . 1.086 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.4 ttt -60.74 -29.82 69.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.501 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.769 HG22 ' HA3' ' A' ' 131' ' ' GLY . 56.8 mt -58.37 -43.59 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.475 ' CE ' ' HB ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -86.67 -13.79 44.47 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.584 -1.644 . . . . 0.0 110.374 178.517 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 1.086 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 71.4 tt0 -84.61 -23.71 29.45 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.79 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.854 HG22 HD11 ' A' ' 133' ' ' ILE . 13.4 mm -107.58 -21.77 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.978 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.3 t70 -62.89 98.43 0.13 Allowed 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.593 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.61 ' OE1' ' HG2' ' A' ' 137' ' ' GLU . 5.5 tm0? -87.24 -13.95 42.39 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 50.5 p30 -127.57 -33.19 2.33 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 20.8 p-10 179.92 -71.71 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.413 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 56.3 m-20 -64.93 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.978 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.53 37.92 77.91 Favored Glycine 0 CA--C 1.505 -0.577 0 C-N-CA 118.358 -1.877 . . . . 0.0 110.044 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.556 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 2.7 pt20 -133.31 170.54 15.3 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 113.929 -1.135 . . . . 0.0 110.073 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.006 HD13 ' HB3' ' A' ' 137' ' ' GLU . 5.0 mm -133.05 121.89 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.856 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.924 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 4.3 p-10 -113.08 162.48 15.88 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.172 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.798 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 22.4 t80 -38.79 -30.45 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.0 0.428 . . . . 0.0 110.738 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.731 ' HA3' ' N ' ' A' ' 153' ' ' ARG . . . -84.25 -45.15 6.32 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.726 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 1.006 ' HB3' HD13 ' A' ' 133' ' ' ILE . 39.3 mt-10 -63.07 -51.3 67.2 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.588 ' HB2' ' CG2' ' A' ' 133' ' ' ILE . 13.5 t80 -56.61 -18.66 12.77 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.611 ' HA ' HD21 ' A' ' 84' ' ' LEU . . . -86.1 -40.82 15.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.593 ' HB3' ' HG3' ' A' ' 127' ' ' GLN . . . -87.29 -11.59 49.1 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.549 ' HG2' ' HA ' ' A' ' 138' ' ' PHE . 5.5 ppp? -72.46 -6.67 45.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.635 0.255 . . . . 0.0 111.543 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -134.94 -31.13 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.009 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.587 ' HG2' ' H ' ' A' ' 144' ' ' LYS . 62.2 ttt180 -112.08 -137.65 0.37 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.397 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.587 ' H ' ' HG2' ' A' ' 143' ' ' ARG . 95.5 mttt -131.18 -175.47 3.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.607 0.241 . . . . 0.0 110.59 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.717 ' H ' ' HE ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -101.32 78.29 1.87 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.249 0.547 . . . . 0.0 111.853 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.704 ' HB2' ' HZ3' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -53.78 155.6 3.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.881 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -85.94 -4.71 84.38 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.83 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -79.75 161.67 25.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 0.0 111.129 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -47.72 -23.84 2.56 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.961 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -42.56 -25.96 0.36 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.349 -0.453 . . . . 0.0 113.008 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.679 ' HA ' ' NH1' ' A' ' 153' ' ' ARG . 44.2 mt -48.78 149.05 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 120.78 0.324 . . . . 0.0 111.104 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.422 ' H ' ' HD2' ' A' ' 153' ' ' ARG . . . -158.98 -4.57 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.885 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.882 ' H ' ' HD2' ' A' ' 153' ' ' ARG . 4.2 mpt_? -53.75 170.57 0.11 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.8 0.333 . . . . 0.0 110.113 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.577 HH11 ' H ' ' A' ' 155' ' ' THR . 23.2 tpt85 -71.19 148.94 46.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.203 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.577 ' H ' HH11 ' A' ' 154' ' ' ARG . 56.2 m -50.16 80.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.394 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.538 ' N ' ' O ' ' A' ' 154' ' ' ARG . 27.8 ttt -175.92 -18.7 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.207 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 6.7 ppt_? -63.19 -15.5 57.14 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.169 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.802 ' HG3' HG22 ' A' ' 159' ' ' THR . 4.9 tppp? -161.53 -87.23 0.03 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.802 HG22 ' HG3' ' A' ' 158' ' ' LYS . 6.9 t -162.96 -36.38 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.814 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.51 179.46 7.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.741 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -103.94 -101.15 0.3 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.0 tp -174.82 154.32 1.89 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.639 0.257 . . . . 0.0 110.81 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -89.76 138.84 31.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.687 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -78.04 146.13 35.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.65 165.0 13.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 167' ' ' GLY . 2.7 pp -94.84 -10.03 32.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.492 ' N ' HD12 ' A' ' 166' ' ' LEU . . . 146.76 150.02 5.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.572 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 97.3 mt -100.11 139.14 36.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.939 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.89 149.76 14.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.935 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -156.68 156.18 32.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 0.0 111.161 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -100.24 -49.57 4.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.652 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.1 -174.47 31.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.511 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 81.4 p -159.6 174.56 14.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.36 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -119.61 -174.78 2.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.966 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -101.82 107.95 19.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.784 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.14 141.53 46.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.287 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 tp -123.85 130.08 74.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.848 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -132.53 141.37 48.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -171.65 -65.89 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.393 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.74 -13.06 22.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.352 . . . . 0.0 110.835 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -110.73 136.9 49.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.565 ' N ' ' HD3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.851 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.26 123.35 29.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.908 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.491 ' HD2' ' C ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -118.47 174.06 6.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.127 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.2 tp -135.8 -82.99 0.4 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.813 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.8 p -172.84 15.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.994 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -96.96 50.48 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.167 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -89.06 -28.28 20.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.815 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.98 -70.56 0.64 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.498 0.666 . . . . 0.0 110.99 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.0 pt -55.92 -24.2 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.642 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.06 164.12 12.86 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.369 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.8 -12.86 53.43 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.098 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.34 -41.03 49.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.401 0.143 . . . . 0.0 110.878 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.669 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 39.9 ttmt -55.89 -33.1 64.3 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -81.65 -37.93 26.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.761 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 51.8 tp -59.53 -25.96 64.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.143 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -70.89 -40.06 72.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.425 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -86.36 -11.97 50.59 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.662 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -59.46 -34.48 72.59 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.509 HD12 HD13 ' A' ' 27' ' ' ILE . 3.0 mt -81.18 -62.09 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.884 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -83.85 66.93 9.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.313 1.054 . . . . 0.0 109.529 178.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -89.34 -20.99 23.34 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.094 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -138.73 8.92 2.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.622 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 14.1 t-20 -82.94 -82.61 0.14 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.593 1.088 . . . . 0.0 110.981 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.0 p -176.13 15.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.05 18.51 9.23 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.628 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.64 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 39.9 p -148.84 161.2 42.3 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.403 0.62 . . . . 0.0 111.749 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.729 ' O ' ' HA ' ' A' ' 62' ' ' THR . 4.7 mt -111.01 103.82 16.09 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.502 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.63 HG22 ' OG1' ' A' ' 62' ' ' THR . 65.4 p -112.7 158.22 20.32 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.644 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.816 ' HE2' ' HB2' ' A' ' 49' ' ' LYS . 14.7 t80 -34.45 -20.01 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.616 ' N ' ' O ' ' A' ' 28' ' ' THR . 32.7 t70 -86.18 -39.06 17.04 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.08 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.622 ' OE2' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -90.87 -32.08 16.18 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.729 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -40.45 -51.45 2.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.401 0.62 . . . . 0.0 110.318 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.721 ' HB3' HG12 ' A' ' 48' ' ' ILE . 12.4 ptpt -71.47 -39.4 70.94 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.267 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 38' ' ' ARG . 8.2 t70 -43.98 -47.81 8.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.217 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.493 ' HA3' HG12 ' A' ' 19' ' ' ILE . . . -45.21 -47.22 10.68 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 114.695 0.638 . . . . 0.0 114.695 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.752 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.7 mm? -95.2 -44.13 7.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.592 0.696 . . . . 0.0 112.214 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.699 ' NZ ' ' HD3' ' A' ' 33' ' ' LYS . 15.3 ptpt -56.32 -18.67 11.46 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HG3' HH11 ' A' ' 38' ' ' ARG . 22.2 ttm-85 -90.83 -25.02 20.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.22 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 36' ' ' LEU . 6.3 p -80.56 -37.48 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.63 -42.65 0.59 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.447 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.6 m -62.75 177.21 0.57 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.795 0.331 . . . . 0.0 110.963 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.34 112.03 7.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 mt -108.02 165.48 11.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.503 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.464 ' O ' HD13 ' A' ' 48' ' ' ILE . 26.8 ptt? -112.22 162.08 15.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.69 -14.29 19.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.7 t -87.64 -17.11 32.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.199 0.523 . . . . 0.0 109.938 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 97.0 mt-10 -90.73 -46.24 8.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.783 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.729 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -50.77 -50.65 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 122.275 1.036 . . . . 0.0 109.086 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.816 ' HB2' ' HE2' ' A' ' 29' ' ' PHE . 52.3 tttp -64.11 -30.3 71.38 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.383 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 64.1 t0 -64.26 -48.71 74.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.721 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 26.9 mt -60.43 -15.75 29.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.525 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.759 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 30.5 mtt -88.02 -65.24 1.04 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.453 ' CA ' ' HG3' ' A' ' 59' ' ' LYS . 2.5 p30 -66.73 -25.6 66.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.654 0.264 . . . . 0.0 111.595 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -91.33 -28.39 17.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -125.41 -43.93 1.88 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.636 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 64.2 t0 -51.18 101.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.032 0.444 . . . . 0.0 110.243 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.9 mm -44.87 -26.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.674 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.61 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 38.7 t70 -133.26 44.72 2.79 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.364 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.759 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 10.2 tmtt? -32.07 92.03 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.941 0.877 . . . . 0.0 112.642 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.1 p -126.71 19.06 7.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.833 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 71.85 16.23 76.29 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.21 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.729 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 58.5 m -147.64 128.14 14.08 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.405 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.725 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 71.5 mt -113.23 130.33 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.157 0.503 . . . . 0.0 110.871 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.43 167.73 9.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.058 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.669 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 66.3 t80 -42.67 -25.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.019 0.437 . . . . 0.0 110.799 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.71 -59.48 2.34 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.753 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.691 ' HB2' HG23 ' A' ' 63' ' ' ILE . 37.8 mt-10 -56.04 -23.26 32.19 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.646 0.26 . . . . 0.0 110.828 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.761 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 60.4 t80 -68.54 -65.54 0.69 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.566 0.698 . . . . 0.0 110.416 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 65' ' ' TYR . 44.2 mm -47.1 -58.47 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.106 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.767 ' HA ' HG22 ' A' ' 73' ' ' VAL . . . -44.65 -53.18 7.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.493 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . -48.06 -37.84 16.01 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 t -95.43 -26.89 15.67 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.767 HG22 ' HA ' ' A' ' 70' ' ' ALA . 16.7 m -85.93 -13.87 10.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.178 0.513 . . . . 0.0 110.696 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.664 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 18.5 t-160 -67.82 -45.65 74.09 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 75' ' ' LEU . 3.6 mm? -67.1 -11.56 57.53 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.426 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 49.6 t30 -123.47 74.13 1.23 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.401 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.681 ' HG3' ' O ' ' A' ' 73' ' ' VAL . 53.0 mtmt -164.79 -82.16 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.107 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.08 91.4 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.419 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -39.84 -39.94 0.89 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.969 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 22.2 ptt-85 -63.95 122.16 15.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.012 0.435 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -113.64 166.17 11.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.76 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -161.32 74.27 0.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.767 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -161.35 147.32 14.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.952 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.828 ' H ' HD23 ' A' ' 84' ' ' LEU . 2.1 pt? -87.71 -17.96 30.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.726 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 m -54.12 -19.47 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.436 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 89' ' ' SER . 81.0 p -46.09 -56.72 5.23 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.923 0.392 . . . . 0.0 110.187 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.432 ' C ' ' N ' ' A' ' 89' ' ' SER . . . -68.58 -45.39 72.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.812 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 18.9 t80 -47.51 -19.26 0.17 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.584 0.707 . . . . 0.0 109.979 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 30.7 m -89.81 -59.61 2.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.695 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.439 ' CG ' ' HB2' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -74.25 -62.97 1.33 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -51.73 -60.55 3.04 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.812 ' HB3' ' O ' ' A' ' 88' ' ' PHE . 62.6 t0 -82.91 69.54 9.74 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 89' ' ' SER . 31.3 ttmt -53.25 -16.05 1.14 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.668 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -97.49 -24.4 15.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.579 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.93 -12.47 0.81 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.804 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.9 p -51.83 -22.84 4.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.204 0.502 . . . . 0.0 110.606 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.589 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 126.01 -3.84 7.9 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.038 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -125.8 144.68 50.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.038 0.447 . . . . 0.0 111.849 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.778 HG12 ' HA ' ' A' ' 92' ' ' ASP . 31.2 mt -131.58 102.59 6.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.61 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 103' ' ' GLU . 70.6 p -81.52 156.94 25.01 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.215 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.524 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.0 pp -35.01 -39.86 0.11 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.69 0.281 . . . . 0.0 111.259 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.497 ' N ' HD12 ' A' ' 101' ' ' LEU . 8.3 t70 -57.86 -57.78 11.29 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.469 ' CB ' HG23 ' A' ' 99' ' ' ILE . 51.0 mt-10 -58.89 -48.22 82.19 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.57 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.832 HG21 HD12 ' A' ' 125' ' ' ILE . 91.1 mt -55.73 -65.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.151 0.5 . . . . 0.0 110.653 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.589 ' OE1' HG22 ' A' ' 118' ' ' ILE . 24.8 mt-30 -56.83 -65.14 0.67 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.11 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -42.38 -32.96 0.58 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.51 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 104' ' ' ILE . . . -53.28 -65.57 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 111' ' ' PHE . 51.6 t -62.01 135.0 57.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.881 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -89.12 -47.87 7.79 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -78.9 -3.32 44.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.628 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.711 ' CE2' ' HB2' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -47.19 -27.21 1.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.412 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 60.44 37.61 93.49 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.371 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.711 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 6.4 tt -31.8 126.92 0.23 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.327 0.584 . . . . 0.0 112.306 -176.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.668 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 29.6 t70 -160.2 177.09 11.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.955 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.723 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 2.9 p30 -89.2 -8.19 54.07 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.704 HG23 ' H ' ' A' ' 117' ' ' HIS . 7.1 tp -88.51 -64.69 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.704 ' H ' HG23 ' A' ' 116' ' ' ILE . 16.6 t-160 -92.7 -67.11 0.88 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.031 0.443 . . . . 0.0 111.975 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.845 HD12 ' H ' ' A' ' 118' ' ' ILE . 4.4 mp -50.23 -20.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.694 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.723 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 7.7 t70 -76.12 -52.34 10.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' GLU . 37.1 t70 -58.92 -19.64 44.5 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.87 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.5 ttt -68.79 -45.39 71.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.259 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.628 HG22 ' HA3' ' A' ' 131' ' ' GLY . 54.1 mt -51.44 -40.85 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.635 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.6 -13.84 44.53 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.512 -1.677 . . . . 0.0 110.267 178.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.87 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 41.8 tp10 -83.98 -21.42 31.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.493 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.832 HD12 HG21 ' A' ' 104' ' ' ILE . 1.1 mt -105.71 -33.75 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 1.031 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.8 t70 -54.75 95.64 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.793 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 151' ' ' ILE . 15.4 mt-30 -87.67 -9.8 53.13 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.188 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 7.1 t70 -126.79 -32.73 2.56 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -177.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.665 HD22 ' NH1' ' A' ' 154' ' ' ARG . 18.5 p-10 178.33 -68.79 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.67 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 7.3 t70 -63.82 -24.18 67.65 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -172.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 1.031 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 94.95 36.83 5.38 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 107.169 -2.372 . . . . 0.0 107.169 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.67 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 5.3 pt20 -138.21 168.01 20.64 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 112.846 -1.677 . . . . 0.0 108.922 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.769 HD11 ' O ' ' A' ' 125' ' ' ILE . 21.5 mm -130.86 131.12 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-O 121.797 0.808 . . . . 0.0 110.978 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.878 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 10.7 t70 -103.03 163.06 12.44 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.69 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.779 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 21.8 t80 -43.76 -37.18 2.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.287 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.619 ' C ' ' HB2' ' A' ' 153' ' ' ARG . . . -82.2 -36.06 18.94 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.834 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.878 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 46.4 mt-10 -61.13 -57.62 11.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.657 ' HD1' HG21 ' A' ' 133' ' ' ILE . 3.4 t80 -55.49 -39.15 70.07 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.916 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.68 -25.11 67.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.785 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 146' ' ' LYS . . . -89.35 -44.68 10.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -31.17 69.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.565 0.221 . . . . 0.0 111.419 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.1 ttp -86.67 -27.95 23.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.04 0.448 . . . . 0.0 110.177 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.547 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 98.7 mtt180 -118.83 -129.8 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.192 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.599 ' HE3' ' HA ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -153.71 38.48 0.47 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.932 0.396 . . . . 0.0 110.44 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 145' ' ' ARG . 14.3 tpp85 -79.05 -2.35 40.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.993 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.51 ' HA ' ' HD3' ' A' ' 153' ' ' ARG . 8.8 ptpp? -80.19 136.6 36.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.925 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.98 40.41 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.927 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -131.15 144.84 51.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.626 0.25 . . . . 0.0 110.327 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.74 -20.19 38.81 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.537 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -71.36 -42.2 57.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.733 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 127' ' ' GLN . 37.6 mt -125.09 134.91 65.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.31 0.576 . . . . 0.0 112.303 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.478 ' O ' ' HD2' ' A' ' 153' ' ' ARG . . . -82.16 -133.17 1.7 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.542 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.619 ' HB2' ' C ' ' A' ' 136' ' ' GLY . 26.0 mmm180 -130.75 82.55 2.06 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.855 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.665 ' NH1' HD22 ' A' ' 129' ' ' ASN . 79.3 ttt180 -107.05 148.13 29.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.843 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 77.0 m -57.02 -19.01 16.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.187 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.535 ' H ' ' HG2' ' A' ' 154' ' ' ARG . 50.2 ttm -67.84 -40.16 83.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.115 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.587 ' HG3' HG21 ' A' ' 151' ' ' ILE . 4.1 mmp_? -83.96 -65.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.951 0.405 . . . . 0.0 110.829 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -156.07 135.41 12.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.825 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.9 t -129.57 32.89 4.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.84 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.7 tp -93.69 91.09 6.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -166.05 101.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 0.0 111.048 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -138.95 80.89 1.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.994 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.414 ' HG3' HH11 ' A' ' 163' ' ' ARG . 20.8 mmt85 -145.79 131.01 18.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.842 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -62.72 111.7 2.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.731 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -125.64 159.9 31.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.192 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.729 ' H ' HD23 ' A' ' 166' ' ' LEU . 2.0 pt? -127.16 11.88 7.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.039 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.14 -142.3 15.92 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.436 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 168' ' ' LEU . 2.8 mm? -90.5 176.51 6.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.35 134.19 27.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -113.85 177.74 4.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.772 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -97.3 30.69 2.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.821 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -161.22 123.56 1.22 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.305 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 79.5 p -112.52 -21.26 11.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.722 0.296 . . . . 0.0 111.161 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -141.39 149.61 41.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.994 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -88.23 117.86 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.813 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 48.0 t -124.24 125.28 70.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.099 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 66.3 mt -79.7 143.11 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -76.44 103.18 6.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.8 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -148.8 -26.99 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.517 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.72 5.72 39.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.784 0.326 . . . . 0.0 110.65 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -101.88 33.7 2.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.794 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.943 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.787 0.327 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -109.43 170.92 7.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -127.91 -56.07 1.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.813 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.489 HD23 ' C ' ' A' ' 4' ' ' LEU . 6.4 tt -156.71 -57.58 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.288 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.0 p -82.92 140.43 32.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.488 ' HB3' HD12 ' A' ' 9' ' ' ILE . 17.8 tp10 -63.71 158.08 22.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.811 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -77.16 -53.9 7.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.45 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.437 ' HG2' ' HG3' ' A' ' 6' ' ' GLU . 24.0 pt-20 -56.34 -27.52 56.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.336 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.488 HD12 ' HB3' ' A' ' 6' ' ' GLU . 68.0 mt -74.26 -58.98 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.816 0.341 . . . . 0.0 110.833 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.3 116.32 4.72 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.411 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.84 52.94 0.82 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.428 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.451 HD22 HG21 ' A' ' 72' ' ' THR . 43.1 tp -81.42 -19.05 43.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.602 0.239 . . . . 0.0 111.005 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.482 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -75.69 -46.61 30.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.438 ' HG3' ' HE3' ' A' ' 17' ' ' LYS . 85.1 tt0 -69.37 -17.91 63.73 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.681 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.818 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 2.3 tm? -83.6 -39.07 20.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.406 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.55 ' HE1' HG13 ' A' ' 27' ' ' ILE . 2.3 t80 -57.79 -42.67 84.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.1 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.438 ' HE3' ' HG3' ' A' ' 14' ' ' GLU . 19.5 pttp -80.48 -17.72 50.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.61 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.818 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.39 -32.87 74.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.653 HG23 ' HA3' ' A' ' 35' ' ' GLY . 1.1 mm -71.5 -62.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.289 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.446 ' HB3' HG12 ' A' ' 27' ' ' ILE . 2.5 p30 -89.08 47.23 1.47 Allowed 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.84 0.829 . . . . 0.0 111.255 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 t -71.35 -18.4 62.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.924 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -108.33 -11.48 15.19 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -83.06 -88.73 0.09 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 111.426 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.4 p -176.45 12.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.119 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.39 17.88 9.01 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.101 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -135.58 143.59 45.73 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.002 0.43 . . . . 0.0 109.86 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.8 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 8.4 mt -103.73 104.03 16.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.599 HG22 ' OG1' ' A' ' 62' ' ' THR . 76.6 p -102.55 159.79 15.13 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.457 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 25.7 t80 -34.37 -34.13 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 O-C-N 123.79 0.681 . . . . 0.0 111.906 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 28' ' ' THR . 35.8 m-20 -73.45 -50.29 22.42 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.338 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 28.2 mp0 -78.06 -14.73 59.39 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.714 0.293 . . . . 0.0 111.033 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.86 HD12 HG13 ' A' ' 48' ' ' ILE . 1.6 tm? -55.43 -48.78 73.9 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.849 0.833 . . . . 0.0 108.928 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.903 ' HB2' ' HE3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -82.89 -49.19 9.92 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.313 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.591 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 36.3 m-20 -39.51 -45.33 1.55 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.653 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -52.37 -50.56 46.79 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.059 -0.591 . . . . 0.0 114.234 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.724 HD12 HD23 ' A' ' 43' ' ' LEU . 85.3 mt -75.53 -52.05 11.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.246 0.523 . . . . 0.0 111.685 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.903 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 18.2 ptpt -55.97 -16.03 4.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.985 0.421 . . . . 0.0 110.211 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.438 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -87.1 -39.58 15.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.995 178.421 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.6 p -70.91 -10.73 14.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.285 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.09 -5.22 22.05 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.502 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 61.5 m -78.93 157.86 28.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.664 0.268 . . . . 0.0 111.401 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 14.2 pt-20 -123.54 104.22 8.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.516 0.674 . . . . 0.0 110.936 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.854 HD13 HD11 ' A' ' 48' ' ' ILE . 1.7 pp -117.96 166.09 12.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.736 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.443 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 25.9 ptm -118.06 156.04 29.31 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.54 ' HA ' HD13 ' A' ' 48' ' ' ILE . 32.6 tt0 -44.65 -58.22 3.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.6 m -49.39 -25.79 2.76 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 97.8 mt-10 -73.52 -31.84 63.9 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.125 0.488 . . . . 0.0 109.838 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.86 HG13 HD12 ' A' ' 32' ' ' LEU . 1.9 mp -59.78 -64.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.752 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.495 ' HD2' ' CD ' ' A' ' 93' ' ' LYS . 4.5 ttmp? -55.35 -34.07 63.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.267 0.555 . . . . 0.0 109.747 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 36.4 t70 -52.86 -61.0 2.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.474 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.814 HD11 HD11 ' A' ' 32' ' ' LEU . 4.1 pp -65.71 -14.88 62.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.794 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 27.3 mtt -80.76 -65.83 0.96 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.171 0.51 . . . . 0.0 110.987 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.516 ' OD2' ' HB2' ' A' ' 90' ' ' TYR . 41.2 t0 -61.71 -21.94 64.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.867 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.53 -40.46 11.35 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -112.33 -44.27 3.41 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 52' ' ' MET . 66.6 t0 -51.67 98.26 0.02 OUTLIER 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.2 mt -38.34 -35.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.802 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 60' ' ' SER . 2.8 p30 -133.65 45.37 2.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.013 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.794 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.6 tmtm? -31.74 90.83 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.914 0.864 . . . . 0.0 112.174 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 58' ' ' ASP . 73.4 p -123.98 16.74 9.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.874 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 83.71 14.22 73.6 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.394 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 57.9 m -153.03 127.2 9.11 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.881 HG23 ' HB2' ' A' ' 67' ' ' GLU . 68.9 mt -112.28 133.46 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.205 0.526 . . . . 0.0 111.798 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.72 167.32 9.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.679 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.529 ' O ' HG13 ' A' ' 69' ' ' ILE . 25.2 t80 -36.54 -48.33 0.68 Allowed 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.49 -59.86 7.76 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.358 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.881 ' HB2' HG23 ' A' ' 63' ' ' ILE . 34.7 mt-10 -51.43 -30.07 18.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.854 0.359 . . . . 0.0 110.567 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.534 ' CD2' ' HB2' ' A' ' 16' ' ' PHE . 30.6 t80 -61.87 -46.9 87.41 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.271 0.558 . . . . 0.0 110.945 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 65' ' ' TYR . 10.7 mt -59.96 -19.45 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.616 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 67' ' ' GLU . . . -67.65 -20.51 65.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.251 0.548 . . . . 0.0 109.617 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 74' ' ' HIS . . . -68.61 -32.86 73.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.057 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.451 HG21 HD22 ' A' ' 12' ' ' LEU . 18.3 p -77.69 -16.93 58.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.403 ' C ' ' H ' ' A' ' 76' ' ' ASN . 80.1 t -90.44 -14.13 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.977 178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.543 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 14.3 t-80 -61.59 -42.92 99.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.955 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 75' ' ' LEU . 6.4 mp -74.82 -6.23 47.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 73' ' ' VAL . 53.9 t-20 -118.71 75.18 1.01 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.939 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 74' ' ' HIS . 98.7 mttt -112.04 50.68 0.84 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.936 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.65 -10.5 19.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.953 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -106.67 171.49 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.884 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 73.0 mtt-85 -115.31 148.17 39.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -134.97 147.37 49.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.554 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -162.45 131.98 4.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.834 0.349 . . . . 0.0 111.475 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.487 ' HB2' ' CB ' ' A' ' 86' ' ' SER . 75.7 m-80 -150.93 -179.65 7.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.556 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.457 ' C ' HD23 ' A' ' 84' ' ' LEU . 6.1 tt -90.3 -65.47 1.01 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.166 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 m -68.11 -25.75 32.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.326 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.487 ' CB ' ' HB2' ' A' ' 83' ' ' ASN . 72.5 m -54.41 -23.87 17.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.238 0.542 . . . . 0.0 109.666 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -84.7 -51.08 7.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.488 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.835 ' HE1' ' HB2' ' A' ' 135' ' ' TYR . 7.9 t80 -39.14 -36.42 0.31 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.116 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.4 t -89.24 -55.49 3.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.228 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.516 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 7.8 t80 -75.77 -63.89 1.2 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.561 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.751 ' HB3' HD13 ' A' ' 99' ' ' ILE . 3.1 m-85 -58.14 -65.21 0.68 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.782 ' HA ' HG12 ' A' ' 99' ' ' ILE . 12.4 t0 -74.54 60.04 0.86 Allowed 'General case' 0 C--N 1.335 -0.056 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.495 ' CD ' ' HD2' ' A' ' 49' ' ' LYS . 3.0 tppp? -49.2 -40.72 34.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.507 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.52 -21.35 60.42 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.383 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 49.02 72.33 0.48 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.1 p -132.57 -5.0 3.29 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 105.87 5.78 38.16 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 113.799 -1.546 . . . . 0.0 113.322 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.778 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -144.27 157.46 44.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.456 0.646 . . . . 0.0 111.495 179.108 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.782 HG12 ' HA ' ' A' ' 92' ' ' ASP . 77.8 mt -133.18 104.14 6.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.956 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 103' ' ' GLU . 43.6 p -70.8 147.99 48.35 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.766 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.685 ' HB3' HG23 ' A' ' 122' ' ' ILE . 3.6 pp -34.84 -39.22 0.09 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.421 ' N ' HD12 ' A' ' 101' ' ' LEU . 1.6 m-20 -55.55 -54.71 40.6 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.59 ' HB2' HG23 ' A' ' 99' ' ' ILE . 49.3 mt-10 -60.48 -44.46 95.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.235 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.77 HG13 HG22 ' A' ' 99' ' ' ILE . 96.6 mt -56.72 -65.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.381 0.61 . . . . 0.0 110.676 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.551 ' HB3' HD12 ' A' ' 113' ' ' LEU . 29.2 mt-30 -58.35 -65.47 0.65 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.488 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -42.79 -34.23 0.89 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.17 -66.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.314 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 98.5 m -49.78 134.17 20.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.811 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -89.29 -60.91 1.82 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -75.49 -3.07 31.92 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.82 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.749 ' O ' HD11 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -46.81 -29.39 1.93 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -178.323 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 62.87 39.21 97.74 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 118.85 -1.643 . . . . 0.0 110.777 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.793 ' HA ' HD12 ' A' ' 118' ' ' ILE . 9.1 tt -31.63 130.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.454 ' OD2' HG13 ' A' ' 116' ' ' ILE . 35.9 t70 -157.21 175.67 13.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.905 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.741 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.0 m-20 -88.89 -7.45 56.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.454 HG13 ' OD2' ' A' ' 114' ' ' ASP . 60.5 mt -84.86 -65.53 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -92.45 -69.04 0.76 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 113' ' ' LEU . 60.5 mt -52.1 -19.68 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.935 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.741 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 37.4 t70 -75.89 -51.67 12.0 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' GLU . 32.2 m-20 -65.07 -17.9 64.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' MET . . . . . 1.064 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 13.6 tmm? -65.31 -41.25 94.25 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.823 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.748 HG22 ' HA3' ' A' ' 131' ' ' GLY . 61.1 mt -54.12 -39.68 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.77 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 10.9 mmpt? -86.7 -13.89 44.1 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 112.403 -2.18 . . . . 0.0 110.574 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 1.064 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 29.7 tt0 -94.27 -14.78 25.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.689 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.845 HG22 ' CD1' ' A' ' 133' ' ' ILE . 29.9 mt -111.97 -35.55 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.379 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.782 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 1.8 t70 -47.02 129.83 12.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.705 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.557 ' HG2' ' HB2' ' A' ' 153' ' ' ARG . 1.0 OUTLIER -88.41 -23.15 23.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.529 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 154' ' ' ARG . 45.3 p-10 -135.24 -32.73 0.93 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 29.8 p-10 179.36 -52.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.694 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 31.1 m-20 -64.6 8.76 0.1 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -173.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.782 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.5 37.06 65.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 118.45 -1.833 . . . . 0.0 108.772 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.694 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 1.7 pt20 -127.59 169.37 13.81 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.805 -1.197 . . . . 0.0 108.982 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.845 ' CD1' HG22 ' A' ' 125' ' ' ILE . 25.6 mm -135.94 129.97 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.4 0 CA-C-O 121.622 0.725 . . . . 0.0 110.803 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.778 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -102.24 165.19 11.27 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.173 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.835 ' HB2' ' HE1' ' A' ' 88' ' ' PHE . 41.0 t80 -48.06 -31.0 4.93 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.47 ' HA3' ' N ' ' A' ' 153' ' ' ARG . . . -85.1 -26.52 36.72 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.462 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.625 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 78.7 mt-10 -76.12 -53.86 7.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.824 -0.188 . . . . 0.0 110.521 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.578 ' HD1' HG21 ' A' ' 133' ' ' ILE . 4.1 t80 -60.85 -23.96 65.53 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.838 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.0 -32.55 21.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.747 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.795 ' HB2' HD11 ' A' ' 151' ' ' ILE . . . -89.8 -27.8 19.75 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -11.4 16.38 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -122.62 -23.31 5.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.749 0.309 . . . . 0.0 111.141 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -100.22 -165.88 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.73 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.559 ' HB2' ' NZ ' ' A' ' 146' ' ' LYS . 67.4 mttm -70.14 -169.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.561 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.675 ' HD3' HH12 ' A' ' 153' ' ' ARG . 24.4 tpp180 -101.39 82.5 2.33 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.43 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.559 ' NZ ' ' HB2' ' A' ' 144' ' ' LYS . 48.7 mmtm -83.85 117.49 23.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.235 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -93.75 -4.97 63.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.342 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.512 ' O ' HG22 ' A' ' 151' ' ' ILE . 22.4 p30 -60.89 161.08 8.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.803 0.335 . . . . 0.0 111.12 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -64.72 -36.87 93.64 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.984 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -42.78 -33.55 1.64 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.451 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.795 HD11 ' HB2' ' A' ' 140' ' ' ALA . 11.5 tt -70.82 -169.74 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.794 ' H ' HG12 ' A' ' 151' ' ' ILE . . . -153.5 -4.65 0.12 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.536 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.675 HH12 ' HD3' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -56.71 143.22 37.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.912 0.387 . . . . 0.0 110.24 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.676 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 2.5 tmt_? -76.8 103.66 6.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.423 0.63 . . . . 0.0 111.798 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.432 ' H ' ' H ' ' A' ' 156' ' ' MET . 95.6 m -168.76 -26.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.432 ' H ' ' H ' ' A' ' 155' ' ' THR . 45.7 ttp -175.25 37.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.705 -1.589 . . . . 0.0 107.694 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.598 ' HD3' ' HG2' ' A' ' 154' ' ' ARG . 10.6 mtm105 -39.19 149.83 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.923 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -153.7 101.18 2.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.635 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.3 m -137.49 88.48 2.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.907 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.438 ' O ' ' HG ' ' A' ' 160' ' ' LEU . 33.7 tp -168.03 33.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.247 0.546 . . . . 0.0 110.419 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -108.89 -177.86 3.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.893 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.435 HD23 ' C ' ' A' ' 162' ' ' LEU . 5.4 tt -85.79 118.33 25.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.368 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.438 HH11 ' HG2' ' A' ' 163' ' ' ARG . 11.6 tpt180 -88.36 105.78 17.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.807 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -134.45 127.87 32.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -56.35 158.38 4.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.391 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 166' ' ' LEU . 6.2 mp -85.85 9.1 17.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.78 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.79 104.58 0.47 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.595 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 168' ' ' LEU . 6.6 mp -109.91 133.02 53.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.832 0.348 . . . . 0.0 110.789 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 41.1 t -69.55 113.29 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -106.1 29.26 6.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -110.99 -23.11 11.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.915 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 104.05 155.43 23.76 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.39 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.408 ' H ' ' H ' ' A' ' 174' ' ' ASN . 42.8 t -153.66 -7.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.723 0.297 . . . . 0.0 111.082 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.408 ' H ' ' H ' ' A' ' 173' ' ' SER . 53.6 t-20 -108.35 112.47 24.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.425 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.56 103.55 16.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.145 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.28 132.95 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.986 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 69.9 mt -115.31 132.91 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.08 130.89 43.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.892 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.04 173.42 14.28 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.529 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -91.59 -91.83 0.15 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.641 0.257 . . . . 0.0 110.68 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.417 ' H ' ' H ' ' A' ' 182' ' ' LYS . 2.0 p90 -173.58 1.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.916 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.417 ' H ' ' H ' ' A' ' 181' ' ' PHE . 28.3 mtpp . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.812 0.339 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -78.15 -62.21 1.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.797 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -100.93 29.88 4.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 63.5 tp -92.63 93.54 8.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.4 p -121.92 179.75 4.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -60.14 137.16 58.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.01 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -80.14 -30.57 38.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.002 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -61.31 -25.14 66.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.034 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.5 mm -79.06 -34.36 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.055 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.58 105.1 0.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.02 28.69 0.54 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.636 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.853 HD11 HG21 ' A' ' 72' ' ' THR . 52.2 tp -60.08 -32.16 70.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.609 0.242 . . . . 0.0 110.624 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 61.6 tttm -60.78 -43.03 98.61 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.97 -26.94 67.79 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.736 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.709 ' HA ' ' HB3' ' A' ' 18' ' ' MET . 33.4 tp -72.48 -31.12 65.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.946 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.461 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 10.4 t80 -65.94 -48.18 72.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.283 0.564 . . . . 0.0 109.788 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.461 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -76.22 -16.23 59.87 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.709 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 3.1 tpp -66.79 -36.21 81.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.887 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.733 HG21 HD13 ' A' ' 27' ' ' ILE . 10.4 mm -62.85 -57.54 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.614 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.596 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 1.3 t70 -82.48 87.55 6.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.285 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 t -88.19 -24.9 23.17 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.62 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -139.71 -6.14 1.32 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.548 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 53.7 t30 -75.43 -80.42 0.09 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.897 1.226 . . . . 0.0 112.837 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 p -172.34 -0.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 110.26 23.57 6.01 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.456 ' HB ' ' OG1' ' A' ' 62' ' ' THR . 65.2 p -138.86 147.37 42.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.013 -1.093 . . . . 0.0 109.464 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.849 ' O ' ' HA ' ' A' ' 62' ' ' THR . 2.3 mt -104.21 103.71 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 59.9 p -101.97 161.97 13.27 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.48 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 2.0 t80 -34.21 -36.67 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.797 0.686 . . . . 0.0 111.076 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -74.95 -52.16 11.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.432 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.596 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 3.1 tt0 -70.85 -16.41 62.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.183 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.863 HD12 HG13 ' A' ' 48' ' ' ILE . 2.4 tm? -58.98 -55.25 37.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.353 0.597 . . . . 0.0 109.992 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.601 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 10.9 ptpt -76.22 -33.42 59.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.668 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -48.47 -58.38 4.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 19' ' ' ILE . . . -61.4 -22.45 61.24 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 114.849 0.7 . . . . 0.0 114.849 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 ' N ' ' A' ' 37' ' ' LYS . 4.6 pp -95.1 -39.09 10.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.785 0.792 . . . . 0.0 111.252 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.679 ' N ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -71.28 -15.23 62.41 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -87.68 -36.85 17.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.255 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.624 HG12 ' O ' ' A' ' 36' ' ' LEU . 9.0 p -75.08 -17.84 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.533 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.49 42.45 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.641 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 35.5 t -130.68 164.1 25.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.676 0.274 . . . . 0.0 110.456 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 10.7 pt-20 -141.89 104.78 4.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.198 0.523 . . . . 0.0 111.695 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.457 HD12 ' CD2' ' A' ' 36' ' ' LEU . 20.5 mt -124.58 165.99 16.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.188 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.4 ptm -113.08 164.03 13.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -45.52 -64.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.8 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.6 p -41.83 -22.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.3 mm-40 -82.31 -47.52 12.27 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.863 HG13 HD12 ' A' ' 32' ' ' LEU . 1.8 mp -51.59 -62.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.553 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.536 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . 3.1 tmtm? -46.67 -33.57 4.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.81 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.506 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 9.6 t70 -65.55 -43.87 88.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.806 HD13 ' N ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -64.35 -26.54 68.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.425 178.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.927 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 17.7 mmt -80.08 -66.43 0.88 Allowed 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.562 0.696 . . . . 0.0 112.183 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.726 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 1.5 m-20 -59.84 -21.86 61.49 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.873 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.721 ' HB1' ' HB3' ' A' ' 89' ' ' SER . . . -92.55 -42.8 9.49 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.721 ' HB1' ' HA ' ' A' ' 71' ' ' ALA . . . -111.73 -39.45 4.58 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.787 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 38.1 t0 -50.07 87.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' ALA . 37.6 mm -47.51 -22.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.559 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.531 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 60.0 m-20 -133.06 43.52 2.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.612 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.927 ' HD3' ' HB3' ' A' ' 52' ' ' MET . 56.5 tptt -33.12 90.32 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.695 0.76 . . . . 0.0 112.609 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.8 p -127.68 18.82 6.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.458 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 84.71 5.37 86.61 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.902 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.849 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 1.3 t -153.41 150.94 29.35 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.983 0.421 . . . . 0.0 111.312 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.904 HG23 ' HB2' ' A' ' 67' ' ' GLU . 68.7 mt -117.08 136.48 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.344 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -105.94 167.57 9.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.139 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.532 ' CE1' HD11 ' A' ' 69' ' ' ILE . 18.9 t80 -36.19 -49.57 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.406 0.441 . . . . 0.0 111.615 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.11 -60.37 7.7 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.723 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.904 ' HB2' HG23 ' A' ' 63' ' ' ILE . 23.8 mt-10 -53.68 -25.13 16.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.716 0.293 . . . . 0.0 110.602 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.578 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 47.1 t80 -64.79 -50.68 65.82 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.264 0.554 . . . . 0.0 110.474 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.532 HD11 ' CE1' ' A' ' 65' ' ' TYR . 5.0 mm -60.27 -50.16 81.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.125 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.96 -30.15 68.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.029 0.442 . . . . 0.0 110.215 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.721 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . -72.46 -45.28 60.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.19 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.853 HG21 HD11 ' A' ' 12' ' ' LEU . 67.3 p -65.41 -30.9 71.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.978 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.07 -15.84 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.723 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.479 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 27.0 t-80 -76.28 -43.7 40.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 71' ' ' ALA . 4.4 mm? -71.79 -15.13 62.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.626 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.15 75.48 7.85 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.202 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 74' ' ' HIS . 97.7 mttt -146.73 42.08 1.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.534 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.25 -4.71 3.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.632 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.54 -80.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.3 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.709 ' HE ' ' HA ' ' A' ' 80' ' ' ARG . 2.7 mmp_? -134.83 115.37 13.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.469 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.668 ' HB2' HG11 ' A' ' 85' ' ' VAL . 10.6 pt-20 -175.0 129.85 0.3 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.801 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -174.29 8.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.492 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -164.68 -79.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.499 HD23 ' H ' ' A' ' 84' ' ' LEU . 2.6 pt? -56.32 -30.25 62.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.89 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.668 HG11 ' HB2' ' A' ' 81' ' ' GLU . 7.2 p -54.78 -23.29 11.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.695 0.284 . . . . 0.0 111.286 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.6 m -56.24 -44.46 79.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.198 0.523 . . . . 0.0 109.666 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HA ' ' CD1' ' A' ' 91' ' ' PHE . . . -75.77 -55.04 6.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.831 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.796 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 4.9 t80 -40.59 -25.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.73 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.721 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 22.6 m -90.92 -64.48 1.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -79.16 -42.38 26.27 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.763 0.316 . . . . 0.0 111.683 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 87' ' ' ALA . 5.7 m-85 -63.65 -64.5 0.88 Allowed 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 176.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.931 ' HA ' HG12 ' A' ' 99' ' ' ILE . 56.9 t0 -77.78 70.56 4.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.726 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 22.4 ttmt -43.54 -49.22 7.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.362 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.501 ' OD2' HG23 ' A' ' 57' ' ' ILE . 7.1 t70 -67.75 -22.71 65.21 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.138 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 49.98 54.27 19.26 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.653 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.8 p -125.49 12.31 8.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.688 ' HA2' ' HE1' ' A' ' 88' ' ' PHE . . . 84.66 21.18 56.78 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.447 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' HA ' ' OD1' ' A' ' 134' ' ' ASP . 14.3 m-85 -143.52 131.9 22.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.931 HG12 ' HA ' ' A' ' 92' ' ' ASP . 48.6 mt -130.19 101.96 6.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.88 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.506 ' HA ' ' HB3' ' A' ' 132' ' ' GLN . 58.8 p -74.12 164.69 26.3 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.07 -0.394 . . . . 0.0 111.086 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.726 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER -41.28 -36.55 0.81 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.425 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -67.46 -52.38 40.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.279 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.487 ' CB ' HG23 ' A' ' 99' ' ' ILE . 56.3 mt-10 -64.95 -15.88 62.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.636 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.723 HG22 ' HE3' ' A' ' 121' ' ' MET . 96.6 mt -87.33 -62.82 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.124 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.726 ' HG2' ' O ' ' A' ' 101' ' ' LEU . 7.1 mm100 -50.27 -51.69 42.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.96 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -60.73 -31.19 70.5 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.22 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 104' ' ' ILE . . . -59.81 -21.54 61.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.87 0.367 . . . . 0.0 110.927 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.55 ' HB3' ' CG ' ' A' ' 111' ' ' PHE . 72.4 m -117.13 66.72 0.73 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.682 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.698 ' HD3' ' H ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -78.4 -39.37 39.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -68.81 -12.6 61.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.183 0.516 . . . . 0.0 110.347 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.55 ' CG ' ' HB3' ' A' ' 108' ' ' CYS . 3.2 m-85 -74.77 -46.81 34.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.827 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.72 37.98 2.66 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.749 ' HA ' HG13 ' A' ' 118' ' ' ILE . 1.0 OUTLIER -33.33 139.07 0.06 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.504 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 52.8 t0 -152.67 150.7 29.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.272 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.692 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 10.2 t70 -57.74 -8.74 0.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.493 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.3 mm -86.67 -64.8 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -91.68 -68.98 0.76 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 1.022 HG23 ' HE2' ' A' ' 121' ' ' MET . 17.5 mm -51.05 -24.36 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.2 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.692 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 36.1 t70 -75.08 -46.26 35.82 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 124' ' ' GLU . 33.3 t70 -62.31 -21.48 65.29 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' MET . . . . . 1.022 ' HE2' HG23 ' A' ' 118' ' ' ILE . 3.8 ttp -65.36 -33.32 75.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.637 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 126' ' ' ASP . 46.3 mt -59.12 -42.48 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.66 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 2.4 mptt -86.72 -12.97 46.73 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.51 -1.677 . . . . 0.0 109.882 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.917 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 17.2 tp10 -86.11 -22.82 26.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.451 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.575 HG21 HD13 ' A' ' 133' ' ' ILE . 14.7 mm -116.56 -13.36 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.585 ' OD1' ' HA ' ' A' ' 123' ' ' LYS . 4.2 p-10 -79.8 54.09 1.77 Allowed 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.564 0.697 . . . . 0.0 110.084 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.689 HE21 ' HB3' ' A' ' 141' ' ' MET . 0.0 OUTLIER -62.56 -9.32 8.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.553 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 157' ' ' ARG . 6.4 t70 -107.95 -32.91 7.38 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.545 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 178.54 -95.65 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 178.491 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.724 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 1.5 m-20 -64.75 29.29 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 119.44 3.126 . . . . 0.0 119.44 -173.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 126' ' ' ASP . . . 58.76 37.67 90.52 Favored Glycine 0 CA--C 1.504 -0.631 0 C-N-CA 117.236 -2.411 . . . . 0.0 109.133 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.724 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 6.6 pt20 -136.57 169.28 17.97 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 113.738 -1.231 . . . . 0.0 109.831 -177.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.613 HG21 ' HD1' ' A' ' 138' ' ' PHE . 49.2 mt -133.16 124.2 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.558 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 54.0 m-20 -101.73 165.53 11.16 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.417 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.643 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 25.8 t80 -44.19 -29.78 0.68 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.068 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 153' ' ' ARG . . . -85.54 -39.64 8.17 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.683 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.691 ' HA ' ' HD2' ' A' ' 153' ' ' ARG . 32.9 mt-10 -60.54 -50.59 72.93 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.613 ' HD1' HG21 ' A' ' 133' ' ' ILE . 1.3 t80 -64.37 -61.11 2.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.49 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.81 -32.95 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.64 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.69 -58.18 2.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.689 ' HB3' HE21 ' A' ' 127' ' ' GLN . 0.0 OUTLIER -46.19 -33.02 3.32 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.238 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 138' ' ' PHE . 27.6 ptt? -87.54 -32.66 19.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.749 0.309 . . . . 0.0 111.097 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.429 ' HG2' ' HG3' ' A' ' 142' ' ' MET . 27.8 mmm180 -95.09 -167.18 1.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.845 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -63.13 177.63 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.377 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.664 ' HB2' ' HD3' ' A' ' 158' ' ' LYS . 16.3 ptp180 -108.08 28.53 8.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.416 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 151' ' ' ILE . 40.3 ttmt -62.29 111.0 1.81 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.32 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.751 ' HA3' ' HA ' ' A' ' 159' ' ' THR . . . -67.45 -17.64 68.83 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.774 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -54.77 161.66 1.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.734 0.302 . . . . 0.0 110.926 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -52.0 -13.78 1.71 Allowed Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.432 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -69.37 -5.13 47.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.511 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.902 HG12 ' H ' ' A' ' 152' ' ' GLY . 10.9 tt -80.88 -156.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.902 ' H ' HG12 ' A' ' 151' ' ' ILE . . . -151.45 -37.37 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.877 ' HG2' ' HG2' ' A' ' 157' ' ' ARG . 3.2 tpm_? -58.75 171.24 0.67 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.014 -0.593 . . . . 0.0 109.942 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.68 ' H ' ' NH1' ' A' ' 153' ' ' ARG . 45.4 ttt85 -69.28 136.15 51.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 110.906 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 76.4 p -43.53 -35.51 1.71 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.576 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.468 ' H ' ' HG2' ' A' ' 154' ' ' ARG . 51.2 ttp -83.21 52.72 2.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.418 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.877 ' HG2' ' HG2' ' A' ' 153' ' ' ARG . 14.9 tpp180 -130.53 -69.93 0.64 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.664 ' HD3' ' HB2' ' A' ' 145' ' ' ARG . 7.6 ptpp? -152.8 112.56 3.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.055 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.751 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 68.3 p -96.93 174.62 6.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.715 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.544 ' HB2' ' H ' ' A' ' 147' ' ' GLY . 7.1 tt -120.85 124.57 45.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.829 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -156.58 75.54 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.336 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 81.6 mt -122.89 179.55 4.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.795 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.567 ' HD2' ' N ' ' A' ' 163' ' ' ARG . 1.0 OUTLIER -86.51 78.86 9.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.653 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -93.69 159.6 15.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.929 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.96 114.04 2.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.244 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.628 ' O ' HD13 ' A' ' 166' ' ' LEU . 3.4 tm? -117.06 -27.23 6.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.335 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -113.85 60.0 0.38 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.478 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 58.6 tp -90.61 152.06 21.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.2 m -73.77 147.18 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.127 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -104.0 120.42 41.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -79.05 -15.86 57.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 124.77 -17.13 7.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.565 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.0 t -163.44 137.18 5.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 0.0 110.807 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -93.17 56.65 2.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.507 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -69.38 99.81 1.27 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.678 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.65 141.13 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.153 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 177' ' ' ILE . 2.5 mp -80.99 117.75 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -110.02 147.99 32.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.988 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 176.49 -168.64 40.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.298 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -125.79 94.1 4.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.87 0.367 . . . . 0.0 111.001 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.52 177.56 7.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.067 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.563 ' HB3' ' NZ ' ' A' ' 182' ' ' LYS . 3.0 mmmp? . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.95 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.95 0.405 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -134.79 162.81 31.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.955 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.821 ' H ' ' HD3' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -119.67 -172.81 2.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.724 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.412 ' C ' HD12 ' A' ' 4' ' ' LEU . 2.0 pp -159.2 -2.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.359 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.8 p -160.41 -62.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.33 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -137.12 109.63 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.34 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HD2' ' A' ' 3' ' ' ARG . 38.9 tt0 -89.15 -47.92 7.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.609 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -87.45 -56.54 3.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.672 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.8 mm -64.78 -25.48 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.579 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.78 165.34 13.93 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.656 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . 109.67 -24.37 19.85 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.6 mt -72.39 -33.7 67.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.745 -0.228 . . . . 0.0 110.793 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.451 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 62.8 tttm -64.68 -51.46 62.38 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -65.54 -18.28 65.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.176 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.822 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -80.15 -40.31 27.6 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.738 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HA ' ' CE1' ' A' ' 68' ' ' PHE . 11.1 t80 -57.4 -44.01 84.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.192 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.57 ' HB2' ' NZ ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -81.75 -12.59 58.52 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.825 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.753 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -67.97 -43.07 79.83 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.862 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 7.7 mt -61.45 -58.07 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -74.96 84.65 2.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.35 1.071 . . . . 0.0 109.817 178.468 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -89.18 -22.29 22.87 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.595 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -138.66 -5.67 1.54 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.524 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -71.16 -87.53 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.141 0.882 . . . . 0.0 111.292 -178.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.1 p -177.77 11.65 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.483 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.479 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 109.84 31.23 3.21 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 55.1 p -144.13 152.06 40.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.612 -0.794 . . . . 0.0 110.627 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.876 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 4.5 mt -114.42 104.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.758 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.677 HG22 ' OG1' ' A' ' 62' ' ' THR . 82.7 p -102.5 160.11 14.85 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.617 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 17.1 t80 -34.24 -34.61 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.723 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -77.85 -45.48 24.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.843 0.354 . . . . 0.0 110.456 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.565 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -73.04 -24.56 60.72 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.204 178.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.755 HD11 HD23 ' A' ' 51' ' ' LEU . 1.4 tm? -50.61 -54.66 20.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.418 0.628 . . . . 0.0 110.059 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.68 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 3.8 ptpt -79.03 -39.03 35.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.334 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 37.8 t70 -47.66 -36.6 11.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.468 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.862 ' HA3' ' HA ' ' A' ' 19' ' ' ILE . . . -95.09 -49.62 2.21 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.259 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.659 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -57.98 -51.71 68.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.467 0.651 . . . . 0.0 109.898 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.68 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.85 -9.19 42.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.728 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.581 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -80.86 -32.21 35.1 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.802 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 36' ' ' LEU . 25.1 m -76.94 2.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.733 0.301 . . . . 0.0 111.404 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.18 10.85 11.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.271 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 40.9 m -92.22 156.98 16.94 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.725 0.298 . . . . 0.0 110.649 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -142.5 104.43 4.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.046 0.45 . . . . 0.0 110.741 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 48' ' ' ILE . 21.4 mt -131.16 165.52 23.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.465 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.444 ' O ' HD13 ' A' ' 48' ' ' ILE . 37.9 mtm -105.0 165.5 11.03 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.8 mp0 -47.96 -60.72 2.39 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.677 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 t -48.94 -17.19 0.17 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 52.0 mt-10 -90.86 -48.75 6.83 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.743 HG23 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -49.83 -58.13 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.566 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . 44.5 tttp -39.9 -34.65 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.106 -1.861 . . . . 0.0 111.115 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.638 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 8.7 t70 -64.26 -50.81 66.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.399 . . . . 0.0 110.216 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.755 HD23 HD11 ' A' ' 32' ' ' LEU . 53.2 tp -56.13 -33.28 65.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.995 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.596 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 41.6 ttm -87.54 -66.5 0.91 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.529 0.68 . . . . 0.0 112.705 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.502 ' HA ' ' CG ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -58.42 -34.52 70.88 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.235 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB1' ' OG ' ' A' ' 89' ' ' SER . . . -91.15 -18.48 24.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -123.91 -43.56 2.11 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' MET . 65.6 t0 -50.48 101.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.033 0.444 . . . . 0.0 110.093 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 6.3 mt -50.73 -17.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.481 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 60' ' ' SER . 55.7 m-20 -129.76 43.36 3.14 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.052 -178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.577 ' C ' ' HD3' ' A' ' 59' ' ' LYS . 1.6 tmtp? -33.42 87.16 0.0 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.68 0.753 . . . . 0.0 111.854 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 58' ' ' ASP . 45.6 m -128.04 19.18 6.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.459 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.596 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 68.84 20.87 74.77 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 86.0 m -155.24 133.02 11.34 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.886 -0.657 . . . . 0.0 110.299 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.876 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.1 mt -113.48 134.76 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.152 0.501 . . . . 0.0 111.14 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.534 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 40.1 m-20 -106.68 167.87 9.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.747 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.557 ' O ' HG13 ' A' ' 69' ' ' ILE . 25.2 t80 -35.79 -46.96 0.48 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.695 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.7 -53.82 7.98 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.976 -1.106 . . . . 0.0 112.313 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.609 ' HB2' HG23 ' A' ' 63' ' ' ILE . 24.2 mt-10 -52.08 -25.15 8.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.297 0.57 . . . . 0.0 109.847 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.822 ' HZ ' HD12 ' A' ' 15' ' ' LEU . 88.9 t80 -67.77 -65.51 0.68 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.139 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 65' ' ' TYR . 2.8 mt -47.35 -46.72 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.629 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -50.16 75.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 110.421 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.681 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . -54.78 -33.55 61.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.027 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.5 p -84.6 -59.52 2.34 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 69' ' ' ILE . 49.4 t -51.41 -15.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.993 0.425 . . . . 0.0 111.366 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -76.22 -49.75 16.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.686 HD11 HD13 ' A' ' 51' ' ' LEU . 5.4 mt -77.86 -15.3 59.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -123.42 91.91 3.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.504 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.449 ' HE2' ' CG ' ' A' ' 79' ' ' GLU . 21.0 ptmt -165.68 168.23 16.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.728 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -79.83 36.89 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.397 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.449 ' CG ' ' HE2' ' A' ' 77' ' ' LYS . 67.4 mm-40 -132.1 164.9 25.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 111.155 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.666 ' HD3' ' H ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -127.09 156.43 41.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.861 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 10.3 pm0 -72.5 147.26 46.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -113.54 -148.69 0.43 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.653 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -112.27 -31.73 6.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.977 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.617 ' O ' HD13 ' A' ' 84' ' ' LEU . 3.4 tm? -78.84 -28.66 44.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.391 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.6 p -54.19 -19.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.544 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -44.45 -50.96 9.13 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.013 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -75.23 -51.51 13.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.511 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.702 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 3.5 t80 -43.34 -26.97 0.22 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.017 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.688 ' OG ' ' HB1' ' A' ' 54' ' ' ALA . 25.3 t -89.38 -57.99 2.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.536 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -84.61 -54.37 4.77 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.734 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 87' ' ' ALA . 3.1 m-85 -56.97 -65.08 0.68 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.85 ' HA ' HG12 ' A' ' 99' ' ' ILE . 66.2 t0 -72.61 63.23 0.58 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 29.6 ttmt -51.26 -39.49 56.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.225 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 63.7 m-20 -72.0 -25.02 61.67 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.189 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 44.39 64.56 2.0 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.364 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 77.8 p -118.38 11.22 12.98 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 97.57 4.92 57.99 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 112.195 -2.275 . . . . 0.0 112.697 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 1.1 p90 -165.25 144.94 6.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.85 HG12 ' HA ' ' A' ' 92' ' ' ASP . 51.1 mt -103.24 141.76 18.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.794 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.504 ' HA ' ' CB ' ' A' ' 132' ' ' GLN . 77.0 p -110.73 159.73 17.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.86 0.3 . . . . 0.0 110.255 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.69 ' HA ' HD12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -38.09 -37.56 0.27 Allowed 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.159 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.42 ' N ' ' HG ' ' A' ' 101' ' ' LEU . 65.1 t0 -60.96 -59.77 4.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.628 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.545 ' HB2' HG23 ' A' ' 99' ' ' ILE . 52.7 mt-10 -60.05 -22.66 62.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.77 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 133' ' ' ILE . 82.9 mt -75.79 -61.38 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.643 ' HG2' ' O ' ' A' ' 101' ' ' LEU . 4.0 mm100 -55.29 -33.57 63.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.638 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -80.47 -28.58 37.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.003 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 103' ' ' GLU . . . -66.71 -4.57 9.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.835 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 76.2 m -115.55 77.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.516 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -79.54 -53.87 6.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.55 -16.75 59.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.005 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.835 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 11.1 m-85 -63.46 -56.67 14.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.916 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.45 38.75 1.07 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.998 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.925 ' HA ' HD12 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -32.63 124.09 0.34 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.541 0.686 . . . . 0.0 112.258 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.609 ' N ' HD22 ' A' ' 113' ' ' LEU . 34.1 t0 -150.71 173.77 13.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.275 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.826 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 1.4 m-20 -77.85 -7.44 56.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.012 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.8 mt -81.71 -65.52 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -92.55 -69.27 0.75 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.925 HD12 ' HA ' ' A' ' 113' ' ' LEU . 15.1 mt -54.29 -18.89 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.826 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 38.8 t70 -70.6 -64.96 0.8 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.429 0.157 . . . . 0.0 110.924 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 124' ' ' GLU . 54.8 p30 -61.13 -16.99 50.33 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.892 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 22.2 ttp -61.15 -33.74 73.9 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.38 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.525 HG22 ' HA3' ' A' ' 131' ' ' GLY . 61.2 mt -58.32 -44.02 87.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.657 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 4.5 mptt -86.33 -13.06 47.66 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.562 -1.654 . . . . 0.0 110.187 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.892 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 41.4 tp10 -81.65 -24.4 36.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.84 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.789 HG21 HD13 ' A' ' 133' ' ' ILE . 19.3 mt -112.17 -19.4 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.206 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.864 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 14.1 t70 -66.13 83.86 0.09 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.844 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.513 ' CB ' ' HD3' ' A' ' 153' ' ' ARG . 58.7 mt-30 -85.19 -8.69 58.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.307 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.592 ' CB ' ' HA ' ' A' ' 154' ' ' ARG . 12.4 p-10 -126.61 -30.25 2.83 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 18.4 p30 -179.74 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.548 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 1.3 m-20 -65.21 25.95 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 -173.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.864 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.65 37.56 68.56 Favored Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 117.505 -2.283 . . . . 0.0 108.193 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.809 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 10.0 pt20 -129.27 167.07 18.23 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.678 -1.261 . . . . 0.0 109.87 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.789 HD13 HG21 ' A' ' 125' ' ' ILE . 18.6 mt -129.75 116.39 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.753 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.764 ' OD1' ' HG3' ' A' ' 137' ' ' GLU . 0.7 OUTLIER -100.33 165.53 11.42 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.702 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 32.5 t80 -45.81 -23.43 0.27 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.178 0.513 . . . . 0.0 110.149 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.633 ' C ' ' HB3' ' A' ' 153' ' ' ARG . . . -82.45 -39.95 10.45 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.049 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.764 ' HG3' ' OD1' ' A' ' 134' ' ' ASP . 38.8 mt-10 -70.01 -57.46 4.97 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 116.075 -0.063 . . . . 0.0 111.065 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.639 ' HD1' HG21 ' A' ' 133' ' ' ILE . 1.3 t80 -57.87 -50.95 71.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.519 -178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.4 -19.52 56.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.648 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 145' ' ' ARG . . . -90.73 -51.72 5.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.956 0.408 . . . . 0.0 111.86 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.445 ' HB3' ' NE2' ' A' ' 127' ' ' GLN . 5.4 ppp? -65.19 8.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.325 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.445 ' H ' ' C ' ' A' ' 140' ' ' ALA . 4.1 ppp? -115.3 3.64 14.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 110.998 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.684 ' HG2' ' HG3' ' A' ' 144' ' ' LYS . 43.5 ttt85 -128.97 -84.52 0.57 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.052 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.684 ' HG3' ' HG2' ' A' ' 143' ' ' ARG . 98.5 mttt -128.14 -68.88 0.75 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.011 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.505 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 39.4 ptt180 -159.12 -49.18 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.402 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.486 ' HD2' ' HA2' ' A' ' 152' ' ' GLY . 24.7 pttm -172.3 142.48 1.34 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.759 0.314 . . . . 0.0 111.171 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -64.52 -57.84 11.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.156 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -85.72 115.36 23.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.688 0.28 . . . . 0.0 110.462 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.484 ' HA2' ' HE2' ' A' ' 146' ' ' LYS . . . -60.0 -14.48 31.64 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.535 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -96.3 -47.21 2.43 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.482 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.473 ' HB ' ' H ' ' A' ' 152' ' ' GLY . 17.0 mm -73.71 -98.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.826 0.346 . . . . 0.0 111.203 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.486 ' HA2' ' HD2' ' A' ' 146' ' ' LYS . . . 130.67 -128.87 5.64 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.24 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.633 ' HB3' ' C ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -141.23 83.78 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.146 0.498 . . . . 0.0 111.064 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.76 ' HD2' ' HG2' ' A' ' 157' ' ' ARG . 66.6 mtt-85 -128.78 148.43 50.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.994 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.9 t -64.75 -33.95 77.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.443 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.5 mtt -143.7 55.65 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.775 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.76 ' HG2' ' HD2' ' A' ' 154' ' ' ARG . 2.8 tmt_? -57.34 127.53 32.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.488 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.627 ' NZ ' ' HB2' ' A' ' 158' ' ' LYS . 4.9 ttmp? -154.01 147.01 24.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.684 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 87.7 m -62.65 -82.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.067 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 64.2 tp -167.51 108.14 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.843 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -151.88 -97.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.928 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.4 mt -129.2 -169.85 2.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.775 0.322 . . . . 0.0 110.906 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -80.55 -47.33 14.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -104.37 137.07 42.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.951 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.577 ' HB2' ' HE2' ' A' ' 158' ' ' LYS . . . -110.31 132.57 54.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.095 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 84.3 mt -121.27 -0.3 9.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.537 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.7 -168.1 37.44 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.187 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.899 HD23 ' H ' ' A' ' 168' ' ' LEU . 2.0 pt? -88.55 90.89 8.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.373 0.606 . . . . 0.0 110.77 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 48.4 t -120.8 132.54 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.039 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -131.52 -46.57 0.98 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.806 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -88.65 45.81 1.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -114.56 -148.39 9.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.551 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 79.4 p -77.53 -170.74 1.9 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -156.04 25.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.944 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -88.83 110.27 20.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.078 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.21 137.07 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.86 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.675 ' O ' HD12 ' A' ' 177' ' ' ILE . 2.6 pp -104.82 148.41 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.047 0.451 . . . . 0.0 111.723 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -148.39 129.51 14.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.537 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 90.93 98.36 1.21 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.03 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -103.43 -3.66 25.14 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -162.88 0.16 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.814 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 27.7 tptp . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.978 179.856 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.791 0.329 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -120.44 42.71 2.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.777 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -160.95 -15.76 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.792 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.9 mt -104.36 99.67 9.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.971 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.5 m -73.11 166.91 22.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.627 ' O ' HG22 ' A' ' 9' ' ' ILE . 63.9 mm-40 -124.23 -166.15 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -12.41 61.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.177 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -56.95 -29.17 62.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.224 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 6' ' ' GLU . 14.4 tt -77.59 -30.88 17.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.821 0.343 . . . . 0.0 111.006 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.5 108.25 0.52 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.597 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.03 13.13 3.36 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.626 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.612 HD12 HD23 ' A' ' 15' ' ' LEU . 44.2 tp -76.17 -32.72 59.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.509 0.195 . . . . 0.0 110.734 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . 22.0 pttp -60.42 -41.42 93.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 18' ' ' MET . 87.6 tt0 -68.01 -27.68 66.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.72 177.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.695 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 32.6 tp -72.08 -32.88 67.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.082 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.438 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 6.0 t80 -64.58 -50.25 67.97 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.337 0.589 . . . . 0.0 109.537 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -73.64 -15.03 61.26 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.695 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -70.07 -20.46 63.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.805 178.465 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.837 HG23 ' HA3' ' A' ' 35' ' ' GLY . 9.2 mm -81.24 -62.16 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.828 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.627 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -85.76 70.42 10.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.895 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.621 HG22 HH22 ' A' ' 38' ' ' ARG . 15.1 t -87.25 -6.46 58.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.244 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -131.98 -24.13 2.16 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -71.58 -76.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.7 p -175.0 -4.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.462 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 110.4 30.12 3.44 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -177.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.585 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 49.6 p -143.71 146.34 33.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 113.837 -1.182 . . . . 0.0 109.413 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.914 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.1 mt -103.24 104.22 16.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 68.6 p -103.39 165.99 10.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.609 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.655 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 9.5 t80 -34.24 -33.33 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.146 -0.933 . . . . 0.0 112.327 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -79.49 -52.66 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.889 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.627 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 31.9 mt-10 -73.65 -14.16 61.12 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.494 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.776 HD12 HG13 ' A' ' 48' ' ' ILE . 2.3 tm? -54.89 -56.21 22.01 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 12.8 ptpt -75.62 -44.01 45.05 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.281 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.631 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 62.3 t0 -43.15 -65.33 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 0.0 110.494 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.837 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -62.21 -50.68 62.79 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.542 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.64 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -60.72 -65.11 0.74 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 117.263 0.532 . . . . 0.0 110.738 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -51.97 -23.95 5.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.204 179.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.631 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 38.4 ttm180 -57.73 -43.67 85.47 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.143 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' LEU . 22.3 m -73.5 20.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 38' ' ' ARG . . . 100.0 -15.45 59.32 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.414 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 37' ' ' LYS . 74.4 m -60.45 155.4 18.36 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.795 0.331 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 15.5 pt-20 -138.56 107.25 5.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.163 0.506 . . . . 0.0 110.854 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 mt -125.34 166.1 17.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.153 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.567 ' O ' HD13 ' A' ' 48' ' ' ILE . 30.2 mtm -111.69 163.99 13.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -49.15 -65.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.043 -178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.2 m -48.9 -20.67 0.53 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.465 0.575 . . . . 0.0 111.932 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 95.1 mt-10 -80.29 -43.84 20.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.776 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -55.44 -54.86 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 122.266 1.031 . . . . 0.0 108.5 177.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.657 ' HZ1' ' HE2' ' A' ' 109' ' ' LYS . 50.8 tttp -58.81 -29.0 66.54 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.322 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 38.0 t70 -67.99 -53.77 23.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.687 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.512 HD22 HD21 ' A' ' 32' ' ' LEU . 2.5 tt -54.91 -32.13 60.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.47 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.534 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 25.2 mtt -72.1 -65.72 0.74 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.588 ' N ' ' HD3' ' A' ' 59' ' ' LYS . 41.9 t0 -65.36 -18.82 65.62 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.119 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.77 -34.1 14.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.859 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -118.67 -43.67 2.67 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' MET . 63.7 t0 -46.89 99.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.5 mm -50.38 -23.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.041 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.654 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 7.9 t70 -130.59 45.66 2.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.416 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.588 ' HD3' ' N ' ' A' ' 53' ' ' ASP . 23.3 tptm -31.99 91.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.83 0.824 . . . . 0.0 112.992 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 58' ' ' ASP . 39.7 m -127.42 18.62 6.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.546 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 68.33 19.09 72.11 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 97.0 m -146.55 143.35 28.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.6 -0.8 . . . . 0.0 109.759 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.914 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.9 mt -128.3 126.6 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.191 0.52 . . . . 0.0 111.587 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 65' ' ' TYR . 31.4 m-20 -104.29 167.73 9.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.596 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.623 ' O ' HG13 ' A' ' 69' ' ' ILE . 33.9 t80 -34.85 -47.92 0.37 Allowed 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.229 0.331 . . . . 0.0 111.412 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.31 -61.71 6.81 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.115 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.777 ' HB2' HG23 ' A' ' 63' ' ' ILE . 28.0 mt-10 -56.28 -24.82 45.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.687 0.28 . . . . 0.0 111.16 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.651 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 39.4 t80 -65.21 -53.8 39.08 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.298 0.571 . . . . 0.0 110.817 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 65' ' ' TYR . 3.7 mt -61.25 -46.3 96.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.063 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.18 -10.78 53.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.308 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.25 -55.43 3.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.558 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 68' ' ' PHE . 5.2 t -65.83 -48.54 71.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.442 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.676 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 58.7 t -61.22 -15.88 13.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.02 0.438 . . . . 0.0 111.199 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -66.21 -44.56 83.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.8 mt -96.17 -8.29 33.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.187 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 55.9 t-20 -108.99 86.55 2.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.647 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -127.02 -84.33 0.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.506 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.9 mm? -109.6 -53.4 2.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.784 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.41 ' OE2' ' HG2' ' A' ' 80' ' ' ARG . 17.3 tp10 -160.98 152.1 18.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.572 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.41 ' HG2' ' OE2' ' A' ' 79' ' ' GLU . 13.5 ptp180 -56.72 119.41 6.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.378 . . . . 0.0 111.063 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -172.97 -36.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.057 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.412 ' OE1' HG21 ' A' ' 85' ' ' VAL . 67.2 mm-40 -85.94 30.46 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.086 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -88.99 -35.29 16.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 139' ' ' ALA . 28.6 mt -74.62 -45.58 44.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.357 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.441 ' HA ' ' CB ' ' A' ' 88' ' ' PHE . 32.6 m -57.91 -19.47 12.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.435 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -53.3 -66.04 0.46 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.847 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.702 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -69.78 -33.27 72.16 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.813 ' HZ ' ' HA2' ' A' ' 97' ' ' GLY . 11.3 t80 -46.42 -22.12 0.23 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.528 177.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.422 ' N ' ' C ' ' A' ' 87' ' ' ALA . 46.6 t -89.17 -43.3 11.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.6 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -81.09 -64.48 1.18 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.496 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.539 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.5 m-85 -56.12 -61.89 2.08 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.806 ' HA ' HG12 ' A' ' 99' ' ' ILE . 63.1 t0 -80.6 61.69 4.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -42.28 -36.08 1.15 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.144 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -89.84 -22.84 21.87 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.601 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 52.97 73.88 0.36 Allowed Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 60.1 p -122.37 -5.3 8.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.813 ' HA2' ' HZ ' ' A' ' 88' ' ' PHE . . . 109.78 -9.8 32.24 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.967 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -142.24 158.54 43.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.558 0.694 . . . . 0.0 112.383 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.806 HG12 ' HA ' ' A' ' 92' ' ' ASP . 82.3 mt -131.61 104.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.711 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.7 p -69.14 147.34 51.53 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.8 ' HB3' HG23 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -35.27 -35.63 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -57.02 -52.82 63.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.672 0.273 . . . . 0.0 111.023 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.728 ' HB2' HG23 ' A' ' 99' ' ' ILE . 97.4 mt-10 -59.93 -30.4 69.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.723 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.802 HD11 HG12 ' A' ' 133' ' ' ILE . 88.4 mt -75.67 -61.58 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.104 0.478 . . . . 0.0 110.283 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.704 HE21 HG23 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -51.91 -29.26 19.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.734 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -63.82 -42.86 97.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.904 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 108' ' ' CYS . . . -50.02 -65.9 0.48 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.974 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.804 ' HB2' ' CD1' ' A' ' 111' ' ' PHE . 10.6 p -34.31 115.89 0.28 Allowed 'General case' 0 C--O 1.22 -0.475 0 O-C-N 123.739 0.649 . . . . 0.0 109.622 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.657 ' HE2' ' HZ1' ' A' ' 49' ' ' LYS . 25.1 ttmm -88.46 -58.66 2.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.25 -15.55 4.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.444 0.64 . . . . 0.0 110.065 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.804 ' CD1' ' HB2' ' A' ' 108' ' ' CYS . 0.2 OUTLIER -112.27 -49.76 2.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.189 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 108' ' ' CYS . . . 79.62 -21.94 4.28 Favored Glycine 0 CA--C 1.509 -0.33 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.248 -177.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.816 HD22 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER 176.44 53.84 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.508 ' O ' HG13 ' A' ' 118' ' ' ILE . 51.1 t0 -34.04 100.2 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 112.248 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.62 -18.0 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.502 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.4 mm -92.35 -49.39 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.795 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.576 ' CD2' ' HG3' ' A' ' 121' ' ' MET . 15.2 t-160 -78.65 -38.85 38.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.448 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.704 HG23 HE21 ' A' ' 105' ' ' GLN . 3.2 mt -36.11 -61.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 118' ' ' ILE . 65.6 t0 -48.26 -60.44 2.65 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.9 0.381 . . . . 0.0 111.412 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.724 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 57.9 m-20 -67.64 -17.08 64.48 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.613 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.785 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.8 mtp -77.26 -52.69 8.78 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 123.631 0.772 . . . . 0.0 112.338 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.8 HG23 ' HB3' ' A' ' 101' ' ' LEU . 55.4 mt -50.05 -39.47 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.662 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.51 -19.13 29.97 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.249 -1.796 . . . . 0.0 110.959 178.401 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.785 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 17.0 tp10 -79.32 -18.26 52.92 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.758 HG22 ' CD1' ' A' ' 133' ' ' ILE . 16.2 mt -115.43 -32.89 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.213 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.714 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 13.1 t0 -62.98 112.7 2.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.236 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.944 HE22 ' HB3' ' A' ' 141' ' ' MET . 20.6 mp0 -89.22 -9.71 49.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.453 ' OD2' ' HB3' ' A' ' 154' ' ' ARG . 53.1 p30 -133.54 -32.35 1.15 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -176.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.693 ' HB3' ' NH2' ' A' ' 154' ' ' ARG . 8.2 t-20 -178.42 -72.49 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 117.314 2.339 . . . . 0.0 117.314 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.454 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 40.1 t0 -63.78 13.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -172.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.767 ' HA3' HG22 ' A' ' 122' ' ' ILE . . . 55.97 37.68 71.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 117.804 -2.141 . . . . 0.0 108.967 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.798 ' O ' HD13 ' A' ' 133' ' ' ILE . 2.3 pt20 -128.98 167.18 17.83 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 113.435 -1.382 . . . . 0.0 109.675 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.802 HG12 HD11 ' A' ' 104' ' ' ILE . 40.1 mm -125.8 124.56 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 CA-C-O 122.107 0.956 . . . . 0.0 111.404 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.909 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 35.4 t70 -103.03 158.79 16.05 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.18 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.626 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 16.0 t80 -48.41 -27.83 2.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.136 0.493 . . . . 0.0 109.872 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -85.51 -38.04 9.2 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 177.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.909 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 51.0 mt-10 -63.45 -57.99 8.49 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.702 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 26.4 t80 -52.41 -18.53 1.68 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.151 0.5 . . . . 0.0 109.978 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -81.69 -36.14 29.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.251 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.786 ' HB2' ' HD2' ' A' ' 153' ' ' ARG . . . -81.64 -38.45 25.92 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.647 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.944 ' HB3' HE22 ' A' ' 127' ' ' GLN . 5.3 ppp? -56.49 -20.19 19.06 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.851 0.357 . . . . 0.0 110.997 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 36.8 ttm -93.0 -64.5 1.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.68 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.447 ' N ' ' HD2' ' A' ' 143' ' ' ARG . 0.2 OUTLIER -74.05 -106.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.106 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -143.6 -168.37 2.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.822 0.344 . . . . 0.0 110.704 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -94.94 -2.84 49.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.701 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -164.33 49.49 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.832 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -86.51 -43.43 6.17 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.779 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -149.08 157.47 43.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.849 0.357 . . . . 0.0 111.162 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -69.22 -5.17 47.23 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.585 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.13 -4.81 12.77 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.58 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 52.4 mt -43.32 151.5 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-O 121.095 0.474 . . . . 0.0 111.915 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.525 ' C ' ' HA3' ' A' ' 136' ' ' GLY . . . -146.99 4.36 0.99 Allowed Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.786 ' HD2' ' HB2' ' A' ' 140' ' ' ALA . 38.4 mtp180 -54.11 168.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.013 -0.593 . . . . 0.0 110.198 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.693 ' NH2' ' HB3' ' A' ' 129' ' ' ASN . 40.7 ttp180 -71.84 149.19 45.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 86.6 m -34.86 -31.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.599 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 65.1 mtm -78.31 48.81 0.79 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.878 0.37 . . . . 0.0 111.17 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.467 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -118.55 -7.76 10.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.803 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.837 ' HA ' ' HE3' ' A' ' 158' ' ' LYS . 0.5 OUTLIER -65.22 -20.51 66.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.833 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.2 m -79.32 124.34 28.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 160' ' ' LEU . 2.3 pt? -144.16 165.82 26.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -115.38 150.84 35.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.622 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 162' ' ' LEU . 2.4 pp -121.8 7.12 9.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.543 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -84.41 -12.96 53.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 110.544 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -92.79 136.7 33.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.728 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.59 143.97 26.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.225 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 57.1 tp -62.77 -21.99 66.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.633 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 178.15 175.07 45.0 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.32 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 168' ' ' LEU . 6.0 mp -71.8 134.91 46.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.791 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.71 133.22 31.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -88.32 94.86 9.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.732 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -113.06 25.73 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.144 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -149.04 44.15 0.75 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.312 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 83.4 p -159.2 122.95 3.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.812 0.339 . . . . 0.0 111.086 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -117.75 30.49 7.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.775 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.447 ' N ' ' OE1' ' A' ' 175' ' ' GLN . 0.5 OUTLIER -66.29 104.9 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.844 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 82.8 t -85.05 115.31 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.099 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.673 ' O ' HD12 ' A' ' 177' ' ' ILE . 2.7 pp -105.44 148.42 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.192 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -87.26 123.21 32.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.033 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -139.42 -169.66 11.66 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.426 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -71.49 -29.83 65.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.755 0.312 . . . . 0.0 111.028 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -60.89 -67.26 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.059 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.913 179.979 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.762 0.315 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -112.57 27.78 9.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.693 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.48 ' HE ' ' N ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -69.34 -166.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.542 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.484 HD22 ' N ' ' A' ' 4' ' ' LEU . 3.1 mm? -113.14 -71.47 0.75 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.768 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.7 m -67.0 161.49 24.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.739 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 9' ' ' ILE . 38.6 tt0 -132.95 136.84 46.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.118 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -86.85 -28.27 22.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.302 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.429 ' HB3' ' OE2' ' A' ' 6' ' ' GLU . 5.5 tp10 -60.95 -27.8 68.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.435 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 6' ' ' GLU . 64.1 mt -58.05 -19.26 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.44 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.55 160.86 15.45 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.33 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.36 30.15 76.96 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.57 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 86.6 mt -59.58 -23.53 63.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.705 -0.248 . . . . 0.0 111.094 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -68.24 -53.7 22.86 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.857 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 39.2 tt0 -64.92 -22.99 67.09 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 47.9 tp -74.88 -37.77 62.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.873 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.534 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 14.1 t80 -61.36 -46.85 88.51 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.857 ' HE2' ' HA ' ' A' ' 14' ' ' GLU . 59.5 pttt -75.96 -12.92 60.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.634 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.73 -18.01 60.56 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.891 178.056 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.869 HG23 ' HA3' ' A' ' 35' ' ' GLY . 7.1 mm -82.61 -61.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.932 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.735 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -77.65 59.81 2.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.823 -178.512 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 t -87.18 -6.15 58.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.495 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.619 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 5.4 m-20 -113.82 -28.1 7.54 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -83.03 -89.81 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.864 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.0 p -176.15 19.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.395 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.616 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.54 22.97 5.86 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 76.2 p -137.62 143.64 41.54 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.911 -0.644 . . . . 0.0 110.154 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.873 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.3 mt -102.34 103.7 15.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.745 -177.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 82.2 p -104.02 165.47 11.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.097 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -34.13 -34.47 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.778 0.674 . . . . 0.0 112.438 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -79.31 -48.02 14.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.929 0.395 . . . . 0.0 110.494 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.619 ' OE2' ' HB2' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -74.57 -14.32 60.77 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.363 178.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.785 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -58.63 -56.03 27.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.614 ' NZ ' HG12 ' A' ' 48' ' ' ILE . 6.4 ptpp? -73.92 -48.1 33.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.523 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.663 ' O ' ' HB3' ' A' ' 38' ' ' ARG . 32.1 t70 -37.84 -64.18 0.42 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.41 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.869 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -47.39 -41.02 16.34 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 115.459 0.944 . . . . 0.0 115.459 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.638 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -94.99 -56.08 2.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.91 0.855 . . . . 0.0 110.955 -178.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -50.18 -18.08 0.53 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.401 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.663 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 6.3 ptm180 -67.14 -38.43 85.51 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 36' ' ' LEU . 27.0 m -77.9 23.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.76 -23.25 33.12 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.735 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m -59.52 156.13 13.88 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.741 0.305 . . . . 0.0 110.632 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -136.78 109.28 7.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.233 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 mt -113.04 165.27 12.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.974 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.436 ' O ' HD13 ' A' ' 48' ' ' ILE . 28.0 mtm -113.86 157.55 22.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 48' ' ' ILE . 37.5 mt-10 -44.87 -64.99 0.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.1 t -42.95 -29.44 0.33 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 56.7 mm-40 -70.39 -40.36 73.96 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.264 0.555 . . . . 0.0 109.569 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.785 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -59.67 -60.94 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.321 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -56.58 -26.63 55.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.645 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.559 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 60.6 t0 -66.29 -46.17 77.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.829 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.753 HD22 HD21 ' A' ' 32' ' ' LEU . 10.5 tt -67.65 -21.69 65.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.142 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.808 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 21.7 mmt -73.24 -43.54 61.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.477 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -86.96 -23.66 25.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.867 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.558 ' HA ' HH12 ' A' ' 80' ' ' ARG . . . -91.56 -25.55 19.17 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.49 -43.77 1.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.758 ' HB3' ' O ' ' A' ' 52' ' ' MET . 67.3 t0 -59.2 94.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.345 0.593 . . . . 0.0 110.241 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.0 mm -51.91 -19.43 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.337 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 60' ' ' SER . 8.4 t70 -130.3 43.9 3.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.638 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.808 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 12.7 tmtt? -32.7 88.2 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.744 0.783 . . . . 0.0 112.436 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' ASP . 76.3 p -128.55 18.32 6.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.062 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 75.89 15.24 81.47 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.375 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 97.2 m -146.55 142.71 28.28 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.118 0.567 . . . . 0.0 109.62 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.873 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 57.7 mt -128.98 133.69 65.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.271 0.558 . . . . 0.0 112.204 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 58.0 m-20 -106.53 167.97 9.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.616 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.413 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 29.4 t80 -35.27 -44.04 0.25 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.509 0.505 . . . . 0.0 111.717 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -56.0 7.99 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.765 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.732 ' HB2' HG23 ' A' ' 63' ' ' ILE . 24.1 mt-10 -56.25 -19.7 15.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 110.441 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.598 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 42.0 t80 -68.57 -60.04 2.7 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.555 0.693 . . . . 0.0 110.495 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.9 mm -59.97 -26.13 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.291 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.439 ' C ' HG12 ' A' ' 73' ' ' VAL . . . -61.78 -8.86 5.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.961 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . . . -95.1 -30.18 14.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.639 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.9 p -80.66 -10.41 59.73 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.598 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.587 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 8.3 p -95.2 -14.42 7.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.589 178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -71.93 -52.99 14.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.251 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -61.53 -16.38 47.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.813 ' N ' HD13 ' A' ' 75' ' ' LEU . 13.4 t-20 -81.49 174.96 10.94 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.451 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 79' ' ' GLU . 8.1 ptpp? -32.52 136.12 0.08 Allowed 'General case' 0 N--CA 1.462 0.127 0 O-C-N 123.304 0.378 . . . . 0.0 110.675 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.3 mt -34.55 79.36 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.959 0.787 . . . . 0.0 112.676 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.597 ' N ' ' O ' ' A' ' 77' ' ' LYS . 42.7 tp10 -101.23 79.1 1.96 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.76 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.558 HH12 ' HA ' ' A' ' 54' ' ' ALA . 44.7 ttt85 -130.73 157.83 41.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.649 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -128.9 -174.94 3.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.937 0.399 . . . . 0.0 111.604 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.432 ' HG2' ' N ' ' A' ' 83' ' ' ASN . 88.6 tt0 -71.66 162.78 28.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.975 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.994 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 12.8 p-10 -170.37 114.5 0.47 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.011 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tt -90.48 -65.74 0.99 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.999 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.549 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . 33.8 m -78.09 -32.31 17.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.994 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 51.2 m -53.73 -21.98 8.29 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -76.92 -55.02 5.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.409 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.718 ' CE1' ' HA ' ' A' ' 135' ' ' TYR . 40.6 m-85 -49.77 -20.07 0.77 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.217 0.532 . . . . 0.0 109.719 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 87' ' ' ALA . 48.1 t -88.93 -48.06 7.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.05 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -83.11 -63.82 1.29 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.492 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.55 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.8 m-85 -58.99 -62.56 1.79 Allowed 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.774 ' HA ' HG12 ' A' ' 99' ' ' ILE . 62.7 t0 -74.81 63.89 1.21 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 93' ' ' LYS . 25.0 ttmt -48.19 -43.33 31.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.231 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.8 m-20 -74.08 -22.63 59.43 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.474 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.56 -10.02 0.34 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.339 -0.458 . . . . 0.0 112.963 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 94' ' ' ASP . 79.1 p -49.58 -16.3 0.21 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.56 -29.78 3.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.623 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.597 ' HB3' ' OE1' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -115.03 163.31 15.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.678 0.751 . . . . 0.0 112.709 -178.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.788 HG22 HG13 ' A' ' 104' ' ' ILE . 54.5 mt -133.13 102.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.221 177.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 101' ' ' LEU . 44.9 p -73.63 149.28 42.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.0 pp -34.95 -39.41 0.1 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.75 0.31 . . . . 0.0 111.115 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.512 ' N ' HD12 ' A' ' 101' ' ' LEU . 1.6 m-20 -54.89 -60.97 2.63 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.516 ' HB2' HG23 ' A' ' 99' ' ' ILE . 50.4 mt-10 -51.87 -47.88 64.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.977 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.788 HG13 HG22 ' A' ' 99' ' ' ILE . 90.5 mt -54.73 -65.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.701 0.762 . . . . 0.0 111.362 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.769 ' HB3' HD22 ' A' ' 113' ' ' LEU . 2.4 mm-40 -62.18 -65.23 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.925 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -42.26 -37.4 1.49 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.699 0.285 . . . . 0.0 111.667 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 103' ' ' GLU . . . -48.65 -57.99 5.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 3.4 t -57.0 131.87 51.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.557 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.9 -48.0 7.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.126 0.489 . . . . 0.0 112.294 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.13 -0.63 55.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.334 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.662 ' CD2' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -44.94 -83.76 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.327 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.461 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 107.05 40.09 1.88 Allowed Glycine 0 C--N 1.333 0.399 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.207 -176.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.853 HD23 HG12 ' A' ' 118' ' ' ILE . 15.2 mt -31.25 133.02 0.09 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -176.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.718 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 12.4 p-10 -152.79 172.78 16.19 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.651 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 8.7 t70 -73.85 -22.22 59.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.505 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 62.3 mt -72.39 -64.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 121' ' ' MET . 16.9 m80 -92.17 -70.1 0.71 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.853 HG12 HD23 ' A' ' 113' ' ' LEU . 1.7 mp -47.31 -55.36 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -177.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.517 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 37.9 m-20 -60.63 -49.3 78.06 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.744 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 8.6 t70 -67.66 -19.48 65.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' MET . . . . . 1.002 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.2 mtp -69.89 -40.04 75.9 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.844 0.858 . . . . 0.0 110.274 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.813 HG23 ' HB3' ' A' ' 101' ' ' LEU . 56.8 mt -50.8 -46.63 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 43.7 mmtt -87.37 -13.58 43.06 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.006 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 1.002 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 15.9 tp10 -86.27 -17.1 35.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.71 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.738 HG22 ' CD1' ' A' ' 133' ' ' ILE . 22.6 mt -113.52 -32.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.331 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.62 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 17.3 t70 -63.33 112.29 2.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.954 0.407 . . . . 0.0 111.618 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.507 ' OE1' ' HB3' ' A' ' 137' ' ' GLU . 27.6 mp0 -88.31 -9.37 53.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.816 ' HB3' ' HA ' ' A' ' 155' ' ' THR . 36.7 m-20 -131.32 -32.13 1.58 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -176.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 128' ' ' ASP . 15.6 p-10 -178.79 -74.26 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.623 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 21.4 m-20 -63.97 17.77 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.76 ' HA3' HG22 ' A' ' 122' ' ' ILE . . . 55.07 37.29 62.91 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.376 -1.869 . . . . 0.0 108.99 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.77 ' O ' HD13 ' A' ' 133' ' ' ILE . 2.7 pt20 -131.55 166.92 20.33 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 113.934 -1.133 . . . . 0.0 109.148 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.771 HG12 HD11 ' A' ' 104' ' ' ILE . 36.0 mm -123.5 131.99 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-O 121.736 0.779 . . . . 0.0 111.172 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.816 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 39.0 t70 -101.09 160.32 14.48 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.876 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.718 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 15.0 t80 -48.05 -31.44 5.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.132 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.72 ' HA3' ' HA3' ' A' ' 152' ' ' GLY . . . -85.61 -33.55 15.99 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 119.888 -1.148 . . . . 0.0 110.429 177.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.816 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 52.6 mt-10 -64.28 -58.0 7.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.37 -0.415 . . . . 0.0 111.197 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.598 ' HD1' HG21 ' A' ' 133' ' ' ILE . 2.8 t80 -54.53 -37.94 65.98 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.753 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.09 -20.92 64.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.181 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.3 -50.33 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.437 ' HB3' HE22 ' A' ' 127' ' ' GLN . 0.0 OUTLIER -55.23 -19.91 9.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.688 0.28 . . . . 0.0 111.292 -178.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 67.6 mtm -99.44 -34.56 10.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.811 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -109.45 -140.41 0.38 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.059 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.615 ' H ' ' HD2' ' A' ' 143' ' ' ARG . 60.6 mttp -114.7 -77.55 0.57 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.744 0.307 . . . . 0.0 111.072 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -133.51 47.6 2.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.074 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -105.51 41.89 1.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.828 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.32 -66.96 2.44 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.158 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -156.22 157.1 35.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.647 0.223 . . . . 0.0 110.952 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -50.75 -31.33 23.2 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -96.03 -65.02 0.95 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.0 tt -175.92 150.71 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.134 -0.533 . . . . 0.0 110.666 178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.72 ' HA3' ' HA3' ' A' ' 136' ' ' GLY . . . -117.72 -104.57 2.27 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.62 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.679 ' H ' ' HD3' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -47.26 100.49 0.02 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.325 0.583 . . . . 0.0 110.91 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.787 ' HB3' ' HB3' ' A' ' 157' ' ' ARG . 11.7 tpt180 -128.76 137.91 51.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.252 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.816 ' HA ' ' HB3' ' A' ' 128' ' ' ASP . 66.5 p -61.1 -33.57 73.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.558 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.625 ' H ' ' HG3' ' A' ' 154' ' ' ARG . 51.9 ttm -149.59 75.72 1.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.3 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.787 ' HB3' ' HB3' ' A' ' 154' ' ' ARG . 3.2 ptm85 -84.55 36.55 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.216 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -164.38 154.7 14.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.843 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.401 ' H ' ' H ' ' A' ' 160' ' ' LEU . 7.2 t -156.26 -12.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.153 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.401 ' H ' ' H ' ' A' ' 159' ' ' THR . 56.7 tp -126.93 151.44 48.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.088 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -61.36 132.39 53.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 162' ' ' LEU . 2.7 mm? -82.69 -154.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.596 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 163' ' ' ARG . 51.9 ttt-85 -54.1 132.14 42.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.795 0.331 . . . . 0.0 110.686 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -58.47 131.24 50.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -130.43 142.28 50.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.967 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.77 ' H ' HD23 ' A' ' 166' ' ' LEU . 2.1 pt? -125.32 12.34 8.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.873 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.48 110.95 2.46 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.537 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.14 176.16 6.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.735 0.302 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.45 138.19 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.068 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -95.24 108.5 20.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.715 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -89.15 31.03 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.027 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -110.7 -104.45 2.82 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.473 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 53.7 m -126.19 -163.77 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.647 0.26 . . . . 0.0 110.838 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -78.45 146.27 34.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.834 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.449 ' N ' ' OE1' ' A' ' 175' ' ' GLN . 1.1 mp0 -83.14 106.83 15.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.7 m -85.29 139.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 13.3 tt -108.2 133.65 52.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.977 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -146.98 127.13 13.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -158.32 158.28 29.09 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.433 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -101.27 -13.12 18.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 110.618 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -60.5 -25.05 65.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.975 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.861 179.846 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.807 0.337 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -91.91 26.03 2.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.013 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -106.23 12.88 29.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.5 mt -93.14 -88.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.335 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.0 t -132.16 1.37 3.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.319 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.563 ' HB3' ' H ' ' A' ' 11' ' ' GLY . 19.7 pt-20 -97.47 88.26 4.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.941 0.401 . . . . 0.0 110.74 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -89.34 -64.39 1.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -90.39 -73.35 0.53 Allowed 'General case' 0 C--O 1.232 0.136 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.0 mm -91.63 -71.52 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-O 120.929 0.395 . . . . 0.0 111.896 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.97 119.91 0.87 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.932 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.563 ' H ' ' HB3' ' A' ' 6' ' ' GLU . . . -70.4 -1.23 34.82 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.636 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 7.5 mp -84.92 -27.68 26.43 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.751 -0.724 . . . . 0.0 111.341 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.604 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 7.9 tmtm? -56.39 -53.64 54.96 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.648 ' HA ' ' NZ ' ' A' ' 17' ' ' LYS . 88.7 tt0 -66.4 -43.82 84.75 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.982 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.759 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 29.0 tp -58.79 -23.04 59.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.729 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' HA ' ' CE1' ' A' ' 68' ' ' PHE . 37.9 t80 -76.02 -56.58 4.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.995 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.648 ' NZ ' ' HA ' ' A' ' 14' ' ' GLU . 25.2 pttm -71.52 -12.52 61.42 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.441 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 10.1 mtp -70.26 -37.98 75.02 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.199 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.704 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 3.3 mt -64.56 -57.6 10.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.997 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' A' ' 26' ' ' THR . 1.6 p30 -81.33 61.09 4.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.876 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.527 HG21 ' HD2' ' A' ' 38' ' ' ARG . 9.8 t -72.85 -14.51 61.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.333 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -138.21 -15.26 1.29 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.645 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 27.6 t-20 -64.18 -81.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.0 p -176.91 2.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.504 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.41 12.43 17.26 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 53.5 p -126.24 152.97 45.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.574 -0.813 . . . . 0.0 108.944 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.844 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 3.6 mt -110.0 103.22 15.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.665 HG22 ' OG1' ' A' ' 62' ' ' THR . 81.3 p -103.9 153.55 20.66 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.898 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.662 ' HZ ' ' HB3' ' A' ' 45' ' ' GLU . 59.8 t80 -34.12 -26.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 28' ' ' THR . 54.9 m-20 -80.5 -39.78 27.31 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.645 ' HG2' ' HB2' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -86.83 -29.6 22.12 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.531 178.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.701 ' CG ' HG23 ' A' ' 48' ' ' ILE . 2.1 tm? -39.91 -49.52 2.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.789 0.804 . . . . 0.0 109.644 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.813 ' HB3' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.24 -37.41 53.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.143 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.596 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 9.5 t70 -46.53 -27.73 1.2 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.08 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.704 ' HA2' ' HA ' ' A' ' 19' ' ' ILE . . . -55.92 -50.5 60.97 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.802 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.783 ' O ' HG12 ' A' ' 39' ' ' VAL . 2.2 mm? -92.59 -28.62 16.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.825 0.345 . . . . 0.0 110.766 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 34' ' ' ASP . 51.7 mtmt -56.94 -48.51 78.12 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.527 ' HD2' HG21 ' A' ' 21' ' ' THR . 25.8 ttt85 -59.74 -37.63 79.48 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.842 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -70.19 -21.99 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.811 -178.087 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.33 -27.11 4.28 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.052 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 74.1 m -65.03 154.54 37.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.689 0.28 . . . . 0.0 111.095 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -126.82 103.08 7.32 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.564 0.697 . . . . 0.0 111.241 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.827 HD13 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -111.61 166.87 10.79 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.397 -179.366 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.554 ' O ' HD13 ' A' ' 48' ' ' ILE . 17.3 ptt? -107.84 165.45 11.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.646 0.26 . . . . 0.0 110.829 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.694 ' HG3' ' HZ3' ' A' ' 33' ' ' LYS . 58.5 mp0 -51.82 -64.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.7 m -43.18 -17.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.517 ' HG3' ' HG3' ' A' ' 44' ' ' MET . 96.0 mt-10 -84.69 -41.59 16.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.827 HD11 HD13 ' A' ' 43' ' ' LEU . 1.5 mp -56.17 -49.77 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.44 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.54 ' CE ' ' HD3' ' A' ' 93' ' ' LYS . 4.3 ttmp? -57.95 -22.45 49.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.566 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.812 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 9.0 t70 -75.18 -25.7 58.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.622 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.779 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 62.4 tp -90.37 -30.89 17.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.05 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.775 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 39.1 ttm -88.02 -66.16 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.802 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.824 ' HA ' ' HG3' ' A' ' 59' ' ' LYS . 60.9 t0 -68.16 -38.77 82.45 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -86.75 -12.06 49.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.81 ' HB1' ' HA ' ' A' ' 71' ' ' ALA . . . -127.34 -44.12 1.58 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.65 ' HB3' ' O ' ' A' ' 52' ' ' MET . 63.2 t0 -53.97 132.67 42.69 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.2 mm -81.61 -14.75 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.805 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 60' ' ' SER . 74.0 m-20 -128.21 28.62 5.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.762 -178.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.824 ' HG3' ' HA ' ' A' ' 53' ' ' ASP . 12.1 tmtt? -31.61 90.68 0.0 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.937 0.875 . . . . 0.0 112.137 -177.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.7 p -128.26 18.39 6.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.519 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 81.72 15.42 75.61 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.65 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.715 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 40.4 m -155.82 128.47 7.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.494 0.318 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.844 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 52.9 mt -110.86 136.47 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 121.178 0.513 . . . . 0.0 110.941 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -104.6 168.96 8.74 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.161 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.604 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 26.6 t80 -40.6 -39.26 1.01 Allowed 'General case' 0 CA--C 1.519 -0.213 0 O-C-N 123.42 0.45 . . . . 0.0 111.093 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.9 -57.78 4.31 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.922 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.84 ' HB2' HG23 ' A' ' 63' ' ' ILE . 34.4 mt-10 -49.79 -20.77 0.92 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.242 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.759 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 68.6 t80 -69.89 -57.26 5.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.389 0.614 . . . . 0.0 110.653 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.464 HG23 HD22 ' A' ' 12' ' ' LEU . 1.2 mt -63.54 -40.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.16 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 74' ' ' HIS . . . -68.92 -6.58 28.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.043 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.81 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . -90.74 -28.27 18.4 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.495 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.1 p -95.66 -54.22 3.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.822 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.734 HG22 ' HE2' ' A' ' 77' ' ' LYS . 9.8 p -56.86 -15.61 3.04 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.133 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.76 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.532 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 30.6 t-80 -69.37 -48.29 61.71 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.1 mt -64.68 -13.21 53.25 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.182 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -118.16 75.34 1.0 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.08 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.734 ' HE2' HG22 ' A' ' 73' ' ' VAL . 71.0 mmtt -154.12 -152.32 0.4 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.797 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.9 mm? -76.13 90.19 3.08 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -41.76 -22.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.299 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -48.16 154.72 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.666 0.27 . . . . 0.0 110.932 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -53.08 153.69 3.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.408 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -95.39 -155.75 0.48 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.04 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.1 m-80 -80.19 -164.74 0.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.421 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -90.09 -27.94 19.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.547 -179.445 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.665 ' N ' HD22 ' A' ' 84' ' ' LEU . 9.0 p -73.93 -19.86 17.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.685 0.278 . . . . 0.0 110.999 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 m -48.9 -30.37 5.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.396 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -81.53 -52.2 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.241 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.829 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 11.9 t80 -42.81 -26.5 0.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.278 0.561 . . . . 0.0 109.854 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.41 ' N ' ' C ' ' A' ' 87' ' ' ALA . 31.7 t -89.22 -58.33 2.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.952 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -77.03 -63.84 1.27 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.398 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.692 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.6 m-85 -55.47 -61.84 2.07 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.829 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 1.0 OUTLIER -74.55 60.41 0.88 Allowed 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.402 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.54 ' HD3' ' CE ' ' A' ' 49' ' ' LYS . 26.3 ttmt -47.61 -41.63 22.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.037 -177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.481 ' HB2' 'CA ' ' A' ' 191' ' ' ' CA' . 1.4 m-20 -79.73 -21.15 44.9 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.919 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . 65.06 -6.16 1.09 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.971 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 94' ' ' ASP . 86.1 p -55.7 -8.28 0.38 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.886 0.374 . . . . 0.0 110.894 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 108.17 -0.49 33.31 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.729 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.6 OUTLIER -139.24 154.1 47.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.675 0.75 . . . . 0.0 112.818 -178.649 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.692 HD13 ' HB3' ' A' ' 91' ' ' PHE . 85.9 mt -132.15 102.95 6.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.345 177.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.522 ' HA ' ' CB ' ' A' ' 132' ' ' GLN . 67.8 p -87.02 163.74 16.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.947 0.794 . . . . 0.0 111.226 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 101' ' ' LEU . 0.5 OUTLIER -35.95 -36.99 0.09 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.105 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.3 -54.15 44.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.905 0.383 . . . . 0.0 110.111 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.412 ' CB ' HG23 ' A' ' 99' ' ' ILE . 52.1 mt-10 -62.66 -31.42 72.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.143 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.666 HG22 ' N ' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -75.39 -64.97 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.666 ' N ' HG22 ' A' ' 104' ' ' ILE . 6.2 mt-30 -54.4 -31.88 56.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.688 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -73.19 -47.33 44.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.044 0.45 . . . . 0.0 110.078 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.82 -2.99 2.89 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.161 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 105' ' ' GLN . 24.2 p -135.58 39.66 2.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.094 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -67.54 -23.05 65.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.956 0.408 . . . . 0.0 110.477 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.36 -6.59 59.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.599 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -91.48 14.27 15.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.851 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.92 37.57 56.63 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.078 -1.058 . . . . 0.0 111.875 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.828 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -34.55 117.25 0.35 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.371 0.605 . . . . 0.0 112.042 -178.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.668 ' N ' HD22 ' A' ' 113' ' ' LEU . 54.5 m-20 -154.58 -177.09 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.027 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.744 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 12.3 p-10 -84.07 -7.65 59.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.436 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.6 mm -83.38 -64.77 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.433 ' O ' ' HB2' ' A' ' 121' ' ' MET . 4.6 m-70 -91.91 -68.5 0.79 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.828 HG13 ' HA ' ' A' ' 113' ' ' LEU . 40.5 mm -52.09 -20.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.214 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.744 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 8.1 t70 -76.5 -60.94 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 124' ' ' GLU . 33.9 m-20 -58.42 -17.09 17.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.762 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 14.2 ttp -67.51 -46.84 71.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.584 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.626 HG22 ' HA3' ' A' ' 131' ' ' GLY . 59.9 mt -48.74 -41.48 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 176.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 24.4 mmtp -87.36 -19.84 27.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.308 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.762 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 4.8 tp10 -76.12 -16.31 59.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.568 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.794 HG21 HD13 ' A' ' 133' ' ' ILE . 1.2 mt -117.15 -34.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.033 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.758 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 22.8 t70 -55.27 93.32 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.113 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.488 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 90.4 mt-30 -83.81 -9.27 58.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.009 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.511 ' O ' ' HE3' ' A' ' 156' ' ' MET . 6.6 p-10 -131.65 -30.6 1.63 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.412 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 25.1 p30 -176.79 -80.42 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 118.277 2.695 . . . . 0.0 118.277 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.627 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 15.7 m-20 -64.08 27.41 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -172.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.758 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 54.95 37.69 63.24 Favored Glycine 0 CA--C 1.498 -1.004 0 C-N-CA 118.184 -1.96 . . . . 0.0 108.893 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.644 ' OE1' ' HB3' ' A' ' 98' ' ' TYR . 5.4 pt20 -135.17 166.26 23.5 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.375 -0.912 . . . . 0.0 110.841 -176.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.794 HD13 HG21 ' A' ' 125' ' ' ILE . 4.4 mt -121.54 125.28 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.353 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -103.97 165.54 10.98 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.636 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.676 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 30.5 t80 -49.84 -24.42 2.43 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.763 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.633 ' C ' ' HB2' ' A' ' 153' ' ' ARG . . . -77.88 -44.87 11.28 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 177.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.536 ' HG3' ' OD1' ' A' ' 134' ' ' ASP . 42.1 mt-10 -62.08 -62.75 1.56 Allowed 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.731 ' HD1' HG21 ' A' ' 133' ' ' ILE . 1.9 t80 -56.38 -32.63 64.97 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.2 -0.6 . . . . 0.0 112.111 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.74 -23.07 49.42 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.143 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 144' ' ' LYS . . . -89.71 -51.2 5.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.037 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.543 ' SD ' ' HA ' ' A' ' 138' ' ' PHE . 27.3 ptm -49.11 -22.91 1.04 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.58 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 63.3 mtm -103.25 -20.58 14.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.868 0.366 . . . . 0.0 110.695 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.521 HH21 ' HE3' ' A' ' 146' ' ' LYS . 71.1 mtp180 -126.94 43.14 3.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.818 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 140' ' ' ALA . 29.2 mtpp -62.78 -57.69 10.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.347 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.598 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -47.0 -26.48 1.03 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.774 -179.469 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.521 ' HE3' HH21 ' A' ' 143' ' ' ARG . 66.3 tttm -80.51 76.1 7.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.595 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -62.73 -4.42 7.08 Favored Glycine 0 C--N 1.33 0.214 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.962 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.439 ' HB2' ' NZ ' ' A' ' 146' ' ' LYS . 34.6 m-20 -47.07 156.1 0.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.017 0.436 . . . . 0.0 111.465 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -65.3 -4.85 18.64 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.128 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -65.72 -5.18 23.0 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.86 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.642 HG12 ' H ' ' A' ' 152' ' ' GLY . 12.5 tt -63.59 177.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.642 ' H ' HG12 ' A' ' 151' ' ' ILE . . . -152.34 -21.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.338 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.822 ' HE ' ' H ' ' A' ' 154' ' ' ARG . 4.2 tpm_? -72.55 168.84 17.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.066 0.46 . . . . 0.0 110.585 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.822 ' H ' ' HE ' ' A' ' 153' ' ' ARG . 38.8 ttt-85 -73.51 148.35 43.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.849 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 69.0 p -46.51 -17.57 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.698 ' HG3' HH11 ' A' ' 154' ' ' ARG . 63.8 mtm -74.39 13.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.548 0.213 . . . . 0.0 111.446 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 154' ' ' ARG . 3.9 ppt_? -84.52 33.6 0.51 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 0.0 111.224 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -58.53 176.43 0.19 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.26 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 86.6 m -56.69 151.0 14.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.81 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.499 HD11 ' OE1' ' A' ' 124' ' ' GLU . 59.6 tp -56.21 99.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.461 ' C ' HD22 ' A' ' 162' ' ' LEU . 75.2 m-80 -148.26 81.12 1.47 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.06 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 162' ' ' LEU . 3.1 mm? -115.8 -69.56 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.797 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -139.87 104.37 4.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.867 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -122.43 130.25 52.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.703 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.9 124.92 28.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.079 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 166' ' ' LEU . 2.2 pt? -127.12 -10.54 5.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.609 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -178.41 -117.89 0.54 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.321 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 92.3 mt -109.27 105.39 14.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 0.0 110.75 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -109.67 142.22 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.012 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -68.62 134.65 50.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -102.07 -44.11 5.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.76 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.72 138.73 44.78 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.571 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 78.1 p -132.61 -170.84 2.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.849 0.357 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -138.25 -37.69 0.56 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.689 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -136.4 -176.16 4.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.776 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.4 m -90.13 134.53 28.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.974 0.416 . . . . 0.0 111.169 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.3 mt -113.72 113.0 42.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.951 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -121.07 153.57 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.68 165.61 52.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.372 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -119.23 129.77 55.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.871 0.367 . . . . 0.0 110.753 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.62 -168.36 2.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.267 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.971 -179.897 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ' CA' . . . . . 0.481 'CA ' ' HB2' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.808 0.337 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -134.36 46.29 2.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 53.1 mtm-85 -90.63 -0.06 57.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.75 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.4 tp -71.73 -37.61 70.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.293 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.0 p -132.53 169.43 16.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.054 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -135.75 -164.19 1.51 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.774 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -77.4 -12.84 60.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.97 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -56.78 -34.42 67.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.148 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.6 mm -65.55 -23.78 33.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.317 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.77 160.74 15.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.659 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.56 25.89 65.86 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.282 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.498 ' C ' HD13 ' A' ' 12' ' ' LEU . 3.2 tm? -87.73 -50.48 6.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.088 . . . . 0.0 110.771 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -51.99 -38.96 58.56 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.101 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.696 ' O ' ' HG2' ' A' ' 18' ' ' MET . 38.6 tt0 -70.94 -49.72 42.53 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.635 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 55.5 tp -47.99 -33.12 7.39 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.037 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.489 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 32.1 t80 -60.05 -50.33 74.15 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.151 0.5 . . . . 0.0 110.927 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -79.95 -15.6 56.95 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.094 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.696 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 81.4 mmm -69.51 -28.73 66.29 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.363 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.72 HG21 HG23 ' A' ' 27' ' ' ILE . 0.9 OUTLIER -69.36 -59.11 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.636 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.765 ' HB3' ' O ' ' A' ' 26' ' ' THR . 2.1 p30 -80.84 45.66 0.83 Allowed 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.932 0.873 . . . . 0.0 111.771 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.643 HG21 ' HD2' ' A' ' 38' ' ' ARG . 15.1 t -66.0 -6.53 13.05 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.986 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.57 -7.17 2.87 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.443 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 24.2 t-20 -91.83 -93.86 0.14 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.698 -0.401 . . . . 0.0 112.063 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.6 p -177.36 14.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.498 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.47 17.17 9.49 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.185 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 74.0 p -125.17 158.98 32.62 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.879 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 1.6 mt -123.09 101.66 9.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.679 HG22 ' HB ' ' A' ' 62' ' ' THR . 76.7 p -103.28 156.87 17.41 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.385 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.43 ' HZ ' ' HB3' ' A' ' 45' ' ' GLU . 60.3 t80 -33.65 -38.49 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.98 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 9.6 t70 -71.18 -43.9 66.52 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 111.243 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -79.43 -27.72 41.7 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.65 178.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.045 HD12 HD12 ' A' ' 48' ' ' ILE . 1.6 tm? -50.75 -55.08 18.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.129 0.49 . . . . 0.0 109.965 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.587 ' HB3' HD11 ' A' ' 48' ' ' ILE . 1.1 ptmm? -77.02 -39.04 51.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.119 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 38.8 t70 -41.73 -41.18 2.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.562 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.99 91.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.443 -0.408 . . . . 0.0 114.097 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.826 HD22 HD11 ' A' ' 43' ' ' LEU . 2.2 mp -89.26 -45.07 9.81 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 41' ' ' SER . 17.4 ptpt -59.12 -21.92 60.04 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.643 ' HD2' HG21 ' A' ' 21' ' ' THR . 36.8 ttt-85 -79.57 -40.56 29.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.39 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 36' ' ' LEU . 2.9 p -78.98 -12.96 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.72 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.54 -44.62 1.19 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.375 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 69.4 m -52.96 161.9 0.71 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.681 0.277 . . . . 0.0 111.525 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -134.24 105.1 6.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.606 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.826 HD11 HD22 ' A' ' 36' ' ' LEU . 68.7 mt -108.42 166.15 10.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.007 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.431 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 32.1 mtm -109.21 165.7 11.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.773 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HB3' ' HZ ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -55.47 -59.79 4.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.128 -179.309 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.7 m -55.09 -17.6 4.28 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.924 0.329 . . . . 0.0 111.737 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.4 mm-40 -79.69 -48.42 13.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.045 HD12 HD12 ' A' ' 32' ' ' LEU . 6.1 mm -56.86 -51.96 61.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.915 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -46.97 -33.16 4.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.006 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 63.9 t0 -60.3 -45.31 93.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.484 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.838 HD12 HD11 ' A' ' 32' ' ' LEU . 67.3 mt -67.07 -14.77 63.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.604 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -87.6 -65.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.04 0.448 . . . . 0.0 111.804 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.66 -37.13 70.84 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -91.28 -13.63 32.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.16 -43.56 1.64 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.614 ' OD1' HG12 ' A' ' 63' ' ' ILE . 34.0 t70 -62.25 103.6 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.857 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.0 mm -43.35 -27.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.286 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.584 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.6 m-20 -133.63 44.66 2.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.035 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.604 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 1.2 tmtp? -31.99 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.819 0.818 . . . . 0.0 112.339 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.0 p -126.81 10.54 7.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.165 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 103.63 -15.31 53.11 Favored Glycine 0 C--O 1.238 0.35 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.597 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.876 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 5.4 t -140.49 148.81 41.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.67 0.272 . . . . 0.0 110.88 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.879 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 78.6 mt -108.88 142.42 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.03 0.443 . . . . 0.0 111.244 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -105.69 166.78 10.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.971 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.653 ' O ' HG13 ' A' ' 69' ' ' ILE . 31.2 t80 -40.58 -48.91 2.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.794 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.34 -59.17 7.03 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.783 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.673 ' HB2' HG23 ' A' ' 63' ' ' ILE . 48.9 mt-10 -45.47 -31.9 1.95 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.804 0.335 . . . . 0.0 110.726 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 16' ' ' PHE . 9.9 t80 -66.06 -55.0 18.82 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.378 0.609 . . . . 0.0 110.152 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.653 HG13 ' O ' ' A' ' 65' ' ' TYR . 10.8 mt -57.06 -65.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.061 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 74' ' ' HIS . . . -44.85 -48.33 11.08 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.557 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.649 ' HB1' ' HB1' ' A' ' 55' ' ' ALA . . . -41.03 -42.59 1.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.455 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.9 p -69.71 -33.04 71.96 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.426 HG12 ' NZ ' ' A' ' 77' ' ' LYS . 46.7 t -95.89 -14.29 7.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.564 0.697 . . . . 0.0 110.328 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 70' ' ' ALA . 18.1 t-160 -83.44 -49.48 9.26 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.889 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.786 ' HB2' ' HD2' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -57.99 -14.54 6.66 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.324 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.464 ' N ' HD23 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -110.94 74.97 0.9 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.689 179.238 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.426 ' NZ ' HG12 ' A' ' 73' ' ' VAL . 60.7 mttp -158.41 -94.93 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.549 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -168.04 67.64 0.08 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.652 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -63.64 98.08 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.867 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.466 ' HG3' HH11 ' A' ' 80' ' ' ARG . 38.2 ttt85 -101.38 144.89 29.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.897 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.54 161.49 16.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.825 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -94.94 -84.03 0.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -84.92 -166.41 1.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.791 HD23 ' H ' ' A' ' 84' ' ' LEU . 2.6 pt? -90.32 -42.8 10.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.456 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 6.4 p -54.73 -30.88 23.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.4 m -56.46 -37.43 70.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.127 0.489 . . . . 0.0 109.797 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.531 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -82.66 -47.92 11.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.064 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.769 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 21.7 t80 -41.85 -30.0 0.23 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.551 0.691 . . . . 0.0 109.65 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -89.9 -47.58 7.78 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.194 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -84.99 -63.88 1.25 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.271 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.606 ' HB3' HD13 ' A' ' 99' ' ' ILE . 4.1 m-85 -56.53 -56.5 20.45 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.813 ' HA ' HG12 ' A' ' 99' ' ' ILE . 0.4 OUTLIER -77.81 54.69 1.29 Allowed 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.532 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.624 ' NZ ' ' HB2' ' A' ' 93' ' ' LYS . 3.7 ttmp? -49.07 -38.28 23.77 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.778 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.406 ' HB3' 'CA ' ' A' ' 191' ' ' ' CA' . 8.6 t70 -75.43 -23.06 56.92 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.777 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.74 73.07 0.31 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.415 ' HG ' ' HD1' ' A' ' 98' ' ' TYR . 25.4 p -132.1 -28.59 1.72 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 134.56 7.13 2.2 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 113.925 -1.488 . . . . 0.0 113.037 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.831 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -150.87 160.73 43.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.451 0.643 . . . . 0.0 111.362 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.813 HG12 ' HA ' ' A' ' 92' ' ' ASP . 70.1 mt -133.96 102.78 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.884 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 103' ' ' GLU . 72.9 p -73.14 150.93 41.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.347 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.599 HD23 ' H ' ' A' ' 101' ' ' LEU . 0.3 OUTLIER -35.03 -34.25 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.642 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -62.13 -51.69 66.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.539 ' HB2' HG23 ' A' ' 99' ' ' ILE . 53.9 mt-10 -71.13 -29.44 65.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.954 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.778 HG13 HG22 ' A' ' 99' ' ' ILE . 27.1 mt -68.39 -64.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.981 0.42 . . . . 0.0 110.395 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.716 ' O ' HD23 ' A' ' 113' ' ' LEU . 29.2 mt-30 -55.49 -39.57 70.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.456 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -65.31 -31.93 73.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.048 0.451 . . . . 0.0 110.447 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.73 -4.09 3.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.145 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 9.8 p -105.04 118.27 36.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.133 0.492 . . . . 0.0 110.587 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.786 ' HD2' ' HB2' ' A' ' 75' ' ' LEU . 38.2 ttpt -88.82 -61.32 1.73 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.257 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.88 -4.45 58.47 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 108' ' ' CYS . 2.8 m-85 -65.71 -18.15 65.12 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.501 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.59 38.95 97.25 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.611 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.999 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -33.27 149.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.242 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.646 ' OD2' HG22 ' A' ' 116' ' ' ILE . 26.7 t70 -160.48 178.89 9.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.185 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.433 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 53.6 p-10 -89.38 -8.45 53.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.921 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.646 HG22 ' OD2' ' A' ' 114' ' ' ASP . 6.6 tp -92.53 -57.6 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.545 ' N ' HG23 ' A' ' 116' ' ' ILE . 10.0 t-80 -91.47 -68.65 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.999 HG13 ' HA ' ' A' ' 113' ' ' LEU . 46.9 mm -54.02 -19.61 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.968 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 38.5 t70 -66.91 -41.9 86.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 124' ' ' GLU . 7.4 t70 -71.2 -26.04 62.78 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.943 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 3.7 ttt -57.77 -30.26 65.5 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.161 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.552 ' HB ' ' HD2' ' A' ' 123' ' ' LYS . 58.9 mt -58.84 -43.95 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.681 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 3.7 mptt -86.64 -13.32 45.93 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 113.271 -1.786 . . . . 0.0 110.351 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.943 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 36.5 tp10 -82.14 -27.77 32.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.753 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.719 HG22 ' CD1' ' A' ' 133' ' ' ILE . 45.0 mt -100.41 -33.88 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.278 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.721 ' CG ' ' H ' ' A' ' 131' ' ' GLY . 7.3 t70 -83.47 84.92 7.34 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.41 0.624 . . . . 0.0 110.318 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.533 ' CD ' ' H ' ' A' ' 127' ' ' GLN . 2.9 pm0 -88.09 -9.29 53.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.806 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.659 ' HB3' ' OE1' ' A' ' 137' ' ' GLU . 5.6 t70 -130.17 -19.52 3.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 -177.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.496 ' ND2' ' NH1' ' A' ' 154' ' ' ARG . 5.4 t-20 -115.37 -127.19 0.29 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -177.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -116.61 27.04 9.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -173.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.721 ' H ' ' CG ' ' A' ' 126' ' ' ASP . . . 94.65 37.11 5.37 Favored Glycine 0 CA--C 1.501 -0.836 0 N-CA-C 108.258 -1.937 . . . . 0.0 108.258 -177.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.549 ' OE1' ' HB3' ' A' ' 98' ' ' TYR . 2.9 pt20 -153.72 169.21 23.88 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.172 -1.514 . . . . 0.0 108.966 -177.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.719 ' CD1' HG22 ' A' ' 125' ' ' ILE . 25.9 mm -131.33 127.01 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-O 121.68 0.752 . . . . 0.0 111.067 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.831 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -102.09 160.51 14.45 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.208 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.736 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 24.4 t80 -41.64 -33.95 0.54 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.576 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 153' ' ' ARG . . . -82.75 -35.54 18.89 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.855 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.659 ' OE1' ' HB3' ' A' ' 128' ' ' ASP . 61.2 mm-40 -62.11 -57.03 13.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.289 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.696 ' HD1' HG21 ' A' ' 133' ' ' ILE . 2.7 t80 -61.09 -38.37 86.02 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.14 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 142' ' ' MET . . . -58.71 -33.82 70.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.163 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.525 ' HB3' ' HA2' ' A' ' 152' ' ' GLY . . . -90.72 -26.87 19.32 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.43 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.529 ' HG2' ' CD1' ' A' ' 138' ' ' PHE . 2.8 ppp? -51.6 -28.0 12.87 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.653 ' HG3' ' H ' ' A' ' 143' ' ' ARG . 17.1 ptp -105.13 -111.13 0.27 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.653 ' H ' ' HG3' ' A' ' 142' ' ' MET . 0.0 OUTLIER -176.4 146.16 0.61 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.701 0.763 . . . . 0.0 112.273 175.719 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.609 ' HZ1' ' HA ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -155.37 -73.29 0.11 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.081 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.469 ' HA ' ' NE ' ' A' ' 145' ' ' ARG . 9.9 mmp_? -104.66 -45.8 4.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.307 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -113.29 119.89 39.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.225 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -90.82 -4.44 69.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.446 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.434 ' ND2' HD12 ' A' ' 151' ' ' ILE . 55.8 t-20 -46.65 112.22 0.48 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.971 0.386 . . . . 0.0 110.425 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -78.37 -17.61 77.57 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.845 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -78.68 -20.27 71.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.596 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.434 HD12 ' ND2' ' A' ' 148' ' ' ASN . 5.0 mt -139.4 153.49 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 CA-C-O 121.105 0.479 . . . . 0.0 111.164 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.525 ' HA2' ' HB3' ' A' ' 140' ' ' ALA . . . -99.93 -132.07 7.59 Favored Glycine 0 N--CA 1.427 -1.938 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 176.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.65 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 78.3 mtp180 -142.01 80.67 1.72 Allowed 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.417 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.657 ' HE ' HG22 ' A' ' 155' ' ' THR . 11.3 tpt180 -111.33 145.12 39.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.298 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.657 HG22 ' HE ' ' A' ' 154' ' ' ARG . 6.6 t -46.67 -40.2 12.75 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.253 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.516 ' HG3' HG23 ' A' ' 155' ' ' THR . 68.7 mtm -111.5 83.84 1.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.348 . . . . 0.0 110.687 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.419 ' HA ' ' OD2' ' A' ' 128' ' ' ASP . 84.3 mtm180 -72.26 141.0 48.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -166.33 134.44 2.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.726 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.0 m -97.71 98.47 9.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.78 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.433 ' C ' HD23 ' A' ' 160' ' ' LEU . 6.4 tt -145.94 101.75 3.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.371 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -171.49 138.37 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 87.2 mt -84.67 147.11 27.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.781 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -89.64 141.25 28.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.754 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -61.84 124.08 19.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.767 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.25 121.32 10.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.122 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 62.3 tp -80.79 -24.76 38.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -124.76 -116.68 2.18 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.575 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.6 mt -68.91 156.15 39.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.909 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.55 134.96 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.053 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.53 -166.95 1.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -96.92 -45.88 6.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.983 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 67.75 -174.33 28.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.438 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.6 t -150.82 -80.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.667 0.27 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -166.09 67.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.407 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -114.71 98.16 6.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.88 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 35.7 m -66.32 139.53 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.213 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.0 mm -120.2 102.93 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.827 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -103.19 104.66 14.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.491 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 175.13 74.36 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.529 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -91.53 32.69 1.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.349 . . . . 0.0 110.647 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -76.86 -51.34 11.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.969 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.8 ' HA ' ' HE2' ' A' ' 182' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.814 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ' CA' . . . . . 0.406 'CA ' ' HB3' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.826 0.346 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -102.75 90.32 3.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.825 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -126.16 21.91 7.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.732 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.738 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.1 pt? -130.24 18.7 5.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.0 p -92.28 -36.36 13.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -121.02 74.65 1.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.029 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.444 ' OE2' ' HA ' ' A' ' 4' ' ' LEU . 56.2 mm-40 -89.04 -12.68 40.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.927 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.758 ' HG3' ' H ' ' A' ' 9' ' ' ILE . 16.8 pt-20 -76.08 -71.44 0.38 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.837 HG13 ' H ' ' A' ' 10' ' ' GLY . 9.2 pt -90.96 -71.83 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.837 ' H ' HG13 ' A' ' 9' ' ' ILE . . . -168.89 166.11 39.42 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.41 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.28 24.81 2.44 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.492 ' H ' ' C ' ' A' ' 10' ' ' GLY . 96.3 mt -51.93 -21.06 2.69 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.528 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 4.5 ttmp? -59.58 -51.35 70.21 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.659 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 84.8 tt0 -62.05 -30.73 71.18 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.134 178.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.72 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 40.4 tp -68.86 -30.33 68.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.662 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.415 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 22.0 t80 -68.16 -49.48 60.68 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.223 0.535 . . . . 0.0 110.333 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' A' ' 14' ' ' GLU . 60.2 pttt -75.66 -12.91 60.29 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.57 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 2.3 tpp -66.03 -28.91 69.22 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.862 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.585 HD12 HD13 ' A' ' 27' ' ' ILE . 3.3 mt -81.26 -55.01 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.052 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.583 ' OD1' ' HA ' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -82.71 62.8 6.51 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.775 0.798 . . . . 0.0 111.292 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 t -81.81 -11.75 58.83 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.173 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.3 p30 -138.36 -11.43 1.42 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -72.25 -81.92 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.143 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 p -175.8 5.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.684 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.58 20.94 7.07 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.51 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 68.5 p -139.22 150.63 45.76 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.042 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.714 ' O ' ' HA ' ' A' ' 62' ' ' THR . 3.8 mt -104.16 103.35 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.697 HG22 ' OG1' ' A' ' 62' ' ' THR . 71.2 p -104.31 162.55 13.11 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.492 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -34.11 -35.95 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.942 0.497 . . . . 0.0 111.821 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -77.36 -41.15 41.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 110.759 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.575 ' HG3' HG22 ' A' ' 19' ' ' ILE . 11.4 tp10 -77.09 -30.55 55.43 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.429 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.893 HD12 HG13 ' A' ' 48' ' ' ILE . 0.9 OUTLIER -41.18 -48.73 3.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.981 0.895 . . . . 0.0 109.732 -179.294 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.835 ' HB3' HD11 ' A' ' 43' ' ' LEU . 6.0 ptpt -85.15 -30.87 23.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.886 -1.507 . . . . 0.0 111.624 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 9.1 t70 -46.62 -46.1 19.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.345 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.15 -37.55 95.09 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.008 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.836 ' HG ' HD23 ' A' ' 43' ' ' LEU . 3.8 mm? -71.62 -58.18 3.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.574 ' NZ ' ' HE2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -58.58 -26.88 64.08 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.108 0.48 . . . . 0.0 110.41 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 56.4 ttt-85 -59.16 -49.45 77.81 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.397 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 36' ' ' LEU . 3.3 m -77.46 -14.25 14.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.33 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.89 -19.99 8.23 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.971 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 49.2 m -55.69 153.77 7.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.749 0.275 . . . . 0.0 110.963 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -131.64 104.17 6.79 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.446 0.641 . . . . 0.0 112.04 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.836 HD23 ' HG ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -116.58 167.6 10.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.865 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.493 ' CE ' ' HB2' ' A' ' 86' ' ' SER . 27.0 ptt? -109.67 165.22 11.85 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.516 0.198 . . . . 0.0 110.562 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -50.19 -55.63 14.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.353 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.554 ' OG ' ' HB2' ' A' ' 87' ' ' ALA . 44.5 t -48.53 -24.27 1.25 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.477 ' HG2' ' OG ' ' A' ' 86' ' ' SER . 49.2 mt-10 -71.15 -36.2 71.97 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.893 HG13 HD12 ' A' ' 32' ' ' LEU . 1.9 mp -66.42 -60.61 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.747 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.448 ' HE3' ' CE1' ' A' ' 111' ' ' PHE . 22.1 ttmm -54.5 -31.26 55.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.489 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 35.8 t70 -70.9 -45.18 64.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.244 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.867 HD23 HD21 ' A' ' 32' ' ' LEU . 36.0 tp -66.35 -16.56 64.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.529 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.677 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 23.5 mmt -85.45 -60.85 1.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.291 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -76.12 -39.32 55.4 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.859 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -82.72 -19.08 38.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.51 -43.98 1.56 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.656 ' HB3' ' O ' ' A' ' 52' ' ' MET . 33.3 t70 -60.26 107.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.214 0.531 . . . . 0.0 110.199 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.452 HD11 ' CB ' ' A' ' 70' ' ' ALA . 7.1 mt -49.45 -25.08 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.676 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.528 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 74.8 m-20 -130.4 44.03 3.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.023 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.677 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 1.3 tmtp? -31.98 92.3 0.01 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.798 0.808 . . . . 0.0 112.468 -177.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' ASP . 82.8 p -128.0 10.46 6.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.796 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 81.45 17.33 71.46 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.601 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 53.2 m -153.94 127.19 8.48 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.42 0.288 . . . . 0.0 110.371 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.661 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 64.2 mt -107.5 132.44 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.034 0.445 . . . . 0.0 111.479 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -105.19 168.15 9.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.3 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.528 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 28.4 t80 -35.82 -48.23 0.54 Allowed 'General case' 0 N--CA 1.464 0.23 0 O-C-N 123.296 0.372 . . . . 0.0 111.913 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.92 -64.0 3.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.709 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.636 ' HB2' HG23 ' A' ' 63' ' ' ILE . 63.7 mt-10 -50.57 -26.18 4.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.764 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 68.2 t80 -62.0 -61.85 2.19 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.48 0.657 . . . . 0.0 110.894 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.569 HD13 ' HD2' ' A' ' 68' ' ' PHE . 10.4 mm -55.07 -50.62 61.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.777 -178.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.452 ' CB ' HD11 ' A' ' 57' ' ' ILE . . . -62.31 -12.5 21.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.936 0.398 . . . . 0.0 111.261 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.597 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -95.11 -53.68 3.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.447 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 76' ' ' ASN . 77.9 p -61.54 -47.87 83.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.205 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.591 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 59.5 t -52.09 -29.86 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -72.21 -40.47 67.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 75' ' ' LEU . 6.9 mp -90.47 4.49 50.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.005 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.591 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 44.8 t30 -95.26 75.21 3.39 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.8 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.551 ' C ' HD22 ' A' ' 78' ' ' LEU . 31.7 mmmt -143.97 -40.69 0.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.43 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.551 HD22 ' C ' ' A' ' 77' ' ' LYS . 3.3 mm? -125.4 107.05 10.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.035 179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -44.2 -34.74 1.97 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.475 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -96.28 102.39 14.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.685 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -102.61 32.01 3.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.133 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -74.13 95.24 2.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.783 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.478 ' HB2' HG22 ' A' ' 85' ' ' VAL . 17.9 p30 -158.73 125.67 4.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.143 0.497 . . . . 0.0 111.447 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.567 HD22 ' C ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -74.98 -17.37 60.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.659 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.478 HG22 ' HB2' ' A' ' 83' ' ' ASN . 22.0 m -47.31 -19.07 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.641 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.493 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 53.1 m -34.98 -65.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.15 0.281 . . . . 0.0 111.701 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.672 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -73.29 -38.55 65.84 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.69 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 25.4 t80 -43.16 -23.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.913 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.1 t -88.88 -42.53 11.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.737 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -82.76 -62.92 1.47 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.592 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.9 m-85 -53.61 -62.82 1.41 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.465 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.605 ' HA ' HG12 ' A' ' 99' ' ' ILE . 1.2 m-20 -79.0 50.16 1.0 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 89' ' ' SER . 37.3 ttmt -36.66 -59.81 0.64 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.629 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -83.48 -20.93 33.11 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.705 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.25 85.69 0.01 OUTLIER Glycine 0 N--CA 1.424 -2.156 0 CA-C-O 121.713 0.618 . . . . 0.0 112.887 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.4 p -100.58 -14.62 18.11 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 124.44 -4.02 8.8 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 111.526 -2.579 . . . . 0.0 110.942 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.689 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.1 OUTLIER -147.9 165.67 29.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.764 -0.718 . . . . 0.0 110.746 178.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.696 HG23 ' HB2' ' A' ' 103' ' ' GLU . 72.4 mt -131.75 104.15 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.512 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 102' ' ' ASP . 71.5 p -72.12 147.08 47.03 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.702 HD23 ' H ' ' A' ' 101' ' ' LEU . 0.3 OUTLIER -34.27 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 106' ' ' GLN . 34.6 t70 -57.16 -56.59 19.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.696 ' HB2' HG23 ' A' ' 99' ' ' ILE . 48.7 mt-10 -69.47 -32.29 71.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.163 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -61.39 -50.07 81.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.179 0.514 . . . . 0.0 110.723 179.228 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.588 ' CD ' HD11 ' A' ' 122' ' ' ILE . 19.3 mt-30 -71.94 -49.45 37.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.031 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 102' ' ' ASP . 87.0 mt-30 -55.83 -41.84 74.85 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.837 0.351 . . . . 0.0 110.979 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.13 -4.01 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.246 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.762 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 74.3 m -119.93 67.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.812 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.748 ' HD3' ' H ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -80.2 -36.34 35.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 -179.781 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -89.04 -5.0 58.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.762 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 4.2 m-85 -83.81 5.08 26.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.744 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.75 37.55 13.35 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.783 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.898 ' HA ' HG13 ' A' ' 118' ' ' ILE . 2.3 tm? -33.88 105.21 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.319 0.58 . . . . 0.0 111.327 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.496 ' OD1' HG12 ' A' ' 116' ' ' ILE . 10.3 t70 -160.5 156.05 25.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.754 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.668 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 10.7 p-10 -64.19 -7.73 10.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.067 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.496 HG12 ' OD1' ' A' ' 114' ' ' ASP . 49.0 mm -80.66 -64.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.586 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -91.69 -68.26 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.898 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.5 mm -48.17 -19.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.257 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.668 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 8.8 t70 -78.12 -59.1 2.92 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 124' ' ' GLU . 34.8 t70 -59.52 -17.15 29.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.775 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 25.2 ttp -64.27 -42.66 96.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.577 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.613 HG22 ' HA3' ' A' ' 131' ' ' GLY . 53.8 mt -54.89 -49.33 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.84 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.654 ' HA ' ' HE3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -76.92 -13.27 60.0 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.513 178.231 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.775 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 40.3 tp10 -84.06 -25.44 29.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.262 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.05 HG22 HD11 ' A' ' 133' ' ' ILE . 31.2 mt -107.41 -15.74 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 1.01 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 1.9 t70 -77.76 82.74 4.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.025 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.553 ' OE1' ' HD3' ' A' ' 153' ' ' ARG . 16.0 mp0 -88.63 -9.36 52.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.663 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.751 ' HB2' ' HG3' ' A' ' 153' ' ' ARG . 45.0 t0 -116.15 -35.49 4.36 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.465 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 17.0 p30 -179.97 -84.82 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.638 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 34.8 t70 -65.36 15.78 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -172.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 1.01 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.56 38.85 83.27 Favored Glycine 0 CA--C 1.509 -0.313 0 C-N-CA 117.223 -2.417 . . . . 0.0 109.193 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.638 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 2.5 pt20 -134.61 167.4 20.88 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 113.461 -1.369 . . . . 0.0 108.692 -177.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.05 HD11 HG22 ' A' ' 125' ' ' ILE . 5.8 mm -129.14 125.26 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 122.26 1.028 . . . . 0.0 111.532 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 1.001 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 6.4 t70 -103.14 152.09 21.83 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.969 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.69 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 17.1 t80 -40.96 -42.68 1.93 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.749 0.309 . . . . 0.0 110.931 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -82.77 -28.53 38.1 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.883 178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 1.001 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 31.9 mt-10 -68.92 -59.07 3.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.672 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 13.4 t80 -50.41 -18.53 0.66 Allowed 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.392 0.615 . . . . 0.0 109.776 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -78.48 -40.21 36.08 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.519 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' A' ' 144' ' ' LYS . . . -90.13 -12.8 37.22 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.703 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.49 ' HG2' ' CD1' ' A' ' 138' ' ' PHE . 4.9 ppp? -55.8 -27.68 52.36 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.735 0.302 . . . . 0.0 111.238 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -102.3 -21.03 14.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 110.227 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 63.1 mtt85 -144.15 73.37 1.38 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.162 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.801 ' HD3' ' H ' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -89.31 -85.43 0.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.496 -179.393 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.762 ' H ' ' HG2' ' A' ' 144' ' ' LYS . 73.3 mtp180 -77.36 23.35 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.769 0.319 . . . . 0.0 110.756 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.439 ' H ' ' C ' ' A' ' 144' ' ' LYS . 61.9 tttp -58.93 -87.17 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.671 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -57.9 -60.9 8.13 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -132.55 110.65 10.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 0.0 110.279 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 145' ' ' ARG . . . -60.18 -23.48 59.8 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.085 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -46.17 -26.06 2.08 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.454 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.597 HG21 ' NH1' ' A' ' 157' ' ' ARG . 12.9 mt -119.47 -109.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 117.032 0.416 . . . . 0.0 111.344 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 151' ' ' ILE . . . 111.96 -128.07 8.4 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.805 ' CZ ' ' HA ' ' A' ' 126' ' ' ASP . 6.0 ptt180 -91.93 131.56 37.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.346 0.594 . . . . 0.0 109.536 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.656 ' HB3' ' HG2' ' A' ' 157' ' ' ARG . 79.9 ttt180 -130.82 150.15 52.12 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.432 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.9 t -47.95 -17.4 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.713 0.292 . . . . 0.0 110.91 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.4 ' N ' ' C ' ' A' ' 154' ' ' ARG . 16.6 tpt -160.59 93.91 1.03 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.252 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.656 ' HG2' ' HB3' ' A' ' 154' ' ' ARG . 23.7 mmm180 -105.68 139.44 40.27 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.825 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -84.79 -179.65 7.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.898 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 56.6 m -92.96 153.7 18.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.548 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.69 HD23 ' H ' ' A' ' 160' ' ' LEU . 2.0 pt? -131.98 -170.79 2.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.97 0.414 . . . . 0.0 111.308 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -75.01 166.27 23.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.737 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 80.2 mt -90.3 172.15 8.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.915 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.487 ' HG2' ' N ' ' A' ' 164' ' ' ASP . 71.5 ttt180 -123.62 157.14 34.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.487 ' N ' ' HG2' ' A' ' 163' ' ' ARG . 57.2 m-20 -107.58 107.3 18.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.634 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.55 158.06 3.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.372 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.82 HD23 ' H ' ' A' ' 166' ' ' LEU . 2.4 pt? -114.21 6.38 16.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.772 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -105.69 108.93 3.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.353 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 168' ' ' LEU . 2.8 mm? -103.36 132.35 49.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.357 . . . . 0.0 110.897 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.9 m -67.1 153.98 8.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -161.4 134.84 6.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.784 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -110.52 -11.14 14.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.308 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 69.37 -129.02 22.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.564 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.4 t -128.41 153.29 47.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.349 . . . . 0.0 111.084 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -155.25 138.26 15.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.823 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -75.83 121.87 23.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.963 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 62.4 t -107.62 119.46 57.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.094 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 12.0 tt -91.19 125.32 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.975 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -87.26 127.56 35.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -160.34 158.83 30.26 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.533 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.452 ' HD1' ' N ' ' A' ' 181' ' ' PHE . 0.2 OUTLIER -60.15 -23.86 64.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.734 0.302 . . . . 0.0 111.413 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.452 ' N ' ' HD1' ' A' ' 180' ' ' TYR . 4.1 m-85 -123.06 101.41 7.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.871 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.845 179.873 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.4 tp . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.516 0.198 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.635 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 6.3 ttpm? -55.83 -30.93 62.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.76 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 8.1 mp0 -76.97 -38.3 53.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.959 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.735 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 54.5 tp -55.01 -28.12 49.62 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.681 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -70.6 -45.07 66.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.776 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.76 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 63.5 pttt -82.47 -12.5 57.78 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.589 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.44 -25.9 68.21 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.431 178.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.532 HG23 ' HA3' ' A' ' 35' ' ' GLY . 3.2 mt -86.39 -59.4 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.511 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -82.62 57.35 3.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.347 0.594 . . . . 0.0 110.547 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.662 HG21 ' NH2' ' A' ' 38' ' ' ARG . 13.6 t -81.24 -6.72 59.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.16 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -129.2 -14.61 4.3 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.564 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -74.42 -87.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.802 0.334 . . . . 0.0 111.208 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 p -176.66 6.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.817 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.549 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.42 31.48 2.79 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 45.9 p -150.07 145.78 26.57 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.189 -0.505 . . . . 0.0 109.946 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.823 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.2 mt -102.87 103.91 15.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.629 HG22 ' OG1' ' A' ' 62' ' ' THR . 68.3 p -103.42 164.84 11.39 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.551 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 20.5 t80 -34.09 -36.4 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.683 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.19 -49.84 16.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.715 0.293 . . . . 0.0 111.659 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.652 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -75.72 -19.9 58.74 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.922 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.892 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -46.03 -47.38 16.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.914 0.864 . . . . 0.0 108.693 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.709 ' HG2' HG12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -85.43 -51.89 6.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.485 179.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.652 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 59.3 m-20 -36.34 -36.17 0.09 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.532 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -68.02 -57.34 8.76 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 115.114 0.805 . . . . 0.0 115.114 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.697 HD21 ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -73.85 -28.55 61.65 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.163 0.981 . . . . 0.0 111.989 -177.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.635 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 19.4 ptpt -66.14 -4.7 7.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.662 ' NH2' HG21 ' A' ' 21' ' ' THR . 36.9 ttm180 -87.15 -42.71 12.8 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.249 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 36' ' ' LEU . 30.8 m -73.44 -0.22 2.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.81 -36.93 3.71 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.352 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.604 ' CB ' HD23 ' A' ' 36' ' ' LEU . 18.5 m -52.45 153.02 3.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.471 0.177 . . . . 0.0 110.553 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -143.3 103.79 4.17 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.298 0.57 . . . . 0.0 112.142 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.7 HD11 ' HB3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -105.35 167.98 9.38 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.124 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 5.3 mtm -104.66 165.51 11.01 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.535 ' HA ' HD13 ' A' ' 48' ' ' ILE . 92.8 mt-10 -47.71 -59.99 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.495 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 94.4 p -39.47 -34.99 0.25 Allowed 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 44' ' ' MET . 37.2 mp0 -66.38 -41.03 89.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.053 0.454 . . . . 0.0 110.172 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.892 HG13 HD12 ' A' ' 32' ' ' LEU . 2.0 mp -57.06 -60.49 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.984 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.551 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 42.4 tttm -64.45 -25.6 68.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.318 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 46' ' ' SER . 62.6 t0 -71.13 -37.45 72.29 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.607 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.52 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 10.2 tt -76.36 -23.07 54.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.024 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.752 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 18.2 mmt -71.88 -45.01 62.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.122 0.487 . . . . 0.0 111.518 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.52 -30.29 20.71 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.988 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.55 -19.31 22.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.02 -43.81 1.65 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.752 ' HB3' ' O ' ' A' ' 52' ' ' MET . 15.6 t0 -61.24 95.98 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.3 mm -48.65 -22.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.031 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.58 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 59.0 t0 -129.11 44.5 2.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.818 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.702 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.5 tmtm? -32.57 90.38 0.0 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.74 0.781 . . . . 0.0 112.662 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.1 p -127.74 18.04 6.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.151 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 70.88 17.76 75.58 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.384 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 86.1 m -150.36 127.15 11.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.542 0.337 . . . . 0.0 110.561 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.823 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 70.1 mt -108.06 129.46 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 121.055 0.455 . . . . 0.0 111.367 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' OD1' HG22 ' A' ' 26' ' ' THR . 56.3 m-20 -105.06 167.33 9.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.09 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.635 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 47.9 t80 -35.52 -45.78 0.37 Allowed 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.389 0.431 . . . . 0.0 111.474 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.38 -63.7 4.12 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.331 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.784 ' HB2' HG23 ' A' ' 63' ' ' ILE . 63.0 mt-10 -51.92 -26.11 9.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.662 0.267 . . . . 0.0 110.905 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.735 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 71.9 t80 -63.87 -65.18 0.72 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.434 0.635 . . . . 0.0 110.879 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.614 HD13 ' HD2' ' A' ' 68' ' ' PHE . 14.5 mm -52.13 -41.17 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.653 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.23 -25.76 66.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.0 110.59 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.035 179.705 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.496 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 14.4 p . . . . . 0 C--O 1.233 0.19 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.7 m -51.05 -55.01 19.66 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.402 . . . . 0.0 110.173 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.584 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -81.18 -39.77 24.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.902 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.808 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 8.1 t80 -45.95 -23.04 0.25 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.366 0.603 . . . . 0.0 110.055 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.3 t -89.13 -44.79 10.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.769 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -89.3 -63.65 1.26 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.609 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.5 m-85 -51.98 -62.36 1.68 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.808 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.6 OUTLIER -76.13 55.29 0.93 Allowed 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 176.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -44.53 -52.91 7.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.451 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.35 -21.46 64.73 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.328 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.08 68.61 1.09 Allowed Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.4 p -115.54 -23.06 8.95 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 134' ' ' ASP . . . 130.58 -4.55 5.84 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 113.162 -1.836 . . . . 0.0 112.606 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.896 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.5 OUTLIER -148.62 161.82 40.94 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.792 HG12 ' HA ' ' A' ' 92' ' ' ASP . 22.1 mt -133.09 104.27 6.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.833 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 102' ' ' ASP . 69.6 p -72.3 147.1 46.69 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.709 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.1 pp -34.44 -33.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.526 ' N ' HD12 ' A' ' 101' ' ' LEU . 54.2 m-20 -54.35 -55.89 24.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.56 ' HB2' HG23 ' A' ' 99' ' ' ILE . 97.4 mt-10 -71.21 -31.43 67.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.174 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.668 HG13 HG22 ' A' ' 99' ' ' ILE . 51.1 mt -65.74 -65.25 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.166 0.508 . . . . 0.0 110.439 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.858 ' HB3' HD12 ' A' ' 113' ' ' LEU . 87.8 mt-30 -58.14 -39.05 77.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.636 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.84 -44.12 94.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.082 0.468 . . . . 0.0 110.66 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.7 -3.05 1.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.145 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.788 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 73.2 m -115.09 44.07 1.88 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.922 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -59.54 -36.63 76.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.841 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -75.09 -22.12 58.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.11 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.788 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 2.7 m-85 -76.78 -5.18 47.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.953 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 113' ' ' LEU . . . 62.35 38.8 96.85 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.036 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.928 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -33.09 132.74 0.15 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.545 0.688 . . . . 0.0 111.501 -177.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.717 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 91.9 m-20 -135.99 167.69 20.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.217 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.635 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.6 m-20 -82.88 -7.98 59.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.178 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.59 -64.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.068 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -89.52 -69.24 0.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.928 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.3 mm -52.77 -19.45 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.942 0.401 . . . . 0.0 111.238 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.635 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 33.6 t70 -71.14 -46.91 60.59 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' GLU . 63.9 t0 -62.37 -26.27 68.37 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 1.026 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.5 ttt -60.75 -29.87 69.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.474 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.777 HG22 ' HA3' ' A' ' 131' ' ' GLY . 56.8 mt -58.32 -43.62 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.477 ' CE ' ' HB ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -86.67 -13.8 44.46 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.367 178.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 1.026 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 71.5 tt0 -84.61 -23.73 29.45 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.789 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.856 HG22 HD11 ' A' ' 133' ' ' ILE . 13.6 mm -107.56 -21.8 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.977 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.4 t70 -62.8 98.37 0.12 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.594 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.957 HE21 ' HG2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -87.23 -13.95 42.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.433 ' OD1' ' ND2' ' A' ' 129' ' ' ASN . 50.6 p30 -127.57 -33.19 2.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.73 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 179.96 -71.76 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 178.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.73 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 56.3 m-20 -64.92 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -173.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.977 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.53 37.93 78.04 Favored Glycine 0 CA--C 1.505 -0.566 0 C-N-CA 118.348 -1.882 . . . . 0.0 110.04 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.562 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 8.6 pt20 -133.33 170.53 15.33 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 113.895 -1.152 . . . . 0.0 110.075 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.042 HD13 ' HB3' ' A' ' 137' ' ' GLU . 5.0 mm -133.02 121.88 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.909 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 4.3 p-10 -113.01 162.47 15.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.161 177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.796 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 22.5 t80 -38.76 -30.48 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.768 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.537 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -84.27 -45.16 6.31 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.728 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 1.042 ' HB3' HD13 ' A' ' 133' ' ' ILE . 39.3 mt-10 -63.04 -51.3 67.29 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 13.6 t80 -56.62 -18.68 12.86 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -86.06 -40.85 15.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.151 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.605 ' HB3' ' HG3' ' A' ' 127' ' ' GLN . . . -87.25 -11.66 49.04 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' A' ' 138' ' ' PHE . 5.5 ppp? -72.41 -6.68 45.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.635 0.255 . . . . 0.0 111.557 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.994 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 15' ' ' LEU . 46.5 tp . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.651 ' HG3' ' OE1' ' A' ' 14' ' ' GLU . 20.6 pttp -58.59 -24.99 62.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.651 ' OE1' ' HG3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -80.43 -52.27 7.85 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.637 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 31.0 tp -47.23 -30.2 2.85 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.847 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.497 ' CZ ' ' N ' ' A' ' 65' ' ' TYR . 20.1 t80 -66.61 -52.04 49.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.164 0.506 . . . . 0.0 110.446 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -76.0 -13.06 60.23 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.625 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 63.4 mmm -71.04 -22.61 62.12 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.499 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.664 HG23 ' HA3' ' A' ' 35' ' ' GLY . 10.9 mm -77.42 -61.31 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.269 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.591 ' HB3' ' O ' ' A' ' 26' ' ' THR . 1.0 OUTLIER -80.23 66.79 5.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.534 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 t -82.75 -6.34 59.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.348 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -131.75 -27.28 1.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.473 ' ND2' ' OG1' ' A' ' 26' ' ' THR . 48.2 t30 -69.82 -82.45 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.1 p -175.91 5.42 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.46 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 111.11 27.13 4.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.373 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.591 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 64.8 p -143.66 149.18 36.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.034 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.86 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.1 mt -103.43 103.02 14.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.654 HG22 ' OG1' ' A' ' 62' ' ' THR . 66.9 p -104.16 162.29 13.3 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.129 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.625 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 44.1 t80 -34.03 -27.87 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 28' ' ' THR . 56.1 m-20 -82.51 -45.06 15.17 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.791 0.329 . . . . 0.0 111.159 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 8.0 mp0 -83.13 -15.13 51.93 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.901 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.71 HD12 HG13 ' A' ' 48' ' ' ILE . 2.2 tm? -53.03 -50.16 64.84 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.909 ' HB2' ' HE3' ' A' ' 37' ' ' LYS . 12.5 ptpt -82.59 -46.15 13.68 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.091 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.609 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 31.0 t70 -42.86 -64.9 0.54 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.664 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -46.43 -28.36 3.33 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.142 -0.552 . . . . 0.0 113.633 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.682 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -90.1 -59.68 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.986 0.393 . . . . 0.0 110.772 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.909 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 18.8 ptpt -60.43 -9.55 3.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.032 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.429 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -68.3 -34.67 76.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.868 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 36' ' ' LEU . 31.4 m -80.84 -8.72 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.393 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.7 -17.66 5.48 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.842 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 65.1 m -63.42 168.51 4.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.964 0.412 . . . . 0.0 111.445 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -147.57 111.12 4.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.608 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.7 mt -120.55 165.83 14.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.374 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.509 ' O ' HD13 ' A' ' 48' ' ' ILE . 24.0 ptt? -114.15 162.43 16.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 47' ' ' GLU . 44.4 mt-10 -47.63 -65.43 0.57 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 80.8 p -41.73 -18.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 55.8 mt-10 -89.72 -47.57 7.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.71 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -53.64 -59.78 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.912 0.863 . . . . 0.0 109.138 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 1.018 ' HD3' ' HD2' ' A' ' 93' ' ' LYS . 21.8 ttmm -55.15 -27.39 45.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.212 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 8.8 t70 -69.9 -45.05 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.153 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.647 HD23 ' O ' ' A' ' 51' ' ' LEU . 9.7 tt -68.26 -21.67 64.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.086 0.47 . . . . 0.0 109.966 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.713 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 13.4 mmt -71.93 -44.01 64.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.855 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 90' ' ' TYR . 9.7 t70 -87.05 -18.04 31.51 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.672 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.58 -42.36 10.26 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.876 ' HB1' ' HA ' ' A' ' 71' ' ' ALA . . . -110.7 -43.13 3.88 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.713 ' HB3' ' O ' ' A' ' 52' ' ' MET . 12.3 t0 -49.39 97.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.706 -0.398 . . . . 0.0 109.979 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.7 mm -54.75 -17.53 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.276 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.561 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 38.9 t70 -132.21 44.48 2.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.951 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.613 ' HD3' ' C ' ' A' ' 52' ' ' MET . 27.1 tptp -30.94 88.03 0.0 OUTLIER 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.5 p -128.7 18.94 6.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.469 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 71.32 17.12 75.81 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.725 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 51.0 m -151.69 128.03 10.61 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.949 -0.625 . . . . 0.0 110.723 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.86 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.7 mt -105.06 133.41 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 120.927 0.394 . . . . 0.0 110.67 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -105.49 167.75 9.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.325 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.568 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 14.9 t80 -35.82 -46.89 0.48 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.476 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.51 -54.07 7.98 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.65 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.744 ' HB2' HG23 ' A' ' 63' ' ' ILE . 48.5 mt-10 -53.25 -24.05 10.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.294 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.637 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 57.1 t80 -67.8 -60.41 2.54 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.505 0.669 . . . . 0.0 110.487 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 65' ' ' TYR . 8.5 mm -49.21 -49.27 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.813 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.42 -47.25 86.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.806 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.876 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.202 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.231 0.121 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 90.9 p -52.8 -34.85 55.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 110.12 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -82.22 -52.69 6.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.161 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.722 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 10.9 t80 -44.25 -26.43 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.056 0.455 . . . . 0.0 110.359 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 t -89.73 -47.69 7.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.66 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.466 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 1.0 OUTLIER -82.64 -62.75 1.52 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.378 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.0 m-85 -56.36 -64.62 0.8 Allowed 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.818 ' HA ' HG12 ' A' ' 99' ' ' ILE . 11.9 t0 -76.85 69.2 3.15 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 1.018 ' HD2' ' HD3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -44.43 -40.85 5.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.347 -177.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.3 m-20 -78.5 -21.35 49.05 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.889 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.62 -8.06 0.57 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.676 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 94' ' ' ASP . 72.2 p -55.37 -9.07 0.4 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 122.628 0.371 . . . . 0.0 111.203 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 134' ' ' ASP . . . 107.28 -6.54 36.6 Favored Glycine 0 C--O 1.216 -1.029 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.683 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -127.46 145.69 50.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.991 0.424 . . . . 0.0 112.01 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.818 HG12 ' HA ' ' A' ' 92' ' ' ASP . 65.5 mt -131.99 102.93 6.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.368 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 132' ' ' GLN . 44.0 p -76.27 152.84 36.37 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.257 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HB3' HG23 ' A' ' 122' ' ' ILE . 3.7 pp -35.47 -39.03 0.12 Allowed 'General case' 0 N--CA 1.461 0.125 0 O-C-N 123.194 0.309 . . . . 0.0 111.139 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -50.89 -57.08 9.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.147 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.607 ' HB2' HG23 ' A' ' 99' ' ' ILE . 50.4 mt-10 -63.82 -32.17 73.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.597 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.745 HG13 HG22 ' A' ' 99' ' ' ILE . 91.3 mt -70.36 -66.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 111.19 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.585 ' NE2' ' HA ' ' A' ' 119' ' ' ASP . 85.1 mt-30 -56.39 -35.76 68.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.289 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -55.69 -40.37 72.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.774 0.321 . . . . 0.0 110.543 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.54 -65.24 0.66 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.239 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.537 ' HB3' ' CG ' ' A' ' 111' ' ' PHE . 83.3 m -64.4 76.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.509 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.529 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 1.0 OUTLIER -88.8 -43.91 10.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.597 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -72.72 -4.68 32.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.721 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.537 ' CG ' ' HB3' ' A' ' 108' ' ' CYS . 1.2 m-85 -81.86 -1.17 46.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.775 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.18 37.2 94.13 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.598 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.72 ' O ' HD12 ' A' ' 113' ' ' LEU . 2.1 pp -34.06 144.5 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.674 0.75 . . . . 0.0 112.875 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 119' ' ' ASP . 11.2 p-10 -160.16 -164.06 1.22 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.986 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.686 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 2.8 p30 -87.73 -7.93 56.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.12 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.406 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 50.7 mm -89.45 -64.69 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.47 ' O ' ' HB2' ' A' ' 121' ' ' MET . 18.0 t-160 -92.06 -68.51 0.79 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 113' ' ' LEU . 2.2 mp -56.89 -20.31 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.686 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 38.8 t70 -79.71 -59.25 2.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' GLU . 1.2 m-20 -59.2 -17.24 25.99 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.758 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 22.4 ttp -59.72 -39.65 85.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.333 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.532 HG22 ' HA3' ' A' ' 131' ' ' GLY . 59.7 mt -54.69 -45.0 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -84.15 -13.6 52.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.98 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.758 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 15.9 tp10 -78.18 -27.8 48.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.894 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.767 HG21 ' CD1' ' A' ' 133' ' ' ILE . 22.6 mt -109.06 -7.87 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.818 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.619 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 28.0 t70 -73.78 81.34 1.59 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.112 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.573 ' OE1' ' HB3' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -87.54 -9.36 54.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.052 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 6.3 m-20 -119.87 -34.56 3.7 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.551 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 10.4 p-10 179.63 -80.89 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 118.438 2.755 . . . . 0.0 118.438 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.832 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 5.7 t70 -64.32 -17.68 63.91 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 118.813 2.894 . . . . 0.0 118.813 -171.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.619 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 92.15 37.13 6.05 Favored Glycine 0 CA--C 1.501 -0.836 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.832 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 3.2 pt20 -139.15 166.53 24.28 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 112.729 -1.735 . . . . 0.0 108.957 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.767 ' CD1' HG21 ' A' ' 125' ' ' ILE . 48.0 mt -123.29 128.32 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 121.441 0.638 . . . . 0.0 110.805 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.843 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 1.5 t70 -104.16 157.9 16.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.476 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.722 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 18.9 t80 -39.33 -46.24 1.56 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.376 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.91 -44.01 80.68 Favored Glycine 0 N--CA 1.422 -2.279 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.303 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.843 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 27.8 mt-10 -55.88 -62.23 1.84 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.413 -0.394 . . . . 0.0 110.143 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.514 ' HD1' HG21 ' A' ' 133' ' ' ILE . 2.5 t80 -55.3 -30.16 59.63 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.943 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.88 -26.36 59.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.339 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.71 -51.23 5.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.851 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -57.72 -12.65 3.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.925 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 C--N 1.332 -0.172 0 CA-C-O 120.683 0.278 . . . . 0.0 110.836 179.741 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 95.7 mt . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.457 0.17 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.642 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 62.2 tttp -57.51 -43.83 84.55 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.665 ' O ' ' HG2' ' A' ' 18' ' ' MET . 44.8 tt0 -71.75 -47.97 50.03 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.725 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 28.2 tp -48.85 -29.01 4.15 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.55 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.488 ' CZ ' ' N ' ' A' ' 65' ' ' TYR . 15.3 t80 -64.87 -51.67 60.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.581 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.553 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.6 ptpt -77.79 -12.77 60.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.05 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 56.8 mmm -68.19 -24.05 64.91 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.491 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.705 HD12 HD13 ' A' ' 27' ' ' ILE . 4.0 mt -83.73 -52.0 13.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.162 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.701 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -80.73 51.84 1.58 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.436 0.636 . . . . 0.0 112.378 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -79.59 -6.31 56.79 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.558 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -111.28 -27.9 8.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.611 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.403 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -87.49 -91.19 0.11 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.889 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.403 ' H ' ' HB3' ' A' ' 23' ' ' ASN . 74.9 m -176.06 21.73 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.261 0.351 . . . . 0.0 110.988 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.451 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 111.18 24.8 5.29 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.529 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.701 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 78.6 p -140.39 142.13 35.51 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.166 0.508 . . . . 0.0 110.218 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.794 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.6 mt -102.95 102.96 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.816 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.746 HG22 ' OG1' ' A' ' 62' ' ' THR . 79.7 p -103.6 165.04 11.28 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.197 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.563 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 52.9 t80 -34.36 -33.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.723 0.64 . . . . 0.0 111.864 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . 33.2 t70 -76.91 -47.58 20.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.955 0.407 . . . . 0.0 110.695 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 20' ' ' ASP . 25.1 mp0 -73.07 -25.09 60.78 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.235 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.827 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -48.73 -51.45 28.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.464 0.649 . . . . 0.0 109.792 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.662 ' HB2' ' HE2' ' A' ' 37' ' ' LYS . 6.9 ptpp? -82.45 -40.32 21.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.898 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.408 ' CB ' ' HA ' ' A' ' 31' ' ' GLU . 9.8 t70 -39.06 -62.11 0.68 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.088 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -50.76 -37.22 34.33 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.211 -0.518 . . . . 0.0 113.984 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.624 ' O ' HG12 ' A' ' 39' ' ' VAL . 49.5 mt -79.67 -58.42 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.34 0.57 . . . . 0.0 111.759 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.662 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -54.93 -17.65 3.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.247 0.546 . . . . 0.0 109.668 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.3 ttt85 -77.37 -42.83 35.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.545 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.624 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -70.89 -1.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.161 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.92 5.71 33.01 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.45 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 74.5 m -81.9 166.46 19.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.79 0.329 . . . . 0.0 111.151 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -138.9 104.68 5.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.816 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.4 mt -128.68 166.09 19.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.407 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.577 ' O ' HD13 ' A' ' 48' ' ' ILE . 23.1 mtp -107.34 161.68 14.59 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HG2' ' HE2' ' A' ' 33' ' ' LYS . 37.1 mt-10 -55.64 -60.28 3.66 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.503 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.464 ' HB2' ' HZ ' ' A' ' 111' ' ' PHE . 41.2 t -43.24 -29.07 0.36 Allowed 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.8 mm-40 -72.98 -42.36 63.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.265 0.555 . . . . 0.0 110.037 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.827 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -55.57 -56.82 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.756 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.597 ' HE2' ' CE1' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -47.53 -28.25 2.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.764 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HA ' ' NZ ' ' A' ' 49' ' ' LYS . 63.8 t0 -75.29 -54.93 6.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.601 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.504 HD23 HD11 ' A' ' 32' ' ' LEU . 36.4 tp -53.89 -37.66 63.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.236 0.541 . . . . 0.0 111.058 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.632 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 33.8 ttm -74.36 -66.35 0.74 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.331 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.671 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -54.48 -26.21 29.92 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.764 -178.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.68 -41.09 15.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -100.3 -43.39 6.29 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 59' ' ' LYS . 60.5 t0 -46.37 98.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 110.144 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.433 HD11 ' HB1' ' A' ' 70' ' ' ALA . 17.4 mm -54.14 -19.64 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.243 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.583 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 62.0 m-20 -131.35 44.47 2.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.872 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.671 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 21.8 tptm -32.27 92.04 0.01 OUTLIER 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 58' ' ' ASP . 49.0 m -127.71 18.44 6.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.404 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.632 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 70.08 23.46 77.14 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.47 -178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 28' ' ' THR . 42.5 m -159.72 129.97 5.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.797 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.794 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 75.8 mt -108.19 130.13 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.962 0.411 . . . . 0.0 111.511 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -104.87 167.61 9.6 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.085 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.642 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 28.9 t80 -35.22 -47.3 0.39 Allowed 'General case' 0 CA--C 1.52 -0.182 0 O-C-N 123.446 0.466 . . . . 0.0 111.731 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.98 -56.66 10.2 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.361 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.659 ' HB2' HG23 ' A' ' 63' ' ' ILE . 71.4 mt-10 -54.75 -22.66 14.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 110.692 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 64.9 t80 -68.32 -64.31 0.89 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.623 0.725 . . . . 0.0 110.905 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.578 HD13 ' HD2' ' A' ' 68' ' ' PHE . 7.9 mm -52.39 -41.79 36.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.613 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -56.75 -32.98 66.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.143 0.497 . . . . 0.0 110.803 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.23 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.234 0.255 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 79.2 p -43.32 -45.28 5.91 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.975 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.405 ' C ' ' N ' ' A' ' 89' ' ' SER . . . -90.14 -38.57 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.712 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.719 ' HZ ' ' HA2' ' A' ' 97' ' ' GLY . 8.6 t80 -44.33 -24.15 0.15 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.269 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 87' ' ' ALA . 47.7 t -89.05 -45.38 9.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.898 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -81.69 -63.68 1.34 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.365 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.597 ' CE1' ' HE2' ' A' ' 49' ' ' LYS . 4.0 m-85 -56.44 -64.41 0.88 Allowed 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.733 ' HA ' HG12 ' A' ' 99' ' ' ILE . 61.8 t0 -76.78 67.4 2.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -55.85 -25.72 43.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.397 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -84.18 -20.69 31.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 39.22 67.3 0.61 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.1 p -122.87 -19.12 6.26 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.719 ' HA2' ' HZ ' ' A' ' 88' ' ' PHE . . . 123.37 -3.14 9.59 Favored Glycine 0 N--CA 1.434 -1.443 0 CA-C-N 113.435 -1.711 . . . . 0.0 112.379 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.791 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -136.05 151.92 50.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.363 0.601 . . . . 0.0 111.702 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.751 HG23 ' HB2' ' A' ' 103' ' ' GLU . 83.0 mt -130.95 102.78 6.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.054 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 101' ' ' LEU . 51.2 p -79.81 151.46 30.28 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.694 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -34.29 -34.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.022 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.97 -54.98 31.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.904 0.383 . . . . 0.0 110.527 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.751 ' HB2' HG23 ' A' ' 99' ' ' ILE . 51.3 mt-10 -65.75 -28.68 69.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.185 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.747 HG13 HG22 ' A' ' 99' ' ' ILE . 72.8 mt -72.42 -65.38 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 111.004 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.818 ' NE2' HD11 ' A' ' 122' ' ' ILE . 2.4 mm-40 -47.65 -45.2 27.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.139 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -64.13 -42.92 96.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.468 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.87 -4.54 32.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 105' ' ' GLN . 26.5 p -124.04 91.4 3.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.069 0.462 . . . . 0.0 111.385 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -88.44 -50.78 6.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.326 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.91 -17.75 62.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.517 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.577 ' HB2' ' HB2' ' A' ' 108' ' ' CYS . 3.7 m-85 -63.92 -11.32 27.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.627 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.41 34.79 24.89 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.3 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.731 ' CD2' HG21 ' A' ' 118' ' ' ILE . 0.5 OUTLIER -35.52 109.94 0.09 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.24 0.543 . . . . 0.0 111.508 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.733 ' O ' HG22 ' A' ' 118' ' ' ILE . 38.4 t70 -160.96 138.54 9.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.334 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -50.81 -9.49 0.05 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 73.4 mt -89.44 -59.55 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.644 0.259 . . . . 0.0 111.648 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -91.07 -59.41 2.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 111.622 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.8 HG23 ' NE2' ' A' ' 105' ' ' GLN . 3.6 tp -48.47 -28.25 2.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.64 -51.52 58.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.874 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 124' ' ' GLU . 7.7 t70 -56.45 -29.23 61.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 1.03 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 6.6 ttt -66.79 -39.64 87.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.661 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.818 HD11 ' NE2' ' A' ' 105' ' ' GLN . 33.1 mm -56.97 -43.06 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.681 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -83.78 -13.3 54.18 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.632 178.304 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 1.03 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 31.1 tt0 -87.65 -17.03 32.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.43 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.839 HG21 HD11 ' A' ' 133' ' ' ILE . 14.9 mm -115.96 -32.13 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.558 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 131' ' ' GLY . 2.7 t70 -75.5 92.11 2.85 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.685 ' NE2' ' H ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -86.02 -8.71 57.75 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.909 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.413 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 20.1 m-20 -111.86 -33.71 6.22 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.618 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.32 -86.34 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 117.603 2.445 . . . . 0.0 117.603 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.749 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 22.0 m-20 -64.65 26.06 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -172.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.559 ' CA ' HG22 ' A' ' 122' ' ' ILE . . . 55.51 37.51 67.26 Favored Glycine 0 CA--C 1.505 -0.574 0 C-N-CA 117.917 -2.087 . . . . 0.0 109.192 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.791 ' NE2' ' HB3' ' A' ' 98' ' ' TYR . 8.7 pt20 -136.3 168.95 18.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.074 -1.063 . . . . 0.0 110.384 -177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.839 HD11 HG21 ' A' ' 125' ' ' ILE . 60.0 mt -123.45 129.49 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.614 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.824 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 30.3 t70 -101.81 158.55 16.03 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.027 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.67 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 4.9 t80 -45.39 -32.54 2.13 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.913 0.387 . . . . 0.0 110.721 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.59 -38.15 17.99 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.071 -1.061 . . . . 0.0 110.729 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.824 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 30.8 mt-10 -59.98 -57.79 11.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.803 -0.198 . . . . 0.0 110.8 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.575 ' HD1' HD13 ' A' ' 133' ' ' ILE . 2.6 t80 -58.89 -26.77 64.6 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.527 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.7 -36.68 37.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.002 0.429 . . . . 0.0 110.836 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -90.0 -14.22 34.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.033 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -57.34 -18.53 17.56 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.486 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 24.4 ptt? . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.083 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.798 HD12 HD23 ' A' ' 15' ' ' LEU . 53.9 tp . . . . . 0 N--CA 1.461 0.109 0 CA-C-O 120.469 0.176 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.625 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 24.0 pttm -66.36 -32.11 73.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 82.2 tt0 -78.18 -36.85 46.9 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.798 HD23 HD12 ' A' ' 12' ' ' LEU . 52.3 tp -53.87 -42.57 68.75 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.366 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.54 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 10.9 t80 -51.69 -45.06 63.34 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.443 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 65.3 pttt -85.06 -12.45 53.03 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.9 ttp -85.55 -13.76 47.95 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.614 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.791 HG23 ' HA3' ' A' ' 35' ' ' GLY . 22.4 mm -74.92 -52.44 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.726 ' HB2' ' HB3' ' A' ' 23' ' ' ASN . 4.4 p-10 -81.93 50.6 1.57 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.033 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.828 HG21 ' HD2' ' A' ' 38' ' ' ARG . 13.0 t -61.97 -6.82 3.12 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.877 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -133.94 -10.88 2.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.979 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.726 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 30.9 t30 -87.49 -95.83 0.09 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.2 p -177.72 12.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 111.59 24.37 5.32 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.948 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.498 ' OG1' ' ND2' ' A' ' 23' ' ' ASN . 40.6 p -147.62 144.23 28.26 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.992 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 6.9 mt -104.02 104.84 17.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 68.8 p -102.21 163.52 12.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.704 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.743 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 49.2 t80 -34.28 -37.32 0.05 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.86 -45.75 40.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.92 0.39 . . . . 0.0 111.167 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -78.56 -13.83 59.63 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.719 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.01 HD13 HG23 ' A' ' 48' ' ' ILE . 6.2 tt -53.05 -49.01 67.2 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.65 ' HD3' ' NZ ' ' A' ' 37' ' ' LYS . 4.0 ptpp? -84.75 -41.17 16.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.491 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.552 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 17.9 t70 -47.57 -30.29 3.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.048 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.791 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -65.03 -40.31 96.99 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.888 -0.673 . . . . 0.0 113.351 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 36' ' ' LEU . 1.3 mm? -91.99 -33.15 14.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.324 0.583 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.65 ' NZ ' ' HD3' ' A' ' 33' ' ' LYS . 76.5 mttt -60.94 -45.8 93.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.698 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.828 ' HD2' HG21 ' A' ' 21' ' ' THR . 46.9 ttt-85 -69.77 -40.74 75.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.62 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 36' ' ' LEU . 8.2 p -71.13 -14.25 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.48 54.86 0.3 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.121 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 70.1 m -146.0 166.98 24.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.605 0.24 . . . . 0.0 110.483 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 23.2 pt-20 -137.29 114.67 10.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 111.378 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.41 ' HB2' HD11 ' A' ' 48' ' ' ILE . 36.4 mt -125.13 165.58 17.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.272 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.614 ' O ' HD13 ' A' ' 48' ' ' ILE . 20.4 mtm -113.41 164.41 13.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -64.98 0.65 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.154 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 89.1 p -39.78 -26.81 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 93.9 mt-10 -79.22 -49.72 12.08 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.01 HG23 HD13 ' A' ' 32' ' ' LEU . 1.7 mp -52.99 -60.86 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.591 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.743 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 51.6 tttp -57.05 -22.79 41.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.889 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 36.8 t70 -76.62 -44.58 33.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 tt -63.44 -44.76 93.62 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 111.092 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.733 ' HB2' HD11 ' A' ' 32' ' ' LEU . 37.3 ttm -66.6 -64.09 0.93 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.249 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.665 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 9.6 t70 -55.88 -29.29 59.72 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.05 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -88.58 -36.64 16.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -103.23 -41.65 5.99 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.545 ' OD1' HG12 ' A' ' 63' ' ' ILE . 15.8 t70 -50.94 95.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.937 0.399 . . . . 0.0 110.188 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.415 ' H ' HG12 ' A' ' 57' ' ' ILE . 27.9 mm -51.49 -18.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.551 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.524 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.2 m-20 -131.05 43.91 3.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.174 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.665 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 28.1 tptp -32.53 89.65 0.0 OUTLIER 'General case' 0 C--O 1.231 0.117 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 58' ' ' ASP . 87.7 p -127.85 18.21 6.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.519 -1.218 . . . . 0.0 109.02 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.522 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 76.34 22.63 72.82 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.087 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 91.1 m -147.54 153.84 39.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.243 0.617 . . . . 0.0 109.597 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.992 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 71.7 mt -135.16 127.53 47.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.995 0.426 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -104.6 167.52 9.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.492 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.625 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 41.2 t80 -35.41 -44.71 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.558 0.536 . . . . 0.0 111.663 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.04 -60.63 5.48 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.197 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.567 ' HB2' HG23 ' A' ' 63' ' ' ILE . 40.9 mt-10 -53.88 -21.83 8.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.851 0.358 . . . . 0.0 110.945 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 26.2 t80 -67.77 -65.11 0.73 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.501 0.667 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 65' ' ' TYR . 10.5 mm -52.44 -43.09 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.583 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.63 -39.44 73.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.47 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.361 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 CA--C 1.53 0.187 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -38.43 -49.23 1.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.264 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -71.89 -50.17 31.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.499 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.779 ' HE1' ' HB2' ' A' ' 135' ' ' TYR . 11.5 t80 -36.23 -33.55 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.492 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 87' ' ' ALA . 29.5 t -89.67 -50.69 5.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.728 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.66 -64.21 1.24 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.165 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.602 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 5.0 m-85 -58.93 -59.9 4.71 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.756 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 1.2 m-20 -75.68 57.65 1.01 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -52.06 -41.15 62.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.701 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -67.87 -20.9 65.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 42.49 64.32 1.62 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.474 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 54.5 p -119.48 -35.32 3.59 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.39 4.1 0.81 Allowed Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.337 -1.756 . . . . 0.0 112.873 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.878 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.3 OUTLIER -152.67 165.64 34.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.494 0.664 . . . . 0.0 112.072 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.817 HG23 ' HB2' ' A' ' 103' ' ' GLU . 91.4 mt -132.35 104.08 7.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.14 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 102' ' ' ASP . 50.5 p -76.09 149.27 37.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.7 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -34.57 -33.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 100' ' ' THR . 1.5 m-20 -57.69 -52.34 65.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.85 0.357 . . . . 0.0 110.276 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.817 ' HB2' HG23 ' A' ' 99' ' ' ILE . 49.3 mt-10 -67.83 -28.39 67.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.543 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.67 HG22 ' OE1' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -70.2 -62.12 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.575 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.709 HE22 HG22 ' A' ' 118' ' ' ILE . 4.7 mm100 -53.66 -38.28 63.98 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.898 0.38 . . . . 0.0 110.49 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -61.81 -59.22 5.48 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.96 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.75 -10.77 13.95 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.198 0.523 . . . . 0.0 110.558 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 31.3 t -100.59 63.44 1.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.737 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.472 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 1.2 tmtp? -85.82 -61.08 1.84 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -57.89 -5.39 0.41 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.578 ' HB2' ' SG ' ' A' ' 108' ' ' CYS . 33.3 m-85 -90.75 7.68 38.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.53 37.05 94.07 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.633 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.989 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -33.67 125.94 0.41 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.317 0.58 . . . . 0.0 112.202 -178.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.681 ' N ' HD22 ' A' ' 113' ' ' LEU . 10.1 t70 -160.65 159.44 30.37 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.681 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 1.4 m-20 -71.74 -6.92 44.85 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.0 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.724 HG13 ' H ' ' A' ' 117' ' ' HIS . 14.0 pt -77.87 -64.6 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.724 ' H ' HG13 ' A' ' 116' ' ' ILE . 13.0 m-70 -92.01 -61.97 1.51 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.09 0.472 . . . . 0.0 111.417 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.989 HG13 ' HA ' ' A' ' 113' ' ' LEU . 13.2 mm -45.16 -36.17 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.11 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.2 -48.28 62.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.946 0.403 . . . . 0.0 110.025 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 124' ' ' GLU . 61.8 t0 -67.59 -27.66 67.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.564 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 1.091 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.0 ttt -62.87 -40.28 97.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.487 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.703 HG22 ' HA3' ' A' ' 131' ' ' GLY . 48.1 mt -53.52 -44.4 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 123' ' ' LYS . 24.3 mmtp -85.18 -13.46 49.96 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.17 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 1.091 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 24.3 tt0 -87.95 -13.52 41.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.497 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.843 ' O ' HD11 ' A' ' 133' ' ' ILE . 81.3 mt -117.31 -23.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.759 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.925 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 22.0 t70 -65.25 101.68 0.58 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.566 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.795 ' NE2' ' HA ' ' A' ' 137' ' ' GLU . 18.8 mt-30 -88.05 -18.44 28.92 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -119.39 -34.63 3.77 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.758 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 178.92 -73.28 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.758 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 1.2 m-20 -64.2 20.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.925 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.31 38.18 67.69 Favored Glycine 0 CA--C 1.5 -0.88 0 C-N-CA 117.48 -2.295 . . . . 0.0 108.075 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.52 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 6.8 pt20 -131.68 167.12 20.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.628 -1.286 . . . . 0.0 109.055 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.843 HD11 ' O ' ' A' ' 125' ' ' ILE . 11.0 mm -134.18 124.99 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.326 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.878 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 2.4 p-10 -102.42 161.25 13.86 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.779 ' HB2' ' HE1' ' A' ' 88' ' ' PHE . 12.0 t80 -41.07 -32.63 0.26 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.812 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.88 -46.43 10.82 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.642 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.795 ' HA ' ' NE2' ' A' ' 127' ' ' GLN . 33.5 mt-10 -54.41 -59.85 4.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.367 -0.416 . . . . 0.0 111.347 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.505 ' N ' HG23 ' A' ' 133' ' ' ILE . 3.6 t80 -57.56 -29.9 64.8 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.92 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.51 -20.06 48.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.074 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.538 ' HB3' HE22 ' A' ' 127' ' ' GLN . . . -89.84 -49.01 6.87 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.085 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.633 ' SD ' HG23 ' A' ' 125' ' ' ILE . 28.0 ptm -55.41 -16.46 3.67 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.35 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 56.0 ttp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.631 179.889 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.679 HD12 HD23 ' A' ' 15' ' ' LEU . 50.0 tp . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 120.667 0.27 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 33.9 mtmm -56.94 -46.68 81.92 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.637 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -68.48 -34.52 76.07 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.679 HD23 HD12 ' A' ' 12' ' ' LEU . 45.2 tp -59.52 -28.7 67.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.169 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.437 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 13.1 t80 -67.47 -38.98 85.22 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.016 0.436 . . . . 0.0 110.971 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.637 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 61.7 pttt -86.63 -19.82 28.75 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.629 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -63.44 -27.2 69.13 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.491 176.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.717 HG21 HD13 ' A' ' 27' ' ' ILE . 18.7 mm -70.61 -59.65 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.212 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -78.59 89.79 4.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.3 178.077 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.5 t -88.27 -34.71 17.61 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.525 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -139.83 16.7 2.49 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.534 ' HB2' ' OE1' ' A' ' 31' ' ' GLU . 3.5 m120 -92.44 -88.65 0.2 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.947 0.794 . . . . 0.0 112.89 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -164.95 -1.55 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.468 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 110.75 20.53 7.22 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.412 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 75.4 p -128.09 166.43 18.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.881 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 6.1 mt -123.14 101.53 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.083 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.553 HG22 ' HB ' ' A' ' 62' ' ' THR . 67.5 p -103.56 164.98 11.31 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.704 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -33.72 -39.21 0.06 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.839 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.676 ' OD1' ' HG3' ' A' ' 31' ' ' GLU . 1.8 p30 -73.05 -43.69 61.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.64 0.257 . . . . 0.0 111.281 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.676 ' HG3' ' OD1' ' A' ' 30' ' ' ASP . 42.4 mt-10 -74.68 -24.07 58.73 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 110.265 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.751 ' HG ' HD23 ' A' ' 51' ' ' LEU . 6.3 tt -54.43 -54.24 43.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.87 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.718 ' HG3' ' H ' ' A' ' 34' ' ' ASP . 17.0 ptpt -75.97 -62.31 1.64 Allowed 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.466 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.718 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 35.9 t70 -37.59 -48.55 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.498 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . -48.85 -54.44 14.18 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.98 -0.555 . . . . 0.0 113.858 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.634 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -89.8 -45.94 8.93 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.216 0.531 . . . . 0.0 110.144 -179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -17.21 0.56 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.079 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 32.0 ttm-85 -59.66 -43.22 94.01 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.778 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 36' ' ' LEU . 34.3 m -78.53 31.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.98 -22.66 24.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.752 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.7 m -53.46 154.44 3.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.648 0.261 . . . . 0.0 110.648 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.09 118.18 9.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 111.432 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 mt -119.67 165.77 14.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.481 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.665 ' SD ' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -105.02 152.92 22.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -42.46 -56.05 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.665 ' HB2' ' SD ' ' A' ' 44' ' ' MET . 52.3 m -54.7 -21.66 11.46 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 119.236 0.925 . . . . 0.0 111.888 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.524 ' HG3' ' HE2' ' A' ' 44' ' ' MET . 38.2 mt-10 -74.57 -44.54 50.42 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.704 HG23 HD13 ' A' ' 32' ' ' LEU . 2.0 mp -58.17 -53.31 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.119 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.61 ' HE2' ' HE1' ' A' ' 91' ' ' PHE . 10.5 ttpp -52.92 -30.27 33.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.459 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.556 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 8.8 t70 -62.96 -50.09 72.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.379 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.751 HD23 ' HG ' ' A' ' 32' ' ' LEU . 41.1 tp -60.63 -14.88 23.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.694 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.939 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 13.4 mmt -88.13 -65.84 0.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -78.94 -32.95 45.72 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.939 -0.475 . . . . 0.0 111.726 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -87.46 -18.32 30.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.662 ' HB3' HD12 ' A' ' 51' ' ' LEU . . . -127.09 -43.57 1.65 Allowed 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.647 ' OD1' HG12 ' A' ' 63' ' ' ILE . 21.2 t70 -59.91 96.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.784 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 57' ' ' ILE . 26.5 mm -46.26 -25.63 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.866 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.527 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.7 m-20 -129.63 44.09 3.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.27 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.939 ' HD3' ' HB3' ' A' ' 52' ' ' MET . 51.4 tptt -33.27 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.046 0.927 . . . . 0.0 113.347 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.7 p -127.29 9.56 6.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.77 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 97.85 -5.7 61.94 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.517 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.844 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 3.0 t -141.11 165.01 28.72 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.062 0.458 . . . . 0.0 110.681 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.881 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 98.4 mt -125.81 135.38 64.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.33 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.89 166.21 10.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.649 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.653 ' O ' HG12 ' A' ' 69' ' ' ILE . 51.3 t80 -36.31 -46.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.733 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.55 -63.84 4.0 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.441 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.731 ' HB2' HG23 ' A' ' 63' ' ' ILE . 40.9 mt-10 -49.86 -29.2 7.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.739 0.304 . . . . 0.0 111.473 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.522 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 34.1 t80 -65.83 -62.63 1.4 Allowed 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.364 0.602 . . . . 0.0 111.16 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.653 HG12 ' O ' ' A' ' 65' ' ' TYR . 19.8 mm -53.32 -48.38 56.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.692 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.45 -41.16 84.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.922 0.392 . . . . 0.0 110.905 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.26 -179.915 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 88' ' ' PHE . 7.3 p . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.598 0.237 . . . . 0.0 111.456 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.645 ' HB3' ' HE3' ' A' ' 44' ' ' MET . 48.3 t -41.75 -62.66 0.85 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.271 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 138' ' ' PHE . . . -73.41 -36.08 65.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.463 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.799 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 2.8 t80 -45.72 -25.74 0.53 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.413 0.625 . . . . 0.0 109.65 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.7 t -89.62 -43.56 10.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.863 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -87.07 -64.45 1.15 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.82 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.61 ' HE1' ' HE2' ' A' ' 49' ' ' LYS . 2.8 m-85 -56.26 -59.99 4.15 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.799 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 1.6 m-20 -78.73 55.66 1.73 Allowed 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -51.16 -41.66 60.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.697 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.56 -20.61 65.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 43.74 65.06 1.67 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.276 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.9 p -119.08 -33.79 4.06 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 147.8 -37.08 1.12 Allowed Glycine 0 N--CA 1.433 -1.53 0 CA-C-N 112.786 -2.006 . . . . 0.0 112.196 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.893 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.2 OUTLIER -109.45 164.88 12.1 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.843 HG22 HG13 ' A' ' 104' ' ' ILE . 77.8 mt -132.6 103.54 6.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.231 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 102' ' ' ASP . 44.4 p -72.2 146.09 47.57 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -34.64 -32.95 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 100' ' ' THR . 45.4 t0 -55.47 -56.38 20.89 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.697 ' HB2' HG23 ' A' ' 99' ' ' ILE . 51.8 mt-10 -66.03 -28.34 68.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.825 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.843 HG13 HG22 ' A' ' 99' ' ' ILE . 78.9 mt -69.57 -65.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.031 0.443 . . . . 0.0 111.247 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.875 ' NE2' HG22 ' A' ' 118' ' ' ILE . 6.6 mm100 -50.09 -51.87 39.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.596 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.482 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 70.1 mt-30 -64.49 -24.68 67.69 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.48 -6.86 58.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 72.2 m -123.78 68.57 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.867 0.365 . . . . 0.0 111.391 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 106' ' ' GLN . 74.6 mmtt -84.03 -32.09 25.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.584 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -83.21 -4.86 58.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.596 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 0.9 OUTLIER -93.46 16.33 13.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.359 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.05 36.82 45.14 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.602 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.883 ' HA ' HG13 ' A' ' 118' ' ' ILE . 3.1 tm? -34.36 110.0 0.09 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.969 0.414 . . . . 0.0 111.323 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.446 ' OD2' ' HB ' ' A' ' 116' ' ' ILE . 12.1 p-10 -160.12 -176.07 5.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.734 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.589 ' HA ' ' CG ' ' A' ' 119' ' ' ASP . 2.8 p30 -89.48 -8.94 51.82 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.446 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 60.5 mt -81.8 -64.6 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.914 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -91.61 -68.9 0.77 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.883 HG13 ' HA ' ' A' ' 113' ' ' LEU . 31.4 mm -40.52 -36.56 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.589 ' CG ' ' HA ' ' A' ' 115' ' ' ASP . 42.2 m-20 -71.2 -52.4 19.3 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 122.139 -0.351 . . . . 0.0 110.86 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 124' ' ' GLU . 32.4 m-20 -57.59 -23.62 51.78 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.992 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.5 ttt -65.39 -36.27 83.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.746 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.528 HG22 ' HA3' ' A' ' 131' ' ' GLY . 52.8 mt -57.06 -45.89 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.824 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 10.6 mmpt? -83.57 -13.19 54.99 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.57 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.992 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 29.8 tt0 -87.97 -19.21 27.53 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.458 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.907 HG21 HD11 ' A' ' 133' ' ' ILE . 63.9 mt -107.59 -50.52 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.89 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.562 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 5.4 p-10 -46.76 100.1 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.858 0.837 . . . . 0.0 110.697 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.776 ' NE2' ' H ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -87.3 -9.9 53.72 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.996 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 53.7 p30 -117.05 -33.19 4.8 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.713 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.43 -81.4 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.713 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 59.0 m-20 -64.51 22.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 -172.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' A' ' 126' ' ' ASP . . . 56.37 38.29 78.33 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 117.219 -2.419 . . . . 0.0 109.414 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.563 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 12.1 pt20 -132.0 167.29 19.92 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.362 -0.919 . . . . 0.0 111.722 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.907 HD11 HG21 ' A' ' 125' ' ' ILE . 15.3 mt -125.67 116.15 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.549 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.893 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 38.6 t70 -104.8 161.78 13.87 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.574 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.631 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 37.0 t80 -40.28 -32.81 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -82.22 -41.41 9.35 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.677 ' CG ' HE22 ' A' ' 127' ' ' GLN . 26.3 mt-10 -62.39 -53.28 57.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 29.0 t80 -52.3 -31.69 34.14 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.284 0.564 . . . . 0.0 109.649 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -68.27 -23.91 64.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.975 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.94 -52.93 4.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.29 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 138' ' ' PHE . 5.2 ppp? -51.35 -22.57 2.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.447 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 36.9 ttm . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.761 178.579 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.538 0.209 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.637 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 6.4 ttpm? -55.74 -30.92 62.03 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.752 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 8.1 mp0 -77.0 -38.26 53.43 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.968 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.748 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 54.5 tp -55.04 -28.12 49.78 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.664 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -70.54 -45.11 66.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.787 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.752 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 63.5 pttt -82.46 -12.46 57.82 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.58 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.45 -25.86 68.21 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.429 178.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.555 HG23 ' HA3' ' A' ' 35' ' ' GLY . 3.3 mt -86.4 -59.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.53 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.607 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.9 OUTLIER -82.68 57.37 3.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.391 0.615 . . . . 0.0 110.523 179.349 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.67 HG21 ' NH2' ' A' ' 38' ' ' ARG . 13.6 t -81.26 -6.66 59.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.17 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -129.21 -14.65 4.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.58 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -74.38 -87.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.832 0.348 . . . . 0.0 111.197 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 p -176.67 6.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.811 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.542 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.44 31.47 2.79 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.607 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 45.8 p -150.07 145.79 26.58 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.192 -0.504 . . . . 0.0 109.938 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.811 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.2 mt -102.85 103.87 15.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.632 HG22 ' OG1' ' A' ' 62' ' ' THR . 67.3 p -103.37 164.83 11.4 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.445 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.561 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 20.4 t80 -34.06 -36.44 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.72 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.15 -49.88 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.715 0.293 . . . . 0.0 111.676 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.637 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -75.7 -19.9 58.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.939 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.871 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -46.03 -47.4 16.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.893 0.854 . . . . 0.0 108.707 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.719 ' HG2' HG12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -85.38 -51.9 6.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.488 179.215 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.637 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 59.4 m-20 -36.34 -36.17 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.555 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -68.02 -57.32 8.79 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 115.124 0.81 . . . . 0.0 115.124 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -73.86 -28.53 61.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.195 0.997 . . . . 0.0 111.983 -177.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.657 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 19.3 ptpt -66.18 -4.67 8.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.67 ' NH2' HG21 ' A' ' 21' ' ' THR . 36.9 ttm180 -87.12 -42.72 12.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.278 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 36' ' ' LEU . 30.8 m -73.45 -0.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.75 -36.86 3.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.361 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.606 ' CB ' HD23 ' A' ' 36' ' ' LEU . 18.5 m -52.45 153.01 3.19 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.565 -0.161 . . . . 0.0 110.565 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -143.31 103.76 4.17 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.285 0.564 . . . . 0.0 112.153 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -105.36 167.97 9.38 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.125 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 5.3 mtm -104.62 165.54 11.0 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.53 ' HA ' HD13 ' A' ' 48' ' ' ILE . 92.8 mt-10 -47.68 -60.04 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.51 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 94.9 p -39.42 -35.0 0.24 Allowed 'General case' 0 C--N 1.335 -0.047 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 44' ' ' MET . 37.1 mp0 -66.42 -41.02 89.87 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.055 0.455 . . . . 0.0 110.15 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.871 HG13 HD12 ' A' ' 32' ' ' LEU . 2.0 mp -57.02 -60.58 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.958 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.561 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 42.3 tttm -64.34 -25.66 68.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.353 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 46' ' ' SER . 62.6 t0 -71.12 -37.46 72.32 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.654 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.53 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 10.2 tt -76.34 -23.04 54.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.049 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.751 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 18.1 mmt -71.92 -45.01 62.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.058 0.456 . . . . 0.0 111.468 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.51 -30.27 20.72 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.716 -0.394 . . . . 0.0 112.01 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.53 -19.36 22.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.04 -43.75 1.65 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.751 ' HB3' ' O ' ' A' ' 52' ' ' MET . 15.6 t0 -61.24 95.96 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.2 mm -48.62 -22.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.044 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 59.1 t0 -129.13 44.49 2.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.864 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.734 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.5 tmtm? -32.58 90.43 0.0 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.741 0.781 . . . . 0.0 112.659 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.3 p -127.72 17.98 6.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.184 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 70.92 17.76 75.66 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.428 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 85.9 m -150.35 127.1 10.97 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 123.779 0.341 . . . . 0.0 110.58 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.811 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 70.3 mt -108.02 129.43 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 121.058 0.456 . . . . 0.0 111.399 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -105.04 167.3 9.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.076 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.637 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 48.1 t80 -35.47 -45.81 0.36 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.486 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.4 -63.71 4.11 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.322 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.797 ' HB2' HG23 ' A' ' 63' ' ' ILE . 63.0 mt-10 -51.89 -26.15 9.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.684 0.278 . . . . 0.0 110.894 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.748 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 71.7 t80 -63.88 -65.12 0.72 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.431 0.634 . . . . 0.0 110.91 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.602 HD13 ' HD2' ' A' ' 68' ' ' PHE . 14.5 mm -52.2 -41.13 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.659 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.2 -25.77 66.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.47 . . . . 0.0 110.572 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.028 179.768 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 14.4 p . . . . . 0 C--O 1.233 0.187 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 52.3 m -51.11 -55.01 19.88 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.921 0.391 . . . . 0.0 110.118 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.583 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -81.12 -39.81 25.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.913 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.823 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 8.1 t80 -45.98 -23.01 0.25 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.358 0.599 . . . . 0.0 110.041 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 87' ' ' ALA . 28.4 t -89.15 -44.81 10.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.737 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -89.29 -63.7 1.25 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.601 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.5 m-85 -51.97 -62.33 1.7 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.823 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.6 OUTLIER -76.13 55.31 0.93 Allowed 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -44.59 -52.88 7.69 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.42 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.4 -21.44 64.69 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.344 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.08 68.69 1.07 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.5 p -115.59 -23.04 8.93 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.599 ' O ' ' HB2' ' A' ' 134' ' ' ASP . . . 130.51 -4.51 5.86 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-N 113.136 -1.847 . . . . 0.0 112.604 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.859 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.5 OUTLIER -148.69 161.83 40.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.399 0.618 . . . . 0.0 112.649 179.437 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.791 HG12 ' HA ' ' A' ' 92' ' ' ASP . 22.1 mt -133.12 104.24 6.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.779 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 102' ' ' ASP . 69.5 p -72.29 147.11 46.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.671 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.1 pp -34.41 -33.97 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.528 ' N ' HD12 ' A' ' 101' ' ' LEU . 54.2 m-20 -54.31 -55.92 23.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.548 ' HB2' HG23 ' A' ' 99' ' ' ILE . 97.4 mt-10 -71.19 -31.38 67.57 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.209 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.698 HG13 HG22 ' A' ' 99' ' ' ILE . 50.9 mt -65.74 -65.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.187 0.518 . . . . 0.0 110.403 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.892 ' HB3' HD12 ' A' ' 113' ' ' LEU . 87.8 mt-30 -58.14 -39.03 77.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.608 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.87 -44.07 94.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.095 0.474 . . . . 0.0 110.644 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.71 -3.06 1.33 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.17 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.762 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 73.2 m -115.09 44.12 1.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.93 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -59.54 -36.71 76.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.811 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -75.02 -22.11 58.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.155 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.762 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 2.7 m-85 -76.76 -5.24 47.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.944 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.37 38.81 96.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.572 -1.299 . . . . 0.0 111.026 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.928 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -33.01 132.72 0.14 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.525 0.679 . . . . 0.0 111.486 -177.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.716 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 91.9 m-20 -135.98 167.68 20.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.259 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.638 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.8 m-20 -82.95 -7.93 59.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.167 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.63 -64.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.039 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -89.46 -69.29 0.72 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.928 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.4 mm -52.72 -19.49 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.958 0.409 . . . . 0.0 111.268 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.638 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 33.6 t70 -71.11 -46.96 60.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 124' ' ' GLU . 63.9 t0 -62.37 -26.26 68.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 1.086 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.4 ttt -60.74 -29.82 69.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.501 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.769 HG22 ' HA3' ' A' ' 131' ' ' GLY . 56.8 mt -58.37 -43.59 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.475 ' CE ' ' HB ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -86.67 -13.79 44.47 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.584 -1.644 . . . . 0.0 110.374 178.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 1.086 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 71.4 tt0 -84.61 -23.71 29.45 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.79 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.854 HG22 HD11 ' A' ' 133' ' ' ILE . 13.4 mm -107.58 -21.77 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.978 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.3 t70 -62.89 98.43 0.13 Allowed 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.593 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.945 HE21 ' HG2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -87.24 -13.95 42.39 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.439 ' OD1' ' ND2' ' A' ' 129' ' ' ASN . 50.5 p30 -127.57 -33.19 2.33 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.728 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 179.92 -71.71 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.728 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 56.3 m-20 -64.93 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.978 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.53 37.92 77.91 Favored Glycine 0 CA--C 1.505 -0.577 0 C-N-CA 118.358 -1.877 . . . . 0.0 110.044 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.556 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 8.5 pt20 -133.31 170.54 15.3 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 113.929 -1.135 . . . . 0.0 110.073 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.006 HD13 ' HB3' ' A' ' 137' ' ' GLU . 5.0 mm -133.05 121.89 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.856 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.924 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 4.3 p-10 -113.08 162.48 15.88 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.172 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.798 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 22.4 t80 -38.79 -30.45 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.0 0.428 . . . . 0.0 110.738 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.548 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -84.25 -45.15 6.32 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.726 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 1.006 ' HB3' HD13 ' A' ' 133' ' ' ILE . 39.3 mt-10 -63.07 -51.3 67.2 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.588 ' HB2' ' CG2' ' A' ' 133' ' ' ILE . 13.5 t80 -56.61 -18.66 12.77 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -86.1 -40.82 15.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.593 ' HB3' ' HG3' ' A' ' 127' ' ' GLN . . . -87.29 -11.59 49.1 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.549 ' HG2' ' HA ' ' A' ' 138' ' ' PHE . 5.5 ppp? -72.46 -6.67 45.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.635 0.255 . . . . 0.0 111.543 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.009 179.886 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.401 0.143 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.669 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 39.9 ttmt -55.89 -33.1 64.3 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -81.65 -37.93 26.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.761 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 51.8 tp -59.53 -25.96 64.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.143 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -70.89 -40.06 72.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.425 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -86.36 -11.97 50.59 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.662 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -59.46 -34.48 72.59 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.509 HD12 HD13 ' A' ' 27' ' ' ILE . 3.0 mt -81.18 -62.09 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.884 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -83.85 66.93 9.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.313 1.054 . . . . 0.0 109.529 178.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -89.34 -20.99 23.34 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.094 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -138.73 8.92 2.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.622 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 31.6 t30 -82.94 -82.61 0.14 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.593 1.088 . . . . 0.0 110.981 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.0 p -176.13 15.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.05 18.51 9.23 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.628 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.64 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 39.9 p -148.84 161.2 42.3 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.403 0.62 . . . . 0.0 111.749 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.729 ' O ' ' HA ' ' A' ' 62' ' ' THR . 4.7 mt -111.01 103.82 16.09 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.502 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.63 HG22 ' OG1' ' A' ' 62' ' ' THR . 65.4 p -112.7 158.22 20.32 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.644 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.816 ' HE2' ' HB2' ' A' ' 49' ' ' LYS . 14.7 t80 -34.45 -20.01 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.616 ' N ' ' O ' ' A' ' 28' ' ' THR . 32.7 t70 -86.18 -39.06 17.04 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.08 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.622 ' OE2' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -90.87 -32.08 16.18 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.729 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -40.45 -51.45 2.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.401 0.62 . . . . 0.0 110.318 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.721 ' HB3' HG12 ' A' ' 48' ' ' ILE . 12.4 ptpt -71.47 -39.4 70.94 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.267 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 38' ' ' ARG . 8.2 t70 -43.98 -47.81 8.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.217 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.493 ' HA3' HG12 ' A' ' 19' ' ' ILE . . . -45.21 -47.22 10.68 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 114.695 0.638 . . . . 0.0 114.695 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.752 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.7 mm? -95.2 -44.13 7.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.592 0.696 . . . . 0.0 112.214 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.699 ' NZ ' ' HD3' ' A' ' 33' ' ' LYS . 15.3 ptpt -56.32 -18.67 11.46 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.476 HH11 ' HG3' ' A' ' 38' ' ' ARG . 22.2 ttm-85 -90.83 -25.02 20.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.22 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 36' ' ' LEU . 6.3 p -80.56 -37.48 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.63 -42.65 0.59 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.447 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.6 m -62.75 177.21 0.57 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.795 0.331 . . . . 0.0 110.963 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.34 112.03 7.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 mt -108.02 165.48 11.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.503 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.464 ' O ' HD13 ' A' ' 48' ' ' ILE . 26.8 ptt? -112.22 162.08 15.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.69 -14.29 19.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.7 t -87.64 -17.11 32.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.199 0.523 . . . . 0.0 109.938 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 97.0 mt-10 -90.73 -46.24 8.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.783 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.729 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -50.77 -50.65 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 122.275 1.036 . . . . 0.0 109.086 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.816 ' HB2' ' HE2' ' A' ' 29' ' ' PHE . 52.3 tttp -64.11 -30.3 71.38 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.383 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 64.1 t0 -64.26 -48.71 74.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.721 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 26.9 mt -60.43 -15.75 29.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.525 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.759 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 30.5 mtt -88.02 -65.24 1.04 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.453 ' CA ' ' HG3' ' A' ' 59' ' ' LYS . 2.5 p30 -66.73 -25.6 66.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.654 0.264 . . . . 0.0 111.595 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -91.33 -28.39 17.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -125.41 -43.93 1.88 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.636 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 64.2 t0 -51.18 101.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.032 0.444 . . . . 0.0 110.243 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.9 mm -44.87 -26.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.674 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.61 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 38.7 t70 -133.26 44.72 2.79 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.364 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.759 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 10.2 tmtt? -32.07 92.03 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.941 0.877 . . . . 0.0 112.642 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.1 p -126.71 19.06 7.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.833 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 71.85 16.23 76.29 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.21 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.729 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 58.5 m -147.64 128.14 14.08 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.405 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.725 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 71.5 mt -113.23 130.33 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.157 0.503 . . . . 0.0 110.871 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.43 167.73 9.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.058 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.669 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 66.3 t80 -42.67 -25.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.019 0.437 . . . . 0.0 110.799 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.71 -59.48 2.34 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.753 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.691 ' HB2' HG23 ' A' ' 63' ' ' ILE . 37.8 mt-10 -56.04 -23.26 32.19 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.646 0.26 . . . . 0.0 110.828 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.761 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 60.4 t80 -68.54 -65.54 0.69 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.566 0.698 . . . . 0.0 110.416 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 65' ' ' TYR . 44.2 mm -47.1 -58.47 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.106 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -44.65 -53.18 7.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.493 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.481 0.181 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 89' ' ' SER . 81.0 p -46.09 -56.72 5.23 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.923 0.392 . . . . 0.0 110.187 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.432 ' C ' ' N ' ' A' ' 89' ' ' SER . . . -68.58 -45.39 72.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.812 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 18.9 t80 -47.51 -19.26 0.17 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.584 0.707 . . . . 0.0 109.979 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 30.7 m -89.81 -59.61 2.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.695 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.439 ' CG ' ' HB2' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -74.25 -62.97 1.33 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -51.73 -60.55 3.04 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.812 ' HB3' ' O ' ' A' ' 88' ' ' PHE . 62.6 t0 -82.91 69.54 9.74 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 89' ' ' SER . 31.3 ttmt -53.25 -16.05 1.14 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.668 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -97.49 -24.4 15.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.579 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.93 -12.47 0.81 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.804 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.9 p -51.83 -22.84 4.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.204 0.502 . . . . 0.0 110.606 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.589 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 126.01 -3.84 7.9 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.038 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -125.8 144.68 50.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.038 0.447 . . . . 0.0 111.849 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.778 HG12 ' HA ' ' A' ' 92' ' ' ASP . 31.2 mt -131.58 102.59 6.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.61 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 103' ' ' GLU . 70.6 p -81.52 156.94 25.01 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.215 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.524 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.0 pp -35.01 -39.86 0.11 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.69 0.281 . . . . 0.0 111.259 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.497 ' N ' HD12 ' A' ' 101' ' ' LEU . 8.3 t70 -57.86 -57.78 11.29 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.469 ' CB ' HG23 ' A' ' 99' ' ' ILE . 51.0 mt-10 -58.89 -48.22 82.19 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.57 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.832 HG21 HD12 ' A' ' 125' ' ' ILE . 91.1 mt -55.73 -65.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.151 0.5 . . . . 0.0 110.653 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.881 HE21 HG22 ' A' ' 118' ' ' ILE . 91.6 mt-30 -56.83 -65.14 0.67 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.11 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -42.38 -32.96 0.58 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.51 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 104' ' ' ILE . . . -53.28 -65.57 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 111' ' ' PHE . 51.6 t -62.01 135.0 57.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.881 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -89.12 -47.87 7.79 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -78.9 -3.32 44.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.628 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.711 ' CE2' ' HB2' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -47.19 -27.21 1.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.412 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 60.44 37.61 93.49 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.371 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.711 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 6.4 tt -31.8 126.92 0.23 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.327 0.584 . . . . 0.0 112.306 -176.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.668 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 29.6 t70 -160.2 177.09 11.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.955 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.723 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 2.9 p30 -89.2 -8.19 54.07 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.704 HG23 ' H ' ' A' ' 117' ' ' HIS . 7.1 tp -88.51 -64.69 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.704 ' H ' HG23 ' A' ' 116' ' ' ILE . 16.6 t-160 -92.7 -67.11 0.88 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.031 0.443 . . . . 0.0 111.975 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.881 HG22 HE21 ' A' ' 105' ' ' GLN . 4.4 mp -50.23 -20.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.694 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.723 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 7.7 t70 -76.12 -52.34 10.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' GLU . 37.1 t70 -58.92 -19.64 44.5 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.87 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.5 ttt -68.79 -45.39 71.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.259 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.628 HG22 ' HA3' ' A' ' 131' ' ' GLY . 54.1 mt -51.44 -40.85 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.635 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.6 -13.84 44.53 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.512 -1.677 . . . . 0.0 110.267 178.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.87 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 41.8 tp10 -83.98 -21.42 31.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.493 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.832 HD12 HG21 ' A' ' 104' ' ' ILE . 1.1 mt -105.71 -33.75 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 1.031 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.8 t70 -54.75 95.64 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.793 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 125' ' ' ILE . 15.4 mt-30 -87.67 -9.8 53.13 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.188 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 7.1 t70 -126.79 -32.73 2.56 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -177.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.743 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 178.33 -68.79 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 179.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.743 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 7.3 t70 -63.82 -24.18 67.65 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -172.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 1.031 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 94.95 36.83 5.38 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 107.169 -2.372 . . . . 0.0 107.169 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.67 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 5.3 pt20 -138.21 168.01 20.64 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 112.846 -1.677 . . . . 0.0 108.922 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.769 HD11 ' O ' ' A' ' 125' ' ' ILE . 21.5 mm -130.86 131.12 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-O 121.797 0.808 . . . . 0.0 110.978 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.878 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 10.7 t70 -103.03 163.06 12.44 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.69 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.779 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 21.8 t80 -43.76 -37.18 2.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.287 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.2 -36.06 18.94 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.834 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.878 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 46.4 mt-10 -61.13 -57.62 11.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.657 ' HD1' HG21 ' A' ' 133' ' ' ILE . 3.4 t80 -55.49 -39.15 70.07 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.916 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.68 -25.11 67.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.785 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.35 -44.68 10.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -31.17 69.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.565 0.221 . . . . 0.0 111.419 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.1 ttp . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.04 0.448 . . . . 0.0 110.177 179.381 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.1 tp . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.602 0.239 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.482 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -75.69 -46.61 30.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.438 ' HG3' ' HE3' ' A' ' 17' ' ' LYS . 85.1 tt0 -69.37 -17.91 63.73 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.681 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.818 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 2.3 tm? -83.6 -39.07 20.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.406 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.55 ' HE1' HG13 ' A' ' 27' ' ' ILE . 2.3 t80 -57.79 -42.67 84.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.1 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.438 ' HE3' ' HG3' ' A' ' 14' ' ' GLU . 19.5 pttp -80.48 -17.72 50.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.61 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.818 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.39 -32.87 74.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.653 HG23 ' HA3' ' A' ' 35' ' ' GLY . 1.1 mm -71.5 -62.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.289 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.446 ' HB3' HG12 ' A' ' 27' ' ' ILE . 2.5 p30 -89.08 47.23 1.47 Allowed 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.84 0.829 . . . . 0.0 111.255 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 t -71.35 -18.4 62.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.924 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -108.33 -11.48 15.19 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.443 ' HB2' ' CD ' ' A' ' 31' ' ' GLU . 27.1 t-20 -83.06 -88.73 0.09 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 111.426 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.4 p -176.45 12.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.119 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.39 17.88 9.01 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.101 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -135.58 143.59 45.73 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.002 0.43 . . . . 0.0 109.86 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.8 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 8.4 mt -103.73 104.03 16.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.599 HG22 ' OG1' ' A' ' 62' ' ' THR . 76.6 p -102.55 159.79 15.13 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.457 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 25.7 t80 -34.37 -34.13 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 O-C-N 123.79 0.681 . . . . 0.0 111.906 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 28' ' ' THR . 35.8 m-20 -73.45 -50.29 22.42 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.338 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 28.2 mp0 -78.06 -14.73 59.39 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.714 0.293 . . . . 0.0 111.033 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.86 HD12 HG13 ' A' ' 48' ' ' ILE . 1.6 tm? -55.43 -48.78 73.9 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.849 0.833 . . . . 0.0 108.928 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.903 ' HB2' ' HE3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -82.89 -49.19 9.92 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.313 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.591 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 36.3 m-20 -39.51 -45.33 1.55 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.653 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -52.37 -50.56 46.79 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.059 -0.591 . . . . 0.0 114.234 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.724 HD12 HD23 ' A' ' 43' ' ' LEU . 85.3 mt -75.53 -52.05 11.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.246 0.523 . . . . 0.0 111.685 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.903 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 18.2 ptpt -55.97 -16.03 4.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.985 0.421 . . . . 0.0 110.211 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.438 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -87.1 -39.58 15.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.995 178.421 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.6 p -70.91 -10.73 14.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.285 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.09 -5.22 22.05 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.502 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 61.5 m -78.93 157.86 28.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.664 0.268 . . . . 0.0 111.401 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 14.2 pt-20 -123.54 104.22 8.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.516 0.674 . . . . 0.0 110.936 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.854 HD13 HD11 ' A' ' 48' ' ' ILE . 1.7 pp -117.96 166.09 12.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.736 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.443 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 25.9 ptm -118.06 156.04 29.31 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.54 ' HA ' HD13 ' A' ' 48' ' ' ILE . 32.6 tt0 -44.65 -58.22 3.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.6 m -49.39 -25.79 2.76 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 97.8 mt-10 -73.52 -31.84 63.9 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.125 0.488 . . . . 0.0 109.838 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.86 HG13 HD12 ' A' ' 32' ' ' LEU . 1.9 mp -59.78 -64.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.752 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.495 ' HD2' ' CD ' ' A' ' 93' ' ' LYS . 4.5 ttmp? -55.35 -34.07 63.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.267 0.555 . . . . 0.0 109.747 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 36.4 t70 -52.86 -61.0 2.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.474 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.814 HD11 HD11 ' A' ' 32' ' ' LEU . 4.1 pp -65.71 -14.88 62.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.794 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 27.3 mtt -80.76 -65.83 0.96 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.171 0.51 . . . . 0.0 110.987 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.516 ' OD2' ' HB2' ' A' ' 90' ' ' TYR . 41.2 t0 -61.71 -21.94 64.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.867 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.53 -40.46 11.35 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -112.33 -44.27 3.41 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 52' ' ' MET . 66.6 t0 -51.67 98.26 0.02 OUTLIER 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.2 mt -38.34 -35.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.802 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 60' ' ' SER . 2.8 p30 -133.65 45.37 2.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.013 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.794 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.6 tmtm? -31.74 90.83 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.914 0.864 . . . . 0.0 112.174 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 58' ' ' ASP . 73.4 p -123.98 16.74 9.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.874 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 83.71 14.22 73.6 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.394 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 57.9 m -153.03 127.2 9.11 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.881 HG23 ' HB2' ' A' ' 67' ' ' GLU . 68.9 mt -112.28 133.46 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.205 0.526 . . . . 0.0 111.798 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.72 167.32 9.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.679 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.529 ' O ' HG13 ' A' ' 69' ' ' ILE . 25.2 t80 -36.54 -48.33 0.68 Allowed 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.49 -59.86 7.76 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.358 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.881 ' HB2' HG23 ' A' ' 63' ' ' ILE . 34.7 mt-10 -51.43 -30.07 18.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.854 0.359 . . . . 0.0 110.567 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.534 ' CD2' ' HB2' ' A' ' 16' ' ' PHE . 30.6 t80 -61.87 -46.9 87.41 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.271 0.558 . . . . 0.0 110.945 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 65' ' ' TYR . 10.7 mt -59.96 -19.45 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.616 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 67' ' ' GLU . . . -67.65 -20.51 65.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.251 0.548 . . . . 0.0 109.617 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.226 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.057 178.369 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.235 0.3 0 CA-C-O 120.476 0.179 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 72.5 m -54.41 -23.87 17.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.238 0.542 . . . . 0.0 109.666 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -84.7 -51.08 7.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.488 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.835 ' HE1' ' HB2' ' A' ' 135' ' ' TYR . 7.9 t80 -39.14 -36.42 0.31 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.116 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.4 t -89.24 -55.49 3.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.228 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.516 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 7.8 t80 -75.77 -63.89 1.2 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.561 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.751 ' HB3' HD13 ' A' ' 99' ' ' ILE . 3.1 m-85 -58.14 -65.21 0.68 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.782 ' HA ' HG12 ' A' ' 99' ' ' ILE . 12.4 t0 -74.54 60.04 0.86 Allowed 'General case' 0 C--N 1.335 -0.056 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.495 ' CD ' ' HD2' ' A' ' 49' ' ' LYS . 3.0 tppp? -49.2 -40.72 34.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.507 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.52 -21.35 60.42 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.383 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 49.02 72.33 0.48 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.1 p -132.57 -5.0 3.29 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 105.87 5.78 38.16 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 113.799 -1.546 . . . . 0.0 113.322 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.778 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -144.27 157.46 44.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.456 0.646 . . . . 0.0 111.495 179.108 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.782 HG12 ' HA ' ' A' ' 92' ' ' ASP . 77.8 mt -133.18 104.14 6.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.956 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 103' ' ' GLU . 43.6 p -70.8 147.99 48.35 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.766 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.685 ' HB3' HG23 ' A' ' 122' ' ' ILE . 3.6 pp -34.84 -39.22 0.09 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.421 ' N ' HD12 ' A' ' 101' ' ' LEU . 1.6 m-20 -55.55 -54.71 40.6 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.59 ' HB2' HG23 ' A' ' 99' ' ' ILE . 49.3 mt-10 -60.48 -44.46 95.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.235 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.77 HG13 HG22 ' A' ' 99' ' ' ILE . 96.6 mt -56.72 -65.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.381 0.61 . . . . 0.0 110.676 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.817 HE21 HG22 ' A' ' 118' ' ' ILE . 87.5 mt-30 -58.35 -65.47 0.65 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.488 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -42.79 -34.23 0.89 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.17 -66.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.314 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 98.5 m -49.78 134.17 20.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.811 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.589 ' HA ' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -89.29 -60.91 1.82 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -75.49 -3.07 31.92 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.82 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.749 ' O ' HD11 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -46.81 -29.39 1.93 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -178.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 62.87 39.21 97.74 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 118.85 -1.643 . . . . 0.0 110.777 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.793 ' HA ' HD12 ' A' ' 118' ' ' ILE . 9.1 tt -31.63 130.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.454 ' OD2' HG13 ' A' ' 116' ' ' ILE . 35.9 t70 -157.21 175.67 13.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.905 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.741 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.0 m-20 -88.89 -7.45 56.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.454 HG13 ' OD2' ' A' ' 114' ' ' ASP . 60.5 mt -84.86 -65.53 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -92.45 -69.04 0.76 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.817 HG22 HE21 ' A' ' 105' ' ' GLN . 60.5 mt -52.1 -19.68 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.935 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.741 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 37.4 t70 -75.89 -51.67 12.0 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' GLU . 32.2 m-20 -65.07 -17.9 64.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 1.064 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 13.6 tmm? -65.31 -41.25 94.25 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.823 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.748 HG22 ' HA3' ' A' ' 131' ' ' GLY . 61.1 mt -54.12 -39.68 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.77 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 10.9 mmpt? -86.7 -13.89 44.1 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 112.403 -2.18 . . . . 0.0 110.574 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 1.064 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 29.7 tt0 -94.27 -14.78 25.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.689 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.845 HG22 ' CD1' ' A' ' 133' ' ' ILE . 29.9 mt -111.97 -35.55 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.379 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.782 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 1.8 t70 -47.02 129.83 12.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.705 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.493 ' HB2' ' CD ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -88.41 -23.15 23.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.529 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 45.3 p-10 -135.24 -32.73 0.93 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.664 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 179.36 -52.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.694 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 31.1 m-20 -64.6 8.76 0.1 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -173.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.782 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.5 37.06 65.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 118.45 -1.833 . . . . 0.0 108.772 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.732 HE22 ' HB3' ' A' ' 98' ' ' TYR . 5.7 pt20 -127.59 169.37 13.81 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.805 -1.197 . . . . 0.0 108.982 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.845 ' CD1' HG22 ' A' ' 125' ' ' ILE . 25.6 mm -135.94 129.97 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.4 0 CA-C-O 121.622 0.725 . . . . 0.0 110.803 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.778 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -102.24 165.19 11.27 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.173 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.835 ' HB2' ' HE1' ' A' ' 88' ' ' PHE . 41.0 t80 -48.06 -31.0 4.93 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.1 -26.52 36.72 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.462 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.625 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 78.7 mt-10 -76.12 -53.86 7.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.824 -0.188 . . . . 0.0 110.521 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.578 ' HD1' HG21 ' A' ' 133' ' ' ILE . 4.1 t80 -60.85 -23.96 65.53 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.838 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.0 -32.55 21.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.747 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.8 -27.8 19.75 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -11.4 16.38 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.749 0.309 . . . . 0.0 111.141 -179.945 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.632 HD12 HD23 ' A' ' 15' ' ' LEU . 52.2 tp . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.609 0.242 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 61.6 tttm -60.78 -43.03 98.61 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.97 -26.94 67.79 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.736 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.709 ' HA ' ' HB3' ' A' ' 18' ' ' MET . 33.4 tp -72.48 -31.12 65.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.946 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.461 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 10.4 t80 -65.94 -48.18 72.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.283 0.564 . . . . 0.0 109.788 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.461 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -76.22 -16.23 59.87 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.709 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 3.1 tpp -66.79 -36.21 81.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.887 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.733 HG21 HD13 ' A' ' 27' ' ' ILE . 10.4 mm -62.85 -57.54 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.614 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.596 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 1.3 t70 -82.48 87.55 6.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.285 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 t -88.19 -24.9 23.17 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.62 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -139.71 -6.14 1.32 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.548 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 53.7 t30 -75.43 -80.42 0.09 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.897 1.226 . . . . 0.0 112.837 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 p -172.34 -0.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 110.26 23.57 6.01 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.456 ' HB ' ' OG1' ' A' ' 62' ' ' THR . 65.2 p -138.86 147.37 42.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.013 -1.093 . . . . 0.0 109.464 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.849 ' O ' ' HA ' ' A' ' 62' ' ' THR . 2.3 mt -104.21 103.71 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 59.9 p -101.97 161.97 13.27 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.48 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 2.0 t80 -34.21 -36.67 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.797 0.686 . . . . 0.0 111.076 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -74.95 -52.16 11.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.432 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.596 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 3.1 tt0 -70.85 -16.41 62.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.183 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.863 HD12 HG13 ' A' ' 48' ' ' ILE . 2.4 tm? -58.98 -55.25 37.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.353 0.597 . . . . 0.0 109.992 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.601 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 10.9 ptpt -76.22 -33.42 59.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.668 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -48.47 -58.38 4.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 19' ' ' ILE . . . -61.4 -22.45 61.24 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 114.849 0.7 . . . . 0.0 114.849 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 ' N ' ' A' ' 37' ' ' LYS . 4.6 pp -95.1 -39.09 10.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.785 0.792 . . . . 0.0 111.252 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.679 ' N ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -71.28 -15.23 62.41 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -87.68 -36.85 17.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.255 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.624 HG12 ' O ' ' A' ' 36' ' ' LEU . 9.0 p -75.08 -17.84 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.533 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.49 42.45 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.641 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 35.5 t -130.68 164.1 25.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.676 0.274 . . . . 0.0 110.456 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 10.7 pt-20 -141.89 104.78 4.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.198 0.523 . . . . 0.0 111.695 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.457 HD12 ' CD2' ' A' ' 36' ' ' LEU . 20.5 mt -124.58 165.99 16.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.188 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.4 ptm -113.08 164.03 13.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -45.52 -64.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.8 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.6 p -41.83 -22.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.3 mm-40 -82.31 -47.52 12.27 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.863 HG13 HD12 ' A' ' 32' ' ' LEU . 1.8 mp -51.59 -62.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.553 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.536 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . 3.1 tmtm? -46.67 -33.57 4.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.81 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.506 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 9.6 t70 -65.55 -43.87 88.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.806 HD13 ' N ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -64.35 -26.54 68.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.425 178.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.927 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 17.7 mmt -80.08 -66.43 0.88 Allowed 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.562 0.696 . . . . 0.0 112.183 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.726 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 1.5 m-20 -59.84 -21.86 61.49 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.873 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.721 ' HB1' ' HB3' ' A' ' 89' ' ' SER . . . -92.55 -42.8 9.49 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.721 ' HB1' ' HA ' ' A' ' 71' ' ' ALA . . . -111.73 -39.45 4.58 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.787 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 38.1 t0 -50.07 87.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' ALA . 37.6 mm -47.51 -22.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.559 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.531 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 60.0 m-20 -133.06 43.52 2.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.612 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.927 ' HD3' ' HB3' ' A' ' 52' ' ' MET . 56.5 tptt -33.12 90.32 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.695 0.76 . . . . 0.0 112.609 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.8 p -127.68 18.82 6.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.458 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 84.71 5.37 86.61 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.902 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.849 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 1.3 t -153.41 150.94 29.35 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.983 0.421 . . . . 0.0 111.312 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.904 HG23 ' HB2' ' A' ' 67' ' ' GLU . 68.7 mt -117.08 136.48 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.344 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -105.94 167.57 9.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.139 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.532 ' CE1' HD11 ' A' ' 69' ' ' ILE . 18.9 t80 -36.19 -49.57 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.406 0.441 . . . . 0.0 111.615 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.11 -60.37 7.7 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.723 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.904 ' HB2' HG23 ' A' ' 63' ' ' ILE . 23.8 mt-10 -53.68 -25.13 16.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.716 0.293 . . . . 0.0 110.602 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.578 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 47.1 t80 -64.79 -50.68 65.82 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.264 0.554 . . . . 0.0 110.474 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.532 HD11 ' CE1' ' A' ' 65' ' ' TYR . 5.0 mm -60.27 -50.16 81.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.125 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.96 -30.15 68.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.029 0.442 . . . . 0.0 110.215 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.721 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.19 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.695 0.284 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.6 m -56.24 -44.46 79.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.198 0.523 . . . . 0.0 109.666 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HA ' ' CD1' ' A' ' 91' ' ' PHE . . . -75.77 -55.04 6.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.831 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.796 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 4.9 t80 -40.59 -25.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.73 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.721 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 22.6 m -90.92 -64.48 1.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -79.16 -42.38 26.27 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.763 0.316 . . . . 0.0 111.683 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 87' ' ' ALA . 5.7 m-85 -63.65 -64.5 0.88 Allowed 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 176.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.931 ' HA ' HG12 ' A' ' 99' ' ' ILE . 56.9 t0 -77.78 70.56 4.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.726 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 22.4 ttmt -43.54 -49.22 7.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.362 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.501 ' OD2' HG23 ' A' ' 57' ' ' ILE . 7.1 t70 -67.75 -22.71 65.21 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.138 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 49.98 54.27 19.26 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.653 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.8 p -125.49 12.31 8.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.688 ' HA2' ' HE1' ' A' ' 88' ' ' PHE . . . 84.66 21.18 56.78 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.447 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' HA ' ' OD1' ' A' ' 134' ' ' ASP . 14.3 m-85 -143.52 131.9 22.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.931 HG12 ' HA ' ' A' ' 92' ' ' ASP . 48.6 mt -130.19 101.96 6.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.88 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.506 ' HA ' ' HB3' ' A' ' 132' ' ' GLN . 58.8 p -74.12 164.69 26.3 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.07 -0.394 . . . . 0.0 111.086 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.726 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER -41.28 -36.55 0.81 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.425 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -67.46 -52.38 40.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.279 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.487 ' CB ' HG23 ' A' ' 99' ' ' ILE . 56.3 mt-10 -64.95 -15.88 62.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.636 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.723 HG22 ' HE3' ' A' ' 121' ' ' MET . 96.6 mt -87.33 -62.82 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.124 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.726 ' HG2' ' O ' ' A' ' 101' ' ' LEU . 7.1 mm100 -50.27 -51.69 42.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.96 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -60.73 -31.19 70.5 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.22 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 104' ' ' ILE . . . -59.81 -21.54 61.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.87 0.367 . . . . 0.0 110.927 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.55 ' HB3' ' CG ' ' A' ' 111' ' ' PHE . 72.4 m -117.13 66.72 0.73 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.682 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.698 ' HD3' ' H ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -78.4 -39.37 39.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -68.81 -12.6 61.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.183 0.516 . . . . 0.0 110.347 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.55 ' CG ' ' HB3' ' A' ' 108' ' ' CYS . 3.2 m-85 -74.77 -46.81 34.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.827 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.72 37.98 2.66 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.749 ' HA ' HG13 ' A' ' 118' ' ' ILE . 1.0 OUTLIER -33.33 139.07 0.06 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.504 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 52.8 t0 -152.67 150.7 29.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.272 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.692 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 10.2 t70 -57.74 -8.74 0.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.493 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.3 mm -86.67 -64.8 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -91.68 -68.98 0.76 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 1.022 HG23 ' HE2' ' A' ' 121' ' ' MET . 17.5 mm -51.05 -24.36 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.2 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.692 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 36.1 t70 -75.08 -46.26 35.82 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 124' ' ' GLU . 33.3 t70 -62.31 -21.48 65.29 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 1.022 ' HE2' HG23 ' A' ' 118' ' ' ILE . 3.8 ttp -65.36 -33.32 75.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.637 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 126' ' ' ASP . 46.3 mt -59.12 -42.48 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.66 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 2.4 mptt -86.72 -12.97 46.73 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.51 -1.677 . . . . 0.0 109.882 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.917 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 17.2 tp10 -86.11 -22.82 26.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.451 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.575 HG21 HD13 ' A' ' 133' ' ' ILE . 14.7 mm -116.56 -13.36 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.585 ' OD1' ' HA ' ' A' ' 123' ' ' LYS . 4.2 p-10 -79.8 54.09 1.77 Allowed 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.564 0.697 . . . . 0.0 110.084 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.565 HE22 ' CG ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -62.56 -9.32 8.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.553 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 6.4 t70 -107.95 -32.91 7.38 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.586 ' N ' HD22 ' A' ' 129' ' ' ASN . 0.0 OUTLIER 178.54 -95.65 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 178.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.724 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 1.5 m-20 -64.75 29.29 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 119.44 3.126 . . . . 0.0 119.44 -173.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 126' ' ' ASP . . . 58.76 37.67 90.52 Favored Glycine 0 CA--C 1.504 -0.631 0 C-N-CA 117.236 -2.411 . . . . 0.0 109.133 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.724 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 6.6 pt20 -136.57 169.28 17.97 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 113.738 -1.231 . . . . 0.0 109.831 -177.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.613 HG21 ' HD1' ' A' ' 138' ' ' PHE . 49.2 mt -133.16 124.2 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.558 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 54.0 m-20 -101.73 165.53 11.16 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.417 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.643 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 25.8 t80 -44.19 -29.78 0.68 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.068 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.54 -39.64 8.17 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.683 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.565 ' CG ' HE22 ' A' ' 127' ' ' GLN . 32.9 mt-10 -60.54 -50.59 72.93 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.613 ' HD1' HG21 ' A' ' 133' ' ' ILE . 1.3 t80 -64.37 -61.11 2.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.49 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.81 -32.95 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.64 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.69 -58.18 2.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.441 ' HG2' HG23 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -46.19 -33.02 3.32 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 138' ' ' PHE . 27.6 ptt? . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.749 0.309 . . . . 0.0 111.097 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.52 -0.192 0 CA-C-O 120.562 0.22 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.451 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 62.8 tttm -64.68 -51.46 62.38 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -65.54 -18.28 65.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.176 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.822 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -80.15 -40.31 27.6 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.738 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HA ' ' CE1' ' A' ' 68' ' ' PHE . 11.1 t80 -57.4 -44.01 84.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.192 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.57 ' NZ ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -81.75 -12.59 58.52 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.825 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.753 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -67.97 -43.07 79.83 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.862 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 7.7 mt -61.45 -58.07 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.674 ' OD1' ' HB3' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -74.96 84.65 2.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.35 1.071 . . . . 0.0 109.817 178.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -89.18 -22.29 22.87 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.595 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -138.66 -5.67 1.54 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.674 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -71.16 -87.53 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.141 0.882 . . . . 0.0 111.292 -178.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.1 p -177.77 11.65 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.483 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.479 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 109.84 31.23 3.21 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 55.1 p -144.13 152.06 40.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.612 -0.794 . . . . 0.0 110.627 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.876 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 4.5 mt -114.42 104.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.758 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.677 HG22 ' OG1' ' A' ' 62' ' ' THR . 82.7 p -102.5 160.11 14.85 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.617 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 17.1 t80 -34.24 -34.61 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.723 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -77.85 -45.48 24.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.843 0.354 . . . . 0.0 110.456 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.565 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -73.04 -24.56 60.72 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.204 178.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.755 HD11 HD23 ' A' ' 51' ' ' LEU . 1.4 tm? -50.61 -54.66 20.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.418 0.628 . . . . 0.0 110.059 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.68 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 3.8 ptpt -79.03 -39.03 35.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.334 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 37.8 t70 -47.66 -36.6 11.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.468 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.862 ' HA3' ' HA ' ' A' ' 19' ' ' ILE . . . -95.09 -49.62 2.21 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.259 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.659 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -57.98 -51.71 68.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.467 0.651 . . . . 0.0 109.898 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.68 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.85 -9.19 42.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.728 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.581 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -80.86 -32.21 35.1 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.802 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 36' ' ' LEU . 25.1 m -76.94 2.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.733 0.301 . . . . 0.0 111.404 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.18 10.85 11.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.271 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 40.9 m -92.22 156.98 16.94 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.725 0.298 . . . . 0.0 110.649 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -142.5 104.43 4.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.046 0.45 . . . . 0.0 110.741 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 48' ' ' ILE . 21.4 mt -131.16 165.52 23.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.465 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.444 ' O ' HD13 ' A' ' 48' ' ' ILE . 37.9 mtm -105.0 165.5 11.03 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.8 mp0 -47.96 -60.72 2.39 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.677 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 t -48.94 -17.19 0.17 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 52.0 mt-10 -90.86 -48.75 6.83 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.743 HG23 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -49.83 -58.13 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.566 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . 44.5 tttp -39.9 -34.65 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.106 -1.861 . . . . 0.0 111.115 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.638 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 8.7 t70 -64.26 -50.81 66.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.399 . . . . 0.0 110.216 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.755 HD23 HD11 ' A' ' 32' ' ' LEU . 53.2 tp -56.13 -33.28 65.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.995 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.596 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 41.6 ttm -87.54 -66.5 0.91 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.529 0.68 . . . . 0.0 112.705 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.502 ' HA ' ' CG ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -58.42 -34.52 70.88 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.235 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB1' ' OG ' ' A' ' 89' ' ' SER . . . -91.15 -18.48 24.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -123.91 -43.56 2.11 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' MET . 65.6 t0 -50.48 101.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.033 0.444 . . . . 0.0 110.093 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 6.3 mt -50.73 -17.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.481 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 60' ' ' SER . 55.7 m-20 -129.76 43.36 3.14 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.052 -178.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.577 ' HD3' ' C ' ' A' ' 59' ' ' LYS . 1.6 tmtp? -33.42 87.16 0.0 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.68 0.753 . . . . 0.0 111.854 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 58' ' ' ASP . 45.6 m -128.04 19.18 6.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.459 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.596 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 68.84 20.87 74.77 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 86.0 m -155.24 133.02 11.34 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.886 -0.657 . . . . 0.0 110.299 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.876 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.1 mt -113.48 134.76 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.152 0.501 . . . . 0.0 111.14 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.534 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 40.1 m-20 -106.68 167.87 9.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.747 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.557 ' O ' HG13 ' A' ' 69' ' ' ILE . 25.2 t80 -35.79 -46.96 0.48 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.695 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.7 -53.82 7.98 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.976 -1.106 . . . . 0.0 112.313 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.609 ' HB2' HG23 ' A' ' 63' ' ' ILE . 24.2 mt-10 -52.08 -25.15 8.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.297 0.57 . . . . 0.0 109.847 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.822 ' HZ ' HD12 ' A' ' 15' ' ' LEU . 88.9 t80 -67.77 -65.51 0.68 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.139 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 65' ' ' TYR . 2.8 mt -47.35 -46.72 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.629 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -50.16 75.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 110.421 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.681 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.027 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.559 0.218 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -44.45 -50.96 9.13 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.013 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -75.23 -51.51 13.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.511 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.702 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 3.5 t80 -43.34 -26.97 0.22 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.017 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.688 ' OG ' ' HB1' ' A' ' 54' ' ' ALA . 25.3 t -89.38 -57.99 2.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.536 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -84.61 -54.37 4.77 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.734 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 87' ' ' ALA . 3.1 m-85 -56.97 -65.08 0.68 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.85 ' HA ' HG12 ' A' ' 99' ' ' ILE . 66.2 t0 -72.61 63.23 0.58 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 29.6 ttmt -51.26 -39.49 56.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.225 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 63.7 m-20 -72.0 -25.02 61.67 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.189 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 44.39 64.56 2.0 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.364 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 77.8 p -118.38 11.22 12.98 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 97.57 4.92 57.99 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 112.195 -2.275 . . . . 0.0 112.697 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 1.1 p90 -165.25 144.94 6.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.85 HG12 ' HA ' ' A' ' 92' ' ' ASP . 51.1 mt -103.24 141.76 18.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.794 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.504 ' HA ' ' CB ' ' A' ' 132' ' ' GLN . 77.0 p -110.73 159.73 17.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.86 0.3 . . . . 0.0 110.255 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.69 ' HA ' HD12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -38.09 -37.56 0.27 Allowed 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.159 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.42 ' N ' ' HG ' ' A' ' 101' ' ' LEU . 65.1 t0 -60.96 -59.77 4.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.628 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.545 ' HB2' HG23 ' A' ' 99' ' ' ILE . 52.7 mt-10 -60.05 -22.66 62.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.77 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 133' ' ' ILE . 82.9 mt -75.79 -61.38 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.643 ' HG2' ' O ' ' A' ' 101' ' ' LEU . 4.0 mm100 -55.29 -33.57 63.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.638 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -80.47 -28.58 37.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.003 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 103' ' ' GLU . . . -66.71 -4.57 9.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.835 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 76.2 m -115.55 77.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.516 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -79.54 -53.87 6.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.55 -16.75 59.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.005 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.835 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 11.1 m-85 -63.46 -56.67 14.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.916 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.45 38.75 1.07 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.998 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.925 ' HA ' HD12 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -32.63 124.09 0.34 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.541 0.686 . . . . 0.0 112.258 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.609 ' N ' HD22 ' A' ' 113' ' ' LEU . 34.1 t0 -150.71 173.77 13.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.275 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.826 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 1.4 m-20 -77.85 -7.44 56.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.012 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.8 mt -81.71 -65.52 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -92.55 -69.27 0.75 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.925 HD12 ' HA ' ' A' ' 113' ' ' LEU . 15.1 mt -54.29 -18.89 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.826 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 38.8 t70 -70.6 -64.96 0.8 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.429 0.157 . . . . 0.0 110.924 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 124' ' ' GLU . 54.8 p30 -61.13 -16.99 50.33 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.892 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 22.2 ttp -61.15 -33.74 73.9 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.38 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.525 HG22 ' HA3' ' A' ' 131' ' ' GLY . 61.2 mt -58.32 -44.02 87.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.657 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 4.5 mptt -86.33 -13.06 47.66 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.562 -1.654 . . . . 0.0 110.187 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.892 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 41.4 tp10 -81.65 -24.4 36.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.84 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.789 HG21 HD13 ' A' ' 133' ' ' ILE . 19.3 mt -112.17 -19.4 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.206 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.864 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 14.1 t70 -66.13 83.86 0.09 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.844 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.563 HE22 ' HA ' ' A' ' 137' ' ' GLU . 8.2 mt-30 -85.19 -8.69 58.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.307 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 12.4 p-10 -126.61 -30.25 2.83 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.756 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.74 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.756 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 1.3 m-20 -65.21 25.95 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 -173.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.864 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.65 37.56 68.56 Favored Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 117.505 -2.283 . . . . 0.0 108.193 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.809 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 10.0 pt20 -129.27 167.07 18.23 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.678 -1.261 . . . . 0.0 109.87 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.789 HD13 HG21 ' A' ' 125' ' ' ILE . 18.6 mt -129.75 116.39 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.753 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.764 ' OD1' ' HG3' ' A' ' 137' ' ' GLU . 0.7 OUTLIER -100.33 165.53 11.42 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.702 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 32.5 t80 -45.81 -23.43 0.27 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.178 0.513 . . . . 0.0 110.149 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.493 ' H ' ' CG ' ' A' ' 134' ' ' ASP . . . -82.45 -39.95 10.45 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.049 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.764 ' HG3' ' OD1' ' A' ' 134' ' ' ASP . 38.8 mt-10 -70.01 -57.46 4.97 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 116.075 -0.063 . . . . 0.0 111.065 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.639 ' HD1' HG21 ' A' ' 133' ' ' ILE . 1.3 t80 -57.87 -50.95 71.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.519 -178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.4 -19.52 56.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.648 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 142' ' ' MET . . . -90.73 -51.72 5.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.956 0.408 . . . . 0.0 111.86 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -65.19 8.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.325 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.445 ' H ' ' C ' ' A' ' 140' ' ' ALA . 4.1 ppp? . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 110.998 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.612 HD12 HD23 ' A' ' 15' ' ' LEU . 44.2 tp . . . . . 0 CA--C 1.522 -0.106 0 CA-C-O 120.509 0.195 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . 22.0 pttp -60.42 -41.42 93.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 18' ' ' MET . 87.6 tt0 -68.01 -27.68 66.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.72 177.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.695 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 32.6 tp -72.08 -32.88 67.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.082 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.438 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 6.0 t80 -64.58 -50.25 67.97 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.337 0.589 . . . . 0.0 109.537 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -73.64 -15.03 61.26 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.695 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -70.07 -20.46 63.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.805 178.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.837 HG23 ' HA3' ' A' ' 35' ' ' GLY . 9.2 mm -81.24 -62.16 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.828 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.627 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -85.76 70.42 10.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.895 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.621 HG22 HH22 ' A' ' 38' ' ' ARG . 15.1 t -87.25 -6.46 58.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.244 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -131.98 -24.13 2.16 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.414 ' C ' HD22 ' A' ' 23' ' ' ASN . 0.7 OUTLIER -71.58 -76.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.7 p -175.0 -4.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.462 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 110.4 30.12 3.44 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -177.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.585 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 49.6 p -143.71 146.34 33.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 113.837 -1.182 . . . . 0.0 109.413 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.914 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.1 mt -103.24 104.22 16.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 68.6 p -103.39 165.99 10.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.609 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.655 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 9.5 t80 -34.24 -33.33 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.146 -0.933 . . . . 0.0 112.327 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -79.49 -52.66 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.889 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.627 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 31.9 mt-10 -73.65 -14.16 61.12 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.494 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.776 HD12 HG13 ' A' ' 48' ' ' ILE . 2.3 tm? -54.89 -56.21 22.01 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 12.8 ptpt -75.62 -44.01 45.05 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.281 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.631 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 62.3 t0 -43.15 -65.33 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 0.0 110.494 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.837 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -62.21 -50.68 62.79 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.542 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.64 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -60.72 -65.11 0.74 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 117.263 0.532 . . . . 0.0 110.738 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -51.97 -23.95 5.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.204 179.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.631 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 38.4 ttm180 -57.73 -43.67 85.47 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.143 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' LEU . 22.3 m -73.5 20.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 38' ' ' ARG . . . 100.0 -15.45 59.32 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.414 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 37' ' ' LYS . 74.4 m -60.45 155.4 18.36 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.795 0.331 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 15.5 pt-20 -138.56 107.25 5.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.163 0.506 . . . . 0.0 110.854 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 mt -125.34 166.1 17.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.153 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.567 ' O ' HD13 ' A' ' 48' ' ' ILE . 30.2 mtm -111.69 163.99 13.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -49.15 -65.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.043 -178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.2 m -48.9 -20.67 0.53 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.465 0.575 . . . . 0.0 111.932 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 95.1 mt-10 -80.29 -43.84 20.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.776 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -55.44 -54.86 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 122.266 1.031 . . . . 0.0 108.5 177.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.657 ' HZ1' ' HE2' ' A' ' 109' ' ' LYS . 50.8 tttp -58.81 -29.0 66.54 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.322 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 38.0 t70 -67.99 -53.77 23.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.687 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.512 HD22 HD21 ' A' ' 32' ' ' LEU . 2.5 tt -54.91 -32.13 60.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.47 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.534 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 25.2 mtt -72.1 -65.72 0.74 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.588 ' HB2' ' NZ ' ' A' ' 59' ' ' LYS . 41.9 t0 -65.36 -18.82 65.62 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.119 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.77 -34.1 14.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.859 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -118.67 -43.67 2.67 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' MET . 63.7 t0 -46.89 99.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.5 mm -50.38 -23.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.041 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.654 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 7.9 t70 -130.59 45.66 2.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.416 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.588 ' NZ ' ' HB2' ' A' ' 53' ' ' ASP . 23.3 tptm -31.99 91.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.83 0.824 . . . . 0.0 112.992 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 58' ' ' ASP . 39.7 m -127.42 18.62 6.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.546 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 68.33 19.09 72.11 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 97.0 m -146.55 143.35 28.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.6 -0.8 . . . . 0.0 109.759 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.914 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.9 mt -128.3 126.6 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.191 0.52 . . . . 0.0 111.587 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 65' ' ' TYR . 31.4 m-20 -104.29 167.73 9.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.596 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.623 ' O ' HG13 ' A' ' 69' ' ' ILE . 33.9 t80 -34.85 -47.92 0.37 Allowed 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.229 0.331 . . . . 0.0 111.412 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.31 -61.71 6.81 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.115 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.777 ' HB2' HG23 ' A' ' 63' ' ' ILE . 28.0 mt-10 -56.28 -24.82 45.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.687 0.28 . . . . 0.0 111.16 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.651 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 39.4 t80 -65.21 -53.8 39.08 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.298 0.571 . . . . 0.0 110.817 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 65' ' ' TYR . 3.7 mt -61.25 -46.3 96.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.063 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.18 -10.78 53.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.308 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.558 -179.837 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.441 ' HA ' ' CB ' ' A' ' 88' ' ' PHE . 32.6 m . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.626 0.25 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -53.3 -66.04 0.46 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.847 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.702 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -69.78 -33.27 72.16 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.813 ' HZ ' ' HA2' ' A' ' 97' ' ' GLY . 11.3 t80 -46.42 -22.12 0.23 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.528 177.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.422 ' N ' ' C ' ' A' ' 87' ' ' ALA . 46.6 t -89.17 -43.3 11.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.6 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -81.09 -64.48 1.18 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.496 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.539 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.5 m-85 -56.12 -61.89 2.08 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.806 ' HA ' HG12 ' A' ' 99' ' ' ILE . 63.1 t0 -80.6 61.69 4.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.466 ' HE3' HE21 ' A' ' 106' ' ' GLN . 19.6 ttmm -42.28 -36.08 1.15 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.144 -177.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -89.84 -22.84 21.87 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.601 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 52.97 73.88 0.36 Allowed Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 60.1 p -122.37 -5.3 8.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.813 ' HA2' ' HZ ' ' A' ' 88' ' ' PHE . . . 109.78 -9.8 32.24 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.967 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.535 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -142.24 158.54 43.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.558 0.694 . . . . 0.0 112.383 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.806 HG12 ' HA ' ' A' ' 92' ' ' ASP . 82.3 mt -131.61 104.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.711 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.7 p -69.14 147.34 51.53 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.8 ' HB3' HG23 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -35.27 -35.63 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -57.02 -52.82 63.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.672 0.273 . . . . 0.0 111.023 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.728 ' HB2' HG23 ' A' ' 99' ' ' ILE . 97.4 mt-10 -59.93 -30.4 69.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.723 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.802 HD11 HG12 ' A' ' 133' ' ' ILE . 88.4 mt -75.67 -61.58 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.104 0.478 . . . . 0.0 110.283 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.704 HE21 HG23 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -51.91 -29.26 19.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.734 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.466 HE21 ' HE3' ' A' ' 93' ' ' LYS . 41.5 tt0 -63.82 -42.86 97.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.904 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 108' ' ' CYS . . . -50.02 -65.9 0.48 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.974 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.804 ' HB2' ' CD1' ' A' ' 111' ' ' PHE . 10.6 p -34.31 115.89 0.28 Allowed 'General case' 0 C--O 1.22 -0.475 0 O-C-N 123.739 0.649 . . . . 0.0 109.622 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.657 ' HE2' ' HZ1' ' A' ' 49' ' ' LYS . 25.1 ttmm -88.46 -58.66 2.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.25 -15.55 4.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.444 0.64 . . . . 0.0 110.065 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.804 ' CD1' ' HB2' ' A' ' 108' ' ' CYS . 0.2 OUTLIER -112.27 -49.76 2.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.189 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 108' ' ' CYS . . . 79.62 -21.94 4.28 Favored Glycine 0 CA--C 1.509 -0.33 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.248 -177.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.816 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 176.44 53.84 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.508 ' O ' HG13 ' A' ' 118' ' ' ILE . 51.1 t0 -34.04 100.2 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 112.248 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.62 -18.0 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.502 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.4 mm -92.35 -49.39 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.795 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.576 ' CD2' ' HG3' ' A' ' 121' ' ' MET . 15.2 t-160 -78.65 -38.85 38.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.448 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.704 HG23 HE21 ' A' ' 105' ' ' GLN . 3.2 mt -36.11 -61.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 118' ' ' ILE . 65.6 t0 -48.26 -60.44 2.65 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.9 0.381 . . . . 0.0 111.412 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.724 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 57.9 m-20 -67.64 -17.08 64.48 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.613 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.785 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.8 mtp -77.26 -52.69 8.78 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 123.631 0.772 . . . . 0.0 112.338 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.8 HG23 ' HB3' ' A' ' 101' ' ' LEU . 55.4 mt -50.05 -39.47 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.662 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.51 -19.13 29.97 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.249 -1.796 . . . . 0.0 110.959 178.401 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.785 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 17.0 tp10 -79.32 -18.26 52.92 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.758 HG22 ' CD1' ' A' ' 133' ' ' ILE . 16.2 mt -115.43 -32.89 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.213 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.714 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 13.1 t0 -62.98 112.7 2.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.236 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.674 ' NE2' ' HB3' ' A' ' 137' ' ' GLU . 0.3 OUTLIER -89.22 -9.71 49.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -133.54 -32.35 1.15 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -178.42 -72.49 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 117.314 2.339 . . . . 0.0 117.314 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.454 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 40.1 t0 -63.78 13.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -172.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.767 ' HA3' HG22 ' A' ' 122' ' ' ILE . . . 55.97 37.68 71.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 117.804 -2.141 . . . . 0.0 108.967 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.798 ' O ' HD13 ' A' ' 133' ' ' ILE . 7.7 pt20 -128.98 167.18 17.83 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 113.435 -1.382 . . . . 0.0 109.675 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.802 HG12 HD11 ' A' ' 104' ' ' ILE . 40.1 mm -125.8 124.56 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 CA-C-O 122.107 0.956 . . . . 0.0 111.404 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.909 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 35.4 t70 -103.03 158.79 16.05 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.18 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.626 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 16.0 t80 -48.41 -27.83 2.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.136 0.493 . . . . 0.0 109.872 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -85.51 -38.04 9.2 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 177.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.909 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 51.0 mt-10 -63.45 -57.99 8.49 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.702 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 26.4 t80 -52.41 -18.53 1.68 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.151 0.5 . . . . 0.0 109.978 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -81.69 -36.14 29.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.251 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.64 -38.45 25.92 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.647 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.579 ' HB3' ' OE1' ' A' ' 127' ' ' GLN . 5.3 ppp? -56.49 -20.19 19.06 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.851 0.357 . . . . 0.0 110.997 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 36.8 ttm . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.68 -179.933 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 86.6 mt . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.483 0.183 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -68.24 -53.7 22.86 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.857 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 39.2 tt0 -64.92 -22.99 67.09 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 47.9 tp -74.88 -37.77 62.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.873 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.534 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 14.1 t80 -61.36 -46.85 88.51 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.857 ' HE2' ' HA ' ' A' ' 14' ' ' GLU . 59.5 pttt -75.96 -12.92 60.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.634 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.73 -18.01 60.56 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.891 178.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.869 HG23 ' HA3' ' A' ' 35' ' ' GLY . 7.1 mm -82.61 -61.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.932 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.735 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -77.65 59.81 2.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.823 -178.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 t -87.18 -6.15 58.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.495 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.619 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 5.4 m-20 -113.82 -28.1 7.54 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -83.03 -89.81 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.864 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.0 p -176.15 19.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.395 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.616 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.54 22.97 5.86 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 76.2 p -137.62 143.64 41.54 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.911 -0.644 . . . . 0.0 110.154 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.873 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.3 mt -102.34 103.7 15.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.745 -177.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 82.2 p -104.02 165.47 11.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.097 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -34.13 -34.47 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.778 0.674 . . . . 0.0 112.438 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -79.31 -48.02 14.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.929 0.395 . . . . 0.0 110.494 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.619 ' OE2' ' HB2' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -74.57 -14.32 60.77 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.363 178.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.785 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -58.63 -56.03 27.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.614 ' NZ ' HG12 ' A' ' 48' ' ' ILE . 6.4 ptpp? -73.92 -48.1 33.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.523 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.663 ' O ' ' HB3' ' A' ' 38' ' ' ARG . 32.1 t70 -37.84 -64.18 0.42 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.41 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.869 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -47.39 -41.02 16.34 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 115.459 0.944 . . . . 0.0 115.459 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.638 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -94.99 -56.08 2.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.91 0.855 . . . . 0.0 110.955 -178.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -50.18 -18.08 0.53 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.401 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.663 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 6.3 ptm180 -67.14 -38.43 85.51 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 36' ' ' LEU . 27.0 m -77.9 23.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.76 -23.25 33.12 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.735 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m -59.52 156.13 13.88 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.741 0.305 . . . . 0.0 110.632 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -136.78 109.28 7.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.233 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 mt -113.04 165.27 12.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.974 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.436 ' O ' HD13 ' A' ' 48' ' ' ILE . 28.0 mtm -113.86 157.55 22.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 48' ' ' ILE . 37.5 mt-10 -44.87 -64.99 0.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.1 t -42.95 -29.44 0.33 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 56.7 mm-40 -70.39 -40.36 73.96 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.264 0.555 . . . . 0.0 109.569 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.785 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -59.67 -60.94 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.321 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -56.58 -26.63 55.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.645 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.559 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 60.6 t0 -66.29 -46.17 77.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.829 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.753 HD22 HD21 ' A' ' 32' ' ' LEU . 10.5 tt -67.65 -21.69 65.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.142 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.808 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 21.7 mmt -73.24 -43.54 61.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.477 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -86.96 -23.66 25.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.867 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.56 -25.55 19.17 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.49 -43.77 1.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.758 ' HB3' ' O ' ' A' ' 52' ' ' MET . 67.3 t0 -59.2 94.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.345 0.593 . . . . 0.0 110.241 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.0 mm -51.91 -19.43 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.337 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 60' ' ' SER . 8.4 t70 -130.3 43.9 3.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.638 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.808 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 12.7 tmtt? -32.7 88.2 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.744 0.783 . . . . 0.0 112.436 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' ASP . 76.3 p -128.55 18.32 6.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.062 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 75.89 15.24 81.47 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.375 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 97.2 m -146.55 142.71 28.28 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.118 0.567 . . . . 0.0 109.62 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.873 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 57.7 mt -128.98 133.69 65.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.271 0.558 . . . . 0.0 112.204 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 58.0 m-20 -106.53 167.97 9.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.616 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.413 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 29.4 t80 -35.27 -44.04 0.25 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.509 0.505 . . . . 0.0 111.717 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -56.0 7.99 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.765 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.732 ' HB2' HG23 ' A' ' 63' ' ' ILE . 24.1 mt-10 -56.25 -19.7 15.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 110.441 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.598 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 42.0 t80 -68.57 -60.04 2.7 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.555 0.693 . . . . 0.0 110.495 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.9 mm -59.97 -26.13 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.291 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.78 -8.86 5.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.961 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.639 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.549 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . 33.8 m . . . . . 0 C--O 1.234 0.246 0 CA-C-O 120.719 0.295 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.2 m -53.73 -21.98 8.29 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -76.92 -55.02 5.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.409 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.718 ' CE1' ' HA ' ' A' ' 135' ' ' TYR . 40.6 m-85 -49.77 -20.07 0.77 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.217 0.532 . . . . 0.0 109.719 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 87' ' ' ALA . 48.1 t -88.93 -48.06 7.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.05 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -83.11 -63.82 1.29 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.492 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.55 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.8 m-85 -58.99 -62.56 1.79 Allowed 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.774 ' HA ' HG12 ' A' ' 99' ' ' ILE . 62.7 t0 -74.81 63.89 1.21 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 93' ' ' LYS . 25.0 ttmt -48.19 -43.33 31.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.231 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.8 m-20 -74.08 -22.63 59.43 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.474 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.56 -10.02 0.34 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.339 -0.458 . . . . 0.0 112.963 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 94' ' ' ASP . 79.1 p -49.58 -16.3 0.21 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.56 -29.78 3.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.623 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.749 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -115.03 163.31 15.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.678 0.751 . . . . 0.0 112.709 -178.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.788 HG22 HG13 ' A' ' 104' ' ' ILE . 54.5 mt -133.13 102.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.221 177.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 101' ' ' LEU . 44.9 p -73.63 149.28 42.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.0 pp -34.95 -39.41 0.1 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.75 0.31 . . . . 0.0 111.115 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.512 ' N ' HD12 ' A' ' 101' ' ' LEU . 1.6 m-20 -54.89 -60.97 2.63 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.516 ' HB2' HG23 ' A' ' 99' ' ' ILE . 50.4 mt-10 -51.87 -47.88 64.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.977 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.788 HG13 HG22 ' A' ' 99' ' ' ILE . 90.5 mt -54.73 -65.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.701 0.762 . . . . 0.0 111.362 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.769 ' HB3' HD22 ' A' ' 113' ' ' LEU . 2.4 mm-40 -62.18 -65.23 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.925 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -42.26 -37.4 1.49 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.699 0.285 . . . . 0.0 111.667 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 103' ' ' GLU . . . -48.65 -57.99 5.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 3.4 t -57.0 131.87 51.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.557 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.9 -48.0 7.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.126 0.489 . . . . 0.0 112.294 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.13 -0.63 55.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.334 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.662 ' CD2' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -44.94 -83.76 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.461 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 107.05 40.09 1.88 Allowed Glycine 0 C--N 1.333 0.399 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.207 -176.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.853 HD23 HG12 ' A' ' 118' ' ' ILE . 15.2 mt -31.25 133.02 0.09 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -176.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.718 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 12.4 p-10 -152.79 172.78 16.19 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.651 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 8.7 t70 -73.85 -22.22 59.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.505 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 62.3 mt -72.39 -64.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 121' ' ' MET . 16.9 m80 -92.17 -70.1 0.71 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.853 HG12 HD23 ' A' ' 113' ' ' LEU . 1.7 mp -47.31 -55.36 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -177.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.517 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 37.9 m-20 -60.63 -49.3 78.06 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.744 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 8.6 t70 -67.66 -19.48 65.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 1.002 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.2 mtp -69.89 -40.04 75.9 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.844 0.858 . . . . 0.0 110.274 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.813 HG23 ' HB3' ' A' ' 101' ' ' LEU . 56.8 mt -50.8 -46.63 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 43.7 mmtt -87.37 -13.58 43.06 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.006 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 1.002 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 15.9 tp10 -86.27 -17.1 35.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.71 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.738 HG22 ' CD1' ' A' ' 133' ' ' ILE . 22.6 mt -113.52 -32.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.331 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.62 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 17.3 t70 -63.33 112.29 2.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.954 0.407 . . . . 0.0 111.618 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.68 HE22 ' HB3' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -88.31 -9.37 53.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.413 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 36.7 m-20 -131.32 -32.13 1.58 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -176.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.684 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -178.79 -74.26 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.684 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 21.4 m-20 -63.97 17.77 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.76 ' HA3' HG22 ' A' ' 122' ' ' ILE . . . 55.07 37.29 62.91 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.376 -1.869 . . . . 0.0 108.99 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.77 ' O ' HD13 ' A' ' 133' ' ' ILE . 8.7 pt20 -131.55 166.92 20.33 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 113.934 -1.133 . . . . 0.0 109.148 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.771 HG12 HD11 ' A' ' 104' ' ' ILE . 36.0 mm -123.5 131.99 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-O 121.736 0.779 . . . . 0.0 111.172 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.816 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 39.0 t70 -101.09 160.32 14.48 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.876 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.718 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 15.0 t80 -48.05 -31.44 5.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.132 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.61 -33.55 15.99 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 119.888 -1.148 . . . . 0.0 110.429 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.816 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 52.6 mt-10 -64.28 -58.0 7.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.37 -0.415 . . . . 0.0 111.197 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.598 ' HD1' HG21 ' A' ' 133' ' ' ILE . 2.8 t80 -54.53 -37.94 65.98 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.753 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.09 -20.92 64.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.181 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.3 -50.33 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -19.91 9.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.688 0.28 . . . . 0.0 111.292 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 67.6 mtm . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.811 179.507 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.636 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 7.5 mp . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 111.341 0.126 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.604 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 7.9 tmtm? -56.39 -53.64 54.96 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.648 ' HA ' ' NZ ' ' A' ' 17' ' ' LYS . 88.7 tt0 -66.4 -43.82 84.75 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.982 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.759 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 29.0 tp -58.79 -23.04 59.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.729 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.45 ' HA ' ' CE1' ' A' ' 68' ' ' PHE . 37.9 t80 -76.02 -56.58 4.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.995 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.648 ' NZ ' ' HA ' ' A' ' 14' ' ' GLU . 25.2 pttm -71.52 -12.52 61.42 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.441 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 10.1 mtp -70.26 -37.98 75.02 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.199 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.704 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 3.3 mt -64.56 -57.6 10.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.997 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' A' ' 26' ' ' THR . 1.6 p30 -81.33 61.09 4.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.876 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.527 HG21 ' HD2' ' A' ' 38' ' ' ARG . 9.8 t -72.85 -14.51 61.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.333 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -138.21 -15.26 1.29 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.645 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 27.6 t-20 -64.18 -81.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.0 p -176.91 2.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.504 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.41 12.43 17.26 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 53.5 p -126.24 152.97 45.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.574 -0.813 . . . . 0.0 108.944 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.844 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 3.6 mt -110.0 103.22 15.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.665 HG22 ' OG1' ' A' ' 62' ' ' THR . 81.3 p -103.9 153.55 20.66 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.898 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.662 ' HZ ' ' HB3' ' A' ' 45' ' ' GLU . 59.8 t80 -34.12 -26.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 28' ' ' THR . 54.9 m-20 -80.5 -39.78 27.31 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.645 ' HG2' ' HB2' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -86.83 -29.6 22.12 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.531 178.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.701 ' CG ' HG23 ' A' ' 48' ' ' ILE . 2.1 tm? -39.91 -49.52 2.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.789 0.804 . . . . 0.0 109.644 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.813 ' HB3' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.24 -37.41 53.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.143 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.596 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 9.5 t70 -46.53 -27.73 1.2 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.08 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.704 ' HA2' ' HA ' ' A' ' 19' ' ' ILE . . . -55.92 -50.5 60.97 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.802 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.783 ' O ' HG12 ' A' ' 39' ' ' VAL . 2.2 mm? -92.59 -28.62 16.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.825 0.345 . . . . 0.0 110.766 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 34' ' ' ASP . 51.7 mtmt -56.94 -48.51 78.12 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.527 ' HD2' HG21 ' A' ' 21' ' ' THR . 25.8 ttt85 -59.74 -37.63 79.48 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.842 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -70.19 -21.99 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.811 -178.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.33 -27.11 4.28 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.052 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 74.1 m -65.03 154.54 37.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.689 0.28 . . . . 0.0 111.095 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -126.82 103.08 7.32 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.564 0.697 . . . . 0.0 111.241 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.827 HD13 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -111.61 166.87 10.79 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.397 -179.366 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.554 ' O ' HD13 ' A' ' 48' ' ' ILE . 17.3 ptt? -107.84 165.45 11.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.646 0.26 . . . . 0.0 110.829 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.694 ' HG3' ' HZ3' ' A' ' 33' ' ' LYS . 58.5 mp0 -51.82 -64.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.7 m -43.18 -17.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.517 ' HG3' ' HG3' ' A' ' 44' ' ' MET . 96.0 mt-10 -84.69 -41.59 16.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.827 HD11 HD13 ' A' ' 43' ' ' LEU . 1.5 mp -56.17 -49.77 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.44 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.54 ' CE ' ' HD3' ' A' ' 93' ' ' LYS . 4.3 ttmp? -57.95 -22.45 49.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.566 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.812 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 9.0 t70 -75.18 -25.7 58.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.622 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.779 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 62.4 tp -90.37 -30.89 17.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.05 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.775 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 39.1 ttm -88.02 -66.16 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.802 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.824 ' HA ' ' HG3' ' A' ' 59' ' ' LYS . 60.9 t0 -68.16 -38.77 82.45 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -86.75 -12.06 49.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.81 ' HB1' ' HA ' ' A' ' 71' ' ' ALA . . . -127.34 -44.12 1.58 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.65 ' HB3' ' O ' ' A' ' 52' ' ' MET . 63.2 t0 -53.97 132.67 42.69 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.2 mm -81.61 -14.75 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.805 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 60' ' ' SER . 74.0 m-20 -128.21 28.62 5.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.762 -178.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.824 ' HG3' ' HA ' ' A' ' 53' ' ' ASP . 12.1 tmtt? -31.61 90.68 0.0 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.937 0.875 . . . . 0.0 112.137 -177.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.7 p -128.26 18.39 6.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.519 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 81.72 15.42 75.61 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.65 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.715 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 40.4 m -155.82 128.47 7.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.494 0.318 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.844 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 52.9 mt -110.86 136.47 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 121.178 0.513 . . . . 0.0 110.941 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -104.6 168.96 8.74 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.161 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.604 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 26.6 t80 -40.6 -39.26 1.01 Allowed 'General case' 0 CA--C 1.519 -0.213 0 O-C-N 123.42 0.45 . . . . 0.0 111.093 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.9 -57.78 4.31 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.922 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.84 ' HB2' HG23 ' A' ' 63' ' ' ILE . 34.4 mt-10 -49.79 -20.77 0.92 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.242 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.759 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 68.6 t80 -69.89 -57.26 5.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.389 0.614 . . . . 0.0 110.653 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.464 HG23 HD22 ' A' ' 12' ' ' LEU . 1.2 mt -63.54 -40.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.16 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.92 -6.58 28.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.043 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.81 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.495 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.685 0.278 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 m -48.9 -30.37 5.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.396 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -81.53 -52.2 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.241 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.829 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 11.9 t80 -42.81 -26.5 0.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.278 0.561 . . . . 0.0 109.854 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.41 ' N ' ' C ' ' A' ' 87' ' ' ALA . 31.7 t -89.22 -58.33 2.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.952 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -77.03 -63.84 1.27 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.398 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.692 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.6 m-85 -55.47 -61.84 2.07 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.829 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 1.0 OUTLIER -74.55 60.41 0.88 Allowed 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.54 ' HD3' ' CE ' ' A' ' 49' ' ' LYS . 26.3 ttmt -47.61 -41.63 22.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.037 -177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 96' ' ' SER . 1.4 m-20 -79.73 -21.15 44.9 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.919 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . 65.06 -6.16 1.09 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.971 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 94' ' ' ASP . 86.1 p -55.7 -8.28 0.38 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.886 0.374 . . . . 0.0 110.894 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 108.17 -0.49 33.31 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.729 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.782 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.6 OUTLIER -139.24 154.1 47.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.675 0.75 . . . . 0.0 112.818 -178.649 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.692 HD13 ' HB3' ' A' ' 91' ' ' PHE . 85.9 mt -132.15 102.95 6.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.345 177.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.522 ' HA ' ' CB ' ' A' ' 132' ' ' GLN . 67.8 p -87.02 163.74 16.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.947 0.794 . . . . 0.0 111.226 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.664 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -35.95 -36.99 0.09 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.105 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.3 -54.15 44.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.905 0.383 . . . . 0.0 110.111 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.412 ' CB ' HG23 ' A' ' 99' ' ' ILE . 52.1 mt-10 -62.66 -31.42 72.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.143 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.666 HG22 ' N ' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -75.39 -64.97 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.666 ' N ' HG22 ' A' ' 104' ' ' ILE . 14.6 mt-30 -54.4 -31.88 56.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.688 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -73.19 -47.33 44.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.044 0.45 . . . . 0.0 110.078 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.82 -2.99 2.89 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.161 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 105' ' ' GLN . 24.2 p -135.58 39.66 2.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.094 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -67.54 -23.05 65.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.956 0.408 . . . . 0.0 110.477 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.36 -6.59 59.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.599 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -91.48 14.27 15.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.851 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.92 37.57 56.63 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.078 -1.058 . . . . 0.0 111.875 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.828 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -34.55 117.25 0.35 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.371 0.605 . . . . 0.0 112.042 -178.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.668 ' N ' HD22 ' A' ' 113' ' ' LEU . 54.5 m-20 -154.58 -177.09 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.027 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.744 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 12.3 p-10 -84.07 -7.65 59.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.436 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.6 mm -83.38 -64.77 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.433 ' O ' ' HB2' ' A' ' 121' ' ' MET . 4.6 m-70 -91.91 -68.5 0.79 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.828 HG13 ' HA ' ' A' ' 113' ' ' LEU . 40.5 mm -52.09 -20.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.214 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.744 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 8.1 t70 -76.5 -60.94 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 124' ' ' GLU . 33.9 m-20 -58.42 -17.09 17.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.762 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 14.2 ttp -67.51 -46.84 71.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.584 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.626 HG22 ' HA3' ' A' ' 131' ' ' GLY . 59.9 mt -48.74 -41.48 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 176.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 24.4 mmtp -87.36 -19.84 27.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.308 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.762 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 4.8 tp10 -76.12 -16.31 59.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.568 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.794 HG21 HD13 ' A' ' 133' ' ' ILE . 1.2 mt -117.15 -34.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.033 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.758 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 22.8 t70 -55.27 93.32 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.113 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.526 ' NE2' ' HA ' ' A' ' 137' ' ' GLU . 17.8 mt-30 -83.81 -9.27 58.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.009 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 6.6 p-10 -131.65 -30.6 1.63 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.753 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -176.79 -80.42 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 118.277 2.695 . . . . 0.0 118.277 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.753 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 15.7 m-20 -64.08 27.41 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -172.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.758 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 54.95 37.69 63.24 Favored Glycine 0 CA--C 1.498 -1.004 0 C-N-CA 118.184 -1.96 . . . . 0.0 108.893 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.782 ' NE2' ' HB3' ' A' ' 98' ' ' TYR . 12.7 pt20 -135.17 166.26 23.5 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.375 -0.912 . . . . 0.0 110.841 -176.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.794 HD13 HG21 ' A' ' 125' ' ' ILE . 4.4 mt -121.54 125.28 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.353 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -103.97 165.54 10.98 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.676 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 30.5 t80 -49.84 -24.42 2.43 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.763 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.88 -44.87 11.28 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.536 ' HG3' ' OD1' ' A' ' 134' ' ' ASP . 42.1 mt-10 -62.08 -62.75 1.56 Allowed 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.731 ' HD1' HG21 ' A' ' 133' ' ' ILE . 1.9 t80 -56.38 -32.63 64.97 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.2 -0.6 . . . . 0.0 112.111 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.74 -23.07 49.42 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.143 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.71 -51.2 5.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.037 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.543 ' SD ' ' HA ' ' A' ' 138' ' ' PHE . 27.3 ptm -49.11 -22.91 1.04 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.58 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 63.3 mtm . . . . . 0 C--N 1.332 -0.185 0 CA-C-O 120.868 0.366 . . . . 0.0 110.695 179.491 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 12' ' ' LEU . 3.2 tm? . . . . . 0 C--O 1.231 0.082 0 N-CA-C 110.771 -0.085 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.521 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -51.99 -38.96 58.56 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.101 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.696 ' O ' ' HG2' ' A' ' 18' ' ' MET . 38.6 tt0 -70.94 -49.72 42.53 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.635 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 55.5 tp -47.99 -33.12 7.39 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.037 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.489 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 32.1 t80 -60.05 -50.33 74.15 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.151 0.5 . . . . 0.0 110.927 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -79.95 -15.6 56.95 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.094 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.696 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 81.4 mmm -69.51 -28.73 66.29 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.363 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.72 HG21 HG23 ' A' ' 27' ' ' ILE . 0.9 OUTLIER -69.36 -59.11 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.636 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.765 ' HB3' ' O ' ' A' ' 26' ' ' THR . 2.1 p30 -80.84 45.66 0.83 Allowed 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.932 0.873 . . . . 0.0 111.771 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.643 HG21 ' HD2' ' A' ' 38' ' ' ARG . 15.1 t -66.0 -6.53 13.05 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.986 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.57 -7.17 2.87 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.443 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 24.2 t-20 -91.83 -93.86 0.14 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.698 -0.401 . . . . 0.0 112.063 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.6 p -177.36 14.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.498 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.47 17.17 9.49 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.185 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 74.0 p -125.17 158.98 32.62 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.879 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 1.6 mt -123.09 101.66 9.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.679 HG22 ' HB ' ' A' ' 62' ' ' THR . 76.7 p -103.28 156.87 17.41 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.385 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.43 ' HZ ' ' HB3' ' A' ' 45' ' ' GLU . 60.3 t80 -33.65 -38.49 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.98 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 9.6 t70 -71.18 -43.9 66.52 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 111.243 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -79.43 -27.72 41.7 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.65 178.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.045 HD12 HD12 ' A' ' 48' ' ' ILE . 1.6 tm? -50.75 -55.08 18.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.129 0.49 . . . . 0.0 109.965 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.587 ' HB3' HD11 ' A' ' 48' ' ' ILE . 1.1 ptmm? -77.02 -39.04 51.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.119 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 38.8 t70 -41.73 -41.18 2.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.562 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.99 91.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.443 -0.408 . . . . 0.0 114.097 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.826 HD22 HD11 ' A' ' 43' ' ' LEU . 2.2 mp -89.26 -45.07 9.81 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 41' ' ' SER . 17.4 ptpt -59.12 -21.92 60.04 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.643 ' HD2' HG21 ' A' ' 21' ' ' THR . 36.8 ttt-85 -79.57 -40.56 29.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.39 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 36' ' ' LEU . 2.9 p -78.98 -12.96 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.72 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.54 -44.62 1.19 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.375 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 69.4 m -52.96 161.9 0.71 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.681 0.277 . . . . 0.0 111.525 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -134.24 105.1 6.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.606 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.826 HD11 HD22 ' A' ' 36' ' ' LEU . 68.7 mt -108.42 166.15 10.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.007 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.431 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 32.1 mtm -109.21 165.7 11.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.773 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HB3' ' HZ ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -55.47 -59.79 4.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.128 -179.309 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.7 m -55.09 -17.6 4.28 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.924 0.329 . . . . 0.0 111.737 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.4 mm-40 -79.69 -48.42 13.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.045 HD12 HD12 ' A' ' 32' ' ' LEU . 6.1 mm -56.86 -51.96 61.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.915 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -46.97 -33.16 4.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.006 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 63.9 t0 -60.3 -45.31 93.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.484 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.838 HD12 HD11 ' A' ' 32' ' ' LEU . 67.3 mt -67.07 -14.77 63.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.604 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -87.6 -65.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.04 0.448 . . . . 0.0 111.804 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.66 -37.13 70.84 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -91.28 -13.63 32.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.16 -43.56 1.64 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.614 ' OD1' HG12 ' A' ' 63' ' ' ILE . 34.0 t70 -62.25 103.6 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.857 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.0 mm -43.35 -27.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.286 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.584 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.6 m-20 -133.63 44.66 2.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.035 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.604 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 1.2 tmtp? -31.99 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.819 0.818 . . . . 0.0 112.339 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.0 p -126.81 10.54 7.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.165 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 103.63 -15.31 53.11 Favored Glycine 0 C--O 1.238 0.35 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.597 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.876 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 5.4 t -140.49 148.81 41.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.67 0.272 . . . . 0.0 110.88 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.879 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 78.6 mt -108.88 142.42 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.03 0.443 . . . . 0.0 111.244 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -105.69 166.78 10.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.971 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.653 ' O ' HG13 ' A' ' 69' ' ' ILE . 31.2 t80 -40.58 -48.91 2.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.794 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.34 -59.17 7.03 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.783 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.673 ' HB2' HG23 ' A' ' 63' ' ' ILE . 48.9 mt-10 -45.47 -31.9 1.95 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.804 0.335 . . . . 0.0 110.726 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 16' ' ' PHE . 9.9 t80 -66.06 -55.0 18.82 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.378 0.609 . . . . 0.0 110.152 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.653 HG13 ' O ' ' A' ' 65' ' ' TYR . 10.8 mt -57.06 -65.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.061 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -44.85 -48.33 11.08 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.557 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.649 ' HB1' ' HB1' ' A' ' 55' ' ' ALA . . . . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.455 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.4 p . . . . . 0 C--O 1.232 0.168 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.4 m -56.46 -37.43 70.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.127 0.489 . . . . 0.0 109.797 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.531 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -82.66 -47.92 11.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.064 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.769 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 21.7 t80 -41.85 -30.0 0.23 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.551 0.691 . . . . 0.0 109.65 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -89.9 -47.58 7.78 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.194 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -84.99 -63.88 1.25 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.271 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.606 ' HB3' HD13 ' A' ' 99' ' ' ILE . 4.1 m-85 -56.53 -56.5 20.45 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.813 ' HA ' HG12 ' A' ' 99' ' ' ILE . 0.4 OUTLIER -77.81 54.69 1.29 Allowed 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.624 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 3.7 ttmp? -49.07 -38.28 23.77 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.778 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.405 ' HB2' ' OE2' ' A' ' 103' ' ' GLU . 8.6 t70 -75.43 -23.06 56.92 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.777 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.74 73.07 0.31 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.415 ' HG ' ' HD1' ' A' ' 98' ' ' TYR . 25.4 p -132.1 -28.59 1.72 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 134.56 7.13 2.2 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 113.925 -1.488 . . . . 0.0 113.037 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.831 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -150.87 160.73 43.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.451 0.643 . . . . 0.0 111.362 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.813 HG12 ' HA ' ' A' ' 92' ' ' ASP . 70.1 mt -133.96 102.78 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.884 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 103' ' ' GLU . 72.9 p -73.14 150.93 41.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.347 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.599 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -35.03 -34.25 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -62.13 -51.69 66.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.539 ' HB2' HG23 ' A' ' 99' ' ' ILE . 53.9 mt-10 -71.13 -29.44 65.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.954 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.778 HG13 HG22 ' A' ' 99' ' ' ILE . 27.1 mt -68.39 -64.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.981 0.42 . . . . 0.0 110.395 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.716 ' O ' HD23 ' A' ' 113' ' ' LEU . 81.8 mt-30 -55.49 -39.57 70.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.456 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -65.31 -31.93 73.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.048 0.451 . . . . 0.0 110.447 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.73 -4.09 3.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.145 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 9.8 p -105.04 118.27 36.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.133 0.492 . . . . 0.0 110.587 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -88.82 -61.32 1.73 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.257 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.88 -4.45 58.47 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 108' ' ' CYS . 2.8 m-85 -65.71 -18.15 65.12 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.501 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.59 38.95 97.25 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.611 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.999 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -33.27 149.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.646 ' OD2' HG22 ' A' ' 116' ' ' ILE . 26.7 t70 -160.48 178.89 9.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.185 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.433 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 53.6 p-10 -89.38 -8.45 53.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.921 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.646 HG22 ' OD2' ' A' ' 114' ' ' ASP . 6.6 tp -92.53 -57.6 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.545 ' N ' HG23 ' A' ' 116' ' ' ILE . 10.0 t-80 -91.47 -68.65 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.999 HG13 ' HA ' ' A' ' 113' ' ' LEU . 46.9 mm -54.02 -19.61 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.968 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.492 ' HA ' ' NE2' ' A' ' 105' ' ' GLN . 38.5 t70 -66.91 -41.9 86.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 124' ' ' GLU . 7.4 t70 -71.2 -26.04 62.78 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.943 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 3.7 ttt -57.77 -30.26 65.5 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.161 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.552 ' HB ' ' HD2' ' A' ' 123' ' ' LYS . 58.9 mt -58.84 -43.95 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.681 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 3.7 mptt -86.64 -13.32 45.93 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 113.271 -1.786 . . . . 0.0 110.351 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.943 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 36.5 tp10 -82.14 -27.77 32.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.753 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.719 HG22 ' CD1' ' A' ' 133' ' ' ILE . 45.0 mt -100.41 -33.88 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.278 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.721 ' CG ' ' H ' ' A' ' 131' ' ' GLY . 7.3 t70 -83.47 84.92 7.34 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.41 0.624 . . . . 0.0 110.318 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.533 ' H ' ' CD ' ' A' ' 127' ' ' GLN . 2.9 pm0 -88.09 -9.29 53.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.806 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.659 ' HB3' ' OE1' ' A' ' 137' ' ' GLU . 5.6 t70 -130.17 -19.52 3.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 -177.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.573 HD22 ' HG2' ' A' ' 132' ' ' GLN . 15.3 t30 -115.37 -127.19 0.29 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -177.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.421 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 9.5 t0 -116.61 27.04 9.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -173.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.721 ' H ' ' CG ' ' A' ' 126' ' ' ASP . . . 94.65 37.11 5.37 Favored Glycine 0 CA--C 1.501 -0.836 0 N-CA-C 108.258 -1.937 . . . . 0.0 108.258 -177.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.699 ' NE2' ' HB3' ' A' ' 98' ' ' TYR . 8.4 pt20 -153.72 169.21 23.88 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.172 -1.514 . . . . 0.0 108.966 -177.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.719 ' CD1' HG22 ' A' ' 125' ' ' ILE . 25.9 mm -131.33 127.01 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-O 121.68 0.752 . . . . 0.0 111.067 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.831 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -102.09 160.51 14.45 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.208 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.736 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 24.4 t80 -41.64 -33.95 0.54 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.576 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.75 -35.54 18.89 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.855 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.659 ' OE1' ' HB3' ' A' ' 128' ' ' ASP . 61.2 mm-40 -62.11 -57.03 13.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.289 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.696 ' HD1' HG21 ' A' ' 133' ' ' ILE . 2.7 t80 -61.09 -38.37 86.02 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.14 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 142' ' ' MET . . . -58.71 -33.82 70.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.163 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.411 ' C ' ' N ' ' A' ' 142' ' ' MET . . . -90.72 -26.87 19.32 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.43 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.529 ' HG2' ' CD1' ' A' ' 138' ' ' PHE . 2.8 ppp? -51.6 -28.0 12.87 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 138' ' ' PHE . 17.1 ptp . . . . . 0 N--CA 1.444 -0.737 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.461 0.08 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.528 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 4.5 ttmp? -59.58 -51.35 70.21 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.659 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 84.8 tt0 -62.05 -30.73 71.18 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.134 178.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.72 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 40.4 tp -68.86 -30.33 68.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.662 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.415 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 22.0 t80 -68.16 -49.48 60.68 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.223 0.535 . . . . 0.0 110.333 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' A' ' 14' ' ' GLU . 60.2 pttt -75.66 -12.91 60.29 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.57 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 2.3 tpp -66.03 -28.91 69.22 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.862 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.585 HD12 HD13 ' A' ' 27' ' ' ILE . 3.3 mt -81.26 -55.01 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.052 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.583 ' OD1' ' HA ' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -82.71 62.8 6.51 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.775 0.798 . . . . 0.0 111.292 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 t -81.81 -11.75 58.83 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.173 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.3 p30 -138.36 -11.43 1.42 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -72.25 -81.92 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.143 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 p -175.8 5.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.684 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.58 20.94 7.07 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.51 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 68.5 p -139.22 150.63 45.76 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.042 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.714 ' O ' ' HA ' ' A' ' 62' ' ' THR . 3.8 mt -104.16 103.35 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.697 HG22 ' OG1' ' A' ' 62' ' ' THR . 71.2 p -104.31 162.55 13.11 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.492 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -34.11 -35.95 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.942 0.497 . . . . 0.0 111.821 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -77.36 -41.15 41.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 110.759 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.575 ' HG3' HG22 ' A' ' 19' ' ' ILE . 11.4 tp10 -77.09 -30.55 55.43 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.429 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.893 HD12 HG13 ' A' ' 48' ' ' ILE . 0.9 OUTLIER -41.18 -48.73 3.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.981 0.895 . . . . 0.0 109.732 -179.294 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.835 ' HB3' HD11 ' A' ' 43' ' ' LEU . 6.0 ptpt -85.15 -30.87 23.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.886 -1.507 . . . . 0.0 111.624 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 9.1 t70 -46.62 -46.1 19.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.345 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.15 -37.55 95.09 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.008 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.836 ' HG ' HD23 ' A' ' 43' ' ' LEU . 3.8 mm? -71.62 -58.18 3.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.574 ' NZ ' ' HE2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -58.58 -26.88 64.08 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.108 0.48 . . . . 0.0 110.41 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 56.4 ttt-85 -59.16 -49.45 77.81 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.397 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 36' ' ' LEU . 3.3 m -77.46 -14.25 14.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.33 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.89 -19.99 8.23 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.971 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 49.2 m -55.69 153.77 7.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.749 0.275 . . . . 0.0 110.963 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -131.64 104.17 6.79 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.446 0.641 . . . . 0.0 112.04 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.836 HD23 ' HG ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -116.58 167.6 10.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.865 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.493 ' CE ' ' HB2' ' A' ' 86' ' ' SER . 27.0 ptt? -109.67 165.22 11.85 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.516 0.198 . . . . 0.0 110.562 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -50.19 -55.63 14.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.554 ' OG ' ' HB2' ' A' ' 87' ' ' ALA . 44.5 t -48.53 -24.27 1.25 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.477 ' HG2' ' OG ' ' A' ' 86' ' ' SER . 49.2 mt-10 -71.15 -36.2 71.97 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.893 HG13 HD12 ' A' ' 32' ' ' LEU . 1.9 mp -66.42 -60.61 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.747 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.448 ' HE3' ' CE1' ' A' ' 111' ' ' PHE . 22.1 ttmm -54.5 -31.26 55.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.489 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 35.8 t70 -70.9 -45.18 64.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.244 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.867 HD23 HD21 ' A' ' 32' ' ' LEU . 36.0 tp -66.35 -16.56 64.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.529 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.677 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 23.5 mmt -85.45 -60.85 1.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.291 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -76.12 -39.32 55.4 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.859 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -82.72 -19.08 38.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.51 -43.98 1.56 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.656 ' HB3' ' O ' ' A' ' 52' ' ' MET . 33.3 t70 -60.26 107.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.214 0.531 . . . . 0.0 110.199 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.452 HD11 ' CB ' ' A' ' 70' ' ' ALA . 7.1 mt -49.45 -25.08 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.676 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.528 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 74.8 m-20 -130.4 44.03 3.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.023 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.677 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 1.3 tmtp? -31.98 92.3 0.01 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.798 0.808 . . . . 0.0 112.468 -177.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' ASP . 82.8 p -128.0 10.46 6.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.796 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 81.45 17.33 71.46 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.601 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 53.2 m -153.94 127.19 8.48 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.42 0.288 . . . . 0.0 110.371 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.661 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 64.2 mt -107.5 132.44 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.034 0.445 . . . . 0.0 111.479 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -105.19 168.15 9.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.3 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.528 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 28.4 t80 -35.82 -48.23 0.54 Allowed 'General case' 0 N--CA 1.464 0.23 0 O-C-N 123.296 0.372 . . . . 0.0 111.913 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.92 -64.0 3.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.709 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.636 ' HB2' HG23 ' A' ' 63' ' ' ILE . 63.7 mt-10 -50.57 -26.18 4.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.764 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 68.2 t80 -62.0 -61.85 2.19 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.48 0.657 . . . . 0.0 110.894 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.569 HD13 ' HD2' ' A' ' 68' ' ' PHE . 10.4 mm -55.07 -50.62 61.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.777 -178.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.452 ' CB ' HD11 ' A' ' 57' ' ' ILE . . . -62.31 -12.5 21.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.936 0.398 . . . . 0.0 111.261 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.597 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.447 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.421 ' HA ' ' CB ' ' A' ' 88' ' ' PHE . 22.0 m . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.493 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 53.1 m -34.98 -65.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.15 0.281 . . . . 0.0 111.701 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.672 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -73.29 -38.55 65.84 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.69 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 25.4 t80 -43.16 -23.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.913 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.1 t -88.88 -42.53 11.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.737 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -82.76 -62.92 1.47 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.592 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.9 m-85 -53.61 -62.82 1.41 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.465 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.605 ' HA ' HG12 ' A' ' 99' ' ' ILE . 1.2 m-20 -79.0 50.16 1.0 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 89' ' ' SER . 37.3 ttmt -36.66 -59.81 0.64 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.629 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -83.48 -20.93 33.11 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.705 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.25 85.69 0.01 OUTLIER Glycine 0 N--CA 1.424 -2.156 0 CA-C-O 121.713 0.618 . . . . 0.0 112.887 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.4 p -100.58 -14.62 18.11 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 124.44 -4.02 8.8 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 111.526 -2.579 . . . . 0.0 110.942 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.689 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.1 OUTLIER -147.9 165.67 29.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.764 -0.718 . . . . 0.0 110.746 178.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.696 HG23 ' HB2' ' A' ' 103' ' ' GLU . 72.4 mt -131.75 104.15 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.512 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 102' ' ' ASP . 71.5 p -72.12 147.08 47.03 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.702 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -34.27 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 106' ' ' GLN . 34.6 t70 -57.16 -56.59 19.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.696 ' HB2' HG23 ' A' ' 99' ' ' ILE . 48.7 mt-10 -69.47 -32.29 71.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.163 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -61.39 -50.07 81.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.179 0.514 . . . . 0.0 110.723 179.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.588 ' CD ' HD11 ' A' ' 122' ' ' ILE . 41.3 mt-30 -71.94 -49.45 37.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.031 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 102' ' ' ASP . 87.0 mt-30 -55.83 -41.84 74.85 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.837 0.351 . . . . 0.0 110.979 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.13 -4.01 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.246 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.762 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 74.3 m -119.93 67.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.812 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.748 ' HD3' ' H ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -80.2 -36.34 35.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 -179.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -89.04 -5.0 58.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.762 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 4.2 m-85 -83.81 5.08 26.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.744 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.75 37.55 13.35 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.783 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.898 ' HA ' HG13 ' A' ' 118' ' ' ILE . 2.3 tm? -33.88 105.21 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.319 0.58 . . . . 0.0 111.327 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.496 ' OD1' HG12 ' A' ' 116' ' ' ILE . 10.3 t70 -160.5 156.05 25.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.754 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.668 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 10.7 p-10 -64.19 -7.73 10.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.067 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.496 HG12 ' OD1' ' A' ' 114' ' ' ASP . 49.0 mm -80.66 -64.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.586 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -91.69 -68.26 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.898 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.5 mm -48.17 -19.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.257 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.668 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 8.8 t70 -78.12 -59.1 2.92 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 124' ' ' GLU . 34.8 t70 -59.52 -17.15 29.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.775 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 25.2 ttp -64.27 -42.66 96.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.577 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.613 HG22 ' HA3' ' A' ' 131' ' ' GLY . 53.8 mt -54.89 -49.33 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.84 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.654 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -76.92 -13.27 60.0 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.513 178.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.775 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 40.3 tp10 -84.06 -25.44 29.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.262 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.05 HG22 HD11 ' A' ' 133' ' ' ILE . 31.2 mt -107.41 -15.74 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 1.01 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 1.9 t70 -77.76 82.74 4.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.025 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.497 HE21 ' HB2' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -88.63 -9.36 52.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.663 179.38 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 45.0 t0 -116.15 -35.49 4.36 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.694 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.97 -84.82 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.694 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 34.8 t70 -65.36 15.78 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -172.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 1.01 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.56 38.85 83.27 Favored Glycine 0 CA--C 1.509 -0.313 0 C-N-CA 117.223 -2.417 . . . . 0.0 109.193 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.638 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 7.4 pt20 -134.61 167.4 20.88 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 113.461 -1.369 . . . . 0.0 108.692 -177.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.05 HD11 HG22 ' A' ' 125' ' ' ILE . 5.8 mm -129.14 125.26 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 122.26 1.028 . . . . 0.0 111.532 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 1.001 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 6.4 t70 -103.14 152.09 21.83 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.969 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.69 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 17.1 t80 -40.96 -42.68 1.93 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.749 0.309 . . . . 0.0 110.931 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -82.77 -28.53 38.1 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.883 178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 1.001 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 31.9 mt-10 -68.92 -59.07 3.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.672 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 13.4 t80 -50.41 -18.53 0.66 Allowed 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.392 0.615 . . . . 0.0 109.776 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -78.48 -40.21 36.08 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.519 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -90.13 -12.8 37.22 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.703 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.49 ' HG2' ' CD1' ' A' ' 138' ' ' PHE . 4.9 ppp? -55.8 -27.68 52.36 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.735 0.302 . . . . 0.0 111.238 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 110.227 179.095 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.814 0.34 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -126.74 -10.93 6.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.008 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.442 ' HD2' ' C ' ' A' ' 3' ' ' ARG . 4.6 tmm_? -162.18 115.91 1.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.344 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.7 tp -159.63 -43.43 0.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.801 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.8 t -95.39 179.67 5.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.81 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -109.33 41.96 1.55 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.975 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -64.27 -16.67 62.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.73 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.13 -43.3 99.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.996 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.0 mp -67.48 -69.02 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.907 0.384 . . . . 0.0 111.264 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 12' ' ' LEU . . . -166.13 165.88 38.42 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.61 77.87 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.494 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 10' ' ' GLY . 31.4 tp -88.25 -46.72 8.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.516 0.198 . . . . 0.0 110.605 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.635 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 6.3 ttpm? -55.83 -30.93 62.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.76 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 8.1 mp0 -76.97 -38.3 53.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.959 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.735 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 54.5 tp -55.01 -28.12 49.62 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.681 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -70.6 -45.07 66.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.776 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.76 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 63.5 pttt -82.47 -12.5 57.78 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.589 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.44 -25.9 68.21 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.431 178.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.532 HG23 ' HA3' ' A' ' 35' ' ' GLY . 3.2 mt -86.39 -59.4 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.511 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.549 ' OD2' ' HA2' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -82.62 57.35 3.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.347 0.594 . . . . 0.0 110.547 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.662 HG21 ' NH2' ' A' ' 38' ' ' ARG . 13.6 t -81.24 -6.72 59.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.16 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -129.2 -14.61 4.3 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.564 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -74.42 -87.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.802 0.334 . . . . 0.0 111.208 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 p -176.66 6.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.817 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.42 31.48 2.79 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.492 ' HB ' ' CG2' ' A' ' 62' ' ' THR . 45.9 p -150.07 145.78 26.57 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.189 -0.505 . . . . 0.0 109.946 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.823 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.2 mt -102.87 103.91 15.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.629 HG22 ' OG1' ' A' ' 62' ' ' THR . 68.3 p -103.42 164.84 11.39 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.551 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 20.5 t80 -34.09 -36.4 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.683 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.19 -49.84 16.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.715 0.293 . . . . 0.0 111.659 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.652 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -75.72 -19.9 58.74 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.922 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.892 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -46.03 -47.38 16.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.914 0.864 . . . . 0.0 108.693 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.709 ' HG2' HG12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -85.43 -51.89 6.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.025 -1.443 . . . . 0.0 111.485 179.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.652 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 59.3 m-20 -36.34 -36.17 0.09 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.532 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -68.02 -57.34 8.76 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 115.114 0.805 . . . . 0.0 115.114 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.697 HD21 ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -73.85 -28.55 61.65 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.163 0.981 . . . . 0.0 111.989 -177.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.635 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 19.4 ptpt -66.14 -4.7 7.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.662 ' NH2' HG21 ' A' ' 21' ' ' THR . 36.9 ttm180 -87.15 -42.71 12.8 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.249 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 36' ' ' LEU . 30.8 m -73.44 -0.22 2.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.81 -36.93 3.71 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.352 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.604 ' CB ' HD23 ' A' ' 36' ' ' LEU . 18.5 m -52.45 153.02 3.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.471 0.177 . . . . 0.0 110.553 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -143.3 103.79 4.17 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.298 0.57 . . . . 0.0 112.142 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.7 HD11 ' HB3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -105.35 167.98 9.38 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.124 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 5.3 mtm -104.66 165.51 11.01 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.535 ' HA ' HD13 ' A' ' 48' ' ' ILE . 92.8 mt-10 -47.71 -59.99 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.495 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 94.4 p -39.47 -34.99 0.25 Allowed 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 44' ' ' MET . 37.2 mp0 -66.38 -41.03 89.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.053 0.454 . . . . 0.0 110.172 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.892 HG13 HD12 ' A' ' 32' ' ' LEU . 2.0 mp -57.06 -60.49 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.984 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.551 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 42.4 tttm -64.45 -25.6 68.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.318 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 46' ' ' SER . 62.6 t0 -71.13 -37.45 72.29 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.607 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.52 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 10.2 tt -76.36 -23.07 54.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.024 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.752 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 18.2 mmt -71.88 -45.01 62.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.122 0.487 . . . . 0.0 111.518 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.52 -30.29 20.71 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.988 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.55 -19.31 22.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.02 -43.81 1.65 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.752 ' HB3' ' O ' ' A' ' 52' ' ' MET . 15.6 t0 -61.24 95.98 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.3 mm -48.65 -22.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.031 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.58 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 59.0 t0 -129.11 44.5 2.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.818 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.702 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.5 tmtm? -32.57 90.38 0.0 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.74 0.781 . . . . 0.0 112.662 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.1 p -127.74 18.04 6.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.151 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 70.88 17.76 75.58 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.384 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 86.1 m -150.36 127.15 11.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.542 0.337 . . . . 0.0 110.561 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.823 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 70.1 mt -108.06 129.46 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 121.055 0.455 . . . . 0.0 111.367 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' OD1' HG22 ' A' ' 26' ' ' THR . 56.3 m-20 -105.06 167.33 9.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.09 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.635 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 47.9 t80 -35.52 -45.78 0.37 Allowed 'General case' 0 C--N 1.332 -0.174 0 O-C-N 123.389 0.431 . . . . 0.0 111.474 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.38 -63.7 4.12 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.331 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.784 ' HB2' HG23 ' A' ' 63' ' ' ILE . 63.0 mt-10 -51.92 -26.11 9.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.662 0.267 . . . . 0.0 110.905 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.735 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 71.9 t80 -63.87 -65.18 0.72 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.434 0.635 . . . . 0.0 110.879 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.614 HD13 ' HD2' ' A' ' 68' ' ' PHE . 14.5 mm -52.13 -41.17 32.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.653 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.23 -25.76 66.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.0 110.59 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.07 -12.55 26.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.035 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.404 HG21 HD11 ' A' ' 12' ' ' LEU . 37.5 m -87.74 -43.69 11.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.738 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.632 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 58.0 t -67.03 -18.11 23.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.117 0.484 . . . . 0.0 110.581 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -71.02 -47.56 58.01 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.7 mt -81.79 0.94 36.98 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.238 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.632 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 0.7 OUTLIER -102.78 75.28 1.4 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.007 -179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -175.4 -156.27 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.294 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.6 mm? -99.19 60.03 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 110.46 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -104.55 150.41 24.65 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.005 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -139.39 100.31 3.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.737 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -165.81 38.89 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.075 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -90.61 22.1 3.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.969 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -109.05 -155.98 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.598 HD21 ' HA ' ' A' ' 139' ' ' ALA . 7.3 mp -57.14 -29.58 63.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.561 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.496 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 14.4 p -45.67 -27.67 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.721 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.7 m -51.05 -55.01 19.66 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.402 . . . . 0.0 110.173 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.584 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -81.18 -39.77 24.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.902 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.808 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 8.1 t80 -45.95 -23.04 0.25 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.366 0.603 . . . . 0.0 110.055 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.3 t -89.13 -44.79 10.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.769 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -89.3 -63.65 1.26 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.609 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.5 m-85 -51.98 -62.36 1.68 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.808 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.6 OUTLIER -76.13 55.29 0.93 Allowed 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 176.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -44.53 -52.91 7.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.451 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.35 -21.46 64.73 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.328 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.08 68.61 1.09 Allowed Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.4 p -115.54 -23.06 8.95 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 134' ' ' ASP . . . 130.58 -4.55 5.84 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 113.162 -1.836 . . . . 0.0 112.606 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.896 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.5 OUTLIER -148.62 161.82 40.94 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.792 HG12 ' HA ' ' A' ' 92' ' ' ASP . 22.1 mt -133.09 104.27 6.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.833 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 102' ' ' ASP . 69.6 p -72.3 147.1 46.69 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.709 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.1 pp -34.44 -33.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.526 ' N ' HD12 ' A' ' 101' ' ' LEU . 54.2 m-20 -54.35 -55.89 24.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.56 ' HB2' HG23 ' A' ' 99' ' ' ILE . 97.4 mt-10 -71.21 -31.43 67.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.174 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.668 HG13 HG22 ' A' ' 99' ' ' ILE . 51.1 mt -65.74 -65.25 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.166 0.508 . . . . 0.0 110.439 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.858 ' HB3' HD12 ' A' ' 113' ' ' LEU . 87.8 mt-30 -58.14 -39.05 77.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.636 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.84 -44.12 94.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.082 0.468 . . . . 0.0 110.66 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.7 -3.05 1.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.145 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.788 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 73.2 m -115.09 44.07 1.88 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.922 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -59.54 -36.63 76.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.841 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -75.09 -22.12 58.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.11 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.788 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 2.7 m-85 -76.78 -5.18 47.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.953 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 113' ' ' LEU . . . 62.35 38.8 96.85 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.036 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.928 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -33.09 132.74 0.15 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.545 0.688 . . . . 0.0 111.501 -177.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.717 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 91.9 m-20 -135.99 167.69 20.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.217 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.635 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.6 m-20 -82.88 -7.98 59.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.178 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.59 -64.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.068 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -89.52 -69.24 0.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.928 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.3 mm -52.77 -19.45 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.942 0.401 . . . . 0.0 111.238 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.635 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 33.6 t70 -71.14 -46.91 60.59 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' GLU . 63.9 t0 -62.37 -26.27 68.37 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 1.026 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.5 ttt -60.75 -29.87 69.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.474 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.777 HG22 ' HA3' ' A' ' 131' ' ' GLY . 56.8 mt -58.32 -43.62 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.477 ' CE ' ' HB ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -86.67 -13.8 44.46 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.367 178.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 1.026 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 71.5 tt0 -84.61 -23.73 29.45 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.789 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.856 HG22 HD11 ' A' ' 133' ' ' ILE . 13.6 mm -107.56 -21.8 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.977 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.4 t70 -62.8 98.37 0.12 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.594 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.957 HE21 ' HG2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -87.23 -13.95 42.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.433 ' OD1' ' ND2' ' A' ' 129' ' ' ASN . 50.6 p30 -127.57 -33.19 2.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.73 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 179.96 -71.76 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 178.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.73 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 56.3 m-20 -64.92 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -173.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.977 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.53 37.93 78.04 Favored Glycine 0 CA--C 1.505 -0.566 0 C-N-CA 118.348 -1.882 . . . . 0.0 110.04 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.562 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 8.6 pt20 -133.33 170.53 15.33 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 113.895 -1.152 . . . . 0.0 110.075 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.042 HD13 ' HB3' ' A' ' 137' ' ' GLU . 5.0 mm -133.02 121.88 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.909 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 4.3 p-10 -113.01 162.47 15.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.161 177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.796 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 22.5 t80 -38.76 -30.48 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.768 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.733 ' HA3' ' N ' ' A' ' 153' ' ' ARG . . . -84.27 -45.16 6.31 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.728 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 1.042 ' HB3' HD13 ' A' ' 133' ' ' ILE . 39.3 mt-10 -63.04 -51.3 67.29 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 13.6 t80 -56.62 -18.68 12.86 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.598 ' HA ' HD21 ' A' ' 84' ' ' LEU . . . -86.06 -40.85 15.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.151 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.605 ' HB3' ' HG3' ' A' ' 127' ' ' GLN . . . -87.25 -11.66 49.04 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.548 ' HG2' ' HA ' ' A' ' 138' ' ' PHE . 5.5 ppp? -72.41 -6.68 45.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.635 0.255 . . . . 0.0 111.557 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -134.97 -31.13 1.02 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.994 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.564 ' HG2' ' H ' ' A' ' 144' ' ' LYS . 62.1 ttt180 -112.11 -137.62 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.438 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.564 ' H ' ' HG2' ' A' ' 143' ' ' ARG . 95.5 mttt -131.23 -175.53 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.623 0.249 . . . . 0.0 110.57 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.727 ' H ' ' HE ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -101.29 78.32 1.88 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.272 0.558 . . . . 0.0 111.855 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.745 ' HB2' ' HZ3' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -53.76 155.57 3.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.916 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -85.87 -4.78 84.48 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.862 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -79.78 161.67 25.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.816 0.341 . . . . 0.0 111.107 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -47.75 -23.75 2.54 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.998 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -42.54 -26.0 0.36 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.356 -0.45 . . . . 0.0 113.032 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.69 ' HA ' ' NH1' ' A' ' 153' ' ' ARG . 44.1 mt -48.78 149.11 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.143 0 CA-C-O 120.751 0.31 . . . . 0.0 111.113 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.416 ' H ' ' HD2' ' A' ' 153' ' ' ARG . . . -159.02 -4.59 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.413 -0.898 . . . . 0.0 111.889 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.89 ' H ' ' HD2' ' A' ' 153' ' ' ARG . 4.2 mpt_? -53.78 170.55 0.12 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.786 0.326 . . . . 0.0 110.13 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.572 HH11 ' H ' ' A' ' 155' ' ' THR . 23.3 tpt85 -71.19 149.02 46.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.179 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.572 ' H ' HH11 ' A' ' 154' ' ' ARG . 56.5 m -50.23 80.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.341 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 154' ' ' ARG . 27.8 ttt -175.9 -18.64 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.213 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.523 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 6.7 ppt_? -63.22 -15.53 57.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.139 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.801 ' HG3' HG22 ' A' ' 159' ' ' THR . 4.9 tppp? -161.49 -87.23 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.801 HG22 ' HG3' ' A' ' 158' ' ' LYS . 6.9 t -162.96 -36.42 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.766 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 97.2 mt -78.47 179.48 7.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.774 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -103.96 -101.17 0.31 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.786 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.1 tp -174.83 154.35 1.89 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.623 0.249 . . . . 0.0 110.821 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -89.75 138.85 31.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.689 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -78.05 146.14 35.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.866 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.69 165.03 13.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.063 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 167' ' ' GLY . 2.7 pp -94.84 -10.03 32.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.191 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.493 ' N ' HD12 ' A' ' 166' ' ' LEU . . . 146.74 150.03 5.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.597 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 97.4 mt -100.15 139.16 36.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.88 149.76 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.932 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -156.72 156.18 32.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 111.155 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.23 -49.57 4.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.652 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.14 -174.48 31.3 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.476 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 81.1 p -159.65 174.52 14.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -119.56 -174.76 2.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.952 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -101.85 107.92 19.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.799 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.08 141.46 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.344 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 tp -123.85 130.11 74.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -132.53 141.36 48.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -171.7 -65.82 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.376 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.75 -13.11 22.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.86 0.362 . . . . 0.0 110.804 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -110.72 136.86 49.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.827 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.559 ' N ' ' HD3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.592 ' HB3' ' NH2' ' A' ' 3' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.813 0.339 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -125.03 -32.08 3.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.045 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.592 ' NH2' ' HB3' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -157.37 169.23 25.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.817 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.499 HD12 ' C ' ' A' ' 3' ' ' ARG . 6.4 mp -115.84 112.55 22.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.897 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -77.82 -15.14 59.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.998 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -83.98 17.95 2.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -67.55 -23.68 65.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.73 -29.17 69.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.781 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.7 mt -69.6 -20.15 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.86 135.45 12.54 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.477 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 14' ' ' GLU . . . 119.76 -39.98 2.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.166 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 15' ' ' LEU . 46.5 tp -71.66 -29.24 64.39 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.651 ' HG3' ' OE1' ' A' ' 14' ' ' GLU . 20.6 pttp -58.59 -24.99 62.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.651 ' OE1' ' HG3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -80.43 -52.27 7.85 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.637 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 31.0 tp -47.23 -30.2 2.85 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.847 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.497 ' CZ ' ' N ' ' A' ' 65' ' ' TYR . 20.1 t80 -66.61 -52.04 49.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.164 0.506 . . . . 0.0 110.446 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -76.0 -13.06 60.23 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.625 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 63.4 mmm -71.04 -22.61 62.12 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.499 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.664 HG23 ' HA3' ' A' ' 35' ' ' GLY . 10.9 mm -77.42 -61.31 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.269 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.509 ' OD1' ' HA ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -80.23 66.79 5.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.534 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 t -82.75 -6.34 59.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.348 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -131.75 -27.28 1.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.473 ' ND2' ' OG1' ' A' ' 26' ' ' THR . 48.2 t30 -69.82 -82.45 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.1 p -175.91 5.42 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.46 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 111.11 27.13 4.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.373 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.473 ' OG1' ' ND2' ' A' ' 23' ' ' ASN . 64.8 p -143.66 149.18 36.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.034 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.86 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.1 mt -103.43 103.02 14.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.654 HG22 ' OG1' ' A' ' 62' ' ' THR . 66.9 p -104.16 162.29 13.3 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.129 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.625 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 44.1 t80 -34.03 -27.87 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 28' ' ' THR . 56.1 m-20 -82.51 -45.06 15.17 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.791 0.329 . . . . 0.0 111.159 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 8.0 mp0 -83.13 -15.13 51.93 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.901 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.71 HD12 HG13 ' A' ' 48' ' ' ILE . 2.2 tm? -53.03 -50.16 64.84 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.909 ' HB2' ' HE3' ' A' ' 37' ' ' LYS . 12.5 ptpt -82.59 -46.15 13.68 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.091 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.609 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 31.0 t70 -42.86 -64.9 0.54 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.664 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -46.43 -28.36 3.33 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.142 -0.552 . . . . 0.0 113.633 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.682 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -90.1 -59.68 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.986 0.393 . . . . 0.0 110.772 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.909 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 18.8 ptpt -60.43 -9.55 3.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.032 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.429 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -68.3 -34.67 76.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.868 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 36' ' ' LEU . 31.4 m -80.84 -8.72 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.393 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.7 -17.66 5.48 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.842 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 65.1 m -63.42 168.51 4.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.964 0.412 . . . . 0.0 111.445 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -147.57 111.12 4.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.608 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.7 mt -120.55 165.83 14.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.374 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.509 ' O ' HD13 ' A' ' 48' ' ' ILE . 24.0 ptt? -114.15 162.43 16.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 47' ' ' GLU . 44.4 mt-10 -47.63 -65.43 0.57 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 80.8 p -41.73 -18.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 55.8 mt-10 -89.72 -47.57 7.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.71 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -53.64 -59.78 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.912 0.863 . . . . 0.0 109.138 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 1.018 ' HD3' ' HD2' ' A' ' 93' ' ' LYS . 21.8 ttmm -55.15 -27.39 45.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.212 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 8.8 t70 -69.9 -45.05 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.153 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.647 HD23 ' O ' ' A' ' 51' ' ' LEU . 9.7 tt -68.26 -21.67 64.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.086 0.47 . . . . 0.0 109.966 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.713 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 13.4 mmt -71.93 -44.01 64.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.855 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 90' ' ' TYR . 9.7 t70 -87.05 -18.04 31.51 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.672 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.454 ' HA ' ' OE2' ' A' ' 81' ' ' GLU . . . -91.58 -42.36 10.26 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.876 ' HB1' ' HA ' ' A' ' 71' ' ' ALA . . . -110.7 -43.13 3.88 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.713 ' HB3' ' O ' ' A' ' 52' ' ' MET . 12.3 t0 -49.39 97.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.706 -0.398 . . . . 0.0 109.979 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.7 mm -54.75 -17.53 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.276 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.561 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 38.9 t70 -132.21 44.48 2.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.951 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.613 ' HD3' ' C ' ' A' ' 52' ' ' MET . 27.1 tptp -30.94 88.03 0.0 OUTLIER 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.5 p -128.7 18.94 6.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.469 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 71.32 17.12 75.81 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.725 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 51.0 m -151.69 128.03 10.61 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.949 -0.625 . . . . 0.0 110.723 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.86 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.7 mt -105.06 133.41 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 120.927 0.394 . . . . 0.0 110.67 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -105.49 167.75 9.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.325 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.568 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 14.9 t80 -35.82 -46.89 0.48 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.476 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.51 -54.07 7.98 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.65 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.744 ' HB2' HG23 ' A' ' 63' ' ' ILE . 48.5 mt-10 -53.25 -24.05 10.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.294 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.637 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 57.1 t80 -67.8 -60.41 2.54 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.505 0.669 . . . . 0.0 110.487 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 65' ' ' TYR . 8.5 mm -49.21 -49.27 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.813 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.682 ' HA ' HG12 ' A' ' 73' ' ' VAL . . . -59.42 -47.25 86.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.806 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.876 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . -44.73 -27.62 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.202 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.9 p -90.94 -51.09 5.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.85 0.357 . . . . 0.0 110.446 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.682 HG12 ' HA ' ' A' ' 70' ' ' ALA . 3.6 p -62.04 -15.16 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.696 0.76 . . . . 0.0 110.031 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -76.36 -50.97 12.85 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.132 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 71' ' ' ALA . 61.1 mt -60.0 -16.12 28.15 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.577 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 24.1 t-20 -122.3 74.75 1.19 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.595 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 76' ' ' ASN . 14.6 mmtp -174.42 -153.91 0.05 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.39 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' H ' ' HB3' ' A' ' 77' ' ' LYS . 90.4 mt -100.78 62.27 1.01 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.482 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -44.36 110.8 0.24 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.518 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.461 ' HD3' ' C ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -139.3 119.86 14.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.202 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.454 ' OE2' ' HA ' ' A' ' 54' ' ' ALA . 55.5 mt-10 -120.47 133.14 55.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.252 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.99 90.47 0.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.888 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.536 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 20.9 t-20 -152.82 164.33 38.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.882 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.528 ' C ' HD13 ' A' ' 84' ' ' LEU . 3.4 tm? -70.71 -64.22 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.766 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.433 HG12 ' OD1' ' A' ' 83' ' ' ASN . 9.9 p -63.19 -28.34 44.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.842 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.536 ' HB3' ' HB3' ' A' ' 83' ' ' ASN . 90.9 p -52.8 -34.85 55.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 110.12 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -82.22 -52.69 6.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.161 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.722 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 10.9 t80 -44.25 -26.43 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.056 0.455 . . . . 0.0 110.359 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 t -89.73 -47.69 7.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.66 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.466 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 1.0 OUTLIER -82.64 -62.75 1.52 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.378 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.0 m-85 -56.36 -64.62 0.8 Allowed 'General case' 0 C--N 1.334 -0.08 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.818 ' HA ' HG12 ' A' ' 99' ' ' ILE . 11.9 t0 -76.85 69.2 3.15 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 1.018 ' HD2' ' HD3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -44.43 -40.85 5.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.347 -177.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.3 m-20 -78.5 -21.35 49.05 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.889 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.62 -8.06 0.57 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.676 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 94' ' ' ASP . 72.2 p -55.37 -9.07 0.4 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 122.628 0.371 . . . . 0.0 111.203 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 134' ' ' ASP . . . 107.28 -6.54 36.6 Favored Glycine 0 C--O 1.216 -1.029 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.683 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -127.46 145.69 50.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.991 0.424 . . . . 0.0 112.01 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.818 HG12 ' HA ' ' A' ' 92' ' ' ASP . 65.5 mt -131.99 102.93 6.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.368 177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 132' ' ' GLN . 44.0 p -76.27 152.84 36.37 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.257 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HB3' HG23 ' A' ' 122' ' ' ILE . 3.7 pp -35.47 -39.03 0.12 Allowed 'General case' 0 N--CA 1.461 0.125 0 O-C-N 123.194 0.309 . . . . 0.0 111.139 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -50.89 -57.08 9.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.147 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.607 ' HB2' HG23 ' A' ' 99' ' ' ILE . 50.4 mt-10 -63.82 -32.17 73.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.597 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.745 HG13 HG22 ' A' ' 99' ' ' ILE . 91.3 mt -70.36 -66.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 111.19 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.585 ' NE2' ' HA ' ' A' ' 119' ' ' ASP . 85.1 mt-30 -56.39 -35.76 68.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.289 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -55.69 -40.37 72.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.774 0.321 . . . . 0.0 110.543 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.54 -65.24 0.66 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.239 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.537 ' HB3' ' CG ' ' A' ' 111' ' ' PHE . 83.3 m -64.4 76.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.509 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.529 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 1.0 OUTLIER -88.8 -43.91 10.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.597 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -72.72 -4.68 32.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.721 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.537 ' CG ' ' HB3' ' A' ' 108' ' ' CYS . 1.2 m-85 -81.86 -1.17 46.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.775 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.18 37.2 94.13 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.598 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.72 ' O ' HD12 ' A' ' 113' ' ' LEU . 2.1 pp -34.06 144.5 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.674 0.75 . . . . 0.0 112.875 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 119' ' ' ASP . 11.2 p-10 -160.16 -164.06 1.22 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.986 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.686 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 2.8 p30 -87.73 -7.93 56.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.12 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.406 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 50.7 mm -89.45 -64.69 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.47 ' O ' ' HB2' ' A' ' 121' ' ' MET . 18.0 t-160 -92.06 -68.51 0.79 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 113' ' ' LEU . 2.2 mp -56.89 -20.31 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.686 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 38.8 t70 -79.71 -59.25 2.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' GLU . 1.2 m-20 -59.2 -17.24 25.99 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.758 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 22.4 ttp -59.72 -39.65 85.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.333 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.532 HG22 ' HA3' ' A' ' 131' ' ' GLY . 59.7 mt -54.69 -45.0 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -84.15 -13.6 52.43 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.98 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.758 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 15.9 tp10 -78.18 -27.8 48.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.894 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.767 HG21 ' CD1' ' A' ' 133' ' ' ILE . 22.6 mt -109.06 -7.87 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.818 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.619 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 28.0 t70 -73.78 81.34 1.59 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.112 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.573 ' OE1' ' HB3' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -87.54 -9.36 54.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.052 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 154' ' ' ARG . 6.3 m-20 -119.87 -34.56 3.7 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.551 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 10.4 p-10 179.63 -80.89 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 118.438 2.755 . . . . 0.0 118.438 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.832 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 5.7 t70 -64.32 -17.68 63.91 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 118.813 2.894 . . . . 0.0 118.813 -171.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.619 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 92.15 37.13 6.05 Favored Glycine 0 CA--C 1.501 -0.836 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.832 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 3.2 pt20 -139.15 166.53 24.28 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 112.729 -1.735 . . . . 0.0 108.957 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.767 ' CD1' HG21 ' A' ' 125' ' ' ILE . 48.0 mt -123.29 128.32 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 121.441 0.638 . . . . 0.0 110.805 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.843 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 1.5 t70 -104.16 157.9 16.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.476 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.722 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 18.9 t80 -39.33 -46.24 1.56 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.376 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 153' ' ' ARG . . . -67.91 -44.01 80.68 Favored Glycine 0 N--CA 1.422 -2.279 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.303 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.843 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 27.8 mt-10 -55.88 -62.23 1.84 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.413 -0.394 . . . . 0.0 110.143 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.514 ' HD1' HG21 ' A' ' 133' ' ' ILE . 2.5 t80 -55.3 -30.16 59.63 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.943 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 143' ' ' ARG . . . -74.88 -26.36 59.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.339 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.71 -51.23 5.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.851 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -57.72 -12.65 3.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.925 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.7 ttp -111.54 -30.17 7.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.683 0.278 . . . . 0.0 110.836 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 139' ' ' ALA . 14.9 tpp85 -65.9 -59.04 4.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.162 0.506 . . . . 0.0 110.078 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.571 ' HB2' ' NZ ' ' A' ' 144' ' ' LYS . 9.9 mtmp? -128.91 -153.53 0.58 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.987 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.485 ' NE ' ' N ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -74.06 -38.85 63.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.714 0.292 . . . . 0.0 110.644 179.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.417 ' NZ ' ' HA2' ' A' ' 149' ' ' GLY . 26.3 ttpp -175.62 159.27 2.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.505 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -65.56 -65.68 2.78 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.18 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -151.37 150.27 30.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.417 ' HA2' ' NZ ' ' A' ' 146' ' ' LYS . . . -40.24 -64.66 1.09 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.102 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.725 ' C ' HD12 ' A' ' 151' ' ' ILE . . . -54.8 -65.31 3.62 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.94 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.725 HD12 ' C ' ' A' ' 150' ' ' GLY . 2.7 mp -129.79 149.85 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.122 0.487 . . . . 0.0 112.064 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.561 ' HA3' ' HB2' ' A' ' 127' ' ' GLN . . . -69.89 -116.19 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.512 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.57 ' HA ' ' HE ' ' A' ' 153' ' ' ARG . 5.4 tpm_? -130.51 83.29 2.11 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 121.261 0.553 . . . . 0.0 111.266 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.798 ' HB3' ' HB3' ' A' ' 157' ' ' ARG . 35.7 ttm180 -89.75 148.21 23.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.159 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 89.6 m -68.28 -19.95 64.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.03 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.746 ' H ' ' HG2' ' A' ' 154' ' ' ARG . 25.1 ptt? -132.42 54.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.878 0.37 . . . . 0.0 111.494 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.798 ' HB3' ' HB3' ' A' ' 154' ' ' ARG . 21.6 tpp180 -157.39 118.44 3.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.009 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.592 ' HB3' ' NZ ' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -164.97 -45.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.203 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.577 HG22 ' HG3' ' A' ' 158' ' ' LYS . 10.1 t -152.05 2.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.002 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.7 mt -76.11 166.9 22.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.864 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -60.6 136.65 58.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.039 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.473 ' N ' HD12 ' A' ' 162' ' ' LEU . 7.0 mp -75.27 -5.04 42.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -96.75 165.57 12.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.721 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -102.43 137.42 40.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.962 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -101.64 156.43 17.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.113 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 166' ' ' LEU . 6.2 mp -82.33 -24.98 34.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.753 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 138.57 -126.47 3.46 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.447 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 55.8 tp -97.82 109.67 22.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.787 0.327 . . . . 0.0 110.818 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.45 141.66 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.24 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -136.07 161.67 35.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.818 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -104.78 -42.04 5.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 109.31 -167.43 12.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.551 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.5 m -151.16 -35.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.756 0.313 . . . . 0.0 110.826 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -97.94 -16.77 19.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.769 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.574 ' NE2' ' H ' ' A' ' 175' ' ' GLN . 0.0 OUTLIER -98.96 97.88 8.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.468 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.84 138.44 22.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.295 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 10.7 tt -114.27 127.15 71.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.88 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -76.9 110.29 11.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.003 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -76.17 164.34 53.55 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.416 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.08 15.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.112 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -143.48 -13.6 0.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.949 -179.867 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.834 0.349 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -165.16 104.78 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.346 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.403 ' HG2' HH11 ' A' ' 3' ' ' ARG . 50.5 ttt-85 -105.9 133.71 50.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.943 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.5 tp -106.37 -91.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.8 p -175.12 157.1 2.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.867 0.365 . . . . 0.0 111.129 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -99.34 41.25 1.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.492 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -67.14 -12.4 59.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.424 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.85 -69.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.113 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.569 HD13 ' H ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -84.18 -14.12 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.54 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.0 165.29 12.86 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.777 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.34 37.04 93.95 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.055 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 95.7 mt -80.63 -32.92 36.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.457 0.17 . . . . 0.0 111.24 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.642 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 62.2 tttp -57.51 -43.83 84.55 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.665 ' O ' ' HG2' ' A' ' 18' ' ' MET . 44.8 tt0 -71.75 -47.97 50.03 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.725 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 28.2 tp -48.85 -29.01 4.15 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.55 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.488 ' CZ ' ' N ' ' A' ' 65' ' ' TYR . 15.3 t80 -64.87 -51.67 60.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.581 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.553 ' HA ' ' OD1' ' A' ' 20' ' ' ASP . 18.6 ptpt -77.79 -12.77 60.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.05 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 56.8 mmm -68.19 -24.05 64.91 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.491 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.705 HD12 HD13 ' A' ' 27' ' ' ILE . 4.0 mt -83.73 -52.0 13.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.162 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.701 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -80.73 51.84 1.58 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.436 0.636 . . . . 0.0 112.378 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -79.59 -6.31 56.79 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.558 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -111.28 -27.9 8.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.611 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -87.49 -91.19 0.11 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.889 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.403 ' H ' ' HB3' ' A' ' 23' ' ' ASN . 74.9 m -176.06 21.73 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.261 0.351 . . . . 0.0 110.988 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.451 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 111.18 24.8 5.29 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.529 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.701 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 78.6 p -140.39 142.13 35.51 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.166 0.508 . . . . 0.0 110.218 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.794 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.6 mt -102.95 102.96 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.816 -177.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.746 HG22 ' OG1' ' A' ' 62' ' ' THR . 79.7 p -103.6 165.04 11.28 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.197 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.563 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 52.9 t80 -34.36 -33.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.723 0.64 . . . . 0.0 111.864 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . 33.2 t70 -76.91 -47.58 20.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.955 0.407 . . . . 0.0 110.695 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 28' ' ' THR . 25.1 mp0 -73.07 -25.09 60.78 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.235 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.827 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -48.73 -51.45 28.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.464 0.649 . . . . 0.0 109.792 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.662 ' HB2' ' HE2' ' A' ' 37' ' ' LYS . 6.9 ptpp? -82.45 -40.32 21.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.898 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.408 ' CB ' ' HA ' ' A' ' 31' ' ' GLU . 9.8 t70 -39.06 -62.11 0.68 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.088 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -50.76 -37.22 34.33 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.211 -0.518 . . . . 0.0 113.984 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.624 ' O ' HG12 ' A' ' 39' ' ' VAL . 49.5 mt -79.67 -58.42 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.34 0.57 . . . . 0.0 111.759 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.662 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -54.93 -17.65 3.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.247 0.546 . . . . 0.0 109.668 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.3 ttt85 -77.37 -42.83 35.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.545 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.624 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -70.89 -1.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.161 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.92 5.71 33.01 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.45 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 74.5 m -81.9 166.46 19.89 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.79 0.329 . . . . 0.0 111.151 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -138.9 104.68 5.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.816 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.4 mt -128.68 166.09 19.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.407 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.577 ' O ' HD13 ' A' ' 48' ' ' ILE . 23.1 mtp -107.34 161.68 14.59 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HG2' ' HE2' ' A' ' 33' ' ' LYS . 37.1 mt-10 -55.64 -60.28 3.66 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.503 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.464 ' HB2' ' HZ ' ' A' ' 111' ' ' PHE . 41.2 t -43.24 -29.07 0.36 Allowed 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.8 mm-40 -72.98 -42.36 63.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.265 0.555 . . . . 0.0 110.037 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.827 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -55.57 -56.82 10.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.756 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.597 ' HE2' ' CE1' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -47.53 -28.25 2.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.764 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HA ' ' NZ ' ' A' ' 49' ' ' LYS . 63.8 t0 -75.29 -54.93 6.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.601 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.504 HD23 HD11 ' A' ' 32' ' ' LEU . 36.4 tp -53.89 -37.66 63.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.236 0.541 . . . . 0.0 111.058 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.632 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 33.8 ttm -74.36 -66.35 0.74 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.331 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.671 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -54.48 -26.21 29.92 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.764 -178.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.68 -41.09 15.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -100.3 -43.39 6.29 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 59' ' ' LYS . 60.5 t0 -46.37 98.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 110.144 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.433 HD11 ' HB1' ' A' ' 70' ' ' ALA . 17.4 mm -54.14 -19.64 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.243 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.583 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 62.0 m-20 -131.35 44.47 2.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.872 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.671 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 21.8 tptm -32.27 92.04 0.01 OUTLIER 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 58' ' ' ASP . 49.0 m -127.71 18.44 6.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.404 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.632 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 70.08 23.46 77.14 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.47 -178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 28' ' ' THR . 42.5 m -159.72 129.97 5.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.797 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.794 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 75.8 mt -108.19 130.13 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.962 0.411 . . . . 0.0 111.511 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -104.87 167.61 9.6 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.085 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.642 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 28.9 t80 -35.22 -47.3 0.39 Allowed 'General case' 0 CA--C 1.52 -0.182 0 O-C-N 123.446 0.466 . . . . 0.0 111.731 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.98 -56.66 10.2 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.361 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.659 ' HB2' HG23 ' A' ' 63' ' ' ILE . 71.4 mt-10 -54.75 -22.66 14.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 110.692 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 64.9 t80 -68.32 -64.31 0.89 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.623 0.725 . . . . 0.0 110.905 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.578 HD13 ' HD2' ' A' ' 68' ' ' PHE . 7.9 mm -52.39 -41.79 36.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.613 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 73' ' ' VAL . . . -56.75 -32.98 66.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.143 0.497 . . . . 0.0 110.803 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.38 -28.34 52.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.23 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.5 p -95.35 -8.53 35.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.977 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 70' ' ' ALA . 9.7 p -95.47 -15.41 7.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.961 0.41 . . . . 0.0 110.668 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -75.98 -47.07 26.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.362 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.787 HD13 ' N ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -73.15 -15.26 61.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.787 ' N ' HD13 ' A' ' 75' ' ' LEU . 43.5 t30 -78.04 79.58 4.5 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.238 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -136.54 -43.05 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.631 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.595 ' HG ' ' HG3' ' A' ' 79' ' ' GLU . 67.9 tp -166.14 -61.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.515 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.595 ' HG3' ' HG ' ' A' ' 78' ' ' LEU . 51.1 mt-10 -145.93 160.46 41.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.717 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -64.33 127.2 30.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.093 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -125.82 10.29 7.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.057 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -85.4 111.91 20.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.764 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.407 ' OD1' HG12 ' A' ' 85' ' ' VAL . 13.0 p-10 -132.6 -155.19 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.344 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 84' ' ' LEU . 3.4 tm? -58.93 -37.63 77.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.183 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.407 HG12 ' OD1' ' A' ' 83' ' ' ASN . 13.5 p -49.63 -25.14 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.61 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 79.2 p -43.32 -45.28 5.91 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.975 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.405 ' C ' ' N ' ' A' ' 89' ' ' SER . . . -90.14 -38.57 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.712 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.719 ' HZ ' ' HA2' ' A' ' 97' ' ' GLY . 8.6 t80 -44.33 -24.15 0.15 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.269 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 87' ' ' ALA . 47.7 t -89.05 -45.38 9.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.898 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -81.69 -63.68 1.34 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.365 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.597 ' CE1' ' HE2' ' A' ' 49' ' ' LYS . 4.0 m-85 -56.44 -64.41 0.88 Allowed 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.733 ' HA ' HG12 ' A' ' 99' ' ' ILE . 61.8 t0 -76.78 67.4 2.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -55.85 -25.72 43.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.397 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -84.18 -20.69 31.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 39.22 67.3 0.61 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.1 p -122.87 -19.12 6.26 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.719 ' HA2' ' HZ ' ' A' ' 88' ' ' PHE . . . 123.37 -3.14 9.59 Favored Glycine 0 N--CA 1.434 -1.443 0 CA-C-N 113.435 -1.711 . . . . 0.0 112.379 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.791 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -136.05 151.92 50.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.363 0.601 . . . . 0.0 111.702 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.751 HG23 ' HB2' ' A' ' 103' ' ' GLU . 83.0 mt -130.95 102.78 6.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.054 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 101' ' ' LEU . 51.2 p -79.81 151.46 30.28 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.694 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -34.29 -34.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.022 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.97 -54.98 31.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.904 0.383 . . . . 0.0 110.527 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.751 ' HB2' HG23 ' A' ' 99' ' ' ILE . 51.3 mt-10 -65.75 -28.68 69.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.185 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.747 HG13 HG22 ' A' ' 99' ' ' ILE . 72.8 mt -72.42 -65.38 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 111.004 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.818 ' NE2' HD11 ' A' ' 122' ' ' ILE . 2.4 mm-40 -47.65 -45.2 27.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.139 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -64.13 -42.92 96.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.468 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.87 -4.54 32.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 105' ' ' GLN . 26.5 p -124.04 91.4 3.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.069 0.462 . . . . 0.0 111.385 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -88.44 -50.78 6.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.326 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.91 -17.75 62.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.517 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.577 ' HB2' ' HB2' ' A' ' 108' ' ' CYS . 3.7 m-85 -63.92 -11.32 27.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.627 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.41 34.79 24.89 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.3 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.731 ' CD2' HG21 ' A' ' 118' ' ' ILE . 0.5 OUTLIER -35.52 109.94 0.09 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.24 0.543 . . . . 0.0 111.508 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.733 ' O ' HG22 ' A' ' 118' ' ' ILE . 38.4 t70 -160.96 138.54 9.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.334 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -50.81 -9.49 0.05 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 73.4 mt -89.44 -59.55 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.644 0.259 . . . . 0.0 111.648 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -91.07 -59.41 2.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 111.622 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.8 HG23 ' NE2' ' A' ' 105' ' ' GLN . 3.6 tp -48.47 -28.25 2.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.64 -51.52 58.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.874 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 124' ' ' GLU . 7.7 t70 -56.45 -29.23 61.43 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 1.03 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 6.6 ttt -66.79 -39.64 87.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.661 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.818 HD11 ' NE2' ' A' ' 105' ' ' GLN . 33.1 mm -56.97 -43.06 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.681 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -83.78 -13.3 54.18 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.251 -1.795 . . . . 0.0 109.632 178.304 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 1.03 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 31.1 tt0 -87.65 -17.03 32.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.43 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.839 HG21 HD11 ' A' ' 133' ' ' ILE . 14.9 mm -115.96 -32.13 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.558 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 131' ' ' GLY . 2.7 t70 -75.5 92.11 2.85 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.685 ' NE2' ' H ' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -86.02 -8.71 57.75 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.909 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.413 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 20.1 m-20 -111.86 -33.71 6.22 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.618 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.32 -86.34 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 117.603 2.445 . . . . 0.0 117.603 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.749 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 22.0 m-20 -64.65 26.06 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -172.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.559 ' CA ' HG22 ' A' ' 122' ' ' ILE . . . 55.51 37.51 67.26 Favored Glycine 0 CA--C 1.505 -0.574 0 C-N-CA 117.917 -2.087 . . . . 0.0 109.192 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.791 ' NE2' ' HB3' ' A' ' 98' ' ' TYR . 8.7 pt20 -136.3 168.95 18.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.074 -1.063 . . . . 0.0 110.384 -177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.839 HD11 HG21 ' A' ' 125' ' ' ILE . 60.0 mt -123.45 129.49 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.614 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.824 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 30.3 t70 -101.81 158.55 16.03 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.027 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.67 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 4.9 t80 -45.39 -32.54 2.13 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.913 0.387 . . . . 0.0 110.721 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.613 ' HA3' ' HA3' ' A' ' 152' ' ' GLY . . . -80.59 -38.15 17.99 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.071 -1.061 . . . . 0.0 110.729 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.97 ' HA ' ' HB3' ' A' ' 153' ' ' ARG . 30.8 mt-10 -59.98 -57.79 11.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.803 -0.198 . . . . 0.0 110.8 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.575 ' HD1' HD13 ' A' ' 133' ' ' ILE . 2.6 t80 -58.89 -26.77 64.6 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.527 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.469 ' HB2' ' HG ' ' A' ' 84' ' ' LEU . . . -79.7 -36.68 37.16 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.002 0.429 . . . . 0.0 110.836 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -90.0 -14.22 34.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.033 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -57.34 -18.53 17.56 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.486 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 24.4 ptt? -127.88 50.12 2.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.083 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.414 ' HB2' ' HE3' ' A' ' 146' ' ' LYS . 38.4 ptt180 -34.26 136.1 0.14 Allowed 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.347 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.88 -56.16 1.77 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.556 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -150.3 38.71 0.72 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.523 ' NZ ' ' HB2' ' A' ' 146' ' ' LYS . 10.0 mtmp? -42.86 105.61 0.05 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -95.9 -37.9 4.8 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.883 -0.675 . . . . 0.0 114.667 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.679 ' O ' HG13 ' A' ' 151' ' ' ILE . 23.4 p30 -149.67 162.29 40.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.33 0.565 . . . . 0.0 111.445 -178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 151' ' ' ILE . . . -36.42 -22.63 0.01 OUTLIER Glycine 0 C--N 1.339 0.744 0 O-C-N 123.814 0.696 . . . . 0.0 114.155 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 148' ' ' ASN . . . -59.89 -4.49 3.3 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.979 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.679 HG13 ' O ' ' A' ' 148' ' ' ASN . 8.4 mt -38.07 -84.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 123.061 0.544 . . . . 0.0 111.407 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.613 ' HA3' ' HA3' ' A' ' 136' ' ' GLY . . . 161.4 -62.96 0.28 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.633 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.97 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . 34.5 ptt85 -76.63 82.37 3.28 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.681 0.753 . . . . 0.0 110.595 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.812 ' HG3' ' H ' ' A' ' 156' ' ' MET . 5.0 tpm_? -130.66 148.29 52.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.33 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.481 ' H ' ' HE ' ' A' ' 154' ' ' ARG . 86.1 m -69.63 -16.03 63.3 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.812 ' H ' ' HG3' ' A' ' 154' ' ' ARG . 25.3 ptm -138.98 34.72 2.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.41 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.696 ' HB3' ' HB3' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -58.19 -12.32 3.46 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.508 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.552 ' N ' ' HD3' ' A' ' 157' ' ' ARG . 17.9 tppt? -55.28 -86.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.171 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 50.3 p -143.43 -72.57 0.29 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.055 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 161' ' ' ASN . 6.1 tt -160.47 123.42 3.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.298 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.473 ' N ' HD23 ' A' ' 160' ' ' LEU . 47.6 t30 -112.46 158.14 20.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 162' ' ' LEU . 5.8 mp -84.86 -81.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.775 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 51.0 mmt-85 -103.2 109.54 21.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.926 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.84 149.38 26.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.953 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -116.66 146.2 42.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.962 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 166' ' ' LEU . 6.2 mp -109.09 -16.54 14.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.994 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.88 -116.83 4.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.515 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.448 ' C ' HD23 ' A' ' 168' ' ' LEU . 5.9 tt -62.75 114.34 3.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.812 0.339 . . . . 0.0 110.26 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.2 m -67.32 127.53 29.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.477 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -151.71 -50.88 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.77 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.87 -32.66 73.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.703 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -144.69 142.1 10.63 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.43 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.3 m -137.44 91.75 2.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 110.891 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.453 ' OD1' ' HG2' ' A' ' 175' ' ' GLN . 25.1 t-20 -141.02 -90.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.55 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.453 ' HG2' ' OD1' ' A' ' 174' ' ' ASN . 98.1 mm-40 -138.03 110.86 7.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.595 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.59 103.41 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.289 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.5 mm -90.28 131.15 38.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.889 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -107.8 119.69 40.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -105.76 101.54 1.85 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.368 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -68.45 157.16 36.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 111.178 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -172.06 -75.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.799 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.867 -179.944 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.564 ' HB1' HH12 ' A' ' 3' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.828 0.347 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -98.39 123.58 42.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.811 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.564 HH12 ' HB1' ' A' ' 1' ' ' ALA . 21.6 ptt-85 -165.13 164.14 20.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.6 tp -165.79 90.97 0.47 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.719 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.2 p -130.51 171.78 12.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 5.1 mm-40 -65.53 148.32 51.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.093 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -89.0 -42.94 11.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.1 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -76.53 -43.08 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.786 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.1 mp -74.05 -43.73 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.791 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.36 115.38 4.41 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.38 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.86 26.57 0.4 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.49 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.798 HD12 HD23 ' A' ' 15' ' ' LEU . 53.9 tp -87.85 -37.98 16.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.469 0.176 . . . . 0.0 110.61 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.625 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 24.0 pttm -66.36 -32.11 73.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 82.2 tt0 -78.18 -36.85 46.9 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.798 HD23 HD12 ' A' ' 12' ' ' LEU . 52.3 tp -53.87 -42.57 68.75 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.366 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.54 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 10.9 t80 -51.69 -45.06 63.34 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.443 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 65.3 pttt -85.06 -12.45 53.03 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.9 ttp -85.55 -13.76 47.95 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.614 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.791 HG23 ' HA3' ' A' ' 35' ' ' GLY . 22.4 mm -74.92 -52.44 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.726 ' HB2' ' HB3' ' A' ' 23' ' ' ASN . 4.4 p-10 -81.93 50.6 1.57 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.033 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.828 HG21 ' HD2' ' A' ' 38' ' ' ARG . 13.0 t -61.97 -6.82 3.12 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.877 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -133.94 -10.88 2.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.979 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.726 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 30.9 t30 -87.49 -95.83 0.09 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.2 p -177.72 12.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 111.59 24.37 5.32 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.948 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.498 ' OG1' ' ND2' ' A' ' 23' ' ' ASN . 40.6 p -147.62 144.23 28.26 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.992 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 6.9 mt -104.02 104.84 17.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 68.8 p -102.21 163.52 12.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.704 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.743 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 49.2 t80 -34.28 -37.32 0.05 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.86 -45.75 40.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.92 0.39 . . . . 0.0 111.167 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -78.56 -13.83 59.63 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.719 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.01 HD13 HG23 ' A' ' 48' ' ' ILE . 6.2 tt -53.05 -49.01 67.2 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.65 ' HD3' ' NZ ' ' A' ' 37' ' ' LYS . 4.0 ptpp? -84.75 -41.17 16.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.491 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.552 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 17.9 t70 -47.57 -30.29 3.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.048 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.791 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -65.03 -40.31 96.99 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.888 -0.673 . . . . 0.0 113.351 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 36' ' ' LEU . 1.3 mm? -91.99 -33.15 14.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.324 0.583 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.65 ' NZ ' ' HD3' ' A' ' 33' ' ' LYS . 76.5 mttt -60.94 -45.8 93.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.698 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.828 ' HD2' HG21 ' A' ' 21' ' ' THR . 46.9 ttt-85 -69.77 -40.74 75.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.62 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 36' ' ' LEU . 8.2 p -71.13 -14.25 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.48 54.86 0.3 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.121 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 70.1 m -146.0 166.98 24.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.605 0.24 . . . . 0.0 110.483 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 23.2 pt-20 -137.29 114.67 10.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 111.378 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.41 ' HB2' HD11 ' A' ' 48' ' ' ILE . 36.4 mt -125.13 165.58 17.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.272 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.614 ' O ' HD13 ' A' ' 48' ' ' ILE . 20.4 mtm -113.41 164.41 13.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -64.98 0.65 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.154 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 89.1 p -39.78 -26.81 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 93.9 mt-10 -79.22 -49.72 12.08 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.01 HG23 HD13 ' A' ' 32' ' ' LEU . 1.7 mp -52.99 -60.86 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.591 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.743 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 51.6 tttp -57.05 -22.79 41.8 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.889 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 36.8 t70 -76.62 -44.58 33.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.719 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 tt -63.44 -44.76 93.62 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 111.092 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.733 ' HB2' HD11 ' A' ' 32' ' ' LEU . 37.3 ttm -66.6 -64.09 0.93 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.249 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.665 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 9.6 t70 -55.88 -29.29 59.72 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.05 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -88.58 -36.64 16.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -103.23 -41.65 5.99 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.545 ' OD1' HG12 ' A' ' 63' ' ' ILE . 15.8 t70 -50.94 95.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.937 0.399 . . . . 0.0 110.188 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.415 ' H ' HG12 ' A' ' 57' ' ' ILE . 27.9 mm -51.49 -18.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.551 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.524 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.2 m-20 -131.05 43.91 3.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.174 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.665 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 28.1 tptp -32.53 89.65 0.0 OUTLIER 'General case' 0 C--O 1.231 0.117 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 58' ' ' ASP . 87.7 p -127.85 18.21 6.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.519 -1.218 . . . . 0.0 109.02 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 76.34 22.63 72.82 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.087 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 91.1 m -147.54 153.84 39.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.243 0.617 . . . . 0.0 109.597 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.992 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 71.7 mt -135.16 127.53 47.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.995 0.426 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -104.6 167.52 9.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.492 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.625 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 41.2 t80 -35.41 -44.71 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.558 0.536 . . . . 0.0 111.663 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.04 -60.63 5.48 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.197 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.567 ' HB2' HG23 ' A' ' 63' ' ' ILE . 40.9 mt-10 -53.88 -21.83 8.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.851 0.358 . . . . 0.0 110.945 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 26.2 t80 -67.77 -65.11 0.73 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.501 0.667 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 65' ' ' TYR . 10.5 mm -52.44 -43.09 40.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.583 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.63 -39.44 73.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.47 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.433 ' O ' HD23 ' A' ' 75' ' ' LEU . . . -64.43 -49.25 72.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.361 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.583 HG21 HD11 ' A' ' 12' ' ' LEU . 65.8 p -55.8 -38.55 70.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.267 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 45.9 t -81.52 -16.75 12.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.063 0.458 . . . . 0.0 110.941 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -81.21 -25.69 36.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 71' ' ' ALA . 4.5 mm? -97.75 -4.07 37.79 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.784 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 26.5 t-20 -101.12 75.84 1.69 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.738 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.725 ' HG3' ' H ' ' A' ' 79' ' ' GLU . 18.5 ptpt -174.91 -161.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.033 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 78' ' ' LEU . 3.0 mm? -80.07 8.09 7.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.965 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.725 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 17.6 tp10 -58.41 157.59 8.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.644 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 45.0 mmt-85 -51.11 143.38 10.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.068 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -60.09 -77.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.171 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.04 31.77 0.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.239 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.533 HD22 ' N ' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -55.97 133.7 51.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.907 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.639 HD12 ' N ' ' A' ' 85' ' ' VAL . 2.0 pp -58.6 -17.01 18.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.433 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.639 ' N ' HD12 ' A' ' 84' ' ' LEU . 14.5 p -48.3 -19.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.832 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -38.43 -49.23 1.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.264 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -71.89 -50.17 31.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.499 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.779 ' HE1' ' HB2' ' A' ' 135' ' ' TYR . 11.5 t80 -36.23 -33.55 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.492 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 87' ' ' ALA . 29.5 t -89.67 -50.69 5.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.728 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.66 -64.21 1.24 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.165 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.602 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 5.0 m-85 -58.93 -59.9 4.71 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.756 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 1.2 m-20 -75.68 57.65 1.01 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -52.06 -41.15 62.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.701 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.469 ' HB3' 'CA ' ' A' ' 191' ' ' ' CA' . 37.2 t70 -67.87 -20.9 65.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 42.49 64.32 1.62 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.474 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 54.5 p -119.48 -35.32 3.59 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.39 4.1 0.81 Allowed Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 113.337 -1.756 . . . . 0.0 112.873 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.878 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.3 OUTLIER -152.67 165.64 34.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.494 0.664 . . . . 0.0 112.072 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.817 HG23 ' HB2' ' A' ' 103' ' ' GLU . 91.4 mt -132.35 104.08 7.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.14 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 102' ' ' ASP . 50.5 p -76.09 149.27 37.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.7 HD23 ' H ' ' A' ' 101' ' ' LEU . 0.5 OUTLIER -34.57 -33.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 100' ' ' THR . 1.5 m-20 -57.69 -52.34 65.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.85 0.357 . . . . 0.0 110.276 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.817 ' HB2' HG23 ' A' ' 99' ' ' ILE . 49.3 mt-10 -67.83 -28.39 67.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.543 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.67 HG22 ' OE1' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -70.2 -62.12 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.575 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.709 HE22 HG22 ' A' ' 118' ' ' ILE . 4.7 mm100 -53.66 -38.28 63.98 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.898 0.38 . . . . 0.0 110.49 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -61.81 -59.22 5.48 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.96 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.75 -10.77 13.95 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.198 0.523 . . . . 0.0 110.558 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 31.3 t -100.59 63.44 1.08 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.737 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.472 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 1.2 tmtp? -85.82 -61.08 1.84 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -57.89 -5.39 0.41 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.578 ' HB2' ' SG ' ' A' ' 108' ' ' CYS . 33.3 m-85 -90.75 7.68 38.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.53 37.05 94.07 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.633 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.989 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -33.67 125.94 0.41 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.317 0.58 . . . . 0.0 112.202 -178.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.681 ' N ' HD22 ' A' ' 113' ' ' LEU . 10.1 t70 -160.65 159.44 30.37 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.681 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 1.4 m-20 -71.74 -6.92 44.85 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.0 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.724 HG13 ' H ' ' A' ' 117' ' ' HIS . 14.0 pt -77.87 -64.6 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.724 ' H ' HG13 ' A' ' 116' ' ' ILE . 13.0 m-70 -92.01 -61.97 1.51 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.09 0.472 . . . . 0.0 111.417 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.989 HG13 ' HA ' ' A' ' 113' ' ' LEU . 13.2 mm -45.16 -36.17 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.11 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.2 -48.28 62.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.946 0.403 . . . . 0.0 110.025 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 124' ' ' GLU . 61.8 t0 -67.59 -27.66 67.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.564 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 1.091 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.0 ttt -62.87 -40.28 97.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.487 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.703 HG22 ' HA3' ' A' ' 131' ' ' GLY . 48.1 mt -53.52 -44.4 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 24.3 mmtp -85.18 -13.46 49.96 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.17 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 1.091 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 24.3 tt0 -87.95 -13.52 41.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.497 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.843 ' O ' HD11 ' A' ' 133' ' ' ILE . 81.3 mt -117.31 -23.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.759 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.925 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 22.0 t70 -65.25 101.68 0.58 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.566 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.795 ' NE2' ' HA ' ' A' ' 137' ' ' GLU . 18.8 mt-30 -88.05 -18.44 28.92 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.766 ' HB2' ' HD2' ' A' ' 153' ' ' ARG . 45.7 t0 -119.39 -34.63 3.77 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.758 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 178.92 -73.28 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.758 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 1.2 m-20 -64.2 20.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.925 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.31 38.18 67.69 Favored Glycine 0 CA--C 1.5 -0.88 0 C-N-CA 117.48 -2.295 . . . . 0.0 108.075 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.52 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 6.8 pt20 -131.68 167.12 20.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.628 -1.286 . . . . 0.0 109.055 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.843 HD11 ' O ' ' A' ' 125' ' ' ILE . 11.0 mm -134.18 124.99 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.326 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.878 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 2.4 p-10 -102.42 161.25 13.86 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.779 ' HB2' ' HE1' ' A' ' 88' ' ' PHE . 12.0 t80 -41.07 -32.63 0.26 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.812 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.719 ' HA3' ' N ' ' A' ' 153' ' ' ARG . . . -76.88 -46.43 10.82 Favored Glycine 0 N--CA 1.434 -1.463 0 C-N-CA 119.466 -1.35 . . . . 0.0 110.642 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.956 ' HG3' ' HE ' ' A' ' 153' ' ' ARG . 33.5 mt-10 -54.41 -59.85 4.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.367 -0.416 . . . . 0.0 111.347 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.505 ' N ' HG23 ' A' ' 133' ' ' ILE . 3.6 t80 -57.56 -29.9 64.8 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.92 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.51 -20.06 48.13 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.074 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.538 ' HB3' HE22 ' A' ' 127' ' ' GLN . . . -89.84 -49.01 6.87 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.085 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.633 ' SD ' HG23 ' A' ' 125' ' ' ILE . 28.0 ptm -55.41 -16.46 3.67 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.35 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 56.0 ttp -99.86 -25.23 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.631 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.513 HH21 HD23 ' A' ' 84' ' ' LEU . 68.0 mtt-85 -111.37 -99.08 0.41 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.792 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -141.01 -163.03 1.46 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.726 0.298 . . . . 0.0 110.346 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.762 ' HG3' ' HG2' ' A' ' 146' ' ' LYS . 23.3 ptt-85 -89.84 -23.04 21.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.87 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.762 ' HG2' ' HG3' ' A' ' 145' ' ' ARG . 17.9 ptpt -175.73 85.22 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.154 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -90.32 -37.68 6.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.695 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -149.13 162.17 40.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.607 0.241 . . . . 0.0 110.839 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -51.66 -14.04 1.55 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.85 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -66.47 -4.2 23.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.173 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.545 HG12 ' N ' ' A' ' 152' ' ' GLY . 6.9 tt -44.02 155.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 121.117 0.484 . . . . 0.0 111.788 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.545 ' N ' HG12 ' A' ' 151' ' ' ILE . . . -133.52 -46.61 0.11 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.956 ' HE ' ' HG3' ' A' ' 137' ' ' GLU . 8.7 tpp180 -75.51 120.71 21.3 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.675 0.75 . . . . 0.0 110.161 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.73 ' N ' ' HD3' ' A' ' 153' ' ' ARG . 70.4 mtp180 -131.22 148.23 52.68 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.693 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.0 t -58.8 -16.0 14.98 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.8 ttt -162.18 59.45 0.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.691 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.571 ' HB3' ' HB2' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -63.0 -172.21 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.433 -179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -165.34 121.2 1.36 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.795 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.8 t -164.85 161.17 20.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.1 mt -77.54 154.86 32.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.776 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -106.27 171.02 7.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.199 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.615 HD23 ' N ' ' A' ' 163' ' ' ARG . 7.9 tt -104.37 140.36 38.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.489 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.615 ' N ' HD23 ' A' ' 162' ' ' LEU . 57.6 ttp180 -132.91 -69.48 0.56 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.53 142.48 58.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.796 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.4 130.6 41.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.363 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 166' ' ' LEU . 6.8 mp -78.65 -14.55 59.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.986 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -106.5 -154.41 20.48 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.553 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.821 HD23 ' H ' ' A' ' 168' ' ' LEU . 2.4 pt? -111.29 -178.75 3.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.736 0.303 . . . . 0.0 110.828 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 50.0 t -71.1 112.31 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.872 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -68.28 90.27 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.125 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -90.52 11.62 21.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.39 124.39 24.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.425 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.3 t -95.74 49.79 1.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.896 0.379 . . . . 0.0 110.869 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -134.11 49.12 2.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.935 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' ' 175' ' ' GLN . 20.7 pt20 -78.46 106.18 10.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.09 0.471 . . . . 0.0 110.975 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.55 136.93 24.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.128 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.641 ' O ' HD12 ' A' ' 177' ' ' ILE . 2.8 pp -121.77 148.65 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.402 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -126.1 134.98 51.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 176.63 45.53 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.705 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -77.81 166.95 22.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.827 0.346 . . . . 0.0 110.949 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -84.38 132.46 34.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.017 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.933 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ' CA' . . . . . 0.469 'CA ' ' HB3' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -117.58 -7.69 11.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.082 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -118.14 80.05 1.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.913 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.3 mt -114.15 -177.3 3.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.8 m -137.9 168.31 19.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.01 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -108.25 -11.74 15.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.904 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -89.26 -19.87 24.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -73.59 -36.29 65.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.192 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.0 tp -66.31 -31.23 52.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.415 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.45 150.92 16.92 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.684 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.42 -11.29 72.48 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.621 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.751 HD11 HG21 ' A' ' 72' ' ' THR . 50.0 tp -86.95 -39.11 16.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.667 0.27 . . . . 0.0 110.823 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 33.9 mtmm -56.94 -46.68 81.92 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.637 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -68.48 -34.52 76.07 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.679 HD23 HD12 ' A' ' 12' ' ' LEU . 45.2 tp -59.52 -28.7 67.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.169 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.437 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 13.1 t80 -67.47 -38.98 85.22 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.016 0.436 . . . . 0.0 110.971 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.637 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 61.7 pttt -86.63 -19.82 28.75 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.629 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -63.44 -27.2 69.13 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.491 176.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.717 HG21 HD13 ' A' ' 27' ' ' ILE . 18.7 mm -70.61 -59.65 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.212 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -78.59 89.79 4.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.3 178.077 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.5 t -88.27 -34.71 17.61 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.525 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -139.83 16.7 2.49 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.534 ' HB2' ' OE1' ' A' ' 31' ' ' GLU . 3.5 m120 -92.44 -88.65 0.2 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.947 0.794 . . . . 0.0 112.89 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -164.95 -1.55 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.468 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 110.75 20.53 7.22 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.412 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 75.4 p -128.09 166.43 18.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.881 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 6.1 mt -123.14 101.53 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.083 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.553 HG22 ' HB ' ' A' ' 62' ' ' THR . 67.5 p -103.56 164.98 11.31 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.704 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -33.72 -39.21 0.06 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.839 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.676 ' OD1' ' HG3' ' A' ' 31' ' ' GLU . 1.8 p30 -73.05 -43.69 61.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.64 0.257 . . . . 0.0 111.281 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.676 ' HG3' ' OD1' ' A' ' 30' ' ' ASP . 42.4 mt-10 -74.68 -24.07 58.73 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 110.265 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.751 ' HG ' HD23 ' A' ' 51' ' ' LEU . 6.3 tt -54.43 -54.24 43.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.87 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.718 ' HG3' ' H ' ' A' ' 34' ' ' ASP . 17.0 ptpt -75.97 -62.31 1.64 Allowed 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.466 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.718 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 35.9 t70 -37.59 -48.55 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.498 ' CA ' ' HA ' ' A' ' 19' ' ' ILE . . . -48.85 -54.44 14.18 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.98 -0.555 . . . . 0.0 113.858 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.634 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -89.8 -45.94 8.93 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.216 0.531 . . . . 0.0 110.144 -179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -17.21 0.56 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.079 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 32.0 ttm-85 -59.66 -43.22 94.01 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.778 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 36' ' ' LEU . 34.3 m -78.53 31.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.98 -22.66 24.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.752 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.7 m -53.46 154.44 3.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.648 0.261 . . . . 0.0 110.648 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.09 118.18 9.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 111.432 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.6 mt -119.67 165.77 14.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.481 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.665 ' SD ' ' HB2' ' A' ' 46' ' ' SER . 0.0 OUTLIER -105.02 152.92 22.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -42.46 -56.05 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.665 ' HB2' ' SD ' ' A' ' 44' ' ' MET . 52.3 m -54.7 -21.66 11.46 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 119.236 0.925 . . . . 0.0 111.888 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.608 ' OE2' ' HA ' ' A' ' 83' ' ' ASN . 38.2 mt-10 -74.57 -44.54 50.42 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.704 HG23 HD13 ' A' ' 32' ' ' LEU . 2.0 mp -58.17 -53.31 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.119 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.61 ' HE2' ' HE1' ' A' ' 91' ' ' PHE . 10.5 ttpp -52.92 -30.27 33.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.459 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.556 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 8.8 t70 -62.96 -50.09 72.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.379 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.751 HD23 ' HG ' ' A' ' 32' ' ' LEU . 41.1 tp -60.63 -14.88 23.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.694 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.939 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 13.4 mmt -88.13 -65.84 0.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -78.94 -32.95 45.72 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.939 -0.475 . . . . 0.0 111.726 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -87.46 -18.32 30.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.662 ' HB3' HD12 ' A' ' 51' ' ' LEU . . . -127.09 -43.57 1.65 Allowed 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.647 ' OD1' HG12 ' A' ' 63' ' ' ILE . 21.2 t70 -59.91 96.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.784 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.409 HG12 ' H ' ' A' ' 57' ' ' ILE . 26.5 mm -46.26 -25.63 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.866 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.527 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.7 m-20 -129.63 44.09 3.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.27 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.939 ' HD3' ' HB3' ' A' ' 52' ' ' MET . 51.4 tptt -33.27 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 122.046 0.927 . . . . 0.0 113.347 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.7 p -127.29 9.56 6.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.77 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 97.85 -5.7 61.94 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.517 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.844 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 3.0 t -141.11 165.01 28.72 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.062 0.458 . . . . 0.0 110.681 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.881 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 98.4 mt -125.81 135.38 64.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.33 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.89 166.21 10.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.649 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.653 ' O ' HG12 ' A' ' 69' ' ' ILE . 51.3 t80 -36.31 -46.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.733 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.55 -63.84 4.0 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.441 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.731 ' HB2' HG23 ' A' ' 63' ' ' ILE . 40.9 mt-10 -49.86 -29.2 7.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.739 0.304 . . . . 0.0 111.473 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.522 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 34.1 t80 -65.83 -62.63 1.4 Allowed 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.364 0.602 . . . . 0.0 111.16 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.653 HG12 ' O ' ' A' ' 65' ' ' TYR . 19.8 mm -53.32 -48.38 56.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.692 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.45 -41.16 84.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.922 0.392 . . . . 0.0 110.905 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 74' ' ' HIS . . . -58.11 -55.85 29.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.26 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.751 HG21 HD11 ' A' ' 12' ' ' LEU . 81.8 p -59.12 -56.07 26.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.492 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.677 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 49.5 t -56.92 -22.23 15.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.374 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.47 ' O ' ' HE3' ' A' ' 77' ' ' LYS . 77.3 t60 -67.9 -52.69 33.51 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.68 -9.45 58.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.227 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.677 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 49.3 t30 -91.51 78.8 5.58 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.087 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.47 ' HE3' ' O ' ' A' ' 74' ' ' HIS . 20.8 pttp -166.45 -24.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.833 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.5 mt -138.91 -85.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.539 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -175.04 137.68 0.42 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.713 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.656 ' O ' ' HD2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -114.16 130.89 56.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.033 0.444 . . . . 0.0 110.978 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -150.74 9.5 0.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.515 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.51 93.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.992 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.608 ' HA ' ' OE2' ' A' ' 47' ' ' GLU . 3.3 m120 -97.39 -87.19 0.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.737 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.515 HD23 ' O ' ' A' ' 84' ' ' LEU . 8.1 tt -74.47 -36.73 63.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.018 0.437 . . . . 0.0 110.311 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 88' ' ' PHE . 7.3 p -57.17 -19.47 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.456 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.59 ' HB3' ' HE3' ' A' ' 44' ' ' MET . 48.3 t -41.75 -62.66 0.85 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.271 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 138' ' ' PHE . . . -73.41 -36.08 65.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.463 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.799 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 2.8 t80 -45.72 -25.74 0.53 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.413 0.625 . . . . 0.0 109.65 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.7 t -89.62 -43.56 10.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.863 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -87.07 -64.45 1.15 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.82 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.61 ' HE1' ' HE2' ' A' ' 49' ' ' LYS . 2.8 m-85 -56.26 -59.99 4.15 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.799 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 1.6 m-20 -78.73 55.66 1.73 Allowed 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -51.16 -41.66 60.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.697 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.433 ' HB3' 'CA ' ' A' ' 191' ' ' ' CA' . 8.6 t70 -67.56 -20.61 65.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 43.74 65.06 1.67 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.276 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.9 p -119.08 -33.79 4.06 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 147.8 -37.08 1.12 Allowed Glycine 0 N--CA 1.433 -1.53 0 CA-C-N 112.786 -2.006 . . . . 0.0 112.196 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.893 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.2 OUTLIER -109.45 164.88 12.1 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.843 HG22 HG13 ' A' ' 104' ' ' ILE . 77.8 mt -132.6 103.54 6.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.231 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 102' ' ' ASP . 44.4 p -72.2 146.09 47.57 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 101' ' ' LEU . 0.3 OUTLIER -34.64 -32.95 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 100' ' ' THR . 45.4 t0 -55.47 -56.38 20.89 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.697 ' HB2' HG23 ' A' ' 99' ' ' ILE . 51.8 mt-10 -66.03 -28.34 68.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.825 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.843 HG13 HG22 ' A' ' 99' ' ' ILE . 78.9 mt -69.57 -65.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.031 0.443 . . . . 0.0 111.247 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.875 ' NE2' HG22 ' A' ' 118' ' ' ILE . 6.6 mm100 -50.09 -51.87 39.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.596 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.482 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 70.1 mt-30 -64.49 -24.68 67.69 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.48 -6.86 58.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 72.2 m -123.78 68.57 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.867 0.365 . . . . 0.0 111.391 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 106' ' ' GLN . 74.6 mmtt -84.03 -32.09 25.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.584 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -83.21 -4.86 58.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.596 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 0.9 OUTLIER -93.46 16.33 13.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.359 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.05 36.82 45.14 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.602 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.883 ' HA ' HG13 ' A' ' 118' ' ' ILE . 3.1 tm? -34.36 110.0 0.09 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.969 0.414 . . . . 0.0 111.323 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.446 ' OD2' ' HB ' ' A' ' 116' ' ' ILE . 12.1 p-10 -160.12 -176.07 5.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.734 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.589 ' HA ' ' CG ' ' A' ' 119' ' ' ASP . 2.8 p30 -89.48 -8.94 51.82 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.446 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 60.5 mt -81.8 -64.6 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.914 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -91.61 -68.9 0.77 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.883 HG13 ' HA ' ' A' ' 113' ' ' LEU . 31.4 mm -40.52 -36.56 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.589 ' CG ' ' HA ' ' A' ' 115' ' ' ASP . 42.2 m-20 -71.2 -52.4 19.3 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 122.139 -0.351 . . . . 0.0 110.86 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 124' ' ' GLU . 32.4 m-20 -57.59 -23.62 51.78 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.992 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.5 ttt -65.39 -36.27 83.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.746 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.528 HG22 ' HA3' ' A' ' 131' ' ' GLY . 52.8 mt -57.06 -45.89 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.824 ' HA ' ' HE2' ' A' ' 123' ' ' LYS . 10.6 mmpt? -83.57 -13.19 54.99 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.57 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.992 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 29.8 tt0 -87.97 -19.21 27.53 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.458 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.907 HG21 HD11 ' A' ' 133' ' ' ILE . 63.9 mt -107.59 -50.52 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.89 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.562 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 5.4 p-10 -46.76 100.1 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.858 0.837 . . . . 0.0 110.697 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.776 ' H ' ' NE2' ' A' ' 127' ' ' GLN . 0.0 OUTLIER -87.3 -9.9 53.72 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.996 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 53.7 p30 -117.05 -33.19 4.8 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.713 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.43 -81.4 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.713 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 59.0 m-20 -64.51 22.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 -172.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' A' ' 126' ' ' ASP . . . 56.37 38.29 78.33 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 117.219 -2.419 . . . . 0.0 109.414 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.563 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 12.1 pt20 -132.0 167.29 19.92 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.362 -0.919 . . . . 0.0 111.722 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.907 HD11 HG21 ' A' ' 125' ' ' ILE . 15.3 mt -125.67 116.15 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.549 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.893 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 38.6 t70 -104.8 161.78 13.87 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.574 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.631 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 37.0 t80 -40.28 -32.81 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -82.22 -41.41 9.35 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.677 ' CG ' HE22 ' A' ' 127' ' ' GLN . 26.3 mt-10 -62.39 -53.28 57.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 29.0 t80 -52.3 -31.69 34.14 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.284 0.564 . . . . 0.0 109.649 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -68.27 -23.91 64.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.975 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.709 ' HB2' ' NH1' ' A' ' 153' ' ' ARG . . . -88.94 -52.93 4.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.29 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 138' ' ' PHE . 5.2 ppp? -51.35 -22.57 2.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.447 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 36.9 ttm -93.09 -68.02 0.82 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.761 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.626 ' HD3' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -83.16 -144.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.326 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.64 ' HZ3' ' HB3' ' A' ' 144' ' ' LYS . 8.2 mtpm? -148.58 47.81 1.03 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.796 0.331 . . . . 0.0 110.845 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.843 ' HA ' HD22 ' A' ' 148' ' ' ASN . 66.4 mtt-85 -83.6 53.57 2.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.411 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.437 ' HE3' ' HZ3' ' A' ' 144' ' ' LYS . 96.1 mttt -53.15 -93.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.487 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -84.98 -4.92 86.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.947 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.843 HD22 ' HA ' ' A' ' 145' ' ' ARG . 75.0 m-80 -52.87 158.22 1.45 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 111.012 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -64.74 -8.98 36.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.376 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -95.63 -3.05 61.22 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.61 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.821 HG23 ' H ' ' A' ' 152' ' ' GLY . 2.7 tt -33.3 -84.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.821 ' H ' HG23 ' A' ' 151' ' ' ILE . . . 85.23 -48.15 3.98 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.468 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.718 HH12 ' HB2' ' A' ' 145' ' ' ARG . 0.1 OUTLIER -57.44 83.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.616 0.722 . . . . 0.0 110.574 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 152' ' ' GLY . 45.4 mtp85 -130.76 149.11 52.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.105 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.564 HG23 ' OD1' ' A' ' 129' ' ' ASN . 77.4 m -55.84 -44.01 77.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.151 0.5 . . . . 0.0 109.809 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -132.83 73.6 1.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.143 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 152' ' ' GLY . 75.1 mtp180 -48.28 155.78 0.46 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.869 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -161.9 152.3 17.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.572 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 82.4 p -112.12 -179.86 3.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.378 . . . . 0.0 110.998 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 160' ' ' LEU . 5.3 mp -111.16 -165.89 1.03 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.815 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -131.48 122.61 26.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 162' ' ' LEU . 2.5 pp -132.44 20.57 4.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.276 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -65.91 -65.02 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.13 145.08 56.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.983 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -68.79 134.38 49.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.025 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 98.3 mt -81.99 -21.18 37.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.93 107.99 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.443 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 168' ' ' LEU . 6.3 mp -83.77 146.93 27.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 111.056 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.94 123.16 56.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.985 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.04 -80.98 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -113.8 46.37 1.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.147 0.499 . . . . 0.0 110.277 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.48 130.6 4.04 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.5 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.3 t -145.04 -6.73 0.65 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.756 0.312 . . . . 0.0 110.809 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -116.13 -30.02 6.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -108.55 114.54 28.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.799 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.4 p -77.48 140.93 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 69.7 mt -90.14 107.54 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.054 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -136.27 127.57 28.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.98 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 69.54 -129.78 22.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.526 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.401 ' H ' ' H ' ' A' ' 181' ' ' PHE . 0.7 OUTLIER -167.97 -5.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.797 0.332 . . . . 0.0 111.192 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.401 ' H ' ' H ' ' A' ' 180' ' ' TYR . 13.2 t80 -97.6 165.75 11.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.589 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 61.5 mttp . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.794 -179.741 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ' CA' . . . . . 0.433 'CA ' ' HB3' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.837 0.351 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -126.73 -10.94 6.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.036 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 3' ' ' ARG . 4.6 tmm_? -162.11 115.91 1.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.361 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.7 tp -159.62 -43.45 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.804 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.8 t -95.42 179.65 5.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.806 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -109.29 41.96 1.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.937 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -64.27 -16.68 62.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.755 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.12 -43.33 99.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.973 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.524 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.0 mp -67.51 -68.97 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.875 0.369 . . . . 0.0 111.25 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 12' ' ' LEU . . . -166.13 165.86 38.41 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.62 77.88 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.537 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 10' ' ' GLY . 31.5 tp -88.25 -46.78 8.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.538 0.209 . . . . 0.0 110.605 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.637 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 6.4 ttpm? -55.74 -30.92 62.03 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.752 ' HG3' ' HE2' ' A' ' 17' ' ' LYS . 8.1 mp0 -77.0 -38.26 53.43 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.968 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.748 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 54.5 tp -55.04 -28.12 49.78 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.664 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -70.54 -45.11 66.11 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.787 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.752 ' HE2' ' HG3' ' A' ' 14' ' ' GLU . 63.5 pttt -82.46 -12.46 57.82 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.58 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -62.45 -25.86 68.21 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.429 178.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.555 HG23 ' HA3' ' A' ' 35' ' ' GLY . 3.3 mt -86.4 -59.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.53 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.542 ' OD2' ' HA2' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -82.68 57.37 3.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.391 0.615 . . . . 0.0 110.523 179.349 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.67 HG21 ' NH2' ' A' ' 38' ' ' ARG . 13.6 t -81.26 -6.66 59.12 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.17 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -129.21 -14.65 4.29 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.58 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -74.38 -87.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.832 0.348 . . . . 0.0 111.197 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 p -176.67 6.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.811 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.542 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.44 31.47 2.79 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.498 ' HB ' ' CG2' ' A' ' 62' ' ' THR . 45.8 p -150.07 145.79 26.58 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.192 -0.504 . . . . 0.0 109.938 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.811 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.2 mt -102.85 103.87 15.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.632 HG22 ' OG1' ' A' ' 62' ' ' THR . 67.3 p -103.37 164.83 11.4 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.445 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.561 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 20.4 t80 -34.06 -36.44 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.72 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.15 -49.88 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.715 0.293 . . . . 0.0 111.676 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.637 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -75.7 -19.9 58.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.939 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.871 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -46.03 -47.4 16.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.893 0.854 . . . . 0.0 108.707 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.719 ' HG2' HG12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -85.38 -51.9 6.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.0 -1.454 . . . . 0.0 111.488 179.215 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.637 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 59.4 m-20 -36.34 -36.17 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.555 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -68.02 -57.32 8.79 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 115.124 0.81 . . . . 0.0 115.124 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -73.86 -28.53 61.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.195 0.997 . . . . 0.0 111.983 -177.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.657 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 19.3 ptpt -66.18 -4.67 8.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.67 ' NH2' HG21 ' A' ' 21' ' ' THR . 36.9 ttm180 -87.12 -42.72 12.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.278 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 36' ' ' LEU . 30.8 m -73.45 -0.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.75 -36.86 3.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.361 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.606 ' CB ' HD23 ' A' ' 36' ' ' LEU . 18.5 m -52.45 153.01 3.19 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.565 -0.161 . . . . 0.0 110.565 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -143.31 103.76 4.17 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.285 0.564 . . . . 0.0 112.153 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -105.36 167.97 9.38 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.125 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 5.3 mtm -104.62 165.54 11.0 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.53 ' HA ' HD13 ' A' ' 48' ' ' ILE . 92.8 mt-10 -47.68 -60.04 2.85 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.51 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 94.9 p -39.42 -35.0 0.24 Allowed 'General case' 0 C--N 1.335 -0.047 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 44' ' ' MET . 37.1 mp0 -66.42 -41.02 89.87 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.055 0.455 . . . . 0.0 110.15 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.871 HG13 HD12 ' A' ' 32' ' ' LEU . 2.0 mp -57.02 -60.58 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.958 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.561 ' HB2' ' HE1' ' A' ' 29' ' ' PHE . 42.3 tttm -64.34 -25.66 68.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.353 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 46' ' ' SER . 62.6 t0 -71.12 -37.46 72.32 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.654 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.53 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 10.2 tt -76.34 -23.04 54.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.049 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.751 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 18.1 mmt -71.92 -45.01 62.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.058 0.456 . . . . 0.0 111.468 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -87.51 -30.27 20.72 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.716 -0.394 . . . . 0.0 112.01 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.53 -19.36 22.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.04 -43.75 1.65 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.751 ' HB3' ' O ' ' A' ' 52' ' ' MET . 15.6 t0 -61.24 95.96 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.2 mm -48.62 -22.69 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.044 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 59.1 t0 -129.13 44.49 2.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.864 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.734 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.5 tmtm? -32.58 90.43 0.0 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.741 0.781 . . . . 0.0 112.659 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.3 p -127.72 17.98 6.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.184 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 70.92 17.76 75.66 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.428 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 85.9 m -150.35 127.1 10.97 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 123.779 0.341 . . . . 0.0 110.58 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.811 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 70.3 mt -108.02 129.43 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 121.058 0.456 . . . . 0.0 111.399 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -105.04 167.3 9.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.076 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.637 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 48.1 t80 -35.47 -45.81 0.36 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.486 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.4 -63.71 4.11 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.322 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.797 ' HB2' HG23 ' A' ' 63' ' ' ILE . 63.0 mt-10 -51.89 -26.15 9.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.684 0.278 . . . . 0.0 110.894 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.748 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 71.7 t80 -63.88 -65.12 0.72 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.431 0.634 . . . . 0.0 110.91 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.602 HD13 ' HD2' ' A' ' 68' ' ' PHE . 14.5 mm -52.2 -41.13 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.659 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.2 -25.77 66.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.47 . . . . 0.0 110.572 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.11 -12.57 26.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.028 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.418 HG21 HD11 ' A' ' 12' ' ' LEU . 37.4 m -87.72 -43.73 11.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.783 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.637 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 57.4 t -67.0 -18.12 23.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.081 0.467 . . . . 0.0 110.594 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -71.01 -47.54 58.19 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.6 mt -81.83 0.98 36.97 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.202 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.637 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 0.7 OUTLIER -102.82 75.29 1.39 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.984 -179.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -175.43 -156.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.274 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.535 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.6 mm? -99.18 59.99 1.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.432 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -104.54 150.33 24.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.036 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -139.34 100.28 3.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.767 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -165.78 38.96 0.06 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.095 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -90.66 22.11 3.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.998 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -109.05 -155.96 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.975 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 139' ' ' ALA . 7.3 mp -57.16 -29.55 63.72 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.59 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' A' ' 88' ' ' PHE . 14.4 p -45.71 -27.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.732 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 52.3 m -51.11 -55.01 19.88 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.921 0.391 . . . . 0.0 110.118 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.583 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -81.12 -39.81 25.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.913 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.823 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 8.1 t80 -45.98 -23.01 0.25 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.358 0.599 . . . . 0.0 110.041 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 87' ' ' ALA . 28.4 t -89.15 -44.81 10.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.737 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -89.29 -63.7 1.25 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.601 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.5 m-85 -51.97 -62.33 1.7 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.823 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.6 OUTLIER -76.13 55.31 0.93 Allowed 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -44.59 -52.88 7.69 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.42 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.4 -21.44 64.69 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.344 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 47.08 68.69 1.07 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.5 p -115.59 -23.04 8.93 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.599 ' O ' ' HB2' ' A' ' 134' ' ' ASP . . . 130.51 -4.51 5.86 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-N 113.136 -1.847 . . . . 0.0 112.604 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.859 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.5 OUTLIER -148.69 161.83 40.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.399 0.618 . . . . 0.0 112.649 179.437 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.791 HG12 ' HA ' ' A' ' 92' ' ' ASP . 22.1 mt -133.12 104.24 6.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.779 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 102' ' ' ASP . 69.5 p -72.29 147.11 46.71 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.671 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.1 pp -34.41 -33.97 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.528 ' N ' HD12 ' A' ' 101' ' ' LEU . 54.2 m-20 -54.31 -55.92 23.58 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.548 ' HB2' HG23 ' A' ' 99' ' ' ILE . 97.4 mt-10 -71.19 -31.38 67.57 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.209 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.698 HG13 HG22 ' A' ' 99' ' ' ILE . 50.9 mt -65.74 -65.3 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.187 0.518 . . . . 0.0 110.403 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.892 ' HB3' HD12 ' A' ' 113' ' ' LEU . 87.8 mt-30 -58.14 -39.03 77.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.608 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.87 -44.07 94.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.095 0.474 . . . . 0.0 110.644 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.71 -3.06 1.33 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.17 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.762 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 73.2 m -115.09 44.12 1.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.93 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -59.54 -36.71 76.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.811 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -75.02 -22.11 58.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.155 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.762 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 2.7 m-85 -76.76 -5.24 47.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.944 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.37 38.81 96.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.572 -1.299 . . . . 0.0 111.026 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.928 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -33.01 132.72 0.14 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.525 0.679 . . . . 0.0 111.486 -177.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.716 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 91.9 m-20 -135.98 167.68 20.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.259 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.638 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.8 m-20 -82.95 -7.93 59.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.167 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.4 mt -92.63 -64.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.039 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -89.46 -69.29 0.72 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.928 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.4 mm -52.72 -19.49 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.958 0.409 . . . . 0.0 111.268 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.638 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 33.6 t70 -71.11 -46.96 60.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 124' ' ' GLU . 63.9 t0 -62.37 -26.26 68.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 1.086 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.4 ttt -60.74 -29.82 69.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.501 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.769 HG22 ' HA3' ' A' ' 131' ' ' GLY . 56.8 mt -58.37 -43.59 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.475 ' CE ' ' HB ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -86.67 -13.79 44.47 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.584 -1.644 . . . . 0.0 110.374 178.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 1.086 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 71.4 tt0 -84.61 -23.71 29.45 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.79 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.854 HG22 HD11 ' A' ' 133' ' ' ILE . 13.4 mm -107.58 -21.77 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.978 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.3 t70 -62.89 98.43 0.13 Allowed 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.593 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.945 HE21 ' HG2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -87.24 -13.95 42.39 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.439 ' OD1' ' ND2' ' A' ' 129' ' ' ASN . 50.5 p30 -127.57 -33.19 2.33 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.728 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 179.92 -71.71 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.728 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 56.3 m-20 -64.93 18.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.978 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.53 37.92 77.91 Favored Glycine 0 CA--C 1.505 -0.577 0 C-N-CA 118.358 -1.877 . . . . 0.0 110.044 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.556 ' HG3' ' OE1' ' A' ' 137' ' ' GLU . 8.5 pt20 -133.31 170.54 15.3 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 113.929 -1.135 . . . . 0.0 110.073 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.006 HD13 ' HB3' ' A' ' 137' ' ' GLU . 5.0 mm -133.05 121.89 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.856 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.924 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 4.3 p-10 -113.08 162.48 15.88 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.172 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.798 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 22.4 t80 -38.79 -30.45 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.0 0.428 . . . . 0.0 110.738 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.731 ' HA3' ' N ' ' A' ' 153' ' ' ARG . . . -84.25 -45.15 6.32 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.726 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 1.006 ' HB3' HD13 ' A' ' 133' ' ' ILE . 39.3 mt-10 -63.07 -51.3 67.2 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.588 ' HB2' ' CG2' ' A' ' 133' ' ' ILE . 13.5 t80 -56.61 -18.66 12.77 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.611 ' HA ' HD21 ' A' ' 84' ' ' LEU . . . -86.1 -40.82 15.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.593 ' HB3' ' HG3' ' A' ' 127' ' ' GLN . . . -87.29 -11.59 49.1 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.549 ' HG2' ' HA ' ' A' ' 138' ' ' PHE . 5.5 ppp? -72.46 -6.67 45.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.635 0.255 . . . . 0.0 111.543 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -134.94 -31.13 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.009 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.587 ' HG2' ' H ' ' A' ' 144' ' ' LYS . 62.2 ttt180 -112.08 -137.65 0.37 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.397 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.587 ' H ' ' HG2' ' A' ' 143' ' ' ARG . 95.5 mttt -131.18 -175.47 3.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.607 0.241 . . . . 0.0 110.59 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.717 ' H ' ' HE ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -101.32 78.29 1.87 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.249 0.547 . . . . 0.0 111.853 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.704 ' HB2' ' HZ3' ' A' ' 146' ' ' LYS . 0.2 OUTLIER -53.78 155.6 3.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.881 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -85.94 -4.71 84.38 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.83 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -79.75 161.67 25.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 0.0 111.129 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -47.72 -23.84 2.56 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.961 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -42.56 -25.96 0.36 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.349 -0.453 . . . . 0.0 113.008 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.679 ' HA ' ' NH1' ' A' ' 153' ' ' ARG . 44.2 mt -48.78 149.05 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 120.78 0.324 . . . . 0.0 111.104 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.422 ' H ' ' HD2' ' A' ' 153' ' ' ARG . . . -158.98 -4.57 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.885 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.882 ' H ' ' HD2' ' A' ' 153' ' ' ARG . 4.2 mpt_? -53.75 170.57 0.11 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.8 0.333 . . . . 0.0 110.113 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.577 HH11 ' H ' ' A' ' 155' ' ' THR . 23.2 tpt85 -71.19 148.94 46.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.203 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.577 ' H ' HH11 ' A' ' 154' ' ' ARG . 56.2 m -50.16 80.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.394 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.538 ' N ' ' O ' ' A' ' 154' ' ' ARG . 27.8 ttt -175.92 -18.7 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.207 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 6.7 ppt_? -63.19 -15.5 57.14 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.169 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.802 ' HG3' HG22 ' A' ' 159' ' ' THR . 4.9 tppp? -161.53 -87.23 0.03 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.802 HG22 ' HG3' ' A' ' 158' ' ' LYS . 6.9 t -162.96 -36.38 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.814 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.51 179.46 7.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.741 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -103.94 -101.15 0.3 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.0 tp -174.82 154.32 1.89 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.639 0.257 . . . . 0.0 110.81 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -89.76 138.84 31.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.687 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -78.04 146.13 35.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.65 165.0 13.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 167' ' ' GLY . 2.7 pp -94.84 -10.03 32.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.492 ' N ' HD12 ' A' ' 166' ' ' LEU . . . 146.76 150.02 5.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.572 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 97.3 mt -100.11 139.14 36.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.939 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.89 149.76 14.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.935 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -156.68 156.18 32.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 0.0 111.161 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.24 -49.57 4.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.652 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.1 -174.47 31.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.511 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 81.4 p -159.6 174.56 14.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.36 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -119.61 -174.78 2.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.966 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -101.82 107.95 19.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.784 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.14 141.53 46.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.287 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 tp -123.85 130.08 74.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.848 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -132.53 141.37 48.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -171.65 -65.89 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.393 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.74 -13.06 22.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.352 . . . . 0.0 110.835 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -110.73 136.9 49.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.565 ' N ' ' HD3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.851 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.78 0.324 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.26 123.35 29.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.908 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.491 ' HD2' ' C ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -118.47 174.06 6.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.127 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.2 tp -135.8 -82.99 0.4 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.813 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.8 p -172.84 15.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.994 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -96.96 50.48 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.167 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -89.06 -28.28 20.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.815 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.98 -70.56 0.64 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.498 0.666 . . . . 0.0 110.99 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.0 pt -55.92 -24.2 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.642 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.06 164.12 12.86 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.369 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.8 -12.86 53.43 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.098 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.34 -41.03 49.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.401 0.143 . . . . 0.0 110.878 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.669 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 39.9 ttmt -55.89 -33.1 64.3 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -81.65 -37.93 26.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.761 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 51.8 tp -59.53 -25.96 64.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.143 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -70.89 -40.06 72.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.425 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -86.36 -11.97 50.59 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.662 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -59.46 -34.48 72.59 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.509 HD12 HD13 ' A' ' 27' ' ' ILE . 3.0 mt -81.18 -62.09 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.884 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -83.85 66.93 9.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.313 1.054 . . . . 0.0 109.529 178.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -89.34 -20.99 23.34 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.094 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -138.73 8.92 2.6 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.622 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 31.6 t30 -82.94 -82.61 0.14 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.593 1.088 . . . . 0.0 110.981 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.0 p -176.13 15.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.05 18.51 9.23 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.628 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.64 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 39.9 p -148.84 161.2 42.3 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.403 0.62 . . . . 0.0 111.749 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.729 ' O ' ' HA ' ' A' ' 62' ' ' THR . 4.7 mt -111.01 103.82 16.09 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.502 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.63 HG22 ' OG1' ' A' ' 62' ' ' THR . 65.4 p -112.7 158.22 20.32 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.644 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.816 ' HE2' ' HB2' ' A' ' 49' ' ' LYS . 14.7 t80 -34.45 -20.01 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.616 ' N ' ' O ' ' A' ' 28' ' ' THR . 32.7 t70 -86.18 -39.06 17.04 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.08 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.622 ' OE2' ' HB2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -90.87 -32.08 16.18 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.729 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -40.45 -51.45 2.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.401 0.62 . . . . 0.0 110.318 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.721 ' HB3' HG12 ' A' ' 48' ' ' ILE . 12.4 ptpt -71.47 -39.4 70.94 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.267 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 38' ' ' ARG . 8.2 t70 -43.98 -47.81 8.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.217 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.493 ' HA3' HG12 ' A' ' 19' ' ' ILE . . . -45.21 -47.22 10.68 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 114.695 0.638 . . . . 0.0 114.695 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.752 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.7 mm? -95.2 -44.13 7.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.592 0.696 . . . . 0.0 112.214 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.699 ' NZ ' ' HD3' ' A' ' 33' ' ' LYS . 15.3 ptpt -56.32 -18.67 11.46 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.476 HH11 ' HG3' ' A' ' 38' ' ' ARG . 22.2 ttm-85 -90.83 -25.02 20.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.22 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 36' ' ' LEU . 6.3 p -80.56 -37.48 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.63 -42.65 0.59 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.447 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.6 m -62.75 177.21 0.57 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.795 0.331 . . . . 0.0 110.963 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.34 112.03 7.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 mt -108.02 165.48 11.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.503 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.464 ' O ' HD13 ' A' ' 48' ' ' ILE . 26.8 ptt? -112.22 162.08 15.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.69 -14.29 19.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.7 t -87.64 -17.11 32.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.199 0.523 . . . . 0.0 109.938 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 97.0 mt-10 -90.73 -46.24 8.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.783 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.729 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -50.77 -50.65 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 122.275 1.036 . . . . 0.0 109.086 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.816 ' HB2' ' HE2' ' A' ' 29' ' ' PHE . 52.3 tttp -64.11 -30.3 71.38 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.383 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 64.1 t0 -64.26 -48.71 74.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.721 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 26.9 mt -60.43 -15.75 29.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.525 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.759 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 30.5 mtt -88.02 -65.24 1.04 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.453 ' CA ' ' HG3' ' A' ' 59' ' ' LYS . 2.5 p30 -66.73 -25.6 66.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.654 0.264 . . . . 0.0 111.595 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -91.33 -28.39 17.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -125.41 -43.93 1.88 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.636 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 64.2 t0 -51.18 101.81 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.032 0.444 . . . . 0.0 110.243 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.9 mm -44.87 -26.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.674 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.61 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 38.7 t70 -133.26 44.72 2.79 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.364 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.759 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 10.2 tmtt? -32.07 92.03 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.941 0.877 . . . . 0.0 112.642 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.1 p -126.71 19.06 7.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.833 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 71.85 16.23 76.29 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.21 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.729 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 58.5 m -147.64 128.14 14.08 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.405 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.725 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 71.5 mt -113.23 130.33 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.157 0.503 . . . . 0.0 110.871 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.43 167.73 9.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.058 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.669 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 66.3 t80 -42.67 -25.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.019 0.437 . . . . 0.0 110.799 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.71 -59.48 2.34 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.753 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.691 ' HB2' HG23 ' A' ' 63' ' ' ILE . 37.8 mt-10 -56.04 -23.26 32.19 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.646 0.26 . . . . 0.0 110.828 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.761 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 60.4 t80 -68.54 -65.54 0.69 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.566 0.698 . . . . 0.0 110.416 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 65' ' ' TYR . 44.2 mm -47.1 -58.47 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.106 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.767 ' HA ' HG22 ' A' ' 73' ' ' VAL . . . -44.65 -53.18 7.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.493 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . -48.06 -37.84 16.01 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 t -95.43 -26.89 15.67 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.767 HG22 ' HA ' ' A' ' 70' ' ' ALA . 16.7 m -85.93 -13.87 10.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.178 0.513 . . . . 0.0 110.696 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.664 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 18.5 t-160 -67.82 -45.65 74.09 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 75' ' ' LEU . 3.6 mm? -67.1 -11.56 57.53 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.426 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 49.6 t30 -123.47 74.13 1.23 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.401 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.681 ' HG3' ' O ' ' A' ' 73' ' ' VAL . 53.0 mtmt -164.79 -82.16 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.107 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.08 91.4 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.419 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -39.84 -39.94 0.89 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.969 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 22.2 ptt-85 -63.95 122.16 15.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.012 0.435 . . . . 0.0 111.014 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -113.64 166.17 11.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.76 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -161.32 74.27 0.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.767 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -161.35 147.32 14.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.952 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.828 HD23 ' H ' ' A' ' 84' ' ' LEU . 2.1 pt? -87.71 -17.96 30.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.726 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 m -54.12 -19.47 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.436 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 89' ' ' SER . 81.0 p -46.09 -56.72 5.23 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.923 0.392 . . . . 0.0 110.187 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.432 ' C ' ' N ' ' A' ' 89' ' ' SER . . . -68.58 -45.39 72.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.812 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 18.9 t80 -47.51 -19.26 0.17 Allowed 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.584 0.707 . . . . 0.0 109.979 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 30.7 m -89.81 -59.61 2.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.695 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.439 ' CG ' ' HB2' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -74.25 -62.97 1.33 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.458 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -51.73 -60.55 3.04 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.812 ' HB3' ' O ' ' A' ' 88' ' ' PHE . 62.6 t0 -82.91 69.54 9.74 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 89' ' ' SER . 31.3 ttmt -53.25 -16.05 1.14 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.668 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -97.49 -24.4 15.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.579 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.93 -12.47 0.81 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.804 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 78.9 p -51.83 -22.84 4.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.204 0.502 . . . . 0.0 110.606 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.589 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 126.01 -3.84 7.9 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.038 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -125.8 144.68 50.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.038 0.447 . . . . 0.0 111.849 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.778 HG12 ' HA ' ' A' ' 92' ' ' ASP . 31.2 mt -131.58 102.59 6.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.61 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 103' ' ' GLU . 70.6 p -81.52 156.94 25.01 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.215 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.524 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.0 pp -35.01 -39.86 0.11 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.69 0.281 . . . . 0.0 111.259 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.497 ' N ' HD12 ' A' ' 101' ' ' LEU . 8.3 t70 -57.86 -57.78 11.29 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.469 ' CB ' HG23 ' A' ' 99' ' ' ILE . 51.0 mt-10 -58.89 -48.22 82.19 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.57 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.832 HG21 HD12 ' A' ' 125' ' ' ILE . 91.1 mt -55.73 -65.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.151 0.5 . . . . 0.0 110.653 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.881 HE21 HG22 ' A' ' 118' ' ' ILE . 91.6 mt-30 -56.83 -65.14 0.67 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.11 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -42.38 -32.96 0.58 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.51 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 104' ' ' ILE . . . -53.28 -65.57 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 111' ' ' PHE . 51.6 t -62.01 135.0 57.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.881 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -89.12 -47.87 7.79 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -78.9 -3.32 44.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.628 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.711 ' CE2' ' HB2' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -47.19 -27.21 1.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.412 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 60.44 37.61 93.49 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.371 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.711 ' HB2' ' CE2' ' A' ' 111' ' ' PHE . 6.4 tt -31.8 126.92 0.23 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.327 0.584 . . . . 0.0 112.306 -176.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.668 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 29.6 t70 -160.2 177.09 11.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.955 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.723 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 2.9 p30 -89.2 -8.19 54.07 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.704 HG23 ' H ' ' A' ' 117' ' ' HIS . 7.1 tp -88.51 -64.69 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.704 ' H ' HG23 ' A' ' 116' ' ' ILE . 16.6 t-160 -92.7 -67.11 0.88 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.031 0.443 . . . . 0.0 111.975 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.881 HG22 HE21 ' A' ' 105' ' ' GLN . 4.4 mp -50.23 -20.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.694 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.723 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 7.7 t70 -76.12 -52.34 10.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' GLU . 37.1 t70 -58.92 -19.64 44.5 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.87 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 4.5 ttt -68.79 -45.39 71.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.259 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.628 HG22 ' HA3' ' A' ' 131' ' ' GLY . 54.1 mt -51.44 -40.85 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.635 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.6 -13.84 44.53 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.512 -1.677 . . . . 0.0 110.267 178.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.87 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 41.8 tp10 -83.98 -21.42 31.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.493 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.832 HD12 HG21 ' A' ' 104' ' ' ILE . 1.1 mt -105.71 -33.75 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 1.031 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 20.8 t70 -54.75 95.64 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.793 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 151' ' ' ILE . 15.4 mt-30 -87.67 -9.8 53.13 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.188 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 129' ' ' ASN . 7.1 t70 -126.79 -32.73 2.56 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -177.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.743 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 178.33 -68.79 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 179.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.743 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 7.3 t70 -63.82 -24.18 67.65 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -172.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 1.031 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 94.95 36.83 5.38 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 107.169 -2.372 . . . . 0.0 107.169 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.67 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 5.3 pt20 -138.21 168.01 20.64 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 112.846 -1.677 . . . . 0.0 108.922 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.769 HD11 ' O ' ' A' ' 125' ' ' ILE . 21.5 mm -130.86 131.12 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-O 121.797 0.808 . . . . 0.0 110.978 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.878 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 10.7 t70 -103.03 163.06 12.44 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.69 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.779 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 21.8 t80 -43.76 -37.18 2.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.287 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.619 ' C ' ' HB2' ' A' ' 153' ' ' ARG . . . -82.2 -36.06 18.94 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.834 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.878 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 46.4 mt-10 -61.13 -57.62 11.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.657 ' HD1' HG21 ' A' ' 133' ' ' ILE . 3.4 t80 -55.49 -39.15 70.07 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.916 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.68 -25.11 67.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.785 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 146' ' ' LYS . . . -89.35 -44.68 10.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -31.17 69.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.565 0.221 . . . . 0.0 111.419 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 55.1 ttp -86.67 -27.95 23.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.04 0.448 . . . . 0.0 110.177 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.547 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 98.7 mtt180 -118.83 -129.8 0.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.192 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.599 ' HA ' ' HE3' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -153.71 38.48 0.47 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.932 0.396 . . . . 0.0 110.44 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 145' ' ' ARG . 14.3 tpp85 -79.05 -2.35 40.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.993 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.51 ' HA ' ' HD3' ' A' ' 153' ' ' ARG . 8.8 ptpp? -80.19 136.6 36.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.925 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.98 40.41 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.927 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.454 ' ND2' ' H ' ' A' ' 150' ' ' GLY . 48.6 t30 -131.15 144.84 51.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.626 0.25 . . . . 0.0 110.327 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.74 -20.19 38.81 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.537 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.454 ' H ' ' ND2' ' A' ' 148' ' ' ASN . . . -71.36 -42.2 57.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.733 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 127' ' ' GLN . 37.6 mt -125.09 134.91 65.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.31 0.576 . . . . 0.0 112.303 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.478 ' O ' ' HD2' ' A' ' 153' ' ' ARG . . . -82.16 -133.17 1.7 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.542 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.619 ' HB2' ' C ' ' A' ' 136' ' ' GLY . 26.0 mmm180 -130.75 82.55 2.06 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.855 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.628 HH11 HD21 ' A' ' 129' ' ' ASN . 79.3 ttt180 -107.05 148.13 29.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.843 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 77.0 m -57.02 -19.01 16.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.187 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.535 ' H ' ' HG2' ' A' ' 154' ' ' ARG . 50.2 ttm -67.84 -40.16 83.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.115 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.587 ' HG3' HG21 ' A' ' 151' ' ' ILE . 4.1 mmp_? -83.96 -65.69 0.98 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.951 0.405 . . . . 0.0 110.829 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -156.07 135.41 12.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.825 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.9 t -129.57 32.89 4.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.84 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.7 tp -93.69 91.09 6.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -166.05 101.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 0.0 111.048 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -138.95 80.89 1.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.994 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.414 HH11 ' HG3' ' A' ' 163' ' ' ARG . 20.8 mmt85 -145.79 131.01 18.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.842 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -62.72 111.7 2.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.731 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -125.64 159.9 31.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.192 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.729 ' H ' HD23 ' A' ' 166' ' ' LEU . 2.0 pt? -127.16 11.88 7.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.039 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.14 -142.3 15.92 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.436 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 168' ' ' LEU . 2.8 mm? -90.5 176.51 6.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.35 134.19 27.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -113.85 177.74 4.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.772 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -97.3 30.69 2.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.821 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -161.22 123.56 1.22 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.305 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 79.5 p -112.52 -21.26 11.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.722 0.296 . . . . 0.0 111.161 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -141.39 149.61 41.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.994 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -88.23 117.86 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.813 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 48.0 t -124.24 125.28 70.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.099 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 66.3 mt -79.7 143.11 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -76.44 103.18 6.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.8 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -148.8 -26.99 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.517 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.72 5.72 39.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.784 0.326 . . . . 0.0 110.65 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -101.88 33.7 2.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.794 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.943 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.787 0.327 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -109.43 170.92 7.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -127.91 -56.07 1.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.813 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.489 HD23 ' C ' ' A' ' 4' ' ' LEU . 6.4 tt -156.71 -57.58 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.288 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.0 p -82.92 140.43 32.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.488 ' HB3' HD12 ' A' ' 9' ' ' ILE . 17.8 tp10 -63.71 158.08 22.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.811 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -77.16 -53.9 7.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.45 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.437 ' HG2' ' HG3' ' A' ' 6' ' ' GLU . 24.0 pt-20 -56.34 -27.52 56.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.336 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.488 HD12 ' HB3' ' A' ' 6' ' ' GLU . 68.0 mt -74.26 -58.98 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.816 0.341 . . . . 0.0 110.833 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.3 116.32 4.72 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.411 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.84 52.94 0.82 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.428 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.451 HD22 HG21 ' A' ' 72' ' ' THR . 43.1 tp -81.42 -19.05 43.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.602 0.239 . . . . 0.0 111.005 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HD2' ' C ' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -75.69 -46.61 30.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.438 ' HG3' ' HE3' ' A' ' 17' ' ' LYS . 85.1 tt0 -69.37 -17.91 63.73 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.681 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.818 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 2.3 tm? -83.6 -39.07 20.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.406 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.55 ' HE1' HG13 ' A' ' 27' ' ' ILE . 2.3 t80 -57.79 -42.67 84.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.1 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.438 ' HE3' ' HG3' ' A' ' 14' ' ' GLU . 19.5 pttp -80.48 -17.72 50.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.61 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.818 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.39 -32.87 74.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.653 HG23 ' HA3' ' A' ' 35' ' ' GLY . 1.1 mm -71.5 -62.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.289 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.446 ' HB3' HG12 ' A' ' 27' ' ' ILE . 2.5 p30 -89.08 47.23 1.47 Allowed 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.84 0.829 . . . . 0.0 111.255 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 t -71.35 -18.4 62.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.924 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -108.33 -11.48 15.19 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -83.06 -88.73 0.09 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.741 0.305 . . . . 0.0 111.426 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.4 p -176.45 12.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.119 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.39 17.88 9.01 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.101 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -135.58 143.59 45.73 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.002 0.43 . . . . 0.0 109.86 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.8 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 8.4 mt -103.73 104.03 16.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.599 HG22 ' OG1' ' A' ' 62' ' ' THR . 76.6 p -102.55 159.79 15.13 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.457 ' HE1' ' HB2' ' A' ' 49' ' ' LYS . 25.7 t80 -34.37 -34.13 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 O-C-N 123.79 0.681 . . . . 0.0 111.906 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 28' ' ' THR . 35.8 m-20 -73.45 -50.29 22.42 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.338 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 28.2 mp0 -78.06 -14.73 59.39 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.714 0.293 . . . . 0.0 111.033 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.86 HD12 HG13 ' A' ' 48' ' ' ILE . 1.6 tm? -55.43 -48.78 73.9 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.849 0.833 . . . . 0.0 108.928 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.903 ' HB2' ' HE3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -82.89 -49.19 9.92 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.313 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.591 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 36.3 m-20 -39.51 -45.33 1.55 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.653 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -52.37 -50.56 46.79 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.059 -0.591 . . . . 0.0 114.234 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.724 HD12 HD23 ' A' ' 43' ' ' LEU . 85.3 mt -75.53 -52.05 11.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.246 0.523 . . . . 0.0 111.685 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.903 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 18.2 ptpt -55.97 -16.03 4.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.985 0.421 . . . . 0.0 110.211 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.438 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -87.1 -39.58 15.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.995 178.421 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.6 p -70.91 -10.73 14.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.285 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.09 -5.22 22.05 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.502 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 61.5 m -78.93 157.86 28.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.664 0.268 . . . . 0.0 111.401 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 14.2 pt-20 -123.54 104.22 8.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.516 0.674 . . . . 0.0 110.936 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.854 HD13 HD11 ' A' ' 48' ' ' ILE . 1.7 pp -117.96 166.09 12.93 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.736 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.443 ' CG ' ' HG3' ' A' ' 47' ' ' GLU . 25.9 ptm -118.06 156.04 29.31 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.54 ' HA ' HD13 ' A' ' 48' ' ' ILE . 32.6 tt0 -44.65 -58.22 3.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.6 m -49.39 -25.79 2.76 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 97.8 mt-10 -73.52 -31.84 63.9 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.125 0.488 . . . . 0.0 109.838 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.86 HG13 HD12 ' A' ' 32' ' ' LEU . 1.9 mp -59.78 -64.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.752 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.495 ' HD2' ' CD ' ' A' ' 93' ' ' LYS . 4.5 ttmp? -55.35 -34.07 63.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.267 0.555 . . . . 0.0 109.747 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 36.4 t70 -52.86 -61.0 2.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.474 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.814 HD11 HD11 ' A' ' 32' ' ' LEU . 4.1 pp -65.71 -14.88 62.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.794 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 27.3 mtt -80.76 -65.83 0.96 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.171 0.51 . . . . 0.0 110.987 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.516 ' OD2' ' HB2' ' A' ' 90' ' ' TYR . 41.2 t0 -61.71 -21.94 64.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.867 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.53 -40.46 11.35 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -112.33 -44.27 3.41 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 52' ' ' MET . 66.6 t0 -51.67 98.26 0.02 OUTLIER 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.2 mt -38.34 -35.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.802 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 60' ' ' SER . 2.8 p30 -133.65 45.37 2.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.013 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.794 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 7.6 tmtm? -31.74 90.83 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.914 0.864 . . . . 0.0 112.174 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 58' ' ' ASP . 73.4 p -123.98 16.74 9.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.874 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 83.71 14.22 73.6 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.394 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 57.9 m -153.03 127.2 9.11 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.881 HG23 ' HB2' ' A' ' 67' ' ' GLU . 68.9 mt -112.28 133.46 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.205 0.526 . . . . 0.0 111.798 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.72 167.32 9.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.679 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.529 ' O ' HG13 ' A' ' 69' ' ' ILE . 25.2 t80 -36.54 -48.33 0.68 Allowed 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.49 -59.86 7.76 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.358 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.881 ' HB2' HG23 ' A' ' 63' ' ' ILE . 34.7 mt-10 -51.43 -30.07 18.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.854 0.359 . . . . 0.0 110.567 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.534 ' CD2' ' HB2' ' A' ' 16' ' ' PHE . 30.6 t80 -61.87 -46.9 87.41 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.271 0.558 . . . . 0.0 110.945 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 65' ' ' TYR . 10.7 mt -59.96 -19.45 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.616 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 67' ' ' GLU . . . -67.65 -20.51 65.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.251 0.548 . . . . 0.0 109.617 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 74' ' ' HIS . . . -68.61 -32.86 73.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.057 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.451 HG21 HD22 ' A' ' 12' ' ' LEU . 18.3 p -77.69 -16.93 58.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.403 ' C ' ' H ' ' A' ' 76' ' ' ASN . 80.1 t -90.44 -14.13 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.977 178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.543 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 14.3 t-80 -61.59 -42.92 99.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.955 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 75' ' ' LEU . 6.4 mp -74.82 -6.23 47.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.539 ' ND2' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -118.71 75.18 1.01 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.939 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 74' ' ' HIS . 98.7 mttt -112.04 50.68 0.84 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.936 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.539 ' HG ' ' ND2' ' A' ' 76' ' ' ASN . 85.7 mt -63.65 -10.5 19.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.953 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -106.67 171.49 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.884 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 73.0 mtt-85 -115.31 148.17 39.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -134.97 147.37 49.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.554 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -162.45 131.98 4.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.834 0.349 . . . . 0.0 111.475 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.487 ' HB2' ' CB ' ' A' ' 86' ' ' SER . 75.7 m-80 -150.93 -179.65 7.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.556 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.457 ' C ' HD23 ' A' ' 84' ' ' LEU . 6.1 tt -90.3 -65.47 1.01 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.166 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 m -68.11 -25.75 32.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.326 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.487 ' CB ' ' HB2' ' A' ' 83' ' ' ASN . 72.5 m -54.41 -23.87 17.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.238 0.542 . . . . 0.0 109.666 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -84.7 -51.08 7.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.488 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.835 ' HE1' ' HB2' ' A' ' 135' ' ' TYR . 7.9 t80 -39.14 -36.42 0.31 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.116 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.4 t -89.24 -55.49 3.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.228 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.516 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 7.8 t80 -75.77 -63.89 1.2 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.561 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.751 ' HB3' HD13 ' A' ' 99' ' ' ILE . 3.1 m-85 -58.14 -65.21 0.68 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.782 ' HA ' HG12 ' A' ' 99' ' ' ILE . 12.4 t0 -74.54 60.04 0.86 Allowed 'General case' 0 C--N 1.335 -0.056 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.495 ' CD ' ' HD2' ' A' ' 49' ' ' LYS . 3.0 tppp? -49.2 -40.72 34.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.507 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -73.52 -21.35 60.42 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.383 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 49.02 72.33 0.48 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.1 p -132.57 -5.0 3.29 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 105.87 5.78 38.16 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 113.799 -1.546 . . . . 0.0 113.322 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.778 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -144.27 157.46 44.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.456 0.646 . . . . 0.0 111.495 179.108 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.782 HG12 ' HA ' ' A' ' 92' ' ' ASP . 77.8 mt -133.18 104.14 6.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.956 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 103' ' ' GLU . 43.6 p -70.8 147.99 48.35 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.766 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.685 ' HB3' HG23 ' A' ' 122' ' ' ILE . 3.6 pp -34.84 -39.22 0.09 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.421 ' N ' HD12 ' A' ' 101' ' ' LEU . 1.6 m-20 -55.55 -54.71 40.6 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.59 ' HB2' HG23 ' A' ' 99' ' ' ILE . 49.3 mt-10 -60.48 -44.46 95.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.235 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.77 HG13 HG22 ' A' ' 99' ' ' ILE . 96.6 mt -56.72 -65.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.381 0.61 . . . . 0.0 110.676 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.817 HE21 HG22 ' A' ' 118' ' ' ILE . 87.5 mt-30 -58.35 -65.47 0.65 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.488 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -42.79 -34.23 0.89 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.17 -66.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.314 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 98.5 m -49.78 134.17 20.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.811 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -89.29 -60.91 1.82 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -75.49 -3.07 31.92 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.82 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.749 ' O ' HD11 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -46.81 -29.39 1.93 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -178.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 62.87 39.21 97.74 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 118.85 -1.643 . . . . 0.0 110.777 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.793 ' HA ' HD12 ' A' ' 118' ' ' ILE . 9.1 tt -31.63 130.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.454 ' OD2' HG13 ' A' ' 116' ' ' ILE . 35.9 t70 -157.21 175.67 13.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.905 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.741 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 30.0 m-20 -88.89 -7.45 56.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.454 HG13 ' OD2' ' A' ' 114' ' ' ASP . 60.5 mt -84.86 -65.53 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -92.45 -69.04 0.76 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.817 HG22 HE21 ' A' ' 105' ' ' GLN . 60.5 mt -52.1 -19.68 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.935 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.741 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 37.4 t70 -75.89 -51.67 12.0 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 124' ' ' GLU . 32.2 m-20 -65.07 -17.9 64.84 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 1.064 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 13.6 tmm? -65.31 -41.25 94.25 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.823 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.748 HG22 ' HA3' ' A' ' 131' ' ' GLY . 61.1 mt -54.12 -39.68 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.77 ' HA ' ' HE2' ' A' ' 123' ' ' LYS . 10.9 mmpt? -86.7 -13.89 44.1 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 112.403 -2.18 . . . . 0.0 110.574 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 1.064 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 29.7 tt0 -94.27 -14.78 25.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.689 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.845 HG22 ' CD1' ' A' ' 133' ' ' ILE . 29.9 mt -111.97 -35.55 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.379 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.782 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 1.8 t70 -47.02 129.83 12.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.705 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.557 ' HG2' ' HB2' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -88.41 -23.15 23.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.529 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 154' ' ' ARG . 45.3 p-10 -135.24 -32.73 0.93 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.664 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 179.36 -52.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.694 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 31.1 m-20 -64.6 8.76 0.1 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -173.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.782 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.5 37.06 65.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 118.45 -1.833 . . . . 0.0 108.772 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.732 HE22 ' HB3' ' A' ' 98' ' ' TYR . 5.7 pt20 -127.59 169.37 13.81 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.805 -1.197 . . . . 0.0 108.982 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.845 ' CD1' HG22 ' A' ' 125' ' ' ILE . 25.6 mm -135.94 129.97 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.4 0 CA-C-O 121.622 0.725 . . . . 0.0 110.803 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.778 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -102.24 165.19 11.27 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.173 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.835 ' HB2' ' HE1' ' A' ' 88' ' ' PHE . 41.0 t80 -48.06 -31.0 4.93 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.47 ' HA3' ' N ' ' A' ' 153' ' ' ARG . . . -85.1 -26.52 36.72 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.462 178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.625 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 78.7 mt-10 -76.12 -53.86 7.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.824 -0.188 . . . . 0.0 110.521 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.578 ' HD1' HG21 ' A' ' 133' ' ' ILE . 4.1 t80 -60.85 -23.96 65.53 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.838 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.0 -32.55 21.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.747 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.795 ' HB2' HD11 ' A' ' 151' ' ' ILE . . . -89.8 -27.8 19.75 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -11.4 16.38 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -122.62 -23.31 5.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.749 0.309 . . . . 0.0 111.141 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -100.22 -165.88 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.73 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.559 ' HB2' ' NZ ' ' A' ' 146' ' ' LYS . 67.4 mttm -70.14 -169.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.561 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.675 ' HD3' HH12 ' A' ' 153' ' ' ARG . 24.4 tpp180 -101.39 82.5 2.33 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.43 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.559 ' NZ ' ' HB2' ' A' ' 144' ' ' LYS . 48.7 mmtm -83.85 117.49 23.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.235 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -93.75 -4.97 63.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.342 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.512 ' O ' HG22 ' A' ' 151' ' ' ILE . 22.4 p30 -60.89 161.08 8.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.803 0.335 . . . . 0.0 111.12 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -64.72 -36.87 93.64 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.984 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -42.78 -33.55 1.64 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.451 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.795 HD11 ' HB2' ' A' ' 140' ' ' ALA . 11.5 tt -70.82 -169.74 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.794 ' H ' HG12 ' A' ' 151' ' ' ILE . . . -153.5 -4.65 0.12 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.536 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.675 HH12 ' HD3' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -56.71 143.22 37.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.912 0.387 . . . . 0.0 110.24 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.676 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 2.5 tmt_? -76.8 103.66 6.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.423 0.63 . . . . 0.0 111.798 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.432 ' H ' ' H ' ' A' ' 156' ' ' MET . 95.6 m -168.76 -26.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.432 ' H ' ' H ' ' A' ' 155' ' ' THR . 45.7 ttp -175.25 37.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.705 -1.589 . . . . 0.0 107.694 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.598 ' HD3' ' HG2' ' A' ' 154' ' ' ARG . 10.6 mtm105 -39.19 149.83 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.923 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -153.7 101.18 2.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.635 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 88.3 m -137.49 88.48 2.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.907 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.438 ' O ' ' HG ' ' A' ' 160' ' ' LEU . 33.7 tp -168.03 33.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.247 0.546 . . . . 0.0 110.419 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -108.89 -177.86 3.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.893 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.435 ' C ' HD23 ' A' ' 162' ' ' LEU . 5.4 tt -85.79 118.33 25.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.368 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' A' ' 163' ' ' ARG . 11.6 tpt180 -88.36 105.78 17.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.807 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -134.45 127.87 32.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.558 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -56.35 158.38 4.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.391 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 166' ' ' LEU . 6.2 mp -85.85 9.1 17.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.78 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.79 104.58 0.47 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.595 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 168' ' ' LEU . 6.6 mp -109.91 133.02 53.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.832 0.348 . . . . 0.0 110.789 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 41.1 t -69.55 113.29 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -106.1 29.26 6.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -110.99 -23.11 11.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.915 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 104.05 155.43 23.76 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.39 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.408 ' H ' ' H ' ' A' ' 174' ' ' ASN . 42.8 t -153.66 -7.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.723 0.297 . . . . 0.0 111.082 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.408 ' H ' ' H ' ' A' ' 173' ' ' SER . 0.7 OUTLIER -108.35 112.47 24.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.425 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.56 103.55 16.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.145 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.28 132.95 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.986 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 69.9 mt -115.31 132.91 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.08 130.89 43.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.892 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.04 173.42 14.28 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.529 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -91.59 -91.83 0.15 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.641 0.257 . . . . 0.0 110.68 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.417 ' H ' ' H ' ' A' ' 182' ' ' LYS . 2.0 p90 -173.58 1.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.916 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.417 ' H ' ' H ' ' A' ' 181' ' ' PHE . 28.3 mtpp . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.812 0.339 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -78.15 -62.21 1.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.797 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -100.93 29.88 4.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 63.5 tp -92.63 93.54 8.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.4 p -121.92 179.75 4.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -60.14 137.16 58.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.01 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -80.14 -30.57 38.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.002 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -61.31 -25.14 66.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.034 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.5 mm -79.06 -34.36 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.055 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.58 105.1 0.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.02 28.69 0.54 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.636 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.853 HD11 HG21 ' A' ' 72' ' ' THR . 52.2 tp -60.08 -32.16 70.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.609 0.242 . . . . 0.0 110.624 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 61.6 tttm -60.78 -43.03 98.61 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.97 -26.94 67.79 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.736 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.709 ' HA ' ' HB3' ' A' ' 18' ' ' MET . 33.4 tp -72.48 -31.12 65.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.946 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.461 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 10.4 t80 -65.94 -48.18 72.2 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.283 0.564 . . . . 0.0 109.788 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.461 ' C ' ' HD3' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -76.22 -16.23 59.87 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.709 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 3.1 tpp -66.79 -36.21 81.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.887 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.733 HG21 HD13 ' A' ' 27' ' ' ILE . 10.4 mm -62.85 -57.54 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.614 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.596 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 1.3 t70 -82.48 87.55 6.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.285 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 t -88.19 -24.9 23.17 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.62 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -139.71 -6.14 1.32 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.548 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 53.7 t30 -75.43 -80.42 0.09 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.897 1.226 . . . . 0.0 112.837 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 p -172.34 -0.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 110.26 23.57 6.01 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.456 ' HB ' ' OG1' ' A' ' 62' ' ' THR . 65.2 p -138.86 147.37 42.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.013 -1.093 . . . . 0.0 109.464 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.849 ' O ' ' HA ' ' A' ' 62' ' ' THR . 2.3 mt -104.21 103.71 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 59.9 p -101.97 161.97 13.27 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.48 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 2.0 t80 -34.21 -36.67 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.797 0.686 . . . . 0.0 111.076 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -74.95 -52.16 11.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.432 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.596 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 3.1 tt0 -70.85 -16.41 62.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.183 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.863 HD12 HG13 ' A' ' 48' ' ' ILE . 2.4 tm? -58.98 -55.25 37.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.353 0.597 . . . . 0.0 109.992 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.601 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 10.9 ptpt -76.22 -33.42 59.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.668 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -48.47 -58.38 4.74 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 19' ' ' ILE . . . -61.4 -22.45 61.24 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 114.849 0.7 . . . . 0.0 114.849 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 ' N ' ' A' ' 37' ' ' LYS . 4.6 pp -95.1 -39.09 10.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.785 0.792 . . . . 0.0 111.252 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.679 ' N ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -71.28 -15.23 62.41 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -87.68 -36.85 17.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.255 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.624 HG12 ' O ' ' A' ' 36' ' ' LEU . 9.0 p -75.08 -17.84 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.533 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.49 42.45 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.641 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 35.5 t -130.68 164.1 25.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.676 0.274 . . . . 0.0 110.456 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 10.7 pt-20 -141.89 104.78 4.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.198 0.523 . . . . 0.0 111.695 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.457 HD12 ' CD2' ' A' ' 36' ' ' LEU . 20.5 mt -124.58 165.99 16.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.188 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 24.4 ptm -113.08 164.03 13.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -45.52 -64.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.8 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.6 p -41.83 -22.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.3 mm-40 -82.31 -47.52 12.27 Favored 'General case' 0 C--N 1.334 -0.097 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.863 HG13 HD12 ' A' ' 32' ' ' LEU . 1.8 mp -51.59 -62.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.553 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.536 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . 3.1 tmtm? -46.67 -33.57 4.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.81 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.506 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 9.6 t70 -65.55 -43.87 88.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.806 HD13 ' N ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -64.35 -26.54 68.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.425 178.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.927 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 17.7 mmt -80.08 -66.43 0.88 Allowed 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.562 0.696 . . . . 0.0 112.183 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.726 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 1.5 m-20 -59.84 -21.86 61.49 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.873 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.721 ' HB1' ' HB3' ' A' ' 89' ' ' SER . . . -92.55 -42.8 9.49 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.721 ' HB1' ' HA ' ' A' ' 71' ' ' ALA . . . -111.73 -39.45 4.58 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.787 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 38.1 t0 -50.07 87.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' ALA . 37.6 mm -47.51 -22.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.559 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.531 ' HB2' ' OE1' ' A' ' 67' ' ' GLU . 60.0 m-20 -133.06 43.52 2.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.612 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.927 ' HD3' ' HB3' ' A' ' 52' ' ' MET . 56.5 tptt -33.12 90.32 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.695 0.76 . . . . 0.0 112.609 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 58' ' ' ASP . 79.8 p -127.68 18.82 6.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.458 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 84.71 5.37 86.61 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.902 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.849 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 1.3 t -153.41 150.94 29.35 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.983 0.421 . . . . 0.0 111.312 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.904 HG23 ' HB2' ' A' ' 67' ' ' GLU . 68.7 mt -117.08 136.48 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.344 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -105.94 167.57 9.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.139 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.532 ' CE1' HD11 ' A' ' 69' ' ' ILE . 18.9 t80 -36.19 -49.57 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.406 0.441 . . . . 0.0 111.615 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.11 -60.37 7.7 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.723 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.904 ' HB2' HG23 ' A' ' 63' ' ' ILE . 23.8 mt-10 -53.68 -25.13 16.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.716 0.293 . . . . 0.0 110.602 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.578 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 47.1 t80 -64.79 -50.68 65.82 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.264 0.554 . . . . 0.0 110.474 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.532 HD11 ' CE1' ' A' ' 65' ' ' TYR . 5.0 mm -60.27 -50.16 81.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.125 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.96 -30.15 68.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.029 0.442 . . . . 0.0 110.215 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.721 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . -72.46 -45.28 60.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.19 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.853 HG21 HD11 ' A' ' 12' ' ' LEU . 67.3 p -65.41 -30.9 71.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.978 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.07 -15.84 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.723 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.479 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 27.0 t-80 -76.28 -43.7 40.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 71' ' ' ALA . 4.4 mm? -71.79 -15.13 62.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.626 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -89.15 75.48 7.85 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.202 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 74' ' ' HIS . 97.7 mttt -146.73 42.08 1.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.534 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.25 -4.71 3.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.632 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.54 -80.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.3 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.709 ' HE ' ' HA ' ' A' ' 80' ' ' ARG . 2.7 mmp_? -134.83 115.37 13.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.469 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.668 ' HB2' HG11 ' A' ' 85' ' ' VAL . 10.6 pt-20 -175.0 129.85 0.3 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.801 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -174.29 8.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.492 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -164.68 -79.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.499 HD23 ' H ' ' A' ' 84' ' ' LEU . 2.6 pt? -56.32 -30.25 62.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.89 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.668 HG11 ' HB2' ' A' ' 81' ' ' GLU . 7.2 p -54.78 -23.29 11.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.695 0.284 . . . . 0.0 111.286 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.6 m -56.24 -44.46 79.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.198 0.523 . . . . 0.0 109.666 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HA ' ' CD1' ' A' ' 91' ' ' PHE . . . -75.77 -55.04 6.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.831 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.796 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 4.9 t80 -40.59 -25.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.73 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.721 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 22.6 m -90.92 -64.48 1.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -79.16 -42.38 26.27 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.763 0.316 . . . . 0.0 111.683 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 87' ' ' ALA . 5.7 m-85 -63.65 -64.5 0.88 Allowed 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 176.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.931 ' HA ' HG12 ' A' ' 99' ' ' ILE . 56.9 t0 -77.78 70.56 4.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.726 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 22.4 ttmt -43.54 -49.22 7.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.362 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.501 ' OD2' HG23 ' A' ' 57' ' ' ILE . 7.1 t70 -67.75 -22.71 65.21 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.138 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 49.98 54.27 19.26 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.653 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.8 p -125.49 12.31 8.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.688 ' HA2' ' HE1' ' A' ' 88' ' ' PHE . . . 84.66 21.18 56.78 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.447 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' HA ' ' OD1' ' A' ' 134' ' ' ASP . 14.3 m-85 -143.52 131.9 22.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.931 HG12 ' HA ' ' A' ' 92' ' ' ASP . 48.6 mt -130.19 101.96 6.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.88 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.506 ' HA ' ' HB3' ' A' ' 132' ' ' GLN . 58.8 p -74.12 164.69 26.3 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.07 -0.394 . . . . 0.0 111.086 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.726 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER -41.28 -36.55 0.81 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.425 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -67.46 -52.38 40.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.279 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.487 ' CB ' HG23 ' A' ' 99' ' ' ILE . 56.3 mt-10 -64.95 -15.88 62.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.636 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.723 HG22 ' HE3' ' A' ' 121' ' ' MET . 96.6 mt -87.33 -62.82 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.124 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.726 ' HG2' ' O ' ' A' ' 101' ' ' LEU . 7.1 mm100 -50.27 -51.69 42.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.96 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -60.73 -31.19 70.5 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.22 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 104' ' ' ILE . . . -59.81 -21.54 61.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.87 0.367 . . . . 0.0 110.927 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.55 ' HB3' ' CG ' ' A' ' 111' ' ' PHE . 72.4 m -117.13 66.72 0.73 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.682 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.698 ' HD3' ' H ' ' A' ' 109' ' ' LYS . 0.2 OUTLIER -78.4 -39.37 39.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -68.81 -12.6 61.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.183 0.516 . . . . 0.0 110.347 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.55 ' CG ' ' HB3' ' A' ' 108' ' ' CYS . 3.2 m-85 -74.77 -46.81 34.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.827 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.72 37.98 2.66 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.749 ' HA ' HG13 ' A' ' 118' ' ' ILE . 1.0 OUTLIER -33.33 139.07 0.06 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.504 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 52.8 t0 -152.67 150.7 29.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.272 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.692 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 10.2 t70 -57.74 -8.74 0.99 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.493 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.3 mm -86.67 -64.8 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -91.68 -68.98 0.76 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 1.022 HG23 ' HE2' ' A' ' 121' ' ' MET . 17.5 mm -51.05 -24.36 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.2 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.692 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 36.1 t70 -75.08 -46.26 35.82 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 124' ' ' GLU . 33.3 t70 -62.31 -21.48 65.29 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 1.022 ' HE2' HG23 ' A' ' 118' ' ' ILE . 3.8 ttp -65.36 -33.32 75.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.637 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 126' ' ' ASP . 46.3 mt -59.12 -42.48 86.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.66 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 2.4 mptt -86.72 -12.97 46.73 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.51 -1.677 . . . . 0.0 109.882 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.917 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 17.2 tp10 -86.11 -22.82 26.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.451 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.575 HG21 HD13 ' A' ' 133' ' ' ILE . 14.7 mm -116.56 -13.36 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.585 ' OD1' ' HA ' ' A' ' 123' ' ' LYS . 4.2 p-10 -79.8 54.09 1.77 Allowed 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.564 0.697 . . . . 0.0 110.084 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.565 HE22 ' CG ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -62.56 -9.32 8.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.553 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 157' ' ' ARG . 6.4 t70 -107.95 -32.91 7.38 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.545 ' CG ' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER 178.54 -95.65 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 178.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.724 ' HB2' ' HG2' ' A' ' 132' ' ' GLN . 1.5 m-20 -64.75 29.29 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 119.44 3.126 . . . . 0.0 119.44 -173.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 126' ' ' ASP . . . 58.76 37.67 90.52 Favored Glycine 0 CA--C 1.504 -0.631 0 C-N-CA 117.236 -2.411 . . . . 0.0 109.133 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.724 ' HG2' ' HB2' ' A' ' 130' ' ' ASP . 6.6 pt20 -136.57 169.28 17.97 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 113.738 -1.231 . . . . 0.0 109.831 -177.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.613 HG21 ' HD1' ' A' ' 138' ' ' PHE . 49.2 mt -133.16 124.2 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.558 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 54.0 m-20 -101.73 165.53 11.16 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.417 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.643 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 25.8 t80 -44.19 -29.78 0.68 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.068 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 153' ' ' ARG . . . -85.54 -39.64 8.17 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.683 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.691 ' HA ' ' HD2' ' A' ' 153' ' ' ARG . 32.9 mt-10 -60.54 -50.59 72.93 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.613 ' HD1' HG21 ' A' ' 133' ' ' ILE . 1.3 t80 -64.37 -61.11 2.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.49 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.81 -32.95 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.64 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.69 -58.18 2.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.441 ' HG2' HG23 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -46.19 -33.02 3.32 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 138' ' ' PHE . 27.6 ptt? -87.54 -32.66 19.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.749 0.309 . . . . 0.0 111.097 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.429 ' HG2' ' HG3' ' A' ' 142' ' ' MET . 27.8 mmm180 -95.09 -167.18 1.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.845 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -63.13 177.63 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.377 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.664 ' HB2' ' HD3' ' A' ' 158' ' ' LYS . 16.3 ptp180 -108.08 28.53 8.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.416 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 151' ' ' ILE . 40.3 ttmt -62.29 111.0 1.81 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.32 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.751 ' HA3' ' HA ' ' A' ' 159' ' ' THR . . . -67.45 -17.64 68.83 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.774 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.406 HD22 ' HG3' ' A' ' 146' ' ' LYS . 77.6 m-20 -54.77 161.66 1.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.734 0.302 . . . . 0.0 110.926 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -52.0 -13.78 1.71 Allowed Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.432 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -69.37 -5.13 47.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.511 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.902 HG12 ' H ' ' A' ' 152' ' ' GLY . 10.9 tt -80.88 -156.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.902 ' H ' HG12 ' A' ' 151' ' ' ILE . . . -151.45 -37.37 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.877 ' HG2' ' HG2' ' A' ' 157' ' ' ARG . 3.2 tpm_? -58.75 171.24 0.67 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.014 -0.593 . . . . 0.0 109.942 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.68 ' H ' ' NH1' ' A' ' 153' ' ' ARG . 45.4 ttt85 -69.28 136.15 51.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 110.906 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 76.4 p -43.53 -35.51 1.71 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.576 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.468 ' H ' ' HG2' ' A' ' 154' ' ' ARG . 51.2 ttp -83.21 52.72 2.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.418 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.877 ' HG2' ' HG2' ' A' ' 153' ' ' ARG . 14.9 tpp180 -130.53 -69.93 0.64 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.664 ' HD3' ' HB2' ' A' ' 145' ' ' ARG . 7.6 ptpp? -152.8 112.56 3.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.055 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.751 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 68.3 p -96.93 174.62 6.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.715 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.544 ' HB2' ' H ' ' A' ' 147' ' ' GLY . 7.1 tt -120.85 124.57 45.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.829 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -156.58 75.54 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.336 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 81.6 mt -122.89 179.55 4.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.795 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.567 ' N ' ' HD2' ' A' ' 163' ' ' ARG . 1.0 OUTLIER -86.51 78.86 9.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.653 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -93.69 159.6 15.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.929 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.96 114.04 2.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.244 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 166' ' ' LEU . 3.4 tm? -117.06 -27.23 6.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.335 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -113.85 60.0 0.38 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.478 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 58.6 tp -90.61 152.06 21.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 110.934 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.2 m -73.77 147.18 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.127 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -104.0 120.42 41.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -79.05 -15.86 57.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 124.77 -17.13 7.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.565 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.0 t -163.44 137.18 5.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 0.0 110.807 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.17 56.65 2.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.507 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -69.38 99.81 1.27 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.678 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.65 141.13 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.153 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 177' ' ' ILE . 2.5 mp -80.99 117.75 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -110.02 147.99 32.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.988 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 176.49 -168.64 40.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.298 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -125.79 94.1 4.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.87 0.367 . . . . 0.0 111.001 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.52 177.56 7.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.067 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.563 ' NZ ' ' HB3' ' A' ' 182' ' ' LYS . 3.0 mmmp? . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.95 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.95 0.405 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -134.79 162.81 31.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.955 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.821 ' H ' ' HD3' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -119.67 -172.81 2.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.724 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 4' ' ' LEU . 2.0 pp -159.2 -2.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.359 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.8 p -160.41 -62.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.33 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -137.12 109.63 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.34 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HD2' ' A' ' 3' ' ' ARG . 38.9 tt0 -89.15 -47.92 7.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.609 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -87.45 -56.54 3.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.672 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.8 mm -64.78 -25.48 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.579 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.78 165.34 13.93 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.656 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . 109.67 -24.37 19.85 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.6 mt -72.39 -33.7 67.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.745 -0.228 . . . . 0.0 110.793 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.451 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 62.8 tttm -64.68 -51.46 62.38 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -65.54 -18.28 65.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.176 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.822 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -80.15 -40.31 27.6 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.738 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HA ' ' CE1' ' A' ' 68' ' ' PHE . 11.1 t80 -57.4 -44.01 84.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.192 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.57 ' HB2' ' NZ ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -81.75 -12.59 58.52 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.825 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.753 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -67.97 -43.07 79.83 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.862 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 7.7 mt -61.45 -58.07 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -74.96 84.65 2.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.35 1.071 . . . . 0.0 109.817 178.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -89.18 -22.29 22.87 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.595 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -138.66 -5.67 1.54 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.524 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -71.16 -87.53 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.141 0.882 . . . . 0.0 111.292 -178.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.1 p -177.77 11.65 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.483 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.479 ' H ' ' CG ' ' A' ' 20' ' ' ASP . . . 109.84 31.23 3.21 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -177.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 55.1 p -144.13 152.06 40.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.612 -0.794 . . . . 0.0 110.627 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.876 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 4.5 mt -114.42 104.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.758 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.677 HG22 ' OG1' ' A' ' 62' ' ' THR . 82.7 p -102.5 160.11 14.85 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.617 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 17.1 t80 -34.24 -34.61 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.723 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -77.85 -45.48 24.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.843 0.354 . . . . 0.0 110.456 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.565 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -73.04 -24.56 60.72 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.204 178.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.755 HD11 HD23 ' A' ' 51' ' ' LEU . 1.4 tm? -50.61 -54.66 20.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.418 0.628 . . . . 0.0 110.059 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.68 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 3.8 ptpt -79.03 -39.03 35.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.334 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 37.8 t70 -47.66 -36.6 11.3 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.468 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.862 ' HA3' ' HA ' ' A' ' 19' ' ' ILE . . . -95.09 -49.62 2.21 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.259 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.659 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -57.98 -51.71 68.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.467 0.651 . . . . 0.0 109.898 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.68 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -67.85 -9.19 42.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.728 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.581 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -80.86 -32.21 35.1 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.802 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 36' ' ' LEU . 25.1 m -76.94 2.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.733 0.301 . . . . 0.0 111.404 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.18 10.85 11.41 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.271 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 40.9 m -92.22 156.98 16.94 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.725 0.298 . . . . 0.0 110.649 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -142.5 104.43 4.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.046 0.45 . . . . 0.0 110.741 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 48' ' ' ILE . 21.4 mt -131.16 165.52 23.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.465 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.444 ' O ' HD13 ' A' ' 48' ' ' ILE . 37.9 mtm -105.0 165.5 11.03 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.8 mp0 -47.96 -60.72 2.39 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.677 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 t -48.94 -17.19 0.17 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 52.0 mt-10 -90.86 -48.75 6.83 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.743 HG23 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -49.83 -58.13 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.566 ' HB2' ' CE2' ' A' ' 29' ' ' PHE . 44.5 tttp -39.9 -34.65 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.106 -1.861 . . . . 0.0 111.115 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.638 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 8.7 t70 -64.26 -50.81 66.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.399 . . . . 0.0 110.216 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.755 HD23 HD11 ' A' ' 32' ' ' LEU . 53.2 tp -56.13 -33.28 65.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.995 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.596 ' SD ' ' HA2' ' A' ' 61' ' ' GLY . 41.6 ttm -87.54 -66.5 0.91 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.529 0.68 . . . . 0.0 112.705 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.502 ' HA ' ' CG ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -58.42 -34.52 70.88 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.235 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.688 ' HB1' ' OG ' ' A' ' 89' ' ' SER . . . -91.15 -18.48 24.42 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -123.91 -43.56 2.11 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' MET . 65.6 t0 -50.48 101.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.033 0.444 . . . . 0.0 110.093 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 6.3 mt -50.73 -17.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.481 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 60' ' ' SER . 55.7 m-20 -129.76 43.36 3.14 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.052 -178.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.577 ' C ' ' HD3' ' A' ' 59' ' ' LYS . 1.6 tmtp? -33.42 87.16 0.0 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.68 0.753 . . . . 0.0 111.854 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 58' ' ' ASP . 45.6 m -128.04 19.18 6.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.459 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.596 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 68.84 20.87 74.77 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 86.0 m -155.24 133.02 11.34 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.886 -0.657 . . . . 0.0 110.299 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.876 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.1 mt -113.48 134.76 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.152 0.501 . . . . 0.0 111.14 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.534 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 40.1 m-20 -106.68 167.87 9.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.747 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.557 ' O ' HG13 ' A' ' 69' ' ' ILE . 25.2 t80 -35.79 -46.96 0.48 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.695 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.7 -53.82 7.98 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.976 -1.106 . . . . 0.0 112.313 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.609 ' HB2' HG23 ' A' ' 63' ' ' ILE . 24.2 mt-10 -52.08 -25.15 8.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.297 0.57 . . . . 0.0 109.847 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.822 ' HZ ' HD12 ' A' ' 15' ' ' LEU . 88.9 t80 -67.77 -65.51 0.68 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.139 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 65' ' ' TYR . 2.8 mt -47.35 -46.72 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.629 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -50.16 75.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 110.421 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.681 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . -54.78 -33.55 61.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.027 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.5 p -84.6 -59.52 2.34 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 69' ' ' ILE . 49.4 t -51.41 -15.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.993 0.425 . . . . 0.0 111.366 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -76.22 -49.75 16.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.686 HD11 HD13 ' A' ' 51' ' ' LEU . 5.4 mt -77.86 -15.3 59.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -123.42 91.91 3.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.504 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.449 ' HE2' ' CG ' ' A' ' 79' ' ' GLU . 21.0 ptmt -165.68 168.23 16.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.728 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -79.83 36.89 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.397 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.449 ' CG ' ' HE2' ' A' ' 77' ' ' LYS . 67.4 mm-40 -132.1 164.9 25.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 111.155 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.666 ' HD3' ' H ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -127.09 156.43 41.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.861 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 81' ' ' GLU . 10.3 pm0 -72.5 147.26 46.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -113.54 -148.69 0.43 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.653 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -112.27 -31.73 6.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.977 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.617 HD13 ' O ' ' A' ' 84' ' ' LEU . 3.4 tm? -78.84 -28.66 44.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.391 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.6 p -54.19 -19.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.544 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.6 m -44.45 -50.96 9.13 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.013 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -75.23 -51.51 13.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.511 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.702 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 3.5 t80 -43.34 -26.97 0.22 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.017 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.688 ' OG ' ' HB1' ' A' ' 54' ' ' ALA . 25.3 t -89.38 -57.99 2.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.536 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -84.61 -54.37 4.77 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.734 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 87' ' ' ALA . 3.1 m-85 -56.97 -65.08 0.68 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.85 ' HA ' HG12 ' A' ' 99' ' ' ILE . 66.2 t0 -72.61 63.23 0.58 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 29.6 ttmt -51.26 -39.49 56.83 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.225 -177.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 63.7 m-20 -72.0 -25.02 61.67 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.189 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 44.39 64.56 2.0 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.364 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 77.8 p -118.38 11.22 12.98 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 88' ' ' PHE . . . 97.57 4.92 57.99 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 112.195 -2.275 . . . . 0.0 112.697 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 1.1 p90 -165.25 144.94 6.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.85 HG12 ' HA ' ' A' ' 92' ' ' ASP . 51.1 mt -103.24 141.76 18.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.794 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.504 ' HA ' ' CB ' ' A' ' 132' ' ' GLN . 77.0 p -110.73 159.73 17.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.86 0.3 . . . . 0.0 110.255 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.69 ' HA ' HD12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -38.09 -37.56 0.27 Allowed 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 179.159 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.42 ' N ' ' HG ' ' A' ' 101' ' ' LEU . 65.1 t0 -60.96 -59.77 4.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.628 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.545 ' HB2' HG23 ' A' ' 99' ' ' ILE . 52.7 mt-10 -60.05 -22.66 62.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.77 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 133' ' ' ILE . 82.9 mt -75.79 -61.38 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.643 ' HG2' ' O ' ' A' ' 101' ' ' LEU . 4.0 mm100 -55.29 -33.57 63.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.638 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -80.47 -28.58 37.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.003 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 103' ' ' GLU . . . -66.71 -4.57 9.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.835 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 76.2 m -115.55 77.79 1.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.516 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -79.54 -53.87 6.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.55 -16.75 59.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.005 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.835 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 11.1 m-85 -63.46 -56.67 14.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.916 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 114.45 38.75 1.07 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.998 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.925 ' HA ' HD12 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -32.63 124.09 0.34 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.541 0.686 . . . . 0.0 112.258 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.609 ' N ' HD22 ' A' ' 113' ' ' LEU . 34.1 t0 -150.71 173.77 13.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.275 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.826 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 1.4 m-20 -77.85 -7.44 56.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.012 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.8 mt -81.71 -65.52 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -92.55 -69.27 0.75 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.925 HD12 ' HA ' ' A' ' 113' ' ' LEU . 15.1 mt -54.29 -18.89 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.826 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 38.8 t70 -70.6 -64.96 0.8 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.429 0.157 . . . . 0.0 110.924 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 124' ' ' GLU . 54.8 p30 -61.13 -16.99 50.33 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.892 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 22.2 ttp -61.15 -33.74 73.9 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.38 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.525 HG22 ' HA3' ' A' ' 131' ' ' GLY . 61.2 mt -58.32 -44.02 87.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.657 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 4.5 mptt -86.33 -13.06 47.66 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.562 -1.654 . . . . 0.0 110.187 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.892 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 41.4 tp10 -81.65 -24.4 36.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.84 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.789 HG21 HD13 ' A' ' 133' ' ' ILE . 19.3 mt -112.17 -19.4 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.206 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.864 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 14.1 t70 -66.13 83.86 0.09 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.844 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.563 HE22 ' HA ' ' A' ' 137' ' ' GLU . 8.2 mt-30 -85.19 -8.69 58.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.307 -178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.592 ' CB ' ' HA ' ' A' ' 154' ' ' ARG . 12.4 p-10 -126.61 -30.25 2.83 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.756 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.74 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.756 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 1.3 m-20 -65.21 25.95 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 -173.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.864 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 55.65 37.56 68.56 Favored Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 117.505 -2.283 . . . . 0.0 108.193 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.809 ' HB2' ' O ' ' A' ' 99' ' ' ILE . 10.0 pt20 -129.27 167.07 18.23 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 113.678 -1.261 . . . . 0.0 109.87 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.789 HD13 HG21 ' A' ' 125' ' ' ILE . 18.6 mt -129.75 116.39 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.753 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.764 ' OD1' ' HG3' ' A' ' 137' ' ' GLU . 0.7 OUTLIER -100.33 165.53 11.42 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.702 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 32.5 t80 -45.81 -23.43 0.27 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.178 0.513 . . . . 0.0 110.149 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.633 ' C ' ' HB3' ' A' ' 153' ' ' ARG . . . -82.45 -39.95 10.45 Favored Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.049 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.764 ' HG3' ' OD1' ' A' ' 134' ' ' ASP . 38.8 mt-10 -70.01 -57.46 4.97 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 116.075 -0.063 . . . . 0.0 111.065 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.639 ' HD1' HG21 ' A' ' 133' ' ' ILE . 1.3 t80 -57.87 -50.95 71.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.519 -178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.4 -19.52 56.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.648 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 145' ' ' ARG . . . -90.73 -51.72 5.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.956 0.408 . . . . 0.0 111.86 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -65.19 8.08 0.16 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.325 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.445 ' H ' ' C ' ' A' ' 140' ' ' ALA . 4.1 ppp? -115.3 3.64 14.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 110.998 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.684 ' HG2' ' HG3' ' A' ' 144' ' ' LYS . 43.5 ttt85 -128.97 -84.52 0.57 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.052 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.684 ' HG3' ' HG2' ' A' ' 143' ' ' ARG . 98.5 mttt -128.14 -68.88 0.75 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.011 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.505 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 39.4 ptt180 -159.12 -49.18 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.402 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.486 ' HD2' ' HA2' ' A' ' 152' ' ' GLY . 24.7 pttm -172.3 142.48 1.34 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.759 0.314 . . . . 0.0 111.171 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -64.52 -57.84 11.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.156 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -85.72 115.36 23.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.688 0.28 . . . . 0.0 110.462 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.484 ' HA2' ' HE2' ' A' ' 146' ' ' LYS . . . -60.0 -14.48 31.64 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.535 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -96.3 -47.21 2.43 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.482 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.473 ' HB ' ' H ' ' A' ' 152' ' ' GLY . 17.0 mm -73.71 -98.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.826 0.346 . . . . 0.0 111.203 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.486 ' HA2' ' HD2' ' A' ' 146' ' ' LYS . . . 130.67 -128.87 5.64 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.24 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.633 ' HB3' ' C ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -141.23 83.78 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.146 0.498 . . . . 0.0 111.064 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.76 ' HD2' ' HG2' ' A' ' 157' ' ' ARG . 66.6 mtt-85 -128.78 148.43 50.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.994 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.9 t -64.75 -33.95 77.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.443 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.5 mtt -143.7 55.65 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.775 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.76 ' HG2' ' HD2' ' A' ' 154' ' ' ARG . 2.8 tmt_? -57.34 127.53 32.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.488 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.627 ' HB2' ' NZ ' ' A' ' 158' ' ' LYS . 4.9 ttmp? -154.01 147.01 24.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.684 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 87.7 m -62.65 -82.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.067 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 64.2 tp -167.51 108.14 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.843 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -151.88 -97.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.928 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.4 mt -129.2 -169.85 2.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.775 0.322 . . . . 0.0 110.906 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -80.55 -47.33 14.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -104.37 137.07 42.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.951 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.577 ' HB2' ' HE2' ' A' ' 158' ' ' LYS . . . -110.31 132.57 54.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.095 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 84.3 mt -121.27 -0.3 9.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.537 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.7 -168.1 37.44 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.187 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.899 HD23 ' H ' ' A' ' 168' ' ' LEU . 2.0 pt? -88.55 90.89 8.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.373 0.606 . . . . 0.0 110.77 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 48.4 t -120.8 132.54 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.039 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -131.52 -46.57 0.98 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.806 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -88.65 45.81 1.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -114.56 -148.39 9.65 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.551 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 79.4 p -77.53 -170.74 1.9 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 0.0 110.865 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.474 ' N ' HD22 ' A' ' 174' ' ' ASN . 0.0 OUTLIER -156.04 25.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.944 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -88.83 110.27 20.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.078 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.21 137.07 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.86 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.675 ' O ' HD12 ' A' ' 177' ' ' ILE . 2.6 pp -104.82 148.41 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.047 0.451 . . . . 0.0 111.723 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -148.39 129.51 14.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.537 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 90.93 98.36 1.21 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.03 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -103.43 -3.66 25.14 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -162.88 0.16 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.814 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 27.7 tptp . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.978 179.856 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.791 0.329 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -120.44 42.71 2.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.777 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -160.95 -15.76 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.792 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.9 mt -104.36 99.67 9.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.971 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.5 m -73.11 166.91 22.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.627 ' O ' HG22 ' A' ' 9' ' ' ILE . 63.9 mm-40 -124.23 -166.15 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -12.41 61.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.177 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -56.95 -29.17 62.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.224 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 6' ' ' GLU . 14.4 tt -77.59 -30.88 17.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.821 0.343 . . . . 0.0 111.006 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.5 108.25 0.52 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.597 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.03 13.13 3.36 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.626 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.612 HD12 HD23 ' A' ' 15' ' ' LEU . 44.2 tp -76.17 -32.72 59.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.509 0.195 . . . . 0.0 110.734 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . 22.0 pttp -60.42 -41.42 93.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 18' ' ' MET . 87.6 tt0 -68.01 -27.68 66.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.72 177.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.695 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 32.6 tp -72.08 -32.88 67.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.082 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.438 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 6.0 t80 -64.58 -50.25 67.97 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.337 0.589 . . . . 0.0 109.537 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -73.64 -15.03 61.26 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.695 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -70.07 -20.46 63.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.805 178.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.837 HG23 ' HA3' ' A' ' 35' ' ' GLY . 9.2 mm -81.24 -62.16 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.828 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.627 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -85.76 70.42 10.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.895 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.621 HG22 HH22 ' A' ' 38' ' ' ARG . 15.1 t -87.25 -6.46 58.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.244 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -131.98 -24.13 2.16 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.414 ' C ' HD22 ' A' ' 23' ' ' ASN . 0.7 OUTLIER -71.58 -76.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.7 p -175.0 -4.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.462 ' HA2' ' OD1' ' A' ' 20' ' ' ASP . . . 110.4 30.12 3.44 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -177.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.585 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 49.6 p -143.71 146.34 33.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 113.837 -1.182 . . . . 0.0 109.413 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.914 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.1 mt -103.24 104.22 16.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 68.6 p -103.39 165.99 10.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.609 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.655 ' CE2' ' HB2' ' A' ' 49' ' ' LYS . 9.5 t80 -34.24 -33.33 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.146 -0.933 . . . . 0.0 112.327 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -79.49 -52.66 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.889 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.627 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 31.9 mt-10 -73.65 -14.16 61.12 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.494 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.776 HD12 HG13 ' A' ' 48' ' ' ILE . 2.3 tm? -54.89 -56.21 22.01 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 37' ' ' LYS . 12.8 ptpt -75.62 -44.01 45.05 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.281 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.631 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 62.3 t0 -43.15 -65.33 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 0.0 110.494 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.837 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -62.21 -50.68 62.79 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.542 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.64 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -60.72 -65.11 0.74 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 117.263 0.532 . . . . 0.0 110.738 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -51.97 -23.95 5.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.204 179.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.631 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 38.4 ttm180 -57.73 -43.67 85.47 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.143 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' LEU . 22.3 m -73.5 20.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 38' ' ' ARG . . . 100.0 -15.45 59.32 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.414 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 37' ' ' LYS . 74.4 m -60.45 155.4 18.36 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.795 0.331 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 15.5 pt-20 -138.56 107.25 5.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.163 0.506 . . . . 0.0 110.854 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 mt -125.34 166.1 17.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.153 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.567 ' O ' HD13 ' A' ' 48' ' ' ILE . 30.2 mtm -111.69 163.99 13.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -49.15 -65.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.043 -178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.2 m -48.9 -20.67 0.53 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.465 0.575 . . . . 0.0 111.932 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 95.1 mt-10 -80.29 -43.84 20.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.776 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -55.44 -54.86 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 122.266 1.031 . . . . 0.0 108.5 177.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.657 ' HZ1' ' HE2' ' A' ' 109' ' ' LYS . 50.8 tttp -58.81 -29.0 66.54 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.369 -1.741 . . . . 0.0 110.322 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 38.0 t70 -67.99 -53.77 23.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.687 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.512 HD22 HD21 ' A' ' 32' ' ' LEU . 2.5 tt -54.91 -32.13 60.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.47 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.534 ' O ' ' HB3' ' A' ' 56' ' ' ASP . 25.2 mtt -72.1 -65.72 0.74 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.588 ' HB2' ' NZ ' ' A' ' 59' ' ' LYS . 41.9 t0 -65.36 -18.82 65.62 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.119 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.77 -34.1 14.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.859 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -118.67 -43.67 2.67 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' MET . 63.7 t0 -46.89 99.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.5 mm -50.38 -23.92 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.041 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.654 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . 7.9 t70 -130.59 45.66 2.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.416 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.588 ' NZ ' ' HB2' ' A' ' 53' ' ' ASP . 23.3 tptm -31.99 91.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.83 0.824 . . . . 0.0 112.992 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 58' ' ' ASP . 39.7 m -127.42 18.62 6.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.546 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 68.33 19.09 72.11 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 97.0 m -146.55 143.35 28.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.6 -0.8 . . . . 0.0 109.759 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.914 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 58.9 mt -128.3 126.6 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.191 0.52 . . . . 0.0 111.587 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 65' ' ' TYR . 31.4 m-20 -104.29 167.73 9.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.596 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.623 ' O ' HG13 ' A' ' 69' ' ' ILE . 33.9 t80 -34.85 -47.92 0.37 Allowed 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.229 0.331 . . . . 0.0 111.412 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.31 -61.71 6.81 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.115 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.777 ' HB2' HG23 ' A' ' 63' ' ' ILE . 28.0 mt-10 -56.28 -24.82 45.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.687 0.28 . . . . 0.0 111.16 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.651 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 39.4 t80 -65.21 -53.8 39.08 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.298 0.571 . . . . 0.0 110.817 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 65' ' ' TYR . 3.7 mt -61.25 -46.3 96.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.063 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.18 -10.78 53.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.308 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.25 -55.43 3.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.558 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 68' ' ' PHE . 5.2 t -65.83 -48.54 71.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.442 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.676 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 58.7 t -61.22 -15.88 13.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.02 0.438 . . . . 0.0 111.199 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -66.21 -44.56 83.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.8 mt -96.17 -8.29 33.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.187 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 0.7 OUTLIER -108.99 86.55 2.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.647 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -127.02 -84.33 0.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.506 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.9 mm? -109.6 -53.4 2.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.784 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.41 ' OE2' ' HG2' ' A' ' 80' ' ' ARG . 17.3 tp10 -160.98 152.1 18.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.572 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.41 ' HG2' ' OE2' ' A' ' 79' ' ' GLU . 13.5 ptp180 -56.72 119.41 6.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.378 . . . . 0.0 111.063 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -172.97 -36.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.057 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.412 ' OE1' HG21 ' A' ' 85' ' ' VAL . 67.2 mm-40 -85.94 30.46 0.66 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.086 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -88.99 -35.29 16.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 139' ' ' ALA . 28.6 mt -74.62 -45.58 44.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.357 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.441 ' HA ' ' CB ' ' A' ' 88' ' ' PHE . 32.6 m -57.91 -19.47 12.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.435 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -53.3 -66.04 0.46 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.847 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.702 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -69.78 -33.27 72.16 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.813 ' HZ ' ' HA2' ' A' ' 97' ' ' GLY . 11.3 t80 -46.42 -22.12 0.23 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.528 177.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.422 ' N ' ' C ' ' A' ' 87' ' ' ALA . 46.6 t -89.17 -43.3 11.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.6 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -81.09 -64.48 1.18 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.496 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.539 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.5 m-85 -56.12 -61.89 2.08 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.806 ' HA ' HG12 ' A' ' 99' ' ' ILE . 63.1 t0 -80.6 61.69 4.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.466 ' HE3' HE21 ' A' ' 106' ' ' GLN . 19.6 ttmm -42.28 -36.08 1.15 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.144 -177.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -89.84 -22.84 21.87 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.601 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 52.97 73.88 0.36 Allowed Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 60.1 p -122.37 -5.3 8.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.813 ' HA2' ' HZ ' ' A' ' 88' ' ' PHE . . . 109.78 -9.8 32.24 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 113.125 -1.852 . . . . 0.0 112.967 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.535 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -142.24 158.54 43.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.558 0.694 . . . . 0.0 112.383 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.806 HG12 ' HA ' ' A' ' 92' ' ' ASP . 82.3 mt -131.61 104.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.711 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.7 p -69.14 147.34 51.53 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.8 ' HB3' HG23 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -35.27 -35.63 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -57.02 -52.82 63.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.672 0.273 . . . . 0.0 111.023 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.728 ' HB2' HG23 ' A' ' 99' ' ' ILE . 97.4 mt-10 -59.93 -30.4 69.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.723 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.802 HD11 HG12 ' A' ' 133' ' ' ILE . 88.4 mt -75.67 -61.58 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.104 0.478 . . . . 0.0 110.283 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.704 HE21 HG23 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -51.91 -29.26 19.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.734 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.466 HE21 ' HE3' ' A' ' 93' ' ' LYS . 41.5 tt0 -63.82 -42.86 97.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.904 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 108' ' ' CYS . . . -50.02 -65.9 0.48 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.974 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.804 ' HB2' ' CD1' ' A' ' 111' ' ' PHE . 10.6 p -34.31 115.89 0.28 Allowed 'General case' 0 C--O 1.22 -0.475 0 O-C-N 123.739 0.649 . . . . 0.0 109.622 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.657 ' HE2' ' HZ1' ' A' ' 49' ' ' LYS . 25.1 ttmm -88.46 -58.66 2.47 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.25 -15.55 4.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.444 0.64 . . . . 0.0 110.065 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.804 ' CD1' ' HB2' ' A' ' 108' ' ' CYS . 0.2 OUTLIER -112.27 -49.76 2.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.189 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 108' ' ' CYS . . . 79.62 -21.94 4.28 Favored Glycine 0 CA--C 1.509 -0.33 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.248 -177.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.816 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 176.44 53.84 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.508 ' O ' HG13 ' A' ' 118' ' ' ILE . 51.1 t0 -34.04 100.2 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 112.248 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.62 -18.0 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.502 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.4 mm -92.35 -49.39 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.795 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.576 ' CD2' ' HG3' ' A' ' 121' ' ' MET . 15.2 t-160 -78.65 -38.85 38.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.448 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.704 HG23 HE21 ' A' ' 105' ' ' GLN . 3.2 mt -36.11 -61.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 118' ' ' ILE . 65.6 t0 -48.26 -60.44 2.65 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.9 0.381 . . . . 0.0 111.412 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.724 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 57.9 m-20 -67.64 -17.08 64.48 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.613 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.785 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.8 mtp -77.26 -52.69 8.78 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 123.631 0.772 . . . . 0.0 112.338 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.8 HG23 ' HB3' ' A' ' 101' ' ' LEU . 55.4 mt -50.05 -39.47 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.662 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.51 -19.13 29.97 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.249 -1.796 . . . . 0.0 110.959 178.401 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.785 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 17.0 tp10 -79.32 -18.26 52.92 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.758 HG22 ' CD1' ' A' ' 133' ' ' ILE . 16.2 mt -115.43 -32.89 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.213 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.714 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 13.1 t0 -62.98 112.7 2.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.236 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.682 ' HB3' ' NH2' ' A' ' 153' ' ' ARG . 0.3 OUTLIER -89.22 -9.71 49.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.453 ' OD2' ' HB3' ' A' ' 154' ' ' ARG . 53.1 p30 -133.54 -32.35 1.15 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -176.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.693 ' HB3' ' NH2' ' A' ' 154' ' ' ARG . 5.0 t30 -178.42 -72.49 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 117.314 2.339 . . . . 0.0 117.314 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.454 ' HB3' ' HG2' ' A' ' 132' ' ' GLN . 40.1 t0 -63.78 13.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -172.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.767 ' HA3' HG22 ' A' ' 122' ' ' ILE . . . 55.97 37.68 71.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 117.804 -2.141 . . . . 0.0 108.967 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.798 ' O ' HD13 ' A' ' 133' ' ' ILE . 7.7 pt20 -128.98 167.18 17.83 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 113.435 -1.382 . . . . 0.0 109.675 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.802 HG12 HD11 ' A' ' 104' ' ' ILE . 40.1 mm -125.8 124.56 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 CA-C-O 122.107 0.956 . . . . 0.0 111.404 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.909 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 35.4 t70 -103.03 158.79 16.05 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.18 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.626 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 16.0 t80 -48.41 -27.83 2.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.136 0.493 . . . . 0.0 109.872 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -85.51 -38.04 9.2 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 177.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.909 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 51.0 mt-10 -63.45 -57.99 8.49 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.702 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 26.4 t80 -52.41 -18.53 1.68 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.151 0.5 . . . . 0.0 109.978 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -81.69 -36.14 29.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.251 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.786 ' HB2' ' HD2' ' A' ' 153' ' ' ARG . . . -81.64 -38.45 25.92 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.647 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.579 ' HB3' ' OE1' ' A' ' 127' ' ' GLN . 5.3 ppp? -56.49 -20.19 19.06 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.851 0.357 . . . . 0.0 110.997 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 36.8 ttm -93.0 -64.5 1.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.68 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 143' ' ' ARG . 0.2 OUTLIER -74.05 -106.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.106 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -143.6 -168.37 2.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.822 0.344 . . . . 0.0 110.704 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.418 HH12 HD22 ' A' ' 161' ' ' ASN . 98.8 mtt180 -94.94 -2.84 49.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.701 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -164.33 49.49 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.832 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -86.51 -43.43 6.17 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.779 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -149.08 157.47 43.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.849 0.357 . . . . 0.0 111.162 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -69.22 -5.17 47.23 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.585 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.13 -4.81 12.77 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.58 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 52.4 mt -43.32 151.5 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-O 121.095 0.474 . . . . 0.0 111.915 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.525 ' C ' ' HA3' ' A' ' 136' ' ' GLY . . . -146.99 4.36 0.99 Allowed Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.786 ' HD2' ' HB2' ' A' ' 140' ' ' ALA . 38.4 mtp180 -54.11 168.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.013 -0.593 . . . . 0.0 110.198 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.693 ' NH2' ' HB3' ' A' ' 129' ' ' ASN . 40.7 ttp180 -71.84 149.19 45.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 86.6 m -34.86 -31.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.599 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 65.1 mtm -78.31 48.81 0.79 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.878 0.37 . . . . 0.0 111.17 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.467 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -118.55 -7.76 10.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.803 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.837 ' HA ' ' HE3' ' A' ' 158' ' ' LYS . 0.5 OUTLIER -65.22 -20.51 66.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.833 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 90.2 m -79.32 124.34 28.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.514 HD23 ' H ' ' A' ' 160' ' ' LEU . 2.3 pt? -144.16 165.82 26.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.418 HD22 HH12 ' A' ' 145' ' ' ARG . 75.9 m-20 -115.38 150.84 35.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.622 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 162' ' ' LEU . 2.4 pp -121.8 7.12 9.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.543 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -84.41 -12.96 53.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 110.544 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -92.79 136.7 33.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.728 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -89.59 143.97 26.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.225 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 57.1 tp -62.77 -21.99 66.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.633 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 178.15 175.07 45.0 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.32 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 168' ' ' LEU . 6.0 mp -71.8 134.91 46.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.791 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.71 133.22 31.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -88.32 94.86 9.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.732 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.576 ' H ' HD22 ' A' ' 171' ' ' ASN . 0.0 OUTLIER -113.06 25.73 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.144 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -149.04 44.15 0.75 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.312 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 83.4 p -159.2 122.95 3.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.812 0.339 . . . . 0.0 111.086 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -117.75 30.49 7.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.775 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.447 ' N ' ' OE1' ' A' ' 175' ' ' GLN . 0.5 OUTLIER -66.29 104.9 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.844 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 82.8 t -85.05 115.31 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.099 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.673 ' O ' HD12 ' A' ' 177' ' ' ILE . 2.7 pp -105.44 148.42 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.192 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -87.26 123.21 32.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.033 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -139.42 -169.66 11.66 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.426 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -71.49 -29.83 65.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.755 0.312 . . . . 0.0 111.028 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -60.89 -67.26 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.059 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.913 179.979 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.762 0.315 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -112.57 27.78 9.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.693 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.48 ' N ' ' HE ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -69.34 -166.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.542 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.484 HD22 ' N ' ' A' ' 4' ' ' LEU . 3.1 mm? -113.14 -71.47 0.75 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.768 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.7 m -67.0 161.49 24.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.739 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 9' ' ' ILE . 38.6 tt0 -132.95 136.84 46.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.118 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -86.85 -28.27 22.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.302 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.429 ' HB3' ' OE2' ' A' ' 6' ' ' GLU . 5.5 tp10 -60.95 -27.8 68.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.435 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 6' ' ' GLU . 64.1 mt -58.05 -19.26 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.44 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.55 160.86 15.45 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.33 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.36 30.15 76.96 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.57 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 86.6 mt -59.58 -23.53 63.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.705 -0.248 . . . . 0.0 111.094 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -68.24 -53.7 22.86 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.857 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 39.2 tt0 -64.92 -22.99 67.09 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 47.9 tp -74.88 -37.77 62.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.873 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.534 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 14.1 t80 -61.36 -46.85 88.51 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.857 ' HE2' ' HA ' ' A' ' 14' ' ' GLU . 59.5 pttt -75.96 -12.92 60.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.634 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.73 -18.01 60.56 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.891 178.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.869 HG23 ' HA3' ' A' ' 35' ' ' GLY . 7.1 mm -82.61 -61.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.932 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.735 ' HB3' ' O ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -77.65 59.81 2.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.823 -178.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 t -87.18 -6.15 58.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.495 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.619 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 5.4 m-20 -113.82 -28.1 7.54 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -83.03 -89.81 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.864 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.0 p -176.15 19.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.395 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.616 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 111.54 22.97 5.86 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 76.2 p -137.62 143.64 41.54 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.911 -0.644 . . . . 0.0 110.154 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.873 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 12.3 mt -102.34 103.7 15.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.745 -177.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 82.2 p -104.02 165.47 11.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.097 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -34.13 -34.47 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.778 0.674 . . . . 0.0 112.438 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -79.31 -48.02 14.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.929 0.395 . . . . 0.0 110.494 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.619 ' OE2' ' HB2' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -74.57 -14.32 60.77 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.363 178.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.785 HD12 HG13 ' A' ' 48' ' ' ILE . 1.8 tm? -58.63 -56.03 27.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.614 ' NZ ' HG12 ' A' ' 48' ' ' ILE . 6.4 ptpp? -73.92 -48.1 33.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.523 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.663 ' O ' ' HB3' ' A' ' 38' ' ' ARG . 32.1 t70 -37.84 -64.18 0.42 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.41 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.869 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . -47.39 -41.02 16.34 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 115.459 0.944 . . . . 0.0 115.459 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.638 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -94.99 -56.08 2.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.91 0.855 . . . . 0.0 110.955 -178.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -50.18 -18.08 0.53 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.401 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.663 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 6.3 ptm180 -67.14 -38.43 85.51 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 36' ' ' LEU . 27.0 m -77.9 23.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.76 -23.25 33.12 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.735 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m -59.52 156.13 13.88 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.741 0.305 . . . . 0.0 110.632 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -136.78 109.28 7.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.233 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 mt -113.04 165.27 12.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.974 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.436 ' O ' HD13 ' A' ' 48' ' ' ILE . 28.0 mtm -113.86 157.55 22.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 48' ' ' ILE . 37.5 mt-10 -44.87 -64.99 0.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.1 t -42.95 -29.44 0.33 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 56.7 mm-40 -70.39 -40.36 73.96 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.264 0.555 . . . . 0.0 109.569 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.785 HG13 HD12 ' A' ' 32' ' ' LEU . 1.7 mp -59.67 -60.94 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.321 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -56.58 -26.63 55.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.645 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.559 ' HB3' ' O ' ' A' ' 47' ' ' GLU . 60.6 t0 -66.29 -46.17 77.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.829 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.753 HD22 HD21 ' A' ' 32' ' ' LEU . 10.5 tt -67.65 -21.69 65.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.142 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.808 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 21.7 mmt -73.24 -43.54 61.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.477 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -86.96 -23.66 25.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.867 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.558 ' HA ' HH12 ' A' ' 80' ' ' ARG . . . -91.56 -25.55 19.17 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.49 -43.77 1.58 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.758 ' HB3' ' O ' ' A' ' 52' ' ' MET . 67.3 t0 -59.2 94.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.345 0.593 . . . . 0.0 110.241 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.0 mm -51.91 -19.43 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.337 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 60' ' ' SER . 8.4 t70 -130.3 43.9 3.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.638 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.808 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 12.7 tmtt? -32.7 88.2 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.744 0.783 . . . . 0.0 112.436 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' ASP . 76.3 p -128.55 18.32 6.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.062 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 75.89 15.24 81.47 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.375 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 97.2 m -146.55 142.71 28.28 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.118 0.567 . . . . 0.0 109.62 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.873 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 57.7 mt -128.98 133.69 65.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.271 0.558 . . . . 0.0 112.204 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 58.0 m-20 -106.53 167.97 9.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.616 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.413 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 29.4 t80 -35.27 -44.04 0.25 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.509 0.505 . . . . 0.0 111.717 -178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -56.0 7.99 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.765 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.732 ' HB2' HG23 ' A' ' 63' ' ' ILE . 24.1 mt-10 -56.25 -19.7 15.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 110.441 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.598 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 42.0 t80 -68.57 -60.04 2.7 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.555 0.693 . . . . 0.0 110.495 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.9 mm -59.97 -26.13 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.291 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.439 ' C ' HG12 ' A' ' 73' ' ' VAL . . . -61.78 -8.86 5.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.961 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . . . -95.1 -30.18 14.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.639 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.9 p -80.66 -10.41 59.73 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.598 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.587 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 8.3 p -95.2 -14.42 7.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.589 178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.446 ' CE1' ' HB1' ' A' ' 54' ' ' ALA . 75.3 t60 -71.93 -52.99 14.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.251 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -61.53 -16.38 47.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.813 ' N ' HD13 ' A' ' 75' ' ' LEU . 55.3 t30 -81.49 174.96 10.94 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.451 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.656 ' HG2' ' ND2' ' A' ' 76' ' ' ASN . 8.1 ptpp? -32.52 136.12 0.08 Allowed 'General case' 0 N--CA 1.462 0.127 0 O-C-N 123.304 0.378 . . . . 0.0 110.675 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.3 mt -34.55 79.36 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.959 0.787 . . . . 0.0 112.676 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.597 ' N ' ' O ' ' A' ' 77' ' ' LYS . 42.7 tp10 -101.23 79.1 1.96 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.76 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.558 HH12 ' HA ' ' A' ' 54' ' ' ALA . 44.7 ttt85 -130.73 157.83 41.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.649 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -128.9 -174.94 3.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.937 0.399 . . . . 0.0 111.604 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.432 ' HG2' ' N ' ' A' ' 83' ' ' ASN . 88.6 tt0 -71.66 162.78 28.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.975 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.994 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 12.8 p-10 -170.37 114.5 0.47 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.011 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tt -90.48 -65.74 0.99 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.999 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.549 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . 33.8 m -78.09 -32.31 17.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.994 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 51.2 m -53.73 -21.98 8.29 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 91' ' ' PHE . . . -76.92 -55.02 5.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.409 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.718 ' CE1' ' HA ' ' A' ' 135' ' ' TYR . 40.6 m-85 -49.77 -20.07 0.77 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.217 0.532 . . . . 0.0 109.719 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 87' ' ' ALA . 48.1 t -88.93 -48.06 7.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.05 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -83.11 -63.82 1.29 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.492 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.55 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.8 m-85 -58.99 -62.56 1.79 Allowed 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.774 ' HA ' HG12 ' A' ' 99' ' ' ILE . 62.7 t0 -74.81 63.89 1.21 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 176.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 93' ' ' LYS . 25.0 ttmt -48.19 -43.33 31.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.231 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.8 m-20 -74.08 -22.63 59.43 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.474 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.56 -10.02 0.34 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.339 -0.458 . . . . 0.0 112.963 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 94' ' ' ASP . 79.1 p -49.58 -16.3 0.21 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.56 -29.78 3.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.623 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.749 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -115.03 163.31 15.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.678 0.751 . . . . 0.0 112.709 -178.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.788 HG22 HG13 ' A' ' 104' ' ' ILE . 54.5 mt -133.13 102.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.221 177.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 101' ' ' LEU . 44.9 p -73.63 149.28 42.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 122' ' ' ILE . 4.0 pp -34.95 -39.41 0.1 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.75 0.31 . . . . 0.0 111.115 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.512 ' N ' HD12 ' A' ' 101' ' ' LEU . 1.6 m-20 -54.89 -60.97 2.63 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.516 ' HB2' HG23 ' A' ' 99' ' ' ILE . 50.4 mt-10 -51.87 -47.88 64.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.977 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.788 HG13 HG22 ' A' ' 99' ' ' ILE . 90.5 mt -54.73 -65.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.701 0.762 . . . . 0.0 111.362 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.769 ' HB3' HD22 ' A' ' 113' ' ' LEU . 2.4 mm-40 -62.18 -65.23 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.925 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -42.26 -37.4 1.49 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.699 0.285 . . . . 0.0 111.667 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 103' ' ' GLU . . . -48.65 -57.99 5.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 111' ' ' PHE . 3.4 t -57.0 131.87 51.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.557 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.9 -48.0 7.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.126 0.489 . . . . 0.0 112.294 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.13 -0.63 55.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.334 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.662 ' CD2' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -44.94 -83.76 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -176.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.461 ' N ' ' CD1' ' A' ' 111' ' ' PHE . . . 107.05 40.09 1.88 Allowed Glycine 0 C--N 1.333 0.399 0 C-N-CA 119.809 -1.186 . . . . 0.0 110.207 -176.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.853 HD23 HG12 ' A' ' 118' ' ' ILE . 15.2 mt -31.25 133.02 0.09 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -176.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.718 ' H ' ' HB ' ' A' ' 118' ' ' ILE . 12.4 p-10 -152.79 172.78 16.19 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.651 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 8.7 t70 -73.85 -22.22 59.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.505 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 62.3 mt -72.39 -64.92 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 121' ' ' MET . 16.9 m80 -92.17 -70.1 0.71 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.853 HG12 HD23 ' A' ' 113' ' ' LEU . 1.7 mp -47.31 -55.36 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -177.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.517 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 37.9 m-20 -60.63 -49.3 78.06 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.744 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 124' ' ' GLU . 8.6 t70 -67.66 -19.48 65.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 1.002 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 2.2 mtp -69.89 -40.04 75.9 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.844 0.858 . . . . 0.0 110.274 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.813 HG23 ' HB3' ' A' ' 101' ' ' LEU . 56.8 mt -50.8 -46.63 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 43.7 mmtt -87.37 -13.58 43.06 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.006 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 1.002 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 15.9 tp10 -86.27 -17.1 35.58 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.71 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.738 HG22 ' CD1' ' A' ' 133' ' ' ILE . 22.6 mt -113.52 -32.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.331 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.62 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 17.3 t70 -63.33 112.29 2.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.954 0.407 . . . . 0.0 111.618 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.68 HE22 ' HB3' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -88.31 -9.37 53.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.816 ' HB3' ' HA ' ' A' ' 155' ' ' THR . 36.7 m-20 -131.32 -32.13 1.58 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -176.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.684 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -178.79 -74.26 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.684 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 21.4 m-20 -63.97 17.77 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.76 ' HA3' HG22 ' A' ' 122' ' ' ILE . . . 55.07 37.29 62.91 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.376 -1.869 . . . . 0.0 108.99 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.77 ' O ' HD13 ' A' ' 133' ' ' ILE . 8.7 pt20 -131.55 166.92 20.33 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 113.934 -1.133 . . . . 0.0 109.148 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.771 HG12 HD11 ' A' ' 104' ' ' ILE . 36.0 mm -123.5 131.99 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-O 121.736 0.779 . . . . 0.0 111.172 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.816 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 39.0 t70 -101.09 160.32 14.48 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.876 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.718 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 15.0 t80 -48.05 -31.44 5.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.132 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.72 ' HA3' ' HA3' ' A' ' 152' ' ' GLY . . . -85.61 -33.55 15.99 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 119.888 -1.148 . . . . 0.0 110.429 177.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.816 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 52.6 mt-10 -64.28 -58.0 7.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.37 -0.415 . . . . 0.0 111.197 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.598 ' HD1' HG21 ' A' ' 133' ' ' ILE . 2.8 t80 -54.53 -37.94 65.98 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.753 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.09 -20.92 64.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.181 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.3 -50.33 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -19.91 9.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.688 0.28 . . . . 0.0 111.292 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 67.6 mtm -99.44 -34.56 10.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.811 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.615 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -109.45 -140.41 0.38 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.059 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.615 ' H ' ' HD2' ' A' ' 143' ' ' ARG . 60.6 mttp -114.7 -77.55 0.57 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.744 0.307 . . . . 0.0 111.072 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -133.51 47.6 2.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.074 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -105.51 41.89 1.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.828 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.32 -66.96 2.44 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.158 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.505 ' ND2' ' H ' ' A' ' 150' ' ' GLY . 46.4 t30 -156.22 157.1 35.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.647 0.223 . . . . 0.0 110.952 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -50.75 -31.33 23.2 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.505 ' H ' ' ND2' ' A' ' 148' ' ' ASN . . . -96.03 -65.02 0.95 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.444 ' H ' HD22 ' A' ' 148' ' ' ASN . 18.0 tt -175.92 150.71 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.134 -0.533 . . . . 0.0 110.666 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.72 ' HA3' ' HA3' ' A' ' 136' ' ' GLY . . . -117.72 -104.57 2.27 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.62 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.679 ' HD3' ' H ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -47.26 100.49 0.02 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.325 0.583 . . . . 0.0 110.91 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.787 ' HB3' ' HB3' ' A' ' 157' ' ' ARG . 11.7 tpt180 -128.76 137.91 51.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.252 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.816 ' HA ' ' HB3' ' A' ' 128' ' ' ASP . 66.5 p -61.1 -33.57 73.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.558 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.625 ' H ' ' HG3' ' A' ' 154' ' ' ARG . 51.9 ttm -149.59 75.72 1.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.3 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.787 ' HB3' ' HB3' ' A' ' 154' ' ' ARG . 3.2 ptm85 -84.55 36.55 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.216 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -164.38 154.7 14.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.843 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.401 ' H ' ' H ' ' A' ' 160' ' ' LEU . 7.2 t -156.26 -12.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.153 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.401 ' H ' ' H ' ' A' ' 159' ' ' THR . 56.7 tp -126.93 151.44 48.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.088 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -61.36 132.39 53.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.535 ' N ' HD22 ' A' ' 162' ' ' LEU . 2.7 mm? -82.69 -154.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.596 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.428 ' HG2' HH11 ' A' ' 163' ' ' ARG . 51.9 ttt-85 -54.1 132.14 42.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.795 0.331 . . . . 0.0 110.686 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -58.47 131.24 50.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -130.43 142.28 50.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.967 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.77 HD23 ' H ' ' A' ' 166' ' ' LEU . 2.1 pt? -125.32 12.34 8.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.873 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.48 110.95 2.46 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.537 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.14 176.16 6.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.735 0.302 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.45 138.19 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.068 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -95.24 108.5 20.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.715 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -89.15 31.03 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.027 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -110.7 -104.45 2.82 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.473 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 53.7 m -126.19 -163.77 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.647 0.26 . . . . 0.0 110.838 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -78.45 146.27 34.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.834 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.449 ' OE1' ' N ' ' A' ' 175' ' ' GLN . 1.1 mp0 -83.14 106.83 15.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.7 m -85.29 139.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 13.3 tt -108.2 133.65 52.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.977 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -146.98 127.13 13.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -158.32 158.28 29.09 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.433 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -101.27 -13.12 18.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 110.618 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -60.5 -25.05 65.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.975 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.861 179.846 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.807 0.337 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -91.91 26.03 2.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.013 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -106.23 12.88 29.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.5 mt -93.14 -88.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.335 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.0 t -132.16 1.37 3.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.319 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.563 ' HB3' ' H ' ' A' ' 11' ' ' GLY . 19.7 pt-20 -97.47 88.26 4.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.941 0.401 . . . . 0.0 110.74 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -89.34 -64.39 1.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -90.39 -73.35 0.53 Allowed 'General case' 0 C--O 1.232 0.136 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.0 mm -91.63 -71.52 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-O 120.929 0.395 . . . . 0.0 111.896 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.97 119.91 0.87 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.932 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.563 ' H ' ' HB3' ' A' ' 6' ' ' GLU . . . -70.4 -1.23 34.82 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 177.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.636 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 7.5 mp -84.92 -27.68 26.43 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.751 -0.724 . . . . 0.0 111.341 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.604 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 7.9 tmtm? -56.39 -53.64 54.96 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.648 ' HA ' ' NZ ' ' A' ' 17' ' ' LYS . 88.7 tt0 -66.4 -43.82 84.75 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.982 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.759 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 29.0 tp -58.79 -23.04 59.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.729 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' HA ' ' CE1' ' A' ' 68' ' ' PHE . 37.9 t80 -76.02 -56.58 4.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.995 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.648 ' NZ ' ' HA ' ' A' ' 14' ' ' GLU . 25.2 pttm -71.52 -12.52 61.42 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.441 ' HB2' ' HA ' ' A' ' 15' ' ' LEU . 10.1 mtp -70.26 -37.98 75.02 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.199 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.704 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 3.3 mt -64.56 -57.6 10.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.997 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' A' ' 26' ' ' THR . 1.6 p30 -81.33 61.09 4.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.876 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.527 HG21 ' HD2' ' A' ' 38' ' ' ARG . 9.8 t -72.85 -14.51 61.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.333 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -138.21 -15.26 1.29 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.645 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 27.6 t-20 -64.18 -81.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.0 p -176.91 2.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.504 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.41 12.43 17.26 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 53.5 p -126.24 152.97 45.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.574 -0.813 . . . . 0.0 108.944 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.844 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 3.6 mt -110.0 103.22 15.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.665 HG22 ' OG1' ' A' ' 62' ' ' THR . 81.3 p -103.9 153.55 20.66 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.898 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.662 ' HZ ' ' HB3' ' A' ' 45' ' ' GLU . 59.8 t80 -34.12 -26.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 28' ' ' THR . 54.9 m-20 -80.5 -39.78 27.31 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.645 ' HG2' ' HB2' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -86.83 -29.6 22.12 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.531 178.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.701 ' CG ' HG23 ' A' ' 48' ' ' ILE . 2.1 tm? -39.91 -49.52 2.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.789 0.804 . . . . 0.0 109.644 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.813 ' HB3' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.24 -37.41 53.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.143 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.596 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 9.5 t70 -46.53 -27.73 1.2 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.08 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.704 ' HA2' ' HA ' ' A' ' 19' ' ' ILE . . . -55.92 -50.5 60.97 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.802 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.783 ' O ' HG12 ' A' ' 39' ' ' VAL . 2.2 mm? -92.59 -28.62 16.62 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.825 0.345 . . . . 0.0 110.766 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 34' ' ' ASP . 51.7 mtmt -56.94 -48.51 78.12 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.527 ' HD2' HG21 ' A' ' 21' ' ' THR . 25.8 ttt85 -59.74 -37.63 79.48 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.842 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -70.19 -21.99 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.811 -178.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.33 -27.11 4.28 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.052 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 74.1 m -65.03 154.54 37.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.689 0.28 . . . . 0.0 111.095 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -126.82 103.08 7.32 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.564 0.697 . . . . 0.0 111.241 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.827 HD13 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -111.61 166.87 10.79 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.397 -179.366 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.554 ' O ' HD13 ' A' ' 48' ' ' ILE . 17.3 ptt? -107.84 165.45 11.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.646 0.26 . . . . 0.0 110.829 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.694 ' HG3' ' HZ3' ' A' ' 33' ' ' LYS . 58.5 mp0 -51.82 -64.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.7 m -43.18 -17.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.517 ' HG3' ' HG3' ' A' ' 44' ' ' MET . 96.0 mt-10 -84.69 -41.59 16.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.827 HD11 HD13 ' A' ' 43' ' ' LEU . 1.5 mp -56.17 -49.77 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.44 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.54 ' CE ' ' HD3' ' A' ' 93' ' ' LYS . 4.3 ttmp? -57.95 -22.45 49.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.566 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.812 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 9.0 t70 -75.18 -25.7 58.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.622 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.779 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 62.4 tp -90.37 -30.89 17.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.05 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.775 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 39.1 ttm -88.02 -66.16 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.802 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.824 ' HA ' ' HG3' ' A' ' 59' ' ' LYS . 60.9 t0 -68.16 -38.77 82.45 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -86.75 -12.06 49.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.81 ' HB1' ' HA ' ' A' ' 71' ' ' ALA . . . -127.34 -44.12 1.58 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.65 ' HB3' ' O ' ' A' ' 52' ' ' MET . 63.2 t0 -53.97 132.67 42.69 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.2 mm -81.61 -14.75 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.805 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 60' ' ' SER . 74.0 m-20 -128.21 28.62 5.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.762 -178.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.824 ' HG3' ' HA ' ' A' ' 53' ' ' ASP . 12.1 tmtt? -31.61 90.68 0.0 OUTLIER 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.937 0.875 . . . . 0.0 112.137 -177.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 58' ' ' ASP . 80.7 p -128.26 18.39 6.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.519 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 81.72 15.42 75.61 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.65 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.715 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 40.4 m -155.82 128.47 7.87 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.494 0.318 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.844 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 52.9 mt -110.86 136.47 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 121.178 0.513 . . . . 0.0 110.941 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -104.6 168.96 8.74 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.161 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.604 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 26.6 t80 -40.6 -39.26 1.01 Allowed 'General case' 0 CA--C 1.519 -0.213 0 O-C-N 123.42 0.45 . . . . 0.0 111.093 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.9 -57.78 4.31 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.922 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.84 ' HB2' HG23 ' A' ' 63' ' ' ILE . 34.4 mt-10 -49.79 -20.77 0.92 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.851 0.358 . . . . 0.0 110.242 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.759 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 68.6 t80 -69.89 -57.26 5.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.389 0.614 . . . . 0.0 110.653 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.464 HG23 HD22 ' A' ' 12' ' ' LEU . 1.2 mt -63.54 -40.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.16 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 74' ' ' HIS . . . -68.92 -6.58 28.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.043 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.81 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . . . -90.74 -28.27 18.4 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.495 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.1 p -95.66 -54.22 3.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.822 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.734 HG22 ' HE2' ' A' ' 77' ' ' LYS . 9.8 p -56.86 -15.61 3.04 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.133 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.76 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.532 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 30.6 t-80 -69.37 -48.29 61.71 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.1 mt -64.68 -13.21 53.25 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.182 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.16 75.34 1.0 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.08 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.734 ' HE2' HG22 ' A' ' 73' ' ' VAL . 71.0 mmtt -154.12 -152.32 0.4 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.797 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.9 mm? -76.13 90.19 3.08 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -41.76 -22.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.299 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -48.16 154.72 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.666 0.27 . . . . 0.0 110.932 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -53.08 153.69 3.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.408 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -95.39 -155.75 0.48 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.04 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.1 m-80 -80.19 -164.74 0.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.421 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -90.09 -27.94 19.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.547 -179.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.665 ' N ' HD22 ' A' ' 84' ' ' LEU . 9.0 p -73.93 -19.86 17.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.685 0.278 . . . . 0.0 110.999 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 m -48.9 -30.37 5.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.396 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -81.53 -52.2 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.241 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.829 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 11.9 t80 -42.81 -26.5 0.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.278 0.561 . . . . 0.0 109.854 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.41 ' N ' ' C ' ' A' ' 87' ' ' ALA . 31.7 t -89.22 -58.33 2.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.952 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -77.03 -63.84 1.27 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.398 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.692 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.6 m-85 -55.47 -61.84 2.07 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.829 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 1.0 OUTLIER -74.55 60.41 0.88 Allowed 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.54 ' HD3' ' CE ' ' A' ' 49' ' ' LYS . 26.3 ttmt -47.61 -41.63 22.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.037 -177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.481 ' HB2' 'CA ' ' A' ' 191' ' ' ' CA' . 1.4 m-20 -79.73 -21.15 44.9 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.919 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . 65.06 -6.16 1.09 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.971 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 94' ' ' ASP . 86.1 p -55.7 -8.28 0.38 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.886 0.374 . . . . 0.0 110.894 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 108.17 -0.49 33.31 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.729 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.782 ' HB3' ' NE2' ' A' ' 132' ' ' GLN . 0.6 OUTLIER -139.24 154.1 47.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.675 0.75 . . . . 0.0 112.818 -178.649 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.692 HD13 ' HB3' ' A' ' 91' ' ' PHE . 85.9 mt -132.15 102.95 6.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.345 177.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.522 ' HA ' ' CB ' ' A' ' 132' ' ' GLN . 67.8 p -87.02 163.74 16.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.947 0.794 . . . . 0.0 111.226 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 101' ' ' LEU . 0.5 OUTLIER -35.95 -36.99 0.09 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.105 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.3 -54.15 44.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.905 0.383 . . . . 0.0 110.111 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.412 ' CB ' HG23 ' A' ' 99' ' ' ILE . 52.1 mt-10 -62.66 -31.42 72.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.143 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.666 HG22 ' N ' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -75.39 -64.97 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.666 ' N ' HG22 ' A' ' 104' ' ' ILE . 14.6 mt-30 -54.4 -31.88 56.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.688 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -73.19 -47.33 44.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.044 0.45 . . . . 0.0 110.078 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.82 -2.99 2.89 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.161 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 105' ' ' GLN . 24.2 p -135.58 39.66 2.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.094 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -67.54 -23.05 65.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.956 0.408 . . . . 0.0 110.477 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.36 -6.59 59.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.599 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -91.48 14.27 15.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.851 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.92 37.57 56.63 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.078 -1.058 . . . . 0.0 111.875 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.828 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -34.55 117.25 0.35 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.371 0.605 . . . . 0.0 112.042 -178.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.668 ' N ' HD22 ' A' ' 113' ' ' LEU . 54.5 m-20 -154.58 -177.09 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.027 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.744 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 12.3 p-10 -84.07 -7.65 59.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.436 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.6 mm -83.38 -64.77 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.433 ' O ' ' HB2' ' A' ' 121' ' ' MET . 4.6 m-70 -91.91 -68.5 0.79 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.828 HG13 ' HA ' ' A' ' 113' ' ' LEU . 40.5 mm -52.09 -20.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.214 -177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.744 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 8.1 t70 -76.5 -60.94 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 124' ' ' GLU . 33.9 m-20 -58.42 -17.09 17.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.762 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 14.2 ttp -67.51 -46.84 71.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.584 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.626 HG22 ' HA3' ' A' ' 131' ' ' GLY . 59.9 mt -48.74 -41.48 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 176.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 24.4 mmtp -87.36 -19.84 27.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.308 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.762 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 4.8 tp10 -76.12 -16.31 59.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.568 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.794 HG21 HD13 ' A' ' 133' ' ' ILE . 1.2 mt -117.15 -34.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.033 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.758 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 22.8 t70 -55.27 93.32 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.113 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.526 ' NE2' ' HA ' ' A' ' 137' ' ' GLU . 17.8 mt-30 -83.81 -9.27 58.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.009 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.511 ' O ' ' HE3' ' A' ' 156' ' ' MET . 6.6 p-10 -131.65 -30.6 1.63 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.753 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -176.79 -80.42 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 118.277 2.695 . . . . 0.0 118.277 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.753 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 15.7 m-20 -64.08 27.41 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -172.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.758 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 54.95 37.69 63.24 Favored Glycine 0 CA--C 1.498 -1.004 0 C-N-CA 118.184 -1.96 . . . . 0.0 108.893 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.782 ' NE2' ' HB3' ' A' ' 98' ' ' TYR . 12.7 pt20 -135.17 166.26 23.5 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.375 -0.912 . . . . 0.0 110.841 -176.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.794 HD13 HG21 ' A' ' 125' ' ' ILE . 4.4 mt -121.54 125.28 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.353 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -103.97 165.54 10.98 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.676 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 30.5 t80 -49.84 -24.42 2.43 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.763 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.633 ' C ' ' HB2' ' A' ' 153' ' ' ARG . . . -77.88 -44.87 11.28 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 177.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.536 ' HG3' ' OD1' ' A' ' 134' ' ' ASP . 42.1 mt-10 -62.08 -62.75 1.56 Allowed 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.731 ' HD1' HG21 ' A' ' 133' ' ' ILE . 1.9 t80 -56.38 -32.63 64.97 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.2 -0.6 . . . . 0.0 112.111 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.74 -23.07 49.42 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.143 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 144' ' ' LYS . . . -89.71 -51.2 5.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.037 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.543 ' SD ' ' HA ' ' A' ' 138' ' ' PHE . 27.3 ptm -49.11 -22.91 1.04 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.58 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 63.3 mtm -103.25 -20.58 14.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.868 0.366 . . . . 0.0 110.695 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.521 HH21 ' HE3' ' A' ' 146' ' ' LYS . 71.1 mtp180 -126.94 43.14 3.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.818 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 140' ' ' ALA . 29.2 mtpp -62.78 -57.69 10.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.347 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.598 ' O ' ' HD3' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -47.0 -26.48 1.03 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.774 -179.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.521 ' HE3' HH21 ' A' ' 143' ' ' ARG . 66.3 tttm -80.51 76.1 7.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.595 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -62.73 -4.42 7.08 Favored Glycine 0 C--N 1.33 0.214 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.962 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.439 ' HB2' ' NZ ' ' A' ' 146' ' ' LYS . 2.9 m120 -47.07 156.1 0.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.017 0.436 . . . . 0.0 111.465 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -65.3 -4.85 18.64 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.128 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -65.72 -5.18 23.0 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.86 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.642 HG12 ' H ' ' A' ' 152' ' ' GLY . 12.5 tt -63.59 177.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.642 ' H ' HG12 ' A' ' 151' ' ' ILE . . . -152.34 -21.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.338 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.822 ' HE ' ' H ' ' A' ' 154' ' ' ARG . 4.2 tpm_? -72.55 168.84 17.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.066 0.46 . . . . 0.0 110.585 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.822 ' H ' ' HE ' ' A' ' 153' ' ' ARG . 38.8 ttt-85 -73.51 148.35 43.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.849 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 69.0 p -46.51 -17.57 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.698 ' HG3' HH11 ' A' ' 154' ' ' ARG . 63.8 mtm -74.39 13.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.548 0.213 . . . . 0.0 111.446 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 154' ' ' ARG . 3.9 ppt_? -84.52 33.6 0.51 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 0.0 111.224 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -58.53 176.43 0.19 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.26 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 86.6 m -56.69 151.0 14.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.81 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.499 HD11 ' OE1' ' A' ' 124' ' ' GLU . 59.6 tp -56.21 99.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.461 ' C ' HD22 ' A' ' 162' ' ' LEU . 75.2 m-80 -148.26 81.12 1.47 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.06 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.481 ' N ' HD22 ' A' ' 162' ' ' LEU . 3.1 mm? -115.8 -69.56 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.797 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -139.87 104.37 4.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.867 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -122.43 130.25 52.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.703 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.9 124.92 28.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.079 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 166' ' ' LEU . 2.2 pt? -127.12 -10.54 5.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.609 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -178.41 -117.89 0.54 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.321 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 92.3 mt -109.27 105.39 14.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 0.0 110.75 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -109.67 142.22 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.012 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -68.62 134.65 50.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -102.07 -44.11 5.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.76 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.72 138.73 44.78 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.571 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 78.1 p -132.61 -170.84 2.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.849 0.357 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -138.25 -37.69 0.56 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.689 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -136.4 -176.16 4.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.776 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.4 m -90.13 134.53 28.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.974 0.416 . . . . 0.0 111.169 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 68.3 mt -113.72 113.0 42.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.951 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -121.07 153.57 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.68 165.61 52.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.372 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -119.23 129.77 55.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.871 0.367 . . . . 0.0 110.753 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.62 -168.36 2.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.267 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.971 -179.897 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ' CA' . . . . . 0.481 'CA ' ' HB2' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.808 0.337 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -134.36 46.29 2.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 53.1 mtm-85 -90.63 -0.06 57.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.75 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.4 tp -71.73 -37.61 70.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.293 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.0 p -132.53 169.43 16.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.054 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -135.75 -164.19 1.51 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.774 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -77.4 -12.84 60.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.97 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -56.78 -34.42 67.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.148 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.6 mm -65.55 -23.78 33.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.317 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.77 160.74 15.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.659 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.56 25.89 65.86 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.282 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.498 ' C ' HD13 ' A' ' 12' ' ' LEU . 3.2 tm? -87.73 -50.48 6.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.088 . . . . 0.0 110.771 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -51.99 -38.96 58.56 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.101 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.696 ' O ' ' HG2' ' A' ' 18' ' ' MET . 38.6 tt0 -70.94 -49.72 42.53 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.635 ' HA ' ' HB2' ' A' ' 18' ' ' MET . 55.5 tp -47.99 -33.12 7.39 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.037 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.489 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 32.1 t80 -60.05 -50.33 74.15 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.151 0.5 . . . . 0.0 110.927 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -79.95 -15.6 56.95 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.094 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.696 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 81.4 mmm -69.51 -28.73 66.29 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.363 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.72 HG21 HG23 ' A' ' 27' ' ' ILE . 0.9 OUTLIER -69.36 -59.11 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.636 179.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.765 ' HB3' ' O ' ' A' ' 26' ' ' THR . 2.1 p30 -80.84 45.66 0.83 Allowed 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.932 0.873 . . . . 0.0 111.771 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.643 HG21 ' HD2' ' A' ' 38' ' ' ARG . 15.1 t -66.0 -6.53 13.05 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.986 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.57 -7.17 2.87 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.443 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 24.2 t-20 -91.83 -93.86 0.14 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.698 -0.401 . . . . 0.0 112.063 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.6 p -177.36 14.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.498 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.47 17.17 9.49 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.185 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.765 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 74.0 p -125.17 158.98 32.62 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.879 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 1.6 mt -123.09 101.66 9.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.679 HG22 ' HB ' ' A' ' 62' ' ' THR . 76.7 p -103.28 156.87 17.41 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.385 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.43 ' HZ ' ' HB3' ' A' ' 45' ' ' GLU . 60.3 t80 -33.65 -38.49 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.98 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 9.6 t70 -71.18 -43.9 66.52 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 111.243 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -79.43 -27.72 41.7 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.65 178.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.045 HD12 HD12 ' A' ' 48' ' ' ILE . 1.6 tm? -50.75 -55.08 18.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.129 0.49 . . . . 0.0 109.965 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.587 ' HB3' HD11 ' A' ' 48' ' ' ILE . 1.1 ptmm? -77.02 -39.04 51.67 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.119 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 38.8 t70 -41.73 -41.18 2.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.562 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.99 91.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.443 -0.408 . . . . 0.0 114.097 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.826 HD22 HD11 ' A' ' 43' ' ' LEU . 2.2 mp -89.26 -45.07 9.81 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 41' ' ' SER . 17.4 ptpt -59.12 -21.92 60.04 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.643 ' HD2' HG21 ' A' ' 21' ' ' THR . 36.8 ttt-85 -79.57 -40.56 29.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.39 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 36' ' ' LEU . 2.9 p -78.98 -12.96 13.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.72 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.54 -44.62 1.19 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.375 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 69.4 m -52.96 161.9 0.71 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.681 0.277 . . . . 0.0 111.525 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -134.24 105.1 6.46 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.606 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.826 HD11 HD22 ' A' ' 36' ' ' LEU . 68.7 mt -108.42 166.15 10.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.007 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.431 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 32.1 mtm -109.21 165.7 11.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.773 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HB3' ' HZ ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -55.47 -59.79 4.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.128 -179.309 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.7 m -55.09 -17.6 4.28 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.924 0.329 . . . . 0.0 111.737 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 59.4 mm-40 -79.69 -48.42 13.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.045 HD12 HD12 ' A' ' 32' ' ' LEU . 6.1 mm -56.86 -51.96 61.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.915 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -46.97 -33.16 4.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.006 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 63.9 t0 -60.3 -45.31 93.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.484 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.838 HD12 HD11 ' A' ' 32' ' ' LEU . 67.3 mt -67.07 -14.77 63.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.604 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -87.6 -65.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.04 0.448 . . . . 0.0 111.804 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.66 -37.13 70.84 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -91.28 -13.63 32.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.16 -43.56 1.64 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.614 ' OD1' HG12 ' A' ' 63' ' ' ILE . 34.0 t70 -62.25 103.6 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.857 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.0 mm -43.35 -27.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.286 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.584 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 59.6 m-20 -133.63 44.66 2.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.035 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.604 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 1.2 tmtp? -31.99 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.819 0.818 . . . . 0.0 112.339 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.0 p -126.81 10.54 7.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.165 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 103.63 -15.31 53.11 Favored Glycine 0 C--O 1.238 0.35 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.597 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.876 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 5.4 t -140.49 148.81 41.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.67 0.272 . . . . 0.0 110.88 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.879 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 78.6 mt -108.88 142.42 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.03 0.443 . . . . 0.0 111.244 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -105.69 166.78 10.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.971 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.653 ' O ' HG13 ' A' ' 69' ' ' ILE . 31.2 t80 -40.58 -48.91 2.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.794 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.34 -59.17 7.03 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.783 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.673 ' HB2' HG23 ' A' ' 63' ' ' ILE . 48.9 mt-10 -45.47 -31.9 1.95 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.804 0.335 . . . . 0.0 110.726 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 16' ' ' PHE . 9.9 t80 -66.06 -55.0 18.82 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.378 0.609 . . . . 0.0 110.152 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.653 HG13 ' O ' ' A' ' 65' ' ' TYR . 10.8 mt -57.06 -65.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.061 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 74' ' ' HIS . . . -44.85 -48.33 11.08 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.557 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.649 ' HB1' ' HB1' ' A' ' 55' ' ' ALA . . . -41.03 -42.59 1.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.455 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.9 p -69.71 -33.04 71.96 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.426 HG12 ' NZ ' ' A' ' 77' ' ' LYS . 46.7 t -95.89 -14.29 7.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.564 0.697 . . . . 0.0 110.328 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 70' ' ' ALA . 18.1 t-160 -83.44 -49.48 9.26 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.889 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.786 ' HB2' ' HD2' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -57.99 -14.54 6.66 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.324 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.464 ' N ' HD23 ' A' ' 75' ' ' LEU . 26.3 t-20 -110.94 74.97 0.9 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.689 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.426 ' NZ ' HG12 ' A' ' 73' ' ' VAL . 60.7 mttp -158.41 -94.93 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.549 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -168.04 67.64 0.08 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.652 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -63.64 98.08 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.867 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.466 HH11 ' HG3' ' A' ' 80' ' ' ARG . 38.2 ttt85 -101.38 144.89 29.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.897 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.54 161.49 16.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.825 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -94.94 -84.03 0.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -84.92 -166.41 1.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.791 HD23 ' H ' ' A' ' 84' ' ' LEU . 2.6 pt? -90.32 -42.8 10.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.456 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 6.4 p -54.73 -30.88 23.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.4 m -56.46 -37.43 70.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.127 0.489 . . . . 0.0 109.797 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.531 ' HB1' ' HB2' ' A' ' 91' ' ' PHE . . . -82.66 -47.92 11.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.064 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.769 ' HA ' ' HB2' ' A' ' 92' ' ' ASP . 21.7 t80 -41.85 -30.0 0.23 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.551 0.691 . . . . 0.0 109.65 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -89.9 -47.58 7.78 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.194 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -84.99 -63.88 1.25 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.271 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.606 ' HB3' HD13 ' A' ' 99' ' ' ILE . 4.1 m-85 -56.53 -56.5 20.45 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.813 ' HA ' HG12 ' A' ' 99' ' ' ILE . 0.4 OUTLIER -77.81 54.69 1.29 Allowed 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.624 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 3.7 ttmp? -49.07 -38.28 23.77 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.778 -177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.406 ' HB3' 'CA ' ' A' ' 191' ' ' ' CA' . 8.6 t70 -75.43 -23.06 56.92 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.777 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.74 73.07 0.31 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.415 ' HG ' ' HD1' ' A' ' 98' ' ' TYR . 25.4 p -132.1 -28.59 1.72 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 134' ' ' ASP . . . 134.56 7.13 2.2 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 113.925 -1.488 . . . . 0.0 113.037 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.831 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -150.87 160.73 43.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.451 0.643 . . . . 0.0 111.362 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.813 HG12 ' HA ' ' A' ' 92' ' ' ASP . 70.1 mt -133.96 102.78 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.884 178.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 103' ' ' GLU . 72.9 p -73.14 150.93 41.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.347 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.599 HD23 ' H ' ' A' ' 101' ' ' LEU . 0.3 OUTLIER -35.03 -34.25 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -62.13 -51.69 66.86 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.539 ' HB2' HG23 ' A' ' 99' ' ' ILE . 53.9 mt-10 -71.13 -29.44 65.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.954 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.778 HG13 HG22 ' A' ' 99' ' ' ILE . 27.1 mt -68.39 -64.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.981 0.42 . . . . 0.0 110.395 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.716 ' O ' HD23 ' A' ' 113' ' ' LEU . 81.8 mt-30 -55.49 -39.57 70.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.456 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -65.31 -31.93 73.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.048 0.451 . . . . 0.0 110.447 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.73 -4.09 3.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.145 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 111' ' ' PHE . 9.8 p -105.04 118.27 36.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.133 0.492 . . . . 0.0 110.587 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.786 ' HD2' ' HB2' ' A' ' 75' ' ' LEU . 38.2 ttpt -88.82 -61.32 1.73 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.257 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.88 -4.45 58.47 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.596 ' HB2' ' HB2' ' A' ' 108' ' ' CYS . 2.8 m-85 -65.71 -18.15 65.12 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.501 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.59 38.95 97.25 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.611 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.999 ' HA ' HG13 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -33.27 149.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.646 ' OD2' HG22 ' A' ' 116' ' ' ILE . 26.7 t70 -160.48 178.89 9.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.185 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.433 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 53.6 p-10 -89.38 -8.45 53.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.921 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.646 HG22 ' OD2' ' A' ' 114' ' ' ASP . 6.6 tp -92.53 -57.6 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.545 ' N ' HG23 ' A' ' 116' ' ' ILE . 10.0 t-80 -91.47 -68.65 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.999 HG13 ' HA ' ' A' ' 113' ' ' LEU . 46.9 mm -54.02 -19.61 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.968 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.492 ' HA ' ' NE2' ' A' ' 105' ' ' GLN . 38.5 t70 -66.91 -41.9 86.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 124' ' ' GLU . 7.4 t70 -71.2 -26.04 62.78 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.943 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 3.7 ttt -57.77 -30.26 65.5 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.161 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.552 ' HB ' ' HD2' ' A' ' 123' ' ' LYS . 58.9 mt -58.84 -43.95 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.681 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 3.7 mptt -86.64 -13.32 45.93 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 113.271 -1.786 . . . . 0.0 110.351 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.943 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 36.5 tp10 -82.14 -27.77 32.55 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.753 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.719 HG22 ' CD1' ' A' ' 133' ' ' ILE . 45.0 mt -100.41 -33.88 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.278 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.721 ' CG ' ' H ' ' A' ' 131' ' ' GLY . 7.3 t70 -83.47 84.92 7.34 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.41 0.624 . . . . 0.0 110.318 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.533 ' CD ' ' H ' ' A' ' 127' ' ' GLN . 2.9 pm0 -88.09 -9.29 53.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.806 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.659 ' HB3' ' OE1' ' A' ' 137' ' ' GLU . 5.6 t70 -130.17 -19.52 3.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 -177.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.573 HD22 ' HG2' ' A' ' 132' ' ' GLN . 15.3 t30 -115.37 -127.19 0.29 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -177.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.421 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 9.5 t0 -116.61 27.04 9.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -173.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.721 ' H ' ' CG ' ' A' ' 126' ' ' ASP . . . 94.65 37.11 5.37 Favored Glycine 0 CA--C 1.501 -0.836 0 N-CA-C 108.258 -1.937 . . . . 0.0 108.258 -177.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.699 ' NE2' ' HB3' ' A' ' 98' ' ' TYR . 8.4 pt20 -153.72 169.21 23.88 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.172 -1.514 . . . . 0.0 108.966 -177.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.719 ' CD1' HG22 ' A' ' 125' ' ' ILE . 25.9 mm -131.33 127.01 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.177 0 CA-C-O 121.68 0.752 . . . . 0.0 111.067 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.831 ' HA ' ' HA ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -102.09 160.51 14.45 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.208 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.736 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 24.4 t80 -41.64 -33.95 0.54 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.576 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 153' ' ' ARG . . . -82.75 -35.54 18.89 Favored Glycine 0 N--CA 1.436 -1.32 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.855 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.659 ' OE1' ' HB3' ' A' ' 128' ' ' ASP . 61.2 mm-40 -62.11 -57.03 13.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.289 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.696 ' HD1' HG21 ' A' ' 133' ' ' ILE . 2.7 t80 -61.09 -38.37 86.02 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.14 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 142' ' ' MET . . . -58.71 -33.82 70.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.163 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.525 ' HB3' ' HA2' ' A' ' 152' ' ' GLY . . . -90.72 -26.87 19.32 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.43 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.529 ' HG2' ' CD1' ' A' ' 138' ' ' PHE . 2.8 ppp? -51.6 -28.0 12.87 Favored 'General case' 0 C--N 1.346 0.425 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.653 ' HG3' ' H ' ' A' ' 143' ' ' ARG . 17.1 ptp -105.13 -111.13 0.27 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.653 ' H ' ' HG3' ' A' ' 142' ' ' MET . 0.0 OUTLIER -176.4 146.16 0.61 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.701 0.763 . . . . 0.0 112.273 175.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.609 ' HZ1' ' HA ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -155.37 -73.29 0.11 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.081 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.469 ' NE ' ' HA ' ' A' ' 145' ' ' ARG . 9.9 mmp_? -104.66 -45.8 4.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.307 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -113.29 119.89 39.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.225 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -90.82 -4.44 69.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.446 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.55 ' ND2' ' H ' ' A' ' 150' ' ' GLY . 0.7 OUTLIER -46.65 112.22 0.48 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.971 0.386 . . . . 0.0 110.425 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -78.37 -17.61 77.57 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.845 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.55 ' H ' ' ND2' ' A' ' 148' ' ' ASN . . . -78.68 -20.27 71.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.596 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 5.0 mt -139.4 153.49 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 CA-C-O 121.105 0.479 . . . . 0.0 111.164 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.525 ' HA2' ' HB3' ' A' ' 140' ' ' ALA . . . -99.93 -132.07 7.59 Favored Glycine 0 N--CA 1.427 -1.938 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 176.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.65 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 78.3 mtp180 -142.01 80.67 1.72 Allowed 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.417 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.657 ' HE ' HG22 ' A' ' 155' ' ' THR . 11.3 tpt180 -111.33 145.12 39.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.298 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.657 HG22 ' HE ' ' A' ' 154' ' ' ARG . 6.6 t -46.67 -40.2 12.75 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.253 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.516 ' HG3' HG23 ' A' ' 155' ' ' THR . 68.7 mtm -111.5 83.84 1.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.348 . . . . 0.0 110.687 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.419 ' HA ' ' OD2' ' A' ' 128' ' ' ASP . 84.3 mtm180 -72.26 141.0 48.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -166.33 134.44 2.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.726 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.0 m -97.71 98.47 9.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.78 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.433 HD23 ' C ' ' A' ' 160' ' ' LEU . 6.4 tt -145.94 101.75 3.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.371 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -171.49 138.37 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 87.2 mt -84.67 147.11 27.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.781 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -89.64 141.25 28.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.754 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -61.84 124.08 19.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.767 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.25 121.32 10.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.122 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 62.3 tp -80.79 -24.76 38.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -124.76 -116.68 2.18 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.575 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.6 mt -68.91 156.15 39.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.909 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.55 134.96 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.053 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.53 -166.95 1.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -96.92 -45.88 6.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.983 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 67.75 -174.33 28.88 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.438 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.6 t -150.82 -80.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.667 0.27 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -166.09 67.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.407 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -114.71 98.16 6.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.88 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 35.7 m -66.32 139.53 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.213 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.0 mm -120.2 102.93 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.827 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -103.19 104.66 14.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.491 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 175.13 74.36 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.529 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -91.53 32.69 1.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.349 . . . . 0.0 110.647 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -76.86 -51.34 11.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.969 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.8 ' HE2' ' HA ' ' A' ' 182' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.814 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ' CA' . . . . . 0.406 'CA ' ' HB3' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.826 0.346 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -102.75 90.32 3.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.825 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -126.16 21.91 7.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.732 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.738 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.1 pt? -130.24 18.7 5.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 79.0 p -92.28 -36.36 13.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -121.02 74.65 1.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.029 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.444 ' OE2' ' HA ' ' A' ' 4' ' ' LEU . 56.2 mm-40 -89.04 -12.68 40.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.927 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.758 ' HG3' ' H ' ' A' ' 9' ' ' ILE . 16.8 pt-20 -76.08 -71.44 0.38 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.837 HG13 ' H ' ' A' ' 10' ' ' GLY . 9.2 pt -90.96 -71.83 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.837 ' H ' HG13 ' A' ' 9' ' ' ILE . . . -168.89 166.11 39.42 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.41 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.28 24.81 2.44 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.492 ' H ' ' C ' ' A' ' 10' ' ' GLY . 96.3 mt -51.93 -21.06 2.69 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.528 ' HA ' ' HE1' ' A' ' 65' ' ' TYR . 4.5 ttmp? -59.58 -51.35 70.21 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.659 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 84.8 tt0 -62.05 -30.73 71.18 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.134 178.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.72 ' HG ' ' HZ ' ' A' ' 68' ' ' PHE . 40.4 tp -68.86 -30.33 68.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.662 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.415 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 22.0 t80 -68.16 -49.48 60.68 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.223 0.535 . . . . 0.0 110.333 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' A' ' 14' ' ' GLU . 60.2 pttt -75.66 -12.91 60.29 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.57 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 2.3 tpp -66.03 -28.91 69.22 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.862 177.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.585 HD12 HD13 ' A' ' 27' ' ' ILE . 3.3 mt -81.26 -55.01 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.052 178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.583 ' OD1' ' HA ' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -82.71 62.8 6.51 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.775 0.798 . . . . 0.0 111.292 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 t -81.81 -11.75 58.83 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.173 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.3 p30 -138.36 -11.43 1.42 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -72.25 -81.92 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.143 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 p -175.8 5.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.684 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.58 20.94 7.07 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.51 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 68.5 p -139.22 150.63 45.76 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.042 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.714 ' O ' ' HA ' ' A' ' 62' ' ' THR . 3.8 mt -104.16 103.35 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.697 HG22 ' OG1' ' A' ' 62' ' ' THR . 71.2 p -104.31 162.55 13.11 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.492 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -34.11 -35.95 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 122.942 0.497 . . . . 0.0 111.821 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -77.36 -41.15 41.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 110.759 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.575 ' HG3' HG22 ' A' ' 19' ' ' ILE . 11.4 tp10 -77.09 -30.55 55.43 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.429 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.893 HD12 HG13 ' A' ' 48' ' ' ILE . 0.9 OUTLIER -41.18 -48.73 3.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.981 0.895 . . . . 0.0 109.732 -179.294 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.835 ' HB3' HD11 ' A' ' 43' ' ' LEU . 6.0 ptpt -85.15 -30.87 23.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.886 -1.507 . . . . 0.0 111.624 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' A' ' 38' ' ' ARG . 9.1 t70 -46.62 -46.1 19.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.345 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.15 -37.55 95.09 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.008 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.836 ' HG ' HD23 ' A' ' 43' ' ' LEU . 3.8 mm? -71.62 -58.18 3.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.574 ' NZ ' ' HE2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -58.58 -26.88 64.08 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.108 0.48 . . . . 0.0 110.41 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 56.4 ttt-85 -59.16 -49.45 77.81 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.397 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 36' ' ' LEU . 3.3 m -77.46 -14.25 14.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.33 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.89 -19.99 8.23 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.971 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' LYS . 49.2 m -55.69 153.77 7.66 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.749 0.275 . . . . 0.0 110.963 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -131.64 104.17 6.79 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.446 0.641 . . . . 0.0 112.04 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.836 HD23 ' HG ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -116.58 167.6 10.92 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.865 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.493 ' CE ' ' HB2' ' A' ' 86' ' ' SER . 27.0 ptt? -109.67 165.22 11.85 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.516 0.198 . . . . 0.0 110.562 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 48' ' ' ILE . 0.7 OUTLIER -50.19 -55.63 14.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.554 ' OG ' ' HB2' ' A' ' 87' ' ' ALA . 44.5 t -48.53 -24.27 1.25 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.477 ' HG2' ' OG ' ' A' ' 86' ' ' SER . 49.2 mt-10 -71.15 -36.2 71.97 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.893 HG13 HD12 ' A' ' 32' ' ' LEU . 1.9 mp -66.42 -60.61 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.747 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.448 ' HE3' ' CE1' ' A' ' 111' ' ' PHE . 22.1 ttmm -54.5 -31.26 55.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.489 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 35.8 t70 -70.9 -45.18 64.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.244 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.867 HD23 HD21 ' A' ' 32' ' ' LEU . 36.0 tp -66.35 -16.56 64.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.529 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.677 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 23.5 mmt -85.45 -60.85 1.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.291 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -76.12 -39.32 55.4 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.859 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 50' ' ' ASP . . . -82.72 -19.08 38.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 51' ' ' LEU . . . -127.51 -43.98 1.56 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.656 ' HB3' ' O ' ' A' ' 52' ' ' MET . 33.3 t70 -60.26 107.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.214 0.531 . . . . 0.0 110.199 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.452 HD11 ' CB ' ' A' ' 70' ' ' ALA . 7.1 mt -49.45 -25.08 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.676 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.528 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 74.8 m-20 -130.4 44.03 3.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.023 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.677 ' HG2' ' HB3' ' A' ' 52' ' ' MET . 1.3 tmtp? -31.98 92.3 0.01 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.798 0.808 . . . . 0.0 112.468 -177.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' ASP . 82.8 p -128.0 10.46 6.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.796 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' THR . . . 81.45 17.33 71.46 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.601 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 53.2 m -153.94 127.19 8.48 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.42 0.288 . . . . 0.0 110.371 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.661 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 64.2 mt -107.5 132.44 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.034 0.445 . . . . 0.0 111.479 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -105.19 168.15 9.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.3 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.528 ' HE1' ' HA ' ' A' ' 13' ' ' LYS . 28.4 t80 -35.82 -48.23 0.54 Allowed 'General case' 0 N--CA 1.464 0.23 0 O-C-N 123.296 0.372 . . . . 0.0 111.913 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.92 -64.0 3.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.709 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.636 ' HB2' HG23 ' A' ' 63' ' ' ILE . 63.7 mt-10 -50.57 -26.18 4.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.764 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HZ ' ' HG ' ' A' ' 15' ' ' LEU . 68.2 t80 -62.0 -61.85 2.19 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.48 0.657 . . . . 0.0 110.894 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.569 HD13 ' HD2' ' A' ' 68' ' ' PHE . 10.4 mm -55.07 -50.62 61.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.777 -178.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.452 ' CB ' HD11 ' A' ' 57' ' ' ILE . . . -62.31 -12.5 21.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.936 0.398 . . . . 0.0 111.261 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.597 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -95.11 -53.68 3.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.447 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 76' ' ' ASN . 77.9 p -61.54 -47.87 83.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.205 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.591 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 59.5 t -52.09 -29.86 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -72.21 -40.47 67.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 75' ' ' LEU . 6.9 mp -90.47 4.49 50.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.005 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.591 ' HB3' ' HA ' ' A' ' 73' ' ' VAL . 44.8 t30 -95.26 75.21 3.39 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.8 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.551 ' C ' HD22 ' A' ' 78' ' ' LEU . 31.7 mmmt -143.97 -40.69 0.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.43 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.551 HD22 ' C ' ' A' ' 77' ' ' LYS . 3.3 mm? -125.4 107.05 10.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.035 179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -44.2 -34.74 1.97 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.475 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -96.28 102.39 14.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.685 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -102.61 32.01 3.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.133 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -74.13 95.24 2.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.783 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.478 ' HB2' HG22 ' A' ' 85' ' ' VAL . 17.9 p30 -158.73 125.67 4.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.143 0.497 . . . . 0.0 111.447 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.567 HD22 ' C ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -74.98 -17.37 60.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.659 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.478 HG22 ' HB2' ' A' ' 83' ' ' ASN . 22.0 m -47.31 -19.07 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.641 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.493 ' HB2' ' CE ' ' A' ' 44' ' ' MET . 53.1 m -34.98 -65.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.15 0.281 . . . . 0.0 111.701 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.672 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . . . -73.29 -38.55 65.84 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.69 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 25.4 t80 -43.16 -23.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.913 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.1 t -88.88 -42.53 11.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.737 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -82.76 -62.92 1.47 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.592 ' HB3' HD13 ' A' ' 99' ' ' ILE . 2.9 m-85 -53.61 -62.82 1.41 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.465 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.605 ' HA ' HG12 ' A' ' 99' ' ' ILE . 1.2 m-20 -79.0 50.16 1.0 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 89' ' ' SER . 37.3 ttmt -36.66 -59.81 0.64 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.629 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -83.48 -20.93 33.11 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.705 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.25 85.69 0.01 OUTLIER Glycine 0 N--CA 1.424 -2.156 0 CA-C-O 121.713 0.618 . . . . 0.0 112.887 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.4 p -100.58 -14.62 18.11 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 124.44 -4.02 8.8 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 111.526 -2.579 . . . . 0.0 110.942 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.689 ' HA ' ' HA ' ' A' ' 134' ' ' ASP . 0.1 OUTLIER -147.9 165.67 29.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.764 -0.718 . . . . 0.0 110.746 178.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.696 HG23 ' HB2' ' A' ' 103' ' ' GLU . 72.4 mt -131.75 104.15 8.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.512 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 102' ' ' ASP . 71.5 p -72.12 147.08 47.03 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.702 HD23 ' H ' ' A' ' 101' ' ' LEU . 0.3 OUTLIER -34.27 -29.76 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 106' ' ' GLN . 34.6 t70 -57.16 -56.59 19.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.696 ' HB2' HG23 ' A' ' 99' ' ' ILE . 48.7 mt-10 -69.47 -32.29 71.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.163 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -61.39 -50.07 81.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.179 0.514 . . . . 0.0 110.723 179.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.588 ' CD ' HD11 ' A' ' 122' ' ' ILE . 41.3 mt-30 -71.94 -49.45 37.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.031 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 102' ' ' ASP . 87.0 mt-30 -55.83 -41.84 74.85 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.837 0.351 . . . . 0.0 110.979 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.13 -4.01 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.246 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.762 ' HB3' ' HB2' ' A' ' 111' ' ' PHE . 74.3 m -119.93 67.74 0.83 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.812 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.748 ' HD3' ' H ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -80.2 -36.34 35.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 -179.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -89.04 -5.0 58.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.762 ' HB2' ' HB3' ' A' ' 108' ' ' CYS . 4.2 m-85 -83.81 5.08 26.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.744 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.75 37.55 13.35 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.783 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.898 ' HA ' HG13 ' A' ' 118' ' ' ILE . 2.3 tm? -33.88 105.21 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.319 0.58 . . . . 0.0 111.327 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.496 ' OD1' HG12 ' A' ' 116' ' ' ILE . 10.3 t70 -160.5 156.05 25.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.754 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.668 ' HA ' ' HB2' ' A' ' 119' ' ' ASP . 10.7 p-10 -64.19 -7.73 10.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.067 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.496 HG12 ' OD1' ' A' ' 114' ' ' ASP . 49.0 mm -80.66 -64.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.586 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -91.69 -68.26 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.898 HG13 ' HA ' ' A' ' 113' ' ' LEU . 48.5 mm -48.17 -19.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.257 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.668 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 8.8 t70 -78.12 -59.1 2.92 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 124' ' ' GLU . 34.8 t70 -59.52 -17.15 29.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.775 ' HA ' ' HB3' ' A' ' 124' ' ' GLU . 25.2 ttp -64.27 -42.66 96.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.577 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.613 HG22 ' HA3' ' A' ' 131' ' ' GLY . 53.8 mt -54.89 -49.33 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.84 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.654 ' HA ' ' HE3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -76.92 -13.27 60.0 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.513 178.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.775 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 40.3 tp10 -84.06 -25.44 29.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.262 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.05 HG22 HD11 ' A' ' 133' ' ' ILE . 31.2 mt -107.41 -15.74 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 1.01 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . 1.9 t70 -77.76 82.74 4.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.025 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.812 HE21 ' HD3' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -88.63 -9.36 52.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.663 179.38 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.751 ' HB2' ' HG3' ' A' ' 153' ' ' ARG . 45.0 t0 -116.15 -35.49 4.36 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.694 ' ND2' ' H ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -179.97 -84.82 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.694 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 34.8 t70 -65.36 15.78 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -172.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 1.01 ' HA2' ' HB2' ' A' ' 126' ' ' ASP . . . 56.56 38.85 83.27 Favored Glycine 0 CA--C 1.509 -0.313 0 C-N-CA 117.223 -2.417 . . . . 0.0 109.193 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.638 ' HG2' ' HB3' ' A' ' 130' ' ' ASP . 7.4 pt20 -134.61 167.4 20.88 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 113.461 -1.369 . . . . 0.0 108.692 -177.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.05 HD11 HG22 ' A' ' 125' ' ' ILE . 5.8 mm -129.14 125.26 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.856 0 CA-C-O 122.26 1.028 . . . . 0.0 111.532 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 1.001 ' H ' ' HB2' ' A' ' 137' ' ' GLU . 6.4 t70 -103.14 152.09 21.83 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.969 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.69 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 17.1 t80 -40.96 -42.68 1.93 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.749 0.309 . . . . 0.0 110.931 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 139' ' ' ALA . . . -82.77 -28.53 38.1 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.883 178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 1.001 ' HB2' ' H ' ' A' ' 134' ' ' ASP . 31.9 mt-10 -68.92 -59.07 3.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.672 ' CE2' ' HB3' ' A' ' 87' ' ' ALA . 13.4 t80 -50.41 -18.53 0.66 Allowed 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.392 0.615 . . . . 0.0 109.776 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 136' ' ' GLY . . . -78.48 -40.21 36.08 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.519 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' A' ' 144' ' ' LYS . . . -90.13 -12.8 37.22 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.703 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.49 ' HG2' ' CD1' ' A' ' 138' ' ' PHE . 4.9 ppp? -55.8 -27.68 52.36 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.735 0.302 . . . . 0.0 111.238 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -102.3 -21.03 14.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 110.227 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 63.1 mtt85 -144.15 73.37 1.38 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.162 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.801 ' H ' ' HD3' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -89.31 -85.43 0.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.496 -179.393 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.762 ' H ' ' HG2' ' A' ' 144' ' ' LYS . 73.3 mtp180 -77.36 23.35 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.769 0.319 . . . . 0.0 110.756 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.439 ' H ' ' C ' ' A' ' 144' ' ' LYS . 61.9 tttp -58.93 -87.17 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.671 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -57.9 -60.9 8.13 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -132.55 110.65 10.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 0.0 110.279 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 145' ' ' ARG . . . -60.18 -23.48 59.8 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.085 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -46.17 -26.06 2.08 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.454 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.597 HG21 ' NH1' ' A' ' 157' ' ' ARG . 12.9 mt -119.47 -109.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 117.032 0.416 . . . . 0.0 111.344 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 151' ' ' ILE . . . 111.96 -128.07 8.4 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.812 ' HD3' HE21 ' A' ' 127' ' ' GLN . 6.0 ptt180 -91.93 131.56 37.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.346 0.594 . . . . 0.0 109.536 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.656 ' HB3' ' HG2' ' A' ' 157' ' ' ARG . 79.9 ttt180 -130.82 150.15 52.12 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.432 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.9 t -47.95 -17.4 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.713 0.292 . . . . 0.0 110.91 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.4 ' N ' ' C ' ' A' ' 154' ' ' ARG . 16.6 tpt -160.59 93.91 1.03 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.252 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.656 ' HG2' ' HB3' ' A' ' 154' ' ' ARG . 23.7 mmm180 -105.68 139.44 40.27 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.825 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -84.79 -179.65 7.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.898 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 56.6 m -92.96 153.7 18.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.548 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.69 HD23 ' H ' ' A' ' 160' ' ' LEU . 2.0 pt? -131.98 -170.79 2.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.97 0.414 . . . . 0.0 111.308 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -75.01 166.27 23.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.737 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 80.2 mt -90.3 172.15 8.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.915 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.487 ' HG2' ' N ' ' A' ' 164' ' ' ASP . 71.5 ttt180 -123.62 157.14 34.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.487 ' N ' ' HG2' ' A' ' 163' ' ' ARG . 57.2 m-20 -107.58 107.3 18.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.634 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.55 158.06 3.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.372 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.82 HD23 ' H ' ' A' ' 166' ' ' LEU . 2.4 pt? -114.21 6.38 16.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.772 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -105.69 108.93 3.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.353 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 168' ' ' LEU . 2.8 mm? -103.36 132.35 49.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.357 . . . . 0.0 110.897 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.9 m -67.1 153.98 8.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -161.4 134.84 6.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.784 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.561 HD22 ' N ' ' A' ' 172' ' ' GLY . 0.0 OUTLIER -110.52 -11.14 14.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.308 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.561 ' N ' HD22 ' A' ' 171' ' ' ASN . . . 69.37 -129.02 22.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.564 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.4 t -128.41 153.29 47.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.349 . . . . 0.0 111.084 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -155.25 138.26 15.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.823 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -75.83 121.87 23.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.963 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 62.4 t -107.62 119.46 57.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.094 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 12.0 tt -91.19 125.32 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.975 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -87.26 127.56 35.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -160.34 158.83 30.26 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.533 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.452 ' HD1' ' N ' ' A' ' 181' ' ' PHE . 0.2 OUTLIER -60.15 -23.86 64.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.734 0.302 . . . . 0.0 111.413 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.452 ' N ' ' HD1' ' A' ' 180' ' ' TYR . 4.1 m-85 -123.06 101.41 7.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.871 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.845 179.873 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_